data_2m56_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m56 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.473 ' HA ' HD11 ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.452 HD11 HG13 ' A' ' 18' ' ' VAL . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.88 ' HG2' HG23 ' A' ' 18' ' ' VAL . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.88 HG23 ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.488 ' HA ' HD23 ' A' ' 22' ' ' LEU . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.415 ' CE2' HG23 ' A' ' 50' ' ' VAL . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.503 ' HE1' HD12 ' A' ' 395' ' ' ILE . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.432 ' HA ' HD12 ' A' ' 34' ' ' LEU . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 39' ' ' GLN . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.514 ' N ' HG12 ' A' ' 38' ' ' VAL . 1.6 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.457 ' O ' HG21 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.423 ' HE3' HD13 ' A' ' 324' ' ' LEU . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.457 HG21 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.49 ' HB3' HG21 ' A' ' 66' ' ' THR . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.412 ' ND2' HG22 ' A' ' 50' ' ' VAL . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.608 HG13 ' HD2' ' A' ' 51' ' ' PRO . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.608 ' HD2' HG13 ' A' ' 50' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.438 HG21 ' HB ' ' A' ' 64' ' ' ILE . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.594 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.8 m120 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.594 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.438 ' HB ' HG21 ' A' ' 54' ' ' VAL . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.49 HG21 ' HB3' ' A' ' 45' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.436 HD11 ' N ' ' A' ' 70' ' ' LEU . 6.0 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.4 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.401 ' HB3' HD12 ' A' ' 320' ' ' LEU . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.462 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.6 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.493 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 26.6 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.4 mtt-85 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.8 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.62 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.1 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.54 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.54 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.754 ' HD2' ' HB2' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.754 ' HB2' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.694 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.927 HD12 ' NE ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.623 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 67.8 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.623 ' OG1' ' HD2' ' A' ' 100' ' ' PRO . 3.9 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.508 ' HE1' HD13 ' A' ' 99' ' ' ILE . 45.3 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.576 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.298 63.0 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.493 ' HD2' ' CD1' ' A' ' 78' ' ' TYR 0.367 53.3 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.576 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 33.9 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.496 ' H ' ' CD ' ' A' ' 106' ' ' PRO 0.409 34.0 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . 0.462 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 1.6 tm0? -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 12.9 mtp180 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.414 ' HA ' ' CE2' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.473 HD22 ' HE1' ' A' ' 241' ' ' MET . 38.0 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.409 HG21 HG11 ' A' ' 119' ' ' VAL . 25.2 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.409 HG11 HG21 ' A' ' 118' ' ' VAL . 27.3 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.489 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.672 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 17.7 mtm -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.672 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.1 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.541 HG13 HD11 ' A' ' 166' ' ' LEU . 72.7 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 45.4 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.475 HD13 HG12 ' A' ' 123' ' ' VAL . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.488 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.506 ' HA ' HD11 ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.615 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.577 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.488 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.782 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.782 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.465 HD11 HG22 ' A' ' 160' ' ' ILE . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.467 ' HA ' HD13 ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.429 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.541 HD11 HG13 ' A' ' 123' ' ' VAL . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.506 ' N ' HD21 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.44 HD21 ' HA ' ' A' ' 169' ' ' LEU . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.417 ' N ' ' CD ' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.566 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.523 ' HA ' HD22 ' A' ' 180' ' ' LEU . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' MET . . . . . 0.499 ' HE2' HG22 ' A' ' 247' ' ' VAL . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.421 HD13 HD13 ' A' ' 180' ' ' LEU . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . 0.441 ' HB3' ' HG ' ' A' ' 221' ' ' SER . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 211' ' ' ARG . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 224' ' ' ALA . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' SER . . . . . 0.441 ' HG ' ' HB3' ' A' ' 211' ' ' ARG . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 42.7 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 42.0 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 220' ' ' ILE . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . 0.455 ' HA3' HD13 ' A' ' 114' ' ' LEU . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 6.2 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 1.3 m120 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 17.1 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . 0.927 ' NE ' HD12 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' MET . . . . . 0.473 ' HE1' HD22 ' A' ' 114' ' ' LEU . 34.2 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.694 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.423 ' HA ' HD22 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.499 HG22 ' HE2' ' A' ' 184' ' ' MET . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 250' ' ' LEU . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.675 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.469 HD22 ' HA ' ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' MET . . . . . 0.577 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.428 HD22 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 16.4 pm0 -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.434 ' N ' ' CD ' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 281' ' ' ILE . 45.4 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' CYS . . . . . 0.422 ' SG ' HG21 ' A' ' 367' ' ' ILE . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . 0.433 HD23 HG21 ' A' ' 349' ' ' THR . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . 0.497 ' CZ ' ' HE1' ' A' ' 336' ' ' MET . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.641 ' HA ' ' HE1' ' A' ' 323' ' ' MET . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 296' ' ' ALA . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . 0.424 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . 0.424 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.7 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.535 HD23 ' N ' ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' PHE . . . . . 0.424 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.6 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' HIS . . . . . 0.424 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 36.9 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 312' ' ' LEU . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' LEU . . . . . 0.63 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' PRO . . . . . 0.63 ' HD3' ' O ' ' A' ' 319' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' MET . . . . . 0.641 ' HE1' ' HA ' ' A' ' 294' ' ' LEU . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.456 HD11 ' HB2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 13.7 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' LEU . . . . . . . . . . . . . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.472 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' PRO . . . . . 0.472 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' MET . . . . . 0.497 ' HE1' ' CZ ' ' A' ' 291' ' ' ARG . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' ARG . . . . . 0.434 ' HB3' HG23 ' A' ' 345' ' ' VAL . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' LYS . . . . . 0.52 ' HD3' ' N ' ' A' ' 344' ' ' LYS . 1.8 mppt? -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.434 HG23 ' HB3' ' A' ' 342' ' ' ARG . 61.0 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 1.1 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 15.8 p80 -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 17.1 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' THR . . . . . 0.433 HG21 HD23 ' A' ' 289' ' ' LEU . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 90.8 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.42 ' HA ' HD12 ' A' ' 362' ' ' LEU . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 7.7 mtm180 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 17.2 tpp85 -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . 0.422 HG21 ' SG ' ' A' ' 285' ' ' CYS . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.1 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.485 HD12 HG23 ' A' ' 383' ' ' ILE . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' ILE . . . . . 0.403 HD11 HD12 ' A' ' 402' ' ' LEU . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.503 HD12 ' HE1' ' A' ' 28' ' ' MET . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . 0.403 HD12 HD11 ' A' ' 389' ' ' ILE . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' LEU . . . . . 0.404 ' HA ' HD22 ' A' ' 404' ' ' LEU . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 407' ' ' ASP . . . . . 0.544 ' HB3' HG23 ' A' ' 410' ' ' THR . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 408' ' ' PRO . . . . . 0.645 ' HA ' HG22 ' A' ' 411' ' ' THR . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 410' ' ' THR . . . . . 0.544 HG23 ' HB3' ' A' ' 407' ' ' ASP . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 411' ' ' THR . . . . . 0.645 HG22 ' HA ' ' A' ' 408' ' ' PRO . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 412' ' ' LYS . . . . . 0.496 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 39.6 m . . . . . 0 N--CA 1.496 1.832 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.51 138.6 38.5 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.234 -0.916 . . . . 0.0 112.92 -178.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 61.4 t -137.15 122.57 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.438 HG13 ' CZ ' ' B' ' 12' ' ' ARG . 98.5 t -106.82 129.59 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.124 -0.985 . . . . 0.0 111.625 -178.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.478 ' HH ' HD23 ' B' ' 23' ' ' LEU . 77.2 m-85 -109.18 110.6 21.87 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.82 127.19 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.93 -1.107 . . . . 0.0 108.343 178.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.2 m -86.15 174.68 8.98 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.789 0.804 . . . . 0.0 112.472 -177.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' HIS . . . . . 0.405 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.68 -46.69 89.39 Favored 'General case' 0 N--CA 1.503 2.18 0 CA-C-O 121.141 0.496 . . . . 0.0 110.453 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -65.94 -11.29 46.41 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.596 -0.69 . . . . 0.0 111.393 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.99 15.49 28.34 Favored Glycine 0 N--CA 1.493 2.441 0 O-C-N 121.174 -0.954 . . . . 0.0 111.238 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.6 m -82.12 147.37 29.1 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 118.789 1.295 . . . . 0.0 109.903 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . 0.438 ' CZ ' HG13 ' B' ' 4' ' ' VAL . 50.8 ttt85 -118.42 128.72 54.89 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.454 -0.779 . . . . 0.0 111.883 -178.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.99 127.64 46.22 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.595 -0.69 . . . . 0.0 109.843 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -111.28 130.6 55.61 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.281 -0.887 . . . . 0.0 111.632 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 84.6 mt -122.72 159.4 28.05 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.752 -0.592 . . . . 0.0 111.082 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -109.64 91.64 3.73 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 176.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.6 t -90.17 133.39 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.571 0.7 . . . . 0.0 112.314 -176.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.07 170.67 16.11 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.788 -0.57 . . . . 0.0 110.251 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -68.45 151.8 46.31 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.535 -0.728 . . . . 0.0 111.0 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.48 -12.52 55.44 Favored Glycine 0 N--CA 1.495 2.602 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.065 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 59.3 t -89.93 133.34 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 120.699 -1.471 . . . . 0.0 110.951 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 22.1 p -80.26 151.97 29.31 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.478 HD23 ' HH ' ' B' ' 5' ' ' TYR . 18.4 mt -61.24 -24.59 66.47 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.316 -0.865 . . . . 0.0 110.618 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 8.8 tmm? -69.76 -49.23 55.0 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.2 -0.938 . . . . 0.0 109.497 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -59.91 -41.62 92.12 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.56 -0.713 . . . . 0.0 109.895 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.07 -40.89 95.33 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.655 -0.653 . . . . 0.0 110.169 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.35 -49.71 58.39 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.219 -0.926 . . . . 0.0 111.058 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 53.8 t -65.42 -39.25 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.298 -0.876 . . . . 0.0 110.711 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 24.0 m -70.01 -14.12 62.55 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.325 -0.859 . . . . 0.0 111.557 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -118.15 23.78 11.39 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.036 -1.04 . . . . 0.0 110.691 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.81 38.21 59.1 Favored Glycine 0 N--CA 1.493 2.454 0 O-C-N 121.527 -0.733 . . . . 0.0 111.83 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -72.53 147.11 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.847 -1.384 . . . . 0.0 108.874 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -62.63 142.43 58.05 Favored 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 117.201 2.297 . . . . 0.0 117.201 -174.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . 0.427 ' O ' ' HG3' ' B' ' 105' ' ' GLN . 65.2 m-20 62.25 -36.14 0.12 Allowed 'General case' 0 N--CA 1.516 2.833 0 N-CA-C 116.66 2.096 . . . . 0.0 116.66 175.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 54.3 mt -59.76 122.89 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.419 0 O-C-N 119.89 -1.756 . . . . 0.0 110.62 -178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.659 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 96.5 t -100.13 -51.36 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.695 -0.628 . . . . 0.0 111.183 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.13 56.4 20.67 Favored Glycine 0 N--CA 1.499 2.873 0 N-CA-C 107.491 -2.244 . . . . 0.0 107.491 -178.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -71.27 -49.23 45.17 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.994 -0.709 . . . . 0.0 112.34 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' CYS . . . . . 0.539 ' HB3' ' HB3' ' B' ' 45' ' ' CYS . 2.3 p -66.6 -10.48 46.15 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.215 -0.928 . . . . 0.0 112.332 -178.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.87 -5.57 63.92 Favored Glycine 0 N--CA 1.498 2.804 0 O-C-N 120.787 -1.195 . . . . 0.0 111.968 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.17 19.5 10.63 Favored Glycine 0 N--CA 1.495 2.605 0 O-C-N 120.803 -1.41 . . . . 0.0 111.002 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 80.6 p -98.97 19.21 15.49 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.028 -1.278 . . . . 0.0 111.132 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.92 40.89 30.46 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.4 -0.812 . . . . 0.0 111.941 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 3.6 t -117.02 11.14 14.18 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.376 -0.828 . . . . 0.0 109.518 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' CYS . . . . . 0.539 ' HB3' ' HB3' ' B' ' 39' ' ' CYS . 15.1 p -149.53 -179.11 6.84 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.05 34.04 3.11 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.803 -1.186 . . . . 0.0 111.367 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' THR . . . . . 0.659 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 23.4 p -97.59 13.24 30.78 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.933 -1.105 . . . . 0.0 111.276 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' CYS . . . . . 0.45 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.1 p -120.58 31.77 6.3 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 177.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . 0.464 ' NE2' ' HB3' ' B' ' 82' ' ' SER . 6.5 t-160 -72.65 132.99 44.43 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.642 -178.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . 0.472 HG23 ' HB3' ' B' ' 85' ' ' CYS . 12.2 m -146.21 160.1 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . 0.4 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.3 m-85 -105.43 102.71 12.17 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.238 -0.914 . . . . 0.0 108.706 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.4 t -61.87 135.13 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.282 -0.886 . . . . 0.0 109.369 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.67 131.74 51.16 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.954 0.883 . . . . 0.0 109.518 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -44.26 -31.08 0.91 Allowed 'General case' 0 N--CA 1.507 2.384 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -178.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.78 -6.88 54.07 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 120.963 -1.086 . . . . 0.0 112.752 -178.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -119.9 -6.73 10.04 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.46 -1.4 . . . . 0.0 111.886 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.4 p -55.45 -37.75 68.13 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.174 -0.954 . . . . 0.0 112.863 -178.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -81.2 -6.62 59.06 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.741 -1.225 . . . . 0.0 111.453 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -89.84 -11.67 41.31 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.045 -1.034 . . . . 0.0 109.859 178.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.616 HG12 ' HD2' ' B' ' 61' ' ' PRO . 40.9 t -104.07 141.04 21.7 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . 0.616 ' HD2' HG12 ' B' ' 60' ' ' VAL . 49.9 Cg_endo -73.74 118.88 5.63 Favored 'Trans proline' 0 N--CA 1.488 1.18 0 O-C-N 123.509 1.268 . . . . 0.0 109.029 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.94 160.59 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.762 0 N-CA-C 116.65 2.092 . . . . 0.0 116.65 -177.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . 0.437 ' HB2' ' HB3' ' B' ' 67' ' ' GLU . . . -65.76 146.18 55.09 Favored 'General case' 0 N--CA 1.503 2.182 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.258 178.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -89.81 -170.76 2.92 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.606 -0.684 . . . . 0.0 110.383 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -59.59 -41.96 91.46 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.337 -0.852 . . . . 0.0 111.705 -178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.46 -41.6 84.4 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.186 -0.946 . . . . 0.0 111.969 -178.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . 0.492 ' HG3' HD11 ' B' ' 84' ' ' LEU . 45.6 tt0 -68.22 -43.96 76.82 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.005 -1.059 . . . . 0.0 110.298 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' ILE . . . . . 0.502 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.6 mm -55.52 -42.22 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.311 -0.868 . . . . 0.0 109.359 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.25 -47.78 81.3 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 26.9 mmt -66.26 -33.91 76.8 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.268 -1.137 . . . . 0.0 111.17 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' LEU . . . . . 0.468 HD22 ' HA ' ' B' ' 71' ' ' LEU . 27.5 mt -63.49 -23.35 67.36 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.207 -0.933 . . . . 0.0 110.623 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . 0.502 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 41.1 mt-10 -70.41 -8.74 53.13 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.354 -0.842 . . . . 0.0 110.911 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 73.5 p -119.82 12.53 12.14 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.009 -1.057 . . . . 0.0 112.504 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 34.9 m -60.78 140.45 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 120.745 -1.222 . . . . 0.0 109.622 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 36.6 m -74.58 -39.06 62.47 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.393 -0.817 . . . . 0.0 110.181 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.2 168.82 17.43 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.47 -0.769 . . . . 0.0 110.094 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.27 139.14 55.67 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.392 -0.818 . . . . 0.0 110.609 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.2 tp -91.02 116.13 28.55 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.489 -0.757 . . . . 0.0 109.869 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -102.97 168.29 9.02 Favored Pre-proline 0 C--N 1.301 -1.518 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -76.62 -0.01 10.02 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 123.243 1.128 . . . . 0.0 110.401 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -120.46 22.36 11.3 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.898 -1.126 . . . . 0.0 108.399 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' SER . . . . . 0.464 ' HB3' ' NE2' ' B' ' 49' ' ' HIS . 4.3 m -80.81 137.19 36.21 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.861 -0.524 . . . . 0.0 110.362 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.4 mmm-85 -149.75 146.38 27.16 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.487 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.492 HD11 ' HG3' ' B' ' 67' ' ' GLU . 97.5 mt -80.54 98.95 7.82 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 175.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' CYS . . . . . 0.472 ' HB3' HG23 ' B' ' 50' ' ' VAL . 10.6 p -48.41 -17.86 0.18 Allowed 'General case' 0 N--CA 1.508 2.455 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -175.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.8 p -70.27 -14.01 62.42 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.616 -1.302 . . . . 0.0 109.464 178.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -92.7 -12.21 32.04 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.453 -0.779 . . . . 0.0 110.53 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' ILE . . . . . 0.468 HG21 HD13 ' B' ' 23' ' ' LEU . 61.8 mt -91.51 103.96 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.133 -0.979 . . . . 0.0 110.609 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 47.6 mm -84.96 131.79 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' MET . . . . . 0.428 ' C ' HG22 ' B' ' 91' ' ' THR . 13.6 tpt -74.84 137.8 42.08 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 122.164 0.983 . . . . 0.0 113.189 -177.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' THR . . . . . 0.428 HG22 ' C ' ' B' ' 90' ' ' MET . 43.7 p -138.25 166.59 24.63 Favored Pre-proline 0 N--CA 1.49 1.548 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 176.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -74.88 1.66 7.42 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 122.638 0.809 . . . . 0.0 111.035 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -87.65 -22.83 24.47 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.5 mt -93.72 12.96 23.75 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.465 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.52 126.44 23.6 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.184 -0.948 . . . . 0.0 111.15 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.21 6.81 68.46 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.66 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.58 142.74 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 CA-C-N 119.325 1.563 . . . . 0.0 110.768 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 60.7 t -122.5 132.98 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.501 -0.749 . . . . 0.0 109.831 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 99' ' ' VAL . . . . . 0.432 ' O ' HG23 ' B' ' 99' ' ' VAL . 16.3 m -130.35 135.71 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.479 -0.763 . . . . 0.0 109.882 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 100' ' ' ASP . . . . . 0.4 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.34 134.16 35.18 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.1 t -103.46 127.32 29.85 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.545 -0.722 . . . . 0.0 110.32 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -80.85 130.93 7.81 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 O-C-N 124.114 1.586 . . . . 0.0 108.267 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' ASP . . . . . 0.405 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.4 p-10 -62.33 3.33 0.19 Allowed 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -178.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 4.0 mtm105 -125.29 114.71 19.29 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.306 -1.496 . . . . 0.0 110.064 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 105' ' ' GLN . . . . . 0.491 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 23.2 mm-40 -113.39 -49.36 2.9 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.486 -0.759 . . . . 0.0 109.969 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' TRP . . . . . 0.414 ' CE2' ' HA ' ' A' ' 113' ' ' ALA . 27.3 m95 . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.521 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.473 ' HA ' HD11 ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.452 HD11 HG13 ' A' ' 18' ' ' VAL . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.88 ' HG2' HG23 ' A' ' 18' ' ' VAL . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.88 HG23 ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.488 ' HA ' HD23 ' A' ' 22' ' ' LEU . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.415 ' CE2' HG23 ' A' ' 50' ' ' VAL . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.503 ' HE1' HD12 ' A' ' 395' ' ' ILE . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.432 ' HA ' HD12 ' A' ' 34' ' ' LEU . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 39' ' ' GLN . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.514 ' N ' HG12 ' A' ' 38' ' ' VAL . 1.6 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.457 ' O ' HG21 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.423 ' HE3' HD13 ' A' ' 324' ' ' LEU . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.457 HG21 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.49 ' HB3' HG21 ' A' ' 66' ' ' THR . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.412 ' ND2' HG22 ' A' ' 50' ' ' VAL . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.608 HG13 ' HD2' ' A' ' 51' ' ' PRO . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.608 ' HD2' HG13 ' A' ' 50' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.438 HG21 ' HB ' ' A' ' 64' ' ' ILE . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.594 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.8 m120 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.594 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.438 ' HB ' HG21 ' A' ' 54' ' ' VAL . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.49 HG21 ' HB3' ' A' ' 45' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.436 HD11 ' N ' ' A' ' 70' ' ' LEU . 6.0 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.4 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.462 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.5 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.41 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 27.0 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.62 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.2 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.54 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.54 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.754 ' HD2' ' HB2' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.754 ' HB2' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.694 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.927 HD12 ' NE ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.631 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 67.6 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.631 ' OG1' ' HD2' ' A' ' 100' ' ' PRO . 3.8 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.508 ' HE1' HD13 ' A' ' 99' ' ' ILE . 46.0 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.614 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.296 50.2 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.456 ' HA ' ' HB3' ' A' ' 108' ' ' GLN 0.366 52.9 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.614 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 35.0 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.469 ' H ' ' CD ' ' A' ' 106' ' ' PRO 0.413 34.1 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . 0.456 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 1.6 tm0? -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 8.6 mtp180 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.464 ' HB2' ' CE3' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.438 HD13 ' HA3' ' A' ' 226' ' ' GLY . 24.5 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.1 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.6 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.489 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.672 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 21.5 mtm -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.672 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.1 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.453 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 72.0 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.7 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.453 ' HD2' ' HA ' ' A' ' 123' ' ' VAL . 35.6 mttt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.488 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.506 ' HA ' HD11 ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.615 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.577 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.488 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.782 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.782 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.465 HD11 HG22 ' A' ' 160' ' ' ILE . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.467 ' HA ' HD13 ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.429 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.513 ' C ' HD21 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.506 ' N ' HD21 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.44 HD21 ' HA ' ' A' ' 169' ' ' LEU . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.417 ' N ' ' CD ' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.566 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.523 ' HA ' HD22 ' A' ' 180' ' ' LEU . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' MET . . . . . 0.499 ' HE2' HG22 ' A' ' 247' ' ' VAL . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.421 HD13 HD13 ' A' ' 180' ' ' LEU . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . 0.441 ' HB3' ' HG ' ' A' ' 221' ' ' SER . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 211' ' ' ARG . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 224' ' ' ALA . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' SER . . . . . 0.441 ' HG ' ' HB3' ' A' ' 211' ' ' ARG . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 33.3 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 53.1 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 220' ' ' ILE . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . 0.438 ' HA3' HD13 ' A' ' 114' ' ' LEU . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 4.6 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 1.3 m120 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 18.1 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . 0.927 ' NE ' HD12 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 45.3 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.694 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.423 ' HA ' HD22 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.499 HG22 ' HE2' ' A' ' 184' ' ' MET . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 250' ' ' LEU . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.675 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.469 HD22 ' HA ' ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' MET . . . . . 0.577 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.428 HD22 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.433 ' N ' ' CD ' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' CYS . . . . . 0.422 ' SG ' HG21 ' A' ' 367' ' ' ILE . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . 0.433 HD23 HG21 ' A' ' 349' ' ' THR . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . 0.497 ' CZ ' ' HE1' ' A' ' 336' ' ' MET . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.641 ' HA ' ' HE1' ' A' ' 323' ' ' MET . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 296' ' ' ALA . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . 0.424 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . 0.424 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.1 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.535 HD23 ' N ' ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' PHE . . . . . 0.424 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.6 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' HIS . . . . . 0.424 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 36.9 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 312' ' ' LEU . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' LEU . . . . . 0.63 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' PRO . . . . . 0.63 ' HD3' ' O ' ' A' ' 319' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' MET . . . . . 0.641 ' HE1' ' HA ' ' A' ' 294' ' ' LEU . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.456 HD11 ' HB2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 13.7 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' LEU . . . . . . . . . . . . . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.472 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' PRO . . . . . 0.472 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' MET . . . . . 0.497 ' HE1' ' CZ ' ' A' ' 291' ' ' ARG . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' LYS . . . . . 0.513 ' HD3' ' N ' ' A' ' 344' ' ' LYS . 0.9 OUTLIER -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 60.7 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 10.6 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 39.9 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' THR . . . . . 0.433 HG21 HD23 ' A' ' 289' ' ' LEU . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' SER . . . . . 0.428 ' HA ' ' HB3' ' B' ' 44' ' ' SER . 97.5 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.42 ' HA ' HD12 ' A' ' 362' ' ' LEU . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 44.0 mtt85 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . 0.422 HG21 ' SG ' ' A' ' 285' ' ' CYS . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.485 HD12 HG23 ' A' ' 383' ' ' ILE . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' ILE . . . . . 0.403 HD11 HD12 ' A' ' 402' ' ' LEU . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.503 HD12 ' HE1' ' A' ' 28' ' ' MET . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . 0.403 HD12 HD11 ' A' ' 389' ' ' ILE . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' LEU . . . . . 0.404 ' HA ' HD22 ' A' ' 404' ' ' LEU . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 407' ' ' ASP . . . . . 0.544 ' HB3' HG23 ' A' ' 410' ' ' THR . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 408' ' ' PRO . . . . . 0.645 ' HA ' HG22 ' A' ' 411' ' ' THR . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 410' ' ' THR . . . . . 0.544 HG23 ' HB3' ' A' ' 407' ' ' ASP . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 411' ' ' THR . . . . . 0.645 HG22 ' HA ' ' A' ' 408' ' ' PRO . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 412' ' ' LYS . . . . . 0.496 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 39.7 m . . . . . 0 N--CA 1.495 1.805 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.49 138.61 38.52 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.246 -0.909 . . . . 0.0 112.958 -178.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 61.0 t -137.16 122.52 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 177.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.427 HG13 ' CZ ' ' B' ' 12' ' ' ARG . 97.9 t -106.74 129.56 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.093 -1.004 . . . . 0.0 111.636 -178.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.547 ' CD1' HD11 ' B' ' 32' ' ' ILE . 77.2 m-85 -109.23 110.58 21.83 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.8 127.27 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 120.93 -1.106 . . . . 0.0 108.377 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.7 m -86.21 174.64 8.97 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.766 0.793 . . . . 0.0 112.498 -177.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' HIS . . . . . 0.421 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.6 -46.75 89.09 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.186 0.517 . . . . 0.0 110.472 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.2 p-10 -65.92 -11.28 46.04 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.583 -0.698 . . . . 0.0 111.419 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.98 15.51 28.3 Favored Glycine 0 N--CA 1.493 2.459 0 O-C-N 121.195 -0.941 . . . . 0.0 111.256 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.6 m -82.1 147.41 29.1 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 118.721 1.26 . . . . 0.0 109.884 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . 0.427 ' CZ ' HG13 ' B' ' 4' ' ' VAL . 50.8 ttt85 -118.52 128.78 54.91 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.508 -0.745 . . . . 0.0 111.816 -178.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.07 127.72 46.27 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.623 -0.673 . . . . 0.0 109.79 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -111.26 130.62 55.6 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.284 -0.885 . . . . 0.0 111.617 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.689 HD11 HD13 ' B' ' 32' ' ' ILE . 84.4 mt -122.83 159.37 28.28 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.357 0.598 . . . . 0.0 111.08 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -109.64 91.67 3.74 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.7 t -90.22 133.49 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-O 121.654 0.74 . . . . 0.0 112.258 -176.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.13 170.67 16.12 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.766 -0.584 . . . . 0.0 110.242 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -68.45 151.83 46.27 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.5 -0.75 . . . . 0.0 110.954 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.42 -12.45 55.43 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.046 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 61.8 t -89.99 133.35 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 120.654 -1.498 . . . . 0.0 110.904 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 21.6 p -80.28 151.92 29.3 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.593 -0.692 . . . . 0.0 109.143 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.479 HD23 ' HH ' ' B' ' 5' ' ' TYR . 18.4 mt -61.19 -24.64 66.47 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.29 -0.881 . . . . 0.0 110.618 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 7.7 ttp -69.71 -49.26 55.05 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.263 -0.898 . . . . 0.0 109.489 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.82 -41.67 91.8 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.562 -0.711 . . . . 0.0 109.937 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.11 -40.89 95.17 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.552 -0.718 . . . . 0.0 110.114 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.31 -49.76 58.18 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.2 -0.937 . . . . 0.0 111.066 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 76.8 t -65.42 -39.17 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.317 -0.864 . . . . 0.0 110.755 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 20.5 t -70.09 -14.06 62.49 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.383 -0.823 . . . . 0.0 111.529 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -118.18 23.85 11.34 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.065 -1.022 . . . . 0.0 110.661 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.7 38.24 58.59 Favored Glycine 0 N--CA 1.493 2.481 0 O-C-N 121.55 -0.719 . . . . 0.0 111.871 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.689 HD13 HD11 ' B' ' 15' ' ' LEU . 0.4 OUTLIER -72.54 147.21 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.792 -1.416 . . . . 0.0 108.892 179.002 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -62.72 142.48 58.11 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 117.202 2.297 . . . . 0.0 117.202 -174.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 62.29 -36.21 0.12 Allowed 'General case' 0 N--CA 1.515 2.787 0 N-CA-C 116.59 2.07 . . . . 0.0 116.59 175.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.8 mt -59.67 122.85 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.395 0 O-C-N 119.828 -1.795 . . . . 0.0 110.718 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.664 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 90.7 t -100.12 -51.4 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.616 -0.678 . . . . 0.0 111.196 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.16 56.41 20.55 Favored Glycine 0 N--CA 1.499 2.873 0 N-CA-C 107.482 -2.247 . . . . 0.0 107.482 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -71.22 -49.33 44.56 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.942 -0.74 . . . . 0.0 112.325 -177.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' CYS . . . . . 0.542 ' HB3' ' HB3' ' B' ' 45' ' ' CYS . 2.3 p -66.55 -10.46 45.39 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.244 -0.91 . . . . 0.0 112.389 -178.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.82 -5.47 64.01 Favored Glycine 0 N--CA 1.499 2.846 0 O-C-N 120.842 -1.161 . . . . 0.0 111.959 177.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.14 19.52 10.63 Favored Glycine 0 N--CA 1.495 2.569 0 O-C-N 120.845 -1.385 . . . . 0.0 110.974 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 14.0 m -98.95 19.12 15.62 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.033 -1.275 . . . . 0.0 111.148 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.97 40.89 30.35 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.418 -0.801 . . . . 0.0 111.892 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' SER . . . . . 0.428 ' HB3' ' HA ' ' A' ' 354' ' ' SER . 37.4 m -117.05 11.22 14.17 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.345 -0.847 . . . . 0.0 109.523 178.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' CYS . . . . . 0.542 ' HB3' ' HB3' ' B' ' 39' ' ' CYS . 15.1 p -149.54 -179.05 6.78 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.09 34.11 3.09 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.85 -1.156 . . . . 0.0 111.345 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' THR . . . . . 0.664 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 16.9 p -97.63 13.23 30.88 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.947 -1.096 . . . . 0.0 111.243 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' CYS . . . . . 0.452 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.1 p -120.57 31.75 6.31 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . 0.42 ' O ' HG13 ' B' ' 50' ' ' VAL . 12.6 t-160 -72.67 133.07 44.45 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.63 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . 0.474 HG23 ' HB3' ' B' ' 85' ' ' CYS . 12.3 m -146.33 160.11 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 178.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . 0.403 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.6 m-85 -105.43 102.75 12.2 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.244 -0.91 . . . . 0.0 108.674 178.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.2 t -61.93 135.17 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.226 -0.921 . . . . 0.0 109.351 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.69 131.76 51.24 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.975 0.893 . . . . 0.0 109.539 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -44.33 -30.98 0.91 Allowed 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -178.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.78 -6.97 54.47 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.982 -1.074 . . . . 0.0 112.75 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -119.87 -6.71 10.06 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.492 -1.38 . . . . 0.0 111.887 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.4 p -55.39 -37.83 68.08 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 121.136 -0.978 . . . . 0.0 112.815 -178.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -81.13 -6.69 59.12 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 120.724 -1.235 . . . . 0.0 111.484 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -89.78 -11.67 41.47 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.974 -1.078 . . . . 0.0 109.878 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.62 HG12 ' HD2' ' B' ' 61' ' ' PRO . 40.9 t -104.08 141.07 21.75 Favored Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . 0.62 ' HD2' HG12 ' B' ' 60' ' ' VAL . 49.9 Cg_endo -73.8 118.87 5.62 Favored 'Trans proline' 0 N--CA 1.488 1.192 0 O-C-N 123.543 1.286 . . . . 0.0 109.016 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.91 160.64 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.759 0 N-CA-C 116.62 2.081 . . . . 0.0 116.62 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' B' ' 67' ' ' GLU . . . -65.82 146.19 55.06 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.253 178.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -89.79 -170.78 2.93 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.628 -0.67 . . . . 0.0 110.4 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -59.47 -42.07 91.18 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.31 -0.868 . . . . 0.0 111.716 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -41.47 84.5 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.171 -0.955 . . . . 0.0 112.016 -178.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . 0.451 ' HB3' ' HB2' ' B' ' 63' ' ' ALA . 45.5 tt0 -68.25 -43.96 76.71 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.97 -1.081 . . . . 0.0 110.335 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' ILE . . . . . 0.511 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.6 mm -55.58 -42.17 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 121.259 -0.901 . . . . 0.0 109.36 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.17 -47.91 80.35 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 13.7 mmt -66.16 -33.97 76.98 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.252 -1.146 . . . . 0.0 111.159 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' LEU . . . . . 0.4 HD21 ' HG ' ' B' ' 84' ' ' LEU . 27.8 mt -63.53 -23.31 67.34 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.231 -0.918 . . . . 0.0 110.568 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . 0.511 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 49.2 mt-10 -70.46 -8.67 52.85 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.352 -0.842 . . . . 0.0 110.919 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 86.4 p -119.83 12.48 12.12 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.035 -1.04 . . . . 0.0 112.528 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 34.9 m -60.68 140.39 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 O-C-N 120.701 -1.249 . . . . 0.0 109.647 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 24.5 m -74.58 -39.01 62.5 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.446 -0.784 . . . . 0.0 110.192 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.28 168.82 17.53 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.464 -0.773 . . . . 0.0 110.063 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -58.19 139.11 55.56 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.403 -0.811 . . . . 0.0 110.634 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.4 tp -90.97 116.14 28.54 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.535 -0.728 . . . . 0.0 109.89 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -103.03 168.34 8.94 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -76.65 -0.06 10.08 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 O-C-N 123.258 1.136 . . . . 0.0 110.388 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -120.4 22.36 11.32 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.992 -1.067 . . . . 0.0 108.395 176.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 4.3 m -80.83 137.23 36.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.898 -0.501 . . . . 0.0 110.382 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.5 mmm-85 -149.75 146.39 27.17 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 120.06 -0.656 . . . . 0.0 111.458 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.452 ' HB3' ' SG ' ' B' ' 48' ' ' CYS . 95.2 mt -80.58 98.92 7.84 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 175.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' CYS . . . . . 0.474 ' HB3' HG23 ' B' ' 50' ' ' VAL . 10.5 p -48.33 -17.88 0.18 Allowed 'General case' 0 N--CA 1.508 2.43 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -175.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.9 p -70.32 -13.98 62.39 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.747 -1.221 . . . . 0.0 109.387 178.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -92.69 -12.25 31.97 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.508 -0.745 . . . . 0.0 110.501 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' ILE . . . . . 0.466 HG21 HD13 ' B' ' 23' ' ' LEU . 61.9 mt -91.49 103.9 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.163 -0.961 . . . . 0.0 110.629 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 45.6 mm -84.94 131.78 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' MET . . . . . 0.435 ' C ' HG22 ' B' ' 91' ' ' THR . 13.6 tpt -74.83 137.74 42.07 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 122.111 0.957 . . . . 0.0 113.266 -177.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' THR . . . . . 0.435 HG22 ' C ' ' B' ' 90' ' ' MET . 43.7 p -138.17 166.63 24.45 Favored Pre-proline 0 N--CA 1.49 1.558 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 176.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -74.99 1.72 7.42 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 122.643 0.812 . . . . 0.0 110.968 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -87.62 -22.87 24.48 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 176.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.6 mt -93.74 12.95 23.84 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.437 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.44 126.38 23.22 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.201 -0.937 . . . . 0.0 111.148 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.15 6.92 68.45 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.575 -0.822 . . . . 0.0 111.682 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.65 142.74 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-N 119.319 1.559 . . . . 0.0 110.727 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 60.7 t -122.52 133.01 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.513 -0.742 . . . . 0.0 109.843 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 99' ' ' VAL . . . . . 0.424 ' O ' HG23 ' B' ' 99' ' ' VAL . 16.5 m -130.41 135.74 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.403 -0.811 . . . . 0.0 109.78 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 100' ' ' ASP . . . . . 0.403 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.35 134.18 35.16 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.9 t -103.39 127.31 29.92 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.525 -0.734 . . . . 0.0 110.353 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -80.85 130.92 7.8 Favored 'Trans proline' 0 C--N 1.316 -1.172 0 O-C-N 124.139 1.6 . . . . 0.0 108.319 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' ASP . . . . . 0.421 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.3 p-10 -62.38 3.46 0.19 Allowed 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -178.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -125.32 114.59 19.11 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.256 -1.528 . . . . 0.0 110.067 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 105' ' ' GLN . . . . . 0.475 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 69.4 mm-40 -113.29 -49.35 2.91 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.497 -0.752 . . . . 0.0 109.987 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' TRP . . . . . 0.464 ' CE3' ' HB2' ' A' ' 113' ' ' ALA . 8.0 m95 . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.495 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.473 ' HA ' HD11 ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.452 HD11 HG13 ' A' ' 18' ' ' VAL . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.88 ' HG2' HG23 ' A' ' 18' ' ' VAL . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.88 HG23 ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.488 ' HA ' HD23 ' A' ' 22' ' ' LEU . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.415 ' CE2' HG23 ' A' ' 50' ' ' VAL . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.503 ' HE1' HD12 ' A' ' 395' ' ' ILE . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.432 ' HA ' HD12 ' A' ' 34' ' ' LEU . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 39' ' ' GLN . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.514 ' N ' HG12 ' A' ' 38' ' ' VAL . 1.6 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.457 ' O ' HG21 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.423 ' HE3' HD13 ' A' ' 324' ' ' LEU . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.457 HG21 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.49 ' HB3' HG21 ' A' ' 66' ' ' THR . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.412 ' ND2' HG22 ' A' ' 50' ' ' VAL . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.608 HG13 ' HD2' ' A' ' 51' ' ' PRO . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.608 ' HD2' HG13 ' A' ' 50' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.438 HG21 ' HB ' ' A' ' 64' ' ' ILE . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.594 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.8 m120 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.594 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.438 ' HB ' HG21 ' A' ' 54' ' ' VAL . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.49 HG21 ' HB3' ' A' ' 45' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.436 HD11 ' N ' ' A' ' 70' ' ' LEU . 6.0 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.408 ' CZ ' HG22 ' A' ' 348' ' ' THR . 5.6 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.462 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.6 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.442 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 27.4 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.2 mmt-85 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.62 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.2 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.54 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.54 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.754 ' HD2' ' HB2' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.754 ' HB2' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.694 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.927 HD12 ' NE ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.629 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 74.3 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.629 ' OG1' ' HD2' ' A' ' 100' ' ' PRO . 3.9 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.508 ' HE1' HD13 ' A' ' 99' ' ' ILE . 46.0 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.614 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.294 50.3 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.461 ' HA ' ' HB3' ' A' ' 108' ' ' GLN 0.366 52.9 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.614 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 34.8 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.469 ' H ' ' CD ' ' A' ' 106' ' ' PRO 0.342 30.7 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . 0.461 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 1.7 tm0? -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.425 ' HB3' ' CG ' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.7 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.0 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.6 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.489 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.672 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 7.0 mtm -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.672 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.1 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.541 HG13 HD11 ' A' ' 166' ' ' LEU . 72.7 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 46.0 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.475 HD13 HG12 ' A' ' 123' ' ' VAL . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.488 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.506 ' HA ' HD11 ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.615 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.577 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.488 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.782 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.782 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.465 HD11 HG22 ' A' ' 160' ' ' ILE . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.467 ' HA ' HD13 ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.429 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.541 HD11 HG13 ' A' ' 123' ' ' VAL . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.506 ' N ' HD21 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.44 HD21 ' HA ' ' A' ' 169' ' ' LEU . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.417 ' N ' ' CD ' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.566 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.523 ' HA ' HD22 ' A' ' 180' ' ' LEU . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' MET . . . . . 0.499 ' HE2' HG22 ' A' ' 247' ' ' VAL . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.421 HD13 HD13 ' A' ' 180' ' ' LEU . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . 0.441 ' HB3' ' HG ' ' A' ' 221' ' ' SER . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 211' ' ' ARG . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 224' ' ' ALA . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' SER . . . . . 0.441 ' HG ' ' HB3' ' A' ' 211' ' ' ARG . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 42.5 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 42.0 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 220' ' ' ILE . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 4.3 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 13.5 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . 0.927 ' NE ' HD12 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 41.0 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.694 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.423 ' HA ' HD22 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.499 HG22 ' HE2' ' A' ' 184' ' ' MET . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 250' ' ' LEU . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.675 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.469 HD22 ' HA ' ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' MET . . . . . 0.577 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.428 HD22 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 16.4 pm0 -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.433 ' N ' ' CD ' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' CYS . . . . . 0.422 ' SG ' HG21 ' A' ' 367' ' ' ILE . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . 0.433 HD23 HG21 ' A' ' 349' ' ' THR . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . 0.497 ' CZ ' ' HE1' ' A' ' 336' ' ' MET . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.641 ' HA ' ' HE1' ' A' ' 323' ' ' MET . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 296' ' ' ALA . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . 0.424 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . 0.424 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.0 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.535 HD23 ' N ' ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' PHE . . . . . 0.424 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.6 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' HIS . . . . . 0.424 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 36.9 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 312' ' ' LEU . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' LEU . . . . . 0.63 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' PRO . . . . . 0.63 ' HD3' ' O ' ' A' ' 319' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' MET . . . . . 0.641 ' HE1' ' HA ' ' A' ' 294' ' ' LEU . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.456 HD11 ' HB2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 13.7 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' LEU . . . . . . . . . . . . . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.472 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' PRO . . . . . 0.472 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' MET . . . . . 0.497 ' HE1' ' CZ ' ' A' ' 291' ' ' ARG . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' GLN . . . . . 0.441 ' CB ' ' HD3' ' A' ' 344' ' ' LYS . 1.9 mp0 -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' LYS . . . . . 0.498 ' HB2' ' HE2' ' A' ' 344' ' ' LYS . 1.7 mppt? -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 57.8 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 22.1 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' THR . . . . . 0.408 HG22 ' CZ ' ' A' ' 72' ' ' ARG . 16.5 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' THR . . . . . 0.433 HG21 HD23 ' A' ' 289' ' ' LEU . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 92.6 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.42 ' HA ' HD12 ' A' ' 362' ' ' LEU . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 39.3 mtt85 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 17.2 tpp85 -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . 0.422 HG21 ' SG ' ' A' ' 285' ' ' CYS . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.485 HD12 HG23 ' A' ' 383' ' ' ILE . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' ILE . . . . . 0.403 HD11 HD12 ' A' ' 402' ' ' LEU . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.503 HD12 ' HE1' ' A' ' 28' ' ' MET . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . 0.403 HD12 HD11 ' A' ' 389' ' ' ILE . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' LEU . . . . . 0.404 ' HA ' HD22 ' A' ' 404' ' ' LEU . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 407' ' ' ASP . . . . . 0.544 ' HB3' HG23 ' A' ' 410' ' ' THR . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 408' ' ' PRO . . . . . 0.645 ' HA ' HG22 ' A' ' 411' ' ' THR . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 410' ' ' THR . . . . . 0.544 HG23 ' HB3' ' A' ' 407' ' ' ASP . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 411' ' ' THR . . . . . 0.645 HG22 ' HA ' ' A' ' 408' ' ' PRO . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 412' ' ' LYS . . . . . 0.496 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 39.6 m . . . . . 0 N--CA 1.495 1.807 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.53 138.58 38.47 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.181 -0.949 . . . . 0.0 112.927 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 61.3 t -137.11 122.6 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 177.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.441 HG13 ' CZ ' ' B' ' 12' ' ' ARG . 97.5 t -106.77 129.52 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.139 -0.976 . . . . 0.0 111.649 -178.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.56 ' CD1' HD11 ' B' ' 32' ' ' ILE . 77.1 m-85 -109.21 110.62 21.88 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 39.7 t -94.77 127.2 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.925 -1.109 . . . . 0.0 108.439 178.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.6 m -86.14 174.71 8.96 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.768 0.794 . . . . 0.0 112.493 -177.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' HIS . . . . . 0.413 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.65 -46.77 89.04 Favored 'General case' 0 N--CA 1.503 2.19 0 CA-C-O 121.193 0.521 . . . . 0.0 110.448 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -65.92 -11.22 45.61 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.544 -0.723 . . . . 0.0 111.425 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.97 15.46 28.48 Favored Glycine 0 N--CA 1.492 2.385 0 O-C-N 121.147 -0.971 . . . . 0.0 111.256 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.4 m -82.07 147.37 29.15 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 118.773 1.287 . . . . 0.0 109.903 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . 0.441 ' CZ ' HG13 ' B' ' 4' ' ' VAL . 50.8 ttt85 -118.49 128.77 54.91 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.529 -0.732 . . . . 0.0 111.829 -178.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.01 127.73 46.34 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.554 -0.716 . . . . 0.0 109.79 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.3 tt0 -111.35 130.66 55.61 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.29 -0.881 . . . . 0.0 111.591 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.565 HD11 HD13 ' B' ' 32' ' ' ILE . 85.0 mt -122.79 159.35 28.27 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.754 -0.591 . . . . 0.0 111.114 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -109.62 91.68 3.74 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.7 t -90.27 133.45 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-O 121.688 0.756 . . . . 0.0 112.248 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.08 170.67 16.12 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.706 -0.621 . . . . 0.0 110.262 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -68.46 151.81 46.29 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.532 -0.73 . . . . 0.0 110.967 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.41 -12.46 55.35 Favored Glycine 0 N--CA 1.495 2.629 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.067 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 59.1 t -89.99 133.33 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 120.69 -1.476 . . . . 0.0 110.936 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 21.7 p -80.29 151.94 29.28 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.568 -0.707 . . . . 0.0 109.145 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.479 HD23 ' HH ' ' B' ' 5' ' ' TYR . 18.5 mt -61.21 -24.63 66.48 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.297 -0.877 . . . . 0.0 110.605 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 7.6 tmm? -69.7 -49.28 54.92 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.235 -0.916 . . . . 0.0 109.5 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -59.81 -41.71 91.87 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.619 -0.675 . . . . 0.0 109.913 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.1 -40.87 95.19 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.631 -0.668 . . . . 0.0 110.121 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.33 -49.77 58.02 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.262 -0.899 . . . . 0.0 111.055 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 51.0 t -65.45 -39.12 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.349 -0.844 . . . . 0.0 110.744 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 15.8 t -70.15 -14.01 62.45 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.41 -0.806 . . . . 0.0 111.503 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -118.14 23.78 11.39 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.024 -1.048 . . . . 0.0 110.664 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.72 38.23 58.67 Favored Glycine 0 N--CA 1.493 2.469 0 O-C-N 121.532 -0.73 . . . . 0.0 111.876 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.565 HD13 HD11 ' B' ' 15' ' ' LEU . 1.7 mt -72.49 147.11 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.882 -1.364 . . . . 0.0 108.887 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.66 142.44 58.08 Favored 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 117.214 2.302 . . . . 0.0 117.214 -174.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 62.29 -36.18 0.12 Allowed 'General case' 0 N--CA 1.516 2.831 0 N-CA-C 116.612 2.079 . . . . 0.0 116.612 175.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 84.2 mt -59.67 122.85 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.401 0 O-C-N 119.85 -1.781 . . . . 0.0 110.672 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.523 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 84.4 t -100.15 -51.39 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.595 -0.691 . . . . 0.0 111.237 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.15 56.48 20.18 Favored Glycine 0 N--CA 1.499 2.866 0 N-CA-C 107.472 -2.251 . . . . 0.0 107.472 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -71.32 -49.33 43.73 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.985 -0.715 . . . . 0.0 112.259 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' CYS . . . . . 0.545 ' HB3' ' HB3' ' B' ' 45' ' ' CYS . 2.3 p -66.5 -10.49 45.2 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.201 -0.937 . . . . 0.0 112.351 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.81 -5.45 64.01 Favored Glycine 0 N--CA 1.497 2.731 0 O-C-N 120.825 -1.172 . . . . 0.0 111.973 177.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.07 19.57 10.63 Favored Glycine 0 N--CA 1.495 2.584 0 O-C-N 120.77 -1.429 . . . . 0.0 110.985 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 87.1 p -99.02 19.23 15.51 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.054 -1.263 . . . . 0.0 111.141 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.94 40.85 30.41 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.383 -0.823 . . . . 0.0 111.918 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.0 11.14 14.2 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.31 -0.868 . . . . 0.0 109.562 178.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' CYS . . . . . 0.545 ' HB3' ' HB3' ' B' ' 39' ' ' CYS . 15.1 p -149.48 -179.1 6.82 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.522 -0.736 . . . . 0.0 109.102 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.06 34.09 3.1 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.86 -1.15 . . . . 0.0 111.411 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' THR . . . . . 0.523 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 72.7 p -97.6 13.31 30.57 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.962 -1.086 . . . . 0.0 111.299 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' CYS . . . . . 0.452 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.3 p -120.58 31.74 6.31 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . 0.433 ' O ' HG13 ' B' ' 50' ' ' VAL . 23.9 t-160 -72.67 133.08 44.45 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.589 -178.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . 0.465 HG23 ' HB3' ' B' ' 85' ' ' CYS . 12.2 m -146.29 160.06 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . 0.4 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.4 m-85 -105.39 102.7 12.16 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.265 -0.897 . . . . 0.0 108.721 178.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.7 t -61.84 135.08 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 121.321 -0.862 . . . . 0.0 109.354 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.61 131.77 51.23 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.983 0.897 . . . . 0.0 109.542 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -44.3 -31.06 0.92 Allowed 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -178.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.77 -6.92 54.23 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.017 -1.052 . . . . 0.0 112.75 -178.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -119.89 -6.71 10.04 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 120.488 -1.383 . . . . 0.0 111.884 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.5 p -55.38 -37.83 68.07 Favored 'General case' 0 N--CA 1.507 2.406 0 O-C-N 121.173 -0.955 . . . . 0.0 112.835 -178.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 -81.14 -6.66 59.08 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.728 -1.232 . . . . 0.0 111.426 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -89.9 -11.57 41.47 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.033 -1.042 . . . . 0.0 109.872 178.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.628 HG12 ' HD2' ' B' ' 61' ' ' PRO . 40.9 t -104.08 141.02 21.65 Favored Pre-proline 0 N--CA 1.488 1.462 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . 0.628 ' HD2' HG12 ' B' ' 60' ' ' VAL . 50.0 Cg_endo -73.79 118.84 5.61 Favored 'Trans proline' 0 N--CA 1.488 1.173 0 O-C-N 123.448 1.236 . . . . 0.0 109.026 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.87 160.61 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.77 0 N-CA-C 116.692 2.108 . . . . 0.0 116.692 -177.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . 0.439 ' HB2' ' HB3' ' B' ' 67' ' ' GLU . . . -65.82 146.13 55.13 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.245 178.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -89.7 -170.78 2.94 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.589 -0.694 . . . . 0.0 110.428 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -59.56 -41.98 91.4 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.321 -0.862 . . . . 0.0 111.748 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.41 -41.57 84.69 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.186 -0.946 . . . . 0.0 112.043 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . 0.439 ' HB3' ' HB2' ' B' ' 63' ' ' ALA . 45.4 tt0 -68.19 -44.03 76.79 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.98 -1.075 . . . . 0.0 110.317 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' ILE . . . . . 0.513 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.6 mm -55.56 -42.21 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.285 -0.884 . . . . 0.0 109.326 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.16 -47.88 80.71 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 12.5 mmt -66.22 -33.91 76.83 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.273 -1.133 . . . . 0.0 111.182 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' LEU . . . . . 0.491 HD22 ' HA ' ' B' ' 71' ' ' LEU . 27.9 mt -63.48 -23.33 67.35 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.214 -0.928 . . . . 0.0 110.616 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . 0.513 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 49.9 mt-10 -70.44 -8.76 53.46 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.366 -0.834 . . . . 0.0 110.875 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 82.7 p -119.83 12.56 12.14 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.053 -1.029 . . . . 0.0 112.548 -178.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 22.3 m -60.76 140.35 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 120.739 -1.225 . . . . 0.0 109.668 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 13.9 m -74.53 -39.02 62.62 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.449 -0.782 . . . . 0.0 110.195 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.24 168.81 17.5 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.428 -0.795 . . . . 0.0 110.106 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.28 139.11 55.75 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.388 -0.82 . . . . 0.0 110.563 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.3 tp -90.93 116.14 28.51 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.494 -0.754 . . . . 0.0 109.935 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -102.99 168.35 8.93 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -76.64 0.01 10.01 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 O-C-N 123.219 1.115 . . . . 0.0 110.434 178.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -120.5 22.38 11.27 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.941 -1.099 . . . . 0.0 108.406 176.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 4.3 m -80.81 137.21 36.21 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.832 -0.542 . . . . 0.0 110.367 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.3 mmm-85 -149.78 146.42 27.16 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 120.059 -0.657 . . . . 0.0 111.448 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.452 ' HB3' ' SG ' ' B' ' 48' ' ' CYS . 95.9 mt -80.61 98.97 7.89 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 104.784 -2.302 . . . . 0.0 104.784 175.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' CYS . . . . . 0.465 ' HB3' HG23 ' B' ' 50' ' ' VAL . 10.6 p -48.36 -17.86 0.18 Allowed 'General case' 0 N--CA 1.508 2.443 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -175.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.8 p -70.33 -14.0 62.39 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.669 -1.269 . . . . 0.0 109.389 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 59.2 mm-40 -92.72 -12.23 31.92 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.512 -0.742 . . . . 0.0 110.534 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' ILE . . . . . 0.47 HG21 HD13 ' B' ' 23' ' ' LEU . 61.7 mt -91.52 103.97 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.194 -0.941 . . . . 0.0 110.647 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.477 HD13 ' HA ' ' B' ' 89' ' ' ILE . 45.7 mm -85.03 131.75 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' MET . . . . . 0.434 ' C ' HG22 ' B' ' 91' ' ' THR . 13.6 tpt -74.82 137.76 42.11 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 122.101 0.953 . . . . 0.0 113.243 -177.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' THR . . . . . 0.434 HG22 ' C ' ' B' ' 90' ' ' MET . 43.6 p -138.16 166.61 24.62 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 176.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -74.98 1.78 7.35 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 122.663 0.823 . . . . 0.0 111.025 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -87.67 -22.81 24.45 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 176.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.3 mt -93.8 13.04 23.69 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.427 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.5 126.4 23.4 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.122 -0.986 . . . . 0.0 111.142 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.22 6.79 68.45 Favored Glycine 0 N--CA 1.492 2.416 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.725 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.61 142.75 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 CA-C-N 119.263 1.532 . . . . 0.0 110.789 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 60.9 t -122.49 132.96 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.561 -0.712 . . . . 0.0 109.856 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 99' ' ' VAL . . . . . 0.428 ' O ' HG23 ' B' ' 99' ' ' VAL . 16.5 m -130.33 135.73 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.47 -0.769 . . . . 0.0 109.877 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 100' ' ' ASP . . . . . 0.4 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.38 134.14 35.22 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.6 t -103.33 127.31 29.96 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.535 -0.728 . . . . 0.0 110.377 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -80.9 131.0 7.79 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 O-C-N 124.079 1.568 . . . . 0.0 108.286 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 103' ' ' ASP . . . . . 0.413 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.4 p-10 -62.47 3.44 0.2 Allowed 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -178.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -125.28 114.64 19.2 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.288 -1.508 . . . . 0.0 110.088 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 105' ' ' GLN . . . . . 0.49 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 32.6 mm-40 -113.31 -49.35 2.91 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.455 -0.778 . . . . 0.0 110.007 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 106' ' ' TRP . . . . . 0.425 ' CG ' ' HB3' ' A' ' 113' ' ' ALA . 10.3 m0 . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.53 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.473 ' HA ' HD11 ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.452 HD11 HG13 ' A' ' 18' ' ' VAL . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.88 ' HG2' HG23 ' A' ' 18' ' ' VAL . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.88 HG23 ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.488 ' HA ' HD23 ' A' ' 22' ' ' LEU . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.415 ' CE2' HG23 ' A' ' 50' ' ' VAL . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.503 ' HE1' HD12 ' A' ' 395' ' ' ILE . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.432 ' HA ' HD12 ' A' ' 34' ' ' LEU . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 39' ' ' GLN . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.514 ' N ' HG12 ' A' ' 38' ' ' VAL . 1.6 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.457 ' O ' HG21 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.423 ' HE3' HD13 ' A' ' 324' ' ' LEU . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.457 HG21 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.49 ' HB3' HG21 ' A' ' 66' ' ' THR . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.412 ' ND2' HG22 ' A' ' 50' ' ' VAL . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.608 HG13 ' HD2' ' A' ' 51' ' ' PRO . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.608 ' HD2' HG13 ' A' ' 50' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.438 HG21 ' HB ' ' A' ' 64' ' ' ILE . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.594 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.8 m120 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.594 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.438 ' HB ' HG21 ' A' ' 54' ' ' VAL . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.49 HG21 ' HB3' ' A' ' 45' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.434 HD11 ' N ' ' A' ' 70' ' ' LEU . 6.0 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.6 mtt180 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.401 ' HB3' HD12 ' A' ' 320' ' ' LEU . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.462 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.5 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.533 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 25.8 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 84.1 mtt-85 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.8 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.62 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.1 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.54 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.54 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.754 ' HD2' ' HB2' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.754 ' HB2' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.694 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.927 HD12 ' NE ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.629 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 74.3 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.629 ' OG1' ' HD2' ' A' ' 100' ' ' PRO . 3.9 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.508 ' HE1' HD13 ' A' ' 99' ' ' ILE . 46.0 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.576 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.298 63.0 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.533 ' HD2' ' CD1' ' A' ' 78' ' ' TYR 0.367 53.3 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.576 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 33.9 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.496 ' H ' ' CD ' ' A' ' 106' ' ' PRO 0.413 34.1 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 15.6 tpt85 -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 5.5 ttt-85 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.433 ' HB3' ' CE3' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.2 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.577 ' HA ' ' CD2' ' A' ' 358' ' ' LEU . 23.3 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.0 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.6 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.489 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.672 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 12.4 mtm -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.672 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.1 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.541 HG13 HD11 ' A' ' 166' ' ' LEU . 72.7 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.2 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.475 HD13 HG12 ' A' ' 123' ' ' VAL . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.488 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.506 ' HA ' HD11 ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.615 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.577 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.488 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.782 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.782 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.465 HD11 HG22 ' A' ' 160' ' ' ILE . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.467 ' HA ' HD13 ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.429 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.541 HD11 HG13 ' A' ' 123' ' ' VAL . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.506 ' N ' HD21 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.44 HD21 ' HA ' ' A' ' 169' ' ' LEU . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.417 ' N ' ' CD ' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.566 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.523 ' HA ' HD22 ' A' ' 180' ' ' LEU . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' MET . . . . . 0.499 ' HE2' HG22 ' A' ' 247' ' ' VAL . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.421 HD13 HD13 ' A' ' 180' ' ' LEU . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . 0.441 ' HB3' ' HG ' ' A' ' 221' ' ' SER . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 211' ' ' ARG . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 224' ' ' ALA . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' SER . . . . . 0.441 ' HG ' ' HB3' ' A' ' 211' ' ' ARG . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 43.5 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 42.0 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 220' ' ' ILE . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 6.9 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 2.6 m120 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 17.1 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . 0.927 ' NE ' HD12 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' MET . . . . . 0.451 ' HB2' ' HE2' ' A' ' 241' ' ' MET . 34.2 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.694 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.423 ' HA ' HD22 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.499 HG22 ' HE2' ' A' ' 184' ' ' MET . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 250' ' ' LEU . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.675 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.469 HD22 ' HA ' ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' MET . . . . . 0.577 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.428 HD22 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 16.4 pm0 -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.433 ' N ' ' CD ' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' CYS . . . . . 0.422 ' SG ' HG21 ' A' ' 367' ' ' ILE . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . 0.433 HD23 HG21 ' A' ' 349' ' ' THR . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . 0.497 ' CZ ' ' HE1' ' A' ' 336' ' ' MET . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.641 ' HA ' ' HE1' ' A' ' 323' ' ' MET . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 296' ' ' ALA . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . 0.424 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . 0.424 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.0 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.535 HD23 ' N ' ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' PHE . . . . . 0.424 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.6 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' HIS . . . . . 0.424 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 36.9 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 312' ' ' LEU . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' LEU . . . . . 0.63 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' PRO . . . . . 0.63 ' HD3' ' O ' ' A' ' 319' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' MET . . . . . 0.641 ' HE1' ' HA ' ' A' ' 294' ' ' LEU . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.456 HD11 ' HB2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 14.7 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' LEU . . . . . . . . . . . . . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.472 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' PRO . . . . . 0.472 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' MET . . . . . 0.497 ' HE1' ' CZ ' ' A' ' 291' ' ' ARG . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 99.3 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 8.8 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 45.1 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' THR . . . . . 0.433 HG21 HD23 ' A' ' 289' ' ' LEU . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 91.4 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . 0.577 ' CD2' ' HA ' ' A' ' 116' ' ' ASN . 0.6 OUTLIER -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.42 ' HA ' HD12 ' A' ' 362' ' ' LEU . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 44.1 mtt85 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 16.6 tpp85 -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . 0.422 HG21 ' SG ' ' A' ' 285' ' ' CYS . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.2 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.485 HD12 HG23 ' A' ' 383' ' ' ILE . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' ILE . . . . . 0.403 HD11 HD12 ' A' ' 402' ' ' LEU . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.503 HD12 ' HE1' ' A' ' 28' ' ' MET . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . 0.403 HD12 HD11 ' A' ' 389' ' ' ILE . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' LEU . . . . . 0.404 ' HA ' HD22 ' A' ' 404' ' ' LEU . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 407' ' ' ASP . . . . . 0.544 ' HB3' HG23 ' A' ' 410' ' ' THR . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 408' ' ' PRO . . . . . 0.645 ' HA ' HG22 ' A' ' 411' ' ' THR . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 410' ' ' THR . . . . . 0.544 HG23 ' HB3' ' A' ' 407' ' ' ASP . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 411' ' ' THR . . . . . 0.645 HG22 ' HA ' ' A' ' 408' ' ' PRO . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 412' ' ' LYS . . . . . 0.496 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 N--CA 1.495 1.815 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.49 138.58 38.5 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.181 -0.949 . . . . 0.0 112.936 -178.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 61.3 t -137.12 122.59 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 177.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.435 HG13 ' CZ ' ' B' ' 12' ' ' ARG . 97.8 t -106.79 129.56 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.109 -0.994 . . . . 0.0 111.635 -178.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.555 ' CD1' HD11 ' B' ' 32' ' ' ILE . 77.1 m-85 -109.23 110.63 21.89 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 40.0 t -94.84 127.25 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.88 -1.138 . . . . 0.0 108.345 178.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.4 m -86.15 174.69 8.97 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.747 0.784 . . . . 0.0 112.499 -177.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' HIS . . . . . 0.415 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.68 -46.8 88.99 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-O 121.129 0.49 . . . . 0.0 110.418 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -65.83 -11.29 45.24 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.56 -0.712 . . . . 0.0 111.405 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.94 15.47 28.53 Favored Glycine 0 N--CA 1.492 2.368 0 O-C-N 121.163 -0.961 . . . . 0.0 111.312 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.1 m -82.09 147.4 29.12 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 118.723 1.261 . . . . 0.0 109.875 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . 0.435 ' CZ ' HG13 ' B' ' 4' ' ' VAL . 50.8 ttt85 -118.46 128.82 54.97 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.476 -0.765 . . . . 0.0 111.803 -178.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.08 127.73 46.27 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.608 -0.683 . . . . 0.0 109.8 179.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.3 tt0 -111.37 130.61 55.63 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.236 -0.915 . . . . 0.0 111.623 -178.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.685 HD11 HD13 ' B' ' 32' ' ' ILE . 84.5 mt -122.8 159.38 28.21 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.732 -0.605 . . . . 0.0 111.075 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -109.63 91.63 3.72 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.8 t -90.2 133.47 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-O 121.625 0.726 . . . . 0.0 112.233 -176.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.09 170.7 16.05 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.784 -0.572 . . . . 0.0 110.266 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -68.47 151.79 46.31 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.503 -0.748 . . . . 0.0 110.965 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.5 -12.52 55.53 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.021 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 91.4 t -89.97 133.36 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 120.696 -1.473 . . . . 0.0 110.933 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 88.5 p -80.25 151.86 29.38 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.523 -0.736 . . . . 0.0 109.129 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.479 HD23 ' HH ' ' B' ' 5' ' ' TYR . 18.4 mt -61.2 -24.68 66.5 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.29 -0.881 . . . . 0.0 110.549 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 2.1 ttp -69.7 -49.24 55.27 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.186 -0.946 . . . . 0.0 109.474 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.81 -41.7 91.82 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.622 -0.674 . . . . 0.0 109.926 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.13 -40.87 95.05 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.607 -0.683 . . . . 0.0 110.099 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.33 -49.79 57.89 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.254 -0.903 . . . . 0.0 111.023 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 71.8 t -65.41 -39.19 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.266 -0.896 . . . . 0.0 110.737 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 15.5 t -70.06 -14.08 62.51 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.342 -0.849 . . . . 0.0 111.562 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -118.13 23.84 11.36 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.016 -1.052 . . . . 0.0 110.658 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.65 38.31 58.55 Favored Glycine 0 N--CA 1.492 2.418 0 O-C-N 121.539 -0.725 . . . . 0.0 111.85 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.685 HD13 HD11 ' B' ' 15' ' ' LEU . 0.4 OUTLIER -72.55 147.13 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.829 -1.395 . . . . 0.0 108.875 178.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -62.7 142.52 58.08 Favored 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 -174.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 62.19 -36.14 0.12 Allowed 'General case' 0 N--CA 1.515 2.785 0 N-CA-C 116.693 2.108 . . . . 0.0 116.693 175.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . 0.421 HD12 ' CG2' ' B' ' 32' ' ' ILE . 12.1 mt -59.7 122.9 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 O-C-N 119.879 -1.763 . . . . 0.0 110.656 -178.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.642 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 58.0 t -100.14 -51.41 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.626 -0.671 . . . . 0.0 111.192 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.17 56.42 20.52 Favored Glycine 0 N--CA 1.499 2.895 0 N-CA-C 107.478 -2.249 . . . . 0.0 107.478 -178.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -71.29 -49.28 44.51 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.983 -0.716 . . . . 0.0 112.279 -177.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' CYS . . . . . 0.551 ' HB3' ' HB3' ' B' ' 45' ' ' CYS . 2.3 p -66.55 -10.48 45.57 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.209 -0.932 . . . . 0.0 112.351 -178.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.82 -5.59 64.08 Favored Glycine 0 N--CA 1.499 2.846 0 O-C-N 120.808 -1.183 . . . . 0.0 112.013 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.16 19.56 10.59 Favored Glycine 0 N--CA 1.495 2.628 0 O-C-N 120.856 -1.379 . . . . 0.0 110.98 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 9.4 t -98.98 19.14 15.63 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.072 -1.251 . . . . 0.0 111.147 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.98 40.84 30.34 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.45 -0.781 . . . . 0.0 111.935 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' SER . . . . . 0.421 ' OG ' ' HB2' ' B' ' 39' ' ' CYS . 2.1 p -117.04 11.23 14.19 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.301 -0.875 . . . . 0.0 109.547 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' CYS . . . . . 0.551 ' HB3' ' HB3' ' B' ' 39' ' ' CYS . 15.0 p -149.55 -179.11 6.83 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.04 34.08 3.11 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.879 -1.138 . . . . 0.0 111.339 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' THR . . . . . 0.642 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 23.0 p -97.6 13.24 30.81 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.978 -1.076 . . . . 0.0 111.268 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' CYS . . . . . 0.454 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.1 p -120.55 31.74 6.31 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 177.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . 0.428 ' O ' HG13 ' B' ' 50' ' ' VAL . 23.9 t-160 -72.68 133.01 44.42 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.612 -178.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . 0.477 HG23 ' HB3' ' B' ' 85' ' ' CYS . 12.4 m -146.24 160.14 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -105.46 102.76 12.21 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.262 -0.899 . . . . 0.0 108.699 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.2 t -61.92 135.13 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 121.296 -0.878 . . . . 0.0 109.34 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.64 131.7 51.03 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.945 0.878 . . . . 0.0 109.525 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -44.21 -31.12 0.9 Allowed 'General case' 0 N--CA 1.506 2.343 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -178.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.73 -6.93 54.23 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.019 -1.051 . . . . 0.0 112.796 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -119.92 -6.68 10.03 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 120.416 -1.427 . . . . 0.0 111.86 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.4 p -55.39 -37.85 68.12 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.132 -0.98 . . . . 0.0 112.846 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -81.1 -6.66 59.07 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.711 -1.243 . . . . 0.0 111.49 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -89.88 -11.61 41.4 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.986 -1.071 . . . . 0.0 109.848 178.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.626 HG12 ' HD2' ' B' ' 61' ' ' PRO . 40.8 t -104.08 141.01 21.63 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . 0.626 ' HD2' HG12 ' B' ' 60' ' ' VAL . 49.7 Cg_endo -73.77 118.84 5.61 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 O-C-N 123.496 1.261 . . . . 0.0 108.983 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.9 160.59 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.75 0 N-CA-C 116.656 2.095 . . . . 0.0 116.656 -177.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . 0.449 ' HB2' ' HB3' ' B' ' 67' ' ' GLU . . . -65.73 146.14 55.14 Favored 'General case' 0 N--CA 1.503 2.178 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.266 178.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -89.78 -170.81 2.94 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.602 -0.686 . . . . 0.0 110.383 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -59.54 -42.02 91.39 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.329 -0.857 . . . . 0.0 111.708 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.45 -41.52 84.57 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.158 -0.964 . . . . 0.0 112.045 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . 0.449 ' HB3' ' HB2' ' B' ' 63' ' ' ALA . 45.5 tt0 -68.21 -43.92 76.93 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.954 -1.091 . . . . 0.0 110.343 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' ILE . . . . . 0.516 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.6 mm -55.63 -42.08 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.278 -0.889 . . . . 0.0 109.379 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.24 -47.87 80.44 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 28.5 mmt -66.17 -33.97 76.98 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.275 -1.132 . . . . 0.0 111.226 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' LEU . . . . . 0.47 HD22 ' HA ' ' B' ' 71' ' ' LEU . 28.1 mt -63.47 -23.33 67.35 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.217 -0.927 . . . . 0.0 110.622 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 66.4 mt-10 -70.41 -8.72 53.02 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.339 -0.851 . . . . 0.0 110.926 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 84.8 p -119.91 12.6 12.09 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.008 -1.057 . . . . 0.0 112.461 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 19.4 m -60.84 140.44 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 O-C-N 120.692 -1.255 . . . . 0.0 109.653 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 25.4 m -74.58 -39.09 62.45 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.387 -0.821 . . . . 0.0 110.153 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.18 168.83 17.4 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.464 -0.773 . . . . 0.0 110.073 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.28 139.16 55.67 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.395 -0.815 . . . . 0.0 110.587 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.4 tp -90.95 116.11 28.5 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.498 -0.751 . . . . 0.0 109.907 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -102.94 168.37 8.91 Favored Pre-proline 0 C--N 1.302 -1.5 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -76.71 0.04 9.99 Favored 'Trans proline' 0 C--N 1.314 -1.255 0 O-C-N 123.279 1.147 . . . . 0.0 110.371 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -120.5 22.3 11.3 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.969 -1.082 . . . . 0.0 108.411 176.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 4.3 m -80.77 137.25 36.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.845 -0.534 . . . . 0.0 110.35 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.5 mmm-85 -149.77 146.41 27.16 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.446 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.454 ' HB3' ' SG ' ' B' ' 48' ' ' CYS . 78.4 mt -80.55 99.0 7.86 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 175.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' CYS . . . . . 0.477 ' HB3' HG23 ' B' ' 50' ' ' VAL . 11.3 p -48.5 -17.82 0.19 Allowed 'General case' 0 N--CA 1.508 2.439 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -175.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.8 p -70.28 -13.99 62.4 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.714 -1.241 . . . . 0.0 109.459 178.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -92.73 -12.25 31.87 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.489 -0.757 . . . . 0.0 110.545 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' ILE . . . . . 0.468 HG21 HD13 ' B' ' 23' ' ' LEU . 61.7 mt -91.47 104.02 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.195 -0.941 . . . . 0.0 110.625 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 39.2 mm -85.04 131.78 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' MET . . . . . 0.435 ' C ' HG22 ' B' ' 91' ' ' THR . 13.8 tpt -74.85 137.84 42.1 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 122.126 0.965 . . . . 0.0 113.229 -177.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' THR . . . . . 0.435 HG22 ' C ' ' B' ' 90' ' ' MET . 43.7 p -138.23 166.57 24.8 Favored Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 176.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -74.92 1.71 7.39 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 O-C-N 122.683 0.833 . . . . 0.0 111.042 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -87.64 -22.82 24.48 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 176.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.7 mt -93.75 12.96 23.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.982 -0.449 . . . . 0.0 110.422 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -54.48 126.36 23.21 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.111 -0.993 . . . . 0.0 111.164 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.21 6.89 68.34 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.669 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.68 142.79 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 CA-C-N 119.36 1.58 . . . . 0.0 110.715 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 98' ' ' VAL . . . . . 0.401 ' C ' HG11 ' B' ' 99' ' ' VAL . 60.7 t -122.53 133.01 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.532 -0.73 . . . . 0.0 109.819 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 99' ' ' VAL . . . . . 0.425 ' O ' HG23 ' B' ' 99' ' ' VAL . 16.5 m -130.41 135.78 59.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.489 -0.757 . . . . 0.0 109.798 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -92.44 134.17 35.2 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.7 t -103.39 127.27 30.01 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.5 -0.75 . . . . 0.0 110.368 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -80.77 130.92 7.89 Favored 'Trans proline' 0 C--N 1.316 -1.168 0 O-C-N 124.064 1.56 . . . . 0.0 108.268 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 103' ' ' ASP . . . . . 0.415 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.4 p-10 -62.42 3.42 0.19 Allowed 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -178.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 39.5 mtm180 -125.32 114.66 19.2 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.306 -1.496 . . . . 0.0 110.061 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 105' ' ' GLN . . . . . 0.481 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 62.7 mm-40 -113.3 -49.39 2.91 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.497 -0.752 . . . . 0.0 109.954 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 106' ' ' TRP . . . . . 0.552 ' HA ' ' CE3' ' B' ' 106' ' ' TRP . 4.9 m95 . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.522 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.473 ' HA ' HD11 ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.452 HD11 HG13 ' A' ' 18' ' ' VAL . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.88 ' HG2' HG23 ' A' ' 18' ' ' VAL . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.88 HG23 ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.488 ' HA ' HD23 ' A' ' 22' ' ' LEU . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.415 ' CE2' HG23 ' A' ' 50' ' ' VAL . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.503 ' HE1' HD12 ' A' ' 395' ' ' ILE . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.432 ' HA ' HD12 ' A' ' 34' ' ' LEU . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 39' ' ' GLN . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.514 ' N ' HG12 ' A' ' 38' ' ' VAL . 1.6 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.457 ' O ' HG21 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.423 ' HE3' HD13 ' A' ' 324' ' ' LEU . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.457 HG21 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.49 ' HB3' HG21 ' A' ' 66' ' ' THR . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.412 ' ND2' HG22 ' A' ' 50' ' ' VAL . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.608 HG13 ' HD2' ' A' ' 51' ' ' PRO . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.608 ' HD2' HG13 ' A' ' 50' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.438 HG21 ' HB ' ' A' ' 64' ' ' ILE . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.594 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.8 m120 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.594 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.438 ' HB ' HG21 ' A' ' 54' ' ' VAL . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.49 HG21 ' HB3' ' A' ' 45' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.436 HD11 ' N ' ' A' ' 70' ' ' LEU . 6.0 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.9 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.462 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.5 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.466 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 24.3 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.5 mtm180 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.62 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.2 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.54 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.54 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.754 ' HD2' ' HB2' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.754 ' HB2' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.694 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.927 HD12 ' NE ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.629 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 74.3 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.629 ' OG1' ' HD2' ' A' ' 100' ' ' PRO . 3.9 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.508 ' HE1' HD13 ' A' ' 99' ' ' ILE . 46.0 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.614 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.296 50.1 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.466 ' HD2' ' CD1' ' A' ' 78' ' ' TYR 0.366 52.6 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.614 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 35.0 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.469 ' H ' ' CD ' ' A' ' 106' ' ' PRO 0.413 34.1 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . 0.466 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 1.5 tm0? -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.434 ' HB3' ' CD2' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.438 HD13 ' HA3' ' A' ' 226' ' ' GLY . 24.8 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.1 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.6 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.489 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.672 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 37.1 mtm -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.672 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.1 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.453 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 72.0 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.7 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.453 ' HD2' ' HA ' ' A' ' 123' ' ' VAL . 35.6 mttt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.488 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.506 ' HA ' HD11 ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.615 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.577 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.488 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.782 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.782 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.465 HD11 HG22 ' A' ' 160' ' ' ILE . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.467 ' HA ' HD13 ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.429 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.513 ' C ' HD21 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.506 ' N ' HD21 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.44 HD21 ' HA ' ' A' ' 169' ' ' LEU . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.417 ' N ' ' CD ' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.566 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.523 ' HA ' HD22 ' A' ' 180' ' ' LEU . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' MET . . . . . 0.499 ' HE2' HG22 ' A' ' 247' ' ' VAL . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.421 HD13 HD13 ' A' ' 180' ' ' LEU . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . 0.441 ' HB3' ' HG ' ' A' ' 221' ' ' SER . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 211' ' ' ARG . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 224' ' ' ALA . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' SER . . . . . 0.441 ' HG ' ' HB3' ' A' ' 211' ' ' ARG . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 33.3 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 53.1 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 220' ' ' ILE . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . 0.438 ' HA3' HD13 ' A' ' 114' ' ' LEU . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 4.6 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 1.1 m120 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 18.1 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . 0.927 ' NE ' HD12 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 45.4 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.694 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.423 ' HA ' HD22 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.499 HG22 ' HE2' ' A' ' 184' ' ' MET . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 250' ' ' LEU . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.675 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.469 HD22 ' HA ' ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' MET . . . . . 0.577 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.428 HD22 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.433 ' N ' ' CD ' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' CYS . . . . . 0.422 ' SG ' HG21 ' A' ' 367' ' ' ILE . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . 0.433 HD23 HG21 ' A' ' 349' ' ' THR . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . 0.497 ' CZ ' ' HE1' ' A' ' 336' ' ' MET . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.641 ' HA ' ' HE1' ' A' ' 323' ' ' MET . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 296' ' ' ALA . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . 0.424 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . 0.424 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.0 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.535 HD23 ' N ' ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' PHE . . . . . 0.424 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.6 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' HIS . . . . . 0.424 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 36.9 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 312' ' ' LEU . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' LEU . . . . . 0.63 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' PRO . . . . . 0.63 ' HD3' ' O ' ' A' ' 319' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' MET . . . . . 0.641 ' HE1' ' HA ' ' A' ' 294' ' ' LEU . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.456 HD11 ' HB2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 13.7 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' LEU . . . . . . . . . . . . . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.472 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' PRO . . . . . 0.472 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' MET . . . . . 0.497 ' HE1' ' CZ ' ' A' ' 291' ' ' ARG . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' GLN . . . . . 0.448 ' CB ' ' HD3' ' A' ' 344' ' ' LYS . 1.9 mp0 -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' LYS . . . . . 0.525 ' HB2' ' HE2' ' A' ' 344' ' ' LYS . 1.5 mppt? -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 60.6 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 28.9 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 14.2 p80 -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 39.6 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' THR . . . . . 0.433 HG21 HD23 ' A' ' 289' ' ' LEU . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 99.6 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' LEU . . . . . 0.478 HD23 ' HA ' ' A' ' 356' ' ' LEU . 0.1 OUTLIER -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 2.9 mt -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.42 ' HA ' HD12 ' A' ' 362' ' ' LEU . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 35.9 mtt85 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . 0.422 HG21 ' SG ' ' A' ' 285' ' ' CYS . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.485 HD12 HG23 ' A' ' 383' ' ' ILE . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' ILE . . . . . 0.403 HD11 HD12 ' A' ' 402' ' ' LEU . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.503 HD12 ' HE1' ' A' ' 28' ' ' MET . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . 0.403 HD12 HD11 ' A' ' 389' ' ' ILE . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' LEU . . . . . 0.404 ' HA ' HD22 ' A' ' 404' ' ' LEU . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 407' ' ' ASP . . . . . 0.544 ' HB3' HG23 ' A' ' 410' ' ' THR . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 408' ' ' PRO . . . . . 0.645 ' HA ' HG22 ' A' ' 411' ' ' THR . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 410' ' ' THR . . . . . 0.544 HG23 ' HB3' ' A' ' 407' ' ' ASP . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 411' ' ' THR . . . . . 0.645 HG22 ' HA ' ' A' ' 408' ' ' PRO . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 412' ' ' LYS . . . . . 0.496 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 N--CA 1.496 1.853 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.49 138.62 38.53 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.226 -0.921 . . . . 0.0 112.939 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 61.3 t -137.13 122.59 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.437 HG13 ' CZ ' ' B' ' 12' ' ' ARG . 97.4 t -106.81 129.54 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.149 -0.969 . . . . 0.0 111.654 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.557 ' CD1' HD11 ' B' ' 32' ' ' ILE . 77.2 m-85 -109.19 110.53 21.77 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.78 127.25 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.922 -1.111 . . . . 0.0 108.421 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.9 m -86.19 174.64 8.98 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.782 0.801 . . . . 0.0 112.481 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' HIS . . . . . 0.415 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.61 -46.73 89.17 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-O 121.145 0.497 . . . . 0.0 110.467 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -65.94 -11.29 46.33 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.552 -0.718 . . . . 0.0 111.416 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.02 15.5 28.25 Favored Glycine 0 N--CA 1.492 2.421 0 O-C-N 121.103 -0.998 . . . . 0.0 111.218 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.3 m -82.14 147.36 29.08 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 118.773 1.286 . . . . 0.0 109.874 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . 0.437 ' CZ ' HG13 ' B' ' 4' ' ' VAL . 50.9 ttt85 -118.46 128.75 54.9 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.434 -0.791 . . . . 0.0 111.832 -178.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.04 127.68 46.24 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.575 -0.703 . . . . 0.0 109.792 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -111.29 130.62 55.61 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.282 -0.887 . . . . 0.0 111.64 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.683 HD11 HD13 ' B' ' 32' ' ' ILE . 84.5 mt -122.77 159.39 28.13 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.741 -0.6 . . . . 0.0 111.107 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -109.66 91.65 3.73 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 176.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.5 t -90.17 133.4 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 CA-C-O 121.605 0.717 . . . . 0.0 112.271 -176.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.13 170.67 16.11 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.812 -0.555 . . . . 0.0 110.257 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -68.36 151.78 46.38 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.491 -0.756 . . . . 0.0 111.01 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.46 -12.46 55.52 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.997 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 60.1 t -89.97 133.27 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 120.691 -1.476 . . . . 0.0 110.932 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 21.2 p -80.22 151.89 29.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.544 -0.723 . . . . 0.0 109.142 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.48 HD23 ' HH ' ' B' ' 5' ' ' TYR . 18.5 mt -61.15 -24.64 66.44 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.362 -0.836 . . . . 0.0 110.619 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 6.3 ttp -69.76 -49.24 54.9 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.212 -0.93 . . . . 0.0 109.463 178.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -59.85 -41.65 91.88 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.583 -0.698 . . . . 0.0 109.921 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.16 -40.85 94.9 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.606 -0.684 . . . . 0.0 110.082 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . 0.464 ' CB ' HD13 ' B' ' 35' ' ' ILE . . . -68.32 -49.73 58.31 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.207 -0.933 . . . . 0.0 111.079 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 81.7 t -65.5 -39.18 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.333 -0.854 . . . . 0.0 110.7 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 21.4 t -70.1 -14.04 62.48 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.386 -0.822 . . . . 0.0 111.564 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -118.12 23.82 11.37 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.027 -1.046 . . . . 0.0 110.653 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.66 38.22 58.4 Favored Glycine 0 N--CA 1.493 2.46 0 O-C-N 121.52 -0.737 . . . . 0.0 111.872 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.683 HD13 HD11 ' B' ' 15' ' ' LEU . 0.4 OUTLIER -72.52 147.18 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.859 -1.377 . . . . 0.0 108.869 179.01 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . 0.4 ' N ' HG22 ' B' ' 32' ' ' ILE . 0.8 OUTLIER -62.67 142.51 58.05 Favored 'General case' 0 N--CA 1.503 2.217 0 N-CA-C 117.169 2.285 . . . . 0.0 117.169 -174.307 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 62.21 -36.14 0.12 Allowed 'General case' 0 N--CA 1.516 2.835 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 175.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . 0.464 HD13 ' CB ' ' B' ' 27' ' ' ALA . 23.1 mt -59.69 122.87 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 O-C-N 119.928 -1.732 . . . . 0.0 110.665 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.593 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 52.5 t -100.07 -51.47 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.633 -0.667 . . . . 0.0 111.248 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.1 56.51 20.14 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 107.459 -2.256 . . . . 0.0 107.459 -178.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -71.27 -49.33 44.16 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.958 -0.731 . . . . 0.0 112.296 -177.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' CYS . . . . . 0.543 ' HB3' ' HB3' ' B' ' 45' ' ' CYS . 2.3 p -66.56 -10.42 45.12 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.249 -0.907 . . . . 0.0 112.359 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . 0.474 ' HA3' HD12 ' A' ' 356' ' ' LEU . . . 96.79 -5.53 64.11 Favored Glycine 0 N--CA 1.498 2.779 0 O-C-N 120.763 -1.211 . . . . 0.0 111.985 177.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.16 19.52 10.62 Favored Glycine 0 N--CA 1.495 2.608 0 O-C-N 120.883 -1.363 . . . . 0.0 110.965 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 1.3 t -98.95 19.11 15.64 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.032 -1.276 . . . . 0.0 111.142 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 56.0 40.84 30.32 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.358 -0.839 . . . . 0.0 111.934 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 57.8 m -117.0 11.17 14.21 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.318 -0.864 . . . . 0.0 109.533 178.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' CYS . . . . . 0.543 ' HB3' ' HB3' ' B' ' 39' ' ' CYS . 15.1 p -149.56 -179.07 6.8 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.511 -0.743 . . . . 0.0 109.039 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.07 33.98 3.11 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.85 -1.156 . . . . 0.0 111.357 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' THR . . . . . 0.593 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 65.1 p -97.51 13.23 30.68 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.0 -1.063 . . . . 0.0 111.275 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' CYS . . . . . 0.455 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.1 p -120.57 31.78 6.29 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 177.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . 0.425 ' O ' HG13 ' B' ' 50' ' ' VAL . 23.9 t-160 -72.68 133.07 44.44 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.588 -178.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . 0.469 HG23 ' HB3' ' B' ' 85' ' ' CYS . 12.3 m -146.29 160.06 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . 0.404 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.5 m-85 -105.45 102.73 12.19 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.239 -0.913 . . . . 0.0 108.74 178.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.1 t -61.9 135.17 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.269 -0.894 . . . . 0.0 109.348 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.67 131.75 51.2 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.961 0.886 . . . . 0.0 109.495 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -44.3 -30.99 0.9 Allowed 'General case' 0 N--CA 1.506 2.357 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.79 -6.92 54.29 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.013 -1.055 . . . . 0.0 112.726 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -119.95 -6.6 10.02 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 120.456 -1.402 . . . . 0.0 111.9 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.4 p -55.48 -37.73 68.2 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 121.155 -0.966 . . . . 0.0 112.892 -178.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -81.2 -6.59 59.03 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 120.743 -1.223 . . . . 0.0 111.44 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -89.89 -11.66 41.21 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.962 -1.087 . . . . 0.0 109.825 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.623 HG12 ' HD2' ' B' ' 61' ' ' PRO . 41.0 t -104.11 141.1 21.81 Favored Pre-proline 0 N--CA 1.488 1.458 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . 0.623 ' HD2' HG12 ' B' ' 60' ' ' VAL . 49.5 Cg_endo -73.82 118.87 5.61 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 O-C-N 123.485 1.255 . . . . 0.0 108.984 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.93 160.62 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.752 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 -177.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . 0.446 ' HB2' ' HB3' ' B' ' 67' ' ' GLU . . . -65.78 146.2 55.06 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.222 178.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -89.76 -170.78 2.93 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.592 -0.693 . . . . 0.0 110.397 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -59.56 -41.99 91.39 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.377 -0.827 . . . . 0.0 111.739 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.47 -41.54 84.46 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.109 -0.994 . . . . 0.0 111.994 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . 0.446 ' HB3' ' HB2' ' B' ' 63' ' ' ALA . 45.4 tt0 -68.23 -43.94 76.81 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.962 -1.086 . . . . 0.0 110.367 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' ILE . . . . . 0.514 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.7 mm -55.57 -42.18 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.292 -0.88 . . . . 0.0 109.37 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.17 -47.86 80.84 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 12.4 mmt -66.19 -33.98 77.0 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.256 -1.144 . . . . 0.0 111.162 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' LEU . . . . . 0.472 HD22 ' HA ' ' B' ' 71' ' ' LEU . 28.0 mt -63.45 -23.34 67.36 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.172 -0.955 . . . . 0.0 110.606 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . 0.514 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 49.2 mt-10 -70.41 -8.75 53.24 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.345 -0.847 . . . . 0.0 110.938 179.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 56.3 p -119.85 12.57 12.13 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.003 -1.061 . . . . 0.0 112.517 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 16.4 m -60.81 140.43 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 120.661 -1.274 . . . . 0.0 109.618 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 41.1 m -74.57 -39.05 62.49 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.432 -0.792 . . . . 0.0 110.187 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.22 168.81 17.47 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.441 -0.787 . . . . 0.0 110.089 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.3 139.18 55.67 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.387 -0.821 . . . . 0.0 110.585 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.4 tp -91.02 116.19 28.6 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.497 -0.752 . . . . 0.0 109.879 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -102.99 168.37 8.9 Favored Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -76.64 -0.05 10.06 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 O-C-N 123.259 1.136 . . . . 0.0 110.404 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -120.5 22.39 11.27 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.001 -1.062 . . . . 0.0 108.375 176.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 4.3 m -80.84 137.2 36.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.833 -0.542 . . . . 0.0 110.359 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.4 mmm-85 -149.74 146.4 27.18 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 120.029 -0.669 . . . . 0.0 111.466 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.455 ' HB3' ' SG ' ' B' ' 48' ' ' CYS . 79.2 mt -80.49 98.97 7.8 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 175.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' CYS . . . . . 0.469 ' HB3' HG23 ' B' ' 50' ' ' VAL . 10.7 p -48.45 -17.9 0.19 Allowed 'General case' 0 N--CA 1.507 2.412 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -175.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.8 p -70.24 -13.99 62.42 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.65 -1.281 . . . . 0.0 109.472 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 48.6 mm-40 -92.75 -12.16 32.03 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.509 -0.744 . . . . 0.0 110.502 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' ILE . . . . . 0.469 HG21 HD13 ' B' ' 23' ' ' LEU . 61.8 mt -91.56 104.0 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.16 -0.962 . . . . 0.0 110.567 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.41 HD13 ' HA ' ' B' ' 89' ' ' ILE . 45.3 mm -85.01 131.78 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' MET . . . . . 0.436 ' C ' HG22 ' B' ' 91' ' ' THR . 13.6 tpt -74.83 137.81 42.11 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 122.166 0.984 . . . . 0.0 113.183 -177.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' THR . . . . . 0.436 HG22 ' C ' ' B' ' 90' ' ' MET . 43.7 p -138.23 166.52 25.18 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 176.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -74.86 1.67 7.39 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 122.595 0.787 . . . . 0.0 111.026 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -87.65 -22.81 24.48 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 176.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.6 mt -93.78 12.97 23.85 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.408 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -54.52 126.39 23.44 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.175 -0.953 . . . . 0.0 111.161 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.22 6.86 68.36 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.64 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.64 142.75 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 CA-C-N 119.367 1.584 . . . . 0.0 110.714 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 60.8 t -122.53 132.99 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.583 -0.698 . . . . 0.0 109.866 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 99' ' ' VAL . . . . . 0.43 ' O ' HG23 ' B' ' 99' ' ' VAL . 16.4 m -130.38 135.77 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.518 -0.739 . . . . 0.0 109.795 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 100' ' ' ASP . . . . . 0.404 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.43 134.15 35.22 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.8 t -103.39 127.26 30.02 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.517 -0.739 . . . . 0.0 110.377 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -80.84 130.97 7.84 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 O-C-N 124.118 1.588 . . . . 0.0 108.273 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 103' ' ' ASP . . . . . 0.415 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.3 p-10 -62.35 3.34 0.19 Allowed 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -178.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 39.5 mtm180 -125.29 114.66 19.22 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.237 -1.539 . . . . 0.0 110.09 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 105' ' ' GLN . . . . . 0.484 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 51.7 mm-40 -113.32 -49.38 2.91 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.436 -0.79 . . . . 0.0 109.979 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 106' ' ' TRP . . . . . 0.434 ' CD2' ' HB3' ' A' ' 113' ' ' ALA . 51.1 m95 . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.491 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.473 ' HA ' HD11 ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.452 HD11 HG13 ' A' ' 18' ' ' VAL . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.88 ' HG2' HG23 ' A' ' 18' ' ' VAL . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.88 HG23 ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.488 ' HA ' HD23 ' A' ' 22' ' ' LEU . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.415 ' CE2' HG23 ' A' ' 50' ' ' VAL . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.503 ' HE1' HD12 ' A' ' 395' ' ' ILE . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.432 ' HA ' HD12 ' A' ' 34' ' ' LEU . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 39' ' ' GLN . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.514 ' N ' HG12 ' A' ' 38' ' ' VAL . 1.6 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.457 ' O ' HG21 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.423 ' HE3' HD13 ' A' ' 324' ' ' LEU . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.457 HG21 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.49 ' HB3' HG21 ' A' ' 66' ' ' THR . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.412 ' ND2' HG22 ' A' ' 50' ' ' VAL . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.608 HG13 ' HD2' ' A' ' 51' ' ' PRO . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.608 ' HD2' HG13 ' A' ' 50' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.438 HG21 ' HB ' ' A' ' 64' ' ' ILE . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.594 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.8 m120 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.594 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.438 ' HB ' HG21 ' A' ' 54' ' ' VAL . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.49 HG21 ' HB3' ' A' ' 45' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.405 HD11 ' N ' ' A' ' 70' ' ' LEU . 5.9 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 45.7 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.462 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.6 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.9 mtm180 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.62 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.2 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.54 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.54 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.754 ' HD2' ' HB2' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.754 ' HB2' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.694 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.927 HD12 ' NE ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.623 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 67.8 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.623 ' OG1' ' HD2' ' A' ' 100' ' ' PRO . 3.9 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.508 ' HE1' HD13 ' A' ' 99' ' ' ILE . 45.3 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.614 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.296 50.2 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . 0.366 52.7 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.614 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 35.0 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.469 ' H ' ' CD ' ' A' ' 106' ' ' PRO 0.372 31.8 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.43 ' HB3' ' CD2' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.8 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.1 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.6 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.489 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.672 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 26.7 mtm -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.672 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.1 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 69.2 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 54.1 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 29.8 mtmt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.488 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.506 ' HA ' HD11 ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.615 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.577 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.488 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.782 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.782 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.465 HD11 HG22 ' A' ' 160' ' ' ILE . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.467 ' HA ' HD13 ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.429 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.513 ' C ' HD21 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.506 ' N ' HD21 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.44 HD21 ' HA ' ' A' ' 169' ' ' LEU . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.417 ' N ' ' CD ' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.566 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.523 ' HA ' HD22 ' A' ' 180' ' ' LEU . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' MET . . . . . 0.499 ' HE2' HG22 ' A' ' 247' ' ' VAL . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.421 HD13 HD13 ' A' ' 180' ' ' LEU . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . 0.441 ' HB3' ' HG ' ' A' ' 221' ' ' SER . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 211' ' ' ARG . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 224' ' ' ALA . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' SER . . . . . 0.441 ' HG ' ' HB3' ' A' ' 211' ' ' ARG . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 26.5 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 42.0 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 220' ' ' ILE . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 4.0 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 1.2 m120 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 17.1 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . 0.927 ' NE ' HD12 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' MET . . . . . 0.451 ' HB2' ' HE2' ' A' ' 241' ' ' MET . 35.4 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.694 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.423 ' HA ' HD22 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.499 HG22 ' HE2' ' A' ' 184' ' ' MET . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 250' ' ' LEU . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.675 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.469 HD22 ' HA ' ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' MET . . . . . 0.577 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.428 HD22 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 8.7 pm0 -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.433 ' N ' ' CD ' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' CYS . . . . . 0.422 ' SG ' HG21 ' A' ' 367' ' ' ILE . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . 0.433 HD23 HG21 ' A' ' 349' ' ' THR . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . 0.497 ' CZ ' ' HE1' ' A' ' 336' ' ' MET . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.641 ' HA ' ' HE1' ' A' ' 323' ' ' MET . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 296' ' ' ALA . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . 0.424 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . 0.424 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.0 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.535 HD23 ' N ' ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' PHE . . . . . 0.424 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.4 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' HIS . . . . . 0.424 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 41.4 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 312' ' ' LEU . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' LEU . . . . . 0.63 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' PRO . . . . . 0.63 ' HD3' ' O ' ' A' ' 319' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' MET . . . . . 0.641 ' HE1' ' HA ' ' A' ' 294' ' ' LEU . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.456 HD11 ' HB2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 39.5 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' LEU . . . . . . . . . . . . . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.472 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' PRO . . . . . 0.472 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' MET . . . . . 0.497 ' HE1' ' CZ ' ' A' ' 291' ' ' ARG . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 92.5 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 1.3 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 47.2 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 349' ' ' THR . . . . . 0.433 HG21 HD23 ' A' ' 289' ' ' LEU . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 62.6 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 91.7 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 356' ' ' LEU . . . . . . . . . . . . . 1.1 tp -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 1.6 mt -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.42 ' HA ' HD12 ' A' ' 362' ' ' LEU . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 9.6 mtm180 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 14.2 tpp85 -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . 0.422 HG21 ' SG ' ' A' ' 285' ' ' CYS . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.485 HD12 HG23 ' A' ' 383' ' ' ILE . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' ILE . . . . . 0.403 HD11 HD12 ' A' ' 402' ' ' LEU . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.503 HD12 ' HE1' ' A' ' 28' ' ' MET . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . 0.403 HD12 HD11 ' A' ' 389' ' ' ILE . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' LEU . . . . . 0.404 ' HA ' HD22 ' A' ' 404' ' ' LEU . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 407' ' ' ASP . . . . . 0.544 ' HB3' HG23 ' A' ' 410' ' ' THR . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 408' ' ' PRO . . . . . 0.645 ' HA ' HG22 ' A' ' 411' ' ' THR . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 410' ' ' THR . . . . . 0.544 HG23 ' HB3' ' A' ' 407' ' ' ASP . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 411' ' ' THR . . . . . 0.645 HG22 ' HA ' ' A' ' 408' ' ' PRO . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 412' ' ' LYS . . . . . 0.496 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 40.1 m . . . . . 0 N--CA 1.496 1.832 0 N-CA-C 109.713 -0.476 . . . . 0.0 109.713 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.46 138.56 38.52 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.211 -0.931 . . . . 0.0 112.94 -178.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 61.0 t -137.1 122.5 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 177.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.44 HG13 ' CZ ' ' B' ' 12' ' ' ARG . 97.6 t -106.77 129.58 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.131 -0.981 . . . . 0.0 111.622 -178.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.481 ' HH ' HD23 ' B' ' 23' ' ' LEU . 77.0 m-85 -109.22 110.62 21.87 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 39.7 t -94.85 127.22 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.886 -1.133 . . . . 0.0 108.382 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.5 m -86.17 174.67 8.97 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.752 0.786 . . . . 0.0 112.534 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' HIS . . . . . 0.412 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.65 -46.77 89.05 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 121.136 0.493 . . . . 0.0 110.428 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -65.85 -11.32 45.67 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.556 -0.715 . . . . 0.0 111.463 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.0 15.49 28.32 Favored Glycine 0 N--CA 1.492 2.376 0 O-C-N 121.166 -0.959 . . . . 0.0 111.273 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.3 m -82.11 147.42 29.09 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.047 -1.267 . . . . 0.0 109.894 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . 0.44 ' CZ ' HG13 ' B' ' 4' ' ' VAL . 50.8 ttt85 -118.49 128.75 54.89 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.408 -0.807 . . . . 0.0 111.808 -178.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.07 127.68 46.21 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.54 -0.725 . . . . 0.0 109.813 179.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -111.32 130.61 55.62 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.312 -0.867 . . . . 0.0 111.602 -178.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.403 ' HA ' HD21 ' B' ' 15' ' ' LEU . 84.5 mt -122.8 159.38 28.21 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.687 -0.633 . . . . 0.0 111.09 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -109.6 91.61 3.72 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 176.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.7 t -90.18 133.45 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-O 121.601 0.715 . . . . 0.0 112.252 -176.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.07 170.67 16.11 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.804 -0.56 . . . . 0.0 110.247 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -68.45 151.83 46.27 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.555 -0.716 . . . . 0.0 110.986 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.43 -12.49 55.32 Favored Glycine 0 N--CA 1.495 2.629 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.02 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 91.3 t -89.95 133.37 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 120.705 -1.468 . . . . 0.0 110.899 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 96.6 p -80.3 151.96 29.26 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.481 HD23 ' HH ' ' B' ' 5' ' ' TYR . 18.5 mt -61.24 -24.62 66.49 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.307 -0.871 . . . . 0.0 110.589 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 13.6 tmm? -69.76 -49.2 55.32 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.238 -0.914 . . . . 0.0 109.493 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -59.83 -41.69 91.88 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.605 -0.684 . . . . 0.0 109.945 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.12 -40.87 95.1 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.648 -0.658 . . . . 0.0 110.165 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . 0.401 ' HB1' ' CE2' ' B' ' 5' ' ' TYR . . . -68.28 -49.79 58.11 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.281 -0.887 . . . . 0.0 111.068 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 55.2 t -65.45 -39.13 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.287 -0.883 . . . . 0.0 110.755 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 24.9 m -70.16 -14.02 62.45 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.386 -0.821 . . . . 0.0 111.502 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' ASN . . . . . 0.49 ' HB3' ' CD1' ' B' ' 32' ' ' ILE . 0.5 OUTLIER -118.17 23.83 11.35 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.021 -1.049 . . . . 0.0 110.652 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.68 38.24 58.54 Favored Glycine 0 N--CA 1.493 2.471 0 O-C-N 121.533 -0.729 . . . . 0.0 111.905 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.49 ' CD1' ' HB3' ' B' ' 30' ' ' ASN . 1.1 mp -72.53 147.22 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.867 -1.372 . . . . 0.0 108.815 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -62.78 142.5 58.15 Favored 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 117.182 2.289 . . . . 0.0 117.182 -174.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 62.24 -36.11 0.12 Allowed 'General case' 0 N--CA 1.515 2.806 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 175.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 57.8 mt -59.74 122.88 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 CA-C-N 121.067 1.758 . . . . 0.0 110.664 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.679 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 48.2 t -100.1 -51.43 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.674 -0.641 . . . . 0.0 111.22 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.13 56.51 20.07 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 107.47 -2.252 . . . . 0.0 107.47 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.35 -49.29 43.85 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.988 -0.713 . . . . 0.0 112.26 -177.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' CYS . . . . . 0.545 ' HB3' ' HB3' ' B' ' 45' ' ' CYS . 2.3 p -66.55 -10.45 45.31 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.229 -0.919 . . . . 0.0 112.372 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.82 -5.52 64.04 Favored Glycine 0 N--CA 1.498 2.823 0 O-C-N 120.841 -1.162 . . . . 0.0 111.938 177.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.2 19.42 10.69 Favored Glycine 0 N--CA 1.494 2.557 0 O-C-N 120.794 -1.415 . . . . 0.0 111.031 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 87.7 p -98.86 19.04 15.66 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.055 -1.262 . . . . 0.0 111.158 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 56.01 40.85 30.28 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.401 -0.812 . . . . 0.0 111.926 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 17.3 m -116.99 11.12 14.21 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.401 -0.812 . . . . 0.0 109.522 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' CYS . . . . . 0.545 ' HB3' ' HB3' ' B' ' 39' ' ' CYS . 15.1 p -149.52 -179.04 6.78 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.537 -0.727 . . . . 0.0 109.073 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.1 34.07 3.09 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.804 -1.185 . . . . 0.0 111.339 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' THR . . . . . 0.679 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 5.6 p -97.6 13.24 30.79 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.972 -1.08 . . . . 0.0 111.288 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' CYS . . . . . 0.452 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.1 p -120.56 31.72 6.32 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 177.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . 0.473 ' NE2' ' HB3' ' B' ' 82' ' ' SER . 6.4 t-160 -72.63 133.02 44.47 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.618 -178.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . 0.471 HG23 ' HB3' ' B' ' 85' ' ' CYS . 12.3 m -146.27 160.05 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . 0.404 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.5 m-85 -105.39 102.71 12.17 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.285 -0.885 . . . . 0.0 108.708 178.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.4 t -61.86 135.09 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.316 -0.865 . . . . 0.0 109.387 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.62 131.82 51.36 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.945 0.879 . . . . 0.0 109.522 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -44.33 -31.03 0.92 Allowed 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.8 -6.91 54.25 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.021 -1.05 . . . . 0.0 112.766 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -119.94 -6.65 10.02 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 120.527 -1.358 . . . . 0.0 111.922 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.5 p -55.41 -37.77 68.06 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.151 -0.968 . . . . 0.0 112.915 -178.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -81.18 -6.59 59.02 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.744 -1.222 . . . . 0.0 111.481 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -89.87 -11.65 41.29 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.97 -1.081 . . . . 0.0 109.854 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.629 HG12 ' HD2' ' B' ' 61' ' ' PRO . 40.8 t -104.07 141.04 21.7 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . 0.629 ' HD2' HG12 ' B' ' 60' ' ' VAL . 49.8 Cg_endo -73.74 118.87 5.63 Favored 'Trans proline' 0 N--CA 1.488 1.176 0 O-C-N 123.444 1.233 . . . . 0.0 109.008 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.95 160.61 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.79 0 N-CA-C 116.645 2.091 . . . . 0.0 116.645 -177.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . 0.446 ' HB2' ' HB3' ' B' ' 67' ' ' GLU . . . -65.77 146.17 55.1 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.216 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -89.75 -170.79 2.94 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.594 -0.691 . . . . 0.0 110.398 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -59.53 -42.02 91.36 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.321 -0.862 . . . . 0.0 111.719 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -41.47 84.46 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.242 -0.911 . . . . 0.0 112.027 -178.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . 0.446 ' HB3' ' HB2' ' B' ' 63' ' ' ALA . 45.3 tt0 -68.26 -43.98 76.63 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.941 -1.099 . . . . 0.0 110.335 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' ILE . . . . . 0.499 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.7 mm -55.53 -42.16 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.283 -0.885 . . . . 0.0 109.394 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.23 -47.86 80.64 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 24.8 mmt -66.18 -33.97 76.98 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.316 -1.108 . . . . 0.0 111.186 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 27.5 mt -63.51 -23.32 67.34 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.203 -0.936 . . . . 0.0 110.62 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . 0.499 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 44.2 mt-10 -70.44 -8.67 52.75 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.38 -0.825 . . . . 0.0 110.926 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 36.4 m -119.87 12.55 12.1 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.069 -1.02 . . . . 0.0 112.518 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 35.3 m -60.78 140.49 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 120.75 -1.219 . . . . 0.0 109.677 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 33.8 m -74.63 -39.08 62.34 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.372 -0.83 . . . . 0.0 110.136 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.22 168.82 17.46 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.451 -0.78 . . . . 0.0 110.087 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.26 139.12 55.68 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.422 -0.799 . . . . 0.0 110.613 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.5 tp -91.01 116.19 28.6 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.569 -0.707 . . . . 0.0 109.873 179.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -103.02 168.3 9.0 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -76.61 -0.0 10.0 Favored 'Trans proline' 0 C--N 1.315 -1.217 0 O-C-N 123.222 1.117 . . . . 0.0 110.398 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -120.48 22.36 11.29 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.918 -1.114 . . . . 0.0 108.42 176.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' SER . . . . . 0.473 ' HB3' ' NE2' ' B' ' 49' ' ' HIS . 4.3 m -80.81 137.23 36.21 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.91 -0.494 . . . . 0.0 110.383 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.4 mmm-85 -149.78 146.41 27.16 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.47 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.452 ' HB3' ' SG ' ' B' ' 48' ' ' CYS . 96.3 mt -80.59 98.97 7.88 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 175.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' CYS . . . . . 0.471 ' HB3' HG23 ' B' ' 50' ' ' VAL . 10.5 p -48.37 -17.88 0.18 Allowed 'General case' 0 N--CA 1.508 2.448 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -175.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.9 p -70.29 -14.0 62.41 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.686 -1.259 . . . . 0.0 109.474 178.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -92.68 -12.23 32.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.492 -0.755 . . . . 0.0 110.553 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' ILE . . . . . 0.469 HG21 HD13 ' B' ' 23' ' ' LEU . 61.8 mt -91.48 103.95 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.179 -0.951 . . . . 0.0 110.648 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 27.6 mm -85.03 131.8 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' MET . . . . . 0.434 ' C ' HG22 ' B' ' 91' ' ' THR . 13.8 tpt -74.89 137.78 41.99 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 122.176 0.988 . . . . 0.0 113.221 -177.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' THR . . . . . 0.434 HG22 ' C ' ' B' ' 90' ' ' MET . 43.6 p -138.2 166.59 24.73 Favored Pre-proline 0 N--CA 1.49 1.546 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 176.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -74.97 1.75 7.37 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 122.678 0.83 . . . . 0.0 111.023 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -87.69 -22.77 24.45 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.4 mt -93.85 12.99 23.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 122.024 -0.423 . . . . 0.0 110.412 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -54.5 126.37 23.31 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.185 -0.947 . . . . 0.0 111.172 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.23 6.86 68.33 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.633 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.65 142.76 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 CA-C-N 119.374 1.587 . . . . 0.0 110.773 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 98' ' ' VAL . . . . . 0.404 ' C ' HG11 ' B' ' 99' ' ' VAL . 60.8 t -122.5 133.01 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.494 -0.754 . . . . 0.0 109.858 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 99' ' ' VAL . . . . . 0.427 ' O ' HG23 ' B' ' 99' ' ' VAL . 16.4 m -130.39 135.76 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.439 -0.788 . . . . 0.0 109.793 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 100' ' ' ASP . . . . . 0.404 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.43 134.17 35.2 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.4 t -103.39 127.29 29.96 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.482 -0.761 . . . . 0.0 110.386 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -80.82 131.01 7.87 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 O-C-N 124.016 1.535 . . . . 0.0 108.306 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 103' ' ' ASP . . . . . 0.412 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.4 p-10 -62.44 3.4 0.2 Allowed 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -178.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 4.0 mtm105 -125.32 114.6 19.12 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.282 -1.511 . . . . 0.0 110.075 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 105' ' ' GLN . . . . . 0.482 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 70.6 mm-40 -113.25 -49.43 2.91 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.46 -0.775 . . . . 0.0 110.0 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 106' ' ' TRP . . . . . 0.43 ' CD2' ' HB3' ' A' ' 113' ' ' ALA . 10.9 m0 . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.5 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.473 ' HA ' HD11 ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.452 HD11 HG13 ' A' ' 18' ' ' VAL . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.88 ' HG2' HG23 ' A' ' 18' ' ' VAL . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.88 HG23 ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.488 ' HA ' HD23 ' A' ' 22' ' ' LEU . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.415 ' CE2' HG23 ' A' ' 50' ' ' VAL . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.503 ' HE1' HD12 ' A' ' 395' ' ' ILE . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.432 ' HA ' HD12 ' A' ' 34' ' ' LEU . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 39' ' ' GLN . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.514 ' N ' HG12 ' A' ' 38' ' ' VAL . 1.6 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.457 ' O ' HG21 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.423 ' HE3' HD13 ' A' ' 324' ' ' LEU . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.457 HG21 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.49 ' HB3' HG21 ' A' ' 66' ' ' THR . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.412 ' ND2' HG22 ' A' ' 50' ' ' VAL . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.608 HG13 ' HD2' ' A' ' 51' ' ' PRO . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.608 ' HD2' HG13 ' A' ' 50' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.438 HG21 ' HB ' ' A' ' 64' ' ' ILE . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.594 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.8 m120 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.594 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.438 ' HB ' HG21 ' A' ' 54' ' ' VAL . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.49 HG21 ' HB3' ' A' ' 45' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.405 HD11 ' N ' ' A' ' 70' ' ' LEU . 5.9 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.2 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.462 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.5 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.457 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 26.4 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.1 mtm180 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.62 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.2 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.54 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.54 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.754 ' HD2' ' HB2' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.754 ' HB2' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.694 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.927 HD12 ' NE ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.623 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 67.8 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.623 ' OG1' ' HD2' ' A' ' 100' ' ' PRO . 3.9 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.508 ' HE1' HD13 ' A' ' 99' ' ' ILE . 45.3 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.614 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.296 50.2 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.457 ' HD2' ' CD1' ' A' ' 78' ' ' TYR 0.366 53.2 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.614 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 35.0 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.469 ' H ' ' CD ' ' A' ' 106' ' ' PRO 0.372 31.8 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.8 ttp85 -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 8.6 mtp180 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.8 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.1 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.6 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.489 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.672 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 28.8 mtm -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.672 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.1 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 69.2 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 54.1 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 29.8 mtmt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.488 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.506 ' HA ' HD11 ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.615 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.577 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.488 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.782 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.782 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.465 HD11 HG22 ' A' ' 160' ' ' ILE . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.467 ' HA ' HD13 ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.429 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.513 ' C ' HD21 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.506 ' N ' HD21 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.44 HD21 ' HA ' ' A' ' 169' ' ' LEU . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.417 ' N ' ' CD ' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.566 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.523 ' HA ' HD22 ' A' ' 180' ' ' LEU . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' MET . . . . . 0.499 ' HE2' HG22 ' A' ' 247' ' ' VAL . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.421 HD13 HD13 ' A' ' 180' ' ' LEU . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . 0.441 ' HB3' ' HG ' ' A' ' 221' ' ' SER . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 211' ' ' ARG . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 224' ' ' ALA . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' SER . . . . . 0.441 ' HG ' ' HB3' ' A' ' 211' ' ' ARG . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 26.5 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 42.0 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 220' ' ' ILE . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 4.0 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 17.1 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . 0.927 ' NE ' HD12 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' MET . . . . . 0.451 ' HB2' ' HE2' ' A' ' 241' ' ' MET . 35.4 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.694 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.423 ' HA ' HD22 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.499 HG22 ' HE2' ' A' ' 184' ' ' MET . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 250' ' ' LEU . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.675 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.469 HD22 ' HA ' ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' MET . . . . . 0.577 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.428 HD22 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 8.7 pm0 -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.433 ' N ' ' CD ' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' CYS . . . . . 0.422 ' SG ' HG21 ' A' ' 367' ' ' ILE . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . 0.433 HD23 HG21 ' A' ' 349' ' ' THR . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . 0.497 ' CZ ' ' HE1' ' A' ' 336' ' ' MET . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.641 ' HA ' ' HE1' ' A' ' 323' ' ' MET . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 296' ' ' ALA . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . 0.424 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . 0.424 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.0 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.535 HD23 ' N ' ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' PHE . . . . . 0.424 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.4 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' HIS . . . . . 0.424 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 41.4 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 312' ' ' LEU . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' LEU . . . . . 0.63 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' PRO . . . . . 0.63 ' HD3' ' O ' ' A' ' 319' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' MET . . . . . 0.641 ' HE1' ' HA ' ' A' ' 294' ' ' LEU . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.456 HD11 ' HB2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 39.5 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' LEU . . . . . . . . . . . . . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.472 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' PRO . . . . . 0.472 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' MET . . . . . 0.497 ' HE1' ' CZ ' ' A' ' 291' ' ' ARG . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 92.5 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 1.3 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 47.2 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 349' ' ' THR . . . . . 0.433 HG21 HD23 ' A' ' 289' ' ' LEU . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 66.3 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 93.8 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 356' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 1.2 tp -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.42 ' HA ' HD12 ' A' ' 362' ' ' LEU . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 14.2 tpp85 -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . 0.422 HG21 ' SG ' ' A' ' 285' ' ' CYS . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.485 HD12 HG23 ' A' ' 383' ' ' ILE . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' ILE . . . . . 0.403 HD11 HD12 ' A' ' 402' ' ' LEU . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.503 HD12 ' HE1' ' A' ' 28' ' ' MET . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . 0.403 HD12 HD11 ' A' ' 389' ' ' ILE . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' LEU . . . . . 0.404 ' HA ' HD22 ' A' ' 404' ' ' LEU . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 407' ' ' ASP . . . . . 0.544 ' HB3' HG23 ' A' ' 410' ' ' THR . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 408' ' ' PRO . . . . . 0.645 ' HA ' HG22 ' A' ' 411' ' ' THR . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 410' ' ' THR . . . . . 0.544 HG23 ' HB3' ' A' ' 407' ' ' ASP . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 411' ' ' THR . . . . . 0.645 HG22 ' HA ' ' A' ' 408' ' ' PRO . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 412' ' ' LYS . . . . . 0.496 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 39.6 m . . . . . 0 N--CA 1.496 1.837 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.54 138.62 38.49 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.218 -0.926 . . . . 0.0 112.934 -178.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 60.6 t -137.14 122.58 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.442 HG13 ' CZ ' ' B' ' 12' ' ' ARG . 98.1 t -106.82 129.54 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.126 -0.984 . . . . 0.0 111.58 -178.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.475 ' HH ' HD23 ' B' ' 23' ' ' LEU . 77.0 m-85 -109.2 110.58 21.83 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 40.0 t -94.79 127.2 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.899 -1.125 . . . . 0.0 108.367 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.4 m -86.12 174.67 9.0 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.773 0.797 . . . . 0.0 112.527 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' HIS . . . . . 0.412 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.66 -46.73 89.24 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 121.132 0.491 . . . . 0.0 110.463 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -65.92 -11.26 45.95 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.592 -0.692 . . . . 0.0 111.401 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.97 15.47 28.45 Favored Glycine 0 N--CA 1.492 2.368 0 O-C-N 121.202 -0.936 . . . . 0.0 111.258 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.4 m -82.11 147.35 29.12 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 118.754 1.277 . . . . 0.0 109.899 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . 0.442 ' CZ ' HG13 ' B' ' 4' ' ' VAL . 50.8 ttt85 -118.42 128.74 54.91 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.418 -0.801 . . . . 0.0 111.873 -178.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.03 127.7 46.29 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.574 -0.703 . . . . 0.0 109.794 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -111.31 130.62 55.61 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.255 -0.903 . . . . 0.0 111.666 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 84.6 mt -122.81 159.39 28.21 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.3 0.571 . . . . 0.0 111.073 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -109.62 91.64 3.73 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 106.436 -1.691 . . . . 0.0 106.436 176.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 39.0 t -90.2 133.44 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.577 0.703 . . . . 0.0 112.254 -176.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.09 170.67 16.1 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.805 -0.559 . . . . 0.0 110.282 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -68.37 151.81 46.34 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.498 -0.751 . . . . 0.0 111.021 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.42 -12.48 55.29 Favored Glycine 0 N--CA 1.495 2.623 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.066 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 98.8 t -89.98 133.36 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.673 -1.487 . . . . 0.0 110.922 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 52.0 p -80.29 151.93 29.29 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.475 HD23 ' HH ' ' B' ' 5' ' ' TYR . 18.4 mt -61.21 -24.54 66.41 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.31 -0.868 . . . . 0.0 110.66 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 11.2 tmm? -69.77 -49.25 54.77 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.258 -0.901 . . . . 0.0 109.462 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.81 -41.74 91.94 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.645 -0.659 . . . . 0.0 109.892 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.06 -40.9 95.39 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.593 -0.692 . . . . 0.0 110.179 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . 0.413 ' HB3' HD13 ' B' ' 35' ' ' ILE . . . -68.28 -49.72 58.6 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.285 -0.884 . . . . 0.0 111.12 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 89.5 t -65.42 -39.24 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.266 -0.896 . . . . 0.0 110.737 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 25.0 m -70.03 -14.11 62.53 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.328 -0.857 . . . . 0.0 111.53 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' ASN . . . . . 0.514 ' HB3' ' CD1' ' B' ' 32' ' ' ILE . 0.5 OUTLIER -118.18 23.86 11.33 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.062 -1.024 . . . . 0.0 110.604 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.68 38.23 58.51 Favored Glycine 0 N--CA 1.493 2.463 0 O-C-N 121.557 -0.714 . . . . 0.0 111.873 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.514 ' CD1' ' HB3' ' B' ' 30' ' ' ASN . 1.0 OUTLIER -72.54 147.18 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.813 -1.404 . . . . 0.0 108.839 179.024 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -62.67 142.5 58.06 Favored 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 117.231 2.308 . . . . 0.0 117.231 -174.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 62.18 -36.09 0.12 Allowed 'General case' 0 N--CA 1.515 2.814 0 N-CA-C 116.657 2.095 . . . . 0.0 116.657 175.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . 0.413 HD13 ' HB3' ' B' ' 27' ' ' ALA . 20.2 mt -59.77 122.92 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 O-C-N 119.821 -1.799 . . . . 0.0 110.635 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.639 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 93.2 t -100.16 -51.4 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.595 -0.691 . . . . 0.0 111.192 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.16 56.45 20.34 Favored Glycine 0 N--CA 1.499 2.897 0 N-CA-C 107.467 -2.253 . . . . 0.0 107.467 -178.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -71.33 -49.29 44.05 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.993 -0.71 . . . . 0.0 112.281 -177.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' CYS . . . . . 0.549 ' HB3' ' HB3' ' B' ' 45' ' ' CYS . 2.3 p -66.53 -10.43 44.8 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.219 -0.925 . . . . 0.0 112.373 -178.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.79 -5.47 64.08 Favored Glycine 0 N--CA 1.497 2.767 0 O-C-N 120.745 -1.222 . . . . 0.0 112.0 177.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.08 19.51 10.68 Favored Glycine 0 N--CA 1.495 2.59 0 O-C-N 120.814 -1.403 . . . . 0.0 111.038 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 87.9 p -98.94 19.17 15.52 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.025 -1.279 . . . . 0.0 111.137 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.94 40.89 30.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.395 -0.816 . . . . 0.0 111.918 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 5.7 t -117.02 11.17 14.19 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.356 -0.84 . . . . 0.0 109.566 178.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' CYS . . . . . 0.549 ' HB3' ' HB3' ' B' ' 39' ' ' CYS . 15.1 p -149.52 -179.1 6.83 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.09 34.06 3.1 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.828 -1.17 . . . . 0.0 111.346 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' THR . . . . . 0.639 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 25.2 p -97.52 13.22 30.7 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.995 -1.066 . . . . 0.0 111.295 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' CYS . . . . . 0.45 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.1 p -120.56 31.74 6.31 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 177.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . 0.465 ' NE2' ' HB3' ' B' ' 82' ' ' SER . 6.5 t-160 -72.69 133.05 44.43 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.628 -178.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . 0.477 HG23 ' HB3' ' B' ' 85' ' ' CYS . 12.3 m -146.27 160.09 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -105.43 102.74 12.19 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.257 -0.902 . . . . 0.0 108.689 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.0 t -61.97 135.12 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.343 -0.848 . . . . 0.0 109.358 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.63 131.79 51.3 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.957 0.884 . . . . 0.0 109.522 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -44.4 -30.9 0.92 Allowed 'General case' 0 N--CA 1.506 2.336 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -178.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.83 -6.91 54.29 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.016 -1.052 . . . . 0.0 112.772 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -119.98 -6.6 10.01 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.465 -1.397 . . . . 0.0 111.898 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.4 p -55.4 -37.85 68.16 Favored 'General case' 0 N--CA 1.507 2.415 0 O-C-N 121.186 -0.946 . . . . 0.0 112.854 -178.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 47.9 p-10 -81.17 -6.59 59.01 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 120.775 -1.203 . . . . 0.0 111.452 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -89.91 -11.68 41.12 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.983 -1.073 . . . . 0.0 109.822 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.617 HG12 ' HD2' ' B' ' 61' ' ' PRO . 40.9 t -104.04 141.08 21.77 Favored Pre-proline 0 N--CA 1.488 1.475 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . 0.617 ' HD2' HG12 ' B' ' 60' ' ' VAL . 49.7 Cg_endo -73.78 118.84 5.61 Favored 'Trans proline' 0 N--CA 1.489 1.208 0 O-C-N 123.49 1.258 . . . . 0.0 109.009 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.83 160.62 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.799 0 N-CA-C 116.621 2.082 . . . . 0.0 116.621 -177.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . 0.438 ' HB2' ' HB3' ' B' ' 67' ' ' GLU . . . -65.81 146.11 55.15 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.285 178.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -89.76 -170.76 2.93 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.61 -0.681 . . . . 0.0 110.393 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -59.58 -41.98 91.49 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.325 -0.859 . . . . 0.0 111.711 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 11.0 ttt180 -67.44 -41.58 84.51 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.141 -0.974 . . . . 0.0 111.989 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . 0.438 ' HB3' ' HB2' ' B' ' 63' ' ' ALA . 45.4 tt0 -68.23 -43.92 76.88 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.985 -1.072 . . . . 0.0 110.354 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' ILE . . . . . 0.503 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.7 mm -55.57 -42.2 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.311 -0.868 . . . . 0.0 109.354 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.17 -47.88 80.61 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 8.4 mmt -66.12 -33.97 76.99 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.234 -1.157 . . . . 0.0 111.241 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' LEU . . . . . 0.46 HD22 ' HA ' ' B' ' 71' ' ' LEU . 27.5 mt -63.5 -23.34 67.36 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.213 -0.929 . . . . 0.0 110.636 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . 0.503 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 44.3 mt-10 -70.42 -8.72 53.04 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.314 -0.866 . . . . 0.0 110.897 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 1.4 t -119.84 12.56 12.13 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.001 -1.062 . . . . 0.0 112.523 -178.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 34.6 m -60.84 140.42 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 120.736 -1.227 . . . . 0.0 109.631 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.59 -39.03 62.46 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.393 -0.817 . . . . 0.0 110.152 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.22 168.84 17.42 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.486 -0.759 . . . . 0.0 110.086 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.33 139.15 55.78 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.397 -0.814 . . . . 0.0 110.602 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.3 tp -90.99 116.22 28.62 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.549 -0.719 . . . . 0.0 109.833 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -103.04 168.3 8.99 Favored Pre-proline 0 N--CA 1.489 1.5 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -76.62 -0.04 10.05 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 O-C-N 123.311 1.164 . . . . 0.0 110.382 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -120.46 22.37 11.29 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.931 -1.106 . . . . 0.0 108.397 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' SER . . . . . 0.465 ' HB3' ' NE2' ' B' ' 49' ' ' HIS . 4.3 m -80.8 137.23 36.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.879 -0.513 . . . . 0.0 110.32 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.4 mmm-85 -149.8 146.37 27.12 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.465 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.45 ' HB3' ' SG ' ' B' ' 48' ' ' CYS . 96.3 mt -80.51 98.96 7.81 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 175.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' CYS . . . . . 0.477 ' HB3' HG23 ' B' ' 50' ' ' VAL . 10.7 p -48.44 -17.86 0.19 Allowed 'General case' 0 N--CA 1.508 2.427 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -175.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.8 p -70.27 -14.0 62.41 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.669 -1.269 . . . . 0.0 109.435 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -92.7 -12.25 31.95 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.459 -0.776 . . . . 0.0 110.526 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' ILE . . . . . 0.46 HG21 HD13 ' B' ' 23' ' ' LEU . 61.8 mt -91.51 103.96 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.198 -0.939 . . . . 0.0 110.664 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 26.5 mm -84.98 131.71 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' MET . . . . . 0.416 ' C ' HG22 ' B' ' 91' ' ' THR . 13.8 tpt -74.8 137.74 42.11 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 122.075 0.941 . . . . 0.0 113.25 -177.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' THR . . . . . 0.416 HG22 ' C ' ' B' ' 90' ' ' MET . 43.6 p -138.17 166.6 24.63 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 176.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -75.0 1.79 7.35 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 O-C-N 122.669 0.826 . . . . 0.0 111.001 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -87.67 -22.82 24.46 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 176.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.6 mt -93.79 13.02 23.72 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.418 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.53 126.4 23.47 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.146 -0.971 . . . . 0.0 111.148 -178.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.25 6.77 68.41 Favored Glycine 0 N--CA 1.494 2.523 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.662 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.61 142.69 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 CA-C-N 119.343 1.572 . . . . 0.0 110.755 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 61.0 t -122.44 132.96 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.519 -0.738 . . . . 0.0 109.88 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 99' ' ' VAL . . . . . 0.43 ' O ' HG23 ' B' ' 99' ' ' VAL . 16.5 m -130.37 135.79 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.481 -0.762 . . . . 0.0 109.802 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -92.44 134.11 35.26 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.9 t -103.34 127.33 29.9 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.493 -0.754 . . . . 0.0 110.391 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -80.89 130.92 7.75 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 O-C-N 124.084 1.571 . . . . 0.0 108.294 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 103' ' ' ASP . . . . . 0.412 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.3 p-10 -62.33 3.38 0.19 Allowed 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -178.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 3.8 mtm105 -125.32 114.68 19.22 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.288 -1.507 . . . . 0.0 110.069 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 105' ' ' GLN . . . . . 0.483 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 69.8 mm-40 -113.31 -49.37 2.91 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.476 -0.765 . . . . 0.0 110.0 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 118.392 -0.813 . . . . 0.0 110.504 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.473 ' HA ' HD11 ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.452 HD11 HG13 ' A' ' 18' ' ' VAL . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.88 ' HG2' HG23 ' A' ' 18' ' ' VAL . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.88 HG23 ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.488 ' HA ' HD23 ' A' ' 22' ' ' LEU . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.415 ' CE2' HG23 ' A' ' 50' ' ' VAL . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.503 ' HE1' HD12 ' A' ' 395' ' ' ILE . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.432 ' HA ' HD12 ' A' ' 34' ' ' LEU . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 39' ' ' GLN . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.514 ' N ' HG12 ' A' ' 38' ' ' VAL . 1.6 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.457 ' O ' HG21 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.423 ' HE3' HD13 ' A' ' 324' ' ' LEU . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.457 HG21 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.49 ' HB3' HG21 ' A' ' 66' ' ' THR . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.412 ' ND2' HG22 ' A' ' 50' ' ' VAL . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.608 HG13 ' HD2' ' A' ' 51' ' ' PRO . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.608 ' HD2' HG13 ' A' ' 50' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.438 HG21 ' HB ' ' A' ' 64' ' ' ILE . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.594 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.8 m120 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.594 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.438 ' HB ' HG21 ' A' ' 54' ' ' VAL . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.49 HG21 ' HB3' ' A' ' 45' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.436 HD11 ' N ' ' A' ' 70' ' ' LEU . 6.0 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.6 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.462 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.5 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.415 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 30.0 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.6 mtm180 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.62 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.2 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.54 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.54 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.754 ' HD2' ' HB2' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.754 ' HB2' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.694 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.927 HD12 ' NE ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.631 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 68.2 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.631 ' OG1' ' HD2' ' A' ' 100' ' ' PRO . 3.8 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.508 ' HE1' HD13 ' A' ' 99' ' ' ILE . 46.0 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.614 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.296 50.2 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.46 ' HA ' ' HB3' ' A' ' 108' ' ' GLN 0.366 52.9 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.614 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 35.0 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.469 ' H ' ' CD ' ' A' ' 106' ' ' PRO 0.413 34.1 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . 0.46 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 1.5 tm0? -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.505 ' HB2' ' CZ3' ' B' ' 106' ' ' TRP . 7.1 mtp180 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.405 ' HB3' ' CD2' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.438 HD13 ' HA3' ' A' ' 226' ' ' GLY . 24.8 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.1 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.6 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.489 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.672 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 31.7 mtm -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.672 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.1 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.453 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 72.0 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.7 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.453 ' HD2' ' HA ' ' A' ' 123' ' ' VAL . 35.6 mttt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.488 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.506 ' HA ' HD11 ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.615 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.577 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.488 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.782 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.782 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.465 HD11 HG22 ' A' ' 160' ' ' ILE . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.467 ' HA ' HD13 ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.429 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.513 ' C ' HD21 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.506 ' N ' HD21 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.44 HD21 ' HA ' ' A' ' 169' ' ' LEU . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.417 ' N ' ' CD ' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.566 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.523 ' HA ' HD22 ' A' ' 180' ' ' LEU . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' MET . . . . . 0.499 ' HE2' HG22 ' A' ' 247' ' ' VAL . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.421 HD13 HD13 ' A' ' 180' ' ' LEU . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . 0.441 ' HB3' ' HG ' ' A' ' 221' ' ' SER . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 211' ' ' ARG . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 224' ' ' ALA . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' SER . . . . . 0.441 ' HG ' ' HB3' ' A' ' 211' ' ' ARG . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 33.3 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 53.1 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 220' ' ' ILE . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . 0.438 ' HA3' HD13 ' A' ' 114' ' ' LEU . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 4.6 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 1.1 m120 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 18.1 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . 0.927 ' NE ' HD12 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 45.4 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.694 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.423 ' HA ' HD22 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.499 HG22 ' HE2' ' A' ' 184' ' ' MET . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 250' ' ' LEU . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.675 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.469 HD22 ' HA ' ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' MET . . . . . 0.577 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.428 HD22 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.433 ' N ' ' CD ' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' CYS . . . . . 0.422 ' SG ' HG21 ' A' ' 367' ' ' ILE . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . 0.433 HD23 HG21 ' A' ' 349' ' ' THR . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . 0.497 ' CZ ' ' HE1' ' A' ' 336' ' ' MET . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.641 ' HA ' ' HE1' ' A' ' 323' ' ' MET . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 296' ' ' ALA . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . 0.424 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . 0.424 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.1 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.535 HD23 ' N ' ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' PHE . . . . . 0.424 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.6 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' HIS . . . . . 0.424 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 36.9 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 312' ' ' LEU . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' LEU . . . . . 0.63 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' PRO . . . . . 0.63 ' HD3' ' O ' ' A' ' 319' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' MET . . . . . 0.641 ' HE1' ' HA ' ' A' ' 294' ' ' LEU . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.456 HD11 ' HB2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 13.7 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' LEU . . . . . . . . . . . . . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.472 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' PRO . . . . . 0.472 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' MET . . . . . 0.497 ' HE1' ' CZ ' ' A' ' 291' ' ' ARG . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' LYS . . . . . 0.513 ' HD3' ' N ' ' A' ' 344' ' ' LYS . 0.9 OUTLIER -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 60.7 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 10.6 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 39.9 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 349' ' ' THR . . . . . 0.433 HG21 HD23 ' A' ' 289' ' ' LEU . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 60.2 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 96.4 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 356' ' ' LEU . . . . . . . . . . . . . 1.5 tp -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 1.4 mp -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.42 ' HA ' HD12 ' A' ' 362' ' ' LEU . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 43.4 mtt85 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . 0.422 HG21 ' SG ' ' A' ' 285' ' ' CYS . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.485 HD12 HG23 ' A' ' 383' ' ' ILE . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' ILE . . . . . 0.403 HD11 HD12 ' A' ' 402' ' ' LEU . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.503 HD12 ' HE1' ' A' ' 28' ' ' MET . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . 0.403 HD12 HD11 ' A' ' 389' ' ' ILE . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' LEU . . . . . 0.404 ' HA ' HD22 ' A' ' 404' ' ' LEU . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 407' ' ' ASP . . . . . 0.544 ' HB3' HG23 ' A' ' 410' ' ' THR . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 408' ' ' PRO . . . . . 0.645 ' HA ' HG22 ' A' ' 411' ' ' THR . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 410' ' ' THR . . . . . 0.544 HG23 ' HB3' ' A' ' 407' ' ' ASP . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 411' ' ' THR . . . . . 0.645 HG22 ' HA ' ' A' ' 408' ' ' PRO . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 412' ' ' LYS . . . . . 0.496 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 N--CA 1.496 1.83 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.52 138.58 38.48 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.224 -0.922 . . . . 0.0 112.963 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 61.2 t -137.11 122.56 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 177.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.436 HG13 ' CZ ' ' B' ' 12' ' ' ARG . 97.0 t -106.76 129.54 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.115 -0.991 . . . . 0.0 111.628 -178.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.555 ' CD1' HD11 ' B' ' 32' ' ' ILE . 76.9 m-85 -109.2 110.6 21.85 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.82 127.26 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.927 -1.108 . . . . 0.0 108.34 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.4 m -86.2 174.64 8.97 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.753 0.787 . . . . 0.0 112.502 -177.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' HIS . . . . . 0.416 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.6 -46.79 88.94 Favored 'General case' 0 N--CA 1.502 2.155 0 CA-C-O 121.138 0.494 . . . . 0.0 110.458 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -65.85 -11.31 45.58 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.57 -0.706 . . . . 0.0 111.433 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.99 15.43 28.49 Favored Glycine 0 N--CA 1.492 2.406 0 O-C-N 121.155 -0.965 . . . . 0.0 111.259 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.5 m -82.05 147.38 29.17 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 118.73 1.265 . . . . 0.0 109.88 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . 0.436 ' CZ ' HG13 ' B' ' 4' ' ' VAL . 50.8 ttt85 -118.43 128.74 54.9 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.487 -0.758 . . . . 0.0 111.859 -178.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.07 127.71 46.24 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.598 -0.689 . . . . 0.0 109.804 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -111.3 130.63 55.61 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.282 -0.886 . . . . 0.0 111.647 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.682 HD11 HD13 ' B' ' 32' ' ' ILE . 84.8 mt -122.8 159.34 28.29 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.734 -0.604 . . . . 0.0 111.129 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -109.61 91.66 3.74 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 176.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.6 t -90.16 133.41 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-O 121.626 0.727 . . . . 0.0 112.253 -176.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.08 170.71 16.04 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.7 -0.625 . . . . 0.0 110.273 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -68.5 151.82 46.25 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.532 -0.73 . . . . 0.0 111.027 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.46 -12.49 55.43 Favored Glycine 0 N--CA 1.496 2.638 0 O-C-N 121.494 -0.754 . . . . 0.0 112.052 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 61.5 t -89.98 133.29 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.706 -1.467 . . . . 0.0 110.963 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 21.3 p -80.21 151.88 29.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.572 -0.705 . . . . 0.0 109.184 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.479 HD23 ' HH ' ' B' ' 5' ' ' TYR . 18.5 mt -61.18 -24.59 66.43 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.349 -0.844 . . . . 0.0 110.595 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 1.9 ttp -69.83 -49.2 54.9 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.236 -0.915 . . . . 0.0 109.473 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -59.79 -41.72 91.81 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.567 -0.708 . . . . 0.0 109.926 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.09 -40.86 95.2 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.59 -0.694 . . . . 0.0 110.152 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.34 -49.74 58.19 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.275 -0.891 . . . . 0.0 111.045 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 78.2 t -65.47 -39.18 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.301 -0.875 . . . . 0.0 110.706 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 23.2 t -70.14 -13.96 62.43 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.359 -0.838 . . . . 0.0 111.553 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -118.21 23.88 11.32 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.057 -1.027 . . . . 0.0 110.665 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.7 38.24 58.63 Favored Glycine 0 N--CA 1.493 2.448 0 O-C-N 121.541 -0.724 . . . . 0.0 111.857 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.682 HD13 HD11 ' B' ' 15' ' ' LEU . 0.4 OUTLIER -72.57 147.19 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.866 -1.373 . . . . 0.0 108.864 179.043 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -62.72 142.53 58.09 Favored 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 117.175 2.287 . . . . 0.0 117.175 -174.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 62.22 -36.12 0.12 Allowed 'General case' 0 N--CA 1.515 2.791 0 N-CA-C 116.643 2.09 . . . . 0.0 116.643 175.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 77.6 mt -59.77 122.9 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.426 0 O-C-N 119.907 -1.746 . . . . 0.0 110.617 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.626 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 97.4 t -100.15 -51.34 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.697 -0.627 . . . . 0.0 111.229 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.14 56.47 20.26 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 107.466 -2.253 . . . . 0.0 107.466 -178.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -71.34 -49.27 44.16 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.994 -0.709 . . . . 0.0 112.274 -177.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' CYS . . . . . 0.55 ' HB3' ' HB3' ' B' ' 45' ' ' CYS . 2.3 p -66.59 -10.4 45.19 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.213 -0.929 . . . . 0.0 112.385 -178.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.77 -5.47 64.13 Favored Glycine 0 N--CA 1.498 2.782 0 O-C-N 120.819 -1.176 . . . . 0.0 112.007 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.1 19.52 10.66 Favored Glycine 0 N--CA 1.494 2.535 0 O-C-N 120.826 -1.397 . . . . 0.0 111.047 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 8.2 t -98.95 19.11 15.64 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.978 -1.307 . . . . 0.0 111.16 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.97 40.87 30.36 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.407 -0.808 . . . . 0.0 111.906 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.04 11.2 14.18 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.343 -0.848 . . . . 0.0 109.467 178.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' CYS . . . . . 0.55 ' HB3' ' HB3' ' B' ' 39' ' ' CYS . 15.1 p -149.53 -179.08 6.81 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.549 -0.72 . . . . 0.0 109.082 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.08 34.08 3.1 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.83 -1.169 . . . . 0.0 111.403 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' THR . . . . . 0.626 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 37.8 p -97.63 13.26 30.76 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.925 -1.109 . . . . 0.0 111.25 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' CYS . . . . . 0.454 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.1 p -120.54 31.73 6.32 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 177.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . 0.427 ' O ' HG13 ' B' ' 50' ' ' VAL . 23.9 t-160 -72.65 133.03 44.46 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-N 115.784 -0.643 . . . . 0.0 112.628 -178.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . 0.475 HG23 ' HB3' ' B' ' 85' ' ' CYS . 12.3 m -146.3 160.11 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . 0.401 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.4 m-85 -105.44 102.68 12.13 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.294 -0.879 . . . . 0.0 108.684 178.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.2 t -61.86 135.11 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.317 -0.864 . . . . 0.0 109.35 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.68 131.81 51.38 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.94 0.876 . . . . 0.0 109.53 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -44.27 -31.08 0.91 Allowed 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -178.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.78 -6.93 54.3 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.969 -1.082 . . . . 0.0 112.749 -178.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -119.89 -6.72 10.04 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 120.449 -1.407 . . . . 0.0 111.908 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.4 p -55.37 -37.84 68.04 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.112 -0.993 . . . . 0.0 112.86 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 -81.18 -6.63 59.06 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.753 -1.217 . . . . 0.0 111.477 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -89.88 -11.62 41.35 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.991 -1.068 . . . . 0.0 109.855 178.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.626 HG12 ' HD2' ' B' ' 61' ' ' PRO . 40.9 t -104.07 141.05 21.72 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . 0.626 ' HD2' HG12 ' B' ' 60' ' ' VAL . 49.6 Cg_endo -73.76 118.89 5.63 Favored 'Trans proline' 0 N--CA 1.488 1.15 0 O-C-N 123.453 1.238 . . . . 0.0 109.016 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.89 160.65 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.764 0 N-CA-C 116.657 2.095 . . . . 0.0 116.657 -177.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . 0.449 ' HB2' ' HB3' ' B' ' 67' ' ' GLU . . . -65.87 146.14 55.1 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-N 114.606 -1.179 . . . . 0.0 111.266 178.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -89.74 -170.79 2.94 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.569 -0.707 . . . . 0.0 110.362 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -59.53 -42.0 91.28 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.35 -0.844 . . . . 0.0 111.754 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -41.48 84.45 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.203 -0.935 . . . . 0.0 112.018 -178.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . 0.449 ' HB3' ' HB2' ' B' ' 63' ' ' ALA . 45.3 tt0 -68.21 -43.98 76.81 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.031 -1.043 . . . . 0.0 110.318 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' ILE . . . . . 0.519 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.6 mm -55.6 -42.18 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.28 -0.888 . . . . 0.0 109.368 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.19 -47.83 81.04 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 11.2 mmt -66.23 -33.92 76.84 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.275 -1.133 . . . . 0.0 111.191 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' LEU . . . . . 0.473 HD22 ' HA ' ' B' ' 71' ' ' LEU . 27.9 mt -63.47 -23.4 67.38 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.236 -0.915 . . . . 0.0 110.588 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . 0.519 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 49.2 mt-10 -70.38 -8.71 52.78 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.358 -0.839 . . . . 0.0 110.919 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 82.8 p -119.87 12.54 12.1 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.067 -1.02 . . . . 0.0 112.509 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 16.2 m -60.76 140.38 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 120.643 -1.286 . . . . 0.0 109.681 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 52.0 m -74.53 -39.06 62.58 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.466 -0.771 . . . . 0.0 110.19 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.26 168.82 17.51 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.456 -0.777 . . . . 0.0 110.1 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -58.22 139.16 55.53 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.365 -0.834 . . . . 0.0 110.613 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.3 tp -90.99 116.15 28.55 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.506 -0.746 . . . . 0.0 109.864 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -103.04 168.3 8.99 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -76.61 -0.02 10.02 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 O-C-N 123.304 1.16 . . . . 0.0 110.372 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -120.46 22.41 11.28 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.01 -1.056 . . . . 0.0 108.45 176.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 4.3 m -80.88 137.27 36.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.908 -0.495 . . . . 0.0 110.32 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.4 mmm-85 -149.77 146.4 27.16 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 120.029 -0.668 . . . . 0.0 111.472 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.454 ' HB3' ' SG ' ' B' ' 48' ' ' CYS . 77.9 mt -80.59 98.94 7.86 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 104.789 -2.3 . . . . 0.0 104.789 175.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' CYS . . . . . 0.475 ' HB3' HG23 ' B' ' 50' ' ' VAL . 10.5 p -48.38 -17.88 0.18 Allowed 'General case' 0 N--CA 1.508 2.444 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -175.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.8 p -70.27 -13.99 62.4 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.628 -1.295 . . . . 0.0 109.429 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -92.65 -12.3 31.91 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.486 -0.759 . . . . 0.0 110.523 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' ILE . . . . . 0.469 HG21 HD13 ' B' ' 23' ' ' LEU . 61.9 mt -91.44 103.89 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.121 -0.987 . . . . 0.0 110.678 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 45.6 mm -85.01 131.8 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' MET . . . . . 0.435 ' C ' HG22 ' B' ' 91' ' ' THR . 13.6 tpt -74.88 137.76 41.98 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 122.165 0.983 . . . . 0.0 113.201 -177.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' THR . . . . . 0.435 HG22 ' C ' ' B' ' 90' ' ' MET . 43.6 p -138.14 166.62 24.53 Favored Pre-proline 0 N--CA 1.491 1.578 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 176.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -74.93 1.67 7.43 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 122.628 0.804 . . . . 0.0 111.028 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -87.61 -22.86 24.5 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 176.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.6 mt -93.76 13.0 23.71 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.392 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -54.5 126.39 23.38 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.138 -0.976 . . . . 0.0 111.188 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.27 6.82 68.3 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 120.581 -0.818 . . . . 0.0 111.637 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.7 tt -62.63 142.81 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 CA-C-N 119.391 1.595 . . . . 0.0 110.747 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 98' ' ' VAL . . . . . 0.4 ' C ' HG11 ' B' ' 99' ' ' VAL . 60.9 t -122.53 132.92 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.554 -0.716 . . . . 0.0 109.876 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 99' ' ' VAL . . . . . 0.425 ' O ' HG23 ' B' ' 99' ' ' VAL . 16.5 m -130.32 135.76 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.451 -0.78 . . . . 0.0 109.842 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 100' ' ' ASP . . . . . 0.401 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.35 134.13 35.21 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.9 t -103.4 127.31 29.92 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.558 -0.714 . . . . 0.0 110.364 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -80.82 130.96 7.84 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 124.115 1.587 . . . . 0.0 108.287 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 103' ' ' ASP . . . . . 0.416 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.4 p-10 -62.34 3.37 0.19 Allowed 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -178.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -125.29 114.71 19.29 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.305 -1.497 . . . . 0.0 110.011 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 105' ' ' GLN . . . . . 0.487 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 51.4 mm-40 -113.35 -49.4 2.91 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.505 -0.747 . . . . 0.0 109.958 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 106' ' ' TRP . . . . . 0.505 ' CZ3' ' HB2' ' A' ' 112' ' ' ARG . 82.7 m95 . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.512 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.473 ' HA ' HD11 ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.452 HD11 HG13 ' A' ' 18' ' ' VAL . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.88 ' HG2' HG23 ' A' ' 18' ' ' VAL . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.88 HG23 ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.488 ' HA ' HD23 ' A' ' 22' ' ' LEU . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.415 ' CE2' HG23 ' A' ' 50' ' ' VAL . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.503 ' HE1' HD12 ' A' ' 395' ' ' ILE . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.432 ' HA ' HD12 ' A' ' 34' ' ' LEU . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 39' ' ' GLN . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.514 ' N ' HG12 ' A' ' 38' ' ' VAL . 1.6 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.457 ' O ' HG21 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.423 ' HE3' HD13 ' A' ' 324' ' ' LEU . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.457 HG21 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.49 ' HB3' HG21 ' A' ' 66' ' ' THR . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.412 ' ND2' HG22 ' A' ' 50' ' ' VAL . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.608 HG13 ' HD2' ' A' ' 51' ' ' PRO . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.608 ' HD2' HG13 ' A' ' 50' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.438 HG21 ' HB ' ' A' ' 64' ' ' ILE . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.594 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.8 m120 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.594 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.438 ' HB ' HG21 ' A' ' 54' ' ' VAL . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.49 HG21 ' HB3' ' A' ' 45' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.436 HD11 ' N ' ' A' ' 70' ' ' LEU . 6.0 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.408 ' CZ ' HG22 ' A' ' 348' ' ' THR . 5.6 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.462 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.6 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.456 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 27.1 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.7 mmt-85 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.62 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.2 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.54 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.54 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.754 ' HD2' ' HB2' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.754 ' HB2' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.694 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.927 HD12 ' NE ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.629 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 74.3 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.629 ' OG1' ' HD2' ' A' ' 100' ' ' PRO . 3.9 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.508 ' HE1' HD13 ' A' ' 99' ' ' ILE . 46.0 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.614 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.296 50.1 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.459 ' HA ' ' HB3' ' A' ' 108' ' ' GLN 0.366 52.7 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.614 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 34.8 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.469 ' H ' ' CD ' ' A' ' 106' ' ' PRO 0.342 30.7 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . 0.459 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 1.8 tm0? -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.9 mtt-85 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.41 ' O ' ' HB2' ' A' ' 117' ' ' GLN . 7.4 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.407 ' HA ' ' CD2' ' A' ' 358' ' ' LEU . 25.4 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' A' ' 114' ' ' LEU . 27.6 mt-30 -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.0 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.6 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.489 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.672 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 0.0 OUTLIER -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.672 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.0 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.541 HG13 HD11 ' A' ' 166' ' ' LEU . 78.3 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.2 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 28.3 mtmt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.475 HD13 HG12 ' A' ' 123' ' ' VAL . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.488 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.506 ' HA ' HD11 ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.615 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.577 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.488 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.782 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.782 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.465 HD11 HG22 ' A' ' 160' ' ' ILE . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.467 ' HA ' HD13 ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.429 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.541 HD11 HG13 ' A' ' 123' ' ' VAL . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.506 ' N ' HD21 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.44 HD21 ' HA ' ' A' ' 169' ' ' LEU . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.417 ' N ' ' CD ' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.566 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.523 ' HA ' HD22 ' A' ' 180' ' ' LEU . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' MET . . . . . 0.499 ' HE2' HG22 ' A' ' 247' ' ' VAL . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.421 HD13 HD13 ' A' ' 180' ' ' LEU . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . 0.441 ' HB3' ' HG ' ' A' ' 221' ' ' SER . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 211' ' ' ARG . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 224' ' ' ALA . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' SER . . . . . 0.441 ' HG ' ' HB3' ' A' ' 211' ' ' ARG . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 44.9 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 42.0 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 220' ' ' ILE . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 4.3 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 13.5 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . 0.927 ' NE ' HD12 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 40.7 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.694 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.423 ' HA ' HD22 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.499 HG22 ' HE2' ' A' ' 184' ' ' MET . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 250' ' ' LEU . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.675 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.469 HD22 ' HA ' ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' MET . . . . . 0.577 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.428 HD22 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 16.4 pm0 -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.433 ' N ' ' CD ' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' CYS . . . . . 0.422 ' SG ' HG21 ' A' ' 367' ' ' ILE . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . 0.433 HD23 HG21 ' A' ' 349' ' ' THR . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . 0.497 ' CZ ' ' HE1' ' A' ' 336' ' ' MET . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.641 ' HA ' ' HE1' ' A' ' 323' ' ' MET . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 296' ' ' ALA . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . 0.424 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . 0.424 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.0 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.535 HD23 ' N ' ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' PHE . . . . . 0.424 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.6 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' HIS . . . . . 0.424 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 36.9 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 312' ' ' LEU . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' LEU . . . . . 0.63 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' PRO . . . . . 0.63 ' HD3' ' O ' ' A' ' 319' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' MET . . . . . 0.641 ' HE1' ' HA ' ' A' ' 294' ' ' LEU . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.456 HD11 ' HB2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 13.7 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' LEU . . . . . . . . . . . . . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.472 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' PRO . . . . . 0.472 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' MET . . . . . 0.497 ' HE1' ' CZ ' ' A' ' 291' ' ' ARG . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' GLN . . . . . 0.441 ' CB ' ' HD3' ' A' ' 344' ' ' LYS . 1.9 mp0 -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' LYS . . . . . 0.498 ' HB2' ' HE2' ' A' ' 344' ' ' LYS . 1.7 mppt? -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 57.8 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 22.1 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 348' ' ' THR . . . . . 0.408 HG22 ' CZ ' ' A' ' 72' ' ' ARG . 16.5 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 349' ' ' THR . . . . . 0.433 HG21 HD23 ' A' ' 289' ' ' LEU . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 73.7 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 354' ' ' SER . . . . . 0.459 ' HA ' ' CB ' ' B' ' 44' ' ' SER . 97.1 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 356' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . 0.407 ' CD2' ' HA ' ' A' ' 116' ' ' ASN . 0.5 OUTLIER -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.42 ' HA ' HD12 ' A' ' 362' ' ' LEU . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 40.9 mtt85 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 17.2 tpp85 -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . 0.422 HG21 ' SG ' ' A' ' 285' ' ' CYS . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.485 HD12 HG23 ' A' ' 383' ' ' ILE . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' ILE . . . . . 0.403 HD11 HD12 ' A' ' 402' ' ' LEU . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.503 HD12 ' HE1' ' A' ' 28' ' ' MET . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . 0.403 HD12 HD11 ' A' ' 389' ' ' ILE . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' LEU . . . . . 0.404 ' HA ' HD22 ' A' ' 404' ' ' LEU . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 407' ' ' ASP . . . . . 0.544 ' HB3' HG23 ' A' ' 410' ' ' THR . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 408' ' ' PRO . . . . . 0.645 ' HA ' HG22 ' A' ' 411' ' ' THR . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 410' ' ' THR . . . . . 0.544 HG23 ' HB3' ' A' ' 407' ' ' ASP . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 411' ' ' THR . . . . . 0.645 HG22 ' HA ' ' A' ' 408' ' ' PRO . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 412' ' ' LYS . . . . . 0.496 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 N--CA 1.495 1.809 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.52 138.58 38.48 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.177 -0.952 . . . . 0.0 113.004 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 61.2 t -137.11 122.6 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.441 HG13 ' CZ ' ' B' ' 12' ' ' ARG . 97.5 t -106.78 129.58 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.15 -0.969 . . . . 0.0 111.635 -178.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.558 ' CD1' HD11 ' B' ' 32' ' ' ILE . 77.2 m-85 -109.28 110.6 21.83 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.82 127.23 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.935 -1.103 . . . . 0.0 108.363 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.6 m -86.2 174.69 8.94 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.737 0.779 . . . . 0.0 112.509 -177.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' HIS . . . . . 0.413 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.66 -46.73 89.22 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 121.19 0.519 . . . . 0.0 110.457 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -65.93 -11.29 46.16 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.52 -0.737 . . . . 0.0 111.381 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.01 15.4 28.55 Favored Glycine 0 N--CA 1.492 2.388 0 O-C-N 121.177 -0.952 . . . . 0.0 111.287 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 89.8 m -82.05 147.35 29.18 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 118.733 1.266 . . . . 0.0 109.929 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . 0.441 ' CZ ' HG13 ' B' ' 4' ' ' VAL . 50.8 ttt85 -118.46 128.74 54.89 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.528 -0.732 . . . . 0.0 111.864 -178.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.06 127.67 46.2 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.571 -0.705 . . . . 0.0 109.81 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -111.34 130.63 55.62 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.275 -0.891 . . . . 0.0 111.612 -178.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.561 HD11 HD13 ' B' ' 32' ' ' ILE . 84.7 mt -122.78 159.35 28.24 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.736 -0.602 . . . . 0.0 111.117 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -109.64 91.62 3.72 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 176.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.6 t -90.21 133.49 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-O 121.604 0.716 . . . . 0.0 112.288 -176.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.11 170.71 16.05 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.779 -0.576 . . . . 0.0 110.27 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -68.47 151.82 46.27 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.479 -0.763 . . . . 0.0 110.958 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.45 -12.51 55.34 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.048 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 59.4 t -90.03 133.32 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.704 -1.468 . . . . 0.0 110.896 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 22.3 p -80.23 151.96 29.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.583 -0.698 . . . . 0.0 109.173 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.478 HD23 ' HH ' ' B' ' 5' ' ' TYR . 18.4 mt -61.22 -24.63 66.48 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.299 -0.876 . . . . 0.0 110.578 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 8.5 tmm? -69.78 -49.19 55.31 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.234 -0.916 . . . . 0.0 109.521 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -59.81 -41.7 91.86 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.594 -0.691 . . . . 0.0 109.953 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.04 -40.91 95.47 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.616 -0.678 . . . . 0.0 110.135 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.3 -49.78 58.12 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.266 -0.896 . . . . 0.0 111.046 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 69.3 t -65.42 -39.19 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.36 -0.837 . . . . 0.0 110.734 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 28.2 m -70.16 -13.97 62.43 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.372 -0.83 . . . . 0.0 111.526 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -118.2 23.8 11.37 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.04 -1.038 . . . . 0.0 110.663 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.72 38.27 58.81 Favored Glycine 0 N--CA 1.492 2.424 0 O-C-N 121.556 -0.715 . . . . 0.0 111.828 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.561 HD13 HD11 ' B' ' 15' ' ' LEU . 1.7 mt -72.55 147.17 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.836 -1.391 . . . . 0.0 108.853 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.68 142.48 58.08 Favored 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 117.215 2.302 . . . . 0.0 117.215 -174.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 62.18 -36.09 0.12 Allowed 'General case' 0 N--CA 1.516 2.855 0 N-CA-C 116.655 2.094 . . . . 0.0 116.655 175.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 84.4 mt -59.78 122.91 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.373 0 O-C-N 119.843 -1.785 . . . . 0.0 110.673 -178.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.573 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 18.9 t -100.12 -51.46 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.63 -0.669 . . . . 0.0 111.193 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.16 56.5 20.08 Favored Glycine 0 N--CA 1.5 2.906 0 N-CA-C 107.447 -2.261 . . . . 0.0 107.447 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.3 -49.31 44.11 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.974 -0.721 . . . . 0.0 112.269 -177.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' CYS . . . . . 0.54 ' HB3' ' HB3' ' B' ' 45' ' ' CYS . 2.3 p -66.59 -10.44 45.51 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.206 -0.934 . . . . 0.0 112.384 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.82 -5.51 64.02 Favored Glycine 0 N--CA 1.499 2.854 0 O-C-N 120.824 -1.172 . . . . 0.0 111.968 177.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.06 19.58 10.63 Favored Glycine 0 N--CA 1.495 2.589 0 O-C-N 120.815 -1.403 . . . . 0.0 111.071 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 90.1 p -99.01 19.15 15.63 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.062 -1.258 . . . . 0.0 111.119 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.99 40.82 30.33 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.42 -0.8 . . . . 0.0 111.941 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' SER . . . . . 0.459 ' CB ' ' HA ' ' A' ' 354' ' ' SER . 70.7 m -117.02 11.19 14.2 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.368 -0.832 . . . . 0.0 109.494 178.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' CYS . . . . . 0.54 ' HB3' ' HB3' ' B' ' 39' ' ' CYS . 15.1 p -149.51 -179.09 6.82 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.54 -0.725 . . . . 0.0 109.049 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.07 34.09 3.1 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.849 -1.157 . . . . 0.0 111.362 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' THR . . . . . 0.573 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 81.9 p -97.61 13.27 30.73 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.0 -1.063 . . . . 0.0 111.277 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' CYS . . . . . 0.408 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.1 p -120.54 31.74 6.31 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 177.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . 0.436 ' O ' HG13 ' B' ' 50' ' ' VAL . 23.9 t-160 -72.74 133.05 44.38 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.574 -178.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . 0.468 HG23 ' HB3' ' B' ' 85' ' ' CYS . 12.3 m -146.26 160.07 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . 0.407 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.5 m-85 -105.41 102.7 12.16 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.26 -0.9 . . . . 0.0 108.709 178.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.3 t -61.87 135.15 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.319 -0.863 . . . . 0.0 109.362 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.7 131.79 51.34 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.981 0.896 . . . . 0.0 109.505 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -44.28 -31.05 0.91 Allowed 'General case' 0 N--CA 1.505 2.314 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.76 -6.96 54.38 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.982 -1.074 . . . . 0.0 112.742 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -119.91 -6.61 10.04 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.492 -1.38 . . . . 0.0 111.892 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.3 p -55.49 -37.77 68.27 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.167 -0.958 . . . . 0.0 112.84 -178.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -81.14 -6.71 59.14 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.773 -1.204 . . . . 0.0 111.447 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -89.83 -11.66 41.37 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.017 -1.052 . . . . 0.0 109.841 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.623 HG12 ' HD2' ' B' ' 61' ' ' PRO . 40.7 t -104.05 141.02 21.65 Favored Pre-proline 0 N--CA 1.489 1.521 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . 0.623 ' HD2' HG12 ' B' ' 60' ' ' VAL . 49.7 Cg_endo -73.81 118.85 5.61 Favored 'Trans proline' 0 N--CA 1.488 1.172 0 O-C-N 123.487 1.256 . . . . 0.0 109.001 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.9 160.6 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.761 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 -177.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . 0.44 ' HB2' ' HB3' ' B' ' 67' ' ' GLU . . . -65.71 146.16 55.13 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.239 178.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -89.84 -170.73 2.91 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.59 -0.694 . . . . 0.0 110.388 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.56 -42.0 91.42 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.287 -0.883 . . . . 0.0 111.75 -178.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 8.7 ttt180 -67.45 -41.55 84.53 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.173 -0.954 . . . . 0.0 112.014 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . 0.528 ' HG3' HD12 ' B' ' 84' ' ' LEU . 45.5 tt0 -68.2 -43.97 76.88 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.938 -1.101 . . . . 0.0 110.329 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' ILE . . . . . 0.517 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.7 mm -55.55 -42.21 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.243 -0.911 . . . . 0.0 109.367 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.15 -47.88 80.75 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 5.3 mmt -66.17 -34.01 77.07 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.264 -1.139 . . . . 0.0 111.172 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' LEU . . . . . 0.441 HD22 ' HA ' ' B' ' 71' ' ' LEU . 28.0 mt -63.48 -23.29 67.33 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.294 -0.879 . . . . 0.0 110.634 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . 0.517 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 49.8 mt-10 -70.45 -8.69 52.94 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.265 -0.897 . . . . 0.0 110.883 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 83.4 p -119.9 12.6 12.1 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.002 -1.061 . . . . 0.0 112.519 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 30.5 m -60.83 140.42 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 120.714 -1.241 . . . . 0.0 109.634 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 81.9 m -74.53 -39.11 62.56 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.419 -0.8 . . . . 0.0 110.15 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.2 168.81 17.46 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.454 -0.779 . . . . 0.0 110.121 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.32 139.15 55.74 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.44 -0.788 . . . . 0.0 110.566 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.4 tp -90.95 116.15 28.53 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.517 -0.739 . . . . 0.0 109.918 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -103.05 168.31 8.97 Favored Pre-proline 0 N--CA 1.489 1.515 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -76.58 -0.06 10.05 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 O-C-N 123.239 1.126 . . . . 0.0 110.404 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -120.46 22.36 11.3 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.002 -1.061 . . . . 0.0 108.385 176.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 4.3 m -80.78 137.22 36.23 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.853 -0.53 . . . . 0.0 110.407 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.5 mmm-85 -149.75 146.38 27.17 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.455 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.528 HD12 ' HG3' ' B' ' 67' ' ' GLU . 92.1 mt -80.6 98.92 7.86 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 175.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' CYS . . . . . 0.468 ' HB3' HG23 ' B' ' 50' ' ' VAL . 10.6 p -48.36 -17.89 0.18 Allowed 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -175.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.8 p -70.29 -14.01 62.41 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.662 -1.273 . . . . 0.0 109.464 178.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 80.5 mm-40 -92.66 -12.2 32.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.511 -0.743 . . . . 0.0 110.589 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' ILE . . . . . 0.465 HG21 HD13 ' B' ' 23' ' ' LEU . 61.9 mt -91.49 103.96 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.188 -0.945 . . . . 0.0 110.624 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.432 HD13 ' HA ' ' B' ' 89' ' ' ILE . 46.0 mm -84.94 131.77 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' MET . . . . . 0.423 ' C ' HG22 ' B' ' 91' ' ' THR . 13.6 tpt -74.88 137.81 42.02 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 122.123 0.963 . . . . 0.0 113.236 -177.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' THR . . . . . 0.423 HG22 ' C ' ' B' ' 90' ' ' MET . 43.7 p -138.24 166.54 25.06 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 176.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -74.9 1.7 7.38 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 122.632 0.807 . . . . 0.0 111.05 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -87.58 -22.89 24.52 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 176.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.2 mt -93.8 13.02 23.75 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.394 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.47 126.39 23.32 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.203 -0.936 . . . . 0.0 111.162 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.27 6.77 68.36 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.666 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.57 142.75 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 CA-C-N 119.328 1.564 . . . . 0.0 110.779 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 60.6 t -122.54 132.95 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.546 -0.722 . . . . 0.0 109.854 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 99' ' ' VAL . . . . . 0.428 ' O ' HG23 ' B' ' 99' ' ' VAL . 16.4 m -130.36 135.75 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.535 -0.728 . . . . 0.0 109.814 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 100' ' ' ASP . . . . . 0.407 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.39 134.15 35.2 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.2 t -103.43 127.35 29.82 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.52 -0.737 . . . . 0.0 110.351 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -80.81 130.95 7.86 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 O-C-N 124.129 1.594 . . . . 0.0 108.283 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 103' ' ' ASP . . . . . 0.413 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.4 p-10 -62.41 3.43 0.19 Allowed 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -125.33 114.63 19.15 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.257 -1.527 . . . . 0.0 110.054 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 105' ' ' GLN . . . . . 0.485 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 52.4 mm-40 -113.32 -49.34 2.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.438 -0.789 . . . . 0.0 110.016 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 106' ' ' TRP . . . . . . . . . . . . . 23.1 m0 . . . . . 0 N--CA 1.495 1.793 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.531 179.305 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.473 ' HA ' HD11 ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.452 HD11 HG13 ' A' ' 18' ' ' VAL . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.88 ' HG2' HG23 ' A' ' 18' ' ' VAL . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.88 HG23 ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.488 ' HA ' HD23 ' A' ' 22' ' ' LEU . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.415 ' CE2' HG23 ' A' ' 50' ' ' VAL . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.503 ' HE1' HD12 ' A' ' 395' ' ' ILE . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.432 ' HA ' HD12 ' A' ' 34' ' ' LEU . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 39' ' ' GLN . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.514 ' N ' HG12 ' A' ' 38' ' ' VAL . 1.6 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.457 ' O ' HG21 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.423 ' HE3' HD13 ' A' ' 324' ' ' LEU . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.457 HG21 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.49 ' HB3' HG21 ' A' ' 66' ' ' THR . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.412 ' ND2' HG22 ' A' ' 50' ' ' VAL . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.608 HG13 ' HD2' ' A' ' 51' ' ' PRO . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.608 ' HD2' HG13 ' A' ' 50' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.438 HG21 ' HB ' ' A' ' 64' ' ' ILE . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.594 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.8 m120 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.594 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.438 ' HB ' HG21 ' A' ' 54' ' ' VAL . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.49 HG21 ' HB3' ' A' ' 45' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.436 HD11 ' N ' ' A' ' 70' ' ' LEU . 6.0 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.406 ' CZ ' HG22 ' A' ' 348' ' ' THR . 5.6 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.462 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.6 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.46 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 27.1 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.7 mmt-85 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.62 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.2 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.54 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.54 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.754 ' HD2' ' HB2' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.754 ' HB2' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.694 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.927 HD12 ' NE ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.629 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 74.3 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.629 ' OG1' ' HD2' ' A' ' 100' ' ' PRO . 3.9 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.508 ' HE1' HD13 ' A' ' 99' ' ' ILE . 46.0 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.614 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.296 50.1 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.46 ' HD2' ' CD1' ' A' ' 78' ' ' TYR 0.366 52.9 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.614 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 34.8 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.469 ' H ' ' CD ' ' A' ' 106' ' ' PRO 0.342 30.7 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . 0.458 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 1.8 tm0? -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.401 ' HB1' ' HB3' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.41 ' O ' ' HB2' ' A' ' 117' ' ' GLN . 7.0 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' A' ' 114' ' ' LEU . 24.3 mt-30 -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 34.9 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.5 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.489 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.672 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 0.0 OUTLIER -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.672 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.0 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.541 HG13 HD11 ' A' ' 166' ' ' LEU . 78.3 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 28.0 mtmt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.475 HD13 HG12 ' A' ' 123' ' ' VAL . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.488 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.506 ' HA ' HD11 ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.615 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.577 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.488 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.782 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.782 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.465 HD11 HG22 ' A' ' 160' ' ' ILE . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.467 ' HA ' HD13 ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.429 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.541 HD11 HG13 ' A' ' 123' ' ' VAL . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.506 ' N ' HD21 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.44 HD21 ' HA ' ' A' ' 169' ' ' LEU . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.417 ' N ' ' CD ' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.566 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.523 ' HA ' HD22 ' A' ' 180' ' ' LEU . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' MET . . . . . 0.499 ' HE2' HG22 ' A' ' 247' ' ' VAL . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.421 HD13 HD13 ' A' ' 180' ' ' LEU . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . 0.441 ' HB3' ' HG ' ' A' ' 221' ' ' SER . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 211' ' ' ARG . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 224' ' ' ALA . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' SER . . . . . 0.441 ' HG ' ' HB3' ' A' ' 211' ' ' ARG . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 44.9 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 42.0 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 220' ' ' ILE . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 4.3 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 13.5 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . 0.927 ' NE ' HD12 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 41.0 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.694 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.423 ' HA ' HD22 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.499 HG22 ' HE2' ' A' ' 184' ' ' MET . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 250' ' ' LEU . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.675 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.469 HD22 ' HA ' ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' MET . . . . . 0.577 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.428 HD22 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 13.2 pm0 -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.433 ' N ' ' CD ' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' CYS . . . . . 0.422 ' SG ' HG21 ' A' ' 367' ' ' ILE . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . 0.433 HD23 HG21 ' A' ' 349' ' ' THR . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . 0.497 ' CZ ' ' HE1' ' A' ' 336' ' ' MET . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.641 ' HA ' ' HE1' ' A' ' 323' ' ' MET . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 296' ' ' ALA . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . 0.424 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . 0.424 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.0 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.535 HD23 ' N ' ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' PHE . . . . . 0.424 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.6 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' HIS . . . . . 0.424 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 36.9 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 312' ' ' LEU . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' LEU . . . . . 0.63 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' PRO . . . . . 0.63 ' HD3' ' O ' ' A' ' 319' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' MET . . . . . 0.641 ' HE1' ' HA ' ' A' ' 294' ' ' LEU . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.456 HD11 ' HB2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 13.7 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' LEU . . . . . . . . . . . . . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.472 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' PRO . . . . . 0.472 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' MET . . . . . 0.497 ' HE1' ' CZ ' ' A' ' 291' ' ' ARG . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 68.2 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' ARG . . . . . 0.418 ' HB3' HG23 ' A' ' 345' ' ' VAL . 43.4 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' GLN . . . . . 0.462 ' CB ' ' HD3' ' A' ' 344' ' ' LYS . 0.1 OUTLIER -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' LYS . . . . . 0.498 ' HB2' ' HE2' ' A' ' 344' ' ' LYS . 1.7 mppt? -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.418 HG23 ' HB3' ' A' ' 342' ' ' ARG . 60.0 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 13.2 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 348' ' ' THR . . . . . 0.406 HG22 ' CZ ' ' A' ' 72' ' ' ARG . 16.5 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 349' ' ' THR . . . . . 0.433 HG21 HD23 ' A' ' 289' ' ' LEU . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 354' ' ' SER . . . . . 0.586 ' HA ' ' HB3' ' B' ' 44' ' ' SER . 95.3 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 356' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 4.9 mp -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.42 ' HA ' HD12 ' A' ' 362' ' ' LEU . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 38.2 mtt85 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 14.3 tpp85 -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . 0.422 HG21 ' SG ' ' A' ' 285' ' ' CYS . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.485 HD12 HG23 ' A' ' 383' ' ' ILE . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' ILE . . . . . 0.403 HD11 HD12 ' A' ' 402' ' ' LEU . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.503 HD12 ' HE1' ' A' ' 28' ' ' MET . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . 0.403 HD12 HD11 ' A' ' 389' ' ' ILE . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' LEU . . . . . 0.404 ' HA ' HD22 ' A' ' 404' ' ' LEU . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 407' ' ' ASP . . . . . 0.544 ' HB3' HG23 ' A' ' 410' ' ' THR . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 408' ' ' PRO . . . . . 0.645 ' HA ' HG22 ' A' ' 411' ' ' THR . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 410' ' ' THR . . . . . 0.544 HG23 ' HB3' ' A' ' 407' ' ' ASP . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 411' ' ' THR . . . . . 0.645 HG22 ' HA ' ' A' ' 408' ' ' PRO . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 412' ' ' LYS . . . . . 0.496 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 40.3 m . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 121.079 0.466 . . . . 0.0 109.757 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.51 138.61 38.51 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.169 -0.957 . . . . 0.0 112.928 -178.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 61.2 t -137.17 122.57 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 177.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.439 HG13 ' CZ ' ' B' ' 12' ' ' ARG . 98.4 t -106.81 129.61 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.159 -0.963 . . . . 0.0 111.62 -178.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.556 ' CD1' HD11 ' B' ' 32' ' ' ILE . 77.3 m-85 -109.22 110.6 21.84 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.83 127.22 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 120.96 -1.087 . . . . 0.0 108.353 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.4 m -86.17 174.67 8.97 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.772 0.796 . . . . 0.0 112.503 -177.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' HIS . . . . . 0.409 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.6 t-80 -60.7 -46.7 89.38 Favored 'General case' 0 N--CA 1.503 2.179 0 CA-C-O 121.142 0.496 . . . . 0.0 110.436 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -65.92 -11.28 46.08 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.575 -0.703 . . . . 0.0 111.387 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.96 15.48 28.45 Favored Glycine 0 N--CA 1.491 2.335 0 O-C-N 121.074 -1.016 . . . . 0.0 111.269 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.0 m -82.07 147.4 29.13 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 118.713 1.257 . . . . 0.0 109.926 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . 0.439 ' CZ ' HG13 ' B' ' 4' ' ' VAL . 50.9 ttt85 -118.49 128.8 54.93 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.428 -0.795 . . . . 0.0 111.83 -178.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.05 127.67 46.2 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.596 -0.69 . . . . 0.0 109.803 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -111.37 130.64 55.62 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.287 -0.883 . . . . 0.0 111.589 -178.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.571 HD11 HD13 ' B' ' 32' ' ' ILE . 84.6 mt -122.79 159.36 28.24 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.753 -0.592 . . . . 0.0 111.118 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -109.61 91.62 3.72 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 176.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.5 t -90.15 133.4 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-O 121.575 0.702 . . . . 0.0 112.303 -176.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.08 170.66 16.12 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.768 -0.582 . . . . 0.0 110.295 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -68.44 151.82 46.29 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.477 -0.764 . . . . 0.0 111.005 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.47 -12.53 55.39 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.03 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 61.1 t -89.99 133.34 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.655 -1.497 . . . . 0.0 110.928 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 97.7 p -80.29 151.88 29.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.513 -0.742 . . . . 0.0 109.127 178.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.478 HD23 ' HH ' ' B' ' 5' ' ' TYR . 18.5 mt -61.16 -24.63 66.43 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.312 -0.868 . . . . 0.0 110.631 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 2.7 ttp -69.75 -49.2 55.41 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.217 -0.927 . . . . 0.0 109.514 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.79 -41.75 91.86 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.591 -0.693 . . . . 0.0 109.941 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.06 -40.89 95.37 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.574 -0.704 . . . . 0.0 110.137 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.3 -49.77 58.2 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.203 -0.935 . . . . 0.0 111.071 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 77.4 t -65.48 -39.15 84.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.305 -0.872 . . . . 0.0 110.723 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 26.0 m -70.14 -14.0 62.45 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.394 -0.816 . . . . 0.0 111.547 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -118.17 23.78 11.39 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.033 -1.042 . . . . 0.0 110.623 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.74 38.27 58.86 Favored Glycine 0 N--CA 1.493 2.459 0 O-C-N 121.566 -0.709 . . . . 0.0 111.81 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.571 HD13 HD11 ' B' ' 15' ' ' LEU . 1.7 mt -72.53 147.12 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.914 -1.345 . . . . 0.0 108.878 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.67 142.51 58.05 Favored 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 117.203 2.297 . . . . 0.0 117.203 -174.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . 0.44 ' O ' ' HG3' ' B' ' 105' ' ' GLN . 65.3 m-20 62.19 -36.14 0.12 Allowed 'General case' 0 N--CA 1.515 2.81 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 175.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 84.4 mt -59.69 122.85 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 O-C-N 119.864 -1.772 . . . . 0.0 110.701 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.613 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 2.4 t -100.09 -51.35 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.577 -0.702 . . . . 0.0 111.241 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.1 56.49 20.24 Favored Glycine 0 N--CA 1.5 2.908 0 N-CA-C 107.447 -2.261 . . . . 0.0 107.447 -178.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -71.34 -49.24 44.44 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.991 -0.711 . . . . 0.0 112.262 -177.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' CYS . . . . . 0.539 ' HB3' ' HB3' ' B' ' 45' ' ' CYS . 2.3 p -66.55 -10.46 45.37 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.22 -0.925 . . . . 0.0 112.394 -178.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.77 -5.48 64.13 Favored Glycine 0 N--CA 1.499 2.836 0 O-C-N 120.806 -1.184 . . . . 0.0 111.981 177.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.14 19.51 10.64 Favored Glycine 0 N--CA 1.494 2.558 0 O-C-N 120.842 -1.387 . . . . 0.0 110.978 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 30.7 p -98.99 19.16 15.61 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.037 -1.273 . . . . 0.0 111.115 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 56.04 40.83 30.24 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.391 -0.818 . . . . 0.0 111.93 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' SER . . . . . 0.586 ' HB3' ' HA ' ' A' ' 354' ' ' SER . 5.7 m -117.05 11.21 14.18 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.318 -0.864 . . . . 0.0 109.557 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' CYS . . . . . 0.539 ' HB3' ' HB3' ' B' ' 39' ' ' CYS . 15.1 p -149.56 -179.1 6.83 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.04 34.07 3.11 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.884 -1.135 . . . . 0.0 111.356 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' THR . . . . . 0.613 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 37.2 p -97.52 13.2 30.79 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.964 -1.085 . . . . 0.0 111.314 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' CYS . . . . . 0.422 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.1 p -120.57 31.77 6.3 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . 0.43 ' O ' HG13 ' B' ' 50' ' ' VAL . 23.8 t-160 -72.7 133.03 44.41 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.609 -178.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . 0.475 HG23 ' HB3' ' B' ' 85' ' ' CYS . 12.3 m -146.29 160.07 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . 0.402 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.5 m-85 -105.42 102.76 12.21 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.3 -0.875 . . . . 0.0 108.681 178.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.2 t -61.98 135.12 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 121.315 -0.865 . . . . 0.0 109.349 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.65 131.81 51.36 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.944 0.878 . . . . 0.0 109.559 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -44.34 -30.98 0.91 Allowed 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.84 -6.9 54.25 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.984 -1.073 . . . . 0.0 112.712 -178.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -119.95 -6.67 10.02 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 120.503 -1.373 . . . . 0.0 111.871 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.5 p -55.37 -37.85 68.06 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.154 -0.967 . . . . 0.0 112.892 -178.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -81.1 -6.65 59.06 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.787 -1.196 . . . . 0.0 111.46 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -89.93 -11.6 41.28 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.078 -1.014 . . . . 0.0 109.831 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.616 HG12 ' HD2' ' B' ' 61' ' ' PRO . 40.8 t -104.07 141.05 21.71 Favored Pre-proline 0 N--CA 1.488 1.467 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . 0.616 ' HD2' HG12 ' B' ' 60' ' ' VAL . 49.4 Cg_endo -73.8 118.92 5.64 Favored 'Trans proline' 0 N--CA 1.489 1.209 0 O-C-N 123.514 1.271 . . . . 0.0 108.986 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.99 160.66 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.761 0 N-CA-C 116.647 2.092 . . . . 0.0 116.647 -177.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . 0.434 ' HB2' ' HB3' ' B' ' 67' ' ' GLU . . . -65.77 146.15 55.12 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 114.572 -1.194 . . . . 0.0 111.247 178.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -89.78 -170.79 2.94 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.565 -0.709 . . . . 0.0 110.392 178.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -59.53 -42.05 91.38 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.343 -0.848 . . . . 0.0 111.686 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 5.0 ttt180 -67.39 -41.57 84.76 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.175 -0.953 . . . . 0.0 112.028 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . 0.434 ' HB3' ' HB2' ' B' ' 63' ' ' ALA . 45.4 tt0 -68.23 -43.91 76.88 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.01 -1.056 . . . . 0.0 110.349 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' ILE . . . . . 0.511 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.6 mm -55.56 -42.18 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 O-C-N 121.287 -0.883 . . . . 0.0 109.372 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.22 -47.84 80.83 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 9.5 mmt -66.18 -33.99 77.01 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.27 -1.135 . . . . 0.0 111.207 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' LEU . . . . . 0.494 HD22 ' HA ' ' B' ' 71' ' ' LEU . 28.1 mt -63.45 -23.35 67.36 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.214 -0.929 . . . . 0.0 110.608 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . 0.511 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 49.9 mt-10 -70.41 -8.79 53.54 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.344 -0.848 . . . . 0.0 110.889 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 82.8 p -119.78 12.54 12.18 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.001 -1.062 . . . . 0.0 112.543 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 28.8 m -60.8 140.46 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 O-C-N 120.761 -1.212 . . . . 0.0 109.627 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 44.8 m -74.58 -39.07 62.45 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.406 -0.809 . . . . 0.0 110.174 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.2 168.82 17.43 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.476 -0.765 . . . . 0.0 110.076 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.27 139.15 55.64 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.451 -0.781 . . . . 0.0 110.615 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.4 tp -91.0 116.19 28.6 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.551 -0.718 . . . . 0.0 109.836 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -103.02 168.33 8.95 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -76.62 -0.03 10.04 Favored 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 123.27 1.142 . . . . 0.0 110.43 178.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -120.43 22.35 11.32 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.963 -1.086 . . . . 0.0 108.419 176.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 4.3 m -80.77 137.17 36.24 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.833 -0.542 . . . . 0.0 110.385 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.5 mmm-85 -149.75 146.39 27.17 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.443 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.422 ' HB3' ' SG ' ' B' ' 48' ' ' CYS . 95.0 mt -80.57 98.99 7.87 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 175.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' CYS . . . . . 0.475 ' HB3' HG23 ' B' ' 50' ' ' VAL . 10.6 p -48.43 -17.91 0.19 Allowed 'General case' 0 N--CA 1.508 2.439 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -175.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.8 p -70.3 -13.92 62.37 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.646 -1.284 . . . . 0.0 109.453 178.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -92.72 -12.3 31.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.465 -0.772 . . . . 0.0 110.533 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' ILE . . . . . 0.466 HG21 HD13 ' B' ' 23' ' ' LEU . 61.8 mt -91.46 103.96 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.117 -0.99 . . . . 0.0 110.671 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 47.3 mm -84.99 131.8 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' MET . . . . . 0.422 ' C ' HG22 ' B' ' 91' ' ' THR . 13.6 tpt -74.85 137.77 42.05 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 122.143 0.973 . . . . 0.0 113.244 -177.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' THR . . . . . 0.422 HG22 ' C ' ' B' ' 90' ' ' MET . 43.8 p -138.2 166.59 24.73 Favored Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 176.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -74.94 1.65 7.46 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 122.689 0.836 . . . . 0.0 110.996 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -87.58 -22.84 24.55 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 176.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.6 mt -93.77 12.95 23.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 122.035 -0.416 . . . . 0.0 110.389 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.45 126.38 23.24 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.128 -0.983 . . . . 0.0 111.177 -178.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.19 6.83 68.48 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.68 179.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.62 142.75 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-N 119.334 1.567 . . . . 0.0 110.81 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 60.6 t -122.47 133.02 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.559 -0.713 . . . . 0.0 109.829 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 99' ' ' VAL . . . . . 0.431 ' O ' HG23 ' B' ' 99' ' ' VAL . 16.4 m -130.41 135.74 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.456 -0.778 . . . . 0.0 109.788 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 100' ' ' ASP . . . . . 0.402 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.38 134.16 35.19 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.2 t -103.4 127.31 29.91 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.505 -0.747 . . . . 0.0 110.359 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -80.87 130.96 7.79 Favored 'Trans proline' 0 C--N 1.316 -1.163 0 O-C-N 124.101 1.579 . . . . 0.0 108.277 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 103' ' ' ASP . . . . . 0.409 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.3 p-10 -62.37 3.41 0.19 Allowed 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -178.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -125.29 114.58 19.12 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.277 -1.514 . . . . 0.0 110.089 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 105' ' ' GLN . . . . . 0.492 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 23.9 mm-40 -113.25 -49.41 2.91 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.455 -0.778 . . . . 0.0 110.029 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 106' ' ' TRP . . . . . 0.401 ' HB3' ' HB1' ' A' ' 113' ' ' ALA . 17.0 m0 . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 118.249 -0.882 . . . . 0.0 110.547 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.473 ' HA ' HD11 ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.452 HD11 HG13 ' A' ' 18' ' ' VAL . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.88 ' HG2' HG23 ' A' ' 18' ' ' VAL . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.88 HG23 ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.488 ' HA ' HD23 ' A' ' 22' ' ' LEU . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.415 ' CE2' HG23 ' A' ' 50' ' ' VAL . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.503 ' HE1' HD12 ' A' ' 395' ' ' ILE . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.432 ' HA ' HD12 ' A' ' 34' ' ' LEU . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 39' ' ' GLN . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.514 ' N ' HG12 ' A' ' 38' ' ' VAL . 1.6 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.457 ' O ' HG21 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.423 ' HE3' HD13 ' A' ' 324' ' ' LEU . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.457 HG21 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.49 ' HB3' HG21 ' A' ' 66' ' ' THR . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.412 ' ND2' HG22 ' A' ' 50' ' ' VAL . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.608 HG13 ' HD2' ' A' ' 51' ' ' PRO . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.608 ' HD2' HG13 ' A' ' 50' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.438 HG21 ' HB ' ' A' ' 64' ' ' ILE . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.594 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.8 m120 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.594 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.438 ' HB ' HG21 ' A' ' 54' ' ' VAL . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.49 HG21 ' HB3' ' A' ' 45' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.436 HD11 ' N ' ' A' ' 70' ' ' LEU . 6.0 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.4 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.401 ' HB3' HD12 ' A' ' 320' ' ' LEU . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.462 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.6 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.493 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 26.6 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.4 mtt-85 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.8 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.62 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.1 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.54 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.54 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.754 ' HD2' ' HB2' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.754 ' HB2' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.694 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.927 HD12 ' NE ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.949 ' O ' ' O2D' ' A' ' 501' ' ' HEM . 67.8 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.623 ' OG1' ' HD2' ' A' ' 100' ' ' PRO . 3.9 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.508 ' HE1' HD13 ' A' ' 99' ' ' ILE . 45.3 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.576 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.298 63.0 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.493 ' HD2' ' CD1' ' A' ' 78' ' ' TYR 0.367 53.3 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.576 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 33.9 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.496 ' H ' ' CD ' ' A' ' 106' ' ' PRO 0.409 34.0 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.462 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 1.6 tm0? -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.499 ' NH1' ' O1D' ' A' ' 501' ' ' HEM . 12.9 mtp180 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.414 ' HA ' ' CE2' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.473 HD22 ' HE1' ' A' ' 241' ' ' MET . 38.0 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.409 HG21 HG11 ' A' ' 119' ' ' VAL . 25.2 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.409 HG11 HG21 ' A' ' 118' ' ' VAL . 27.3 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.489 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.672 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 17.7 mtm -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.672 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.1 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.541 HG13 HD11 ' A' ' 166' ' ' LEU . 72.7 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 45.4 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.475 HD13 HG12 ' A' ' 123' ' ' VAL . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.488 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.506 ' HA ' HD11 ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.615 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.577 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.488 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.782 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.782 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.465 HD11 HG22 ' A' ' 160' ' ' ILE . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.467 ' HA ' HD13 ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.429 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.541 HD11 HG13 ' A' ' 123' ' ' VAL . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.506 ' N ' HD21 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.44 HD21 ' HA ' ' A' ' 169' ' ' LEU . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.417 ' N ' ' CD ' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.566 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.523 ' HA ' HD22 ' A' ' 180' ' ' LEU . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' MET . . . . . 0.499 ' HE2' HG22 ' A' ' 247' ' ' VAL . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.421 HD13 HD13 ' A' ' 180' ' ' LEU . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.441 ' HB3' ' HG ' ' A' ' 221' ' ' SER . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 211' ' ' ARG . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 224' ' ' ALA . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' SER . . . . . 0.441 ' HG ' ' HB3' ' A' ' 211' ' ' ARG . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 42.7 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 42.0 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 220' ' ' ILE . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.455 ' HA3' HD13 ' A' ' 114' ' ' LEU . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 6.2 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 1.3 m120 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 17.1 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.927 ' NE ' HD12 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' MET . . . . . 0.473 ' HE1' HD22 ' A' ' 114' ' ' LEU . 34.2 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.694 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.423 ' HA ' HD22 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.499 HG22 ' HE2' ' A' ' 184' ' ' MET . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 250' ' ' LEU . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.675 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.469 HD22 ' HA ' ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' MET . . . . . 0.577 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.428 HD22 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 16.4 pm0 -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.434 ' N ' ' CD ' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 281' ' ' ILE . 45.4 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' CYS . . . . . 0.422 ' SG ' HG21 ' A' ' 367' ' ' ILE . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . 0.433 HD23 HG21 ' A' ' 349' ' ' THR . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . 0.497 ' CZ ' ' HE1' ' A' ' 336' ' ' MET . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.641 ' HA ' ' HE1' ' A' ' 323' ' ' MET . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 296' ' ' ALA . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . 0.513 ' OD2' ' O2A' ' A' ' 501' ' ' HEM . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . 0.424 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . 0.424 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.7 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.535 HD23 ' N ' ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' PHE . . . . . 0.424 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.6 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' HIS . . . . . 0.424 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 36.9 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 312' ' ' LEU . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . 0.63 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . 0.63 ' HD3' ' O ' ' A' ' 319' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' MET . . . . . 0.641 ' HE1' ' HA ' ' A' ' 294' ' ' LEU . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.456 HD11 ' HB2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 13.7 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' LEU . . . . . . . . . . . . . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.472 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' PRO . . . . . 0.472 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 0.497 ' HE1' ' CZ ' ' A' ' 291' ' ' ARG . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' ARG . . . . . 0.434 ' HB3' HG23 ' A' ' 345' ' ' VAL . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' LYS . . . . . 0.52 ' HD3' ' N ' ' A' ' 344' ' ' LYS . 1.8 mppt? -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.434 HG23 ' HB3' ' A' ' 342' ' ' ARG . 61.0 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 1.1 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 15.8 p80 -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 17.1 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' THR . . . . . 0.433 HG21 HD23 ' A' ' 289' ' ' LEU . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 90.8 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.42 ' HA ' HD12 ' A' ' 362' ' ' LEU . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 7.7 mtm180 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 17.2 tpp85 -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . 0.422 HG21 ' SG ' ' A' ' 285' ' ' CYS . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.1 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.485 HD12 HG23 ' A' ' 383' ' ' ILE . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' ILE . . . . . 0.403 HD11 HD12 ' A' ' 402' ' ' LEU . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.503 HD12 ' HE1' ' A' ' 28' ' ' MET . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . 0.403 HD12 HD11 ' A' ' 389' ' ' ILE . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . 0.404 ' HA ' HD22 ' A' ' 404' ' ' LEU . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' ASP . . . . . 0.544 ' HB3' HG23 ' A' ' 410' ' ' THR . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' PRO . . . . . 0.645 ' HA ' HG22 ' A' ' 411' ' ' THR . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' THR . . . . . 0.544 HG23 ' HB3' ' A' ' 407' ' ' ASP . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' THR . . . . . 0.645 HG22 ' HA ' ' A' ' 408' ' ' PRO . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . 0.496 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 39.6 m . . . . . 0 N--CA 1.496 1.832 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.51 138.6 38.5 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.234 -0.916 . . . . 0.0 112.92 -178.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 61.4 t -137.15 122.57 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.438 HG13 ' CZ ' ' B' ' 12' ' ' ARG . 98.5 t -106.82 129.59 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.124 -0.985 . . . . 0.0 111.625 -178.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.478 ' HH ' HD23 ' B' ' 23' ' ' LEU . 77.2 m-85 -109.18 110.6 21.87 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.82 127.19 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.93 -1.107 . . . . 0.0 108.343 178.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.2 m -86.15 174.68 8.98 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.789 0.804 . . . . 0.0 112.472 -177.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.405 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.68 -46.69 89.39 Favored 'General case' 0 N--CA 1.503 2.18 0 CA-C-O 121.141 0.496 . . . . 0.0 110.453 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -65.94 -11.29 46.41 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.596 -0.69 . . . . 0.0 111.393 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.99 15.49 28.34 Favored Glycine 0 N--CA 1.493 2.441 0 O-C-N 121.174 -0.954 . . . . 0.0 111.238 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.6 m -82.12 147.37 29.1 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 118.789 1.295 . . . . 0.0 109.903 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . 0.438 ' CZ ' HG13 ' B' ' 4' ' ' VAL . 50.8 ttt85 -118.42 128.72 54.89 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.454 -0.779 . . . . 0.0 111.883 -178.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.99 127.64 46.22 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.595 -0.69 . . . . 0.0 109.843 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -111.28 130.6 55.61 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.281 -0.887 . . . . 0.0 111.632 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 84.6 mt -122.72 159.4 28.05 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.752 -0.592 . . . . 0.0 111.082 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -109.64 91.64 3.73 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 176.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.6 t -90.17 133.39 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.571 0.7 . . . . 0.0 112.314 -176.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.07 170.67 16.11 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.788 -0.57 . . . . 0.0 110.251 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -68.45 151.8 46.31 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.535 -0.728 . . . . 0.0 111.0 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.48 -12.52 55.44 Favored Glycine 0 N--CA 1.495 2.602 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.065 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 59.3 t -89.93 133.34 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 120.699 -1.471 . . . . 0.0 110.951 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 22.1 p -80.26 151.97 29.31 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.478 HD23 ' HH ' ' B' ' 5' ' ' TYR . 18.4 mt -61.24 -24.59 66.47 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.316 -0.865 . . . . 0.0 110.618 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 8.8 tmm? -69.76 -49.23 55.0 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.2 -0.938 . . . . 0.0 109.497 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -59.91 -41.62 92.12 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.56 -0.713 . . . . 0.0 109.895 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.07 -40.89 95.33 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.655 -0.653 . . . . 0.0 110.169 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.35 -49.71 58.39 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.219 -0.926 . . . . 0.0 111.058 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 53.8 t -65.42 -39.25 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.298 -0.876 . . . . 0.0 110.711 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 24.0 m -70.01 -14.12 62.55 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.325 -0.859 . . . . 0.0 111.557 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -118.15 23.78 11.39 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.036 -1.04 . . . . 0.0 110.691 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.81 38.21 59.1 Favored Glycine 0 N--CA 1.493 2.454 0 O-C-N 121.527 -0.733 . . . . 0.0 111.83 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -72.53 147.11 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.847 -1.384 . . . . 0.0 108.874 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -62.63 142.43 58.05 Favored 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 117.201 2.297 . . . . 0.0 117.201 -174.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . 0.427 ' O ' ' HG3' ' B' ' 105' ' ' GLN . 65.2 m-20 62.25 -36.14 0.12 Allowed 'General case' 0 N--CA 1.516 2.833 0 N-CA-C 116.66 2.096 . . . . 0.0 116.66 175.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 54.3 mt -59.76 122.89 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.419 0 O-C-N 119.89 -1.756 . . . . 0.0 110.62 -178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.659 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 96.5 t -100.13 -51.36 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.695 -0.628 . . . . 0.0 111.183 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . 0.608 ' HA2' ' S2 ' ' B' ' 201' ' ' FES . . . 63.13 56.4 20.67 Favored Glycine 0 N--CA 1.499 2.873 0 N-CA-C 107.491 -2.244 . . . . 0.0 107.491 -178.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -71.27 -49.23 45.17 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.994 -0.709 . . . . 0.0 112.34 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' CYS . . . . . 0.539 ' HB3' ' HB3' ' B' ' 45' ' ' CYS . 2.3 p -66.6 -10.48 46.15 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.215 -0.928 . . . . 0.0 112.332 -178.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.87 -5.57 63.92 Favored Glycine 0 N--CA 1.498 2.804 0 O-C-N 120.787 -1.195 . . . . 0.0 111.968 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.17 19.5 10.63 Favored Glycine 0 N--CA 1.495 2.605 0 O-C-N 120.803 -1.41 . . . . 0.0 111.002 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 80.6 p -98.97 19.21 15.49 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.028 -1.278 . . . . 0.0 111.132 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.92 40.89 30.46 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.4 -0.812 . . . . 0.0 111.941 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 3.6 t -117.02 11.14 14.18 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.376 -0.828 . . . . 0.0 109.518 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' CYS . . . . . 0.643 ' SG ' 'FE1 ' ' B' ' 201' ' ' FES . 15.1 p -149.53 -179.11 6.84 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.05 34.04 3.11 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.803 -1.186 . . . . 0.0 111.367 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' THR . . . . . 0.659 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 23.4 p -97.59 13.24 30.78 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.933 -1.105 . . . . 0.0 111.276 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' CYS . . . . . 0.45 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.1 p -120.58 31.77 6.3 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 177.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . 0.464 ' NE2' ' HB3' ' B' ' 82' ' ' SER . 6.5 t-160 -72.65 132.99 44.43 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.642 -178.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . 0.472 HG23 ' HB3' ' B' ' 85' ' ' CYS . 12.2 m -146.21 160.1 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . 0.4 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.3 m-85 -105.43 102.71 12.17 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.238 -0.914 . . . . 0.0 108.706 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.4 t -61.87 135.13 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.282 -0.886 . . . . 0.0 109.369 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.67 131.74 51.16 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.954 0.883 . . . . 0.0 109.518 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -44.26 -31.08 0.91 Allowed 'General case' 0 N--CA 1.507 2.384 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -178.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.78 -6.88 54.07 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 120.963 -1.086 . . . . 0.0 112.752 -178.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -119.9 -6.73 10.04 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.46 -1.4 . . . . 0.0 111.886 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.4 p -55.45 -37.75 68.13 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.174 -0.954 . . . . 0.0 112.863 -178.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -81.2 -6.62 59.06 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.741 -1.225 . . . . 0.0 111.453 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -89.84 -11.67 41.31 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.045 -1.034 . . . . 0.0 109.859 178.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.616 HG12 ' HD2' ' B' ' 61' ' ' PRO . 40.9 t -104.07 141.04 21.7 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . 0.616 ' HD2' HG12 ' B' ' 60' ' ' VAL . 49.9 Cg_endo -73.74 118.88 5.63 Favored 'Trans proline' 0 N--CA 1.488 1.18 0 O-C-N 123.509 1.268 . . . . 0.0 109.029 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.94 160.59 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.762 0 N-CA-C 116.65 2.092 . . . . 0.0 116.65 -177.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.437 ' HB2' ' HB3' ' B' ' 67' ' ' GLU . . . -65.76 146.18 55.09 Favored 'General case' 0 N--CA 1.503 2.182 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.258 178.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -89.81 -170.76 2.92 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.606 -0.684 . . . . 0.0 110.383 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -59.59 -41.96 91.46 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.337 -0.852 . . . . 0.0 111.705 -178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.46 -41.6 84.4 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.186 -0.946 . . . . 0.0 111.969 -178.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.492 ' HG3' HD11 ' B' ' 84' ' ' LEU . 45.6 tt0 -68.22 -43.96 76.82 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.005 -1.059 . . . . 0.0 110.298 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . 0.502 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.6 mm -55.52 -42.22 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.311 -0.868 . . . . 0.0 109.359 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.25 -47.78 81.3 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 26.9 mmt -66.26 -33.91 76.8 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.268 -1.137 . . . . 0.0 111.17 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . 0.468 HD22 ' HA ' ' B' ' 71' ' ' LEU . 27.5 mt -63.49 -23.35 67.36 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.207 -0.933 . . . . 0.0 110.623 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . 0.502 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 41.1 mt-10 -70.41 -8.74 53.13 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.354 -0.842 . . . . 0.0 110.911 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 73.5 p -119.82 12.53 12.14 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.009 -1.057 . . . . 0.0 112.504 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 34.9 m -60.78 140.45 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 120.745 -1.222 . . . . 0.0 109.622 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 36.6 m -74.58 -39.06 62.47 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.393 -0.817 . . . . 0.0 110.181 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.2 168.82 17.43 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.47 -0.769 . . . . 0.0 110.094 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.27 139.14 55.67 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.392 -0.818 . . . . 0.0 110.609 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.2 tp -91.02 116.13 28.55 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.489 -0.757 . . . . 0.0 109.869 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -102.97 168.29 9.02 Favored Pre-proline 0 C--N 1.301 -1.518 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -76.62 -0.01 10.02 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 123.243 1.128 . . . . 0.0 110.401 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -120.46 22.36 11.3 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.898 -1.126 . . . . 0.0 108.399 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' SER . . . . . 0.464 ' HB3' ' NE2' ' B' ' 49' ' ' HIS . 4.3 m -80.81 137.19 36.21 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.861 -0.524 . . . . 0.0 110.362 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.4 mmm-85 -149.75 146.38 27.16 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.487 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.492 HD11 ' HG3' ' B' ' 67' ' ' GLU . 97.5 mt -80.54 98.95 7.82 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 175.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' CYS . . . . . 0.472 ' HB3' HG23 ' B' ' 50' ' ' VAL . 10.6 p -48.41 -17.86 0.18 Allowed 'General case' 0 N--CA 1.508 2.455 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -175.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.8 p -70.27 -14.01 62.42 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.616 -1.302 . . . . 0.0 109.464 178.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -92.7 -12.21 32.04 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.453 -0.779 . . . . 0.0 110.53 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . 0.468 HG21 HD13 ' B' ' 23' ' ' LEU . 61.8 mt -91.51 103.96 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.133 -0.979 . . . . 0.0 110.609 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 47.6 mm -84.96 131.79 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' MET . . . . . 0.428 ' C ' HG22 ' B' ' 91' ' ' THR . 13.6 tpt -74.84 137.8 42.08 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 122.164 0.983 . . . . 0.0 113.189 -177.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' THR . . . . . 0.428 HG22 ' C ' ' B' ' 90' ' ' MET . 43.7 p -138.25 166.59 24.63 Favored Pre-proline 0 N--CA 1.49 1.548 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 176.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -74.88 1.66 7.42 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 122.638 0.809 . . . . 0.0 111.035 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -87.65 -22.83 24.47 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.5 mt -93.72 12.96 23.75 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.465 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.52 126.44 23.6 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.184 -0.948 . . . . 0.0 111.15 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.21 6.81 68.46 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.66 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.58 142.74 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 CA-C-N 119.325 1.563 . . . . 0.0 110.768 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 60.7 t -122.5 132.98 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.501 -0.749 . . . . 0.0 109.831 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' VAL . . . . . 0.432 ' O ' HG23 ' B' ' 99' ' ' VAL . 16.3 m -130.35 135.71 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.479 -0.763 . . . . 0.0 109.882 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' ASP . . . . . 0.4 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.34 134.16 35.18 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.1 t -103.46 127.32 29.85 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.545 -0.722 . . . . 0.0 110.32 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -80.85 130.93 7.81 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 O-C-N 124.114 1.586 . . . . 0.0 108.267 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' ASP . . . . . 0.405 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.4 p-10 -62.33 3.33 0.19 Allowed 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -178.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 4.0 mtm105 -125.29 114.71 19.29 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.306 -1.496 . . . . 0.0 110.064 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . 0.491 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 23.2 mm-40 -113.39 -49.36 2.9 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.486 -0.759 . . . . 0.0 109.969 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' TRP . . . . . 0.414 ' CE2' ' HA ' ' A' ' 113' ' ' ALA . 27.3 m95 . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.521 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 501' ' ' HEM . . . . . 0.949 ' O2D' ' O ' ' A' ' 100' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 502' ' ' CAM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 201' ' ' FES . . . . . 0.643 'FE1 ' ' SG ' ' B' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.473 ' HA ' HD11 ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.452 HD11 HG13 ' A' ' 18' ' ' VAL . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.88 ' HG2' HG23 ' A' ' 18' ' ' VAL . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.88 HG23 ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.488 ' HA ' HD23 ' A' ' 22' ' ' LEU . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.415 ' CE2' HG23 ' A' ' 50' ' ' VAL . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.503 ' HE1' HD12 ' A' ' 395' ' ' ILE . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.432 ' HA ' HD12 ' A' ' 34' ' ' LEU . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 39' ' ' GLN . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.514 ' N ' HG12 ' A' ' 38' ' ' VAL . 1.6 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.457 ' O ' HG21 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.423 ' HE3' HD13 ' A' ' 324' ' ' LEU . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.457 HG21 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.49 ' HB3' HG21 ' A' ' 66' ' ' THR . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.412 ' ND2' HG22 ' A' ' 50' ' ' VAL . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.608 HG13 ' HD2' ' A' ' 51' ' ' PRO . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.608 ' HD2' HG13 ' A' ' 50' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.438 HG21 ' HB ' ' A' ' 64' ' ' ILE . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.594 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.8 m120 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.594 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.438 ' HB ' HG21 ' A' ' 54' ' ' VAL . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.49 HG21 ' HB3' ' A' ' 45' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.436 HD11 ' N ' ' A' ' 70' ' ' LEU . 6.0 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.4 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.462 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.5 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.41 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 27.0 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.62 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.2 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.54 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.54 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.754 ' HD2' ' HB2' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.754 ' HB2' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.694 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.927 HD12 ' NE ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.949 ' O ' ' O2D' ' A' ' 501' ' ' HEM . 67.6 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.631 ' OG1' ' HD2' ' A' ' 100' ' ' PRO . 3.8 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.508 ' HE1' HD13 ' A' ' 99' ' ' ILE . 46.0 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.614 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.296 50.2 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.456 ' HA ' ' HB3' ' A' ' 108' ' ' GLN 0.366 52.9 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.614 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 35.0 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.469 ' H ' ' CD ' ' A' ' 106' ' ' PRO 0.413 34.1 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.456 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 1.6 tm0? -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 8.6 mtp180 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.464 ' HB2' ' CE3' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.438 HD13 ' HA3' ' A' ' 226' ' ' GLY . 24.5 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.1 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.6 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.489 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.672 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 21.5 mtm -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.672 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.1 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.453 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 72.0 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.7 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.453 ' HD2' ' HA ' ' A' ' 123' ' ' VAL . 35.6 mttt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.488 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.506 ' HA ' HD11 ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.615 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.577 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.488 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.782 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.782 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.465 HD11 HG22 ' A' ' 160' ' ' ILE . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.467 ' HA ' HD13 ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.429 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.513 ' C ' HD21 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.506 ' N ' HD21 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.44 HD21 ' HA ' ' A' ' 169' ' ' LEU . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.417 ' N ' ' CD ' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.566 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.523 ' HA ' HD22 ' A' ' 180' ' ' LEU . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' MET . . . . . 0.499 ' HE2' HG22 ' A' ' 247' ' ' VAL . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.421 HD13 HD13 ' A' ' 180' ' ' LEU . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.441 ' HB3' ' HG ' ' A' ' 221' ' ' SER . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 211' ' ' ARG . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 224' ' ' ALA . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' SER . . . . . 0.441 ' HG ' ' HB3' ' A' ' 211' ' ' ARG . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 33.3 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 53.1 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 220' ' ' ILE . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.438 ' HA3' HD13 ' A' ' 114' ' ' LEU . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 4.6 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 1.3 m120 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 18.1 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.927 ' NE ' HD12 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 45.3 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.694 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.423 ' HA ' HD22 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.499 HG22 ' HE2' ' A' ' 184' ' ' MET . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 250' ' ' LEU . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.675 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.469 HD22 ' HA ' ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' MET . . . . . 0.577 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.428 HD22 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.433 ' N ' ' CD ' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' CYS . . . . . 0.422 ' SG ' HG21 ' A' ' 367' ' ' ILE . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . 0.433 HD23 HG21 ' A' ' 349' ' ' THR . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . 0.497 ' CZ ' ' HE1' ' A' ' 336' ' ' MET . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.641 ' HA ' ' HE1' ' A' ' 323' ' ' MET . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 296' ' ' ALA . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . 0.513 ' OD2' ' O2A' ' A' ' 501' ' ' HEM . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . 0.424 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . 0.424 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.1 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.535 HD23 ' N ' ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' PHE . . . . . 0.424 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.6 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' HIS . . . . . 0.424 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 36.9 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 312' ' ' LEU . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . 0.63 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . 0.63 ' HD3' ' O ' ' A' ' 319' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' MET . . . . . 0.641 ' HE1' ' HA ' ' A' ' 294' ' ' LEU . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.456 HD11 ' HB2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 13.7 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' LEU . . . . . . . . . . . . . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.472 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' PRO . . . . . 0.472 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 0.497 ' HE1' ' CZ ' ' A' ' 291' ' ' ARG . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' LYS . . . . . 0.513 ' HD3' ' N ' ' A' ' 344' ' ' LYS . 0.9 OUTLIER -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 60.7 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 10.6 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 39.9 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' THR . . . . . 0.433 HG21 HD23 ' A' ' 289' ' ' LEU . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' SER . . . . . 0.428 ' HA ' ' HB3' ' B' ' 44' ' ' SER . 97.5 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.42 ' HA ' HD12 ' A' ' 362' ' ' LEU . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 44.0 mtt85 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . 0.422 HG21 ' SG ' ' A' ' 285' ' ' CYS . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.485 HD12 HG23 ' A' ' 383' ' ' ILE . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' ILE . . . . . 0.403 HD11 HD12 ' A' ' 402' ' ' LEU . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.503 HD12 ' HE1' ' A' ' 28' ' ' MET . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . 0.403 HD12 HD11 ' A' ' 389' ' ' ILE . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . 0.404 ' HA ' HD22 ' A' ' 404' ' ' LEU . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' ASP . . . . . 0.544 ' HB3' HG23 ' A' ' 410' ' ' THR . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' PRO . . . . . 0.645 ' HA ' HG22 ' A' ' 411' ' ' THR . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' THR . . . . . 0.544 HG23 ' HB3' ' A' ' 407' ' ' ASP . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' THR . . . . . 0.645 HG22 ' HA ' ' A' ' 408' ' ' PRO . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . 0.496 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 39.7 m . . . . . 0 N--CA 1.495 1.805 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.49 138.61 38.52 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.246 -0.909 . . . . 0.0 112.958 -178.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 61.0 t -137.16 122.52 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 177.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.427 HG13 ' CZ ' ' B' ' 12' ' ' ARG . 97.9 t -106.74 129.56 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.093 -1.004 . . . . 0.0 111.636 -178.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.547 ' CD1' HD11 ' B' ' 32' ' ' ILE . 77.2 m-85 -109.23 110.58 21.83 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.8 127.27 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 120.93 -1.106 . . . . 0.0 108.377 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.7 m -86.21 174.64 8.97 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.766 0.793 . . . . 0.0 112.498 -177.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.421 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.6 -46.75 89.09 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.186 0.517 . . . . 0.0 110.472 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.2 p-10 -65.92 -11.28 46.04 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.583 -0.698 . . . . 0.0 111.419 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.98 15.51 28.3 Favored Glycine 0 N--CA 1.493 2.459 0 O-C-N 121.195 -0.941 . . . . 0.0 111.256 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.6 m -82.1 147.41 29.1 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 118.721 1.26 . . . . 0.0 109.884 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . 0.427 ' CZ ' HG13 ' B' ' 4' ' ' VAL . 50.8 ttt85 -118.52 128.78 54.91 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.508 -0.745 . . . . 0.0 111.816 -178.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.07 127.72 46.27 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.623 -0.673 . . . . 0.0 109.79 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -111.26 130.62 55.6 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.284 -0.885 . . . . 0.0 111.617 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.689 HD11 HD13 ' B' ' 32' ' ' ILE . 84.4 mt -122.83 159.37 28.28 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.357 0.598 . . . . 0.0 111.08 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -109.64 91.67 3.74 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.7 t -90.22 133.49 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-O 121.654 0.74 . . . . 0.0 112.258 -176.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.13 170.67 16.12 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.766 -0.584 . . . . 0.0 110.242 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -68.45 151.83 46.27 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.5 -0.75 . . . . 0.0 110.954 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.42 -12.45 55.43 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.046 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 61.8 t -89.99 133.35 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 120.654 -1.498 . . . . 0.0 110.904 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 21.6 p -80.28 151.92 29.3 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.593 -0.692 . . . . 0.0 109.143 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.479 HD23 ' HH ' ' B' ' 5' ' ' TYR . 18.4 mt -61.19 -24.64 66.47 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.29 -0.881 . . . . 0.0 110.618 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' MET . . . . . 0.425 ' SD ' ' S2 ' ' B' ' 201' ' ' FES . 7.7 ttp -69.71 -49.26 55.05 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.263 -0.898 . . . . 0.0 109.489 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.82 -41.67 91.8 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.562 -0.711 . . . . 0.0 109.937 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.11 -40.89 95.17 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.552 -0.718 . . . . 0.0 110.114 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.31 -49.76 58.18 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.2 -0.937 . . . . 0.0 111.066 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 76.8 t -65.42 -39.17 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.317 -0.864 . . . . 0.0 110.755 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 20.5 t -70.09 -14.06 62.49 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.383 -0.823 . . . . 0.0 111.529 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -118.18 23.85 11.34 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.065 -1.022 . . . . 0.0 110.661 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.7 38.24 58.59 Favored Glycine 0 N--CA 1.493 2.481 0 O-C-N 121.55 -0.719 . . . . 0.0 111.871 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.689 HD13 HD11 ' B' ' 15' ' ' LEU . 0.4 OUTLIER -72.54 147.21 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.792 -1.416 . . . . 0.0 108.892 179.002 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -62.72 142.48 58.11 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 117.202 2.297 . . . . 0.0 117.202 -174.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 62.29 -36.21 0.12 Allowed 'General case' 0 N--CA 1.515 2.787 0 N-CA-C 116.59 2.07 . . . . 0.0 116.59 175.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.8 mt -59.67 122.85 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.395 0 O-C-N 119.828 -1.795 . . . . 0.0 110.718 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.664 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 90.7 t -100.12 -51.4 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.616 -0.678 . . . . 0.0 111.196 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . 0.612 ' HA2' ' S2 ' ' B' ' 201' ' ' FES . . . 63.16 56.41 20.55 Favored Glycine 0 N--CA 1.499 2.873 0 N-CA-C 107.482 -2.247 . . . . 0.0 107.482 -178.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -71.22 -49.33 44.56 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.942 -0.74 . . . . 0.0 112.325 -177.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' CYS . . . . . 0.542 ' HB3' ' HB3' ' B' ' 45' ' ' CYS . 2.3 p -66.55 -10.46 45.39 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.244 -0.91 . . . . 0.0 112.389 -178.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.82 -5.47 64.01 Favored Glycine 0 N--CA 1.499 2.846 0 O-C-N 120.842 -1.161 . . . . 0.0 111.959 177.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.14 19.52 10.63 Favored Glycine 0 N--CA 1.495 2.569 0 O-C-N 120.845 -1.385 . . . . 0.0 110.974 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 14.0 m -98.95 19.12 15.62 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.033 -1.275 . . . . 0.0 111.148 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.97 40.89 30.35 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.418 -0.801 . . . . 0.0 111.892 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' SER . . . . . 0.428 ' HB3' ' HA ' ' A' ' 354' ' ' SER . 37.4 m -117.05 11.22 14.17 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.345 -0.847 . . . . 0.0 109.523 178.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' CYS . . . . . 0.643 ' SG ' 'FE1 ' ' B' ' 201' ' ' FES . 15.1 p -149.54 -179.05 6.78 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.09 34.11 3.09 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.85 -1.156 . . . . 0.0 111.345 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' THR . . . . . 0.664 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 16.9 p -97.63 13.23 30.88 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.947 -1.096 . . . . 0.0 111.243 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' CYS . . . . . 0.452 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.1 p -120.57 31.75 6.31 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . 0.42 ' O ' HG13 ' B' ' 50' ' ' VAL . 12.6 t-160 -72.67 133.07 44.45 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.63 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . 0.474 HG23 ' HB3' ' B' ' 85' ' ' CYS . 12.3 m -146.33 160.11 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 178.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . 0.403 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.6 m-85 -105.43 102.75 12.2 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.244 -0.91 . . . . 0.0 108.674 178.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.2 t -61.93 135.17 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.226 -0.921 . . . . 0.0 109.351 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.69 131.76 51.24 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.975 0.893 . . . . 0.0 109.539 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -44.33 -30.98 0.91 Allowed 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -178.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.78 -6.97 54.47 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.982 -1.074 . . . . 0.0 112.75 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -119.87 -6.71 10.06 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.492 -1.38 . . . . 0.0 111.887 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.4 p -55.39 -37.83 68.08 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 121.136 -0.978 . . . . 0.0 112.815 -178.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -81.13 -6.69 59.12 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 120.724 -1.235 . . . . 0.0 111.484 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -89.78 -11.67 41.47 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.974 -1.078 . . . . 0.0 109.878 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.62 HG12 ' HD2' ' B' ' 61' ' ' PRO . 40.9 t -104.08 141.07 21.75 Favored Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . 0.62 ' HD2' HG12 ' B' ' 60' ' ' VAL . 49.9 Cg_endo -73.8 118.87 5.62 Favored 'Trans proline' 0 N--CA 1.488 1.192 0 O-C-N 123.543 1.286 . . . . 0.0 109.016 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.91 160.64 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.759 0 N-CA-C 116.62 2.081 . . . . 0.0 116.62 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' B' ' 67' ' ' GLU . . . -65.82 146.19 55.06 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.253 178.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -89.79 -170.78 2.93 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.628 -0.67 . . . . 0.0 110.4 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -59.47 -42.07 91.18 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.31 -0.868 . . . . 0.0 111.716 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -41.47 84.5 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.171 -0.955 . . . . 0.0 112.016 -178.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.451 ' HB3' ' HB2' ' B' ' 63' ' ' ALA . 45.5 tt0 -68.25 -43.96 76.71 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.97 -1.081 . . . . 0.0 110.335 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . 0.511 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.6 mm -55.58 -42.17 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 121.259 -0.901 . . . . 0.0 109.36 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.17 -47.91 80.35 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 13.7 mmt -66.16 -33.97 76.98 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.252 -1.146 . . . . 0.0 111.159 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . 0.4 HD21 ' HG ' ' B' ' 84' ' ' LEU . 27.8 mt -63.53 -23.31 67.34 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.231 -0.918 . . . . 0.0 110.568 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . 0.511 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 49.2 mt-10 -70.46 -8.67 52.85 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.352 -0.842 . . . . 0.0 110.919 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 86.4 p -119.83 12.48 12.12 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.035 -1.04 . . . . 0.0 112.528 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 34.9 m -60.68 140.39 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 O-C-N 120.701 -1.249 . . . . 0.0 109.647 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 24.5 m -74.58 -39.01 62.5 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.446 -0.784 . . . . 0.0 110.192 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.28 168.82 17.53 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.464 -0.773 . . . . 0.0 110.063 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -58.19 139.11 55.56 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.403 -0.811 . . . . 0.0 110.634 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.4 tp -90.97 116.14 28.54 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.535 -0.728 . . . . 0.0 109.89 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -103.03 168.34 8.94 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -76.65 -0.06 10.08 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 O-C-N 123.258 1.136 . . . . 0.0 110.388 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -120.4 22.36 11.32 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.992 -1.067 . . . . 0.0 108.395 176.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 4.3 m -80.83 137.23 36.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.898 -0.501 . . . . 0.0 110.382 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.5 mmm-85 -149.75 146.39 27.17 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 120.06 -0.656 . . . . 0.0 111.458 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.452 ' HB3' ' SG ' ' B' ' 48' ' ' CYS . 95.2 mt -80.58 98.92 7.84 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 175.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' CYS . . . . . 0.474 ' HB3' HG23 ' B' ' 50' ' ' VAL . 10.5 p -48.33 -17.88 0.18 Allowed 'General case' 0 N--CA 1.508 2.43 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -175.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.9 p -70.32 -13.98 62.39 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.747 -1.221 . . . . 0.0 109.387 178.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -92.69 -12.25 31.97 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.508 -0.745 . . . . 0.0 110.501 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . 0.466 HG21 HD13 ' B' ' 23' ' ' LEU . 61.9 mt -91.49 103.9 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.163 -0.961 . . . . 0.0 110.629 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 45.6 mm -84.94 131.78 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' MET . . . . . 0.435 ' C ' HG22 ' B' ' 91' ' ' THR . 13.6 tpt -74.83 137.74 42.07 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 122.111 0.957 . . . . 0.0 113.266 -177.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' THR . . . . . 0.435 HG22 ' C ' ' B' ' 90' ' ' MET . 43.7 p -138.17 166.63 24.45 Favored Pre-proline 0 N--CA 1.49 1.558 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 176.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -74.99 1.72 7.42 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 122.643 0.812 . . . . 0.0 110.968 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -87.62 -22.87 24.48 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 176.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.6 mt -93.74 12.95 23.84 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.437 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.44 126.38 23.22 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.201 -0.937 . . . . 0.0 111.148 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.15 6.92 68.45 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.575 -0.822 . . . . 0.0 111.682 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.65 142.74 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-N 119.319 1.559 . . . . 0.0 110.727 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 60.7 t -122.52 133.01 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.513 -0.742 . . . . 0.0 109.843 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' VAL . . . . . 0.424 ' O ' HG23 ' B' ' 99' ' ' VAL . 16.5 m -130.41 135.74 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.403 -0.811 . . . . 0.0 109.78 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' ASP . . . . . 0.403 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.35 134.18 35.16 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.9 t -103.39 127.31 29.92 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.525 -0.734 . . . . 0.0 110.353 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -80.85 130.92 7.8 Favored 'Trans proline' 0 C--N 1.316 -1.172 0 O-C-N 124.139 1.6 . . . . 0.0 108.319 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' ASP . . . . . 0.421 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.3 p-10 -62.38 3.46 0.19 Allowed 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -178.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -125.32 114.59 19.11 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.256 -1.528 . . . . 0.0 110.067 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . 0.475 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 69.4 mm-40 -113.29 -49.35 2.91 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.497 -0.752 . . . . 0.0 109.987 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' TRP . . . . . 0.464 ' CE3' ' HB2' ' A' ' 113' ' ' ALA . 8.0 m95 . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.495 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 501' ' ' HEM . . . . . 0.949 ' O2D' ' O ' ' A' ' 100' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 502' ' ' CAM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 201' ' ' FES . . . . . 0.643 'FE1 ' ' SG ' ' B' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.473 ' HA ' HD11 ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.452 HD11 HG13 ' A' ' 18' ' ' VAL . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.88 ' HG2' HG23 ' A' ' 18' ' ' VAL . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.88 HG23 ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.488 ' HA ' HD23 ' A' ' 22' ' ' LEU . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.415 ' CE2' HG23 ' A' ' 50' ' ' VAL . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.503 ' HE1' HD12 ' A' ' 395' ' ' ILE . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.432 ' HA ' HD12 ' A' ' 34' ' ' LEU . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 39' ' ' GLN . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.514 ' N ' HG12 ' A' ' 38' ' ' VAL . 1.6 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.457 ' O ' HG21 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.423 ' HE3' HD13 ' A' ' 324' ' ' LEU . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.457 HG21 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.49 ' HB3' HG21 ' A' ' 66' ' ' THR . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.412 ' ND2' HG22 ' A' ' 50' ' ' VAL . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.608 HG13 ' HD2' ' A' ' 51' ' ' PRO . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.608 ' HD2' HG13 ' A' ' 50' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.438 HG21 ' HB ' ' A' ' 64' ' ' ILE . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.594 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.8 m120 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.594 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.438 ' HB ' HG21 ' A' ' 54' ' ' VAL . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.49 HG21 ' HB3' ' A' ' 45' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.436 HD11 ' N ' ' A' ' 70' ' ' LEU . 6.0 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.408 ' CZ ' HG22 ' A' ' 348' ' ' THR . 5.6 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.462 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.6 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.442 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 27.4 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.2 mmt-85 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.62 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.2 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.54 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.54 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.754 ' HD2' ' HB2' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.754 ' HB2' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.694 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.927 HD12 ' NE ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.949 ' O ' ' O2D' ' A' ' 501' ' ' HEM . 74.3 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.629 ' OG1' ' HD2' ' A' ' 100' ' ' PRO . 3.9 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.508 ' HE1' HD13 ' A' ' 99' ' ' ILE . 46.0 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.614 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.294 50.3 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.461 ' HA ' ' HB3' ' A' ' 108' ' ' GLN 0.366 52.9 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.614 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 34.8 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.469 ' H ' ' CD ' ' A' ' 106' ' ' PRO 0.342 30.7 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.461 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 1.7 tm0? -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.425 ' HB3' ' CG ' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.7 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.0 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.6 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.489 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.672 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 7.0 mtm -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.672 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.1 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.541 HG13 HD11 ' A' ' 166' ' ' LEU . 72.7 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 46.0 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.475 HD13 HG12 ' A' ' 123' ' ' VAL . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.488 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.506 ' HA ' HD11 ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.615 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.577 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.488 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.782 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.782 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.465 HD11 HG22 ' A' ' 160' ' ' ILE . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.467 ' HA ' HD13 ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.429 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.541 HD11 HG13 ' A' ' 123' ' ' VAL . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.506 ' N ' HD21 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.44 HD21 ' HA ' ' A' ' 169' ' ' LEU . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.417 ' N ' ' CD ' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.566 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.523 ' HA ' HD22 ' A' ' 180' ' ' LEU . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' MET . . . . . 0.499 ' HE2' HG22 ' A' ' 247' ' ' VAL . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.421 HD13 HD13 ' A' ' 180' ' ' LEU . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.441 ' HB3' ' HG ' ' A' ' 221' ' ' SER . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 211' ' ' ARG . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 224' ' ' ALA . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' SER . . . . . 0.441 ' HG ' ' HB3' ' A' ' 211' ' ' ARG . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 42.5 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 42.0 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 220' ' ' ILE . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 4.3 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 13.5 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.927 ' NE ' HD12 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 41.0 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.694 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.423 ' HA ' HD22 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.499 HG22 ' HE2' ' A' ' 184' ' ' MET . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 250' ' ' LEU . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.675 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.469 HD22 ' HA ' ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' MET . . . . . 0.577 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.428 HD22 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 16.4 pm0 -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.433 ' N ' ' CD ' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' CYS . . . . . 0.422 ' SG ' HG21 ' A' ' 367' ' ' ILE . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . 0.433 HD23 HG21 ' A' ' 349' ' ' THR . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . 0.497 ' CZ ' ' HE1' ' A' ' 336' ' ' MET . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.641 ' HA ' ' HE1' ' A' ' 323' ' ' MET . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 296' ' ' ALA . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . 0.513 ' OD2' ' O2A' ' A' ' 501' ' ' HEM . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . 0.424 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . 0.424 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.0 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.535 HD23 ' N ' ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' PHE . . . . . 0.424 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.6 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' HIS . . . . . 0.424 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 36.9 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 312' ' ' LEU . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . 0.63 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . 0.63 ' HD3' ' O ' ' A' ' 319' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' MET . . . . . 0.641 ' HE1' ' HA ' ' A' ' 294' ' ' LEU . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.456 HD11 ' HB2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 13.7 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' LEU . . . . . . . . . . . . . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.472 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' PRO . . . . . 0.472 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 0.497 ' HE1' ' CZ ' ' A' ' 291' ' ' ARG . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . 0.441 ' CB ' ' HD3' ' A' ' 344' ' ' LYS . 1.9 mp0 -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' LYS . . . . . 0.498 ' HB2' ' HE2' ' A' ' 344' ' ' LYS . 1.7 mppt? -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 57.8 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 22.1 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' THR . . . . . 0.408 HG22 ' CZ ' ' A' ' 72' ' ' ARG . 16.5 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' THR . . . . . 0.433 HG21 HD23 ' A' ' 289' ' ' LEU . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 92.6 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.42 ' HA ' HD12 ' A' ' 362' ' ' LEU . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 39.3 mtt85 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 17.2 tpp85 -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . 0.422 HG21 ' SG ' ' A' ' 285' ' ' CYS . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.485 HD12 HG23 ' A' ' 383' ' ' ILE . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' ILE . . . . . 0.403 HD11 HD12 ' A' ' 402' ' ' LEU . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.503 HD12 ' HE1' ' A' ' 28' ' ' MET . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . 0.403 HD12 HD11 ' A' ' 389' ' ' ILE . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . 0.404 ' HA ' HD22 ' A' ' 404' ' ' LEU . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' ASP . . . . . 0.544 ' HB3' HG23 ' A' ' 410' ' ' THR . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' PRO . . . . . 0.645 ' HA ' HG22 ' A' ' 411' ' ' THR . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' THR . . . . . 0.544 HG23 ' HB3' ' A' ' 407' ' ' ASP . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' THR . . . . . 0.645 HG22 ' HA ' ' A' ' 408' ' ' PRO . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . 0.496 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 39.6 m . . . . . 0 N--CA 1.495 1.807 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.53 138.58 38.47 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.181 -0.949 . . . . 0.0 112.927 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 61.3 t -137.11 122.6 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 177.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.441 HG13 ' CZ ' ' B' ' 12' ' ' ARG . 97.5 t -106.77 129.52 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.139 -0.976 . . . . 0.0 111.649 -178.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.56 ' CD1' HD11 ' B' ' 32' ' ' ILE . 77.1 m-85 -109.21 110.62 21.88 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 39.7 t -94.77 127.2 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.925 -1.109 . . . . 0.0 108.439 178.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.6 m -86.14 174.71 8.96 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.768 0.794 . . . . 0.0 112.493 -177.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.413 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.65 -46.77 89.04 Favored 'General case' 0 N--CA 1.503 2.19 0 CA-C-O 121.193 0.521 . . . . 0.0 110.448 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -65.92 -11.22 45.61 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.544 -0.723 . . . . 0.0 111.425 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.97 15.46 28.48 Favored Glycine 0 N--CA 1.492 2.385 0 O-C-N 121.147 -0.971 . . . . 0.0 111.256 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.4 m -82.07 147.37 29.15 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 118.773 1.287 . . . . 0.0 109.903 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . 0.441 ' CZ ' HG13 ' B' ' 4' ' ' VAL . 50.8 ttt85 -118.49 128.77 54.91 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.529 -0.732 . . . . 0.0 111.829 -178.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.01 127.73 46.34 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.554 -0.716 . . . . 0.0 109.79 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.3 tt0 -111.35 130.66 55.61 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.29 -0.881 . . . . 0.0 111.591 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.565 HD11 HD13 ' B' ' 32' ' ' ILE . 85.0 mt -122.79 159.35 28.27 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.754 -0.591 . . . . 0.0 111.114 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -109.62 91.68 3.74 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.7 t -90.27 133.45 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-O 121.688 0.756 . . . . 0.0 112.248 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.08 170.67 16.12 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.706 -0.621 . . . . 0.0 110.262 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -68.46 151.81 46.29 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.532 -0.73 . . . . 0.0 110.967 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.41 -12.46 55.35 Favored Glycine 0 N--CA 1.495 2.629 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.067 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 59.1 t -89.99 133.33 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 120.69 -1.476 . . . . 0.0 110.936 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 21.7 p -80.29 151.94 29.28 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.568 -0.707 . . . . 0.0 109.145 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.479 HD23 ' HH ' ' B' ' 5' ' ' TYR . 18.5 mt -61.21 -24.63 66.48 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.297 -0.877 . . . . 0.0 110.605 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' MET . . . . . 0.884 ' HE2' ' S2 ' ' B' ' 201' ' ' FES . 7.6 tmm? -69.7 -49.28 54.92 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.235 -0.916 . . . . 0.0 109.5 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -59.81 -41.71 91.87 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.619 -0.675 . . . . 0.0 109.913 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.1 -40.87 95.19 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.631 -0.668 . . . . 0.0 110.121 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.33 -49.77 58.02 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.262 -0.899 . . . . 0.0 111.055 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 51.0 t -65.45 -39.12 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.349 -0.844 . . . . 0.0 110.744 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 15.8 t -70.15 -14.01 62.45 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.41 -0.806 . . . . 0.0 111.503 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -118.14 23.78 11.39 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.024 -1.048 . . . . 0.0 110.664 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.72 38.23 58.67 Favored Glycine 0 N--CA 1.493 2.469 0 O-C-N 121.532 -0.73 . . . . 0.0 111.876 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.565 HD13 HD11 ' B' ' 15' ' ' LEU . 1.7 mt -72.49 147.11 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.882 -1.364 . . . . 0.0 108.887 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.66 142.44 58.08 Favored 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 117.214 2.302 . . . . 0.0 117.214 -174.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 62.29 -36.18 0.12 Allowed 'General case' 0 N--CA 1.516 2.831 0 N-CA-C 116.612 2.079 . . . . 0.0 116.612 175.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 84.2 mt -59.67 122.85 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.401 0 O-C-N 119.85 -1.781 . . . . 0.0 110.672 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.523 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 84.4 t -100.15 -51.39 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.595 -0.691 . . . . 0.0 111.237 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . 0.608 ' HA2' ' S2 ' ' B' ' 201' ' ' FES . . . 63.15 56.48 20.18 Favored Glycine 0 N--CA 1.499 2.866 0 N-CA-C 107.472 -2.251 . . . . 0.0 107.472 -178.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -71.32 -49.33 43.73 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.985 -0.715 . . . . 0.0 112.259 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' CYS . . . . . 0.545 ' HB3' ' HB3' ' B' ' 45' ' ' CYS . 2.3 p -66.5 -10.49 45.2 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.201 -0.937 . . . . 0.0 112.351 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.81 -5.45 64.01 Favored Glycine 0 N--CA 1.497 2.731 0 O-C-N 120.825 -1.172 . . . . 0.0 111.973 177.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.07 19.57 10.63 Favored Glycine 0 N--CA 1.495 2.584 0 O-C-N 120.77 -1.429 . . . . 0.0 110.985 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 87.1 p -99.02 19.23 15.51 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.054 -1.263 . . . . 0.0 111.141 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.94 40.85 30.41 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.383 -0.823 . . . . 0.0 111.918 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.0 11.14 14.2 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.31 -0.868 . . . . 0.0 109.562 178.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' CYS . . . . . 0.641 ' SG ' 'FE1 ' ' B' ' 201' ' ' FES . 15.1 p -149.48 -179.1 6.82 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.522 -0.736 . . . . 0.0 109.102 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.06 34.09 3.1 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.86 -1.15 . . . . 0.0 111.411 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' THR . . . . . 0.523 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 72.7 p -97.6 13.31 30.57 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.962 -1.086 . . . . 0.0 111.299 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' CYS . . . . . 0.452 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.3 p -120.58 31.74 6.31 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . 0.433 ' O ' HG13 ' B' ' 50' ' ' VAL . 23.9 t-160 -72.67 133.08 44.45 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.589 -178.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . 0.465 HG23 ' HB3' ' B' ' 85' ' ' CYS . 12.2 m -146.29 160.06 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . 0.4 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.4 m-85 -105.39 102.7 12.16 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.265 -0.897 . . . . 0.0 108.721 178.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.7 t -61.84 135.08 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 121.321 -0.862 . . . . 0.0 109.354 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.61 131.77 51.23 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.983 0.897 . . . . 0.0 109.542 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -44.3 -31.06 0.92 Allowed 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -178.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.77 -6.92 54.23 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.017 -1.052 . . . . 0.0 112.75 -178.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -119.89 -6.71 10.04 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 120.488 -1.383 . . . . 0.0 111.884 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.5 p -55.38 -37.83 68.07 Favored 'General case' 0 N--CA 1.507 2.406 0 O-C-N 121.173 -0.955 . . . . 0.0 112.835 -178.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 -81.14 -6.66 59.08 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.728 -1.232 . . . . 0.0 111.426 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -89.9 -11.57 41.47 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.033 -1.042 . . . . 0.0 109.872 178.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.628 HG12 ' HD2' ' B' ' 61' ' ' PRO . 40.9 t -104.08 141.02 21.65 Favored Pre-proline 0 N--CA 1.488 1.462 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . 0.628 ' HD2' HG12 ' B' ' 60' ' ' VAL . 50.0 Cg_endo -73.79 118.84 5.61 Favored 'Trans proline' 0 N--CA 1.488 1.173 0 O-C-N 123.448 1.236 . . . . 0.0 109.026 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.87 160.61 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.77 0 N-CA-C 116.692 2.108 . . . . 0.0 116.692 -177.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.439 ' HB2' ' HB3' ' B' ' 67' ' ' GLU . . . -65.82 146.13 55.13 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.245 178.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -89.7 -170.78 2.94 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.589 -0.694 . . . . 0.0 110.428 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -59.56 -41.98 91.4 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.321 -0.862 . . . . 0.0 111.748 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.41 -41.57 84.69 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.186 -0.946 . . . . 0.0 112.043 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.439 ' HB3' ' HB2' ' B' ' 63' ' ' ALA . 45.4 tt0 -68.19 -44.03 76.79 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.98 -1.075 . . . . 0.0 110.317 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . 0.513 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.6 mm -55.56 -42.21 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.285 -0.884 . . . . 0.0 109.326 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.16 -47.88 80.71 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 12.5 mmt -66.22 -33.91 76.83 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.273 -1.133 . . . . 0.0 111.182 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . 0.491 HD22 ' HA ' ' B' ' 71' ' ' LEU . 27.9 mt -63.48 -23.33 67.35 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.214 -0.928 . . . . 0.0 110.616 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . 0.513 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 49.9 mt-10 -70.44 -8.76 53.46 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.366 -0.834 . . . . 0.0 110.875 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 82.7 p -119.83 12.56 12.14 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.053 -1.029 . . . . 0.0 112.548 -178.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 22.3 m -60.76 140.35 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 120.739 -1.225 . . . . 0.0 109.668 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 13.9 m -74.53 -39.02 62.62 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.449 -0.782 . . . . 0.0 110.195 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.24 168.81 17.5 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.428 -0.795 . . . . 0.0 110.106 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.28 139.11 55.75 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.388 -0.82 . . . . 0.0 110.563 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.3 tp -90.93 116.14 28.51 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.494 -0.754 . . . . 0.0 109.935 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -102.99 168.35 8.93 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -76.64 0.01 10.01 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 O-C-N 123.219 1.115 . . . . 0.0 110.434 178.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -120.5 22.38 11.27 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.941 -1.099 . . . . 0.0 108.406 176.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 4.3 m -80.81 137.21 36.21 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.832 -0.542 . . . . 0.0 110.367 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.3 mmm-85 -149.78 146.42 27.16 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 120.059 -0.657 . . . . 0.0 111.448 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.452 ' HB3' ' SG ' ' B' ' 48' ' ' CYS . 95.9 mt -80.61 98.97 7.89 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 104.784 -2.302 . . . . 0.0 104.784 175.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' CYS . . . . . 0.465 ' HB3' HG23 ' B' ' 50' ' ' VAL . 10.6 p -48.36 -17.86 0.18 Allowed 'General case' 0 N--CA 1.508 2.443 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -175.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.8 p -70.33 -14.0 62.39 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.669 -1.269 . . . . 0.0 109.389 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 59.2 mm-40 -92.72 -12.23 31.92 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.512 -0.742 . . . . 0.0 110.534 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . 0.47 HG21 HD13 ' B' ' 23' ' ' LEU . 61.7 mt -91.52 103.97 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.194 -0.941 . . . . 0.0 110.647 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.477 HD13 ' HA ' ' B' ' 89' ' ' ILE . 45.7 mm -85.03 131.75 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' MET . . . . . 0.434 ' C ' HG22 ' B' ' 91' ' ' THR . 13.6 tpt -74.82 137.76 42.11 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 122.101 0.953 . . . . 0.0 113.243 -177.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' THR . . . . . 0.434 HG22 ' C ' ' B' ' 90' ' ' MET . 43.6 p -138.16 166.61 24.62 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 176.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -74.98 1.78 7.35 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 122.663 0.823 . . . . 0.0 111.025 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -87.67 -22.81 24.45 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 176.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.3 mt -93.8 13.04 23.69 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.427 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.5 126.4 23.4 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.122 -0.986 . . . . 0.0 111.142 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.22 6.79 68.45 Favored Glycine 0 N--CA 1.492 2.416 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.725 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.61 142.75 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 CA-C-N 119.263 1.532 . . . . 0.0 110.789 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 60.9 t -122.49 132.96 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.561 -0.712 . . . . 0.0 109.856 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' VAL . . . . . 0.428 ' O ' HG23 ' B' ' 99' ' ' VAL . 16.5 m -130.33 135.73 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.47 -0.769 . . . . 0.0 109.877 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' ASP . . . . . 0.4 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.38 134.14 35.22 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.6 t -103.33 127.31 29.96 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.535 -0.728 . . . . 0.0 110.377 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -80.9 131.0 7.79 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 O-C-N 124.079 1.568 . . . . 0.0 108.286 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' ASP . . . . . 0.413 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.4 p-10 -62.47 3.44 0.2 Allowed 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -178.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -125.28 114.64 19.2 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.288 -1.508 . . . . 0.0 110.088 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . 0.49 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 32.6 mm-40 -113.31 -49.35 2.91 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.455 -0.778 . . . . 0.0 110.007 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' TRP . . . . . 0.425 ' CG ' ' HB3' ' A' ' 113' ' ' ALA . 10.3 m0 . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.53 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 501' ' ' HEM . . . . . 0.949 ' O2D' ' O ' ' A' ' 100' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 502' ' ' CAM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 201' ' ' FES . . . . . 0.884 ' S2 ' ' HE2' ' B' ' 24' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.473 ' HA ' HD11 ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.452 HD11 HG13 ' A' ' 18' ' ' VAL . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.88 ' HG2' HG23 ' A' ' 18' ' ' VAL . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.88 HG23 ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.488 ' HA ' HD23 ' A' ' 22' ' ' LEU . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.415 ' CE2' HG23 ' A' ' 50' ' ' VAL . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.503 ' HE1' HD12 ' A' ' 395' ' ' ILE . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.432 ' HA ' HD12 ' A' ' 34' ' ' LEU . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 39' ' ' GLN . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.514 ' N ' HG12 ' A' ' 38' ' ' VAL . 1.6 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.457 ' O ' HG21 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.423 ' HE3' HD13 ' A' ' 324' ' ' LEU . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.457 HG21 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.49 ' HB3' HG21 ' A' ' 66' ' ' THR . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.412 ' ND2' HG22 ' A' ' 50' ' ' VAL . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.608 HG13 ' HD2' ' A' ' 51' ' ' PRO . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.608 ' HD2' HG13 ' A' ' 50' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.438 HG21 ' HB ' ' A' ' 64' ' ' ILE . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.594 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.8 m120 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.594 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.438 ' HB ' HG21 ' A' ' 54' ' ' VAL . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.49 HG21 ' HB3' ' A' ' 45' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.434 HD11 ' N ' ' A' ' 70' ' ' LEU . 6.0 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.6 mtt180 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.401 ' HB3' HD12 ' A' ' 320' ' ' LEU . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.462 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.5 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.533 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 25.8 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 84.1 mtt-85 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.8 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.62 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.1 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.54 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.54 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.754 ' HD2' ' HB2' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.754 ' HB2' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.694 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.927 HD12 ' NE ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.949 ' O ' ' O2D' ' A' ' 501' ' ' HEM . 74.3 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.629 ' OG1' ' HD2' ' A' ' 100' ' ' PRO . 3.9 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.508 ' HE1' HD13 ' A' ' 99' ' ' ILE . 46.0 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.576 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.298 63.0 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.533 ' HD2' ' CD1' ' A' ' 78' ' ' TYR 0.367 53.3 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.576 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 33.9 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.496 ' H ' ' CD ' ' A' ' 106' ' ' PRO 0.413 34.1 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 15.6 tpt85 -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 5.5 ttt-85 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.433 ' HB3' ' CE3' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.2 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.577 ' HA ' ' CD2' ' A' ' 358' ' ' LEU . 23.3 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.0 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.6 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.489 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.672 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 12.4 mtm -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.672 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.1 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.541 HG13 HD11 ' A' ' 166' ' ' LEU . 72.7 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.2 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.475 HD13 HG12 ' A' ' 123' ' ' VAL . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.488 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.506 ' HA ' HD11 ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.615 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.577 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.488 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.782 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.782 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.465 HD11 HG22 ' A' ' 160' ' ' ILE . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.467 ' HA ' HD13 ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.429 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.541 HD11 HG13 ' A' ' 123' ' ' VAL . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.506 ' N ' HD21 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.44 HD21 ' HA ' ' A' ' 169' ' ' LEU . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.417 ' N ' ' CD ' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.566 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.523 ' HA ' HD22 ' A' ' 180' ' ' LEU . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' MET . . . . . 0.499 ' HE2' HG22 ' A' ' 247' ' ' VAL . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.421 HD13 HD13 ' A' ' 180' ' ' LEU . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.441 ' HB3' ' HG ' ' A' ' 221' ' ' SER . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 211' ' ' ARG . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 224' ' ' ALA . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' SER . . . . . 0.441 ' HG ' ' HB3' ' A' ' 211' ' ' ARG . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 43.5 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 42.0 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 220' ' ' ILE . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 6.9 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 2.6 m120 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 17.1 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.927 ' NE ' HD12 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' MET . . . . . 0.451 ' HB2' ' HE2' ' A' ' 241' ' ' MET . 34.2 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.694 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.423 ' HA ' HD22 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.499 HG22 ' HE2' ' A' ' 184' ' ' MET . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 250' ' ' LEU . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.675 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.469 HD22 ' HA ' ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' MET . . . . . 0.577 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.428 HD22 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 16.4 pm0 -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.433 ' N ' ' CD ' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' CYS . . . . . 0.422 ' SG ' HG21 ' A' ' 367' ' ' ILE . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . 0.433 HD23 HG21 ' A' ' 349' ' ' THR . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . 0.497 ' CZ ' ' HE1' ' A' ' 336' ' ' MET . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.641 ' HA ' ' HE1' ' A' ' 323' ' ' MET . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 296' ' ' ALA . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . 0.513 ' OD2' ' O2A' ' A' ' 501' ' ' HEM . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . 0.424 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . 0.424 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.0 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.535 HD23 ' N ' ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' PHE . . . . . 0.424 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.6 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' HIS . . . . . 0.424 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 36.9 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 312' ' ' LEU . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . 0.63 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . 0.63 ' HD3' ' O ' ' A' ' 319' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' MET . . . . . 0.641 ' HE1' ' HA ' ' A' ' 294' ' ' LEU . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.456 HD11 ' HB2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 14.7 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' LEU . . . . . . . . . . . . . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.472 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' PRO . . . . . 0.472 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 0.497 ' HE1' ' CZ ' ' A' ' 291' ' ' ARG . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 99.3 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 8.8 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 45.1 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' THR . . . . . 0.433 HG21 HD23 ' A' ' 289' ' ' LEU . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 91.4 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . 0.577 ' CD2' ' HA ' ' A' ' 116' ' ' ASN . 0.6 OUTLIER -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.42 ' HA ' HD12 ' A' ' 362' ' ' LEU . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 44.1 mtt85 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 16.6 tpp85 -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . 0.422 HG21 ' SG ' ' A' ' 285' ' ' CYS . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.2 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.485 HD12 HG23 ' A' ' 383' ' ' ILE . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' ILE . . . . . 0.403 HD11 HD12 ' A' ' 402' ' ' LEU . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.503 HD12 ' HE1' ' A' ' 28' ' ' MET . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . 0.403 HD12 HD11 ' A' ' 389' ' ' ILE . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . 0.404 ' HA ' HD22 ' A' ' 404' ' ' LEU . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' ASP . . . . . 0.544 ' HB3' HG23 ' A' ' 410' ' ' THR . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' PRO . . . . . 0.645 ' HA ' HG22 ' A' ' 411' ' ' THR . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' THR . . . . . 0.544 HG23 ' HB3' ' A' ' 407' ' ' ASP . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' THR . . . . . 0.645 HG22 ' HA ' ' A' ' 408' ' ' PRO . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . 0.496 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 N--CA 1.495 1.815 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.49 138.58 38.5 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.181 -0.949 . . . . 0.0 112.936 -178.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 61.3 t -137.12 122.59 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 177.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.435 HG13 ' CZ ' ' B' ' 12' ' ' ARG . 97.8 t -106.79 129.56 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.109 -0.994 . . . . 0.0 111.635 -178.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.555 ' CD1' HD11 ' B' ' 32' ' ' ILE . 77.1 m-85 -109.23 110.63 21.89 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 40.0 t -94.84 127.25 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.88 -1.138 . . . . 0.0 108.345 178.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.4 m -86.15 174.69 8.97 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.747 0.784 . . . . 0.0 112.499 -177.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.415 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.68 -46.8 88.99 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-O 121.129 0.49 . . . . 0.0 110.418 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -65.83 -11.29 45.24 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.56 -0.712 . . . . 0.0 111.405 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.94 15.47 28.53 Favored Glycine 0 N--CA 1.492 2.368 0 O-C-N 121.163 -0.961 . . . . 0.0 111.312 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.1 m -82.09 147.4 29.12 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 118.723 1.261 . . . . 0.0 109.875 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . 0.435 ' CZ ' HG13 ' B' ' 4' ' ' VAL . 50.8 ttt85 -118.46 128.82 54.97 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.476 -0.765 . . . . 0.0 111.803 -178.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.08 127.73 46.27 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.608 -0.683 . . . . 0.0 109.8 179.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.3 tt0 -111.37 130.61 55.63 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.236 -0.915 . . . . 0.0 111.623 -178.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.685 HD11 HD13 ' B' ' 32' ' ' ILE . 84.5 mt -122.8 159.38 28.21 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.732 -0.605 . . . . 0.0 111.075 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -109.63 91.63 3.72 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.8 t -90.2 133.47 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-O 121.625 0.726 . . . . 0.0 112.233 -176.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.09 170.7 16.05 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.784 -0.572 . . . . 0.0 110.266 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -68.47 151.79 46.31 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.503 -0.748 . . . . 0.0 110.965 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.5 -12.52 55.53 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.021 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 91.4 t -89.97 133.36 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 120.696 -1.473 . . . . 0.0 110.933 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 88.5 p -80.25 151.86 29.38 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.523 -0.736 . . . . 0.0 109.129 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.479 HD23 ' HH ' ' B' ' 5' ' ' TYR . 18.4 mt -61.2 -24.68 66.5 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.29 -0.881 . . . . 0.0 110.549 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' MET . . . . . 0.406 ' SD ' ' S2 ' ' B' ' 201' ' ' FES . 2.1 ttp -69.7 -49.24 55.27 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.186 -0.946 . . . . 0.0 109.474 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.81 -41.7 91.82 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.622 -0.674 . . . . 0.0 109.926 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.13 -40.87 95.05 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.607 -0.683 . . . . 0.0 110.099 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.33 -49.79 57.89 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.254 -0.903 . . . . 0.0 111.023 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 71.8 t -65.41 -39.19 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.266 -0.896 . . . . 0.0 110.737 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 15.5 t -70.06 -14.08 62.51 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.342 -0.849 . . . . 0.0 111.562 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -118.13 23.84 11.36 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.016 -1.052 . . . . 0.0 110.658 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.65 38.31 58.55 Favored Glycine 0 N--CA 1.492 2.418 0 O-C-N 121.539 -0.725 . . . . 0.0 111.85 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.685 HD13 HD11 ' B' ' 15' ' ' LEU . 0.4 OUTLIER -72.55 147.13 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.829 -1.395 . . . . 0.0 108.875 178.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -62.7 142.52 58.08 Favored 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 -174.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 62.19 -36.14 0.12 Allowed 'General case' 0 N--CA 1.515 2.785 0 N-CA-C 116.693 2.108 . . . . 0.0 116.693 175.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . 0.421 HD12 ' CG2' ' B' ' 32' ' ' ILE . 12.1 mt -59.7 122.9 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 O-C-N 119.879 -1.763 . . . . 0.0 110.656 -178.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.642 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 58.0 t -100.14 -51.41 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.626 -0.671 . . . . 0.0 111.192 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . 0.609 ' HA2' ' S2 ' ' B' ' 201' ' ' FES . . . 63.17 56.42 20.52 Favored Glycine 0 N--CA 1.499 2.895 0 N-CA-C 107.478 -2.249 . . . . 0.0 107.478 -178.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -71.29 -49.28 44.51 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.983 -0.716 . . . . 0.0 112.279 -177.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' CYS . . . . . 0.551 ' HB3' ' HB3' ' B' ' 45' ' ' CYS . 2.3 p -66.55 -10.48 45.57 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.209 -0.932 . . . . 0.0 112.351 -178.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.82 -5.59 64.08 Favored Glycine 0 N--CA 1.499 2.846 0 O-C-N 120.808 -1.183 . . . . 0.0 112.013 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.16 19.56 10.59 Favored Glycine 0 N--CA 1.495 2.628 0 O-C-N 120.856 -1.379 . . . . 0.0 110.98 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 9.4 t -98.98 19.14 15.63 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.072 -1.251 . . . . 0.0 111.147 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.98 40.84 30.34 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.45 -0.781 . . . . 0.0 111.935 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' SER . . . . . 0.421 ' OG ' ' HB2' ' B' ' 39' ' ' CYS . 2.1 p -117.04 11.23 14.19 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.301 -0.875 . . . . 0.0 109.547 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' CYS . . . . . 0.64 ' SG ' 'FE1 ' ' B' ' 201' ' ' FES . 15.0 p -149.55 -179.11 6.83 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.04 34.08 3.11 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.879 -1.138 . . . . 0.0 111.339 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' THR . . . . . 0.642 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 23.0 p -97.6 13.24 30.81 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.978 -1.076 . . . . 0.0 111.268 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' CYS . . . . . 0.454 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.1 p -120.55 31.74 6.31 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 177.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . 0.428 ' O ' HG13 ' B' ' 50' ' ' VAL . 23.9 t-160 -72.68 133.01 44.42 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.612 -178.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . 0.477 HG23 ' HB3' ' B' ' 85' ' ' CYS . 12.4 m -146.24 160.14 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -105.46 102.76 12.21 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.262 -0.899 . . . . 0.0 108.699 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.2 t -61.92 135.13 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 121.296 -0.878 . . . . 0.0 109.34 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.64 131.7 51.03 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.945 0.878 . . . . 0.0 109.525 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -44.21 -31.12 0.9 Allowed 'General case' 0 N--CA 1.506 2.343 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -178.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.73 -6.93 54.23 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.019 -1.051 . . . . 0.0 112.796 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -119.92 -6.68 10.03 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 120.416 -1.427 . . . . 0.0 111.86 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.4 p -55.39 -37.85 68.12 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.132 -0.98 . . . . 0.0 112.846 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -81.1 -6.66 59.07 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.711 -1.243 . . . . 0.0 111.49 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -89.88 -11.61 41.4 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.986 -1.071 . . . . 0.0 109.848 178.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.626 HG12 ' HD2' ' B' ' 61' ' ' PRO . 40.8 t -104.08 141.01 21.63 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . 0.626 ' HD2' HG12 ' B' ' 60' ' ' VAL . 49.7 Cg_endo -73.77 118.84 5.61 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 O-C-N 123.496 1.261 . . . . 0.0 108.983 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.9 160.59 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.75 0 N-CA-C 116.656 2.095 . . . . 0.0 116.656 -177.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.449 ' HB2' ' HB3' ' B' ' 67' ' ' GLU . . . -65.73 146.14 55.14 Favored 'General case' 0 N--CA 1.503 2.178 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.266 178.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -89.78 -170.81 2.94 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.602 -0.686 . . . . 0.0 110.383 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -59.54 -42.02 91.39 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.329 -0.857 . . . . 0.0 111.708 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.45 -41.52 84.57 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.158 -0.964 . . . . 0.0 112.045 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.449 ' HB3' ' HB2' ' B' ' 63' ' ' ALA . 45.5 tt0 -68.21 -43.92 76.93 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.954 -1.091 . . . . 0.0 110.343 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . 0.516 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.6 mm -55.63 -42.08 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.278 -0.889 . . . . 0.0 109.379 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.24 -47.87 80.44 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 28.5 mmt -66.17 -33.97 76.98 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.275 -1.132 . . . . 0.0 111.226 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . 0.47 HD22 ' HA ' ' B' ' 71' ' ' LEU . 28.1 mt -63.47 -23.33 67.35 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.217 -0.927 . . . . 0.0 110.622 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 66.4 mt-10 -70.41 -8.72 53.02 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.339 -0.851 . . . . 0.0 110.926 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 84.8 p -119.91 12.6 12.09 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.008 -1.057 . . . . 0.0 112.461 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 19.4 m -60.84 140.44 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 O-C-N 120.692 -1.255 . . . . 0.0 109.653 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 25.4 m -74.58 -39.09 62.45 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.387 -0.821 . . . . 0.0 110.153 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.18 168.83 17.4 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.464 -0.773 . . . . 0.0 110.073 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.28 139.16 55.67 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.395 -0.815 . . . . 0.0 110.587 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.4 tp -90.95 116.11 28.5 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.498 -0.751 . . . . 0.0 109.907 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -102.94 168.37 8.91 Favored Pre-proline 0 C--N 1.302 -1.5 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -76.71 0.04 9.99 Favored 'Trans proline' 0 C--N 1.314 -1.255 0 O-C-N 123.279 1.147 . . . . 0.0 110.371 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -120.5 22.3 11.3 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.969 -1.082 . . . . 0.0 108.411 176.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 4.3 m -80.77 137.25 36.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.845 -0.534 . . . . 0.0 110.35 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.5 mmm-85 -149.77 146.41 27.16 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.446 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.454 ' HB3' ' SG ' ' B' ' 48' ' ' CYS . 78.4 mt -80.55 99.0 7.86 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 175.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' CYS . . . . . 0.477 ' HB3' HG23 ' B' ' 50' ' ' VAL . 11.3 p -48.5 -17.82 0.19 Allowed 'General case' 0 N--CA 1.508 2.439 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -175.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.8 p -70.28 -13.99 62.4 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.714 -1.241 . . . . 0.0 109.459 178.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -92.73 -12.25 31.87 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.489 -0.757 . . . . 0.0 110.545 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . 0.468 HG21 HD13 ' B' ' 23' ' ' LEU . 61.7 mt -91.47 104.02 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.195 -0.941 . . . . 0.0 110.625 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 39.2 mm -85.04 131.78 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' MET . . . . . 0.435 ' C ' HG22 ' B' ' 91' ' ' THR . 13.8 tpt -74.85 137.84 42.1 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 122.126 0.965 . . . . 0.0 113.229 -177.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' THR . . . . . 0.435 HG22 ' C ' ' B' ' 90' ' ' MET . 43.7 p -138.23 166.57 24.8 Favored Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 176.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -74.92 1.71 7.39 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 O-C-N 122.683 0.833 . . . . 0.0 111.042 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -87.64 -22.82 24.48 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 176.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.7 mt -93.75 12.96 23.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.982 -0.449 . . . . 0.0 110.422 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -54.48 126.36 23.21 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.111 -0.993 . . . . 0.0 111.164 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.21 6.89 68.34 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.669 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.68 142.79 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 CA-C-N 119.36 1.58 . . . . 0.0 110.715 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' VAL . . . . . 0.401 ' C ' HG11 ' B' ' 99' ' ' VAL . 60.7 t -122.53 133.01 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.532 -0.73 . . . . 0.0 109.819 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' VAL . . . . . 0.425 ' O ' HG23 ' B' ' 99' ' ' VAL . 16.5 m -130.41 135.78 59.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.489 -0.757 . . . . 0.0 109.798 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -92.44 134.17 35.2 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.7 t -103.39 127.27 30.01 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.5 -0.75 . . . . 0.0 110.368 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -80.77 130.92 7.89 Favored 'Trans proline' 0 C--N 1.316 -1.168 0 O-C-N 124.064 1.56 . . . . 0.0 108.268 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' ASP . . . . . 0.415 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.4 p-10 -62.42 3.42 0.19 Allowed 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -178.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 39.5 mtm180 -125.32 114.66 19.2 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.306 -1.496 . . . . 0.0 110.061 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . 0.481 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 62.7 mm-40 -113.3 -49.39 2.91 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.497 -0.752 . . . . 0.0 109.954 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' TRP . . . . . 0.552 ' HA ' ' CE3' ' B' ' 106' ' ' TRP . 4.9 m95 . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.522 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 501' ' ' HEM . . . . . 0.949 ' O2D' ' O ' ' A' ' 100' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 502' ' ' CAM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 201' ' ' FES . . . . . 0.64 'FE1 ' ' SG ' ' B' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.473 ' HA ' HD11 ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.452 HD11 HG13 ' A' ' 18' ' ' VAL . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.88 ' HG2' HG23 ' A' ' 18' ' ' VAL . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.88 HG23 ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.488 ' HA ' HD23 ' A' ' 22' ' ' LEU . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.415 ' CE2' HG23 ' A' ' 50' ' ' VAL . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.503 ' HE1' HD12 ' A' ' 395' ' ' ILE . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.432 ' HA ' HD12 ' A' ' 34' ' ' LEU . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 39' ' ' GLN . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.514 ' N ' HG12 ' A' ' 38' ' ' VAL . 1.6 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.457 ' O ' HG21 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.423 ' HE3' HD13 ' A' ' 324' ' ' LEU . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.457 HG21 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.49 ' HB3' HG21 ' A' ' 66' ' ' THR . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.412 ' ND2' HG22 ' A' ' 50' ' ' VAL . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.608 HG13 ' HD2' ' A' ' 51' ' ' PRO . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.608 ' HD2' HG13 ' A' ' 50' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.438 HG21 ' HB ' ' A' ' 64' ' ' ILE . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.594 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.8 m120 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.594 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.438 ' HB ' HG21 ' A' ' 54' ' ' VAL . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.49 HG21 ' HB3' ' A' ' 45' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.436 HD11 ' N ' ' A' ' 70' ' ' LEU . 6.0 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.9 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.462 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.5 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.466 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 24.3 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.5 mtm180 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.62 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.2 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.54 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.54 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.754 ' HD2' ' HB2' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.754 ' HB2' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.694 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.927 HD12 ' NE ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.949 ' O ' ' O2D' ' A' ' 501' ' ' HEM . 74.3 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.629 ' OG1' ' HD2' ' A' ' 100' ' ' PRO . 3.9 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.508 ' HE1' HD13 ' A' ' 99' ' ' ILE . 46.0 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.614 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.296 50.1 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.466 ' HD2' ' CD1' ' A' ' 78' ' ' TYR 0.366 52.6 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.614 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 35.0 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.469 ' H ' ' CD ' ' A' ' 106' ' ' PRO 0.413 34.1 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.466 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 1.5 tm0? -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.772 ' NH1' ' CBD' ' A' ' 501' ' ' HEM . 6.7 mtp180 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.434 ' HB3' ' CD2' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.438 HD13 ' HA3' ' A' ' 226' ' ' GLY . 24.8 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.1 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.6 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.489 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.672 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 37.1 mtm -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.672 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.1 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.453 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 72.0 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.7 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.453 ' HD2' ' HA ' ' A' ' 123' ' ' VAL . 35.6 mttt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.488 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.506 ' HA ' HD11 ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.615 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.577 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.488 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.782 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.782 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.465 HD11 HG22 ' A' ' 160' ' ' ILE . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.467 ' HA ' HD13 ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.429 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.513 ' C ' HD21 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.506 ' N ' HD21 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.44 HD21 ' HA ' ' A' ' 169' ' ' LEU . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.417 ' N ' ' CD ' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.566 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.523 ' HA ' HD22 ' A' ' 180' ' ' LEU . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' MET . . . . . 0.499 ' HE2' HG22 ' A' ' 247' ' ' VAL . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.421 HD13 HD13 ' A' ' 180' ' ' LEU . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.441 ' HB3' ' HG ' ' A' ' 221' ' ' SER . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 211' ' ' ARG . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 224' ' ' ALA . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' SER . . . . . 0.441 ' HG ' ' HB3' ' A' ' 211' ' ' ARG . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 33.3 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 53.1 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 220' ' ' ILE . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.438 ' HA3' HD13 ' A' ' 114' ' ' LEU . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 4.6 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 1.1 m120 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 18.1 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.927 ' NE ' HD12 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 45.4 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.694 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.423 ' HA ' HD22 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.499 HG22 ' HE2' ' A' ' 184' ' ' MET . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 250' ' ' LEU . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.675 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.469 HD22 ' HA ' ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' MET . . . . . 0.577 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.428 HD22 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.433 ' N ' ' CD ' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' CYS . . . . . 0.422 ' SG ' HG21 ' A' ' 367' ' ' ILE . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . 0.433 HD23 HG21 ' A' ' 349' ' ' THR . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . 0.497 ' CZ ' ' HE1' ' A' ' 336' ' ' MET . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.641 ' HA ' ' HE1' ' A' ' 323' ' ' MET . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 296' ' ' ALA . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . 0.513 ' OD2' ' O2A' ' A' ' 501' ' ' HEM . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . 0.424 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . 0.424 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.0 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.535 HD23 ' N ' ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' PHE . . . . . 0.424 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.6 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' HIS . . . . . 0.424 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 36.9 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 312' ' ' LEU . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . 0.63 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . 0.63 ' HD3' ' O ' ' A' ' 319' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' MET . . . . . 0.641 ' HE1' ' HA ' ' A' ' 294' ' ' LEU . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.456 HD11 ' HB2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 13.7 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' LEU . . . . . . . . . . . . . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.472 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' PRO . . . . . 0.472 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 0.497 ' HE1' ' CZ ' ' A' ' 291' ' ' ARG . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . 0.448 ' CB ' ' HD3' ' A' ' 344' ' ' LYS . 1.9 mp0 -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' LYS . . . . . 0.525 ' HB2' ' HE2' ' A' ' 344' ' ' LYS . 1.5 mppt? -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 60.6 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 28.9 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 14.2 p80 -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 39.6 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' THR . . . . . 0.433 HG21 HD23 ' A' ' 289' ' ' LEU . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 99.6 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' LEU . . . . . 0.478 HD23 ' HA ' ' A' ' 356' ' ' LEU . 0.1 OUTLIER -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 2.9 mt -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.42 ' HA ' HD12 ' A' ' 362' ' ' LEU . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 35.9 mtt85 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . 0.422 HG21 ' SG ' ' A' ' 285' ' ' CYS . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.485 HD12 HG23 ' A' ' 383' ' ' ILE . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' ILE . . . . . 0.403 HD11 HD12 ' A' ' 402' ' ' LEU . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.503 HD12 ' HE1' ' A' ' 28' ' ' MET . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . 0.403 HD12 HD11 ' A' ' 389' ' ' ILE . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . 0.404 ' HA ' HD22 ' A' ' 404' ' ' LEU . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' ASP . . . . . 0.544 ' HB3' HG23 ' A' ' 410' ' ' THR . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' PRO . . . . . 0.645 ' HA ' HG22 ' A' ' 411' ' ' THR . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' THR . . . . . 0.544 HG23 ' HB3' ' A' ' 407' ' ' ASP . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' THR . . . . . 0.645 HG22 ' HA ' ' A' ' 408' ' ' PRO . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . 0.496 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 N--CA 1.496 1.853 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.49 138.62 38.53 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.226 -0.921 . . . . 0.0 112.939 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 61.3 t -137.13 122.59 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.437 HG13 ' CZ ' ' B' ' 12' ' ' ARG . 97.4 t -106.81 129.54 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.149 -0.969 . . . . 0.0 111.654 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.557 ' CD1' HD11 ' B' ' 32' ' ' ILE . 77.2 m-85 -109.19 110.53 21.77 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.78 127.25 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.922 -1.111 . . . . 0.0 108.421 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.9 m -86.19 174.64 8.98 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.782 0.801 . . . . 0.0 112.481 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.415 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.61 -46.73 89.17 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-O 121.145 0.497 . . . . 0.0 110.467 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -65.94 -11.29 46.33 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.552 -0.718 . . . . 0.0 111.416 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.02 15.5 28.25 Favored Glycine 0 N--CA 1.492 2.421 0 O-C-N 121.103 -0.998 . . . . 0.0 111.218 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.3 m -82.14 147.36 29.08 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 118.773 1.286 . . . . 0.0 109.874 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . 0.437 ' CZ ' HG13 ' B' ' 4' ' ' VAL . 50.9 ttt85 -118.46 128.75 54.9 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.434 -0.791 . . . . 0.0 111.832 -178.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.04 127.68 46.24 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.575 -0.703 . . . . 0.0 109.792 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -111.29 130.62 55.61 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.282 -0.887 . . . . 0.0 111.64 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.683 HD11 HD13 ' B' ' 32' ' ' ILE . 84.5 mt -122.77 159.39 28.13 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.741 -0.6 . . . . 0.0 111.107 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -109.66 91.65 3.73 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 176.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.5 t -90.17 133.4 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 CA-C-O 121.605 0.717 . . . . 0.0 112.271 -176.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.13 170.67 16.11 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.812 -0.555 . . . . 0.0 110.257 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -68.36 151.78 46.38 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.491 -0.756 . . . . 0.0 111.01 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.46 -12.46 55.52 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.997 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 60.1 t -89.97 133.27 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 120.691 -1.476 . . . . 0.0 110.932 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 21.2 p -80.22 151.89 29.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.544 -0.723 . . . . 0.0 109.142 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.48 HD23 ' HH ' ' B' ' 5' ' ' TYR . 18.5 mt -61.15 -24.64 66.44 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.362 -0.836 . . . . 0.0 110.619 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' MET . . . . . 0.478 ' SD ' ' S2 ' ' B' ' 201' ' ' FES . 6.3 ttp -69.76 -49.24 54.9 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.212 -0.93 . . . . 0.0 109.463 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -59.85 -41.65 91.88 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.583 -0.698 . . . . 0.0 109.921 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.16 -40.85 94.9 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.606 -0.684 . . . . 0.0 110.082 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . 0.464 ' CB ' HD13 ' B' ' 35' ' ' ILE . . . -68.32 -49.73 58.31 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.207 -0.933 . . . . 0.0 111.079 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 81.7 t -65.5 -39.18 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.333 -0.854 . . . . 0.0 110.7 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 21.4 t -70.1 -14.04 62.48 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.386 -0.822 . . . . 0.0 111.564 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -118.12 23.82 11.37 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.027 -1.046 . . . . 0.0 110.653 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.66 38.22 58.4 Favored Glycine 0 N--CA 1.493 2.46 0 O-C-N 121.52 -0.737 . . . . 0.0 111.872 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.683 HD13 HD11 ' B' ' 15' ' ' LEU . 0.4 OUTLIER -72.52 147.18 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.859 -1.377 . . . . 0.0 108.869 179.01 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . 0.4 ' N ' HG22 ' B' ' 32' ' ' ILE . 0.8 OUTLIER -62.67 142.51 58.05 Favored 'General case' 0 N--CA 1.503 2.217 0 N-CA-C 117.169 2.285 . . . . 0.0 117.169 -174.307 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 62.21 -36.14 0.12 Allowed 'General case' 0 N--CA 1.516 2.835 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 175.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . 0.464 HD13 ' CB ' ' B' ' 27' ' ' ALA . 23.1 mt -59.69 122.87 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 O-C-N 119.928 -1.732 . . . . 0.0 110.665 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.593 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 52.5 t -100.07 -51.47 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.633 -0.667 . . . . 0.0 111.248 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . 0.611 ' HA2' ' S2 ' ' B' ' 201' ' ' FES . . . 63.1 56.51 20.14 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 107.459 -2.256 . . . . 0.0 107.459 -178.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -71.27 -49.33 44.16 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.958 -0.731 . . . . 0.0 112.296 -177.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' CYS . . . . . 0.543 ' HB3' ' HB3' ' B' ' 45' ' ' CYS . 2.3 p -66.56 -10.42 45.12 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.249 -0.907 . . . . 0.0 112.359 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . 0.474 ' HA3' HD12 ' A' ' 356' ' ' LEU . . . 96.79 -5.53 64.11 Favored Glycine 0 N--CA 1.498 2.779 0 O-C-N 120.763 -1.211 . . . . 0.0 111.985 177.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.16 19.52 10.62 Favored Glycine 0 N--CA 1.495 2.608 0 O-C-N 120.883 -1.363 . . . . 0.0 110.965 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 1.3 t -98.95 19.11 15.64 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.032 -1.276 . . . . 0.0 111.142 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 56.0 40.84 30.32 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.358 -0.839 . . . . 0.0 111.934 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 57.8 m -117.0 11.17 14.21 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.318 -0.864 . . . . 0.0 109.533 178.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' CYS . . . . . 0.639 ' SG ' 'FE1 ' ' B' ' 201' ' ' FES . 15.1 p -149.56 -179.07 6.8 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.511 -0.743 . . . . 0.0 109.039 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.07 33.98 3.11 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.85 -1.156 . . . . 0.0 111.357 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' THR . . . . . 0.593 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 65.1 p -97.51 13.23 30.68 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.0 -1.063 . . . . 0.0 111.275 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' CYS . . . . . 0.455 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.1 p -120.57 31.78 6.29 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 177.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . 0.425 ' O ' HG13 ' B' ' 50' ' ' VAL . 23.9 t-160 -72.68 133.07 44.44 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.588 -178.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . 0.469 HG23 ' HB3' ' B' ' 85' ' ' CYS . 12.3 m -146.29 160.06 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . 0.404 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.5 m-85 -105.45 102.73 12.19 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.239 -0.913 . . . . 0.0 108.74 178.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.1 t -61.9 135.17 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.269 -0.894 . . . . 0.0 109.348 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.67 131.75 51.2 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.961 0.886 . . . . 0.0 109.495 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -44.3 -30.99 0.9 Allowed 'General case' 0 N--CA 1.506 2.357 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.79 -6.92 54.29 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.013 -1.055 . . . . 0.0 112.726 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -119.95 -6.6 10.02 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 120.456 -1.402 . . . . 0.0 111.9 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.4 p -55.48 -37.73 68.2 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 121.155 -0.966 . . . . 0.0 112.892 -178.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -81.2 -6.59 59.03 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 120.743 -1.223 . . . . 0.0 111.44 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -89.89 -11.66 41.21 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.962 -1.087 . . . . 0.0 109.825 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.623 HG12 ' HD2' ' B' ' 61' ' ' PRO . 41.0 t -104.11 141.1 21.81 Favored Pre-proline 0 N--CA 1.488 1.458 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . 0.623 ' HD2' HG12 ' B' ' 60' ' ' VAL . 49.5 Cg_endo -73.82 118.87 5.61 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 O-C-N 123.485 1.255 . . . . 0.0 108.984 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.93 160.62 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.752 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 -177.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.446 ' HB2' ' HB3' ' B' ' 67' ' ' GLU . . . -65.78 146.2 55.06 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.222 178.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -89.76 -170.78 2.93 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.592 -0.693 . . . . 0.0 110.397 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -59.56 -41.99 91.39 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.377 -0.827 . . . . 0.0 111.739 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.47 -41.54 84.46 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.109 -0.994 . . . . 0.0 111.994 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.446 ' HB3' ' HB2' ' B' ' 63' ' ' ALA . 45.4 tt0 -68.23 -43.94 76.81 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.962 -1.086 . . . . 0.0 110.367 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . 0.514 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.7 mm -55.57 -42.18 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.292 -0.88 . . . . 0.0 109.37 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.17 -47.86 80.84 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 12.4 mmt -66.19 -33.98 77.0 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.256 -1.144 . . . . 0.0 111.162 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . 0.472 HD22 ' HA ' ' B' ' 71' ' ' LEU . 28.0 mt -63.45 -23.34 67.36 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.172 -0.955 . . . . 0.0 110.606 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . 0.514 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 49.2 mt-10 -70.41 -8.75 53.24 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.345 -0.847 . . . . 0.0 110.938 179.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 56.3 p -119.85 12.57 12.13 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.003 -1.061 . . . . 0.0 112.517 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 16.4 m -60.81 140.43 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 120.661 -1.274 . . . . 0.0 109.618 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 41.1 m -74.57 -39.05 62.49 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.432 -0.792 . . . . 0.0 110.187 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.22 168.81 17.47 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.441 -0.787 . . . . 0.0 110.089 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.3 139.18 55.67 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.387 -0.821 . . . . 0.0 110.585 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.4 tp -91.02 116.19 28.6 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.497 -0.752 . . . . 0.0 109.879 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -102.99 168.37 8.9 Favored Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -76.64 -0.05 10.06 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 O-C-N 123.259 1.136 . . . . 0.0 110.404 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -120.5 22.39 11.27 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.001 -1.062 . . . . 0.0 108.375 176.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 4.3 m -80.84 137.2 36.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.833 -0.542 . . . . 0.0 110.359 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.4 mmm-85 -149.74 146.4 27.18 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 120.029 -0.669 . . . . 0.0 111.466 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.455 ' HB3' ' SG ' ' B' ' 48' ' ' CYS . 79.2 mt -80.49 98.97 7.8 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 175.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' CYS . . . . . 0.469 ' HB3' HG23 ' B' ' 50' ' ' VAL . 10.7 p -48.45 -17.9 0.19 Allowed 'General case' 0 N--CA 1.507 2.412 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -175.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.8 p -70.24 -13.99 62.42 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.65 -1.281 . . . . 0.0 109.472 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 48.6 mm-40 -92.75 -12.16 32.03 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.509 -0.744 . . . . 0.0 110.502 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . 0.469 HG21 HD13 ' B' ' 23' ' ' LEU . 61.8 mt -91.56 104.0 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.16 -0.962 . . . . 0.0 110.567 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.41 HD13 ' HA ' ' B' ' 89' ' ' ILE . 45.3 mm -85.01 131.78 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' MET . . . . . 0.436 ' C ' HG22 ' B' ' 91' ' ' THR . 13.6 tpt -74.83 137.81 42.11 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 122.166 0.984 . . . . 0.0 113.183 -177.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' THR . . . . . 0.436 HG22 ' C ' ' B' ' 90' ' ' MET . 43.7 p -138.23 166.52 25.18 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 176.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -74.86 1.67 7.39 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 122.595 0.787 . . . . 0.0 111.026 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -87.65 -22.81 24.48 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 176.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.6 mt -93.78 12.97 23.85 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.408 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -54.52 126.39 23.44 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.175 -0.953 . . . . 0.0 111.161 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.22 6.86 68.36 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.64 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.64 142.75 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 CA-C-N 119.367 1.584 . . . . 0.0 110.714 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 60.8 t -122.53 132.99 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.583 -0.698 . . . . 0.0 109.866 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' VAL . . . . . 0.43 ' O ' HG23 ' B' ' 99' ' ' VAL . 16.4 m -130.38 135.77 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.518 -0.739 . . . . 0.0 109.795 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' ASP . . . . . 0.404 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.43 134.15 35.22 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.8 t -103.39 127.26 30.02 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.517 -0.739 . . . . 0.0 110.377 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -80.84 130.97 7.84 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 O-C-N 124.118 1.588 . . . . 0.0 108.273 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' ASP . . . . . 0.415 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.3 p-10 -62.35 3.34 0.19 Allowed 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -178.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 39.5 mtm180 -125.29 114.66 19.22 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.237 -1.539 . . . . 0.0 110.09 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . 0.484 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 51.7 mm-40 -113.32 -49.38 2.91 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.436 -0.79 . . . . 0.0 109.979 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' TRP . . . . . 0.434 ' CD2' ' HB3' ' A' ' 113' ' ' ALA . 51.1 m95 . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.491 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 501' ' ' HEM . . . . . 0.949 ' O2D' ' O ' ' A' ' 100' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 502' ' ' CAM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 201' ' ' FES . . . . . 0.639 'FE1 ' ' SG ' ' B' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.473 ' HA ' HD11 ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.452 HD11 HG13 ' A' ' 18' ' ' VAL . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.88 ' HG2' HG23 ' A' ' 18' ' ' VAL . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.88 HG23 ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.488 ' HA ' HD23 ' A' ' 22' ' ' LEU . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.415 ' CE2' HG23 ' A' ' 50' ' ' VAL . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.503 ' HE1' HD12 ' A' ' 395' ' ' ILE . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.432 ' HA ' HD12 ' A' ' 34' ' ' LEU . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 39' ' ' GLN . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.514 ' N ' HG12 ' A' ' 38' ' ' VAL . 1.6 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.457 ' O ' HG21 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.423 ' HE3' HD13 ' A' ' 324' ' ' LEU . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.457 HG21 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.49 ' HB3' HG21 ' A' ' 66' ' ' THR . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.412 ' ND2' HG22 ' A' ' 50' ' ' VAL . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.608 HG13 ' HD2' ' A' ' 51' ' ' PRO . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.608 ' HD2' HG13 ' A' ' 50' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.438 HG21 ' HB ' ' A' ' 64' ' ' ILE . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.594 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.8 m120 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.594 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.438 ' HB ' HG21 ' A' ' 54' ' ' VAL . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.49 HG21 ' HB3' ' A' ' 45' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.405 HD11 ' N ' ' A' ' 70' ' ' LEU . 5.9 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 45.7 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.462 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.6 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.9 mtm180 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.62 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.2 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.54 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.54 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.754 ' HD2' ' HB2' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.754 ' HB2' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.694 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.927 HD12 ' NE ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.949 ' O ' ' O2D' ' A' ' 501' ' ' HEM . 67.8 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.623 ' OG1' ' HD2' ' A' ' 100' ' ' PRO . 3.9 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.508 ' HE1' HD13 ' A' ' 99' ' ' ILE . 45.3 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.614 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.296 50.2 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . 0.366 52.7 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.614 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 35.0 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.469 ' H ' ' CD ' ' A' ' 106' ' ' PRO 0.372 31.8 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.43 ' HB3' ' CD2' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.8 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.1 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.6 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.489 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.672 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 26.7 mtm -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.672 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.1 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 69.2 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 54.1 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 29.8 mtmt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.488 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.506 ' HA ' HD11 ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.615 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.577 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.488 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.782 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.782 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.465 HD11 HG22 ' A' ' 160' ' ' ILE . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.467 ' HA ' HD13 ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.429 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.513 ' C ' HD21 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.506 ' N ' HD21 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.44 HD21 ' HA ' ' A' ' 169' ' ' LEU . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.417 ' N ' ' CD ' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.566 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.523 ' HA ' HD22 ' A' ' 180' ' ' LEU . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' MET . . . . . 0.499 ' HE2' HG22 ' A' ' 247' ' ' VAL . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.421 HD13 HD13 ' A' ' 180' ' ' LEU . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.441 ' HB3' ' HG ' ' A' ' 221' ' ' SER . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 211' ' ' ARG . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 224' ' ' ALA . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' SER . . . . . 0.441 ' HG ' ' HB3' ' A' ' 211' ' ' ARG . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 26.5 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 42.0 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 220' ' ' ILE . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 4.0 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 1.2 m120 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 17.1 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.927 ' NE ' HD12 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' MET . . . . . 0.451 ' HB2' ' HE2' ' A' ' 241' ' ' MET . 35.4 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.694 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.423 ' HA ' HD22 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.499 HG22 ' HE2' ' A' ' 184' ' ' MET . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 250' ' ' LEU . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.675 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.469 HD22 ' HA ' ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' MET . . . . . 0.577 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.428 HD22 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 8.7 pm0 -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.433 ' N ' ' CD ' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' CYS . . . . . 0.422 ' SG ' HG21 ' A' ' 367' ' ' ILE . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . 0.433 HD23 HG21 ' A' ' 349' ' ' THR . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . 0.497 ' CZ ' ' HE1' ' A' ' 336' ' ' MET . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.641 ' HA ' ' HE1' ' A' ' 323' ' ' MET . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 296' ' ' ALA . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . 0.513 ' OD2' ' O2A' ' A' ' 501' ' ' HEM . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . 0.424 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . 0.424 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.0 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.535 HD23 ' N ' ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' PHE . . . . . 0.424 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.4 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' HIS . . . . . 0.424 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 41.4 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 312' ' ' LEU . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . 0.63 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . 0.63 ' HD3' ' O ' ' A' ' 319' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' MET . . . . . 0.641 ' HE1' ' HA ' ' A' ' 294' ' ' LEU . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.456 HD11 ' HB2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 39.5 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' LEU . . . . . . . . . . . . . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.472 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' PRO . . . . . 0.472 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 0.497 ' HE1' ' CZ ' ' A' ' 291' ' ' ARG . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 92.5 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 1.3 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 47.2 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' THR . . . . . 0.433 HG21 HD23 ' A' ' 289' ' ' LEU . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 62.6 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 91.7 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' LEU . . . . . . . . . . . . . 1.1 tp -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 1.6 mt -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.42 ' HA ' HD12 ' A' ' 362' ' ' LEU . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 9.6 mtm180 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 14.2 tpp85 -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . 0.422 HG21 ' SG ' ' A' ' 285' ' ' CYS . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.485 HD12 HG23 ' A' ' 383' ' ' ILE . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' ILE . . . . . 0.403 HD11 HD12 ' A' ' 402' ' ' LEU . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.503 HD12 ' HE1' ' A' ' 28' ' ' MET . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . 0.403 HD12 HD11 ' A' ' 389' ' ' ILE . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . 0.404 ' HA ' HD22 ' A' ' 404' ' ' LEU . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' ASP . . . . . 0.544 ' HB3' HG23 ' A' ' 410' ' ' THR . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' PRO . . . . . 0.645 ' HA ' HG22 ' A' ' 411' ' ' THR . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' THR . . . . . 0.544 HG23 ' HB3' ' A' ' 407' ' ' ASP . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' THR . . . . . 0.645 HG22 ' HA ' ' A' ' 408' ' ' PRO . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . 0.496 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 40.1 m . . . . . 0 N--CA 1.496 1.832 0 N-CA-C 109.713 -0.476 . . . . 0.0 109.713 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.46 138.56 38.52 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.211 -0.931 . . . . 0.0 112.94 -178.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 61.0 t -137.1 122.5 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 177.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.44 HG13 ' CZ ' ' B' ' 12' ' ' ARG . 97.6 t -106.77 129.58 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.131 -0.981 . . . . 0.0 111.622 -178.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.481 ' HH ' HD23 ' B' ' 23' ' ' LEU . 77.0 m-85 -109.22 110.62 21.87 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 39.7 t -94.85 127.22 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.886 -1.133 . . . . 0.0 108.382 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.5 m -86.17 174.67 8.97 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.752 0.786 . . . . 0.0 112.534 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.412 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.65 -46.77 89.05 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 121.136 0.493 . . . . 0.0 110.428 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -65.85 -11.32 45.67 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.556 -0.715 . . . . 0.0 111.463 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.0 15.49 28.32 Favored Glycine 0 N--CA 1.492 2.376 0 O-C-N 121.166 -0.959 . . . . 0.0 111.273 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.3 m -82.11 147.42 29.09 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.047 -1.267 . . . . 0.0 109.894 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . 0.44 ' CZ ' HG13 ' B' ' 4' ' ' VAL . 50.8 ttt85 -118.49 128.75 54.89 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.408 -0.807 . . . . 0.0 111.808 -178.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.07 127.68 46.21 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.54 -0.725 . . . . 0.0 109.813 179.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -111.32 130.61 55.62 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.312 -0.867 . . . . 0.0 111.602 -178.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.403 ' HA ' HD21 ' B' ' 15' ' ' LEU . 84.5 mt -122.8 159.38 28.21 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.687 -0.633 . . . . 0.0 111.09 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -109.6 91.61 3.72 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 176.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.7 t -90.18 133.45 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-O 121.601 0.715 . . . . 0.0 112.252 -176.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.07 170.67 16.11 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.804 -0.56 . . . . 0.0 110.247 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -68.45 151.83 46.27 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.555 -0.716 . . . . 0.0 110.986 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.43 -12.49 55.32 Favored Glycine 0 N--CA 1.495 2.629 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.02 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 91.3 t -89.95 133.37 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 120.705 -1.468 . . . . 0.0 110.899 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 96.6 p -80.3 151.96 29.26 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.481 HD23 ' HH ' ' B' ' 5' ' ' TYR . 18.5 mt -61.24 -24.62 66.49 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.307 -0.871 . . . . 0.0 110.589 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 13.6 tmm? -69.76 -49.2 55.32 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.238 -0.914 . . . . 0.0 109.493 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -59.83 -41.69 91.88 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.605 -0.684 . . . . 0.0 109.945 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.12 -40.87 95.1 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.648 -0.658 . . . . 0.0 110.165 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . 0.401 ' HB1' ' CE2' ' B' ' 5' ' ' TYR . . . -68.28 -49.79 58.11 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.281 -0.887 . . . . 0.0 111.068 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 55.2 t -65.45 -39.13 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.287 -0.883 . . . . 0.0 110.755 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 24.9 m -70.16 -14.02 62.45 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.386 -0.821 . . . . 0.0 111.502 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' ASN . . . . . 0.49 ' HB3' ' CD1' ' B' ' 32' ' ' ILE . 0.5 OUTLIER -118.17 23.83 11.35 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.021 -1.049 . . . . 0.0 110.652 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.68 38.24 58.54 Favored Glycine 0 N--CA 1.493 2.471 0 O-C-N 121.533 -0.729 . . . . 0.0 111.905 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.49 ' CD1' ' HB3' ' B' ' 30' ' ' ASN . 1.1 mp -72.53 147.22 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.867 -1.372 . . . . 0.0 108.815 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -62.78 142.5 58.15 Favored 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 117.182 2.289 . . . . 0.0 117.182 -174.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 62.24 -36.11 0.12 Allowed 'General case' 0 N--CA 1.515 2.806 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 175.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 57.8 mt -59.74 122.88 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 CA-C-N 121.067 1.758 . . . . 0.0 110.664 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.679 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 48.2 t -100.1 -51.43 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.674 -0.641 . . . . 0.0 111.22 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . 0.61 ' HA2' ' S2 ' ' B' ' 201' ' ' FES . . . 63.13 56.51 20.07 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 107.47 -2.252 . . . . 0.0 107.47 -178.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.35 -49.29 43.85 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.988 -0.713 . . . . 0.0 112.26 -177.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' CYS . . . . . 0.545 ' HB3' ' HB3' ' B' ' 45' ' ' CYS . 2.3 p -66.55 -10.45 45.31 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.229 -0.919 . . . . 0.0 112.372 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.82 -5.52 64.04 Favored Glycine 0 N--CA 1.498 2.823 0 O-C-N 120.841 -1.162 . . . . 0.0 111.938 177.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.2 19.42 10.69 Favored Glycine 0 N--CA 1.494 2.557 0 O-C-N 120.794 -1.415 . . . . 0.0 111.031 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 87.7 p -98.86 19.04 15.66 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.055 -1.262 . . . . 0.0 111.158 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 56.01 40.85 30.28 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.401 -0.812 . . . . 0.0 111.926 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 17.3 m -116.99 11.12 14.21 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.401 -0.812 . . . . 0.0 109.522 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' CYS . . . . . 0.643 ' SG ' 'FE1 ' ' B' ' 201' ' ' FES . 15.1 p -149.52 -179.04 6.78 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.537 -0.727 . . . . 0.0 109.073 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.1 34.07 3.09 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.804 -1.185 . . . . 0.0 111.339 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' THR . . . . . 0.679 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 5.6 p -97.6 13.24 30.79 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.972 -1.08 . . . . 0.0 111.288 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' CYS . . . . . 0.452 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.1 p -120.56 31.72 6.32 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 177.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . 0.473 ' NE2' ' HB3' ' B' ' 82' ' ' SER . 6.4 t-160 -72.63 133.02 44.47 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.618 -178.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . 0.471 HG23 ' HB3' ' B' ' 85' ' ' CYS . 12.3 m -146.27 160.05 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . 0.404 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.5 m-85 -105.39 102.71 12.17 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.285 -0.885 . . . . 0.0 108.708 178.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.4 t -61.86 135.09 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.316 -0.865 . . . . 0.0 109.387 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.62 131.82 51.36 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.945 0.879 . . . . 0.0 109.522 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -44.33 -31.03 0.92 Allowed 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.8 -6.91 54.25 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.021 -1.05 . . . . 0.0 112.766 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -119.94 -6.65 10.02 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 120.527 -1.358 . . . . 0.0 111.922 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.5 p -55.41 -37.77 68.06 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.151 -0.968 . . . . 0.0 112.915 -178.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -81.18 -6.59 59.02 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.744 -1.222 . . . . 0.0 111.481 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -89.87 -11.65 41.29 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.97 -1.081 . . . . 0.0 109.854 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.629 HG12 ' HD2' ' B' ' 61' ' ' PRO . 40.8 t -104.07 141.04 21.7 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . 0.629 ' HD2' HG12 ' B' ' 60' ' ' VAL . 49.8 Cg_endo -73.74 118.87 5.63 Favored 'Trans proline' 0 N--CA 1.488 1.176 0 O-C-N 123.444 1.233 . . . . 0.0 109.008 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.95 160.61 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.79 0 N-CA-C 116.645 2.091 . . . . 0.0 116.645 -177.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.446 ' HB2' ' HB3' ' B' ' 67' ' ' GLU . . . -65.77 146.17 55.1 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.216 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -89.75 -170.79 2.94 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.594 -0.691 . . . . 0.0 110.398 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -59.53 -42.02 91.36 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.321 -0.862 . . . . 0.0 111.719 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -41.47 84.46 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.242 -0.911 . . . . 0.0 112.027 -178.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.446 ' HB3' ' HB2' ' B' ' 63' ' ' ALA . 45.3 tt0 -68.26 -43.98 76.63 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.941 -1.099 . . . . 0.0 110.335 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . 0.499 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.7 mm -55.53 -42.16 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.283 -0.885 . . . . 0.0 109.394 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.23 -47.86 80.64 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 24.8 mmt -66.18 -33.97 76.98 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.316 -1.108 . . . . 0.0 111.186 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 27.5 mt -63.51 -23.32 67.34 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.203 -0.936 . . . . 0.0 110.62 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . 0.499 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 44.2 mt-10 -70.44 -8.67 52.75 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.38 -0.825 . . . . 0.0 110.926 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 36.4 m -119.87 12.55 12.1 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.069 -1.02 . . . . 0.0 112.518 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 35.3 m -60.78 140.49 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 120.75 -1.219 . . . . 0.0 109.677 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 33.8 m -74.63 -39.08 62.34 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.372 -0.83 . . . . 0.0 110.136 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.22 168.82 17.46 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.451 -0.78 . . . . 0.0 110.087 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.26 139.12 55.68 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.422 -0.799 . . . . 0.0 110.613 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.5 tp -91.01 116.19 28.6 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.569 -0.707 . . . . 0.0 109.873 179.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -103.02 168.3 9.0 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -76.61 -0.0 10.0 Favored 'Trans proline' 0 C--N 1.315 -1.217 0 O-C-N 123.222 1.117 . . . . 0.0 110.398 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -120.48 22.36 11.29 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.918 -1.114 . . . . 0.0 108.42 176.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' SER . . . . . 0.473 ' HB3' ' NE2' ' B' ' 49' ' ' HIS . 4.3 m -80.81 137.23 36.21 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.91 -0.494 . . . . 0.0 110.383 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.4 mmm-85 -149.78 146.41 27.16 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.47 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.452 ' HB3' ' SG ' ' B' ' 48' ' ' CYS . 96.3 mt -80.59 98.97 7.88 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 175.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' CYS . . . . . 0.471 ' HB3' HG23 ' B' ' 50' ' ' VAL . 10.5 p -48.37 -17.88 0.18 Allowed 'General case' 0 N--CA 1.508 2.448 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -175.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.9 p -70.29 -14.0 62.41 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.686 -1.259 . . . . 0.0 109.474 178.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -92.68 -12.23 32.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.492 -0.755 . . . . 0.0 110.553 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . 0.469 HG21 HD13 ' B' ' 23' ' ' LEU . 61.8 mt -91.48 103.95 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.179 -0.951 . . . . 0.0 110.648 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 27.6 mm -85.03 131.8 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' MET . . . . . 0.434 ' C ' HG22 ' B' ' 91' ' ' THR . 13.8 tpt -74.89 137.78 41.99 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 122.176 0.988 . . . . 0.0 113.221 -177.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' THR . . . . . 0.434 HG22 ' C ' ' B' ' 90' ' ' MET . 43.6 p -138.2 166.59 24.73 Favored Pre-proline 0 N--CA 1.49 1.546 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 176.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -74.97 1.75 7.37 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 122.678 0.83 . . . . 0.0 111.023 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -87.69 -22.77 24.45 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.4 mt -93.85 12.99 23.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 122.024 -0.423 . . . . 0.0 110.412 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -54.5 126.37 23.31 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.185 -0.947 . . . . 0.0 111.172 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.23 6.86 68.33 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.633 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.65 142.76 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 CA-C-N 119.374 1.587 . . . . 0.0 110.773 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' VAL . . . . . 0.404 ' C ' HG11 ' B' ' 99' ' ' VAL . 60.8 t -122.5 133.01 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.494 -0.754 . . . . 0.0 109.858 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' VAL . . . . . 0.427 ' O ' HG23 ' B' ' 99' ' ' VAL . 16.4 m -130.39 135.76 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.439 -0.788 . . . . 0.0 109.793 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' ASP . . . . . 0.404 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.43 134.17 35.2 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.4 t -103.39 127.29 29.96 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.482 -0.761 . . . . 0.0 110.386 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -80.82 131.01 7.87 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 O-C-N 124.016 1.535 . . . . 0.0 108.306 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' ASP . . . . . 0.412 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.4 p-10 -62.44 3.4 0.2 Allowed 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -178.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 4.0 mtm105 -125.32 114.6 19.12 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.282 -1.511 . . . . 0.0 110.075 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . 0.482 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 70.6 mm-40 -113.25 -49.43 2.91 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.46 -0.775 . . . . 0.0 110.0 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' TRP . . . . . 0.43 ' CD2' ' HB3' ' A' ' 113' ' ' ALA . 10.9 m0 . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.5 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 501' ' ' HEM . . . . . 0.949 ' O2D' ' O ' ' A' ' 100' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 502' ' ' CAM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 201' ' ' FES . . . . . 0.643 'FE1 ' ' SG ' ' B' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.473 ' HA ' HD11 ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.452 HD11 HG13 ' A' ' 18' ' ' VAL . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.88 ' HG2' HG23 ' A' ' 18' ' ' VAL . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.88 HG23 ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.488 ' HA ' HD23 ' A' ' 22' ' ' LEU . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.415 ' CE2' HG23 ' A' ' 50' ' ' VAL . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.503 ' HE1' HD12 ' A' ' 395' ' ' ILE . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.432 ' HA ' HD12 ' A' ' 34' ' ' LEU . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 39' ' ' GLN . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.514 ' N ' HG12 ' A' ' 38' ' ' VAL . 1.6 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.457 ' O ' HG21 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.423 ' HE3' HD13 ' A' ' 324' ' ' LEU . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.457 HG21 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.49 ' HB3' HG21 ' A' ' 66' ' ' THR . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.412 ' ND2' HG22 ' A' ' 50' ' ' VAL . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.608 HG13 ' HD2' ' A' ' 51' ' ' PRO . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.608 ' HD2' HG13 ' A' ' 50' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.438 HG21 ' HB ' ' A' ' 64' ' ' ILE . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.594 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.8 m120 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.594 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.438 ' HB ' HG21 ' A' ' 54' ' ' VAL . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.49 HG21 ' HB3' ' A' ' 45' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.405 HD11 ' N ' ' A' ' 70' ' ' LEU . 5.9 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.2 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.462 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.5 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.457 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 26.4 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.1 mtm180 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.62 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.2 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.54 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.54 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.754 ' HD2' ' HB2' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.754 ' HB2' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.694 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.927 HD12 ' NE ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.949 ' O ' ' O2D' ' A' ' 501' ' ' HEM . 67.8 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.623 ' OG1' ' HD2' ' A' ' 100' ' ' PRO . 3.9 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.508 ' HE1' HD13 ' A' ' 99' ' ' ILE . 45.3 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.614 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.296 50.2 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.457 ' HD2' ' CD1' ' A' ' 78' ' ' TYR 0.366 53.2 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.614 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 35.0 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.469 ' H ' ' CD ' ' A' ' 106' ' ' PRO 0.372 31.8 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.8 ttp85 -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 8.6 mtp180 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.8 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.1 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.6 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.489 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.672 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 28.8 mtm -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.672 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.1 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 69.2 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 54.1 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 29.8 mtmt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.488 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.506 ' HA ' HD11 ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.615 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.577 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.488 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.782 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.782 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.465 HD11 HG22 ' A' ' 160' ' ' ILE . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.467 ' HA ' HD13 ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.429 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.513 ' C ' HD21 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.506 ' N ' HD21 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.44 HD21 ' HA ' ' A' ' 169' ' ' LEU . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.417 ' N ' ' CD ' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.566 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.523 ' HA ' HD22 ' A' ' 180' ' ' LEU . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' MET . . . . . 0.499 ' HE2' HG22 ' A' ' 247' ' ' VAL . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.421 HD13 HD13 ' A' ' 180' ' ' LEU . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.441 ' HB3' ' HG ' ' A' ' 221' ' ' SER . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 211' ' ' ARG . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 224' ' ' ALA . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' SER . . . . . 0.441 ' HG ' ' HB3' ' A' ' 211' ' ' ARG . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 26.5 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 42.0 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 220' ' ' ILE . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 4.0 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 17.1 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.927 ' NE ' HD12 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' MET . . . . . 0.451 ' HB2' ' HE2' ' A' ' 241' ' ' MET . 35.4 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.694 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.423 ' HA ' HD22 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.499 HG22 ' HE2' ' A' ' 184' ' ' MET . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 250' ' ' LEU . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.675 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.469 HD22 ' HA ' ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' MET . . . . . 0.577 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.428 HD22 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 8.7 pm0 -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.433 ' N ' ' CD ' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' CYS . . . . . 0.422 ' SG ' HG21 ' A' ' 367' ' ' ILE . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . 0.433 HD23 HG21 ' A' ' 349' ' ' THR . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . 0.497 ' CZ ' ' HE1' ' A' ' 336' ' ' MET . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.641 ' HA ' ' HE1' ' A' ' 323' ' ' MET . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 296' ' ' ALA . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . 0.513 ' OD2' ' O2A' ' A' ' 501' ' ' HEM . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . 0.424 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . 0.424 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.0 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.535 HD23 ' N ' ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' PHE . . . . . 0.424 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.4 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' HIS . . . . . 0.424 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 41.4 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 312' ' ' LEU . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . 0.63 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . 0.63 ' HD3' ' O ' ' A' ' 319' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' MET . . . . . 0.641 ' HE1' ' HA ' ' A' ' 294' ' ' LEU . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.456 HD11 ' HB2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 39.5 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' LEU . . . . . . . . . . . . . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.472 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' PRO . . . . . 0.472 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 0.497 ' HE1' ' CZ ' ' A' ' 291' ' ' ARG . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 92.5 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 1.3 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 47.2 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' THR . . . . . 0.433 HG21 HD23 ' A' ' 289' ' ' LEU . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 66.3 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 93.8 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 1.2 tp -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.42 ' HA ' HD12 ' A' ' 362' ' ' LEU . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 14.2 tpp85 -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . 0.422 HG21 ' SG ' ' A' ' 285' ' ' CYS . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.485 HD12 HG23 ' A' ' 383' ' ' ILE . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' ILE . . . . . 0.403 HD11 HD12 ' A' ' 402' ' ' LEU . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.503 HD12 ' HE1' ' A' ' 28' ' ' MET . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . 0.403 HD12 HD11 ' A' ' 389' ' ' ILE . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . 0.404 ' HA ' HD22 ' A' ' 404' ' ' LEU . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' ASP . . . . . 0.544 ' HB3' HG23 ' A' ' 410' ' ' THR . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' PRO . . . . . 0.645 ' HA ' HG22 ' A' ' 411' ' ' THR . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' THR . . . . . 0.544 HG23 ' HB3' ' A' ' 407' ' ' ASP . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' THR . . . . . 0.645 HG22 ' HA ' ' A' ' 408' ' ' PRO . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . 0.496 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 39.6 m . . . . . 0 N--CA 1.496 1.837 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.54 138.62 38.49 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.218 -0.926 . . . . 0.0 112.934 -178.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 60.6 t -137.14 122.58 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.442 HG13 ' CZ ' ' B' ' 12' ' ' ARG . 98.1 t -106.82 129.54 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.126 -0.984 . . . . 0.0 111.58 -178.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.475 ' HH ' HD23 ' B' ' 23' ' ' LEU . 77.0 m-85 -109.2 110.58 21.83 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 40.0 t -94.79 127.2 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.899 -1.125 . . . . 0.0 108.367 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.4 m -86.12 174.67 9.0 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.773 0.797 . . . . 0.0 112.527 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.412 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.66 -46.73 89.24 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 121.132 0.491 . . . . 0.0 110.463 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -65.92 -11.26 45.95 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.592 -0.692 . . . . 0.0 111.401 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.97 15.47 28.45 Favored Glycine 0 N--CA 1.492 2.368 0 O-C-N 121.202 -0.936 . . . . 0.0 111.258 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.4 m -82.11 147.35 29.12 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 118.754 1.277 . . . . 0.0 109.899 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . 0.442 ' CZ ' HG13 ' B' ' 4' ' ' VAL . 50.8 ttt85 -118.42 128.74 54.91 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.418 -0.801 . . . . 0.0 111.873 -178.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.03 127.7 46.29 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.574 -0.703 . . . . 0.0 109.794 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -111.31 130.62 55.61 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.255 -0.903 . . . . 0.0 111.666 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 84.6 mt -122.81 159.39 28.21 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.3 0.571 . . . . 0.0 111.073 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -109.62 91.64 3.73 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 106.436 -1.691 . . . . 0.0 106.436 176.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 39.0 t -90.2 133.44 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.577 0.703 . . . . 0.0 112.254 -176.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.09 170.67 16.1 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.805 -0.559 . . . . 0.0 110.282 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -68.37 151.81 46.34 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.498 -0.751 . . . . 0.0 111.021 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.42 -12.48 55.29 Favored Glycine 0 N--CA 1.495 2.623 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.066 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 98.8 t -89.98 133.36 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.673 -1.487 . . . . 0.0 110.922 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 52.0 p -80.29 151.93 29.29 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.475 HD23 ' HH ' ' B' ' 5' ' ' TYR . 18.4 mt -61.21 -24.54 66.41 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.31 -0.868 . . . . 0.0 110.66 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' MET . . . . . 0.675 ' HE3' ' S2 ' ' B' ' 201' ' ' FES . 11.2 tmm? -69.77 -49.25 54.77 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.258 -0.901 . . . . 0.0 109.462 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.81 -41.74 91.94 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.645 -0.659 . . . . 0.0 109.892 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.06 -40.9 95.39 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.593 -0.692 . . . . 0.0 110.179 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . 0.413 ' HB3' HD13 ' B' ' 35' ' ' ILE . . . -68.28 -49.72 58.6 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.285 -0.884 . . . . 0.0 111.12 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 89.5 t -65.42 -39.24 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.266 -0.896 . . . . 0.0 110.737 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 25.0 m -70.03 -14.11 62.53 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.328 -0.857 . . . . 0.0 111.53 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' ASN . . . . . 0.514 ' HB3' ' CD1' ' B' ' 32' ' ' ILE . 0.5 OUTLIER -118.18 23.86 11.33 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.062 -1.024 . . . . 0.0 110.604 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.68 38.23 58.51 Favored Glycine 0 N--CA 1.493 2.463 0 O-C-N 121.557 -0.714 . . . . 0.0 111.873 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.514 ' CD1' ' HB3' ' B' ' 30' ' ' ASN . 1.0 OUTLIER -72.54 147.18 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.813 -1.404 . . . . 0.0 108.839 179.024 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -62.67 142.5 58.06 Favored 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 117.231 2.308 . . . . 0.0 117.231 -174.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 62.18 -36.09 0.12 Allowed 'General case' 0 N--CA 1.515 2.814 0 N-CA-C 116.657 2.095 . . . . 0.0 116.657 175.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . 0.413 HD13 ' HB3' ' B' ' 27' ' ' ALA . 20.2 mt -59.77 122.92 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 O-C-N 119.821 -1.799 . . . . 0.0 110.635 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.639 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 93.2 t -100.16 -51.4 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.595 -0.691 . . . . 0.0 111.192 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . 0.609 ' HA2' ' S2 ' ' B' ' 201' ' ' FES . . . 63.16 56.45 20.34 Favored Glycine 0 N--CA 1.499 2.897 0 N-CA-C 107.467 -2.253 . . . . 0.0 107.467 -178.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -71.33 -49.29 44.05 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.993 -0.71 . . . . 0.0 112.281 -177.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' CYS . . . . . 0.549 ' HB3' ' HB3' ' B' ' 45' ' ' CYS . 2.3 p -66.53 -10.43 44.8 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.219 -0.925 . . . . 0.0 112.373 -178.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.79 -5.47 64.08 Favored Glycine 0 N--CA 1.497 2.767 0 O-C-N 120.745 -1.222 . . . . 0.0 112.0 177.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.08 19.51 10.68 Favored Glycine 0 N--CA 1.495 2.59 0 O-C-N 120.814 -1.403 . . . . 0.0 111.038 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 87.9 p -98.94 19.17 15.52 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.025 -1.279 . . . . 0.0 111.137 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.94 40.89 30.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.395 -0.816 . . . . 0.0 111.918 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 5.7 t -117.02 11.17 14.19 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.356 -0.84 . . . . 0.0 109.566 178.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' CYS . . . . . 0.641 ' SG ' 'FE1 ' ' B' ' 201' ' ' FES . 15.1 p -149.52 -179.1 6.83 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.09 34.06 3.1 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.828 -1.17 . . . . 0.0 111.346 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' THR . . . . . 0.639 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 25.2 p -97.52 13.22 30.7 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.995 -1.066 . . . . 0.0 111.295 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' CYS . . . . . 0.45 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.1 p -120.56 31.74 6.31 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 177.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . 0.465 ' NE2' ' HB3' ' B' ' 82' ' ' SER . 6.5 t-160 -72.69 133.05 44.43 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.628 -178.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . 0.477 HG23 ' HB3' ' B' ' 85' ' ' CYS . 12.3 m -146.27 160.09 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -105.43 102.74 12.19 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.257 -0.902 . . . . 0.0 108.689 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.0 t -61.97 135.12 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.343 -0.848 . . . . 0.0 109.358 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.63 131.79 51.3 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.957 0.884 . . . . 0.0 109.522 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -44.4 -30.9 0.92 Allowed 'General case' 0 N--CA 1.506 2.336 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -178.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.83 -6.91 54.29 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.016 -1.052 . . . . 0.0 112.772 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -119.98 -6.6 10.01 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.465 -1.397 . . . . 0.0 111.898 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.4 p -55.4 -37.85 68.16 Favored 'General case' 0 N--CA 1.507 2.415 0 O-C-N 121.186 -0.946 . . . . 0.0 112.854 -178.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 47.9 p-10 -81.17 -6.59 59.01 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 120.775 -1.203 . . . . 0.0 111.452 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -89.91 -11.68 41.12 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.983 -1.073 . . . . 0.0 109.822 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.617 HG12 ' HD2' ' B' ' 61' ' ' PRO . 40.9 t -104.04 141.08 21.77 Favored Pre-proline 0 N--CA 1.488 1.475 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . 0.617 ' HD2' HG12 ' B' ' 60' ' ' VAL . 49.7 Cg_endo -73.78 118.84 5.61 Favored 'Trans proline' 0 N--CA 1.489 1.208 0 O-C-N 123.49 1.258 . . . . 0.0 109.009 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.83 160.62 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.799 0 N-CA-C 116.621 2.082 . . . . 0.0 116.621 -177.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.438 ' HB2' ' HB3' ' B' ' 67' ' ' GLU . . . -65.81 146.11 55.15 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.285 178.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -89.76 -170.76 2.93 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.61 -0.681 . . . . 0.0 110.393 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -59.58 -41.98 91.49 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.325 -0.859 . . . . 0.0 111.711 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 11.0 ttt180 -67.44 -41.58 84.51 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.141 -0.974 . . . . 0.0 111.989 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.438 ' HB3' ' HB2' ' B' ' 63' ' ' ALA . 45.4 tt0 -68.23 -43.92 76.88 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.985 -1.072 . . . . 0.0 110.354 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . 0.503 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.7 mm -55.57 -42.2 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.311 -0.868 . . . . 0.0 109.354 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.17 -47.88 80.61 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 8.4 mmt -66.12 -33.97 76.99 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.234 -1.157 . . . . 0.0 111.241 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . 0.46 HD22 ' HA ' ' B' ' 71' ' ' LEU . 27.5 mt -63.5 -23.34 67.36 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.213 -0.929 . . . . 0.0 110.636 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . 0.503 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 44.3 mt-10 -70.42 -8.72 53.04 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.314 -0.866 . . . . 0.0 110.897 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 1.4 t -119.84 12.56 12.13 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.001 -1.062 . . . . 0.0 112.523 -178.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 34.6 m -60.84 140.42 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 120.736 -1.227 . . . . 0.0 109.631 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.59 -39.03 62.46 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.393 -0.817 . . . . 0.0 110.152 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.22 168.84 17.42 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.486 -0.759 . . . . 0.0 110.086 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.33 139.15 55.78 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.397 -0.814 . . . . 0.0 110.602 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.3 tp -90.99 116.22 28.62 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.549 -0.719 . . . . 0.0 109.833 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -103.04 168.3 8.99 Favored Pre-proline 0 N--CA 1.489 1.5 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -76.62 -0.04 10.05 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 O-C-N 123.311 1.164 . . . . 0.0 110.382 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -120.46 22.37 11.29 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.931 -1.106 . . . . 0.0 108.397 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' SER . . . . . 0.465 ' HB3' ' NE2' ' B' ' 49' ' ' HIS . 4.3 m -80.8 137.23 36.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.879 -0.513 . . . . 0.0 110.32 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.4 mmm-85 -149.8 146.37 27.12 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.465 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.45 ' HB3' ' SG ' ' B' ' 48' ' ' CYS . 96.3 mt -80.51 98.96 7.81 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 175.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' CYS . . . . . 0.477 ' HB3' HG23 ' B' ' 50' ' ' VAL . 10.7 p -48.44 -17.86 0.19 Allowed 'General case' 0 N--CA 1.508 2.427 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -175.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.8 p -70.27 -14.0 62.41 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.669 -1.269 . . . . 0.0 109.435 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -92.7 -12.25 31.95 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.459 -0.776 . . . . 0.0 110.526 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . 0.46 HG21 HD13 ' B' ' 23' ' ' LEU . 61.8 mt -91.51 103.96 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.198 -0.939 . . . . 0.0 110.664 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 26.5 mm -84.98 131.71 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' MET . . . . . 0.416 ' C ' HG22 ' B' ' 91' ' ' THR . 13.8 tpt -74.8 137.74 42.11 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 122.075 0.941 . . . . 0.0 113.25 -177.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' THR . . . . . 0.416 HG22 ' C ' ' B' ' 90' ' ' MET . 43.6 p -138.17 166.6 24.63 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 176.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -75.0 1.79 7.35 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 O-C-N 122.669 0.826 . . . . 0.0 111.001 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -87.67 -22.82 24.46 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 176.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.6 mt -93.79 13.02 23.72 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.418 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.53 126.4 23.47 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.146 -0.971 . . . . 0.0 111.148 -178.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.25 6.77 68.41 Favored Glycine 0 N--CA 1.494 2.523 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.662 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.61 142.69 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 CA-C-N 119.343 1.572 . . . . 0.0 110.755 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 61.0 t -122.44 132.96 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.519 -0.738 . . . . 0.0 109.88 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' VAL . . . . . 0.43 ' O ' HG23 ' B' ' 99' ' ' VAL . 16.5 m -130.37 135.79 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.481 -0.762 . . . . 0.0 109.802 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -92.44 134.11 35.26 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.9 t -103.34 127.33 29.9 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.493 -0.754 . . . . 0.0 110.391 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -80.89 130.92 7.75 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 O-C-N 124.084 1.571 . . . . 0.0 108.294 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' ASP . . . . . 0.412 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.3 p-10 -62.33 3.38 0.19 Allowed 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -178.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 3.8 mtm105 -125.32 114.68 19.22 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.288 -1.507 . . . . 0.0 110.069 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . 0.483 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 69.8 mm-40 -113.31 -49.37 2.91 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.476 -0.765 . . . . 0.0 110.0 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 118.392 -0.813 . . . . 0.0 110.504 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 501' ' ' HEM . . . . . 0.949 ' O2D' ' O ' ' A' ' 100' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 502' ' ' CAM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 201' ' ' FES . . . . . 0.675 ' S2 ' ' HE3' ' B' ' 24' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.473 ' HA ' HD11 ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.452 HD11 HG13 ' A' ' 18' ' ' VAL . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.88 ' HG2' HG23 ' A' ' 18' ' ' VAL . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.88 HG23 ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.488 ' HA ' HD23 ' A' ' 22' ' ' LEU . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.415 ' CE2' HG23 ' A' ' 50' ' ' VAL . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.503 ' HE1' HD12 ' A' ' 395' ' ' ILE . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.432 ' HA ' HD12 ' A' ' 34' ' ' LEU . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 39' ' ' GLN . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.514 ' N ' HG12 ' A' ' 38' ' ' VAL . 1.6 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.457 ' O ' HG21 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.423 ' HE3' HD13 ' A' ' 324' ' ' LEU . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.457 HG21 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.49 ' HB3' HG21 ' A' ' 66' ' ' THR . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.412 ' ND2' HG22 ' A' ' 50' ' ' VAL . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.608 HG13 ' HD2' ' A' ' 51' ' ' PRO . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.608 ' HD2' HG13 ' A' ' 50' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.438 HG21 ' HB ' ' A' ' 64' ' ' ILE . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.594 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.8 m120 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.594 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.438 ' HB ' HG21 ' A' ' 54' ' ' VAL . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.49 HG21 ' HB3' ' A' ' 45' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.436 HD11 ' N ' ' A' ' 70' ' ' LEU . 6.0 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.6 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.462 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.5 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.415 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 30.0 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.6 mtm180 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.62 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.2 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.54 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.54 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.754 ' HD2' ' HB2' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.754 ' HB2' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.694 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.927 HD12 ' NE ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.949 ' O ' ' O2D' ' A' ' 501' ' ' HEM . 68.2 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.631 ' OG1' ' HD2' ' A' ' 100' ' ' PRO . 3.8 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.508 ' HE1' HD13 ' A' ' 99' ' ' ILE . 46.0 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.614 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.296 50.2 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.46 ' HA ' ' HB3' ' A' ' 108' ' ' GLN 0.366 52.9 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.614 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 35.0 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.469 ' H ' ' CD ' ' A' ' 106' ' ' PRO 0.413 34.1 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.46 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 1.5 tm0? -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.505 ' HB2' ' CZ3' ' B' ' 106' ' ' TRP . 7.1 mtp180 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.405 ' HB3' ' CD2' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.438 HD13 ' HA3' ' A' ' 226' ' ' GLY . 24.8 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.1 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.6 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.489 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.672 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 31.7 mtm -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.672 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.1 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.453 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 72.0 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.7 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.453 ' HD2' ' HA ' ' A' ' 123' ' ' VAL . 35.6 mttt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.488 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.506 ' HA ' HD11 ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.615 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.577 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.488 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.782 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.782 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.465 HD11 HG22 ' A' ' 160' ' ' ILE . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.467 ' HA ' HD13 ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.429 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.513 ' C ' HD21 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.506 ' N ' HD21 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.44 HD21 ' HA ' ' A' ' 169' ' ' LEU . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.417 ' N ' ' CD ' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.566 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.523 ' HA ' HD22 ' A' ' 180' ' ' LEU . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' MET . . . . . 0.499 ' HE2' HG22 ' A' ' 247' ' ' VAL . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.421 HD13 HD13 ' A' ' 180' ' ' LEU . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.441 ' HB3' ' HG ' ' A' ' 221' ' ' SER . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 211' ' ' ARG . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 224' ' ' ALA . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' SER . . . . . 0.441 ' HG ' ' HB3' ' A' ' 211' ' ' ARG . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 33.3 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 53.1 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 220' ' ' ILE . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.438 ' HA3' HD13 ' A' ' 114' ' ' LEU . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 4.6 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 1.1 m120 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 18.1 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.927 ' NE ' HD12 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 45.4 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.694 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.423 ' HA ' HD22 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.499 HG22 ' HE2' ' A' ' 184' ' ' MET . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 250' ' ' LEU . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.675 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.469 HD22 ' HA ' ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' MET . . . . . 0.577 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.428 HD22 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.433 ' N ' ' CD ' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' CYS . . . . . 0.422 ' SG ' HG21 ' A' ' 367' ' ' ILE . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . 0.433 HD23 HG21 ' A' ' 349' ' ' THR . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . 0.497 ' CZ ' ' HE1' ' A' ' 336' ' ' MET . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.641 ' HA ' ' HE1' ' A' ' 323' ' ' MET . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 296' ' ' ALA . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . 0.513 ' OD2' ' O2A' ' A' ' 501' ' ' HEM . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . 0.424 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . 0.424 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.1 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.535 HD23 ' N ' ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' PHE . . . . . 0.424 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.6 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' HIS . . . . . 0.424 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 36.9 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 312' ' ' LEU . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . 0.63 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . 0.63 ' HD3' ' O ' ' A' ' 319' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' MET . . . . . 0.641 ' HE1' ' HA ' ' A' ' 294' ' ' LEU . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.456 HD11 ' HB2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 13.7 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' LEU . . . . . . . . . . . . . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.472 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' PRO . . . . . 0.472 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 0.497 ' HE1' ' CZ ' ' A' ' 291' ' ' ARG . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' LYS . . . . . 0.513 ' HD3' ' N ' ' A' ' 344' ' ' LYS . 0.9 OUTLIER -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 60.7 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 10.6 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 39.9 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' THR . . . . . 0.433 HG21 HD23 ' A' ' 289' ' ' LEU . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 60.2 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 96.4 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' LEU . . . . . . . . . . . . . 1.5 tp -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . 0.977 HD11 ' CBD' ' A' ' 501' ' ' HEM . 1.4 mp -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.42 ' HA ' HD12 ' A' ' 362' ' ' LEU . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 43.4 mtt85 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . 0.422 HG21 ' SG ' ' A' ' 285' ' ' CYS . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.485 HD12 HG23 ' A' ' 383' ' ' ILE . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' ILE . . . . . 0.403 HD11 HD12 ' A' ' 402' ' ' LEU . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.503 HD12 ' HE1' ' A' ' 28' ' ' MET . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . 0.403 HD12 HD11 ' A' ' 389' ' ' ILE . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . 0.404 ' HA ' HD22 ' A' ' 404' ' ' LEU . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' ASP . . . . . 0.544 ' HB3' HG23 ' A' ' 410' ' ' THR . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' PRO . . . . . 0.645 ' HA ' HG22 ' A' ' 411' ' ' THR . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' THR . . . . . 0.544 HG23 ' HB3' ' A' ' 407' ' ' ASP . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' THR . . . . . 0.645 HG22 ' HA ' ' A' ' 408' ' ' PRO . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . 0.496 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 N--CA 1.496 1.83 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.52 138.58 38.48 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.224 -0.922 . . . . 0.0 112.963 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 61.2 t -137.11 122.56 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 177.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.436 HG13 ' CZ ' ' B' ' 12' ' ' ARG . 97.0 t -106.76 129.54 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.115 -0.991 . . . . 0.0 111.628 -178.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.555 ' CD1' HD11 ' B' ' 32' ' ' ILE . 76.9 m-85 -109.2 110.6 21.85 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.82 127.26 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.927 -1.108 . . . . 0.0 108.34 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.4 m -86.2 174.64 8.97 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.753 0.787 . . . . 0.0 112.502 -177.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.416 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.6 -46.79 88.94 Favored 'General case' 0 N--CA 1.502 2.155 0 CA-C-O 121.138 0.494 . . . . 0.0 110.458 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -65.85 -11.31 45.58 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.57 -0.706 . . . . 0.0 111.433 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.99 15.43 28.49 Favored Glycine 0 N--CA 1.492 2.406 0 O-C-N 121.155 -0.965 . . . . 0.0 111.259 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.5 m -82.05 147.38 29.17 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 118.73 1.265 . . . . 0.0 109.88 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . 0.436 ' CZ ' HG13 ' B' ' 4' ' ' VAL . 50.8 ttt85 -118.43 128.74 54.9 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.487 -0.758 . . . . 0.0 111.859 -178.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.07 127.71 46.24 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.598 -0.689 . . . . 0.0 109.804 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -111.3 130.63 55.61 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.282 -0.886 . . . . 0.0 111.647 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.682 HD11 HD13 ' B' ' 32' ' ' ILE . 84.8 mt -122.8 159.34 28.29 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.734 -0.604 . . . . 0.0 111.129 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -109.61 91.66 3.74 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 176.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.6 t -90.16 133.41 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-O 121.626 0.727 . . . . 0.0 112.253 -176.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.08 170.71 16.04 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.7 -0.625 . . . . 0.0 110.273 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -68.5 151.82 46.25 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.532 -0.73 . . . . 0.0 111.027 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.46 -12.49 55.43 Favored Glycine 0 N--CA 1.496 2.638 0 O-C-N 121.494 -0.754 . . . . 0.0 112.052 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 61.5 t -89.98 133.29 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.706 -1.467 . . . . 0.0 110.963 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 21.3 p -80.21 151.88 29.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.572 -0.705 . . . . 0.0 109.184 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.479 HD23 ' HH ' ' B' ' 5' ' ' TYR . 18.5 mt -61.18 -24.59 66.43 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.349 -0.844 . . . . 0.0 110.595 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 1.9 ttp -69.83 -49.2 54.9 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.236 -0.915 . . . . 0.0 109.473 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -59.79 -41.72 91.81 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.567 -0.708 . . . . 0.0 109.926 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.09 -40.86 95.2 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.59 -0.694 . . . . 0.0 110.152 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.34 -49.74 58.19 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.275 -0.891 . . . . 0.0 111.045 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 78.2 t -65.47 -39.18 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.301 -0.875 . . . . 0.0 110.706 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 23.2 t -70.14 -13.96 62.43 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.359 -0.838 . . . . 0.0 111.553 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -118.21 23.88 11.32 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.057 -1.027 . . . . 0.0 110.665 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.7 38.24 58.63 Favored Glycine 0 N--CA 1.493 2.448 0 O-C-N 121.541 -0.724 . . . . 0.0 111.857 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.682 HD13 HD11 ' B' ' 15' ' ' LEU . 0.4 OUTLIER -72.57 147.19 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.866 -1.373 . . . . 0.0 108.864 179.043 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -62.72 142.53 58.09 Favored 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 117.175 2.287 . . . . 0.0 117.175 -174.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 62.22 -36.12 0.12 Allowed 'General case' 0 N--CA 1.515 2.791 0 N-CA-C 116.643 2.09 . . . . 0.0 116.643 175.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 77.6 mt -59.77 122.9 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.426 0 O-C-N 119.907 -1.746 . . . . 0.0 110.617 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.626 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 97.4 t -100.15 -51.34 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.697 -0.627 . . . . 0.0 111.229 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . 0.608 ' HA2' ' S2 ' ' B' ' 201' ' ' FES . . . 63.14 56.47 20.26 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 107.466 -2.253 . . . . 0.0 107.466 -178.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -71.34 -49.27 44.16 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.994 -0.709 . . . . 0.0 112.274 -177.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' CYS . . . . . 0.55 ' HB3' ' HB3' ' B' ' 45' ' ' CYS . 2.3 p -66.59 -10.4 45.19 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.213 -0.929 . . . . 0.0 112.385 -178.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.77 -5.47 64.13 Favored Glycine 0 N--CA 1.498 2.782 0 O-C-N 120.819 -1.176 . . . . 0.0 112.007 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.1 19.52 10.66 Favored Glycine 0 N--CA 1.494 2.535 0 O-C-N 120.826 -1.397 . . . . 0.0 111.047 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 8.2 t -98.95 19.11 15.64 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.978 -1.307 . . . . 0.0 111.16 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.97 40.87 30.36 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.407 -0.808 . . . . 0.0 111.906 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.04 11.2 14.18 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.343 -0.848 . . . . 0.0 109.467 178.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' CYS . . . . . 0.64 ' SG ' 'FE1 ' ' B' ' 201' ' ' FES . 15.1 p -149.53 -179.08 6.81 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.549 -0.72 . . . . 0.0 109.082 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.08 34.08 3.1 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.83 -1.169 . . . . 0.0 111.403 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' THR . . . . . 0.626 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 37.8 p -97.63 13.26 30.76 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.925 -1.109 . . . . 0.0 111.25 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' CYS . . . . . 0.454 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.1 p -120.54 31.73 6.32 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 177.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . 0.427 ' O ' HG13 ' B' ' 50' ' ' VAL . 23.9 t-160 -72.65 133.03 44.46 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-N 115.784 -0.643 . . . . 0.0 112.628 -178.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . 0.475 HG23 ' HB3' ' B' ' 85' ' ' CYS . 12.3 m -146.3 160.11 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . 0.401 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.4 m-85 -105.44 102.68 12.13 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.294 -0.879 . . . . 0.0 108.684 178.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.2 t -61.86 135.11 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.317 -0.864 . . . . 0.0 109.35 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.68 131.81 51.38 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.94 0.876 . . . . 0.0 109.53 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -44.27 -31.08 0.91 Allowed 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -178.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.78 -6.93 54.3 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.969 -1.082 . . . . 0.0 112.749 -178.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -119.89 -6.72 10.04 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 120.449 -1.407 . . . . 0.0 111.908 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.4 p -55.37 -37.84 68.04 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.112 -0.993 . . . . 0.0 112.86 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 -81.18 -6.63 59.06 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.753 -1.217 . . . . 0.0 111.477 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -89.88 -11.62 41.35 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.991 -1.068 . . . . 0.0 109.855 178.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.626 HG12 ' HD2' ' B' ' 61' ' ' PRO . 40.9 t -104.07 141.05 21.72 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . 0.626 ' HD2' HG12 ' B' ' 60' ' ' VAL . 49.6 Cg_endo -73.76 118.89 5.63 Favored 'Trans proline' 0 N--CA 1.488 1.15 0 O-C-N 123.453 1.238 . . . . 0.0 109.016 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.89 160.65 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.764 0 N-CA-C 116.657 2.095 . . . . 0.0 116.657 -177.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.449 ' HB2' ' HB3' ' B' ' 67' ' ' GLU . . . -65.87 146.14 55.1 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-N 114.606 -1.179 . . . . 0.0 111.266 178.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -89.74 -170.79 2.94 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.569 -0.707 . . . . 0.0 110.362 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -59.53 -42.0 91.28 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.35 -0.844 . . . . 0.0 111.754 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -41.48 84.45 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.203 -0.935 . . . . 0.0 112.018 -178.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.449 ' HB3' ' HB2' ' B' ' 63' ' ' ALA . 45.3 tt0 -68.21 -43.98 76.81 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.031 -1.043 . . . . 0.0 110.318 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . 0.519 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.6 mm -55.6 -42.18 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.28 -0.888 . . . . 0.0 109.368 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.19 -47.83 81.04 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 11.2 mmt -66.23 -33.92 76.84 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.275 -1.133 . . . . 0.0 111.191 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . 0.473 HD22 ' HA ' ' B' ' 71' ' ' LEU . 27.9 mt -63.47 -23.4 67.38 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.236 -0.915 . . . . 0.0 110.588 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . 0.519 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 49.2 mt-10 -70.38 -8.71 52.78 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.358 -0.839 . . . . 0.0 110.919 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 82.8 p -119.87 12.54 12.1 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.067 -1.02 . . . . 0.0 112.509 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 16.2 m -60.76 140.38 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 120.643 -1.286 . . . . 0.0 109.681 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 52.0 m -74.53 -39.06 62.58 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.466 -0.771 . . . . 0.0 110.19 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.26 168.82 17.51 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.456 -0.777 . . . . 0.0 110.1 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -58.22 139.16 55.53 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.365 -0.834 . . . . 0.0 110.613 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.3 tp -90.99 116.15 28.55 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.506 -0.746 . . . . 0.0 109.864 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -103.04 168.3 8.99 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -76.61 -0.02 10.02 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 O-C-N 123.304 1.16 . . . . 0.0 110.372 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -120.46 22.41 11.28 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.01 -1.056 . . . . 0.0 108.45 176.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 4.3 m -80.88 137.27 36.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.908 -0.495 . . . . 0.0 110.32 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.4 mmm-85 -149.77 146.4 27.16 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 120.029 -0.668 . . . . 0.0 111.472 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.454 ' HB3' ' SG ' ' B' ' 48' ' ' CYS . 77.9 mt -80.59 98.94 7.86 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 104.789 -2.3 . . . . 0.0 104.789 175.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' CYS . . . . . 0.475 ' HB3' HG23 ' B' ' 50' ' ' VAL . 10.5 p -48.38 -17.88 0.18 Allowed 'General case' 0 N--CA 1.508 2.444 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -175.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.8 p -70.27 -13.99 62.4 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.628 -1.295 . . . . 0.0 109.429 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -92.65 -12.3 31.91 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.486 -0.759 . . . . 0.0 110.523 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . 0.469 HG21 HD13 ' B' ' 23' ' ' LEU . 61.9 mt -91.44 103.89 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.121 -0.987 . . . . 0.0 110.678 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 45.6 mm -85.01 131.8 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' MET . . . . . 0.435 ' C ' HG22 ' B' ' 91' ' ' THR . 13.6 tpt -74.88 137.76 41.98 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 122.165 0.983 . . . . 0.0 113.201 -177.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' THR . . . . . 0.435 HG22 ' C ' ' B' ' 90' ' ' MET . 43.6 p -138.14 166.62 24.53 Favored Pre-proline 0 N--CA 1.491 1.578 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 176.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -74.93 1.67 7.43 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 122.628 0.804 . . . . 0.0 111.028 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -87.61 -22.86 24.5 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 176.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.6 mt -93.76 13.0 23.71 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.392 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -54.5 126.39 23.38 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.138 -0.976 . . . . 0.0 111.188 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.27 6.82 68.3 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 120.581 -0.818 . . . . 0.0 111.637 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.7 tt -62.63 142.81 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 CA-C-N 119.391 1.595 . . . . 0.0 110.747 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' VAL . . . . . 0.4 ' C ' HG11 ' B' ' 99' ' ' VAL . 60.9 t -122.53 132.92 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.554 -0.716 . . . . 0.0 109.876 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' VAL . . . . . 0.425 ' O ' HG23 ' B' ' 99' ' ' VAL . 16.5 m -130.32 135.76 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.451 -0.78 . . . . 0.0 109.842 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' ASP . . . . . 0.401 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.35 134.13 35.21 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.9 t -103.4 127.31 29.92 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.558 -0.714 . . . . 0.0 110.364 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -80.82 130.96 7.84 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 124.115 1.587 . . . . 0.0 108.287 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' ASP . . . . . 0.416 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.4 p-10 -62.34 3.37 0.19 Allowed 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -178.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -125.29 114.71 19.29 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.305 -1.497 . . . . 0.0 110.011 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . 0.487 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 51.4 mm-40 -113.35 -49.4 2.91 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.505 -0.747 . . . . 0.0 109.958 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' TRP . . . . . 0.505 ' CZ3' ' HB2' ' A' ' 112' ' ' ARG . 82.7 m95 . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.512 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 501' ' ' HEM . . . . . 0.977 ' CBD' HD11 ' A' ' 358' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 502' ' ' CAM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 201' ' ' FES . . . . . 0.64 'FE1 ' ' SG ' ' B' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.473 ' HA ' HD11 ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.452 HD11 HG13 ' A' ' 18' ' ' VAL . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.88 ' HG2' HG23 ' A' ' 18' ' ' VAL . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.88 HG23 ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.488 ' HA ' HD23 ' A' ' 22' ' ' LEU . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.415 ' CE2' HG23 ' A' ' 50' ' ' VAL . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.503 ' HE1' HD12 ' A' ' 395' ' ' ILE . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.432 ' HA ' HD12 ' A' ' 34' ' ' LEU . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 39' ' ' GLN . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.514 ' N ' HG12 ' A' ' 38' ' ' VAL . 1.6 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.457 ' O ' HG21 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.423 ' HE3' HD13 ' A' ' 324' ' ' LEU . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.457 HG21 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.49 ' HB3' HG21 ' A' ' 66' ' ' THR . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.412 ' ND2' HG22 ' A' ' 50' ' ' VAL . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.608 HG13 ' HD2' ' A' ' 51' ' ' PRO . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.608 ' HD2' HG13 ' A' ' 50' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.438 HG21 ' HB ' ' A' ' 64' ' ' ILE . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.594 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.8 m120 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.594 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.438 ' HB ' HG21 ' A' ' 54' ' ' VAL . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.49 HG21 ' HB3' ' A' ' 45' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.436 HD11 ' N ' ' A' ' 70' ' ' LEU . 6.0 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.408 ' CZ ' HG22 ' A' ' 348' ' ' THR . 5.6 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.462 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.6 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.456 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 27.1 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.7 mmt-85 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.62 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.2 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.54 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.54 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.754 ' HD2' ' HB2' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.754 ' HB2' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.694 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.927 HD12 ' NE ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.949 ' O ' ' O2D' ' A' ' 501' ' ' HEM . 74.3 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.629 ' OG1' ' HD2' ' A' ' 100' ' ' PRO . 3.9 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.508 ' HE1' HD13 ' A' ' 99' ' ' ILE . 46.0 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.614 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.296 50.1 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.459 ' HA ' ' HB3' ' A' ' 108' ' ' GLN 0.366 52.7 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.614 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 34.8 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.469 ' H ' ' CD ' ' A' ' 106' ' ' PRO 0.342 30.7 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.459 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 1.8 tm0? -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.9 mtt-85 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.41 ' O ' ' HB2' ' A' ' 117' ' ' GLN . 7.4 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.407 ' HA ' ' CD2' ' A' ' 358' ' ' LEU . 25.4 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' A' ' 114' ' ' LEU . 27.6 mt-30 -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.0 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.6 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.489 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.672 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 0.0 OUTLIER -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.672 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.0 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.541 HG13 HD11 ' A' ' 166' ' ' LEU . 78.3 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.2 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 28.3 mtmt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.475 HD13 HG12 ' A' ' 123' ' ' VAL . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.488 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.506 ' HA ' HD11 ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.615 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.577 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.488 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.782 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.782 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.465 HD11 HG22 ' A' ' 160' ' ' ILE . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.467 ' HA ' HD13 ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.429 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.541 HD11 HG13 ' A' ' 123' ' ' VAL . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.506 ' N ' HD21 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.44 HD21 ' HA ' ' A' ' 169' ' ' LEU . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.417 ' N ' ' CD ' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.566 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.523 ' HA ' HD22 ' A' ' 180' ' ' LEU . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' MET . . . . . 0.499 ' HE2' HG22 ' A' ' 247' ' ' VAL . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.421 HD13 HD13 ' A' ' 180' ' ' LEU . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.441 ' HB3' ' HG ' ' A' ' 221' ' ' SER . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 211' ' ' ARG . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 224' ' ' ALA . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' SER . . . . . 0.441 ' HG ' ' HB3' ' A' ' 211' ' ' ARG . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 44.9 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 42.0 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 220' ' ' ILE . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 4.3 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 13.5 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.927 ' NE ' HD12 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 40.7 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.694 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.423 ' HA ' HD22 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.499 HG22 ' HE2' ' A' ' 184' ' ' MET . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 250' ' ' LEU . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.675 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.469 HD22 ' HA ' ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' MET . . . . . 0.577 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.428 HD22 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 16.4 pm0 -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.433 ' N ' ' CD ' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' CYS . . . . . 0.422 ' SG ' HG21 ' A' ' 367' ' ' ILE . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . 0.433 HD23 HG21 ' A' ' 349' ' ' THR . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . 0.497 ' CZ ' ' HE1' ' A' ' 336' ' ' MET . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.641 ' HA ' ' HE1' ' A' ' 323' ' ' MET . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 296' ' ' ALA . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . 0.513 ' OD2' ' O2A' ' A' ' 501' ' ' HEM . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . 0.424 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . 0.424 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.0 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.535 HD23 ' N ' ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' PHE . . . . . 0.424 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.6 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' HIS . . . . . 0.424 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 36.9 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 312' ' ' LEU . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . 0.63 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . 0.63 ' HD3' ' O ' ' A' ' 319' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' MET . . . . . 0.641 ' HE1' ' HA ' ' A' ' 294' ' ' LEU . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.456 HD11 ' HB2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 13.7 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' LEU . . . . . . . . . . . . . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.472 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' PRO . . . . . 0.472 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 0.497 ' HE1' ' CZ ' ' A' ' 291' ' ' ARG . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . 0.441 ' CB ' ' HD3' ' A' ' 344' ' ' LYS . 1.9 mp0 -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' LYS . . . . . 0.498 ' HB2' ' HE2' ' A' ' 344' ' ' LYS . 1.7 mppt? -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 57.8 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 22.1 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' THR . . . . . 0.408 HG22 ' CZ ' ' A' ' 72' ' ' ARG . 16.5 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' THR . . . . . 0.433 HG21 HD23 ' A' ' 289' ' ' LEU . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 73.7 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' SER . . . . . 0.459 ' HA ' ' CB ' ' B' ' 44' ' ' SER . 97.1 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . 0.407 ' CD2' ' HA ' ' A' ' 116' ' ' ASN . 0.5 OUTLIER -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.42 ' HA ' HD12 ' A' ' 362' ' ' LEU . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 40.9 mtt85 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 17.2 tpp85 -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . 0.422 HG21 ' SG ' ' A' ' 285' ' ' CYS . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.485 HD12 HG23 ' A' ' 383' ' ' ILE . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' ILE . . . . . 0.403 HD11 HD12 ' A' ' 402' ' ' LEU . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.503 HD12 ' HE1' ' A' ' 28' ' ' MET . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . 0.403 HD12 HD11 ' A' ' 389' ' ' ILE . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . 0.404 ' HA ' HD22 ' A' ' 404' ' ' LEU . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' ASP . . . . . 0.544 ' HB3' HG23 ' A' ' 410' ' ' THR . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' PRO . . . . . 0.645 ' HA ' HG22 ' A' ' 411' ' ' THR . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' THR . . . . . 0.544 HG23 ' HB3' ' A' ' 407' ' ' ASP . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' THR . . . . . 0.645 HG22 ' HA ' ' A' ' 408' ' ' PRO . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . 0.496 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 N--CA 1.495 1.809 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.52 138.58 38.48 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.177 -0.952 . . . . 0.0 113.004 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 61.2 t -137.11 122.6 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.441 HG13 ' CZ ' ' B' ' 12' ' ' ARG . 97.5 t -106.78 129.58 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.15 -0.969 . . . . 0.0 111.635 -178.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.558 ' CD1' HD11 ' B' ' 32' ' ' ILE . 77.2 m-85 -109.28 110.6 21.83 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.82 127.23 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.935 -1.103 . . . . 0.0 108.363 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.6 m -86.2 174.69 8.94 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.737 0.779 . . . . 0.0 112.509 -177.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.413 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.66 -46.73 89.22 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 121.19 0.519 . . . . 0.0 110.457 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -65.93 -11.29 46.16 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.52 -0.737 . . . . 0.0 111.381 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.01 15.4 28.55 Favored Glycine 0 N--CA 1.492 2.388 0 O-C-N 121.177 -0.952 . . . . 0.0 111.287 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 89.8 m -82.05 147.35 29.18 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 118.733 1.266 . . . . 0.0 109.929 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . 0.441 ' CZ ' HG13 ' B' ' 4' ' ' VAL . 50.8 ttt85 -118.46 128.74 54.89 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.528 -0.732 . . . . 0.0 111.864 -178.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.06 127.67 46.2 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.571 -0.705 . . . . 0.0 109.81 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -111.34 130.63 55.62 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.275 -0.891 . . . . 0.0 111.612 -178.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.561 HD11 HD13 ' B' ' 32' ' ' ILE . 84.7 mt -122.78 159.35 28.24 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.736 -0.602 . . . . 0.0 111.117 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -109.64 91.62 3.72 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 176.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.6 t -90.21 133.49 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-O 121.604 0.716 . . . . 0.0 112.288 -176.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.11 170.71 16.05 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.779 -0.576 . . . . 0.0 110.27 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -68.47 151.82 46.27 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.479 -0.763 . . . . 0.0 110.958 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.45 -12.51 55.34 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.048 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 59.4 t -90.03 133.32 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.704 -1.468 . . . . 0.0 110.896 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 22.3 p -80.23 151.96 29.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.583 -0.698 . . . . 0.0 109.173 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.478 HD23 ' HH ' ' B' ' 5' ' ' TYR . 18.4 mt -61.22 -24.63 66.48 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.299 -0.876 . . . . 0.0 110.578 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' MET . . . . . 0.821 ' HE3' ' S2 ' ' B' ' 201' ' ' FES . 8.5 tmm? -69.78 -49.19 55.31 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.234 -0.916 . . . . 0.0 109.521 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -59.81 -41.7 91.86 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.594 -0.691 . . . . 0.0 109.953 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.04 -40.91 95.47 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.616 -0.678 . . . . 0.0 110.135 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.3 -49.78 58.12 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.266 -0.896 . . . . 0.0 111.046 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 69.3 t -65.42 -39.19 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.36 -0.837 . . . . 0.0 110.734 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 28.2 m -70.16 -13.97 62.43 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.372 -0.83 . . . . 0.0 111.526 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -118.2 23.8 11.37 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.04 -1.038 . . . . 0.0 110.663 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.72 38.27 58.81 Favored Glycine 0 N--CA 1.492 2.424 0 O-C-N 121.556 -0.715 . . . . 0.0 111.828 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.561 HD13 HD11 ' B' ' 15' ' ' LEU . 1.7 mt -72.55 147.17 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.836 -1.391 . . . . 0.0 108.853 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.68 142.48 58.08 Favored 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 117.215 2.302 . . . . 0.0 117.215 -174.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 62.18 -36.09 0.12 Allowed 'General case' 0 N--CA 1.516 2.855 0 N-CA-C 116.655 2.094 . . . . 0.0 116.655 175.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 84.4 mt -59.78 122.91 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.373 0 O-C-N 119.843 -1.785 . . . . 0.0 110.673 -178.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.573 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 18.9 t -100.12 -51.46 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.63 -0.669 . . . . 0.0 111.193 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . 0.616 ' HA2' ' S2 ' ' B' ' 201' ' ' FES . . . 63.16 56.5 20.08 Favored Glycine 0 N--CA 1.5 2.906 0 N-CA-C 107.447 -2.261 . . . . 0.0 107.447 -178.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.3 -49.31 44.11 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.974 -0.721 . . . . 0.0 112.269 -177.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' CYS . . . . . 0.54 ' HB3' ' HB3' ' B' ' 45' ' ' CYS . 2.3 p -66.59 -10.44 45.51 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.206 -0.934 . . . . 0.0 112.384 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.82 -5.51 64.02 Favored Glycine 0 N--CA 1.499 2.854 0 O-C-N 120.824 -1.172 . . . . 0.0 111.968 177.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.06 19.58 10.63 Favored Glycine 0 N--CA 1.495 2.589 0 O-C-N 120.815 -1.403 . . . . 0.0 111.071 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 90.1 p -99.01 19.15 15.63 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.062 -1.258 . . . . 0.0 111.119 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.99 40.82 30.33 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.42 -0.8 . . . . 0.0 111.941 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' SER . . . . . 0.459 ' CB ' ' HA ' ' A' ' 354' ' ' SER . 70.7 m -117.02 11.19 14.2 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.368 -0.832 . . . . 0.0 109.494 178.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' CYS . . . . . 0.643 ' SG ' 'FE1 ' ' B' ' 201' ' ' FES . 15.1 p -149.51 -179.09 6.82 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.54 -0.725 . . . . 0.0 109.049 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.07 34.09 3.1 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.849 -1.157 . . . . 0.0 111.362 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' THR . . . . . 0.573 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 81.9 p -97.61 13.27 30.73 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.0 -1.063 . . . . 0.0 111.277 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' CYS . . . . . 0.408 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.1 p -120.54 31.74 6.31 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 177.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . 0.436 ' O ' HG13 ' B' ' 50' ' ' VAL . 23.9 t-160 -72.74 133.05 44.38 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.574 -178.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . 0.468 HG23 ' HB3' ' B' ' 85' ' ' CYS . 12.3 m -146.26 160.07 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . 0.407 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.5 m-85 -105.41 102.7 12.16 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.26 -0.9 . . . . 0.0 108.709 178.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.3 t -61.87 135.15 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.319 -0.863 . . . . 0.0 109.362 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.7 131.79 51.34 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.981 0.896 . . . . 0.0 109.505 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -44.28 -31.05 0.91 Allowed 'General case' 0 N--CA 1.505 2.314 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.76 -6.96 54.38 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.982 -1.074 . . . . 0.0 112.742 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -119.91 -6.61 10.04 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.492 -1.38 . . . . 0.0 111.892 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.3 p -55.49 -37.77 68.27 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.167 -0.958 . . . . 0.0 112.84 -178.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -81.14 -6.71 59.14 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.773 -1.204 . . . . 0.0 111.447 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -89.83 -11.66 41.37 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.017 -1.052 . . . . 0.0 109.841 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.623 HG12 ' HD2' ' B' ' 61' ' ' PRO . 40.7 t -104.05 141.02 21.65 Favored Pre-proline 0 N--CA 1.489 1.521 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . 0.623 ' HD2' HG12 ' B' ' 60' ' ' VAL . 49.7 Cg_endo -73.81 118.85 5.61 Favored 'Trans proline' 0 N--CA 1.488 1.172 0 O-C-N 123.487 1.256 . . . . 0.0 109.001 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.9 160.6 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.761 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 -177.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.44 ' HB2' ' HB3' ' B' ' 67' ' ' GLU . . . -65.71 146.16 55.13 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.239 178.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -89.84 -170.73 2.91 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.59 -0.694 . . . . 0.0 110.388 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.56 -42.0 91.42 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.287 -0.883 . . . . 0.0 111.75 -178.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 8.7 ttt180 -67.45 -41.55 84.53 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.173 -0.954 . . . . 0.0 112.014 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.528 ' HG3' HD12 ' B' ' 84' ' ' LEU . 45.5 tt0 -68.2 -43.97 76.88 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.938 -1.101 . . . . 0.0 110.329 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . 0.517 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.7 mm -55.55 -42.21 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.243 -0.911 . . . . 0.0 109.367 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.15 -47.88 80.75 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 5.3 mmt -66.17 -34.01 77.07 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.264 -1.139 . . . . 0.0 111.172 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . 0.441 HD22 ' HA ' ' B' ' 71' ' ' LEU . 28.0 mt -63.48 -23.29 67.33 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.294 -0.879 . . . . 0.0 110.634 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . 0.517 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 49.8 mt-10 -70.45 -8.69 52.94 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.265 -0.897 . . . . 0.0 110.883 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 83.4 p -119.9 12.6 12.1 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.002 -1.061 . . . . 0.0 112.519 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 30.5 m -60.83 140.42 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 120.714 -1.241 . . . . 0.0 109.634 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 81.9 m -74.53 -39.11 62.56 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.419 -0.8 . . . . 0.0 110.15 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.2 168.81 17.46 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.454 -0.779 . . . . 0.0 110.121 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.32 139.15 55.74 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.44 -0.788 . . . . 0.0 110.566 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.4 tp -90.95 116.15 28.53 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.517 -0.739 . . . . 0.0 109.918 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -103.05 168.31 8.97 Favored Pre-proline 0 N--CA 1.489 1.515 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -76.58 -0.06 10.05 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 O-C-N 123.239 1.126 . . . . 0.0 110.404 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -120.46 22.36 11.3 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.002 -1.061 . . . . 0.0 108.385 176.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 4.3 m -80.78 137.22 36.23 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.853 -0.53 . . . . 0.0 110.407 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.5 mmm-85 -149.75 146.38 27.17 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.455 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.528 HD12 ' HG3' ' B' ' 67' ' ' GLU . 92.1 mt -80.6 98.92 7.86 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 175.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' CYS . . . . . 0.468 ' HB3' HG23 ' B' ' 50' ' ' VAL . 10.6 p -48.36 -17.89 0.18 Allowed 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -175.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.8 p -70.29 -14.01 62.41 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.662 -1.273 . . . . 0.0 109.464 178.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 80.5 mm-40 -92.66 -12.2 32.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.511 -0.743 . . . . 0.0 110.589 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . 0.465 HG21 HD13 ' B' ' 23' ' ' LEU . 61.9 mt -91.49 103.96 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.188 -0.945 . . . . 0.0 110.624 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.432 HD13 ' HA ' ' B' ' 89' ' ' ILE . 46.0 mm -84.94 131.77 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' MET . . . . . 0.423 ' C ' HG22 ' B' ' 91' ' ' THR . 13.6 tpt -74.88 137.81 42.02 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 122.123 0.963 . . . . 0.0 113.236 -177.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' THR . . . . . 0.423 HG22 ' C ' ' B' ' 90' ' ' MET . 43.7 p -138.24 166.54 25.06 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 176.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -74.9 1.7 7.38 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 122.632 0.807 . . . . 0.0 111.05 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -87.58 -22.89 24.52 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 176.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.2 mt -93.8 13.02 23.75 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.394 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.47 126.39 23.32 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.203 -0.936 . . . . 0.0 111.162 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.27 6.77 68.36 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.666 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.57 142.75 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 CA-C-N 119.328 1.564 . . . . 0.0 110.779 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 60.6 t -122.54 132.95 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.546 -0.722 . . . . 0.0 109.854 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' VAL . . . . . 0.428 ' O ' HG23 ' B' ' 99' ' ' VAL . 16.4 m -130.36 135.75 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.535 -0.728 . . . . 0.0 109.814 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' ASP . . . . . 0.407 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.39 134.15 35.2 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.2 t -103.43 127.35 29.82 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.52 -0.737 . . . . 0.0 110.351 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -80.81 130.95 7.86 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 O-C-N 124.129 1.594 . . . . 0.0 108.283 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' ASP . . . . . 0.413 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.4 p-10 -62.41 3.43 0.19 Allowed 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -125.33 114.63 19.15 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.257 -1.527 . . . . 0.0 110.054 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . 0.485 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 52.4 mm-40 -113.32 -49.34 2.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.438 -0.789 . . . . 0.0 110.016 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' TRP . . . . . . . . . . . . . 23.1 m0 . . . . . 0 N--CA 1.495 1.793 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.531 179.305 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 501' ' ' HEM . . . . . 0.949 ' O2D' ' O ' ' A' ' 100' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 502' ' ' CAM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 201' ' ' FES . . . . . 0.821 ' S2 ' ' HE3' ' B' ' 24' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.473 ' HA ' HD11 ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.452 HD11 HG13 ' A' ' 18' ' ' VAL . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.88 ' HG2' HG23 ' A' ' 18' ' ' VAL . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.88 HG23 ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.488 ' HA ' HD23 ' A' ' 22' ' ' LEU . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.415 ' CE2' HG23 ' A' ' 50' ' ' VAL . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.503 ' HE1' HD12 ' A' ' 395' ' ' ILE . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.432 ' HA ' HD12 ' A' ' 34' ' ' LEU . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 39' ' ' GLN . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.514 ' N ' HG12 ' A' ' 38' ' ' VAL . 1.6 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.457 ' O ' HG21 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.423 ' HE3' HD13 ' A' ' 324' ' ' LEU . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.457 HG21 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.49 ' HB3' HG21 ' A' ' 66' ' ' THR . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.412 ' ND2' HG22 ' A' ' 50' ' ' VAL . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.608 HG13 ' HD2' ' A' ' 51' ' ' PRO . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.608 ' HD2' HG13 ' A' ' 50' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.438 HG21 ' HB ' ' A' ' 64' ' ' ILE . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.594 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.8 m120 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.594 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.438 ' HB ' HG21 ' A' ' 54' ' ' VAL . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.49 HG21 ' HB3' ' A' ' 45' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.436 HD11 ' N ' ' A' ' 70' ' ' LEU . 6.0 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.406 ' CZ ' HG22 ' A' ' 348' ' ' THR . 5.6 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.462 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.6 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.46 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 27.1 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.7 mmt-85 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.62 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.2 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.54 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.54 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.754 ' HD2' ' HB2' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.754 ' HB2' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.694 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.927 HD12 ' NE ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.949 ' O ' ' O2D' ' A' ' 501' ' ' HEM . 74.3 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.629 ' OG1' ' HD2' ' A' ' 100' ' ' PRO . 3.9 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.508 ' HE1' HD13 ' A' ' 99' ' ' ILE . 46.0 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.614 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.296 50.1 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.46 ' HD2' ' CD1' ' A' ' 78' ' ' TYR 0.366 52.9 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.614 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 34.8 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.469 ' H ' ' CD ' ' A' ' 106' ' ' PRO 0.342 30.7 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.458 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 1.8 tm0? -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.401 ' HB1' ' HB3' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.41 ' O ' ' HB2' ' A' ' 117' ' ' GLN . 7.0 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' A' ' 114' ' ' LEU . 24.3 mt-30 -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 34.9 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.5 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.489 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.672 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 0.0 OUTLIER -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.672 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.0 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.541 HG13 HD11 ' A' ' 166' ' ' LEU . 78.3 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 28.0 mtmt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.475 HD13 HG12 ' A' ' 123' ' ' VAL . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.488 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.506 ' HA ' HD11 ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.615 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.577 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.488 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.782 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.782 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.465 HD11 HG22 ' A' ' 160' ' ' ILE . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.467 ' HA ' HD13 ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.429 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.541 HD11 HG13 ' A' ' 123' ' ' VAL . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.506 ' N ' HD21 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.44 HD21 ' HA ' ' A' ' 169' ' ' LEU . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.417 ' N ' ' CD ' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.566 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.523 ' HA ' HD22 ' A' ' 180' ' ' LEU . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' MET . . . . . 0.499 ' HE2' HG22 ' A' ' 247' ' ' VAL . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.421 HD13 HD13 ' A' ' 180' ' ' LEU . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.441 ' HB3' ' HG ' ' A' ' 221' ' ' SER . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 211' ' ' ARG . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 224' ' ' ALA . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' SER . . . . . 0.441 ' HG ' ' HB3' ' A' ' 211' ' ' ARG . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 44.9 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 42.0 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 220' ' ' ILE . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 4.3 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 13.5 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.927 ' NE ' HD12 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 41.0 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.694 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.423 ' HA ' HD22 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.499 HG22 ' HE2' ' A' ' 184' ' ' MET . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 250' ' ' LEU . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.675 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.469 HD22 ' HA ' ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' MET . . . . . 0.577 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.428 HD22 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 13.2 pm0 -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.433 ' N ' ' CD ' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' CYS . . . . . 0.422 ' SG ' HG21 ' A' ' 367' ' ' ILE . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . 0.433 HD23 HG21 ' A' ' 349' ' ' THR . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . 0.497 ' CZ ' ' HE1' ' A' ' 336' ' ' MET . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.641 ' HA ' ' HE1' ' A' ' 323' ' ' MET . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 296' ' ' ALA . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . 0.513 ' OD2' ' O2A' ' A' ' 501' ' ' HEM . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . 0.424 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . 0.424 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.0 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.535 HD23 ' N ' ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' PHE . . . . . 0.424 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.6 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' HIS . . . . . 0.424 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 36.9 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 312' ' ' LEU . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . 0.63 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . 0.63 ' HD3' ' O ' ' A' ' 319' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' MET . . . . . 0.641 ' HE1' ' HA ' ' A' ' 294' ' ' LEU . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.456 HD11 ' HB2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 13.7 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' LEU . . . . . . . . . . . . . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.472 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' PRO . . . . . 0.472 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 0.497 ' HE1' ' CZ ' ' A' ' 291' ' ' ARG . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 68.2 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' ARG . . . . . 0.418 ' HB3' HG23 ' A' ' 345' ' ' VAL . 43.4 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . 0.462 ' CB ' ' HD3' ' A' ' 344' ' ' LYS . 0.1 OUTLIER -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' LYS . . . . . 0.498 ' HB2' ' HE2' ' A' ' 344' ' ' LYS . 1.7 mppt? -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.418 HG23 ' HB3' ' A' ' 342' ' ' ARG . 60.0 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 13.2 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' THR . . . . . 0.406 HG22 ' CZ ' ' A' ' 72' ' ' ARG . 16.5 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' THR . . . . . 0.433 HG21 HD23 ' A' ' 289' ' ' LEU . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' SER . . . . . 0.586 ' HA ' ' HB3' ' B' ' 44' ' ' SER . 95.3 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . 0.687 ' CD1' ' CBD' ' A' ' 501' ' ' HEM . 4.9 mp -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.42 ' HA ' HD12 ' A' ' 362' ' ' LEU . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 38.2 mtt85 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 14.3 tpp85 -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . 0.422 HG21 ' SG ' ' A' ' 285' ' ' CYS . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.485 HD12 HG23 ' A' ' 383' ' ' ILE . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' ILE . . . . . 0.403 HD11 HD12 ' A' ' 402' ' ' LEU . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.503 HD12 ' HE1' ' A' ' 28' ' ' MET . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . 0.403 HD12 HD11 ' A' ' 389' ' ' ILE . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . 0.404 ' HA ' HD22 ' A' ' 404' ' ' LEU . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' ASP . . . . . 0.544 ' HB3' HG23 ' A' ' 410' ' ' THR . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' PRO . . . . . 0.645 ' HA ' HG22 ' A' ' 411' ' ' THR . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' THR . . . . . 0.544 HG23 ' HB3' ' A' ' 407' ' ' ASP . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' THR . . . . . 0.645 HG22 ' HA ' ' A' ' 408' ' ' PRO . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . 0.496 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 40.3 m . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 121.079 0.466 . . . . 0.0 109.757 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.51 138.61 38.51 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.169 -0.957 . . . . 0.0 112.928 -178.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 61.2 t -137.17 122.57 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 177.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.439 HG13 ' CZ ' ' B' ' 12' ' ' ARG . 98.4 t -106.81 129.61 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.159 -0.963 . . . . 0.0 111.62 -178.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.556 ' CD1' HD11 ' B' ' 32' ' ' ILE . 77.3 m-85 -109.22 110.6 21.84 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.83 127.22 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 120.96 -1.087 . . . . 0.0 108.353 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.4 m -86.17 174.67 8.97 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.772 0.796 . . . . 0.0 112.503 -177.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.409 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.6 t-80 -60.7 -46.7 89.38 Favored 'General case' 0 N--CA 1.503 2.179 0 CA-C-O 121.142 0.496 . . . . 0.0 110.436 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -65.92 -11.28 46.08 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.575 -0.703 . . . . 0.0 111.387 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.96 15.48 28.45 Favored Glycine 0 N--CA 1.491 2.335 0 O-C-N 121.074 -1.016 . . . . 0.0 111.269 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.0 m -82.07 147.4 29.13 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 118.713 1.257 . . . . 0.0 109.926 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . 0.439 ' CZ ' HG13 ' B' ' 4' ' ' VAL . 50.9 ttt85 -118.49 128.8 54.93 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.428 -0.795 . . . . 0.0 111.83 -178.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.05 127.67 46.2 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.596 -0.69 . . . . 0.0 109.803 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -111.37 130.64 55.62 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.287 -0.883 . . . . 0.0 111.589 -178.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.571 HD11 HD13 ' B' ' 32' ' ' ILE . 84.6 mt -122.79 159.36 28.24 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.753 -0.592 . . . . 0.0 111.118 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -109.61 91.62 3.72 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 176.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.5 t -90.15 133.4 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-O 121.575 0.702 . . . . 0.0 112.303 -176.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.08 170.66 16.12 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.768 -0.582 . . . . 0.0 110.295 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -68.44 151.82 46.29 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.477 -0.764 . . . . 0.0 111.005 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.47 -12.53 55.39 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.03 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 61.1 t -89.99 133.34 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.655 -1.497 . . . . 0.0 110.928 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 97.7 p -80.29 151.88 29.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.513 -0.742 . . . . 0.0 109.127 178.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.478 HD23 ' HH ' ' B' ' 5' ' ' TYR . 18.5 mt -61.16 -24.63 66.43 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.312 -0.868 . . . . 0.0 110.631 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' MET . . . . . 0.459 ' SD ' ' S2 ' ' B' ' 201' ' ' FES . 2.7 ttp -69.75 -49.2 55.41 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.217 -0.927 . . . . 0.0 109.514 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.79 -41.75 91.86 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.591 -0.693 . . . . 0.0 109.941 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.06 -40.89 95.37 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.574 -0.704 . . . . 0.0 110.137 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.3 -49.77 58.2 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.203 -0.935 . . . . 0.0 111.071 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 77.4 t -65.48 -39.15 84.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.305 -0.872 . . . . 0.0 110.723 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 26.0 m -70.14 -14.0 62.45 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.394 -0.816 . . . . 0.0 111.547 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -118.17 23.78 11.39 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.033 -1.042 . . . . 0.0 110.623 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.74 38.27 58.86 Favored Glycine 0 N--CA 1.493 2.459 0 O-C-N 121.566 -0.709 . . . . 0.0 111.81 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.571 HD13 HD11 ' B' ' 15' ' ' LEU . 1.7 mt -72.53 147.12 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.914 -1.345 . . . . 0.0 108.878 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.67 142.51 58.05 Favored 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 117.203 2.297 . . . . 0.0 117.203 -174.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . 0.44 ' O ' ' HG3' ' B' ' 105' ' ' GLN . 65.3 m-20 62.19 -36.14 0.12 Allowed 'General case' 0 N--CA 1.515 2.81 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 175.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 84.4 mt -59.69 122.85 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 O-C-N 119.864 -1.772 . . . . 0.0 110.701 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.613 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 2.4 t -100.09 -51.35 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.577 -0.702 . . . . 0.0 111.241 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . 0.611 ' HA2' ' S2 ' ' B' ' 201' ' ' FES . . . 63.1 56.49 20.24 Favored Glycine 0 N--CA 1.5 2.908 0 N-CA-C 107.447 -2.261 . . . . 0.0 107.447 -178.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -71.34 -49.24 44.44 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.991 -0.711 . . . . 0.0 112.262 -177.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' CYS . . . . . 0.539 ' HB3' ' HB3' ' B' ' 45' ' ' CYS . 2.3 p -66.55 -10.46 45.37 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.22 -0.925 . . . . 0.0 112.394 -178.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.77 -5.48 64.13 Favored Glycine 0 N--CA 1.499 2.836 0 O-C-N 120.806 -1.184 . . . . 0.0 111.981 177.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.14 19.51 10.64 Favored Glycine 0 N--CA 1.494 2.558 0 O-C-N 120.842 -1.387 . . . . 0.0 110.978 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 30.7 p -98.99 19.16 15.61 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.037 -1.273 . . . . 0.0 111.115 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 56.04 40.83 30.24 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.391 -0.818 . . . . 0.0 111.93 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' SER . . . . . 0.586 ' HB3' ' HA ' ' A' ' 354' ' ' SER . 5.7 m -117.05 11.21 14.18 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.318 -0.864 . . . . 0.0 109.557 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' CYS . . . . . 0.641 ' SG ' 'FE1 ' ' B' ' 201' ' ' FES . 15.1 p -149.56 -179.1 6.83 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.04 34.07 3.11 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.884 -1.135 . . . . 0.0 111.356 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' THR . . . . . 0.613 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 37.2 p -97.52 13.2 30.79 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.964 -1.085 . . . . 0.0 111.314 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' CYS . . . . . 0.422 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.1 p -120.57 31.77 6.3 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . 0.43 ' O ' HG13 ' B' ' 50' ' ' VAL . 23.8 t-160 -72.7 133.03 44.41 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.609 -178.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . 0.475 HG23 ' HB3' ' B' ' 85' ' ' CYS . 12.3 m -146.29 160.07 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . 0.402 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.5 m-85 -105.42 102.76 12.21 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.3 -0.875 . . . . 0.0 108.681 178.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.2 t -61.98 135.12 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 121.315 -0.865 . . . . 0.0 109.349 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.65 131.81 51.36 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.944 0.878 . . . . 0.0 109.559 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -44.34 -30.98 0.91 Allowed 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.84 -6.9 54.25 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.984 -1.073 . . . . 0.0 112.712 -178.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -119.95 -6.67 10.02 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 120.503 -1.373 . . . . 0.0 111.871 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.5 p -55.37 -37.85 68.06 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.154 -0.967 . . . . 0.0 112.892 -178.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -81.1 -6.65 59.06 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.787 -1.196 . . . . 0.0 111.46 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -89.93 -11.6 41.28 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.078 -1.014 . . . . 0.0 109.831 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.616 HG12 ' HD2' ' B' ' 61' ' ' PRO . 40.8 t -104.07 141.05 21.71 Favored Pre-proline 0 N--CA 1.488 1.467 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . 0.616 ' HD2' HG12 ' B' ' 60' ' ' VAL . 49.4 Cg_endo -73.8 118.92 5.64 Favored 'Trans proline' 0 N--CA 1.489 1.209 0 O-C-N 123.514 1.271 . . . . 0.0 108.986 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.99 160.66 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.761 0 N-CA-C 116.647 2.092 . . . . 0.0 116.647 -177.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.434 ' HB2' ' HB3' ' B' ' 67' ' ' GLU . . . -65.77 146.15 55.12 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 114.572 -1.194 . . . . 0.0 111.247 178.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -89.78 -170.79 2.94 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.565 -0.709 . . . . 0.0 110.392 178.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -59.53 -42.05 91.38 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.343 -0.848 . . . . 0.0 111.686 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 5.0 ttt180 -67.39 -41.57 84.76 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.175 -0.953 . . . . 0.0 112.028 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.434 ' HB3' ' HB2' ' B' ' 63' ' ' ALA . 45.4 tt0 -68.23 -43.91 76.88 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.01 -1.056 . . . . 0.0 110.349 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . 0.511 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.6 mm -55.56 -42.18 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 O-C-N 121.287 -0.883 . . . . 0.0 109.372 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.22 -47.84 80.83 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 9.5 mmt -66.18 -33.99 77.01 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.27 -1.135 . . . . 0.0 111.207 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . 0.494 HD22 ' HA ' ' B' ' 71' ' ' LEU . 28.1 mt -63.45 -23.35 67.36 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.214 -0.929 . . . . 0.0 110.608 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . 0.511 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 49.9 mt-10 -70.41 -8.79 53.54 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.344 -0.848 . . . . 0.0 110.889 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 82.8 p -119.78 12.54 12.18 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.001 -1.062 . . . . 0.0 112.543 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 28.8 m -60.8 140.46 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 O-C-N 120.761 -1.212 . . . . 0.0 109.627 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 44.8 m -74.58 -39.07 62.45 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.406 -0.809 . . . . 0.0 110.174 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.2 168.82 17.43 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.476 -0.765 . . . . 0.0 110.076 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.27 139.15 55.64 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.451 -0.781 . . . . 0.0 110.615 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.4 tp -91.0 116.19 28.6 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.551 -0.718 . . . . 0.0 109.836 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -103.02 168.33 8.95 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -76.62 -0.03 10.04 Favored 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 123.27 1.142 . . . . 0.0 110.43 178.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -120.43 22.35 11.32 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.963 -1.086 . . . . 0.0 108.419 176.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 4.3 m -80.77 137.17 36.24 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.833 -0.542 . . . . 0.0 110.385 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.5 mmm-85 -149.75 146.39 27.17 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.443 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.422 ' HB3' ' SG ' ' B' ' 48' ' ' CYS . 95.0 mt -80.57 98.99 7.87 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 175.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' CYS . . . . . 0.475 ' HB3' HG23 ' B' ' 50' ' ' VAL . 10.6 p -48.43 -17.91 0.19 Allowed 'General case' 0 N--CA 1.508 2.439 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -175.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.8 p -70.3 -13.92 62.37 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.646 -1.284 . . . . 0.0 109.453 178.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -92.72 -12.3 31.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.465 -0.772 . . . . 0.0 110.533 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . 0.466 HG21 HD13 ' B' ' 23' ' ' LEU . 61.8 mt -91.46 103.96 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.117 -0.99 . . . . 0.0 110.671 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 47.3 mm -84.99 131.8 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' MET . . . . . 0.422 ' C ' HG22 ' B' ' 91' ' ' THR . 13.6 tpt -74.85 137.77 42.05 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 122.143 0.973 . . . . 0.0 113.244 -177.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' THR . . . . . 0.422 HG22 ' C ' ' B' ' 90' ' ' MET . 43.8 p -138.2 166.59 24.73 Favored Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 176.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -74.94 1.65 7.46 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 122.689 0.836 . . . . 0.0 110.996 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -87.58 -22.84 24.55 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 176.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.6 mt -93.77 12.95 23.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 122.035 -0.416 . . . . 0.0 110.389 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.45 126.38 23.24 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.128 -0.983 . . . . 0.0 111.177 -178.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.19 6.83 68.48 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.68 179.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.62 142.75 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-N 119.334 1.567 . . . . 0.0 110.81 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 60.6 t -122.47 133.02 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.559 -0.713 . . . . 0.0 109.829 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' VAL . . . . . 0.431 ' O ' HG23 ' B' ' 99' ' ' VAL . 16.4 m -130.41 135.74 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.456 -0.778 . . . . 0.0 109.788 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' ASP . . . . . 0.402 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.38 134.16 35.19 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.2 t -103.4 127.31 29.91 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.505 -0.747 . . . . 0.0 110.359 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -80.87 130.96 7.79 Favored 'Trans proline' 0 C--N 1.316 -1.163 0 O-C-N 124.101 1.579 . . . . 0.0 108.277 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' ASP . . . . . 0.409 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.3 p-10 -62.37 3.41 0.19 Allowed 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -178.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -125.29 114.58 19.12 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.277 -1.514 . . . . 0.0 110.089 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . 0.492 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 23.9 mm-40 -113.25 -49.41 2.91 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.455 -0.778 . . . . 0.0 110.029 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' TRP . . . . . 0.401 ' HB3' ' HB1' ' A' ' 113' ' ' ALA . 17.0 m0 . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 118.249 -0.882 . . . . 0.0 110.547 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 501' ' ' HEM . . . . . 0.949 ' O2D' ' O ' ' A' ' 100' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 502' ' ' CAM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 201' ' ' FES . . . . . 0.641 'FE1 ' ' SG ' ' B' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.514 HD12 ' HD2' ' A' ' 15' ' ' PRO . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 14' ' ' LEU . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.419 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HG2' HG12 ' A' ' 54' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.569 HG12 ' HG2' ' A' ' 51' ' ' PRO . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.609 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.609 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 64' ' ' ILE . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.435 ' HA ' HD23 ' A' ' 324' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.0 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.4 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.6 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.511 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 26.6 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.4 mtt-85 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.8 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.64 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.1 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.556 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.717 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.717 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 1.068 HD11 ' CZ ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.622 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 67.8 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.64 ' O ' ' HB3' ' A' ' 83' ' ' SER . 3.9 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 45.3 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.605 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.298 63.0 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.511 ' HD2' ' CD1' ' A' ' 78' ' ' TYR 0.367 53.3 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.605 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 33.9 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.452 ' H ' ' CD ' ' A' ' 106' ' ' PRO 0.409 34.0 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 12.9 mtp180 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.425 ' HB2' ' CE3' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.538 HD11 ' HA3' ' A' ' 226' ' ' GLY . 38.0 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.503 ' O ' HG22 ' A' ' 119' ' ' VAL . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.66 HG23 HG13 ' A' ' 119' ' ' VAL . 25.2 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.66 HG13 HG23 ' A' ' 118' ' ' VAL . 27.3 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.493 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.698 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 17.7 mtm -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.698 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.1 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.606 HG21 ' HA ' ' A' ' 118' ' ' VAL . 72.7 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 45.4 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.455 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.63 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.412 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.595 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 151' ' ' THR . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.799 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.799 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.441 ' O ' ' HG2' ' A' ' 164' ' ' MET . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.578 ' C ' HD23 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.455 ' N ' HD23 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.425 ' N ' ' HD2' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' HIS . . . . . 0.405 ' O ' ' HG ' ' A' ' 180' ' ' LEU . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.574 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 176' ' ' HIS . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.561 ' HA ' ' HE3' ' A' ' 184' ' ' MET . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' MET . . . . . 0.561 ' HE3' ' HA ' ' A' ' 181' ' ' THR . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.421 HD22 ' HE1' ' A' ' 184' ' ' MET . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ARG . . . . . 0.453 ' HG3' ' HB1' ' A' ' 224' ' ' ALA . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 220' ' ' ILE . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 42.7 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 42.0 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.453 ' HB1' ' HG3' ' A' ' 212' ' ' ARG . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.538 ' HA3' HD11 ' A' ' 114' ' ' LEU . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 6.2 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 1.3 m120 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 17.1 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' ARG . . . . . 1.068 ' CZ ' HD11 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 34.2 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.717 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.487 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' MET . . . . . 0.595 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 16.4 pm0 -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.439 ' N ' ' HD2' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 282' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 281' ' ' ILE . 45.4 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 285' ' ' CYS . . . . . . . . . . . . . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 288' ' ' LEU . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.706 HD23 ' H ' ' A' ' 294' ' ' LEU . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 298' ' ' GLY . . . . . 0.419 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 299' ' ' ARG . . . . . 0.419 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.7 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.459 ' HA ' HD13 ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 314' ' ' LYS . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 307' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.6 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 308' ' ' HIS . . . . . 0.425 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 36.9 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 314' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 303' ' ' SER . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 318' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 318' ' ' ILE . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 319' ' ' LEU . . . . . 0.647 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 321' ' ' PRO . . . . . 0.68 ' HG2' HD22 ' A' ' 324' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.68 HD22 ' HG2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 13.7 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 327' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 327' ' ' LEU . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.522 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 335' ' ' PRO . . . . . 0.522 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 343' ' ' GLN . . . . . 0.413 ' CB ' ' HD3' ' A' ' 344' ' ' LYS . 1.9 mp0 -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 344' ' ' LYS . . . . . 0.519 ' HD3' ' N ' ' A' ' 344' ' ' LYS . 1.8 mppt? -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 61.0 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 1.1 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 15.8 p80 -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 17.1 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 349' ' ' THR . . . . . . . . . . . . . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 90.8 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 356' ' ' LEU . . . . . 0.58 HD13 ' O ' ' B' ' 39' ' ' CYS . 0.6 OUTLIER -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 7.7 mtm180 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 17.2 tpp85 -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.1 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 68.2 mm-40 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 412' ' ' LYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 39.6 m . . . . . 0 N--CA 1.496 1.832 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.51 138.6 38.5 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.234 -0.916 . . . . 0.0 112.92 -178.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 3' ' ' VAL . . . . . 0.736 HG11 HD22 ' B' ' 23' ' ' LEU . 61.4 t -137.15 122.57 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.53 HG11 ' CZ ' ' B' ' 12' ' ' ARG . 98.5 t -106.82 129.59 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.124 -0.985 . . . . 0.0 111.625 -178.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -109.18 110.6 21.87 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.82 127.19 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.93 -1.107 . . . . 0.0 108.343 178.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.2 m -86.15 174.68 8.98 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.789 0.804 . . . . 0.0 112.472 -177.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 8' ' ' HIS . . . . . 0.418 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.68 -46.69 89.39 Favored 'General case' 0 N--CA 1.503 2.18 0 CA-C-O 121.141 0.496 . . . . 0.0 110.453 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -65.94 -11.29 46.41 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.596 -0.69 . . . . 0.0 111.393 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.99 15.49 28.34 Favored Glycine 0 N--CA 1.493 2.441 0 O-C-N 121.174 -0.954 . . . . 0.0 111.238 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.6 m -82.12 147.37 29.1 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 118.789 1.295 . . . . 0.0 109.903 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 12' ' ' ARG . . . . . 0.53 ' CZ ' HG11 ' B' ' 4' ' ' VAL . 50.8 ttt85 -118.42 128.72 54.89 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.454 -0.779 . . . . 0.0 111.883 -178.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.99 127.64 46.22 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.595 -0.69 . . . . 0.0 109.843 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -111.28 130.6 55.61 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.281 -0.887 . . . . 0.0 111.632 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.62 HD11 HD11 ' B' ' 32' ' ' ILE . 84.6 mt -122.72 159.4 28.05 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.752 -0.592 . . . . 0.0 111.082 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -109.64 91.64 3.73 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 176.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.6 t -90.17 133.39 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.571 0.7 . . . . 0.0 112.314 -176.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.07 170.67 16.11 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.788 -0.57 . . . . 0.0 110.251 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -68.45 151.8 46.31 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.535 -0.728 . . . . 0.0 111.0 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.48 -12.52 55.44 Favored Glycine 0 N--CA 1.495 2.602 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.065 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 59.3 t -89.93 133.34 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 120.699 -1.471 . . . . 0.0 110.951 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 22.1 p -80.26 151.97 29.31 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.736 HD22 HG11 ' B' ' 3' ' ' VAL . 18.4 mt -61.24 -24.59 66.47 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.316 -0.865 . . . . 0.0 110.618 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 8.8 tmm? -69.76 -49.23 55.0 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.2 -0.938 . . . . 0.0 109.497 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -59.91 -41.62 92.12 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.56 -0.713 . . . . 0.0 109.895 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.07 -40.89 95.33 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.655 -0.653 . . . . 0.0 110.169 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' ALA . . . . . 0.697 ' HA ' HD13 ' B' ' 32' ' ' ILE . . . -68.35 -49.71 58.39 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.219 -0.926 . . . . 0.0 111.058 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 53.8 t -65.42 -39.25 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.298 -0.876 . . . . 0.0 110.711 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 24.0 m -70.01 -14.12 62.55 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.325 -0.859 . . . . 0.0 111.557 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -118.15 23.78 11.39 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.036 -1.04 . . . . 0.0 110.691 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.81 38.21 59.1 Favored Glycine 0 N--CA 1.493 2.454 0 O-C-N 121.527 -0.733 . . . . 0.0 111.83 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.697 HD13 ' HA ' ' B' ' 27' ' ' ALA . 1.0 OUTLIER -72.53 147.11 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.847 -1.384 . . . . 0.0 108.874 179.055 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -62.63 142.43 58.05 Favored 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 117.201 2.297 . . . . 0.0 117.201 -174.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 34' ' ' ASP . . . . . 0.447 ' O ' ' HG3' ' B' ' 105' ' ' GLN . 65.2 m-20 62.25 -36.14 0.12 Allowed 'General case' 0 N--CA 1.516 2.833 0 N-CA-C 116.66 2.096 . . . . 0.0 116.66 175.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 54.3 mt -59.76 122.89 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.419 0 O-C-N 119.89 -1.756 . . . . 0.0 110.62 -178.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.68 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 96.5 t -100.13 -51.36 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.695 -0.628 . . . . 0.0 111.183 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.13 56.4 20.67 Favored Glycine 0 N--CA 1.499 2.873 0 N-CA-C 107.491 -2.244 . . . . 0.0 107.491 -178.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -71.27 -49.23 45.17 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.994 -0.709 . . . . 0.0 112.34 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 39' ' ' CYS . . . . . 0.58 ' O ' HD13 ' A' ' 356' ' ' LEU . 2.3 p -66.6 -10.48 46.15 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.215 -0.928 . . . . 0.0 112.332 -178.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.87 -5.57 63.92 Favored Glycine 0 N--CA 1.498 2.804 0 O-C-N 120.787 -1.195 . . . . 0.0 111.968 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.17 19.5 10.63 Favored Glycine 0 N--CA 1.495 2.605 0 O-C-N 120.803 -1.41 . . . . 0.0 111.002 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 80.6 p -98.97 19.21 15.49 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.028 -1.278 . . . . 0.0 111.132 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.92 40.89 30.46 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.4 -0.812 . . . . 0.0 111.941 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 3.6 t -117.02 11.14 14.18 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.376 -0.828 . . . . 0.0 109.518 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 45' ' ' CYS . . . . . 0.549 ' HB3' ' HB3' ' B' ' 39' ' ' CYS . 15.1 p -149.53 -179.11 6.84 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.05 34.04 3.11 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.803 -1.186 . . . . 0.0 111.367 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 47' ' ' THR . . . . . 0.68 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 23.4 p -97.59 13.24 30.78 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.933 -1.105 . . . . 0.0 111.276 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 48' ' ' CYS . . . . . 0.442 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.1 p -120.58 31.77 6.3 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 177.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 49' ' ' HIS . . . . . 0.468 ' NE2' ' HB3' ' B' ' 82' ' ' SER . 6.5 t-160 -72.65 132.99 44.43 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.642 -178.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.2 m -146.21 160.1 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 51' ' ' TYR . . . . . 0.413 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.3 m-85 -105.43 102.71 12.17 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.238 -0.914 . . . . 0.0 108.706 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.4 t -61.87 135.13 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.282 -0.886 . . . . 0.0 109.369 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.67 131.74 51.16 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.954 0.883 . . . . 0.0 109.518 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' B' ' 54' ' ' GLU . 11.0 mp0 -44.26 -31.08 0.91 Allowed 'General case' 0 N--CA 1.507 2.384 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -178.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.78 -6.88 54.07 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 120.963 -1.086 . . . . 0.0 112.752 -178.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -119.9 -6.73 10.04 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.46 -1.4 . . . . 0.0 111.886 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.4 p -55.45 -37.75 68.13 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.174 -0.954 . . . . 0.0 112.863 -178.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -81.2 -6.62 59.06 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.741 -1.225 . . . . 0.0 111.453 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -89.84 -11.67 41.31 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.045 -1.034 . . . . 0.0 109.859 178.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -104.07 141.04 21.7 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -73.74 118.88 5.63 Favored 'Trans proline' 0 N--CA 1.488 1.18 0 O-C-N 123.509 1.268 . . . . 0.0 109.029 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.94 160.59 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.762 0 N-CA-C 116.65 2.092 . . . . 0.0 116.65 -177.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 63' ' ' ALA . . . . . 0.615 ' HB1' ' HB3' ' B' ' 67' ' ' GLU . . . -65.76 146.18 55.09 Favored 'General case' 0 N--CA 1.503 2.182 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.258 178.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -89.81 -170.76 2.92 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.606 -0.684 . . . . 0.0 110.383 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -59.59 -41.96 91.46 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.337 -0.852 . . . . 0.0 111.705 -178.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.46 -41.6 84.4 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.186 -0.946 . . . . 0.0 111.969 -178.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 67' ' ' GLU . . . . . 0.615 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 45.6 tt0 -68.22 -43.96 76.82 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.005 -1.059 . . . . 0.0 110.298 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 68' ' ' ILE . . . . . 0.516 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.6 mm -55.52 -42.22 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.311 -0.868 . . . . 0.0 109.359 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.25 -47.78 81.3 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 26.9 mmt -66.26 -33.91 76.8 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.268 -1.137 . . . . 0.0 111.17 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 71' ' ' LEU . . . . . 0.422 ' HA ' HD23 ' B' ' 71' ' ' LEU . 27.5 mt -63.49 -23.35 67.36 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.207 -0.933 . . . . 0.0 110.623 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 72' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 41.1 mt-10 -70.41 -8.74 53.13 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.354 -0.842 . . . . 0.0 110.911 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 73.5 p -119.82 12.53 12.14 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.009 -1.057 . . . . 0.0 112.504 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 34.9 m -60.78 140.45 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 120.745 -1.222 . . . . 0.0 109.622 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 36.6 m -74.58 -39.06 62.47 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.393 -0.817 . . . . 0.0 110.181 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.2 168.82 17.43 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.47 -0.769 . . . . 0.0 110.094 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.27 139.14 55.67 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.392 -0.818 . . . . 0.0 110.609 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.2 tp -91.02 116.13 28.55 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.489 -0.757 . . . . 0.0 109.869 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -102.97 168.29 9.02 Favored Pre-proline 0 C--N 1.301 -1.518 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -76.62 -0.01 10.02 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 123.243 1.128 . . . . 0.0 110.401 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -120.46 22.36 11.3 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.898 -1.126 . . . . 0.0 108.399 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 82' ' ' SER . . . . . 0.468 ' HB3' ' NE2' ' B' ' 49' ' ' HIS . 4.3 m -80.81 137.19 36.21 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.861 -0.524 . . . . 0.0 110.362 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.4 mmm-85 -149.75 146.38 27.16 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.487 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.593 HD12 ' HG3' ' B' ' 67' ' ' GLU . 97.5 mt -80.54 98.95 7.82 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 175.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 10.6 p -48.41 -17.86 0.18 Allowed 'General case' 0 N--CA 1.508 2.455 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -175.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.8 p -70.27 -14.01 62.42 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.616 -1.302 . . . . 0.0 109.464 178.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -92.7 -12.21 32.04 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.453 -0.779 . . . . 0.0 110.53 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 88' ' ' ILE . . . . . 0.4 HG21 HD13 ' B' ' 88' ' ' ILE . 61.8 mt -91.51 103.96 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.133 -0.979 . . . . 0.0 110.609 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 47.6 mm -84.96 131.79 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 13.6 tpt -74.84 137.8 42.08 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 122.164 0.983 . . . . 0.0 113.189 -177.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 43.7 p -138.25 166.59 24.63 Favored Pre-proline 0 N--CA 1.49 1.548 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 176.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -74.88 1.66 7.42 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 122.638 0.809 . . . . 0.0 111.035 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -87.65 -22.83 24.47 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.5 mt -93.72 12.96 23.75 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.465 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.52 126.44 23.6 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.184 -0.948 . . . . 0.0 111.15 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.21 6.81 68.46 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.66 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.58 142.74 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 CA-C-N 119.325 1.563 . . . . 0.0 110.768 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 98' ' ' VAL . . . . . 0.463 HG22 ' HB ' ' B' ' 4' ' ' VAL . 60.7 t -122.5 132.98 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.501 -0.749 . . . . 0.0 109.831 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 16.3 m -130.35 135.71 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.479 -0.763 . . . . 0.0 109.882 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 100' ' ' ASP . . . . . 0.413 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.34 134.16 35.18 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.1 t -103.46 127.32 29.85 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.545 -0.722 . . . . 0.0 110.32 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -80.85 130.93 7.81 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 O-C-N 124.114 1.586 . . . . 0.0 108.267 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 103' ' ' ASP . . . . . 0.418 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.4 p-10 -62.33 3.33 0.19 Allowed 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -178.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 4.0 mtm105 -125.29 114.71 19.29 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.306 -1.496 . . . . 0.0 110.064 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 105' ' ' GLN . . . . . 0.512 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 23.2 mm-40 -113.39 -49.36 2.9 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.486 -0.759 . . . . 0.0 109.969 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 106' ' ' TRP . . . . . 0.425 ' CE3' ' HB2' ' A' ' 113' ' ' ALA . 27.3 m95 . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.521 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.514 HD12 ' HD2' ' A' ' 15' ' ' PRO . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 14' ' ' LEU . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.419 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HG2' HG12 ' A' ' 54' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.569 HG12 ' HG2' ' A' ' 51' ' ' PRO . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.609 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.609 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 64' ' ' ILE . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.435 ' HA ' HD23 ' A' ' 324' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.0 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.4 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.5 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.427 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 27.0 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.64 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.2 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.556 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.717 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.717 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 1.068 HD11 ' CZ ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 002 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.63 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 67.6 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.64 ' O ' ' HB3' ' A' ' 83' ' ' SER . 3.8 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 46.0 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.647 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.296 50.2 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 104' ' ' ASP 0.366 52.9 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.647 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 35.0 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.452 ' H ' ' CG ' ' A' ' 106' ' ' PRO 0.413 34.1 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 8.6 mtp180 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.552 ' HB2' ' CE3' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.687 HD11 ' HA3' ' A' ' 226' ' ' GLY . 24.5 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.546 ' O ' HG22 ' A' ' 119' ' ' VAL . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.603 ' HA ' HG21 ' A' ' 123' ' ' VAL . 35.1 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.593 HG13 HG23 ' A' ' 118' ' ' VAL . 30.6 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.493 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.698 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 21.5 mtm -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.698 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.1 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.603 HG21 ' HA ' ' A' ' 118' ' ' VAL . 72.0 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.7 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.452 ' HD2' ' HA ' ' A' ' 123' ' ' VAL . 35.6 mttt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.455 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.63 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.412 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.595 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 151' ' ' THR . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.799 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.799 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.441 ' O ' ' HG2' ' A' ' 164' ' ' MET . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.578 ' C ' HD23 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.455 ' N ' HD23 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.425 ' N ' ' HD2' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' HIS . . . . . 0.405 ' O ' ' HG ' ' A' ' 180' ' ' LEU . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.574 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 176' ' ' HIS . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.561 ' HA ' ' HE3' ' A' ' 184' ' ' MET . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' MET . . . . . 0.561 ' HE3' ' HA ' ' A' ' 181' ' ' THR . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.421 HD22 ' HE1' ' A' ' 184' ' ' MET . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ARG . . . . . 0.453 ' HG3' ' HB1' ' A' ' 224' ' ' ALA . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 220' ' ' ILE . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 33.3 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 53.1 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.453 ' HB1' ' HG3' ' A' ' 212' ' ' ARG . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.687 ' HA3' HD11 ' A' ' 114' ' ' LEU . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 4.6 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 1.3 m120 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 18.1 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' ARG . . . . . 1.068 ' CZ ' HD11 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 45.3 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.717 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.487 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 261' ' ' MET . . . . . 0.595 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.437 ' N ' ' HD2' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 282' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' CYS . . . . . . . . . . . . . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 288' ' ' LEU . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.706 HD23 ' H ' ' A' ' 294' ' ' LEU . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 298' ' ' GLY . . . . . 0.419 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 299' ' ' ARG . . . . . 0.419 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.1 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.459 ' HA ' HD13 ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 314' ' ' LYS . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 307' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.6 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 308' ' ' HIS . . . . . 0.425 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 36.9 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 314' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 303' ' ' SER . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 318' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 318' ' ' ILE . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 319' ' ' LEU . . . . . 0.647 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 321' ' ' PRO . . . . . 0.68 ' HG2' HD22 ' A' ' 324' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.68 HD22 ' HG2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 13.7 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 327' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 327' ' ' LEU . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.522 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 335' ' ' PRO . . . . . 0.522 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 343' ' ' GLN . . . . . 0.41 ' CB ' ' HD3' ' A' ' 344' ' ' LYS . 1.9 mp0 -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 344' ' ' LYS . . . . . 0.511 ' HD3' ' N ' ' A' ' 344' ' ' LYS . 0.9 OUTLIER -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 60.7 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 10.6 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 39.9 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 349' ' ' THR . . . . . . . . . . . . . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 353' ' ' GLY . . . . . 0.669 ' O ' HD12 ' A' ' 356' ' ' LEU . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 354' ' ' SER . . . . . 0.408 ' HA ' ' HB3' ' B' ' 44' ' ' SER . 97.5 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 356' ' ' LEU . . . . . 0.669 HD12 ' O ' ' A' ' 353' ' ' GLY . 0.2 OUTLIER -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 44.0 mtt85 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 68.2 mm-40 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 412' ' ' LYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 39.7 m . . . . . 0 N--CA 1.495 1.805 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.49 138.61 38.52 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.246 -0.909 . . . . 0.0 112.958 -178.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 3' ' ' VAL . . . . . 0.744 HG11 HD22 ' B' ' 23' ' ' LEU . 61.0 t -137.16 122.52 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 177.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.528 HG11 ' CZ ' ' B' ' 12' ' ' ARG . 97.9 t -106.74 129.56 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.093 -1.004 . . . . 0.0 111.636 -178.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.513 ' CG ' HD13 ' B' ' 32' ' ' ILE . 77.2 m-85 -109.23 110.58 21.83 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.8 127.27 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 120.93 -1.106 . . . . 0.0 108.377 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.7 m -86.21 174.64 8.97 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.766 0.793 . . . . 0.0 112.498 -177.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 8' ' ' HIS . . . . . 0.432 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.6 -46.75 89.09 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.186 0.517 . . . . 0.0 110.472 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.2 p-10 -65.92 -11.28 46.04 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.583 -0.698 . . . . 0.0 111.419 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.98 15.51 28.3 Favored Glycine 0 N--CA 1.493 2.459 0 O-C-N 121.195 -0.941 . . . . 0.0 111.256 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.6 m -82.1 147.41 29.1 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 118.721 1.26 . . . . 0.0 109.884 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' ARG . . . . . 0.528 ' CZ ' HG11 ' B' ' 4' ' ' VAL . 50.8 ttt85 -118.52 128.78 54.91 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.508 -0.745 . . . . 0.0 111.816 -178.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 13' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' B' ' 13' ' ' ARG . 0.0 OUTLIER -126.07 127.72 46.27 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.623 -0.673 . . . . 0.0 109.79 179.109 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -111.26 130.62 55.6 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.284 -0.885 . . . . 0.0 111.617 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 84.4 mt -122.83 159.37 28.28 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.357 0.598 . . . . 0.0 111.08 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -109.64 91.67 3.74 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.7 t -90.22 133.49 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-O 121.654 0.74 . . . . 0.0 112.258 -176.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.13 170.67 16.12 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.766 -0.584 . . . . 0.0 110.242 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -68.45 151.83 46.27 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.5 -0.75 . . . . 0.0 110.954 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.42 -12.45 55.43 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.046 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.462 HG13 ' NE2' ' B' ' 25' ' ' GLN . 61.8 t -89.99 133.35 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 120.654 -1.498 . . . . 0.0 110.904 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 21.6 p -80.28 151.92 29.3 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.593 -0.692 . . . . 0.0 109.143 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.744 HD22 HG11 ' B' ' 3' ' ' VAL . 18.4 mt -61.19 -24.64 66.47 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.29 -0.881 . . . . 0.0 110.618 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 7.7 ttp -69.71 -49.26 55.05 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.263 -0.898 . . . . 0.0 109.489 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 25' ' ' GLN . . . . . 0.462 ' NE2' HG13 ' B' ' 21' ' ' VAL . 0.1 OUTLIER -59.82 -41.67 91.8 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.562 -0.711 . . . . 0.0 109.937 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.11 -40.89 95.17 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.552 -0.718 . . . . 0.0 110.114 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' ALA . . . . . 0.589 ' HA ' HD12 ' B' ' 32' ' ' ILE . . . -68.31 -49.76 58.18 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.2 -0.937 . . . . 0.0 111.066 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 76.8 t -65.42 -39.17 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.317 -0.864 . . . . 0.0 110.755 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 20.5 t -70.09 -14.06 62.49 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.383 -0.823 . . . . 0.0 111.529 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -118.18 23.85 11.34 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.065 -1.022 . . . . 0.0 110.661 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.7 38.24 58.59 Favored Glycine 0 N--CA 1.493 2.481 0 O-C-N 121.55 -0.719 . . . . 0.0 111.871 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.589 HD12 ' HA ' ' B' ' 27' ' ' ALA . 0.4 OUTLIER -72.54 147.21 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.792 -1.416 . . . . 0.0 108.892 179.002 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -62.72 142.48 58.11 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 117.202 2.297 . . . . 0.0 117.202 -174.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 62.29 -36.21 0.12 Allowed 'General case' 0 N--CA 1.515 2.787 0 N-CA-C 116.59 2.07 . . . . 0.0 116.59 175.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.8 mt -59.67 122.85 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.395 0 O-C-N 119.828 -1.795 . . . . 0.0 110.718 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.688 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 90.7 t -100.12 -51.4 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.616 -0.678 . . . . 0.0 111.196 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.16 56.41 20.55 Favored Glycine 0 N--CA 1.499 2.873 0 N-CA-C 107.482 -2.247 . . . . 0.0 107.482 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -71.22 -49.33 44.56 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.942 -0.74 . . . . 0.0 112.325 -177.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 39' ' ' CYS . . . . . 0.635 ' O ' HD13 ' A' ' 356' ' ' LEU . 2.3 p -66.55 -10.46 45.39 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.244 -0.91 . . . . 0.0 112.389 -178.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.82 -5.47 64.01 Favored Glycine 0 N--CA 1.499 2.846 0 O-C-N 120.842 -1.161 . . . . 0.0 111.959 177.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.14 19.52 10.63 Favored Glycine 0 N--CA 1.495 2.569 0 O-C-N 120.845 -1.385 . . . . 0.0 110.974 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 14.0 m -98.95 19.12 15.62 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.033 -1.275 . . . . 0.0 111.148 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.97 40.89 30.35 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.418 -0.801 . . . . 0.0 111.892 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 44' ' ' SER . . . . . 0.408 ' HB3' ' HA ' ' A' ' 354' ' ' SER . 37.4 m -117.05 11.22 14.17 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.345 -0.847 . . . . 0.0 109.523 178.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 45' ' ' CYS . . . . . 0.55 ' HB3' ' HB3' ' B' ' 39' ' ' CYS . 15.1 p -149.54 -179.05 6.78 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.09 34.11 3.09 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.85 -1.156 . . . . 0.0 111.345 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 47' ' ' THR . . . . . 0.688 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 16.9 p -97.63 13.23 30.88 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.947 -1.096 . . . . 0.0 111.243 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 48' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.1 p -120.57 31.75 6.31 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -72.67 133.07 44.45 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.63 -178.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.3 m -146.33 160.11 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 51' ' ' TYR . . . . . 0.419 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.6 m-85 -105.43 102.75 12.2 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.244 -0.91 . . . . 0.0 108.674 178.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.2 t -61.93 135.17 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.226 -0.921 . . . . 0.0 109.351 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.69 131.76 51.24 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.975 0.893 . . . . 0.0 109.539 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.407 ' CD ' ' H ' ' B' ' 54' ' ' GLU . 11.0 mp0 -44.33 -30.98 0.91 Allowed 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -178.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.78 -6.97 54.47 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.982 -1.074 . . . . 0.0 112.75 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -119.87 -6.71 10.06 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.492 -1.38 . . . . 0.0 111.887 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.4 p -55.39 -37.83 68.08 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 121.136 -0.978 . . . . 0.0 112.815 -178.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -81.13 -6.69 59.12 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 120.724 -1.235 . . . . 0.0 111.484 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -89.78 -11.67 41.47 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.974 -1.078 . . . . 0.0 109.878 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -104.08 141.07 21.75 Favored Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -73.8 118.87 5.62 Favored 'Trans proline' 0 N--CA 1.488 1.192 0 O-C-N 123.543 1.286 . . . . 0.0 109.016 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.91 160.64 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.759 0 N-CA-C 116.62 2.081 . . . . 0.0 116.62 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 63' ' ' ALA . . . . . 0.611 ' HB1' ' HB3' ' B' ' 67' ' ' GLU . . . -65.82 146.19 55.06 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.253 178.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -89.79 -170.78 2.93 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.628 -0.67 . . . . 0.0 110.4 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -59.47 -42.07 91.18 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.31 -0.868 . . . . 0.0 111.716 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -41.47 84.5 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.171 -0.955 . . . . 0.0 112.016 -178.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 67' ' ' GLU . . . . . 0.709 ' HG3' HD12 ' B' ' 84' ' ' LEU . 45.5 tt0 -68.25 -43.96 76.71 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.97 -1.081 . . . . 0.0 110.335 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 68' ' ' ILE . . . . . 0.525 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.6 mm -55.58 -42.17 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 121.259 -0.901 . . . . 0.0 109.36 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.17 -47.91 80.35 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 13.7 mmt -66.16 -33.97 76.98 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.252 -1.146 . . . . 0.0 111.159 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 71' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' B' ' 71' ' ' LEU . 27.8 mt -63.53 -23.31 67.34 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.231 -0.918 . . . . 0.0 110.568 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 72' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 49.2 mt-10 -70.46 -8.67 52.85 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.352 -0.842 . . . . 0.0 110.919 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 86.4 p -119.83 12.48 12.12 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.035 -1.04 . . . . 0.0 112.528 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 34.9 m -60.68 140.39 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 O-C-N 120.701 -1.249 . . . . 0.0 109.647 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 24.5 m -74.58 -39.01 62.5 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.446 -0.784 . . . . 0.0 110.192 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.28 168.82 17.53 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.464 -0.773 . . . . 0.0 110.063 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -58.19 139.11 55.56 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.403 -0.811 . . . . 0.0 110.634 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.4 tp -90.97 116.14 28.54 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.535 -0.728 . . . . 0.0 109.89 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -103.03 168.34 8.94 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -76.65 -0.06 10.08 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 O-C-N 123.258 1.136 . . . . 0.0 110.388 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -120.4 22.36 11.32 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.992 -1.067 . . . . 0.0 108.395 176.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 4.3 m -80.83 137.23 36.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.898 -0.501 . . . . 0.0 110.382 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.5 mmm-85 -149.75 146.39 27.17 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 120.06 -0.656 . . . . 0.0 111.458 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.709 HD12 ' HG3' ' B' ' 67' ' ' GLU . 95.2 mt -80.58 98.92 7.84 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 175.076 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 10.5 p -48.33 -17.88 0.18 Allowed 'General case' 0 N--CA 1.508 2.43 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -175.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.9 p -70.32 -13.98 62.39 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.747 -1.221 . . . . 0.0 109.387 178.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -92.69 -12.25 31.97 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.508 -0.745 . . . . 0.0 110.501 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 61.9 mt -91.49 103.9 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.163 -0.961 . . . . 0.0 110.629 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 45.6 mm -84.94 131.78 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 13.6 tpt -74.83 137.74 42.07 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 122.111 0.957 . . . . 0.0 113.266 -177.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 43.7 p -138.17 166.63 24.45 Favored Pre-proline 0 N--CA 1.49 1.558 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 176.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -74.99 1.72 7.42 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 122.643 0.812 . . . . 0.0 110.968 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -87.62 -22.87 24.48 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 176.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.6 mt -93.74 12.95 23.84 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.437 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.44 126.38 23.22 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.201 -0.937 . . . . 0.0 111.148 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.15 6.92 68.45 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.575 -0.822 . . . . 0.0 111.682 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.65 142.74 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-N 119.319 1.559 . . . . 0.0 110.727 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 98' ' ' VAL . . . . . 0.481 HG22 ' HB ' ' B' ' 4' ' ' VAL . 60.7 t -122.52 133.01 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.513 -0.742 . . . . 0.0 109.843 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 16.5 m -130.41 135.74 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.403 -0.811 . . . . 0.0 109.78 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 100' ' ' ASP . . . . . 0.419 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.35 134.18 35.16 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.9 t -103.39 127.31 29.92 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.525 -0.734 . . . . 0.0 110.353 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -80.85 130.92 7.8 Favored 'Trans proline' 0 C--N 1.316 -1.172 0 O-C-N 124.139 1.6 . . . . 0.0 108.319 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 103' ' ' ASP . . . . . 0.432 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.3 p-10 -62.38 3.46 0.19 Allowed 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -178.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -125.32 114.59 19.11 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.256 -1.528 . . . . 0.0 110.067 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 105' ' ' GLN . . . . . 0.5 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 69.4 mm-40 -113.29 -49.35 2.91 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.497 -0.752 . . . . 0.0 109.987 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 106' ' ' TRP . . . . . 0.552 ' CE3' ' HB2' ' A' ' 113' ' ' ALA . 8.0 m95 . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.495 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.514 HD12 ' HD2' ' A' ' 15' ' ' PRO . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 14' ' ' LEU . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.419 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HG2' HG12 ' A' ' 54' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.569 HG12 ' HG2' ' A' ' 51' ' ' PRO . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.609 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.609 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 64' ' ' ILE . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.435 ' HA ' HD23 ' A' ' 324' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.0 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.415 ' CZ ' HG23 ' A' ' 348' ' ' THR . 5.6 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.6 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.458 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 27.4 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.2 mmt-85 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.64 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.2 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.556 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.717 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.717 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 1.068 HD11 ' CZ ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.621 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 74.3 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.64 ' O ' ' HB3' ' A' ' 83' ' ' SER . 3.9 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 46.0 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.646 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.294 50.3 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 104' ' ' ASP 0.366 52.9 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.646 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 34.8 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.451 ' H ' ' CG ' ' A' ' 106' ' ' PRO 0.342 30.7 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.581 ' CG ' HD11 ' A' ' 358' ' ' LEU . 3.0 ttp180 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.528 ' HB2' ' CG ' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.752 HD11 ' HA3' ' A' ' 226' ' ' GLY . 6.7 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.546 ' O ' HG22 ' A' ' 119' ' ' VAL . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.603 ' HA ' HG21 ' A' ' 123' ' ' VAL . 35.0 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.594 HG13 HG23 ' A' ' 118' ' ' VAL . 30.6 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.493 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.698 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 7.0 mtm -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.698 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.1 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.603 HG21 ' HA ' ' A' ' 118' ' ' VAL . 72.7 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 46.0 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.455 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.63 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.412 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.595 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 151' ' ' THR . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.799 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.799 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.441 ' O ' ' HG2' ' A' ' 164' ' ' MET . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.578 ' C ' HD23 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.455 ' N ' HD23 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.425 ' N ' ' HD2' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' HIS . . . . . 0.405 ' O ' ' HG ' ' A' ' 180' ' ' LEU . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.574 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 176' ' ' HIS . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.561 ' HA ' ' HE3' ' A' ' 184' ' ' MET . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' MET . . . . . 0.561 ' HE3' ' HA ' ' A' ' 181' ' ' THR . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.421 HD22 ' HE1' ' A' ' 184' ' ' MET . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ARG . . . . . 0.453 ' HG3' ' HB1' ' A' ' 224' ' ' ALA . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 220' ' ' ILE . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 42.5 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 42.0 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.453 ' HB1' ' HG3' ' A' ' 212' ' ' ARG . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.752 ' HA3' HD11 ' A' ' 114' ' ' LEU . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 4.3 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 13.5 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' ARG . . . . . 1.068 ' CZ ' HD11 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 41.0 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.717 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.487 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' MET . . . . . 0.595 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 16.4 pm0 -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.437 ' N ' ' HD2' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 282' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 285' ' ' CYS . . . . . . . . . . . . . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 288' ' ' LEU . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.706 HD23 ' H ' ' A' ' 294' ' ' LEU . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 298' ' ' GLY . . . . . 0.419 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 299' ' ' ARG . . . . . 0.419 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.0 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.459 ' HA ' HD13 ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 314' ' ' LYS . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 307' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.6 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 308' ' ' HIS . . . . . 0.425 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 36.9 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 314' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 303' ' ' SER . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 318' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 318' ' ' ILE . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 319' ' ' LEU . . . . . 0.647 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 321' ' ' PRO . . . . . 0.68 ' HG2' HD22 ' A' ' 324' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.68 HD22 ' HG2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 13.7 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 327' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 327' ' ' LEU . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.522 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 335' ' ' PRO . . . . . 0.522 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 343' ' ' GLN . . . . . 0.46 ' CB ' ' HD3' ' A' ' 344' ' ' LYS . 1.9 mp0 -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 344' ' ' LYS . . . . . 0.504 ' HB2' ' HE2' ' A' ' 344' ' ' LYS . 1.7 mppt? -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 57.8 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 22.1 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 348' ' ' THR . . . . . 0.415 HG23 ' CZ ' ' A' ' 72' ' ' ARG . 16.5 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 349' ' ' THR . . . . . . . . . . . . . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 92.6 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 356' ' ' LEU . . . . . 0.583 HD13 ' O ' ' B' ' 39' ' ' CYS . 1.0 OUTLIER -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 358' ' ' LEU . . . . . 0.581 HD11 ' CG ' ' A' ' 112' ' ' ARG . 0.4 OUTLIER -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 39.3 mtt85 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 17.2 tpp85 -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 68.2 mm-40 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 412' ' ' LYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 39.6 m . . . . . 0 N--CA 1.495 1.807 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.53 138.58 38.47 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.181 -0.949 . . . . 0.0 112.927 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 3' ' ' VAL . . . . . 0.733 HG11 HD22 ' B' ' 23' ' ' LEU . 61.3 t -137.11 122.6 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 177.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.524 HG11 ' CZ ' ' B' ' 12' ' ' ARG . 97.5 t -106.77 129.52 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.139 -0.976 . . . . 0.0 111.649 -178.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.679 ' CG ' HD13 ' B' ' 32' ' ' ILE . 77.1 m-85 -109.21 110.62 21.88 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 39.7 t -94.77 127.2 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.925 -1.109 . . . . 0.0 108.439 178.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.6 m -86.14 174.71 8.96 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.768 0.794 . . . . 0.0 112.493 -177.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 8' ' ' HIS . . . . . 0.422 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.65 -46.77 89.04 Favored 'General case' 0 N--CA 1.503 2.19 0 CA-C-O 121.193 0.521 . . . . 0.0 110.448 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -65.92 -11.22 45.61 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.544 -0.723 . . . . 0.0 111.425 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.97 15.46 28.48 Favored Glycine 0 N--CA 1.492 2.385 0 O-C-N 121.147 -0.971 . . . . 0.0 111.256 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.4 m -82.07 147.37 29.15 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 118.773 1.287 . . . . 0.0 109.903 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 12' ' ' ARG . . . . . 0.524 ' CZ ' HG11 ' B' ' 4' ' ' VAL . 50.8 ttt85 -118.49 128.77 54.91 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.529 -0.732 . . . . 0.0 111.829 -178.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 13' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' B' ' 13' ' ' ARG . 0.0 OUTLIER -126.01 127.73 46.34 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.554 -0.716 . . . . 0.0 109.79 179.11 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.3 tt0 -111.35 130.66 55.61 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.29 -0.881 . . . . 0.0 111.591 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 85.0 mt -122.79 159.35 28.27 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.754 -0.591 . . . . 0.0 111.114 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -109.62 91.68 3.74 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.7 t -90.27 133.45 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-O 121.688 0.756 . . . . 0.0 112.248 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.08 170.67 16.12 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.706 -0.621 . . . . 0.0 110.262 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -68.46 151.81 46.29 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.532 -0.73 . . . . 0.0 110.967 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.41 -12.46 55.35 Favored Glycine 0 N--CA 1.495 2.629 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.067 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 59.1 t -89.99 133.33 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 120.69 -1.476 . . . . 0.0 110.936 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 21.7 p -80.29 151.94 29.28 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.568 -0.707 . . . . 0.0 109.145 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.733 HD22 HG11 ' B' ' 3' ' ' VAL . 18.5 mt -61.21 -24.63 66.48 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.297 -0.877 . . . . 0.0 110.605 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 7.6 tmm? -69.7 -49.28 54.92 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.235 -0.916 . . . . 0.0 109.5 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -59.81 -41.71 91.87 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.619 -0.675 . . . . 0.0 109.913 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.1 -40.87 95.19 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.631 -0.668 . . . . 0.0 110.121 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' ALA . . . . . 0.73 ' HA ' HD12 ' B' ' 32' ' ' ILE . . . -68.33 -49.77 58.02 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.262 -0.899 . . . . 0.0 111.055 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 51.0 t -65.45 -39.12 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.349 -0.844 . . . . 0.0 110.744 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 15.8 t -70.15 -14.01 62.45 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.41 -0.806 . . . . 0.0 111.503 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -118.14 23.78 11.39 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.024 -1.048 . . . . 0.0 110.664 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.72 38.23 58.67 Favored Glycine 0 N--CA 1.493 2.469 0 O-C-N 121.532 -0.73 . . . . 0.0 111.876 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.73 HD12 ' HA ' ' B' ' 27' ' ' ALA . 1.7 mt -72.49 147.11 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.882 -1.364 . . . . 0.0 108.887 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.66 142.44 58.08 Favored 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 117.214 2.302 . . . . 0.0 117.214 -174.349 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 62.29 -36.18 0.12 Allowed 'General case' 0 N--CA 1.516 2.831 0 N-CA-C 116.612 2.079 . . . . 0.0 116.612 175.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 84.2 mt -59.67 122.85 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.401 0 O-C-N 119.85 -1.781 . . . . 0.0 110.672 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.535 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 84.4 t -100.15 -51.39 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.595 -0.691 . . . . 0.0 111.237 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.15 56.48 20.18 Favored Glycine 0 N--CA 1.499 2.866 0 N-CA-C 107.472 -2.251 . . . . 0.0 107.472 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -71.32 -49.33 43.73 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.985 -0.715 . . . . 0.0 112.259 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 39' ' ' CYS . . . . . 0.583 ' O ' HD13 ' A' ' 356' ' ' LEU . 2.3 p -66.5 -10.49 45.2 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.201 -0.937 . . . . 0.0 112.351 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 40' ' ' GLY . . . . . 0.454 ' CA ' HD22 ' A' ' 356' ' ' LEU . . . 96.81 -5.45 64.01 Favored Glycine 0 N--CA 1.497 2.731 0 O-C-N 120.825 -1.172 . . . . 0.0 111.973 177.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.07 19.57 10.63 Favored Glycine 0 N--CA 1.495 2.584 0 O-C-N 120.77 -1.429 . . . . 0.0 110.985 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 87.1 p -99.02 19.23 15.51 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.054 -1.263 . . . . 0.0 111.141 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.94 40.85 30.41 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.383 -0.823 . . . . 0.0 111.918 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.0 11.14 14.2 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.31 -0.868 . . . . 0.0 109.562 178.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 45' ' ' CYS . . . . . 0.552 ' HB3' ' HB3' ' B' ' 39' ' ' CYS . 15.1 p -149.48 -179.1 6.82 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.522 -0.736 . . . . 0.0 109.102 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.06 34.09 3.1 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.86 -1.15 . . . . 0.0 111.411 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 47' ' ' THR . . . . . 0.535 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 72.7 p -97.6 13.31 30.57 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.962 -1.086 . . . . 0.0 111.299 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 48' ' ' CYS . . . . . 0.441 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.3 p -120.58 31.74 6.31 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 23.9 t-160 -72.67 133.08 44.45 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.589 -178.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.2 m -146.29 160.06 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 51' ' ' TYR . . . . . 0.413 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.4 m-85 -105.39 102.7 12.16 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.265 -0.897 . . . . 0.0 108.721 178.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.7 t -61.84 135.08 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 121.321 -0.862 . . . . 0.0 109.354 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.61 131.77 51.23 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.983 0.897 . . . . 0.0 109.542 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.416 ' H ' ' CD ' ' B' ' 54' ' ' GLU . 11.0 mp0 -44.3 -31.06 0.92 Allowed 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -178.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.77 -6.92 54.23 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.017 -1.052 . . . . 0.0 112.75 -178.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -119.89 -6.71 10.04 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 120.488 -1.383 . . . . 0.0 111.884 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.5 p -55.38 -37.83 68.07 Favored 'General case' 0 N--CA 1.507 2.406 0 O-C-N 121.173 -0.955 . . . . 0.0 112.835 -178.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 -81.14 -6.66 59.08 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.728 -1.232 . . . . 0.0 111.426 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -89.9 -11.57 41.47 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.033 -1.042 . . . . 0.0 109.872 178.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -104.08 141.02 21.65 Favored Pre-proline 0 N--CA 1.488 1.462 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.79 118.84 5.61 Favored 'Trans proline' 0 N--CA 1.488 1.173 0 O-C-N 123.448 1.236 . . . . 0.0 109.026 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.87 160.61 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.77 0 N-CA-C 116.692 2.108 . . . . 0.0 116.692 -177.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 63' ' ' ALA . . . . . 0.614 ' HB1' ' HB3' ' B' ' 67' ' ' GLU . . . -65.82 146.13 55.13 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.245 178.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -89.7 -170.78 2.94 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.589 -0.694 . . . . 0.0 110.428 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -59.56 -41.98 91.4 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.321 -0.862 . . . . 0.0 111.748 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.41 -41.57 84.69 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.186 -0.946 . . . . 0.0 112.043 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 67' ' ' GLU . . . . . 0.623 ' HG3' HD12 ' B' ' 84' ' ' LEU . 45.4 tt0 -68.19 -44.03 76.79 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.98 -1.075 . . . . 0.0 110.317 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 68' ' ' ILE . . . . . 0.527 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.6 mm -55.56 -42.21 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.285 -0.884 . . . . 0.0 109.326 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.16 -47.88 80.71 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 12.5 mmt -66.22 -33.91 76.83 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.273 -1.133 . . . . 0.0 111.182 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 71' ' ' LEU . . . . . 0.432 ' HA ' HD23 ' B' ' 71' ' ' LEU . 27.9 mt -63.48 -23.33 67.35 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.214 -0.928 . . . . 0.0 110.616 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 72' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 49.9 mt-10 -70.44 -8.76 53.46 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.366 -0.834 . . . . 0.0 110.875 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 82.7 p -119.83 12.56 12.14 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.053 -1.029 . . . . 0.0 112.548 -178.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 22.3 m -60.76 140.35 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 120.739 -1.225 . . . . 0.0 109.668 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 13.9 m -74.53 -39.02 62.62 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.449 -0.782 . . . . 0.0 110.195 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.24 168.81 17.5 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.428 -0.795 . . . . 0.0 110.106 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.28 139.11 55.75 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.388 -0.82 . . . . 0.0 110.563 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.3 tp -90.93 116.14 28.51 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.494 -0.754 . . . . 0.0 109.935 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -102.99 168.35 8.93 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -76.64 0.01 10.01 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 O-C-N 123.219 1.115 . . . . 0.0 110.434 178.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -120.5 22.38 11.27 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.941 -1.099 . . . . 0.0 108.406 176.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 4.3 m -80.81 137.21 36.21 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.832 -0.542 . . . . 0.0 110.367 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.3 mmm-85 -149.78 146.42 27.16 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 120.059 -0.657 . . . . 0.0 111.448 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.623 HD12 ' HG3' ' B' ' 67' ' ' GLU . 95.9 mt -80.61 98.97 7.89 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 104.784 -2.302 . . . . 0.0 104.784 175.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 85' ' ' CYS . . . . . 0.41 ' HB2' ' HB2' ' B' ' 23' ' ' LEU . 10.6 p -48.36 -17.86 0.18 Allowed 'General case' 0 N--CA 1.508 2.443 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -175.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.8 p -70.33 -14.0 62.39 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.669 -1.269 . . . . 0.0 109.389 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 59.2 mm-40 -92.72 -12.23 31.92 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.512 -0.742 . . . . 0.0 110.534 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 61.7 mt -91.52 103.97 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.194 -0.941 . . . . 0.0 110.647 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 45.7 mm -85.03 131.75 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 13.6 tpt -74.82 137.76 42.11 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 122.101 0.953 . . . . 0.0 113.243 -177.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 43.6 p -138.16 166.61 24.62 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 176.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -74.98 1.78 7.35 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 122.663 0.823 . . . . 0.0 111.025 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -87.67 -22.81 24.45 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 176.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.3 mt -93.8 13.04 23.69 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.427 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.5 126.4 23.4 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.122 -0.986 . . . . 0.0 111.142 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.22 6.79 68.45 Favored Glycine 0 N--CA 1.492 2.416 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.725 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.61 142.75 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 CA-C-N 119.263 1.532 . . . . 0.0 110.789 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 98' ' ' VAL . . . . . 0.471 HG22 ' HB ' ' B' ' 4' ' ' VAL . 60.9 t -122.49 132.96 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.561 -0.712 . . . . 0.0 109.856 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 16.5 m -130.33 135.73 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.47 -0.769 . . . . 0.0 109.877 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 100' ' ' ASP . . . . . 0.413 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.38 134.14 35.22 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.6 t -103.33 127.31 29.96 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.535 -0.728 . . . . 0.0 110.377 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -80.9 131.0 7.79 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 O-C-N 124.079 1.568 . . . . 0.0 108.286 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 103' ' ' ASP . . . . . 0.422 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.4 p-10 -62.47 3.44 0.2 Allowed 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -178.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -125.28 114.64 19.2 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.288 -1.508 . . . . 0.0 110.088 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 105' ' ' GLN . . . . . 0.505 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 32.6 mm-40 -113.31 -49.35 2.91 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.455 -0.778 . . . . 0.0 110.007 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 106' ' ' TRP . . . . . 0.528 ' CG ' ' HB2' ' A' ' 113' ' ' ALA . 10.3 m0 . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.53 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.514 HD12 ' HD2' ' A' ' 15' ' ' PRO . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 14' ' ' LEU . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.419 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HG2' HG12 ' A' ' 54' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.569 HG12 ' HG2' ' A' ' 51' ' ' PRO . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.609 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.609 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 64' ' ' ILE . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.435 ' HA ' HD23 ' A' ' 324' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.0 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.6 mtt180 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.5 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.552 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 25.8 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 84.1 mtt-85 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.8 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.64 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.1 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.556 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.717 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.717 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 1.068 HD11 ' CZ ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.621 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 74.3 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.64 ' O ' ' HB3' ' A' ' 83' ' ' SER . 3.9 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 46.0 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.605 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.298 63.0 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.552 ' HD2' ' CD1' ' A' ' 78' ' ' TYR 0.367 53.3 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.605 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 33.9 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.452 ' H ' ' CD ' ' A' ' 106' ' ' PRO 0.413 34.1 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 15.6 tpt85 -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 5.5 ttt-85 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.478 ' HB2' ' CE3' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.766 HD11 ' HA3' ' A' ' 226' ' ' GLY . 4.2 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.546 ' O ' HG22 ' A' ' 119' ' ' VAL . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.539 ' HA ' ' CD2' ' A' ' 358' ' ' LEU . 23.3 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.603 ' HA ' HG21 ' A' ' 123' ' ' VAL . 35.0 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.595 HG13 HG23 ' A' ' 118' ' ' VAL . 30.6 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.493 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.698 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 12.4 mtm -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.698 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.1 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.603 HG21 ' HA ' ' A' ' 118' ' ' VAL . 72.7 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.2 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.455 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.63 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.412 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.595 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 151' ' ' THR . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.799 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.799 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.441 ' O ' ' HG2' ' A' ' 164' ' ' MET . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.578 ' C ' HD23 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.455 ' N ' HD23 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.425 ' N ' ' HD2' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' HIS . . . . . 0.405 ' O ' ' HG ' ' A' ' 180' ' ' LEU . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.574 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 176' ' ' HIS . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.561 ' HA ' ' HE3' ' A' ' 184' ' ' MET . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' MET . . . . . 0.561 ' HE3' ' HA ' ' A' ' 181' ' ' THR . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.421 HD22 ' HE1' ' A' ' 184' ' ' MET . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ARG . . . . . 0.453 ' HG3' ' HB1' ' A' ' 224' ' ' ALA . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 220' ' ' ILE . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 43.5 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 42.0 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.453 ' HB1' ' HG3' ' A' ' 212' ' ' ARG . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.766 ' HA3' HD11 ' A' ' 114' ' ' LEU . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 6.9 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 2.6 m120 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 17.1 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' ARG . . . . . 1.068 ' CZ ' HD11 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 34.2 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.717 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.487 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' MET . . . . . 0.595 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 16.4 pm0 -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.437 ' N ' ' HD2' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 282' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 285' ' ' CYS . . . . . . . . . . . . . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 288' ' ' LEU . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.706 HD23 ' H ' ' A' ' 294' ' ' LEU . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 298' ' ' GLY . . . . . 0.419 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 299' ' ' ARG . . . . . 0.419 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.0 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.459 ' HA ' HD13 ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 314' ' ' LYS . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 307' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.6 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 308' ' ' HIS . . . . . 0.425 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 36.9 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 314' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 303' ' ' SER . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 318' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 318' ' ' ILE . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 319' ' ' LEU . . . . . 0.647 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 321' ' ' PRO . . . . . 0.68 ' HG2' HD22 ' A' ' 324' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.68 HD22 ' HG2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 14.7 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 327' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 327' ' ' LEU . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.522 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 335' ' ' PRO . . . . . 0.522 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 99.3 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 8.8 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 45.1 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 349' ' ' THR . . . . . . . . . . . . . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 353' ' ' GLY . . . . . 0.413 ' O ' HD12 ' A' ' 356' ' ' LEU . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 91.4 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 356' ' ' LEU . . . . . 0.57 HD13 ' O ' ' B' ' 39' ' ' CYS . 0.3 OUTLIER -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 358' ' ' LEU . . . . . 0.539 ' CD2' ' HA ' ' A' ' 116' ' ' ASN . 0.6 OUTLIER -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 44.1 mtt85 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 16.6 tpp85 -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.2 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 68.2 mm-40 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 412' ' ' LYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 N--CA 1.495 1.815 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.49 138.58 38.5 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.181 -0.949 . . . . 0.0 112.936 -178.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 3' ' ' VAL . . . . . 0.744 HG11 HD22 ' B' ' 23' ' ' LEU . 61.3 t -137.12 122.59 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 177.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.526 HG11 ' CZ ' ' B' ' 12' ' ' ARG . 97.8 t -106.79 129.56 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.109 -0.994 . . . . 0.0 111.635 -178.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.504 ' CG ' HD13 ' B' ' 32' ' ' ILE . 77.1 m-85 -109.23 110.63 21.89 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 40.0 t -94.84 127.25 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.88 -1.138 . . . . 0.0 108.345 178.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.4 m -86.15 174.69 8.97 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.747 0.784 . . . . 0.0 112.499 -177.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 8' ' ' HIS . . . . . 0.427 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.68 -46.8 88.99 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-O 121.129 0.49 . . . . 0.0 110.418 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -65.83 -11.29 45.24 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.56 -0.712 . . . . 0.0 111.405 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.94 15.47 28.53 Favored Glycine 0 N--CA 1.492 2.368 0 O-C-N 121.163 -0.961 . . . . 0.0 111.312 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.1 m -82.09 147.4 29.12 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 118.723 1.261 . . . . 0.0 109.875 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 12' ' ' ARG . . . . . 0.526 ' CZ ' HG11 ' B' ' 4' ' ' VAL . 50.8 ttt85 -118.46 128.82 54.97 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.476 -0.765 . . . . 0.0 111.803 -178.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 13' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' B' ' 13' ' ' ARG . 0.0 OUTLIER -126.08 127.73 46.27 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.608 -0.683 . . . . 0.0 109.8 179.084 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.3 tt0 -111.37 130.61 55.63 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.236 -0.915 . . . . 0.0 111.623 -178.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 84.5 mt -122.8 159.38 28.21 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.732 -0.605 . . . . 0.0 111.075 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -109.63 91.63 3.72 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.8 t -90.2 133.47 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-O 121.625 0.726 . . . . 0.0 112.233 -176.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.09 170.7 16.05 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.784 -0.572 . . . . 0.0 110.266 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -68.47 151.79 46.31 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.503 -0.748 . . . . 0.0 110.965 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.5 -12.52 55.53 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.021 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 91.4 t -89.97 133.36 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 120.696 -1.473 . . . . 0.0 110.933 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 88.5 p -80.25 151.86 29.38 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.523 -0.736 . . . . 0.0 109.129 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.744 HD22 HG11 ' B' ' 3' ' ' VAL . 18.4 mt -61.2 -24.68 66.5 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.29 -0.881 . . . . 0.0 110.549 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 2.1 ttp -69.7 -49.24 55.27 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.186 -0.946 . . . . 0.0 109.474 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.81 -41.7 91.82 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.622 -0.674 . . . . 0.0 109.926 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.13 -40.87 95.05 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.607 -0.683 . . . . 0.0 110.099 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' ALA . . . . . 0.583 ' HA ' HD12 ' B' ' 32' ' ' ILE . . . -68.33 -49.79 57.89 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.254 -0.903 . . . . 0.0 111.023 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 71.8 t -65.41 -39.19 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.266 -0.896 . . . . 0.0 110.737 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 15.5 t -70.06 -14.08 62.51 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.342 -0.849 . . . . 0.0 111.562 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -118.13 23.84 11.36 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.016 -1.052 . . . . 0.0 110.658 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.65 38.31 58.55 Favored Glycine 0 N--CA 1.492 2.418 0 O-C-N 121.539 -0.725 . . . . 0.0 111.85 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.583 HD12 ' HA ' ' B' ' 27' ' ' ALA . 0.4 OUTLIER -72.55 147.13 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.829 -1.395 . . . . 0.0 108.875 178.991 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -62.7 142.52 58.08 Favored 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 -174.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 62.19 -36.14 0.12 Allowed 'General case' 0 N--CA 1.515 2.785 0 N-CA-C 116.693 2.108 . . . . 0.0 116.693 175.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.524 HD12 ' CG2' ' B' ' 32' ' ' ILE . 12.1 mt -59.7 122.9 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 O-C-N 119.879 -1.763 . . . . 0.0 110.656 -178.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.663 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 58.0 t -100.14 -51.41 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.626 -0.671 . . . . 0.0 111.192 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.17 56.42 20.52 Favored Glycine 0 N--CA 1.499 2.895 0 N-CA-C 107.478 -2.249 . . . . 0.0 107.478 -178.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -71.29 -49.28 44.51 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.983 -0.716 . . . . 0.0 112.279 -177.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 39' ' ' CYS . . . . . 0.57 ' O ' HD13 ' A' ' 356' ' ' LEU . 2.3 p -66.55 -10.48 45.57 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.209 -0.932 . . . . 0.0 112.351 -178.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.82 -5.59 64.08 Favored Glycine 0 N--CA 1.499 2.846 0 O-C-N 120.808 -1.183 . . . . 0.0 112.013 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.16 19.56 10.59 Favored Glycine 0 N--CA 1.495 2.628 0 O-C-N 120.856 -1.379 . . . . 0.0 110.98 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 9.4 t -98.98 19.14 15.63 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.072 -1.251 . . . . 0.0 111.147 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.98 40.84 30.34 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.45 -0.781 . . . . 0.0 111.935 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 44' ' ' SER . . . . . 0.429 ' OG ' ' HB2' ' B' ' 39' ' ' CYS . 2.1 p -117.04 11.23 14.19 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.301 -0.875 . . . . 0.0 109.547 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 45' ' ' CYS . . . . . 0.56 ' HB3' ' HB3' ' B' ' 39' ' ' CYS . 15.0 p -149.55 -179.11 6.83 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.04 34.08 3.11 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.879 -1.138 . . . . 0.0 111.339 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 47' ' ' THR . . . . . 0.663 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 23.0 p -97.6 13.24 30.81 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.978 -1.076 . . . . 0.0 111.268 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 48' ' ' CYS . . . . . 0.444 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.1 p -120.55 31.74 6.31 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 177.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 23.9 t-160 -72.68 133.01 44.42 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.612 -178.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.4 m -146.24 160.14 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 51' ' ' TYR . . . . . 0.414 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.5 m-85 -105.46 102.76 12.21 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.262 -0.899 . . . . 0.0 108.699 178.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.2 t -61.92 135.13 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 121.296 -0.878 . . . . 0.0 109.34 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.64 131.7 51.03 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.945 0.878 . . . . 0.0 109.525 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.413 ' H ' ' CD ' ' B' ' 54' ' ' GLU . 11.1 mp0 -44.21 -31.12 0.9 Allowed 'General case' 0 N--CA 1.506 2.343 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -178.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.73 -6.93 54.23 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.019 -1.051 . . . . 0.0 112.796 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -119.92 -6.68 10.03 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 120.416 -1.427 . . . . 0.0 111.86 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.4 p -55.39 -37.85 68.12 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.132 -0.98 . . . . 0.0 112.846 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -81.1 -6.66 59.07 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.711 -1.243 . . . . 0.0 111.49 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -89.88 -11.61 41.4 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.986 -1.071 . . . . 0.0 109.848 178.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.8 t -104.08 141.01 21.63 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -73.77 118.84 5.61 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 O-C-N 123.496 1.261 . . . . 0.0 108.983 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.9 160.59 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.75 0 N-CA-C 116.656 2.095 . . . . 0.0 116.656 -177.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 63' ' ' ALA . . . . . 0.615 ' HB1' ' HB3' ' B' ' 67' ' ' GLU . . . -65.73 146.14 55.14 Favored 'General case' 0 N--CA 1.503 2.178 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.266 178.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -89.78 -170.81 2.94 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.602 -0.686 . . . . 0.0 110.383 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -59.54 -42.02 91.39 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.329 -0.857 . . . . 0.0 111.708 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.45 -41.52 84.57 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.158 -0.964 . . . . 0.0 112.045 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 67' ' ' GLU . . . . . 0.615 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 45.5 tt0 -68.21 -43.92 76.93 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.954 -1.091 . . . . 0.0 110.343 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 68' ' ' ILE . . . . . 0.529 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.6 mm -55.63 -42.08 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.278 -0.889 . . . . 0.0 109.379 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.24 -47.87 80.44 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 28.5 mmt -66.17 -33.97 76.98 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.275 -1.132 . . . . 0.0 111.226 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 71' ' ' LEU . . . . . 0.447 ' HA ' HD23 ' B' ' 71' ' ' LEU . 28.1 mt -63.47 -23.33 67.35 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.217 -0.927 . . . . 0.0 110.622 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 72' ' ' GLU . . . . . 0.529 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 66.4 mt-10 -70.41 -8.72 53.02 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.339 -0.851 . . . . 0.0 110.926 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 84.8 p -119.91 12.6 12.09 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.008 -1.057 . . . . 0.0 112.461 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 19.4 m -60.84 140.44 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 O-C-N 120.692 -1.255 . . . . 0.0 109.653 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 25.4 m -74.58 -39.09 62.45 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.387 -0.821 . . . . 0.0 110.153 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.18 168.83 17.4 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.464 -0.773 . . . . 0.0 110.073 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.28 139.16 55.67 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.395 -0.815 . . . . 0.0 110.587 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.4 tp -90.95 116.11 28.5 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.498 -0.751 . . . . 0.0 109.907 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -102.94 168.37 8.91 Favored Pre-proline 0 C--N 1.302 -1.5 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -76.71 0.04 9.99 Favored 'Trans proline' 0 C--N 1.314 -1.255 0 O-C-N 123.279 1.147 . . . . 0.0 110.371 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -120.5 22.3 11.3 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.969 -1.082 . . . . 0.0 108.411 176.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 4.3 m -80.77 137.25 36.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.845 -0.534 . . . . 0.0 110.35 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.5 mmm-85 -149.77 146.41 27.16 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.446 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.444 ' HB3' ' SG ' ' B' ' 48' ' ' CYS . 78.4 mt -80.55 99.0 7.86 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 175.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 85' ' ' CYS . . . . . 0.405 ' HB2' ' HB2' ' B' ' 23' ' ' LEU . 11.3 p -48.5 -17.82 0.19 Allowed 'General case' 0 N--CA 1.508 2.439 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -175.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.8 p -70.28 -13.99 62.4 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.714 -1.241 . . . . 0.0 109.459 178.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -92.73 -12.25 31.87 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.489 -0.757 . . . . 0.0 110.545 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 61.7 mt -91.47 104.02 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.195 -0.941 . . . . 0.0 110.625 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 39.2 mm -85.04 131.78 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 13.8 tpt -74.85 137.84 42.1 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 122.126 0.965 . . . . 0.0 113.229 -177.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 43.7 p -138.23 166.57 24.8 Favored Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 176.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -74.92 1.71 7.39 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 O-C-N 122.683 0.833 . . . . 0.0 111.042 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -87.64 -22.82 24.48 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 176.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.7 mt -93.75 12.96 23.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.982 -0.449 . . . . 0.0 110.422 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -54.48 126.36 23.21 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.111 -0.993 . . . . 0.0 111.164 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.21 6.89 68.34 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.669 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.68 142.79 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 CA-C-N 119.36 1.58 . . . . 0.0 110.715 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 98' ' ' VAL . . . . . 0.48 HG22 ' HB ' ' B' ' 4' ' ' VAL . 60.7 t -122.53 133.01 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.532 -0.73 . . . . 0.0 109.819 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 16.5 m -130.41 135.78 59.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.489 -0.757 . . . . 0.0 109.798 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 100' ' ' ASP . . . . . 0.414 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.44 134.17 35.2 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.7 t -103.39 127.27 30.01 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.5 -0.75 . . . . 0.0 110.368 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -80.77 130.92 7.89 Favored 'Trans proline' 0 C--N 1.316 -1.168 0 O-C-N 124.064 1.56 . . . . 0.0 108.268 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 103' ' ' ASP . . . . . 0.427 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.4 p-10 -62.42 3.42 0.19 Allowed 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -178.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 39.5 mtm180 -125.32 114.66 19.2 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.306 -1.496 . . . . 0.0 110.061 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 105' ' ' GLN . . . . . 0.502 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 62.7 mm-40 -113.3 -49.39 2.91 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.497 -0.752 . . . . 0.0 109.954 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 106' ' ' TRP . . . . . 0.522 ' HA ' ' CE3' ' B' ' 106' ' ' TRP . 4.9 m95 . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.522 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.514 HD12 ' HD2' ' A' ' 15' ' ' PRO . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 14' ' ' LEU . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.419 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HG2' HG12 ' A' ' 54' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.569 HG12 ' HG2' ' A' ' 51' ' ' PRO . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.609 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.609 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 64' ' ' ILE . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.435 ' HA ' HD23 ' A' ' 324' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.0 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.9 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.5 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.484 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 24.3 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.5 mtm180 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.64 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.2 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.556 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.717 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.717 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 1.068 HD11 ' CZ ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 005 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.621 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 74.3 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.64 ' O ' ' HB3' ' A' ' 83' ' ' SER . 3.9 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 46.0 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.647 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.296 50.1 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 104' ' ' ASP 0.366 52.6 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.647 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 35.0 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.452 ' H ' ' CG ' ' A' ' 106' ' ' PRO 0.413 34.1 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.789 ' HB2' ' CD2' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.685 HD11 ' HA3' ' A' ' 226' ' ' GLY . 24.8 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.546 ' O ' HG22 ' A' ' 119' ' ' VAL . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.603 ' HA ' HG21 ' A' ' 123' ' ' VAL . 35.1 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.593 HG13 HG23 ' A' ' 118' ' ' VAL . 30.6 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.493 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.697 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 37.1 mtm -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.697 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.1 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.603 HG21 ' HA ' ' A' ' 118' ' ' VAL . 72.0 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.7 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.452 ' HD2' ' HA ' ' A' ' 123' ' ' VAL . 35.6 mttt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.455 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.63 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.412 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.595 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 151' ' ' THR . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.799 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.799 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.441 ' O ' ' HG2' ' A' ' 164' ' ' MET . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.578 ' C ' HD23 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.455 ' N ' HD23 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.425 ' N ' ' HD2' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' HIS . . . . . 0.405 ' O ' ' HG ' ' A' ' 180' ' ' LEU . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.574 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 176' ' ' HIS . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.561 ' HA ' ' HE3' ' A' ' 184' ' ' MET . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' MET . . . . . 0.561 ' HE3' ' HA ' ' A' ' 181' ' ' THR . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.421 HD22 ' HE1' ' A' ' 184' ' ' MET . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ARG . . . . . 0.453 ' HG3' ' HB1' ' A' ' 224' ' ' ALA . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 220' ' ' ILE . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 33.3 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 53.1 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.453 ' HB1' ' HG3' ' A' ' 212' ' ' ARG . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.685 ' HA3' HD11 ' A' ' 114' ' ' LEU . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 4.6 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 1.1 m120 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 18.1 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' ARG . . . . . 1.068 ' CZ ' HD11 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 45.4 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.717 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.487 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' MET . . . . . 0.595 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.437 ' N ' ' HD2' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 282' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 285' ' ' CYS . . . . . . . . . . . . . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 288' ' ' LEU . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.706 HD23 ' H ' ' A' ' 294' ' ' LEU . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 298' ' ' GLY . . . . . 0.419 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 299' ' ' ARG . . . . . 0.419 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.0 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.459 ' HA ' HD13 ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 314' ' ' LYS . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 307' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.6 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 308' ' ' HIS . . . . . 0.425 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 36.9 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 314' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 303' ' ' SER . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 318' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 318' ' ' ILE . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 319' ' ' LEU . . . . . 0.647 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 321' ' ' PRO . . . . . 0.68 ' HG2' HD22 ' A' ' 324' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.68 HD22 ' HG2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 13.7 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 327' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 327' ' ' LEU . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.522 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 335' ' ' PRO . . . . . 0.522 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 343' ' ' GLN . . . . . 0.466 ' CB ' ' HD3' ' A' ' 344' ' ' LYS . 1.9 mp0 -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 344' ' ' LYS . . . . . 0.524 ' HB2' ' HE2' ' A' ' 344' ' ' LYS . 1.5 mppt? -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 60.6 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 28.9 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 14.2 p80 -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 39.6 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 349' ' ' THR . . . . . . . . . . . . . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 99.6 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 356' ' ' LEU . . . . . 0.681 HD12 ' O ' ' B' ' 39' ' ' CYS . 0.1 OUTLIER -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 2.9 mt -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 35.9 mtt85 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 68.2 mm-40 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 412' ' ' LYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 N--CA 1.496 1.853 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.49 138.62 38.53 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.226 -0.921 . . . . 0.0 112.939 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 3' ' ' VAL . . . . . 0.738 HG11 HD22 ' B' ' 23' ' ' LEU . 61.3 t -137.13 122.59 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.528 HG11 ' CZ ' ' B' ' 12' ' ' ARG . 97.4 t -106.81 129.54 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.149 -0.969 . . . . 0.0 111.654 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.511 ' CG ' HD13 ' B' ' 32' ' ' ILE . 77.2 m-85 -109.19 110.53 21.77 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.78 127.25 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.922 -1.111 . . . . 0.0 108.421 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.9 m -86.19 174.64 8.98 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.782 0.801 . . . . 0.0 112.481 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 8' ' ' HIS . . . . . 0.427 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.61 -46.73 89.17 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-O 121.145 0.497 . . . . 0.0 110.467 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -65.94 -11.29 46.33 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.552 -0.718 . . . . 0.0 111.416 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.02 15.5 28.25 Favored Glycine 0 N--CA 1.492 2.421 0 O-C-N 121.103 -0.998 . . . . 0.0 111.218 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.3 m -82.14 147.36 29.08 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 118.773 1.286 . . . . 0.0 109.874 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 12' ' ' ARG . . . . . 0.528 ' CZ ' HG11 ' B' ' 4' ' ' VAL . 50.9 ttt85 -118.46 128.75 54.9 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.434 -0.791 . . . . 0.0 111.832 -178.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 13' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' B' ' 13' ' ' ARG . 0.0 OUTLIER -126.04 127.68 46.24 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.575 -0.703 . . . . 0.0 109.792 179.11 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -111.29 130.62 55.61 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.282 -0.887 . . . . 0.0 111.64 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 84.5 mt -122.77 159.39 28.13 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.741 -0.6 . . . . 0.0 111.107 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -109.66 91.65 3.73 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 176.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.5 t -90.17 133.4 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 CA-C-O 121.605 0.717 . . . . 0.0 112.271 -176.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.13 170.67 16.11 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.812 -0.555 . . . . 0.0 110.257 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -68.36 151.78 46.38 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.491 -0.756 . . . . 0.0 111.01 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.46 -12.46 55.52 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.997 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 60.1 t -89.97 133.27 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 120.691 -1.476 . . . . 0.0 110.932 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 21.2 p -80.22 151.89 29.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.544 -0.723 . . . . 0.0 109.142 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.738 HD22 HG11 ' B' ' 3' ' ' VAL . 18.5 mt -61.15 -24.64 66.44 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.362 -0.836 . . . . 0.0 110.619 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 6.3 ttp -69.76 -49.24 54.9 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.212 -0.93 . . . . 0.0 109.463 178.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -59.85 -41.65 91.88 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.583 -0.698 . . . . 0.0 109.921 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.16 -40.85 94.9 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.606 -0.684 . . . . 0.0 110.082 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' ALA . . . . . 0.578 ' HA ' HD12 ' B' ' 32' ' ' ILE . . . -68.32 -49.73 58.31 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.207 -0.933 . . . . 0.0 111.079 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 81.7 t -65.5 -39.18 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.333 -0.854 . . . . 0.0 110.7 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 21.4 t -70.1 -14.04 62.48 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.386 -0.822 . . . . 0.0 111.564 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -118.12 23.82 11.37 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.027 -1.046 . . . . 0.0 110.653 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.66 38.22 58.4 Favored Glycine 0 N--CA 1.493 2.46 0 O-C-N 121.52 -0.737 . . . . 0.0 111.872 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.578 HD12 ' HA ' ' B' ' 27' ' ' ALA . 0.4 OUTLIER -72.52 147.18 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.859 -1.377 . . . . 0.0 108.869 179.01 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.67 142.51 58.05 Favored 'General case' 0 N--CA 1.503 2.217 0 N-CA-C 117.169 2.285 . . . . 0.0 117.169 -174.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 62.21 -36.14 0.12 Allowed 'General case' 0 N--CA 1.516 2.835 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 175.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 23.1 mt -59.69 122.87 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 O-C-N 119.928 -1.732 . . . . 0.0 110.665 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.61 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 52.5 t -100.07 -51.47 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.633 -0.667 . . . . 0.0 111.248 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.1 56.51 20.14 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 107.459 -2.256 . . . . 0.0 107.459 -178.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -71.27 -49.33 44.16 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.958 -0.731 . . . . 0.0 112.296 -177.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 39' ' ' CYS . . . . . 0.681 ' O ' HD12 ' A' ' 356' ' ' LEU . 2.3 p -66.56 -10.42 45.12 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.249 -0.907 . . . . 0.0 112.359 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 40' ' ' GLY . . . . . 0.516 ' HA3' HD12 ' A' ' 356' ' ' LEU . . . 96.79 -5.53 64.11 Favored Glycine 0 N--CA 1.498 2.779 0 O-C-N 120.763 -1.211 . . . . 0.0 111.985 177.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.16 19.52 10.62 Favored Glycine 0 N--CA 1.495 2.608 0 O-C-N 120.883 -1.363 . . . . 0.0 110.965 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 1.3 t -98.95 19.11 15.64 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.032 -1.276 . . . . 0.0 111.142 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 56.0 40.84 30.32 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.358 -0.839 . . . . 0.0 111.934 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 57.8 m -117.0 11.17 14.21 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.318 -0.864 . . . . 0.0 109.533 178.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 45' ' ' CYS . . . . . 0.551 ' HB3' ' HB3' ' B' ' 39' ' ' CYS . 15.1 p -149.56 -179.07 6.8 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.511 -0.743 . . . . 0.0 109.039 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.07 33.98 3.11 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.85 -1.156 . . . . 0.0 111.357 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 47' ' ' THR . . . . . 0.61 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 65.1 p -97.51 13.23 30.68 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.0 -1.063 . . . . 0.0 111.275 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 48' ' ' CYS . . . . . 0.444 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.1 p -120.57 31.78 6.29 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 177.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 23.9 t-160 -72.68 133.07 44.44 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.588 -178.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.3 m -146.29 160.06 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 51' ' ' TYR . . . . . 0.419 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.5 m-85 -105.45 102.73 12.19 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.239 -0.913 . . . . 0.0 108.74 178.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.1 t -61.9 135.17 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.269 -0.894 . . . . 0.0 109.348 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.67 131.75 51.2 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.961 0.886 . . . . 0.0 109.495 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.414 ' H ' ' CD ' ' B' ' 54' ' ' GLU . 11.0 mp0 -44.3 -30.99 0.9 Allowed 'General case' 0 N--CA 1.506 2.357 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -178.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.79 -6.92 54.29 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.013 -1.055 . . . . 0.0 112.726 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -119.95 -6.6 10.02 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 120.456 -1.402 . . . . 0.0 111.9 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.4 p -55.48 -37.73 68.2 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 121.155 -0.966 . . . . 0.0 112.892 -178.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -81.2 -6.59 59.03 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 120.743 -1.223 . . . . 0.0 111.44 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -89.89 -11.66 41.21 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.962 -1.087 . . . . 0.0 109.825 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 41.0 t -104.11 141.1 21.81 Favored Pre-proline 0 N--CA 1.488 1.458 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -73.82 118.87 5.61 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 O-C-N 123.485 1.255 . . . . 0.0 108.984 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.93 160.62 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.752 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 -177.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 63' ' ' ALA . . . . . 0.616 ' HB1' ' HB3' ' B' ' 67' ' ' GLU . . . -65.78 146.2 55.06 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.222 178.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -89.76 -170.78 2.93 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.592 -0.693 . . . . 0.0 110.397 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -59.56 -41.99 91.39 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.377 -0.827 . . . . 0.0 111.739 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.47 -41.54 84.46 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.109 -0.994 . . . . 0.0 111.994 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 67' ' ' GLU . . . . . 0.616 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 45.4 tt0 -68.23 -43.94 76.81 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.962 -1.086 . . . . 0.0 110.367 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 68' ' ' ILE . . . . . 0.527 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.7 mm -55.57 -42.18 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.292 -0.88 . . . . 0.0 109.37 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.17 -47.86 80.84 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 12.4 mmt -66.19 -33.98 77.0 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.256 -1.144 . . . . 0.0 111.162 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 71' ' ' LEU . . . . . 0.456 ' HA ' HD23 ' B' ' 71' ' ' LEU . 28.0 mt -63.45 -23.34 67.36 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.172 -0.955 . . . . 0.0 110.606 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 72' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 49.2 mt-10 -70.41 -8.75 53.24 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.345 -0.847 . . . . 0.0 110.938 179.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 56.3 p -119.85 12.57 12.13 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.003 -1.061 . . . . 0.0 112.517 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 16.4 m -60.81 140.43 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 120.661 -1.274 . . . . 0.0 109.618 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 41.1 m -74.57 -39.05 62.49 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.432 -0.792 . . . . 0.0 110.187 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.22 168.81 17.47 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.441 -0.787 . . . . 0.0 110.089 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.3 139.18 55.67 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.387 -0.821 . . . . 0.0 110.585 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.4 tp -91.02 116.19 28.6 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.497 -0.752 . . . . 0.0 109.879 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -102.99 168.37 8.9 Favored Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -76.64 -0.05 10.06 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 O-C-N 123.259 1.136 . . . . 0.0 110.404 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -120.5 22.39 11.27 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.001 -1.062 . . . . 0.0 108.375 176.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 4.3 m -80.84 137.2 36.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.833 -0.542 . . . . 0.0 110.359 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.4 mmm-85 -149.74 146.4 27.18 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 120.029 -0.669 . . . . 0.0 111.466 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.444 ' HB3' ' SG ' ' B' ' 48' ' ' CYS . 79.2 mt -80.49 98.97 7.8 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 175.096 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 85' ' ' CYS . . . . . 0.403 ' HB2' ' HB2' ' B' ' 23' ' ' LEU . 10.7 p -48.45 -17.9 0.19 Allowed 'General case' 0 N--CA 1.507 2.412 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -175.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.8 p -70.24 -13.99 62.42 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.65 -1.281 . . . . 0.0 109.472 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 48.6 mm-40 -92.75 -12.16 32.03 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.509 -0.744 . . . . 0.0 110.502 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 88' ' ' ILE . . . . . 0.404 HG21 HD13 ' B' ' 88' ' ' ILE . 61.8 mt -91.56 104.0 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.16 -0.962 . . . . 0.0 110.567 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 45.3 mm -85.01 131.78 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 13.6 tpt -74.83 137.81 42.11 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 122.166 0.984 . . . . 0.0 113.183 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 43.7 p -138.23 166.52 25.18 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 176.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -74.86 1.67 7.39 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 122.595 0.787 . . . . 0.0 111.026 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -87.65 -22.81 24.48 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 176.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.6 mt -93.78 12.97 23.85 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.408 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -54.52 126.39 23.44 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.175 -0.953 . . . . 0.0 111.161 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.22 6.86 68.36 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.64 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.64 142.75 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 CA-C-N 119.367 1.584 . . . . 0.0 110.714 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 98' ' ' VAL . . . . . 0.477 HG22 ' HB ' ' B' ' 4' ' ' VAL . 60.8 t -122.53 132.99 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.583 -0.698 . . . . 0.0 109.866 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 16.4 m -130.38 135.77 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.518 -0.739 . . . . 0.0 109.795 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 100' ' ' ASP . . . . . 0.419 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.43 134.15 35.22 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.8 t -103.39 127.26 30.02 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.517 -0.739 . . . . 0.0 110.377 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -80.84 130.97 7.84 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 O-C-N 124.118 1.588 . . . . 0.0 108.273 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 103' ' ' ASP . . . . . 0.427 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.3 p-10 -62.35 3.34 0.19 Allowed 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -178.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 39.5 mtm180 -125.29 114.66 19.22 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.237 -1.539 . . . . 0.0 110.09 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 105' ' ' GLN . . . . . 0.509 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 51.7 mm-40 -113.32 -49.38 2.91 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.436 -0.79 . . . . 0.0 109.979 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 106' ' ' TRP . . . . . 0.789 ' CD2' ' HB2' ' A' ' 113' ' ' ALA . 51.1 m95 . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.491 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.514 HD12 ' HD2' ' A' ' 15' ' ' PRO . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 14' ' ' LEU . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.419 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HG2' HG12 ' A' ' 54' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.569 HG12 ' HG2' ' A' ' 51' ' ' PRO . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.609 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.609 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 64' ' ' ILE . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.435 ' HA ' HD23 ' A' ' 324' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.9 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 45.7 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.6 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.402 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 29.5 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.9 mtm180 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.64 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.2 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.556 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.717 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.717 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 1.068 HD11 ' CZ ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.622 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 67.8 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.64 ' O ' ' HB3' ' A' ' 83' ' ' SER . 3.9 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 45.3 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.647 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.296 50.2 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 104' ' ' ASP 0.366 52.7 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.647 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 35.0 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.452 ' H ' ' CG ' ' A' ' 106' ' ' PRO 0.372 31.8 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.53 ' HG2' HD11 ' A' ' 358' ' ' LEU . 3.3 mtp180 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.568 ' HB2' ' CG ' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.744 HD11 ' HA3' ' A' ' 226' ' ' GLY . 6.8 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.546 ' O ' HG22 ' A' ' 119' ' ' VAL . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.603 ' HA ' HG21 ' A' ' 123' ' ' VAL . 35.1 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.593 HG13 HG23 ' A' ' 118' ' ' VAL . 30.6 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.493 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.698 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 26.7 mtm -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.698 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.1 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.603 HG21 ' HA ' ' A' ' 118' ' ' VAL . 69.2 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 54.1 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 29.8 mtmt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.455 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.63 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.412 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.595 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 151' ' ' THR . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.799 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.799 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.441 ' O ' ' HG2' ' A' ' 164' ' ' MET . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.578 ' C ' HD23 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.455 ' N ' HD23 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.425 ' N ' ' HD2' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' HIS . . . . . 0.405 ' O ' ' HG ' ' A' ' 180' ' ' LEU . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.574 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 176' ' ' HIS . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.561 ' HA ' ' HE3' ' A' ' 184' ' ' MET . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' MET . . . . . 0.561 ' HE3' ' HA ' ' A' ' 181' ' ' THR . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.421 HD22 ' HE1' ' A' ' 184' ' ' MET . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' ARG . . . . . 0.453 ' HG3' ' HB1' ' A' ' 224' ' ' ALA . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 220' ' ' ILE . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' A' ' 222' ' ' ILE . 26.5 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 42.0 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.453 ' HB1' ' HG3' ' A' ' 212' ' ' ARG . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.744 ' HA3' HD11 ' A' ' 114' ' ' LEU . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 4.0 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 1.2 m120 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 17.1 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' ARG . . . . . 1.068 ' CZ ' HD11 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 35.4 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.717 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.487 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 261' ' ' MET . . . . . 0.595 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 8.7 pm0 -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.437 ' N ' ' HD2' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 282' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 285' ' ' CYS . . . . . . . . . . . . . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 288' ' ' LEU . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.706 HD23 ' H ' ' A' ' 294' ' ' LEU . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 298' ' ' GLY . . . . . 0.419 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 299' ' ' ARG . . . . . 0.419 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.0 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.459 ' HA ' HD13 ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 314' ' ' LYS . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 307' ' ' PHE . . . . . 0.428 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.4 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 308' ' ' HIS . . . . . 0.428 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 41.4 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 314' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 303' ' ' SER . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 318' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 318' ' ' ILE . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 319' ' ' LEU . . . . . 0.647 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 321' ' ' PRO . . . . . 0.68 ' HG2' HD22 ' A' ' 324' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.68 HD22 ' HG2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 39.5 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 327' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 327' ' ' LEU . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.522 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 335' ' ' PRO . . . . . 0.522 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 92.5 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 1.3 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 47.2 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 349' ' ' THR . . . . . . . . . . . . . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 62.6 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 91.7 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 356' ' ' LEU . . . . . 0.544 HD13 ' O ' ' B' ' 39' ' ' CYS . 1.1 tp -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 358' ' ' LEU . . . . . 0.53 HD11 ' HG2' ' A' ' 112' ' ' ARG . 1.6 mt -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 9.6 mtm180 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 14.2 tpp85 -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 68.2 mm-40 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 412' ' ' LYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 40.1 m . . . . . 0 N--CA 1.496 1.832 0 N-CA-C 109.713 -0.476 . . . . 0.0 109.713 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.46 138.56 38.52 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.211 -0.931 . . . . 0.0 112.94 -178.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 3' ' ' VAL . . . . . 0.735 HG11 HD22 ' B' ' 23' ' ' LEU . 61.0 t -137.1 122.5 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 177.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.521 HG11 ' CZ ' ' B' ' 12' ' ' ARG . 97.6 t -106.77 129.58 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.131 -0.981 . . . . 0.0 111.622 -178.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -109.22 110.62 21.87 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 39.7 t -94.85 127.22 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.886 -1.133 . . . . 0.0 108.382 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.5 m -86.17 174.67 8.97 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.752 0.786 . . . . 0.0 112.534 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 8' ' ' HIS . . . . . 0.423 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.65 -46.77 89.05 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 121.136 0.493 . . . . 0.0 110.428 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -65.85 -11.32 45.67 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.556 -0.715 . . . . 0.0 111.463 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.0 15.49 28.32 Favored Glycine 0 N--CA 1.492 2.376 0 O-C-N 121.166 -0.959 . . . . 0.0 111.273 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.3 m -82.11 147.42 29.09 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.047 -1.267 . . . . 0.0 109.894 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 12' ' ' ARG . . . . . 0.521 ' CZ ' HG11 ' B' ' 4' ' ' VAL . 50.8 ttt85 -118.49 128.75 54.89 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.408 -0.807 . . . . 0.0 111.808 -178.052 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 13' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' B' ' 13' ' ' ARG . 0.0 OUTLIER -126.07 127.68 46.21 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.54 -0.725 . . . . 0.0 109.813 179.104 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -111.32 130.61 55.62 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.312 -0.867 . . . . 0.0 111.602 -178.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 84.5 mt -122.8 159.38 28.21 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.687 -0.633 . . . . 0.0 111.09 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -109.6 91.61 3.72 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 176.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.7 t -90.18 133.45 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-O 121.601 0.715 . . . . 0.0 112.252 -176.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.07 170.67 16.11 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.804 -0.56 . . . . 0.0 110.247 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -68.45 151.83 46.27 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.555 -0.716 . . . . 0.0 110.986 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.43 -12.49 55.32 Favored Glycine 0 N--CA 1.495 2.629 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.02 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 91.3 t -89.95 133.37 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 120.705 -1.468 . . . . 0.0 110.899 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 96.6 p -80.3 151.96 29.26 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.735 HD22 HG11 ' B' ' 3' ' ' VAL . 18.5 mt -61.24 -24.62 66.49 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.307 -0.871 . . . . 0.0 110.589 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 13.6 tmm? -69.76 -49.2 55.32 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.238 -0.914 . . . . 0.0 109.493 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -59.83 -41.69 91.88 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.605 -0.684 . . . . 0.0 109.945 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.12 -40.87 95.1 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.648 -0.658 . . . . 0.0 110.165 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.28 -49.79 58.11 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.281 -0.887 . . . . 0.0 111.068 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 55.2 t -65.45 -39.13 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.287 -0.883 . . . . 0.0 110.755 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 24.9 m -70.16 -14.02 62.45 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.386 -0.821 . . . . 0.0 111.502 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 30' ' ' ASN . . . . . 0.509 ' HB3' ' CD1' ' B' ' 32' ' ' ILE . 0.5 OUTLIER -118.17 23.83 11.35 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.021 -1.049 . . . . 0.0 110.652 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.68 38.24 58.54 Favored Glycine 0 N--CA 1.493 2.471 0 O-C-N 121.533 -0.729 . . . . 0.0 111.905 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.509 ' CD1' ' HB3' ' B' ' 30' ' ' ASN . 1.1 mp -72.53 147.22 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.867 -1.372 . . . . 0.0 108.815 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -62.78 142.5 58.15 Favored 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 117.182 2.289 . . . . 0.0 117.182 -174.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 62.24 -36.11 0.12 Allowed 'General case' 0 N--CA 1.515 2.806 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 175.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 57.8 mt -59.74 122.88 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 CA-C-N 121.067 1.758 . . . . 0.0 110.664 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.705 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 48.2 t -100.1 -51.43 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.674 -0.641 . . . . 0.0 111.22 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.13 56.51 20.07 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 107.47 -2.252 . . . . 0.0 107.47 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.35 -49.29 43.85 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.988 -0.713 . . . . 0.0 112.26 -177.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 39' ' ' CYS . . . . . 0.553 ' HB3' ' HB3' ' B' ' 45' ' ' CYS . 2.3 p -66.55 -10.45 45.31 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.229 -0.919 . . . . 0.0 112.372 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 40' ' ' GLY . . . . . 0.507 ' CA ' HD22 ' A' ' 356' ' ' LEU . . . 96.82 -5.52 64.04 Favored Glycine 0 N--CA 1.498 2.823 0 O-C-N 120.841 -1.162 . . . . 0.0 111.938 177.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.2 19.42 10.69 Favored Glycine 0 N--CA 1.494 2.557 0 O-C-N 120.794 -1.415 . . . . 0.0 111.031 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 87.7 p -98.86 19.04 15.66 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.055 -1.262 . . . . 0.0 111.158 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 56.01 40.85 30.28 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.401 -0.812 . . . . 0.0 111.926 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 17.3 m -116.99 11.12 14.21 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.401 -0.812 . . . . 0.0 109.522 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 45' ' ' CYS . . . . . 0.553 ' HB3' ' HB3' ' B' ' 39' ' ' CYS . 15.1 p -149.52 -179.04 6.78 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.537 -0.727 . . . . 0.0 109.073 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.1 34.07 3.09 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.804 -1.185 . . . . 0.0 111.339 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 47' ' ' THR . . . . . 0.705 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 5.6 p -97.6 13.24 30.79 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.972 -1.08 . . . . 0.0 111.288 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 48' ' ' CYS . . . . . 0.444 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.1 p -120.56 31.72 6.32 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 177.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 49' ' ' HIS . . . . . 0.476 ' NE2' ' HB3' ' B' ' 82' ' ' SER . 6.4 t-160 -72.63 133.02 44.47 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.618 -178.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.3 m -146.27 160.05 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 51' ' ' TYR . . . . . 0.417 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.5 m-85 -105.39 102.71 12.17 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.285 -0.885 . . . . 0.0 108.708 178.154 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.4 t -61.86 135.09 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.316 -0.865 . . . . 0.0 109.387 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.62 131.82 51.36 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.945 0.879 . . . . 0.0 109.522 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' B' ' 54' ' ' GLU . 11.0 mp0 -44.33 -31.03 0.92 Allowed 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.8 -6.91 54.25 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.021 -1.05 . . . . 0.0 112.766 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -119.94 -6.65 10.02 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 120.527 -1.358 . . . . 0.0 111.922 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.5 p -55.41 -37.77 68.06 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.151 -0.968 . . . . 0.0 112.915 -178.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -81.18 -6.59 59.02 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.744 -1.222 . . . . 0.0 111.481 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -89.87 -11.65 41.29 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.97 -1.081 . . . . 0.0 109.854 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.8 t -104.07 141.04 21.7 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -73.74 118.87 5.63 Favored 'Trans proline' 0 N--CA 1.488 1.176 0 O-C-N 123.444 1.233 . . . . 0.0 109.008 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.95 160.61 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.79 0 N-CA-C 116.645 2.091 . . . . 0.0 116.645 -177.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 63' ' ' ALA . . . . . 0.618 ' HB1' ' HB3' ' B' ' 67' ' ' GLU . . . -65.77 146.17 55.1 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.216 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -89.75 -170.79 2.94 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.594 -0.691 . . . . 0.0 110.398 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -59.53 -42.02 91.36 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.321 -0.862 . . . . 0.0 111.719 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -41.47 84.46 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.242 -0.911 . . . . 0.0 112.027 -178.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 67' ' ' GLU . . . . . 0.668 ' HG3' HD12 ' B' ' 84' ' ' LEU . 45.3 tt0 -68.26 -43.98 76.63 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.941 -1.099 . . . . 0.0 110.335 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 68' ' ' ILE . . . . . 0.513 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.7 mm -55.53 -42.16 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.283 -0.885 . . . . 0.0 109.394 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.23 -47.86 80.64 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 24.8 mmt -66.18 -33.97 76.98 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.316 -1.108 . . . . 0.0 111.186 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 71' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' B' ' 71' ' ' LEU . 27.5 mt -63.51 -23.32 67.34 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.203 -0.936 . . . . 0.0 110.62 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 72' ' ' GLU . . . . . 0.513 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 44.2 mt-10 -70.44 -8.67 52.75 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.38 -0.825 . . . . 0.0 110.926 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 36.4 m -119.87 12.55 12.1 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.069 -1.02 . . . . 0.0 112.518 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 35.3 m -60.78 140.49 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 120.75 -1.219 . . . . 0.0 109.677 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 33.8 m -74.63 -39.08 62.34 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.372 -0.83 . . . . 0.0 110.136 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.22 168.82 17.46 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.451 -0.78 . . . . 0.0 110.087 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.26 139.12 55.68 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.422 -0.799 . . . . 0.0 110.613 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.5 tp -91.01 116.19 28.6 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.569 -0.707 . . . . 0.0 109.873 179.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -103.02 168.3 9.0 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -76.61 -0.0 10.0 Favored 'Trans proline' 0 C--N 1.315 -1.217 0 O-C-N 123.222 1.117 . . . . 0.0 110.398 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -120.48 22.36 11.29 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.918 -1.114 . . . . 0.0 108.42 176.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 82' ' ' SER . . . . . 0.476 ' HB3' ' NE2' ' B' ' 49' ' ' HIS . 4.3 m -80.81 137.23 36.21 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.91 -0.494 . . . . 0.0 110.383 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.4 mmm-85 -149.78 146.41 27.16 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.47 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.668 HD12 ' HG3' ' B' ' 67' ' ' GLU . 96.3 mt -80.59 98.97 7.88 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 175.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 85' ' ' CYS . . . . . 0.409 ' HB2' ' HB2' ' B' ' 23' ' ' LEU . 10.5 p -48.37 -17.88 0.18 Allowed 'General case' 0 N--CA 1.508 2.448 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -175.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.9 p -70.29 -14.0 62.41 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.686 -1.259 . . . . 0.0 109.474 178.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -92.68 -12.23 32.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.492 -0.755 . . . . 0.0 110.553 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 61.8 mt -91.48 103.95 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.179 -0.951 . . . . 0.0 110.648 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 27.6 mm -85.03 131.8 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 13.8 tpt -74.89 137.78 41.99 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 122.176 0.988 . . . . 0.0 113.221 -177.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 43.6 p -138.2 166.59 24.73 Favored Pre-proline 0 N--CA 1.49 1.546 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 176.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -74.97 1.75 7.37 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 122.678 0.83 . . . . 0.0 111.023 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -87.69 -22.77 24.45 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.4 mt -93.85 12.99 23.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 122.024 -0.423 . . . . 0.0 110.412 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -54.5 126.37 23.31 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.185 -0.947 . . . . 0.0 111.172 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.23 6.86 68.33 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.633 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.65 142.76 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 CA-C-N 119.374 1.587 . . . . 0.0 110.773 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 98' ' ' VAL . . . . . 0.478 HG22 ' HB ' ' B' ' 4' ' ' VAL . 60.8 t -122.5 133.01 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.494 -0.754 . . . . 0.0 109.858 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 16.4 m -130.39 135.76 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.439 -0.788 . . . . 0.0 109.793 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 100' ' ' ASP . . . . . 0.417 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.43 134.17 35.2 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.4 t -103.39 127.29 29.96 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.482 -0.761 . . . . 0.0 110.386 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -80.82 131.01 7.87 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 O-C-N 124.016 1.535 . . . . 0.0 108.306 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 103' ' ' ASP . . . . . 0.423 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.4 p-10 -62.44 3.4 0.2 Allowed 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -178.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 4.0 mtm105 -125.32 114.6 19.12 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.282 -1.511 . . . . 0.0 110.075 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 105' ' ' GLN . . . . . 0.501 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 70.6 mm-40 -113.25 -49.43 2.91 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.46 -0.775 . . . . 0.0 110.0 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 106' ' ' TRP . . . . . 0.568 ' CG ' ' HB2' ' A' ' 113' ' ' ALA . 10.9 m0 . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.5 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.514 HD12 ' HD2' ' A' ' 15' ' ' PRO . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 14' ' ' LEU . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.419 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HG2' HG12 ' A' ' 54' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.569 HG12 ' HG2' ' A' ' 51' ' ' PRO . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.609 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.609 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 64' ' ' ILE . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.435 ' HA ' HD23 ' A' ' 324' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.9 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.2 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.5 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.475 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 26.4 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.1 mtm180 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.64 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.2 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.556 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.717 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.717 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 1.068 HD11 ' CZ ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.622 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 67.8 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.64 ' O ' ' HB3' ' A' ' 83' ' ' SER . 3.9 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 45.3 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.647 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.296 50.2 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' ' 104' ' ' ASP 0.366 53.2 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.647 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 35.0 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.452 ' H ' ' CG ' ' A' ' 106' ' ' PRO 0.372 31.8 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.8 ttp85 -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 8.6 mtp180 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.493 ' HB2' ' CG ' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.744 HD11 ' HA3' ' A' ' 226' ' ' GLY . 6.8 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.546 ' O ' HG22 ' A' ' 119' ' ' VAL . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.603 ' HA ' HG21 ' A' ' 123' ' ' VAL . 35.1 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.594 HG13 HG23 ' A' ' 118' ' ' VAL . 30.6 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.493 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.698 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 28.8 mtm -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.698 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.1 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.603 HG21 ' HA ' ' A' ' 118' ' ' VAL . 69.2 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 54.1 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 29.8 mtmt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.455 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.63 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.412 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.595 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 151' ' ' THR . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.799 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.799 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.441 ' O ' ' HG2' ' A' ' 164' ' ' MET . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.578 ' C ' HD23 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.455 ' N ' HD23 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.425 ' N ' ' HD2' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' HIS . . . . . 0.405 ' O ' ' HG ' ' A' ' 180' ' ' LEU . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.574 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 176' ' ' HIS . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.561 ' HA ' ' HE3' ' A' ' 184' ' ' MET . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' MET . . . . . 0.561 ' HE3' ' HA ' ' A' ' 181' ' ' THR . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.421 HD22 ' HE1' ' A' ' 184' ' ' MET . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' ARG . . . . . 0.453 ' HG3' ' HB1' ' A' ' 224' ' ' ALA . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 220' ' ' ILE . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' A' ' 222' ' ' ILE . 26.5 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 42.0 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.453 ' HB1' ' HG3' ' A' ' 212' ' ' ARG . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.744 ' HA3' HD11 ' A' ' 114' ' ' LEU . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 4.0 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 17.1 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' ARG . . . . . 1.068 ' CZ ' HD11 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 35.4 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.717 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.487 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' MET . . . . . 0.595 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 8.7 pm0 -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.437 ' N ' ' HD2' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 282' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' CYS . . . . . . . . . . . . . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 288' ' ' LEU . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.706 HD23 ' H ' ' A' ' 294' ' ' LEU . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 298' ' ' GLY . . . . . 0.419 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 299' ' ' ARG . . . . . 0.419 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.0 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.459 ' HA ' HD13 ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 314' ' ' LYS . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 307' ' ' PHE . . . . . 0.428 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.4 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 308' ' ' HIS . . . . . 0.428 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 41.4 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 314' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 303' ' ' SER . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 318' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 318' ' ' ILE . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 319' ' ' LEU . . . . . 0.647 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 321' ' ' PRO . . . . . 0.68 ' HG2' HD22 ' A' ' 324' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.68 HD22 ' HG2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 39.5 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 327' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 327' ' ' LEU . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.522 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 335' ' ' PRO . . . . . 0.522 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 92.5 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 1.3 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 47.2 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 349' ' ' THR . . . . . . . . . . . . . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 66.3 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 93.8 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 356' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 1.2 tp -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 14.2 tpp85 -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 68.2 mm-40 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 412' ' ' LYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 39.6 m . . . . . 0 N--CA 1.496 1.837 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.54 138.62 38.49 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.218 -0.926 . . . . 0.0 112.934 -178.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 3' ' ' VAL . . . . . 0.725 HG11 HD22 ' B' ' 23' ' ' LEU . 60.6 t -137.14 122.58 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.533 HG11 ' CZ ' ' B' ' 12' ' ' ARG . 98.1 t -106.82 129.54 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.126 -0.984 . . . . 0.0 111.58 -178.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -109.2 110.58 21.83 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 40.0 t -94.79 127.2 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.899 -1.125 . . . . 0.0 108.367 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.4 m -86.12 174.67 9.0 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.773 0.797 . . . . 0.0 112.527 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 8' ' ' HIS . . . . . 0.421 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.66 -46.73 89.24 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 121.132 0.491 . . . . 0.0 110.463 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -65.92 -11.26 45.95 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.592 -0.692 . . . . 0.0 111.401 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.97 15.47 28.45 Favored Glycine 0 N--CA 1.492 2.368 0 O-C-N 121.202 -0.936 . . . . 0.0 111.258 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.4 m -82.11 147.35 29.12 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 118.754 1.277 . . . . 0.0 109.899 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 12' ' ' ARG . . . . . 0.533 ' CZ ' HG11 ' B' ' 4' ' ' VAL . 50.8 ttt85 -118.42 128.74 54.91 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.418 -0.801 . . . . 0.0 111.873 -178.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 13' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' B' ' 13' ' ' ARG . 0.0 OUTLIER -126.03 127.7 46.29 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.574 -0.703 . . . . 0.0 109.794 179.117 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -111.31 130.62 55.61 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.255 -0.903 . . . . 0.0 111.666 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 84.6 mt -122.81 159.39 28.21 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.3 0.571 . . . . 0.0 111.073 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -109.62 91.64 3.73 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 106.436 -1.691 . . . . 0.0 106.436 176.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 39.0 t -90.2 133.44 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.577 0.703 . . . . 0.0 112.254 -176.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.09 170.67 16.1 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.805 -0.559 . . . . 0.0 110.282 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -68.37 151.81 46.34 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.498 -0.751 . . . . 0.0 111.021 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.42 -12.48 55.29 Favored Glycine 0 N--CA 1.495 2.623 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.066 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 98.8 t -89.98 133.36 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.673 -1.487 . . . . 0.0 110.922 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 52.0 p -80.29 151.93 29.29 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.725 HD22 HG11 ' B' ' 3' ' ' VAL . 18.4 mt -61.21 -24.54 66.41 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.31 -0.868 . . . . 0.0 110.66 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 11.2 tmm? -69.77 -49.25 54.77 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.258 -0.901 . . . . 0.0 109.462 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.81 -41.74 91.94 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.645 -0.659 . . . . 0.0 109.892 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.06 -40.9 95.39 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.593 -0.692 . . . . 0.0 110.179 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.28 -49.72 58.6 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.285 -0.884 . . . . 0.0 111.12 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 89.5 t -65.42 -39.24 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.266 -0.896 . . . . 0.0 110.737 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 25.0 m -70.03 -14.11 62.53 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.328 -0.857 . . . . 0.0 111.53 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 30' ' ' ASN . . . . . 0.536 ' HB3' ' CD1' ' B' ' 32' ' ' ILE . 0.5 OUTLIER -118.18 23.86 11.33 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.062 -1.024 . . . . 0.0 110.604 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.68 38.23 58.51 Favored Glycine 0 N--CA 1.493 2.463 0 O-C-N 121.557 -0.714 . . . . 0.0 111.873 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.579 ' CG2' HD12 ' B' ' 35' ' ' ILE . 1.0 OUTLIER -72.54 147.18 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.813 -1.404 . . . . 0.0 108.839 179.024 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -62.67 142.5 58.06 Favored 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 117.231 2.308 . . . . 0.0 117.231 -174.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 62.18 -36.09 0.12 Allowed 'General case' 0 N--CA 1.515 2.814 0 N-CA-C 116.657 2.095 . . . . 0.0 116.657 175.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.579 HD12 ' CG2' ' B' ' 32' ' ' ILE . 20.2 mt -59.77 122.92 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 O-C-N 119.821 -1.799 . . . . 0.0 110.635 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.66 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 93.2 t -100.16 -51.4 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.595 -0.691 . . . . 0.0 111.192 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.16 56.45 20.34 Favored Glycine 0 N--CA 1.499 2.897 0 N-CA-C 107.467 -2.253 . . . . 0.0 107.467 -178.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -71.33 -49.29 44.05 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.993 -0.71 . . . . 0.0 112.281 -177.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 39' ' ' CYS . . . . . 0.557 ' HB3' ' HB3' ' B' ' 45' ' ' CYS . 2.3 p -66.53 -10.43 44.8 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.219 -0.925 . . . . 0.0 112.373 -178.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.79 -5.47 64.08 Favored Glycine 0 N--CA 1.497 2.767 0 O-C-N 120.745 -1.222 . . . . 0.0 112.0 177.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.08 19.51 10.68 Favored Glycine 0 N--CA 1.495 2.59 0 O-C-N 120.814 -1.403 . . . . 0.0 111.038 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 87.9 p -98.94 19.17 15.52 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.025 -1.279 . . . . 0.0 111.137 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.664 ' HB3' ' HD3' ' B' ' 66' ' ' ARG . . . 55.94 40.89 30.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.395 -0.816 . . . . 0.0 111.918 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 5.7 t -117.02 11.17 14.19 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.356 -0.84 . . . . 0.0 109.566 178.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 45' ' ' CYS . . . . . 0.557 ' HB3' ' HB3' ' B' ' 39' ' ' CYS . 15.1 p -149.52 -179.1 6.83 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.09 34.06 3.1 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.828 -1.17 . . . . 0.0 111.346 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 47' ' ' THR . . . . . 0.66 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 25.2 p -97.52 13.22 30.7 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.995 -1.066 . . . . 0.0 111.295 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 48' ' ' CYS . . . . . 0.439 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.1 p -120.56 31.74 6.31 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 177.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 49' ' ' HIS . . . . . 0.469 ' NE2' ' HB3' ' B' ' 82' ' ' SER . 6.5 t-160 -72.69 133.05 44.43 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.628 -178.137 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.3 m -146.27 160.09 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 51' ' ' TYR . . . . . 0.417 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.5 m-85 -105.43 102.74 12.19 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.257 -0.902 . . . . 0.0 108.689 178.18 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.0 t -61.97 135.12 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.343 -0.848 . . . . 0.0 109.358 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.63 131.79 51.3 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.957 0.884 . . . . 0.0 109.522 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.416 ' H ' ' CD ' ' B' ' 54' ' ' GLU . 11.0 mp0 -44.4 -30.9 0.92 Allowed 'General case' 0 N--CA 1.506 2.336 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -178.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.83 -6.91 54.29 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.016 -1.052 . . . . 0.0 112.772 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -119.98 -6.6 10.01 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.465 -1.397 . . . . 0.0 111.898 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.4 p -55.4 -37.85 68.16 Favored 'General case' 0 N--CA 1.507 2.415 0 O-C-N 121.186 -0.946 . . . . 0.0 112.854 -178.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 47.9 p-10 -81.17 -6.59 59.01 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 120.775 -1.203 . . . . 0.0 111.452 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -89.91 -11.68 41.12 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.983 -1.073 . . . . 0.0 109.822 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -104.04 141.08 21.77 Favored Pre-proline 0 N--CA 1.488 1.475 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -73.78 118.84 5.61 Favored 'Trans proline' 0 N--CA 1.489 1.208 0 O-C-N 123.49 1.258 . . . . 0.0 109.009 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.83 160.62 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.799 0 N-CA-C 116.621 2.082 . . . . 0.0 116.621 -177.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 63' ' ' ALA . . . . . 0.604 ' HB1' ' HB3' ' B' ' 67' ' ' GLU . . . -65.81 146.11 55.15 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.285 178.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -89.76 -170.76 2.93 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.61 -0.681 . . . . 0.0 110.393 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -59.58 -41.98 91.49 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.325 -0.859 . . . . 0.0 111.711 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 66' ' ' ARG . . . . . 0.664 ' HD3' ' HB3' ' B' ' 43' ' ' ALA . 11.0 ttt180 -67.44 -41.58 84.51 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.141 -0.974 . . . . 0.0 111.989 -178.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 67' ' ' GLU . . . . . 0.676 ' HG3' HD12 ' B' ' 84' ' ' LEU . 45.4 tt0 -68.23 -43.92 76.88 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.985 -1.072 . . . . 0.0 110.354 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 68' ' ' ILE . . . . . 0.517 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.7 mm -55.57 -42.2 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.311 -0.868 . . . . 0.0 109.354 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.17 -47.88 80.61 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 8.4 mmt -66.12 -33.97 76.99 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.234 -1.157 . . . . 0.0 111.241 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 27.5 mt -63.5 -23.34 67.36 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.213 -0.929 . . . . 0.0 110.636 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 72' ' ' GLU . . . . . 0.517 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 44.3 mt-10 -70.42 -8.72 53.04 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.314 -0.866 . . . . 0.0 110.897 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 1.4 t -119.84 12.56 12.13 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.001 -1.062 . . . . 0.0 112.523 -178.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 34.6 m -60.84 140.42 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 120.736 -1.227 . . . . 0.0 109.631 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.59 -39.03 62.46 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.393 -0.817 . . . . 0.0 110.152 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.22 168.84 17.42 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.486 -0.759 . . . . 0.0 110.086 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.33 139.15 55.78 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.397 -0.814 . . . . 0.0 110.602 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.3 tp -90.99 116.22 28.62 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.549 -0.719 . . . . 0.0 109.833 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -103.04 168.3 8.99 Favored Pre-proline 0 N--CA 1.489 1.5 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -76.62 -0.04 10.05 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 O-C-N 123.311 1.164 . . . . 0.0 110.382 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -120.46 22.37 11.29 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.931 -1.106 . . . . 0.0 108.397 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 82' ' ' SER . . . . . 0.469 ' HB3' ' NE2' ' B' ' 49' ' ' HIS . 4.3 m -80.8 137.23 36.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.879 -0.513 . . . . 0.0 110.32 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.4 mmm-85 -149.8 146.37 27.12 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.465 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.676 HD12 ' HG3' ' B' ' 67' ' ' GLU . 96.3 mt -80.51 98.96 7.81 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 175.081 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 85' ' ' CYS . . . . . 0.405 ' HB2' ' HB2' ' B' ' 23' ' ' LEU . 10.7 p -48.44 -17.86 0.19 Allowed 'General case' 0 N--CA 1.508 2.427 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -175.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.8 p -70.27 -14.0 62.41 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.669 -1.269 . . . . 0.0 109.435 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -92.7 -12.25 31.95 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.459 -0.776 . . . . 0.0 110.526 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 61.8 mt -91.51 103.96 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.198 -0.939 . . . . 0.0 110.664 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 26.5 mm -84.98 131.71 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 13.8 tpt -74.8 137.74 42.11 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 122.075 0.941 . . . . 0.0 113.25 -177.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 43.6 p -138.17 166.6 24.63 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -75.0 1.79 7.35 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 O-C-N 122.669 0.826 . . . . 0.0 111.001 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -87.67 -22.82 24.46 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 176.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.6 mt -93.79 13.02 23.72 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.418 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.53 126.4 23.47 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.146 -0.971 . . . . 0.0 111.148 -178.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.25 6.77 68.41 Favored Glycine 0 N--CA 1.494 2.523 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.662 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.61 142.69 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 CA-C-N 119.343 1.572 . . . . 0.0 110.755 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 98' ' ' VAL . . . . . 0.47 HG22 ' HB ' ' B' ' 4' ' ' VAL . 61.0 t -122.44 132.96 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.519 -0.738 . . . . 0.0 109.88 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 16.5 m -130.37 135.79 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.481 -0.762 . . . . 0.0 109.802 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 100' ' ' ASP . . . . . 0.417 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.44 134.11 35.26 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.9 t -103.34 127.33 29.9 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.493 -0.754 . . . . 0.0 110.391 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -80.89 130.92 7.75 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 O-C-N 124.084 1.571 . . . . 0.0 108.294 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 103' ' ' ASP . . . . . 0.421 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.3 p-10 -62.33 3.38 0.19 Allowed 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -178.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 3.8 mtm105 -125.32 114.68 19.22 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.288 -1.507 . . . . 0.0 110.069 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 105' ' ' GLN . . . . . 0.491 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 69.8 mm-40 -113.31 -49.37 2.91 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.476 -0.765 . . . . 0.0 110.0 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 106' ' ' TRP . . . . . 0.493 ' CG ' ' HB2' ' A' ' 113' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 118.392 -0.813 . . . . 0.0 110.504 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.514 HD12 ' HD2' ' A' ' 15' ' ' PRO . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 14' ' ' LEU . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.419 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HG2' HG12 ' A' ' 54' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.569 HG12 ' HG2' ' A' ' 51' ' ' PRO . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.609 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.609 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 64' ' ' ILE . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.435 ' HA ' HD23 ' A' ' 324' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.0 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.6 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.5 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.427 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 30.0 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.6 mtm180 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.64 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.2 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.556 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.717 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.717 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 1.068 HD11 ' CZ ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.63 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 68.2 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.64 ' O ' ' HB3' ' A' ' 83' ' ' SER . 3.8 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 46.0 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.647 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.296 50.2 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 104' ' ' ASP 0.366 52.9 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.647 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 35.0 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.452 ' H ' ' CG ' ' A' ' 106' ' ' PRO 0.413 34.1 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.642 ' CZ ' HD11 ' A' ' 358' ' ' LEU . 7.1 mtp180 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.723 ' HB2' ' CD2' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.685 HD11 ' HA3' ' A' ' 226' ' ' GLY . 24.8 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.546 ' O ' HG22 ' A' ' 119' ' ' VAL . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.603 ' HA ' HG21 ' A' ' 123' ' ' VAL . 35.1 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.593 HG13 HG23 ' A' ' 118' ' ' VAL . 30.6 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.493 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.697 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 31.7 mtm -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.697 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.1 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.603 HG21 ' HA ' ' A' ' 118' ' ' VAL . 72.0 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.7 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.452 ' HD2' ' HA ' ' A' ' 123' ' ' VAL . 35.6 mttt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.455 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.63 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.412 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.595 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 151' ' ' THR . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.799 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.799 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.441 ' O ' ' HG2' ' A' ' 164' ' ' MET . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.578 ' C ' HD23 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.455 ' N ' HD23 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.425 ' N ' ' HD2' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' HIS . . . . . 0.405 ' O ' ' HG ' ' A' ' 180' ' ' LEU . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.574 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 176' ' ' HIS . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.561 ' HA ' ' HE3' ' A' ' 184' ' ' MET . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' MET . . . . . 0.561 ' HE3' ' HA ' ' A' ' 181' ' ' THR . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.421 HD22 ' HE1' ' A' ' 184' ' ' MET . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' ARG . . . . . 0.453 ' HG3' ' HB1' ' A' ' 224' ' ' ALA . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 220' ' ' ILE . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 33.3 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 53.1 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.453 ' HB1' ' HG3' ' A' ' 212' ' ' ARG . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.685 ' HA3' HD11 ' A' ' 114' ' ' LEU . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 4.6 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 1.1 m120 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 18.1 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' ARG . . . . . 1.068 ' CZ ' HD11 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 45.4 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.717 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.487 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 261' ' ' MET . . . . . 0.595 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.437 ' N ' ' HD2' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 282' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 285' ' ' CYS . . . . . . . . . . . . . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 288' ' ' LEU . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.706 HD23 ' H ' ' A' ' 294' ' ' LEU . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 298' ' ' GLY . . . . . 0.419 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 299' ' ' ARG . . . . . 0.419 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.1 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.459 ' HA ' HD13 ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 314' ' ' LYS . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 307' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.6 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 308' ' ' HIS . . . . . 0.425 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 36.9 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 314' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 303' ' ' SER . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 318' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 318' ' ' ILE . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 319' ' ' LEU . . . . . 0.647 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 321' ' ' PRO . . . . . 0.68 ' HG2' HD22 ' A' ' 324' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.68 HD22 ' HG2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 13.7 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 327' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 327' ' ' LEU . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.522 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 335' ' ' PRO . . . . . 0.522 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 343' ' ' GLN . . . . . 0.41 ' CB ' ' HD3' ' A' ' 344' ' ' LYS . 1.9 mp0 -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 344' ' ' LYS . . . . . 0.511 ' HD3' ' N ' ' A' ' 344' ' ' LYS . 0.9 OUTLIER -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 60.7 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 10.6 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 39.9 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 349' ' ' THR . . . . . . . . . . . . . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 60.2 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 96.4 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 356' ' ' LEU . . . . . 0.509 HD22 ' CA ' ' B' ' 40' ' ' GLY . 1.5 tp -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 358' ' ' LEU . . . . . 0.642 HD11 ' CZ ' ' A' ' 112' ' ' ARG . 1.4 mp -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 43.4 mtt85 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 68.2 mm-40 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 412' ' ' LYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 N--CA 1.496 1.83 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.52 138.58 38.48 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.224 -0.922 . . . . 0.0 112.963 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 3' ' ' VAL . . . . . 0.743 HG11 HD22 ' B' ' 23' ' ' LEU . 61.2 t -137.11 122.56 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.526 HG11 ' CZ ' ' B' ' 12' ' ' ARG . 97.0 t -106.76 129.54 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.115 -0.991 . . . . 0.0 111.628 -178.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.509 ' CG ' HD13 ' B' ' 32' ' ' ILE . 76.9 m-85 -109.2 110.6 21.85 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.82 127.26 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.927 -1.108 . . . . 0.0 108.34 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.4 m -86.2 174.64 8.97 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.753 0.787 . . . . 0.0 112.502 -177.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 8' ' ' HIS . . . . . 0.427 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.6 -46.79 88.94 Favored 'General case' 0 N--CA 1.502 2.155 0 CA-C-O 121.138 0.494 . . . . 0.0 110.458 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -65.85 -11.31 45.58 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.57 -0.706 . . . . 0.0 111.433 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.99 15.43 28.49 Favored Glycine 0 N--CA 1.492 2.406 0 O-C-N 121.155 -0.965 . . . . 0.0 111.259 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.5 m -82.05 147.38 29.17 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 118.73 1.265 . . . . 0.0 109.88 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 12' ' ' ARG . . . . . 0.526 ' CZ ' HG11 ' B' ' 4' ' ' VAL . 50.8 ttt85 -118.43 128.74 54.9 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.487 -0.758 . . . . 0.0 111.859 -178.099 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 13' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' B' ' 13' ' ' ARG . 0.0 OUTLIER -126.07 127.71 46.24 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.598 -0.689 . . . . 0.0 109.804 179.08 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -111.3 130.63 55.61 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.282 -0.886 . . . . 0.0 111.647 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 84.8 mt -122.8 159.34 28.29 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.734 -0.604 . . . . 0.0 111.129 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -109.61 91.66 3.74 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 176.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.6 t -90.16 133.41 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-O 121.626 0.727 . . . . 0.0 112.253 -176.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.08 170.71 16.04 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.7 -0.625 . . . . 0.0 110.273 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -68.5 151.82 46.25 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.532 -0.73 . . . . 0.0 111.027 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.46 -12.49 55.43 Favored Glycine 0 N--CA 1.496 2.638 0 O-C-N 121.494 -0.754 . . . . 0.0 112.052 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 61.5 t -89.98 133.29 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.706 -1.467 . . . . 0.0 110.963 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 21.3 p -80.21 151.88 29.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.572 -0.705 . . . . 0.0 109.184 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.743 HD22 HG11 ' B' ' 3' ' ' VAL . 18.5 mt -61.18 -24.59 66.43 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.349 -0.844 . . . . 0.0 110.595 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 1.9 ttp -69.83 -49.2 54.9 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.236 -0.915 . . . . 0.0 109.473 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -59.79 -41.72 91.81 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.567 -0.708 . . . . 0.0 109.926 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.09 -40.86 95.2 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.59 -0.694 . . . . 0.0 110.152 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' ALA . . . . . 0.582 ' HA ' HD12 ' B' ' 32' ' ' ILE . . . -68.34 -49.74 58.19 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.275 -0.891 . . . . 0.0 111.045 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 78.2 t -65.47 -39.18 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.301 -0.875 . . . . 0.0 110.706 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 23.2 t -70.14 -13.96 62.43 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.359 -0.838 . . . . 0.0 111.553 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -118.21 23.88 11.32 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.057 -1.027 . . . . 0.0 110.665 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.7 38.24 58.63 Favored Glycine 0 N--CA 1.493 2.448 0 O-C-N 121.541 -0.724 . . . . 0.0 111.857 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.582 HD12 ' HA ' ' B' ' 27' ' ' ALA . 0.4 OUTLIER -72.57 147.19 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.866 -1.373 . . . . 0.0 108.864 179.043 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -62.72 142.53 58.09 Favored 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 117.175 2.287 . . . . 0.0 117.175 -174.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 62.22 -36.12 0.12 Allowed 'General case' 0 N--CA 1.515 2.791 0 N-CA-C 116.643 2.09 . . . . 0.0 116.643 175.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 77.6 mt -59.77 122.9 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.426 0 O-C-N 119.907 -1.746 . . . . 0.0 110.617 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.919 HG11 ' CZ2' ' B' ' 106' ' ' TRP . 97.4 t -100.15 -51.34 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.697 -0.627 . . . . 0.0 111.229 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.14 56.47 20.26 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 107.466 -2.253 . . . . 0.0 107.466 -178.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 38' ' ' ASP . . . . . 0.403 ' HB2' ' CH2' ' B' ' 106' ' ' TRP . 12.6 t70 -71.34 -49.27 44.16 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.994 -0.709 . . . . 0.0 112.274 -177.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 39' ' ' CYS . . . . . 0.558 ' HB3' ' HB3' ' B' ' 45' ' ' CYS . 2.3 p -66.59 -10.4 45.19 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.213 -0.929 . . . . 0.0 112.385 -178.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 40' ' ' GLY . . . . . 0.509 ' CA ' HD22 ' A' ' 356' ' ' LEU . . . 96.77 -5.47 64.13 Favored Glycine 0 N--CA 1.498 2.782 0 O-C-N 120.819 -1.176 . . . . 0.0 112.007 177.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.1 19.52 10.66 Favored Glycine 0 N--CA 1.494 2.535 0 O-C-N 120.826 -1.397 . . . . 0.0 111.047 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 8.2 t -98.95 19.11 15.64 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.978 -1.307 . . . . 0.0 111.16 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.97 40.87 30.36 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.407 -0.808 . . . . 0.0 111.906 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.04 11.2 14.18 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.343 -0.848 . . . . 0.0 109.467 178.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 45' ' ' CYS . . . . . 0.558 ' HB3' ' HB3' ' B' ' 39' ' ' CYS . 15.1 p -149.53 -179.08 6.81 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.549 -0.72 . . . . 0.0 109.082 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.08 34.08 3.1 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.83 -1.169 . . . . 0.0 111.403 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 47' ' ' THR . . . . . 0.648 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 37.8 p -97.63 13.26 30.76 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.925 -1.109 . . . . 0.0 111.25 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 48' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.1 p -120.54 31.73 6.32 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 177.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 23.9 t-160 -72.65 133.03 44.46 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-N 115.784 -0.643 . . . . 0.0 112.628 -178.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.3 m -146.3 160.11 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 51' ' ' TYR . . . . . 0.413 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.4 m-85 -105.44 102.68 12.13 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.294 -0.879 . . . . 0.0 108.684 178.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.2 t -61.86 135.11 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.317 -0.864 . . . . 0.0 109.35 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.68 131.81 51.38 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.94 0.876 . . . . 0.0 109.53 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.412 ' CD ' ' H ' ' B' ' 54' ' ' GLU . 11.0 mp0 -44.27 -31.08 0.91 Allowed 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -178.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.78 -6.93 54.3 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.969 -1.082 . . . . 0.0 112.749 -178.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -119.89 -6.72 10.04 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 120.449 -1.407 . . . . 0.0 111.908 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.4 p -55.37 -37.84 68.04 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.112 -0.993 . . . . 0.0 112.86 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 -81.18 -6.63 59.06 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.753 -1.217 . . . . 0.0 111.477 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -89.88 -11.62 41.35 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.991 -1.068 . . . . 0.0 109.855 178.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -104.07 141.05 21.72 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -73.76 118.89 5.63 Favored 'Trans proline' 0 N--CA 1.488 1.15 0 O-C-N 123.453 1.238 . . . . 0.0 109.016 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.89 160.65 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.764 0 N-CA-C 116.657 2.095 . . . . 0.0 116.657 -177.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 63' ' ' ALA . . . . . 0.616 ' HB1' ' HB3' ' B' ' 67' ' ' GLU . . . -65.87 146.14 55.1 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-N 114.606 -1.179 . . . . 0.0 111.266 178.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -89.74 -170.79 2.94 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.569 -0.707 . . . . 0.0 110.362 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -59.53 -42.0 91.28 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.35 -0.844 . . . . 0.0 111.754 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -41.48 84.45 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.203 -0.935 . . . . 0.0 112.018 -178.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 67' ' ' GLU . . . . . 0.616 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 45.3 tt0 -68.21 -43.98 76.81 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.031 -1.043 . . . . 0.0 110.318 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 68' ' ' ILE . . . . . 0.533 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.6 mm -55.6 -42.18 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.28 -0.888 . . . . 0.0 109.368 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.19 -47.83 81.04 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 11.2 mmt -66.23 -33.92 76.84 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.275 -1.133 . . . . 0.0 111.191 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 71' ' ' LEU . . . . . 0.45 ' HA ' HD23 ' B' ' 71' ' ' LEU . 27.9 mt -63.47 -23.4 67.38 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.236 -0.915 . . . . 0.0 110.588 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 72' ' ' GLU . . . . . 0.533 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 49.2 mt-10 -70.38 -8.71 52.78 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.358 -0.839 . . . . 0.0 110.919 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 82.8 p -119.87 12.54 12.1 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.067 -1.02 . . . . 0.0 112.509 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 16.2 m -60.76 140.38 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 120.643 -1.286 . . . . 0.0 109.681 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 52.0 m -74.53 -39.06 62.58 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.466 -0.771 . . . . 0.0 110.19 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.26 168.82 17.51 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.456 -0.777 . . . . 0.0 110.1 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -58.22 139.16 55.53 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.365 -0.834 . . . . 0.0 110.613 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.3 tp -90.99 116.15 28.55 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.506 -0.746 . . . . 0.0 109.864 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -103.04 168.3 8.99 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -76.61 -0.02 10.02 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 O-C-N 123.304 1.16 . . . . 0.0 110.372 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -120.46 22.41 11.28 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.01 -1.056 . . . . 0.0 108.45 176.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 4.3 m -80.88 137.27 36.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.908 -0.495 . . . . 0.0 110.32 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.4 mmm-85 -149.77 146.4 27.16 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 120.029 -0.668 . . . . 0.0 111.472 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.445 ' HB3' ' SG ' ' B' ' 48' ' ' CYS . 77.9 mt -80.59 98.94 7.86 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 104.789 -2.3 . . . . 0.0 104.789 175.104 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 85' ' ' CYS . . . . . 0.404 ' HB2' ' HB2' ' B' ' 23' ' ' LEU . 10.5 p -48.38 -17.88 0.18 Allowed 'General case' 0 N--CA 1.508 2.444 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -175.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.8 p -70.27 -13.99 62.4 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.628 -1.295 . . . . 0.0 109.429 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -92.65 -12.3 31.91 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.486 -0.759 . . . . 0.0 110.523 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 61.9 mt -91.44 103.89 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.121 -0.987 . . . . 0.0 110.678 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 45.6 mm -85.01 131.8 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 13.6 tpt -74.88 137.76 41.98 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 122.165 0.983 . . . . 0.0 113.201 -177.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 43.6 p -138.14 166.62 24.53 Favored Pre-proline 0 N--CA 1.491 1.578 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 176.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -74.93 1.67 7.43 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 122.628 0.804 . . . . 0.0 111.028 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -87.61 -22.86 24.5 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 176.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.6 mt -93.76 13.0 23.71 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.392 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -54.5 126.39 23.38 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.138 -0.976 . . . . 0.0 111.188 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.27 6.82 68.3 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 120.581 -0.818 . . . . 0.0 111.637 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.7 tt -62.63 142.81 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 CA-C-N 119.391 1.595 . . . . 0.0 110.747 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 98' ' ' VAL . . . . . 0.481 HG22 ' HB ' ' B' ' 4' ' ' VAL . 60.9 t -122.53 132.92 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.554 -0.716 . . . . 0.0 109.876 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 16.5 m -130.32 135.76 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.451 -0.78 . . . . 0.0 109.842 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 100' ' ' ASP . . . . . 0.413 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.35 134.13 35.21 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.9 t -103.4 127.31 29.92 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.558 -0.714 . . . . 0.0 110.364 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -80.82 130.96 7.84 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 124.115 1.587 . . . . 0.0 108.287 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 103' ' ' ASP . . . . . 0.427 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.4 p-10 -62.34 3.37 0.19 Allowed 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -178.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -125.29 114.71 19.29 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.305 -1.497 . . . . 0.0 110.011 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 105' ' ' GLN . . . . . 0.511 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 51.4 mm-40 -113.35 -49.4 2.91 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.505 -0.747 . . . . 0.0 109.958 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 106' ' ' TRP . . . . . 0.919 ' CZ2' HG11 ' B' ' 36' ' ' VAL . 82.7 m95 . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.512 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.514 HD12 ' HD2' ' A' ' 15' ' ' PRO . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 14' ' ' LEU . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.419 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HG2' HG12 ' A' ' 54' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.569 HG12 ' HG2' ' A' ' 51' ' ' PRO . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.609 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.609 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 64' ' ' ILE . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.435 ' HA ' HD23 ' A' ' 324' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.0 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.415 ' CZ ' HG23 ' A' ' 348' ' ' THR . 5.6 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.6 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.474 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 27.1 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.7 mmt-85 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.64 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.2 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.556 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.717 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.717 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 1.068 HD11 ' CZ ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.621 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 74.3 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.64 ' O ' ' HB3' ' A' ' 83' ' ' SER . 3.9 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 46.0 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.646 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.296 50.1 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' ' 104' ' ' ASP 0.366 52.7 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.646 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 34.8 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.451 ' H ' ' CG ' ' A' ' 106' ' ' PRO 0.342 30.7 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.406 ' O ' HD11 ' A' ' 358' ' ' LEU . 2.9 mtt-85 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.688 ' HB1' ' CD1' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.735 HD11 ' HA3' ' A' ' 226' ' ' GLY . 7.4 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.546 ' O ' HG22 ' A' ' 119' ' ' VAL . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.442 ' HA ' HD22 ' A' ' 358' ' ' LEU . 25.4 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.417 ' HB2' ' O ' ' A' ' 114' ' ' LEU . 27.6 mt-30 -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.597 ' HA ' HG21 ' A' ' 123' ' ' VAL . 35.0 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.595 HG13 HG23 ' A' ' 118' ' ' VAL . 30.6 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.493 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.698 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 0.0 OUTLIER -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.698 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.0 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.597 HG21 ' HA ' ' A' ' 118' ' ' VAL . 78.3 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.2 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 28.3 mtmt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.455 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.63 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.412 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.595 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 151' ' ' THR . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.799 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.799 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.441 ' O ' ' HG2' ' A' ' 164' ' ' MET . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.578 ' C ' HD23 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.455 ' N ' HD23 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.425 ' N ' ' HD2' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' HIS . . . . . 0.405 ' O ' ' HG ' ' A' ' 180' ' ' LEU . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.574 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 176' ' ' HIS . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.561 ' HA ' ' HE3' ' A' ' 184' ' ' MET . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' MET . . . . . 0.561 ' HE3' ' HA ' ' A' ' 181' ' ' THR . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.421 HD22 ' HE1' ' A' ' 184' ' ' MET . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' ARG . . . . . 0.453 ' HG3' ' HB1' ' A' ' 224' ' ' ALA . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 220' ' ' ILE . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 44.9 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 42.0 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.453 ' HB1' ' HG3' ' A' ' 212' ' ' ARG . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.735 ' HA3' HD11 ' A' ' 114' ' ' LEU . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 4.3 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 13.5 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' ARG . . . . . 1.068 ' CZ ' HD11 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 40.7 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.717 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.487 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' MET . . . . . 0.595 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 16.4 pm0 -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.437 ' N ' ' HD2' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 282' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 285' ' ' CYS . . . . . . . . . . . . . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 288' ' ' LEU . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.706 HD23 ' H ' ' A' ' 294' ' ' LEU . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 298' ' ' GLY . . . . . 0.419 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 299' ' ' ARG . . . . . 0.419 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.0 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.459 ' HA ' HD13 ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 314' ' ' LYS . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 307' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.6 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 308' ' ' HIS . . . . . 0.425 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 36.9 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 314' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 303' ' ' SER . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 318' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 318' ' ' ILE . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 319' ' ' LEU . . . . . 0.647 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 321' ' ' PRO . . . . . 0.68 ' HG2' HD22 ' A' ' 324' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.68 HD22 ' HG2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 13.7 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 327' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 327' ' ' LEU . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.522 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 335' ' ' PRO . . . . . 0.522 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 343' ' ' GLN . . . . . 0.46 ' CB ' ' HD3' ' A' ' 344' ' ' LYS . 1.9 mp0 -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 344' ' ' LYS . . . . . 0.504 ' HB2' ' HE2' ' A' ' 344' ' ' LYS . 1.7 mppt? -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 57.8 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 22.1 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 348' ' ' THR . . . . . 0.415 HG23 ' CZ ' ' A' ' 72' ' ' ARG . 16.5 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 349' ' ' THR . . . . . . . . . . . . . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 73.7 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 354' ' ' SER . . . . . 0.429 ' HA ' ' CB ' ' B' ' 44' ' ' SER . 97.1 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 356' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 358' ' ' LEU . . . . . 0.442 HD22 ' HA ' ' A' ' 116' ' ' ASN . 0.5 OUTLIER -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 40.9 mtt85 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 17.2 tpp85 -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 68.2 mm-40 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 412' ' ' LYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 N--CA 1.495 1.809 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.52 138.58 38.48 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.177 -0.952 . . . . 0.0 113.004 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 3' ' ' VAL . . . . . 0.738 HG11 HD22 ' B' ' 23' ' ' LEU . 61.2 t -137.11 122.6 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.526 HG11 ' CZ ' ' B' ' 12' ' ' ARG . 97.5 t -106.78 129.58 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.15 -0.969 . . . . 0.0 111.635 -178.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.682 ' CG ' HD13 ' B' ' 32' ' ' ILE . 77.2 m-85 -109.28 110.6 21.83 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.82 127.23 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.935 -1.103 . . . . 0.0 108.363 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.6 m -86.2 174.69 8.94 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.737 0.779 . . . . 0.0 112.509 -177.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 8' ' ' HIS . . . . . 0.422 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.66 -46.73 89.22 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 121.19 0.519 . . . . 0.0 110.457 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -65.93 -11.29 46.16 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.52 -0.737 . . . . 0.0 111.381 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.01 15.4 28.55 Favored Glycine 0 N--CA 1.492 2.388 0 O-C-N 121.177 -0.952 . . . . 0.0 111.287 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 89.8 m -82.05 147.35 29.18 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 118.733 1.266 . . . . 0.0 109.929 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 12' ' ' ARG . . . . . 0.526 ' CZ ' HG11 ' B' ' 4' ' ' VAL . 50.8 ttt85 -118.46 128.74 54.89 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.528 -0.732 . . . . 0.0 111.864 -178.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 13' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' B' ' 13' ' ' ARG . 0.0 OUTLIER -126.06 127.67 46.2 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.571 -0.705 . . . . 0.0 109.81 179.146 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -111.34 130.63 55.62 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.275 -0.891 . . . . 0.0 111.612 -178.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 84.7 mt -122.78 159.35 28.24 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.736 -0.602 . . . . 0.0 111.117 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -109.64 91.62 3.72 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 176.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.6 t -90.21 133.49 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-O 121.604 0.716 . . . . 0.0 112.288 -176.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.11 170.71 16.05 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.779 -0.576 . . . . 0.0 110.27 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -68.47 151.82 46.27 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.479 -0.763 . . . . 0.0 110.958 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.45 -12.51 55.34 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.048 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 59.4 t -90.03 133.32 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.704 -1.468 . . . . 0.0 110.896 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 22.3 p -80.23 151.96 29.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.583 -0.698 . . . . 0.0 109.173 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.738 HD22 HG11 ' B' ' 3' ' ' VAL . 18.4 mt -61.22 -24.63 66.48 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.299 -0.876 . . . . 0.0 110.578 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 8.5 tmm? -69.78 -49.19 55.31 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.234 -0.916 . . . . 0.0 109.521 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -59.81 -41.7 91.86 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.594 -0.691 . . . . 0.0 109.953 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.04 -40.91 95.47 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.616 -0.678 . . . . 0.0 110.135 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' ALA . . . . . 0.73 ' HA ' HD12 ' B' ' 32' ' ' ILE . . . -68.3 -49.78 58.12 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.266 -0.896 . . . . 0.0 111.046 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 69.3 t -65.42 -39.19 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.36 -0.837 . . . . 0.0 110.734 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 28.2 m -70.16 -13.97 62.43 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.372 -0.83 . . . . 0.0 111.526 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -118.2 23.8 11.37 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.04 -1.038 . . . . 0.0 110.663 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.72 38.27 58.81 Favored Glycine 0 N--CA 1.492 2.424 0 O-C-N 121.556 -0.715 . . . . 0.0 111.828 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.73 HD12 ' HA ' ' B' ' 27' ' ' ALA . 1.7 mt -72.55 147.17 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.836 -1.391 . . . . 0.0 108.853 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.68 142.48 58.08 Favored 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 117.215 2.302 . . . . 0.0 117.215 -174.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 62.18 -36.09 0.12 Allowed 'General case' 0 N--CA 1.516 2.855 0 N-CA-C 116.655 2.094 . . . . 0.0 116.655 175.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 84.4 mt -59.78 122.91 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.373 0 O-C-N 119.843 -1.785 . . . . 0.0 110.673 -178.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.591 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 18.9 t -100.12 -51.46 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.63 -0.669 . . . . 0.0 111.193 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.16 56.5 20.08 Favored Glycine 0 N--CA 1.5 2.906 0 N-CA-C 107.447 -2.261 . . . . 0.0 107.447 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.3 -49.31 44.11 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.974 -0.721 . . . . 0.0 112.269 -177.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 39' ' ' CYS . . . . . 0.555 ' HB3' ' HB3' ' B' ' 45' ' ' CYS . 2.3 p -66.59 -10.44 45.51 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.206 -0.934 . . . . 0.0 112.384 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.82 -5.51 64.02 Favored Glycine 0 N--CA 1.499 2.854 0 O-C-N 120.824 -1.172 . . . . 0.0 111.968 177.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.06 19.58 10.63 Favored Glycine 0 N--CA 1.495 2.589 0 O-C-N 120.815 -1.403 . . . . 0.0 111.071 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 90.1 p -99.01 19.15 15.63 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.062 -1.258 . . . . 0.0 111.119 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.99 40.82 30.33 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.42 -0.8 . . . . 0.0 111.941 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 44' ' ' SER . . . . . 0.429 ' CB ' ' HA ' ' A' ' 354' ' ' SER . 70.7 m -117.02 11.19 14.2 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.368 -0.832 . . . . 0.0 109.494 178.184 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 45' ' ' CYS . . . . . 0.555 ' HB3' ' HB3' ' B' ' 39' ' ' CYS . 15.1 p -149.51 -179.09 6.82 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.54 -0.725 . . . . 0.0 109.049 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.07 34.09 3.1 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.849 -1.157 . . . . 0.0 111.362 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 47' ' ' THR . . . . . 0.591 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 81.9 p -97.61 13.27 30.73 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.0 -1.063 . . . . 0.0 111.277 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 29.1 p -120.54 31.74 6.31 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 23.9 t-160 -72.74 133.05 44.38 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.574 -178.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.3 m -146.26 160.07 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 51' ' ' TYR . . . . . 0.422 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.5 m-85 -105.41 102.7 12.16 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.26 -0.9 . . . . 0.0 108.709 178.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.3 t -61.87 135.15 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.319 -0.863 . . . . 0.0 109.362 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.7 131.79 51.34 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.981 0.896 . . . . 0.0 109.505 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' B' ' 54' ' ' GLU . 11.1 mp0 -44.28 -31.05 0.91 Allowed 'General case' 0 N--CA 1.505 2.314 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -178.544 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.76 -6.96 54.38 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.982 -1.074 . . . . 0.0 112.742 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -119.91 -6.61 10.04 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.492 -1.38 . . . . 0.0 111.892 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.3 p -55.49 -37.77 68.27 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.167 -0.958 . . . . 0.0 112.84 -178.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -81.14 -6.71 59.14 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.773 -1.204 . . . . 0.0 111.447 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -89.83 -11.66 41.37 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.017 -1.052 . . . . 0.0 109.841 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.7 t -104.05 141.02 21.65 Favored Pre-proline 0 N--CA 1.489 1.521 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -73.81 118.85 5.61 Favored 'Trans proline' 0 N--CA 1.488 1.172 0 O-C-N 123.487 1.256 . . . . 0.0 109.001 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.9 160.6 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.761 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 -177.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 63' ' ' ALA . . . . . 0.616 ' HB1' ' HB3' ' B' ' 67' ' ' GLU . . . -65.71 146.16 55.13 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.239 178.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -89.84 -170.73 2.91 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.59 -0.694 . . . . 0.0 110.388 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.56 -42.0 91.42 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.287 -0.883 . . . . 0.0 111.75 -178.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 8.7 ttt180 -67.45 -41.55 84.53 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.173 -0.954 . . . . 0.0 112.014 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 67' ' ' GLU . . . . . 0.616 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 45.5 tt0 -68.2 -43.97 76.88 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.938 -1.101 . . . . 0.0 110.329 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 68' ' ' ILE . . . . . 0.533 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.7 mm -55.55 -42.21 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.243 -0.911 . . . . 0.0 109.367 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.15 -47.88 80.75 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 70' ' ' MET . . . . . 0.415 ' HB3' HD11 ' B' ' 84' ' ' LEU . 5.3 mmt -66.17 -34.01 77.07 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.264 -1.139 . . . . 0.0 111.172 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 71' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' B' ' 71' ' ' LEU . 28.0 mt -63.48 -23.29 67.33 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.294 -0.879 . . . . 0.0 110.634 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 72' ' ' GLU . . . . . 0.533 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 49.8 mt-10 -70.45 -8.69 52.94 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.265 -0.897 . . . . 0.0 110.883 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 83.4 p -119.9 12.6 12.1 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.002 -1.061 . . . . 0.0 112.519 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 30.5 m -60.83 140.42 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 120.714 -1.241 . . . . 0.0 109.634 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 81.9 m -74.53 -39.11 62.56 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.419 -0.8 . . . . 0.0 110.15 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.2 168.81 17.46 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.454 -0.779 . . . . 0.0 110.121 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.32 139.15 55.74 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.44 -0.788 . . . . 0.0 110.566 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.4 tp -90.95 116.15 28.53 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.517 -0.739 . . . . 0.0 109.918 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -103.05 168.31 8.97 Favored Pre-proline 0 N--CA 1.489 1.515 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -76.58 -0.06 10.05 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 O-C-N 123.239 1.126 . . . . 0.0 110.404 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -120.46 22.36 11.3 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.002 -1.061 . . . . 0.0 108.385 176.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 4.3 m -80.78 137.22 36.23 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.853 -0.53 . . . . 0.0 110.407 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.5 mmm-85 -149.75 146.38 27.17 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.455 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.555 HD12 ' HG3' ' B' ' 67' ' ' GLU . 92.1 mt -80.6 98.92 7.86 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 175.091 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 85' ' ' CYS . . . . . 0.409 ' HB2' ' HB2' ' B' ' 23' ' ' LEU . 10.6 p -48.36 -17.89 0.18 Allowed 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -175.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.8 p -70.29 -14.01 62.41 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.662 -1.273 . . . . 0.0 109.464 178.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 80.5 mm-40 -92.66 -12.2 32.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.511 -0.743 . . . . 0.0 110.589 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 61.9 mt -91.49 103.96 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.188 -0.945 . . . . 0.0 110.624 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 46.0 mm -84.94 131.77 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 13.6 tpt -74.88 137.81 42.02 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 122.123 0.963 . . . . 0.0 113.236 -177.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 43.7 p -138.24 166.54 25.06 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 176.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -74.9 1.7 7.38 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 122.632 0.807 . . . . 0.0 111.05 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -87.58 -22.89 24.52 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 176.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.2 mt -93.8 13.02 23.75 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.394 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.47 126.39 23.32 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.203 -0.936 . . . . 0.0 111.162 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.27 6.77 68.36 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.666 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.57 142.75 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 CA-C-N 119.328 1.564 . . . . 0.0 110.779 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 98' ' ' VAL . . . . . 0.469 HG22 ' HB ' ' B' ' 4' ' ' VAL . 60.6 t -122.54 132.95 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.546 -0.722 . . . . 0.0 109.854 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 16.4 m -130.36 135.75 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.535 -0.728 . . . . 0.0 109.814 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 100' ' ' ASP . . . . . 0.422 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.39 134.15 35.2 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.2 t -103.43 127.35 29.82 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.52 -0.737 . . . . 0.0 110.351 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -80.81 130.95 7.86 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 O-C-N 124.129 1.594 . . . . 0.0 108.283 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 103' ' ' ASP . . . . . 0.422 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.4 p-10 -62.41 3.43 0.19 Allowed 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -125.33 114.63 19.15 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.257 -1.527 . . . . 0.0 110.054 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 105' ' ' GLN . . . . . 0.501 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 52.4 mm-40 -113.32 -49.34 2.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.438 -0.789 . . . . 0.0 110.016 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 106' ' ' TRP . . . . . 0.688 ' CD1' ' HB1' ' A' ' 113' ' ' ALA . 23.1 m0 . . . . . 0 N--CA 1.495 1.793 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.531 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.514 HD12 ' HD2' ' A' ' 15' ' ' PRO . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 14' ' ' LEU . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.419 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HG2' HG12 ' A' ' 54' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.569 HG12 ' HG2' ' A' ' 51' ' ' PRO . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.609 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.609 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 64' ' ' ILE . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.435 ' HA ' HD23 ' A' ' 324' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.0 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.414 ' CZ ' HG23 ' A' ' 348' ' ' THR . 5.6 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.6 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.478 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 27.1 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.7 mmt-85 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.64 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.2 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.556 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.717 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.717 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 1.068 HD11 ' CZ ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.621 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 74.3 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.64 ' O ' ' HB3' ' A' ' 83' ' ' SER . 3.9 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 46.0 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.646 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.296 50.1 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 104' ' ' ASP 0.366 52.9 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.646 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 34.8 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.451 ' H ' ' CG ' ' A' ' 106' ' ' PRO 0.342 30.7 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.478 ' HB1' ' HB3' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.739 HD11 ' HA3' ' A' ' 226' ' ' GLY . 7.0 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.566 ' O ' HG22 ' A' ' 119' ' ' VAL . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.417 ' HB2' ' O ' ' A' ' 114' ' ' LEU . 24.3 mt-30 -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.597 ' HA ' HG21 ' A' ' 123' ' ' VAL . 34.9 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.566 HG22 ' O ' ' A' ' 115' ' ' ALA . 27.5 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.493 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.698 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 0.0 OUTLIER -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.698 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.0 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.597 HG21 ' HA ' ' A' ' 118' ' ' VAL . 78.3 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 28.0 mtmt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.455 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.63 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.412 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.595 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 151' ' ' THR . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.799 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.799 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.441 ' O ' ' HG2' ' A' ' 164' ' ' MET . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.578 ' C ' HD23 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.455 ' N ' HD23 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.425 ' N ' ' HD2' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' HIS . . . . . 0.405 ' O ' ' HG ' ' A' ' 180' ' ' LEU . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.574 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 176' ' ' HIS . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.561 ' HA ' ' HE3' ' A' ' 184' ' ' MET . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' MET . . . . . 0.561 ' HE3' ' HA ' ' A' ' 181' ' ' THR . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.421 HD22 ' HE1' ' A' ' 184' ' ' MET . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' ARG . . . . . 0.453 ' HG3' ' HB1' ' A' ' 224' ' ' ALA . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 220' ' ' ILE . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 44.9 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 42.0 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.453 ' HB1' ' HG3' ' A' ' 212' ' ' ARG . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.739 ' HA3' HD11 ' A' ' 114' ' ' LEU . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 4.3 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 13.5 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' ARG . . . . . 1.068 ' CZ ' HD11 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 41.0 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.717 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.487 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 261' ' ' MET . . . . . 0.595 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 13.2 pm0 -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.437 ' N ' ' HD2' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 282' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 285' ' ' CYS . . . . . . . . . . . . . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 288' ' ' LEU . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.706 HD23 ' H ' ' A' ' 294' ' ' LEU . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 298' ' ' GLY . . . . . 0.419 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 299' ' ' ARG . . . . . 0.419 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.0 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.459 ' HA ' HD13 ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 314' ' ' LYS . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 307' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.6 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 308' ' ' HIS . . . . . 0.425 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 36.9 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 314' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 303' ' ' SER . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 318' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 318' ' ' ILE . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 319' ' ' LEU . . . . . 0.647 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 321' ' ' PRO . . . . . 0.68 ' HG2' HD22 ' A' ' 324' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.68 HD22 ' HG2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 13.7 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 327' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 327' ' ' LEU . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.522 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 335' ' ' PRO . . . . . 0.522 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 68.2 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 342' ' ' ARG . . . . . 0.4 ' HB3' HG22 ' A' ' 345' ' ' VAL . 43.4 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 343' ' ' GLN . . . . . 0.482 ' CB ' ' HD3' ' A' ' 344' ' ' LYS . 0.1 OUTLIER -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 344' ' ' LYS . . . . . 0.503 ' HB2' ' HE2' ' A' ' 344' ' ' LYS . 1.7 mppt? -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.4 HG22 ' HB3' ' A' ' 342' ' ' ARG . 60.0 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 13.2 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 348' ' ' THR . . . . . 0.414 HG23 ' CZ ' ' A' ' 72' ' ' ARG . 16.5 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 349' ' ' THR . . . . . . . . . . . . . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 354' ' ' SER . . . . . 0.592 ' HA ' ' HB3' ' B' ' 44' ' ' SER . 95.3 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 356' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 4.9 mp -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 38.2 mtt85 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 14.3 tpp85 -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 68.2 mm-40 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 412' ' ' LYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 40.3 m . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 121.079 0.466 . . . . 0.0 109.757 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.51 138.61 38.51 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.169 -0.957 . . . . 0.0 112.928 -178.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 3' ' ' VAL . . . . . 0.727 HG11 HD22 ' B' ' 23' ' ' LEU . 61.2 t -137.17 122.57 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 177.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.53 HG11 ' CZ ' ' B' ' 12' ' ' ARG . 98.4 t -106.81 129.61 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.159 -0.963 . . . . 0.0 111.62 -178.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.683 ' CG ' HD13 ' B' ' 32' ' ' ILE . 77.3 m-85 -109.22 110.6 21.84 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.83 127.22 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 120.96 -1.087 . . . . 0.0 108.353 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.4 m -86.17 174.67 8.97 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.772 0.796 . . . . 0.0 112.503 -177.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 8' ' ' HIS . . . . . 0.419 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.6 t-80 -60.7 -46.7 89.38 Favored 'General case' 0 N--CA 1.503 2.179 0 CA-C-O 121.142 0.496 . . . . 0.0 110.436 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -65.92 -11.28 46.08 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.575 -0.703 . . . . 0.0 111.387 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.96 15.48 28.45 Favored Glycine 0 N--CA 1.491 2.335 0 O-C-N 121.074 -1.016 . . . . 0.0 111.269 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.0 m -82.07 147.4 29.13 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 118.713 1.257 . . . . 0.0 109.926 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 12' ' ' ARG . . . . . 0.53 ' CZ ' HG11 ' B' ' 4' ' ' VAL . 50.9 ttt85 -118.49 128.8 54.93 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.428 -0.795 . . . . 0.0 111.83 -178.079 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.05 127.67 46.2 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.596 -0.69 . . . . 0.0 109.803 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -111.37 130.64 55.62 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.287 -0.883 . . . . 0.0 111.589 -178.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 84.6 mt -122.79 159.36 28.24 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.753 -0.592 . . . . 0.0 111.118 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -109.61 91.62 3.72 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 176.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.5 t -90.15 133.4 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-O 121.575 0.702 . . . . 0.0 112.303 -176.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.08 170.66 16.12 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.768 -0.582 . . . . 0.0 110.295 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -68.44 151.82 46.29 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.477 -0.764 . . . . 0.0 111.005 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.47 -12.53 55.39 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.03 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 61.1 t -89.99 133.34 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.655 -1.497 . . . . 0.0 110.928 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 97.7 p -80.29 151.88 29.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.513 -0.742 . . . . 0.0 109.127 178.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.727 HD22 HG11 ' B' ' 3' ' ' VAL . 18.5 mt -61.16 -24.63 66.43 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.312 -0.868 . . . . 0.0 110.631 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 2.7 ttp -69.75 -49.2 55.41 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.217 -0.927 . . . . 0.0 109.514 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.79 -41.75 91.86 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.591 -0.693 . . . . 0.0 109.941 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.06 -40.89 95.37 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.574 -0.704 . . . . 0.0 110.137 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' ALA . . . . . 0.718 ' HA ' HD12 ' B' ' 32' ' ' ILE . . . -68.3 -49.77 58.2 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.203 -0.935 . . . . 0.0 111.071 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 77.4 t -65.48 -39.15 84.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.305 -0.872 . . . . 0.0 110.723 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 26.0 m -70.14 -14.0 62.45 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.394 -0.816 . . . . 0.0 111.547 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -118.17 23.78 11.39 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.033 -1.042 . . . . 0.0 110.623 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.74 38.27 58.86 Favored Glycine 0 N--CA 1.493 2.459 0 O-C-N 121.566 -0.709 . . . . 0.0 111.81 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.718 HD12 ' HA ' ' B' ' 27' ' ' ALA . 1.7 mt -72.53 147.12 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.914 -1.345 . . . . 0.0 108.878 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.67 142.51 58.05 Favored 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 117.203 2.297 . . . . 0.0 117.203 -174.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 34' ' ' ASP . . . . . 0.458 ' O ' ' HG3' ' B' ' 105' ' ' GLN . 65.3 m-20 62.19 -36.14 0.12 Allowed 'General case' 0 N--CA 1.515 2.81 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 175.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 84.4 mt -59.69 122.85 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 O-C-N 119.864 -1.772 . . . . 0.0 110.701 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.634 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 2.4 t -100.09 -51.35 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.577 -0.702 . . . . 0.0 111.241 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.1 56.49 20.24 Favored Glycine 0 N--CA 1.5 2.908 0 N-CA-C 107.447 -2.261 . . . . 0.0 107.447 -178.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 38' ' ' ASP . . . . . 0.419 ' N ' HG12 ' B' ' 36' ' ' VAL . 29.7 t0 -71.34 -49.24 44.44 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.991 -0.711 . . . . 0.0 112.262 -177.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 39' ' ' CYS . . . . . 0.555 ' HB3' ' HB3' ' B' ' 45' ' ' CYS . 2.3 p -66.55 -10.46 45.37 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.22 -0.925 . . . . 0.0 112.394 -178.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.77 -5.48 64.13 Favored Glycine 0 N--CA 1.499 2.836 0 O-C-N 120.806 -1.184 . . . . 0.0 111.981 177.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.14 19.51 10.64 Favored Glycine 0 N--CA 1.494 2.558 0 O-C-N 120.842 -1.387 . . . . 0.0 110.978 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 30.7 p -98.99 19.16 15.61 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.037 -1.273 . . . . 0.0 111.115 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 56.04 40.83 30.24 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.391 -0.818 . . . . 0.0 111.93 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 44' ' ' SER . . . . . 0.592 ' HB3' ' HA ' ' A' ' 354' ' ' SER . 5.7 m -117.05 11.21 14.18 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.318 -0.864 . . . . 0.0 109.557 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 45' ' ' CYS . . . . . 0.555 ' HB3' ' HB3' ' B' ' 39' ' ' CYS . 15.1 p -149.56 -179.1 6.83 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.04 34.07 3.11 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.884 -1.135 . . . . 0.0 111.356 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 47' ' ' THR . . . . . 0.634 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 37.2 p -97.52 13.2 30.79 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.964 -1.085 . . . . 0.0 111.314 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 48' ' ' CYS . . . . . 0.415 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.1 p -120.57 31.77 6.3 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 23.8 t-160 -72.7 133.03 44.41 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.609 -178.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.3 m -146.29 160.07 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 51' ' ' TYR . . . . . 0.417 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.5 m-85 -105.42 102.76 12.21 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.3 -0.875 . . . . 0.0 108.681 178.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.2 t -61.98 135.12 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 121.315 -0.865 . . . . 0.0 109.349 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.65 131.81 51.36 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.944 0.878 . . . . 0.0 109.559 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.408 ' H ' ' CD ' ' B' ' 54' ' ' GLU . 11.0 mp0 -44.34 -30.98 0.91 Allowed 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.84 -6.9 54.25 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.984 -1.073 . . . . 0.0 112.712 -178.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -119.95 -6.67 10.02 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 120.503 -1.373 . . . . 0.0 111.871 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.5 p -55.37 -37.85 68.06 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.154 -0.967 . . . . 0.0 112.892 -178.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -81.1 -6.65 59.06 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.787 -1.196 . . . . 0.0 111.46 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -89.93 -11.6 41.28 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.078 -1.014 . . . . 0.0 109.831 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.8 t -104.07 141.05 21.71 Favored Pre-proline 0 N--CA 1.488 1.467 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -73.8 118.92 5.64 Favored 'Trans proline' 0 N--CA 1.489 1.209 0 O-C-N 123.514 1.271 . . . . 0.0 108.986 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.99 160.66 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.761 0 N-CA-C 116.647 2.092 . . . . 0.0 116.647 -177.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 63' ' ' ALA . . . . . 0.612 ' HB1' ' HB3' ' B' ' 67' ' ' GLU . . . -65.77 146.15 55.12 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 114.572 -1.194 . . . . 0.0 111.247 178.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -89.78 -170.79 2.94 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.565 -0.709 . . . . 0.0 110.392 178.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -59.53 -42.05 91.38 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.343 -0.848 . . . . 0.0 111.686 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 5.0 ttt180 -67.39 -41.57 84.76 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.175 -0.953 . . . . 0.0 112.028 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 67' ' ' GLU . . . . . 0.612 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 45.4 tt0 -68.23 -43.91 76.88 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.01 -1.056 . . . . 0.0 110.349 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 68' ' ' ILE . . . . . 0.526 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.6 mm -55.56 -42.18 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 O-C-N 121.287 -0.883 . . . . 0.0 109.372 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.22 -47.84 80.83 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 9.5 mmt -66.18 -33.99 77.01 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.27 -1.135 . . . . 0.0 111.207 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 71' ' ' LEU . . . . . 0.441 ' HA ' HD23 ' B' ' 71' ' ' LEU . 28.1 mt -63.45 -23.35 67.36 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.214 -0.929 . . . . 0.0 110.608 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 72' ' ' GLU . . . . . 0.526 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 49.9 mt-10 -70.41 -8.79 53.54 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.344 -0.848 . . . . 0.0 110.889 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 82.8 p -119.78 12.54 12.18 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.001 -1.062 . . . . 0.0 112.543 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 28.8 m -60.8 140.46 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 O-C-N 120.761 -1.212 . . . . 0.0 109.627 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 44.8 m -74.58 -39.07 62.45 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.406 -0.809 . . . . 0.0 110.174 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.2 168.82 17.43 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.476 -0.765 . . . . 0.0 110.076 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.27 139.15 55.64 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.451 -0.781 . . . . 0.0 110.615 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.4 tp -91.0 116.19 28.6 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.551 -0.718 . . . . 0.0 109.836 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -103.02 168.33 8.95 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -76.62 -0.03 10.04 Favored 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 123.27 1.142 . . . . 0.0 110.43 178.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -120.43 22.35 11.32 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.963 -1.086 . . . . 0.0 108.419 176.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 4.3 m -80.77 137.17 36.24 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.833 -0.542 . . . . 0.0 110.385 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.5 mmm-85 -149.75 146.39 27.17 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.443 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.592 HD12 ' HG3' ' B' ' 67' ' ' GLU . 95.0 mt -80.57 98.99 7.87 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 175.056 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 85' ' ' CYS . . . . . 0.402 ' HB2' ' HB2' ' B' ' 23' ' ' LEU . 10.6 p -48.43 -17.91 0.19 Allowed 'General case' 0 N--CA 1.508 2.439 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -175.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.8 p -70.3 -13.92 62.37 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.646 -1.284 . . . . 0.0 109.453 178.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -92.72 -12.3 31.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.465 -0.772 . . . . 0.0 110.533 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 88' ' ' ILE . . . . . 0.402 HG21 HD13 ' B' ' 88' ' ' ILE . 61.8 mt -91.46 103.96 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.117 -0.99 . . . . 0.0 110.671 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 47.3 mm -84.99 131.8 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 13.6 tpt -74.85 137.77 42.05 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 122.143 0.973 . . . . 0.0 113.244 -177.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 43.8 p -138.2 166.59 24.73 Favored Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 176.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -74.94 1.65 7.46 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 122.689 0.836 . . . . 0.0 110.996 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -87.58 -22.84 24.55 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 176.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.6 mt -93.77 12.95 23.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 122.035 -0.416 . . . . 0.0 110.389 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.45 126.38 23.24 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.128 -0.983 . . . . 0.0 111.177 -178.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.19 6.83 68.48 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.68 179.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.62 142.75 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-N 119.334 1.567 . . . . 0.0 110.81 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 98' ' ' VAL . . . . . 0.461 HG22 ' HB ' ' B' ' 4' ' ' VAL . 60.6 t -122.47 133.02 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.559 -0.713 . . . . 0.0 109.829 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 16.4 m -130.41 135.74 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.456 -0.778 . . . . 0.0 109.788 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 100' ' ' ASP . . . . . 0.417 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.38 134.16 35.19 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.2 t -103.4 127.31 29.91 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.505 -0.747 . . . . 0.0 110.359 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -80.87 130.96 7.79 Favored 'Trans proline' 0 C--N 1.316 -1.163 0 O-C-N 124.101 1.579 . . . . 0.0 108.277 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 103' ' ' ASP . . . . . 0.419 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.3 p-10 -62.37 3.41 0.19 Allowed 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -178.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -125.29 114.58 19.12 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.277 -1.514 . . . . 0.0 110.089 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 105' ' ' GLN . . . . . 0.513 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 23.9 mm-40 -113.25 -49.41 2.91 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.455 -0.778 . . . . 0.0 110.029 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 106' ' ' TRP . . . . . 0.478 ' HB3' ' HB1' ' A' ' 113' ' ' ALA . 17.0 m0 . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 118.249 -0.882 . . . . 0.0 110.547 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.514 HD12 ' HD2' ' A' ' 15' ' ' PRO . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 14' ' ' LEU . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.419 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HG2' HG12 ' A' ' 54' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.569 HG12 ' HG2' ' A' ' 51' ' ' PRO . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.609 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.609 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 64' ' ' ILE . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.435 ' HA ' HD23 ' A' ' 324' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.0 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.4 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.6 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.511 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 26.6 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.4 mtt-85 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.8 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.64 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.1 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.556 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.717 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.717 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 1.068 HD11 ' CZ ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.949 ' O ' ' O2D' ' A' ' 501' ' ' HEM . 67.8 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.64 ' O ' ' HB3' ' A' ' 83' ' ' SER . 3.9 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 45.3 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.605 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.298 63.0 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.511 ' HD2' ' CD1' ' A' ' 78' ' ' TYR 0.367 53.3 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.605 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 33.9 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.452 ' H ' ' CD ' ' A' ' 106' ' ' PRO 0.409 34.0 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.499 ' NH1' ' O1D' ' A' ' 501' ' ' HEM . 12.9 mtp180 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.425 ' HB2' ' CE3' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.538 HD11 ' HA3' ' A' ' 226' ' ' GLY . 38.0 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.503 ' O ' HG22 ' A' ' 119' ' ' VAL . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.66 HG23 HG13 ' A' ' 119' ' ' VAL . 25.2 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.66 HG13 HG23 ' A' ' 118' ' ' VAL . 27.3 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.493 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.698 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 17.7 mtm -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.698 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.1 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.606 HG21 ' HA ' ' A' ' 118' ' ' VAL . 72.7 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 45.4 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.455 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.63 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.412 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.595 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 151' ' ' THR . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.799 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.799 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.441 ' O ' ' HG2' ' A' ' 164' ' ' MET . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.578 ' C ' HD23 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.455 ' N ' HD23 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.425 ' N ' ' HD2' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' HIS . . . . . 0.405 ' O ' ' HG ' ' A' ' 180' ' ' LEU . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.574 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 176' ' ' HIS . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.561 ' HA ' ' HE3' ' A' ' 184' ' ' MET . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' MET . . . . . 0.561 ' HE3' ' HA ' ' A' ' 181' ' ' THR . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.421 HD22 ' HE1' ' A' ' 184' ' ' MET . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.453 ' HG3' ' HB1' ' A' ' 224' ' ' ALA . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 220' ' ' ILE . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 42.7 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 42.0 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.453 ' HB1' ' HG3' ' A' ' 212' ' ' ARG . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.538 ' HA3' HD11 ' A' ' 114' ' ' LEU . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 6.2 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 1.3 m120 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 17.1 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 1.068 ' CZ ' HD11 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 34.2 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.717 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.487 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' MET . . . . . 0.595 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 16.4 pm0 -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.439 ' N ' ' HD2' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 282' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 281' ' ' ILE . 45.4 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' CYS . . . . . . . . . . . . . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 288' ' ' LEU . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.706 HD23 ' H ' ' A' ' 294' ' ' LEU . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.502 HG11 HMA3 ' A' ' 501' ' ' HEM . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 297' ' ' ASP . . . . . 0.513 ' OD2' ' O2A' ' A' ' 501' ' ' HEM . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 298' ' ' GLY . . . . . 0.419 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 299' ' ' ARG . . . . . 0.419 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.7 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.459 ' HA ' HD13 ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 314' ' ' LYS . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.6 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 308' ' ' HIS . . . . . 0.425 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 36.9 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 303' ' ' SER . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 318' ' ' ILE . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 319' ' ' LEU . . . . . 0.647 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 321' ' ' PRO . . . . . 0.68 ' HG2' HD22 ' A' ' 324' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.68 HD22 ' HG2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 13.7 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 327' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 327' ' ' LEU . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.522 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 335' ' ' PRO . . . . . 0.522 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 343' ' ' GLN . . . . . 0.413 ' CB ' ' HD3' ' A' ' 344' ' ' LYS . 1.9 mp0 -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 344' ' ' LYS . . . . . 0.519 ' HD3' ' N ' ' A' ' 344' ' ' LYS . 1.8 mppt? -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 61.0 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 1.1 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 15.8 p80 -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 17.1 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 349' ' ' THR . . . . . . . . . . . . . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 90.8 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 356' ' ' LEU . . . . . 0.58 HD13 ' O ' ' B' ' 39' ' ' CYS . 0.6 OUTLIER -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 7.7 mtm180 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 17.2 tpp85 -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.1 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 68.2 mm-40 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 412' ' ' LYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 39.6 m . . . . . 0 N--CA 1.496 1.832 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.51 138.6 38.5 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.234 -0.916 . . . . 0.0 112.92 -178.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.736 HG11 HD22 ' B' ' 23' ' ' LEU . 61.4 t -137.15 122.57 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.53 HG11 ' CZ ' ' B' ' 12' ' ' ARG . 98.5 t -106.82 129.59 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.124 -0.985 . . . . 0.0 111.625 -178.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -109.18 110.6 21.87 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.82 127.19 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.93 -1.107 . . . . 0.0 108.343 178.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.2 m -86.15 174.68 8.98 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.789 0.804 . . . . 0.0 112.472 -177.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.418 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.68 -46.69 89.39 Favored 'General case' 0 N--CA 1.503 2.18 0 CA-C-O 121.141 0.496 . . . . 0.0 110.453 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -65.94 -11.29 46.41 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.596 -0.69 . . . . 0.0 111.393 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.99 15.49 28.34 Favored Glycine 0 N--CA 1.493 2.441 0 O-C-N 121.174 -0.954 . . . . 0.0 111.238 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.6 m -82.12 147.37 29.1 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 118.789 1.295 . . . . 0.0 109.903 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' ARG . . . . . 0.53 ' CZ ' HG11 ' B' ' 4' ' ' VAL . 50.8 ttt85 -118.42 128.72 54.89 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.454 -0.779 . . . . 0.0 111.883 -178.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.99 127.64 46.22 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.595 -0.69 . . . . 0.0 109.843 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -111.28 130.6 55.61 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.281 -0.887 . . . . 0.0 111.632 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.62 HD11 HD11 ' B' ' 32' ' ' ILE . 84.6 mt -122.72 159.4 28.05 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.752 -0.592 . . . . 0.0 111.082 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -109.64 91.64 3.73 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 176.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.6 t -90.17 133.39 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.571 0.7 . . . . 0.0 112.314 -176.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.07 170.67 16.11 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.788 -0.57 . . . . 0.0 110.251 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -68.45 151.8 46.31 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.535 -0.728 . . . . 0.0 111.0 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.48 -12.52 55.44 Favored Glycine 0 N--CA 1.495 2.602 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.065 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 59.3 t -89.93 133.34 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 120.699 -1.471 . . . . 0.0 110.951 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 22.1 p -80.26 151.97 29.31 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.736 HD22 HG11 ' B' ' 3' ' ' VAL . 18.4 mt -61.24 -24.59 66.47 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.316 -0.865 . . . . 0.0 110.618 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 8.8 tmm? -69.76 -49.23 55.0 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.2 -0.938 . . . . 0.0 109.497 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -59.91 -41.62 92.12 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.56 -0.713 . . . . 0.0 109.895 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.07 -40.89 95.33 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.655 -0.653 . . . . 0.0 110.169 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' ALA . . . . . 0.697 ' HA ' HD13 ' B' ' 32' ' ' ILE . . . -68.35 -49.71 58.39 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.219 -0.926 . . . . 0.0 111.058 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 53.8 t -65.42 -39.25 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.298 -0.876 . . . . 0.0 110.711 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 24.0 m -70.01 -14.12 62.55 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.325 -0.859 . . . . 0.0 111.557 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -118.15 23.78 11.39 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.036 -1.04 . . . . 0.0 110.691 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.81 38.21 59.1 Favored Glycine 0 N--CA 1.493 2.454 0 O-C-N 121.527 -0.733 . . . . 0.0 111.83 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.697 HD13 ' HA ' ' B' ' 27' ' ' ALA . 1.0 OUTLIER -72.53 147.11 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.847 -1.384 . . . . 0.0 108.874 179.055 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -62.63 142.43 58.05 Favored 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 117.201 2.297 . . . . 0.0 117.201 -174.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 34' ' ' ASP . . . . . 0.447 ' O ' ' HG3' ' B' ' 105' ' ' GLN . 65.2 m-20 62.25 -36.14 0.12 Allowed 'General case' 0 N--CA 1.516 2.833 0 N-CA-C 116.66 2.096 . . . . 0.0 116.66 175.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 54.3 mt -59.76 122.89 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.419 0 O-C-N 119.89 -1.756 . . . . 0.0 110.62 -178.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.68 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 96.5 t -100.13 -51.36 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.695 -0.628 . . . . 0.0 111.183 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 37' ' ' GLY . . . . . 0.625 ' HA2' ' S2 ' ' B' ' 201' ' ' FES . . . 63.13 56.4 20.67 Favored Glycine 0 N--CA 1.499 2.873 0 N-CA-C 107.491 -2.244 . . . . 0.0 107.491 -178.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -71.27 -49.23 45.17 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.994 -0.709 . . . . 0.0 112.34 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' CYS . . . . . 0.58 ' O ' HD13 ' A' ' 356' ' ' LEU . 2.3 p -66.6 -10.48 46.15 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.215 -0.928 . . . . 0.0 112.332 -178.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.87 -5.57 63.92 Favored Glycine 0 N--CA 1.498 2.804 0 O-C-N 120.787 -1.195 . . . . 0.0 111.968 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.17 19.5 10.63 Favored Glycine 0 N--CA 1.495 2.605 0 O-C-N 120.803 -1.41 . . . . 0.0 111.002 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 80.6 p -98.97 19.21 15.49 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.028 -1.278 . . . . 0.0 111.132 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.401 ' HA ' ' S1 ' ' B' ' 201' ' ' FES . . . 55.92 40.89 30.46 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.4 -0.812 . . . . 0.0 111.941 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 3.6 t -117.02 11.14 14.18 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.376 -0.828 . . . . 0.0 109.518 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' CYS . . . . . 0.723 ' HG ' 'FE1 ' ' B' ' 201' ' ' FES . 15.1 p -149.53 -179.11 6.84 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.05 34.04 3.11 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.803 -1.186 . . . . 0.0 111.367 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' THR . . . . . 0.68 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 23.4 p -97.59 13.24 30.78 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.933 -1.105 . . . . 0.0 111.276 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' CYS . . . . . 0.442 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.1 p -120.58 31.77 6.3 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 177.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' HIS . . . . . 0.468 ' NE2' ' HB3' ' B' ' 82' ' ' SER . 6.5 t-160 -72.65 132.99 44.43 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.642 -178.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.2 m -146.21 160.1 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' TYR . . . . . 0.413 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.3 m-85 -105.43 102.71 12.17 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.238 -0.914 . . . . 0.0 108.706 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.4 t -61.87 135.13 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.282 -0.886 . . . . 0.0 109.369 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.67 131.74 51.16 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.954 0.883 . . . . 0.0 109.518 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' B' ' 54' ' ' GLU . 11.0 mp0 -44.26 -31.08 0.91 Allowed 'General case' 0 N--CA 1.507 2.384 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -178.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.78 -6.88 54.07 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 120.963 -1.086 . . . . 0.0 112.752 -178.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -119.9 -6.73 10.04 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.46 -1.4 . . . . 0.0 111.886 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.4 p -55.45 -37.75 68.13 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.174 -0.954 . . . . 0.0 112.863 -178.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -81.2 -6.62 59.06 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.741 -1.225 . . . . 0.0 111.453 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -89.84 -11.67 41.31 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.045 -1.034 . . . . 0.0 109.859 178.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -104.07 141.04 21.7 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -73.74 118.88 5.63 Favored 'Trans proline' 0 N--CA 1.488 1.18 0 O-C-N 123.509 1.268 . . . . 0.0 109.029 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.94 160.59 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.762 0 N-CA-C 116.65 2.092 . . . . 0.0 116.65 -177.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.615 ' HB1' ' HB3' ' B' ' 67' ' ' GLU . . . -65.76 146.18 55.09 Favored 'General case' 0 N--CA 1.503 2.182 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.258 178.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -89.81 -170.76 2.92 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.606 -0.684 . . . . 0.0 110.383 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -59.59 -41.96 91.46 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.337 -0.852 . . . . 0.0 111.705 -178.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.46 -41.6 84.4 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.186 -0.946 . . . . 0.0 111.969 -178.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.615 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 45.6 tt0 -68.22 -43.96 76.82 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.005 -1.059 . . . . 0.0 110.298 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 68' ' ' ILE . . . . . 0.516 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.6 mm -55.52 -42.22 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.311 -0.868 . . . . 0.0 109.359 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.25 -47.78 81.3 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 26.9 mmt -66.26 -33.91 76.8 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.268 -1.137 . . . . 0.0 111.17 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 71' ' ' LEU . . . . . 0.422 ' HA ' HD23 ' B' ' 71' ' ' LEU . 27.5 mt -63.49 -23.35 67.36 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.207 -0.933 . . . . 0.0 110.623 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 72' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 41.1 mt-10 -70.41 -8.74 53.13 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.354 -0.842 . . . . 0.0 110.911 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 73.5 p -119.82 12.53 12.14 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.009 -1.057 . . . . 0.0 112.504 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 34.9 m -60.78 140.45 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 120.745 -1.222 . . . . 0.0 109.622 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 36.6 m -74.58 -39.06 62.47 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.393 -0.817 . . . . 0.0 110.181 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.2 168.82 17.43 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.47 -0.769 . . . . 0.0 110.094 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.27 139.14 55.67 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.392 -0.818 . . . . 0.0 110.609 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.2 tp -91.02 116.13 28.55 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.489 -0.757 . . . . 0.0 109.869 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -102.97 168.29 9.02 Favored Pre-proline 0 C--N 1.301 -1.518 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -76.62 -0.01 10.02 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 123.243 1.128 . . . . 0.0 110.401 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -120.46 22.36 11.3 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.898 -1.126 . . . . 0.0 108.399 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 82' ' ' SER . . . . . 0.468 ' HB3' ' NE2' ' B' ' 49' ' ' HIS . 4.3 m -80.81 137.19 36.21 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.861 -0.524 . . . . 0.0 110.362 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.4 mmm-85 -149.75 146.38 27.16 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.487 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.593 HD12 ' HG3' ' B' ' 67' ' ' GLU . 97.5 mt -80.54 98.95 7.82 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 175.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 10.6 p -48.41 -17.86 0.18 Allowed 'General case' 0 N--CA 1.508 2.455 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -175.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.8 p -70.27 -14.01 62.42 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.616 -1.302 . . . . 0.0 109.464 178.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -92.7 -12.21 32.04 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.453 -0.779 . . . . 0.0 110.53 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 88' ' ' ILE . . . . . 0.4 HG21 HD13 ' B' ' 88' ' ' ILE . 61.8 mt -91.51 103.96 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.133 -0.979 . . . . 0.0 110.609 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 47.6 mm -84.96 131.79 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 13.6 tpt -74.84 137.8 42.08 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 122.164 0.983 . . . . 0.0 113.189 -177.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 43.7 p -138.25 166.59 24.63 Favored Pre-proline 0 N--CA 1.49 1.548 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 176.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -74.88 1.66 7.42 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 122.638 0.809 . . . . 0.0 111.035 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -87.65 -22.83 24.47 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.5 mt -93.72 12.96 23.75 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.465 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.52 126.44 23.6 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.184 -0.948 . . . . 0.0 111.15 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.21 6.81 68.46 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.66 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.58 142.74 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 CA-C-N 119.325 1.563 . . . . 0.0 110.768 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 98' ' ' VAL . . . . . 0.463 HG22 ' HB ' ' B' ' 4' ' ' VAL . 60.7 t -122.5 132.98 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.501 -0.749 . . . . 0.0 109.831 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 16.3 m -130.35 135.71 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.479 -0.763 . . . . 0.0 109.882 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 100' ' ' ASP . . . . . 0.413 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.34 134.16 35.18 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.1 t -103.46 127.32 29.85 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.545 -0.722 . . . . 0.0 110.32 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -80.85 130.93 7.81 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 O-C-N 124.114 1.586 . . . . 0.0 108.267 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 103' ' ' ASP . . . . . 0.418 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.4 p-10 -62.33 3.33 0.19 Allowed 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -178.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 4.0 mtm105 -125.29 114.71 19.29 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.306 -1.496 . . . . 0.0 110.064 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 105' ' ' GLN . . . . . 0.512 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 23.2 mm-40 -113.39 -49.36 2.9 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.486 -0.759 . . . . 0.0 109.969 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 106' ' ' TRP . . . . . 0.425 ' CE3' ' HB2' ' A' ' 113' ' ' ALA . 27.3 m95 . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.521 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 501' ' ' HEM . . . . . 0.949 ' O2D' ' O ' ' A' ' 100' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 502' ' ' CAM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 201' ' ' FES . . . . . 0.723 'FE1 ' ' HG ' ' B' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.514 HD12 ' HD2' ' A' ' 15' ' ' PRO . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 14' ' ' LEU . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.419 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HG2' HG12 ' A' ' 54' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.569 HG12 ' HG2' ' A' ' 51' ' ' PRO . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.609 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.609 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 64' ' ' ILE . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.435 ' HA ' HD23 ' A' ' 324' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.0 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.4 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.5 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.427 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 27.0 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.64 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.2 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.556 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.717 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.717 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 1.068 HD11 ' CZ ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.949 ' O ' ' O2D' ' A' ' 501' ' ' HEM . 67.6 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.64 ' O ' ' HB3' ' A' ' 83' ' ' SER . 3.8 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 46.0 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.647 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.296 50.2 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 104' ' ' ASP 0.366 52.9 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.647 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 35.0 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.452 ' H ' ' CG ' ' A' ' 106' ' ' PRO 0.413 34.1 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 8.6 mtp180 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.552 ' HB2' ' CE3' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.687 HD11 ' HA3' ' A' ' 226' ' ' GLY . 24.5 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.546 ' O ' HG22 ' A' ' 119' ' ' VAL . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.603 ' HA ' HG21 ' A' ' 123' ' ' VAL . 35.1 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.593 HG13 HG23 ' A' ' 118' ' ' VAL . 30.6 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.493 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.698 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 21.5 mtm -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.698 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.1 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.603 HG21 ' HA ' ' A' ' 118' ' ' VAL . 72.0 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.7 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.452 ' HD2' ' HA ' ' A' ' 123' ' ' VAL . 35.6 mttt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.455 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.63 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.412 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.595 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 151' ' ' THR . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.799 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.799 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.441 ' O ' ' HG2' ' A' ' 164' ' ' MET . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.578 ' C ' HD23 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.455 ' N ' HD23 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.425 ' N ' ' HD2' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' HIS . . . . . 0.405 ' O ' ' HG ' ' A' ' 180' ' ' LEU . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.574 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 176' ' ' HIS . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.561 ' HA ' ' HE3' ' A' ' 184' ' ' MET . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' MET . . . . . 0.561 ' HE3' ' HA ' ' A' ' 181' ' ' THR . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.421 HD22 ' HE1' ' A' ' 184' ' ' MET . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.453 ' HG3' ' HB1' ' A' ' 224' ' ' ALA . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 220' ' ' ILE . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 33.3 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 53.1 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.453 ' HB1' ' HG3' ' A' ' 212' ' ' ARG . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.687 ' HA3' HD11 ' A' ' 114' ' ' LEU . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 4.6 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 1.3 m120 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 18.1 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 1.068 ' CZ ' HD11 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 45.3 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.717 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.487 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' MET . . . . . 0.595 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.437 ' N ' ' HD2' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 282' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' CYS . . . . . . . . . . . . . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 288' ' ' LEU . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.706 HD23 ' H ' ' A' ' 294' ' ' LEU . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.502 HG11 HMA3 ' A' ' 501' ' ' HEM . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 297' ' ' ASP . . . . . 0.513 ' OD2' ' O2A' ' A' ' 501' ' ' HEM . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 298' ' ' GLY . . . . . 0.419 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 299' ' ' ARG . . . . . 0.419 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.1 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.459 ' HA ' HD13 ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 314' ' ' LYS . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.6 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 308' ' ' HIS . . . . . 0.425 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 36.9 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 303' ' ' SER . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 318' ' ' ILE . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 319' ' ' LEU . . . . . 0.647 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 321' ' ' PRO . . . . . 0.68 ' HG2' HD22 ' A' ' 324' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.68 HD22 ' HG2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 13.7 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 327' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 327' ' ' LEU . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.522 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 335' ' ' PRO . . . . . 0.522 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 343' ' ' GLN . . . . . 0.41 ' CB ' ' HD3' ' A' ' 344' ' ' LYS . 1.9 mp0 -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 344' ' ' LYS . . . . . 0.511 ' HD3' ' N ' ' A' ' 344' ' ' LYS . 0.9 OUTLIER -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 60.7 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 10.6 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 39.9 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 349' ' ' THR . . . . . . . . . . . . . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 353' ' ' GLY . . . . . 0.669 ' O ' HD12 ' A' ' 356' ' ' LEU . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 354' ' ' SER . . . . . 0.408 ' HA ' ' HB3' ' B' ' 44' ' ' SER . 97.5 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 356' ' ' LEU . . . . . 0.669 HD12 ' O ' ' A' ' 353' ' ' GLY . 0.2 OUTLIER -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 44.0 mtt85 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 68.2 mm-40 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 412' ' ' LYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 39.7 m . . . . . 0 N--CA 1.495 1.805 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.49 138.61 38.52 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.246 -0.909 . . . . 0.0 112.958 -178.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.744 HG11 HD22 ' B' ' 23' ' ' LEU . 61.0 t -137.16 122.52 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 177.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.528 HG11 ' CZ ' ' B' ' 12' ' ' ARG . 97.9 t -106.74 129.56 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.093 -1.004 . . . . 0.0 111.636 -178.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.513 ' CG ' HD13 ' B' ' 32' ' ' ILE . 77.2 m-85 -109.23 110.58 21.83 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.8 127.27 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 120.93 -1.106 . . . . 0.0 108.377 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.7 m -86.21 174.64 8.97 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.766 0.793 . . . . 0.0 112.498 -177.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.432 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.6 -46.75 89.09 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.186 0.517 . . . . 0.0 110.472 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.2 p-10 -65.92 -11.28 46.04 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.583 -0.698 . . . . 0.0 111.419 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.98 15.51 28.3 Favored Glycine 0 N--CA 1.493 2.459 0 O-C-N 121.195 -0.941 . . . . 0.0 111.256 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.6 m -82.1 147.41 29.1 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 118.721 1.26 . . . . 0.0 109.884 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' ARG . . . . . 0.528 ' CZ ' HG11 ' B' ' 4' ' ' VAL . 50.8 ttt85 -118.52 128.78 54.91 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.508 -0.745 . . . . 0.0 111.816 -178.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 13' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' B' ' 13' ' ' ARG . 0.0 OUTLIER -126.07 127.72 46.27 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.623 -0.673 . . . . 0.0 109.79 179.109 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -111.26 130.62 55.6 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.284 -0.885 . . . . 0.0 111.617 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 84.4 mt -122.83 159.37 28.28 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.357 0.598 . . . . 0.0 111.08 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -109.64 91.67 3.74 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.7 t -90.22 133.49 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-O 121.654 0.74 . . . . 0.0 112.258 -176.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.13 170.67 16.12 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.766 -0.584 . . . . 0.0 110.242 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -68.45 151.83 46.27 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.5 -0.75 . . . . 0.0 110.954 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.42 -12.45 55.43 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.046 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.462 HG13 ' NE2' ' B' ' 25' ' ' GLN . 61.8 t -89.99 133.35 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 120.654 -1.498 . . . . 0.0 110.904 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 21.6 p -80.28 151.92 29.3 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.593 -0.692 . . . . 0.0 109.143 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.744 HD22 HG11 ' B' ' 3' ' ' VAL . 18.4 mt -61.19 -24.64 66.47 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.29 -0.881 . . . . 0.0 110.618 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' MET . . . . . 0.425 ' SD ' ' S2 ' ' B' ' 201' ' ' FES . 7.7 ttp -69.71 -49.26 55.05 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.263 -0.898 . . . . 0.0 109.489 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' GLN . . . . . 0.462 ' NE2' HG13 ' B' ' 21' ' ' VAL . 0.1 OUTLIER -59.82 -41.67 91.8 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.562 -0.711 . . . . 0.0 109.937 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.11 -40.89 95.17 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.552 -0.718 . . . . 0.0 110.114 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' ALA . . . . . 0.589 ' HA ' HD12 ' B' ' 32' ' ' ILE . . . -68.31 -49.76 58.18 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.2 -0.937 . . . . 0.0 111.066 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 76.8 t -65.42 -39.17 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.317 -0.864 . . . . 0.0 110.755 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 20.5 t -70.09 -14.06 62.49 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.383 -0.823 . . . . 0.0 111.529 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -118.18 23.85 11.34 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.065 -1.022 . . . . 0.0 110.661 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.7 38.24 58.59 Favored Glycine 0 N--CA 1.493 2.481 0 O-C-N 121.55 -0.719 . . . . 0.0 111.871 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.589 HD12 ' HA ' ' B' ' 27' ' ' ALA . 0.4 OUTLIER -72.54 147.21 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.792 -1.416 . . . . 0.0 108.892 179.002 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -62.72 142.48 58.11 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 117.202 2.297 . . . . 0.0 117.202 -174.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 62.29 -36.21 0.12 Allowed 'General case' 0 N--CA 1.515 2.787 0 N-CA-C 116.59 2.07 . . . . 0.0 116.59 175.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.8 mt -59.67 122.85 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.395 0 O-C-N 119.828 -1.795 . . . . 0.0 110.718 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.688 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 90.7 t -100.12 -51.4 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.616 -0.678 . . . . 0.0 111.196 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 37' ' ' GLY . . . . . 0.628 ' HA2' ' S2 ' ' B' ' 201' ' ' FES . . . 63.16 56.41 20.55 Favored Glycine 0 N--CA 1.499 2.873 0 N-CA-C 107.482 -2.247 . . . . 0.0 107.482 -178.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -71.22 -49.33 44.56 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.942 -0.74 . . . . 0.0 112.325 -177.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 39' ' ' CYS . . . . . 0.635 ' O ' HD13 ' A' ' 356' ' ' LEU . 2.3 p -66.55 -10.46 45.39 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.244 -0.91 . . . . 0.0 112.389 -178.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.82 -5.47 64.01 Favored Glycine 0 N--CA 1.499 2.846 0 O-C-N 120.842 -1.161 . . . . 0.0 111.959 177.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.14 19.52 10.63 Favored Glycine 0 N--CA 1.495 2.569 0 O-C-N 120.845 -1.385 . . . . 0.0 110.974 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 14.0 m -98.95 19.12 15.62 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.033 -1.275 . . . . 0.0 111.148 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.97 40.89 30.35 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.418 -0.801 . . . . 0.0 111.892 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 44' ' ' SER . . . . . 0.408 ' HB3' ' HA ' ' A' ' 354' ' ' SER . 37.4 m -117.05 11.22 14.17 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.345 -0.847 . . . . 0.0 109.523 178.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 45' ' ' CYS . . . . . 0.712 ' HG ' 'FE1 ' ' B' ' 201' ' ' FES . 15.1 p -149.54 -179.05 6.78 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.09 34.11 3.09 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.85 -1.156 . . . . 0.0 111.345 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 47' ' ' THR . . . . . 0.688 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 16.9 p -97.63 13.23 30.88 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.947 -1.096 . . . . 0.0 111.243 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 48' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.1 p -120.57 31.75 6.31 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -72.67 133.07 44.45 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.63 -178.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.3 m -146.33 160.11 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 51' ' ' TYR . . . . . 0.419 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.6 m-85 -105.43 102.75 12.2 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.244 -0.91 . . . . 0.0 108.674 178.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.2 t -61.93 135.17 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.226 -0.921 . . . . 0.0 109.351 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.69 131.76 51.24 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.975 0.893 . . . . 0.0 109.539 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.407 ' CD ' ' H ' ' B' ' 54' ' ' GLU . 11.0 mp0 -44.33 -30.98 0.91 Allowed 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -178.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.78 -6.97 54.47 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.982 -1.074 . . . . 0.0 112.75 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -119.87 -6.71 10.06 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.492 -1.38 . . . . 0.0 111.887 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.4 p -55.39 -37.83 68.08 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 121.136 -0.978 . . . . 0.0 112.815 -178.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -81.13 -6.69 59.12 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 120.724 -1.235 . . . . 0.0 111.484 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -89.78 -11.67 41.47 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.974 -1.078 . . . . 0.0 109.878 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -104.08 141.07 21.75 Favored Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -73.8 118.87 5.62 Favored 'Trans proline' 0 N--CA 1.488 1.192 0 O-C-N 123.543 1.286 . . . . 0.0 109.016 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.91 160.64 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.759 0 N-CA-C 116.62 2.081 . . . . 0.0 116.62 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.611 ' HB1' ' HB3' ' B' ' 67' ' ' GLU . . . -65.82 146.19 55.06 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.253 178.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -89.79 -170.78 2.93 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.628 -0.67 . . . . 0.0 110.4 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -59.47 -42.07 91.18 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.31 -0.868 . . . . 0.0 111.716 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -41.47 84.5 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.171 -0.955 . . . . 0.0 112.016 -178.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.709 ' HG3' HD12 ' B' ' 84' ' ' LEU . 45.5 tt0 -68.25 -43.96 76.71 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.97 -1.081 . . . . 0.0 110.335 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 68' ' ' ILE . . . . . 0.525 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.6 mm -55.58 -42.17 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 121.259 -0.901 . . . . 0.0 109.36 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.17 -47.91 80.35 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 13.7 mmt -66.16 -33.97 76.98 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.252 -1.146 . . . . 0.0 111.159 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 71' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' B' ' 71' ' ' LEU . 27.8 mt -63.53 -23.31 67.34 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.231 -0.918 . . . . 0.0 110.568 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 72' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 49.2 mt-10 -70.46 -8.67 52.85 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.352 -0.842 . . . . 0.0 110.919 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 86.4 p -119.83 12.48 12.12 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.035 -1.04 . . . . 0.0 112.528 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 34.9 m -60.68 140.39 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 O-C-N 120.701 -1.249 . . . . 0.0 109.647 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 24.5 m -74.58 -39.01 62.5 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.446 -0.784 . . . . 0.0 110.192 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.28 168.82 17.53 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.464 -0.773 . . . . 0.0 110.063 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -58.19 139.11 55.56 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.403 -0.811 . . . . 0.0 110.634 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.4 tp -90.97 116.14 28.54 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.535 -0.728 . . . . 0.0 109.89 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -103.03 168.34 8.94 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -76.65 -0.06 10.08 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 O-C-N 123.258 1.136 . . . . 0.0 110.388 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -120.4 22.36 11.32 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.992 -1.067 . . . . 0.0 108.395 176.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 4.3 m -80.83 137.23 36.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.898 -0.501 . . . . 0.0 110.382 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.5 mmm-85 -149.75 146.39 27.17 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 120.06 -0.656 . . . . 0.0 111.458 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.709 HD12 ' HG3' ' B' ' 67' ' ' GLU . 95.2 mt -80.58 98.92 7.84 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 175.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 10.5 p -48.33 -17.88 0.18 Allowed 'General case' 0 N--CA 1.508 2.43 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -175.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.9 p -70.32 -13.98 62.39 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.747 -1.221 . . . . 0.0 109.387 178.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -92.69 -12.25 31.97 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.508 -0.745 . . . . 0.0 110.501 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 61.9 mt -91.49 103.9 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.163 -0.961 . . . . 0.0 110.629 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 45.6 mm -84.94 131.78 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 13.6 tpt -74.83 137.74 42.07 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 122.111 0.957 . . . . 0.0 113.266 -177.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 43.7 p -138.17 166.63 24.45 Favored Pre-proline 0 N--CA 1.49 1.558 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 176.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -74.99 1.72 7.42 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 122.643 0.812 . . . . 0.0 110.968 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -87.62 -22.87 24.48 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 176.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.6 mt -93.74 12.95 23.84 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.437 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.44 126.38 23.22 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.201 -0.937 . . . . 0.0 111.148 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.15 6.92 68.45 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.575 -0.822 . . . . 0.0 111.682 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.65 142.74 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-N 119.319 1.559 . . . . 0.0 110.727 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 98' ' ' VAL . . . . . 0.481 HG22 ' HB ' ' B' ' 4' ' ' VAL . 60.7 t -122.52 133.01 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.513 -0.742 . . . . 0.0 109.843 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 16.5 m -130.41 135.74 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.403 -0.811 . . . . 0.0 109.78 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 100' ' ' ASP . . . . . 0.419 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.35 134.18 35.16 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.9 t -103.39 127.31 29.92 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.525 -0.734 . . . . 0.0 110.353 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -80.85 130.92 7.8 Favored 'Trans proline' 0 C--N 1.316 -1.172 0 O-C-N 124.139 1.6 . . . . 0.0 108.319 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 103' ' ' ASP . . . . . 0.432 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.3 p-10 -62.38 3.46 0.19 Allowed 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -178.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -125.32 114.59 19.11 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.256 -1.528 . . . . 0.0 110.067 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 105' ' ' GLN . . . . . 0.5 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 69.4 mm-40 -113.29 -49.35 2.91 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.497 -0.752 . . . . 0.0 109.987 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 106' ' ' TRP . . . . . 0.552 ' CE3' ' HB2' ' A' ' 113' ' ' ALA . 8.0 m95 . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.495 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 501' ' ' HEM . . . . . 0.949 ' O2D' ' O ' ' A' ' 100' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 502' ' ' CAM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 201' ' ' FES . . . . . 0.712 'FE1 ' ' HG ' ' B' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.514 HD12 ' HD2' ' A' ' 15' ' ' PRO . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 14' ' ' LEU . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.419 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HG2' HG12 ' A' ' 54' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.569 HG12 ' HG2' ' A' ' 51' ' ' PRO . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.609 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.609 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 64' ' ' ILE . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.435 ' HA ' HD23 ' A' ' 324' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.0 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.415 ' CZ ' HG23 ' A' ' 348' ' ' THR . 5.6 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.6 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.458 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 27.4 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.2 mmt-85 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.64 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.2 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.556 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.717 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.717 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 1.068 HD11 ' CZ ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.949 ' O ' ' O2D' ' A' ' 501' ' ' HEM . 74.3 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.64 ' O ' ' HB3' ' A' ' 83' ' ' SER . 3.9 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 46.0 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.646 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.294 50.3 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 104' ' ' ASP 0.366 52.9 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.646 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 34.8 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.451 ' H ' ' CG ' ' A' ' 106' ' ' PRO 0.342 30.7 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.581 ' CG ' HD11 ' A' ' 358' ' ' LEU . 3.0 ttp180 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.528 ' HB2' ' CG ' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.752 HD11 ' HA3' ' A' ' 226' ' ' GLY . 6.7 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.546 ' O ' HG22 ' A' ' 119' ' ' VAL . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.603 ' HA ' HG21 ' A' ' 123' ' ' VAL . 35.0 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.594 HG13 HG23 ' A' ' 118' ' ' VAL . 30.6 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.493 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.698 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 7.0 mtm -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.698 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.1 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.603 HG21 ' HA ' ' A' ' 118' ' ' VAL . 72.7 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 46.0 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.455 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.63 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.412 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.595 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 151' ' ' THR . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.799 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.799 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.441 ' O ' ' HG2' ' A' ' 164' ' ' MET . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.578 ' C ' HD23 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.455 ' N ' HD23 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.425 ' N ' ' HD2' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' HIS . . . . . 0.405 ' O ' ' HG ' ' A' ' 180' ' ' LEU . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.574 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 176' ' ' HIS . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.561 ' HA ' ' HE3' ' A' ' 184' ' ' MET . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' MET . . . . . 0.561 ' HE3' ' HA ' ' A' ' 181' ' ' THR . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.421 HD22 ' HE1' ' A' ' 184' ' ' MET . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.453 ' HG3' ' HB1' ' A' ' 224' ' ' ALA . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 220' ' ' ILE . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 42.5 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 42.0 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.453 ' HB1' ' HG3' ' A' ' 212' ' ' ARG . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.752 ' HA3' HD11 ' A' ' 114' ' ' LEU . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 4.3 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 13.5 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 1.068 ' CZ ' HD11 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 41.0 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.717 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.487 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' MET . . . . . 0.595 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 16.4 pm0 -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.437 ' N ' ' HD2' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 282' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' CYS . . . . . . . . . . . . . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 288' ' ' LEU . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.706 HD23 ' H ' ' A' ' 294' ' ' LEU . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.502 HG11 HMA3 ' A' ' 501' ' ' HEM . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 297' ' ' ASP . . . . . 0.513 ' OD2' ' O2A' ' A' ' 501' ' ' HEM . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 298' ' ' GLY . . . . . 0.419 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 299' ' ' ARG . . . . . 0.419 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.0 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.459 ' HA ' HD13 ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 314' ' ' LYS . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.6 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 308' ' ' HIS . . . . . 0.425 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 36.9 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 303' ' ' SER . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 318' ' ' ILE . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 319' ' ' LEU . . . . . 0.647 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 321' ' ' PRO . . . . . 0.68 ' HG2' HD22 ' A' ' 324' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.68 HD22 ' HG2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 13.7 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 327' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 327' ' ' LEU . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.522 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 335' ' ' PRO . . . . . 0.522 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 343' ' ' GLN . . . . . 0.46 ' CB ' ' HD3' ' A' ' 344' ' ' LYS . 1.9 mp0 -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 344' ' ' LYS . . . . . 0.504 ' HB2' ' HE2' ' A' ' 344' ' ' LYS . 1.7 mppt? -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 57.8 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 22.1 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 348' ' ' THR . . . . . 0.415 HG23 ' CZ ' ' A' ' 72' ' ' ARG . 16.5 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 349' ' ' THR . . . . . . . . . . . . . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 92.6 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 356' ' ' LEU . . . . . 0.583 HD13 ' O ' ' B' ' 39' ' ' CYS . 1.0 OUTLIER -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 358' ' ' LEU . . . . . 0.772 ' CD1' HBD2 ' A' ' 501' ' ' HEM . 0.4 OUTLIER -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 39.3 mtt85 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 17.2 tpp85 -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 68.2 mm-40 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 412' ' ' LYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 39.6 m . . . . . 0 N--CA 1.495 1.807 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.53 138.58 38.47 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.181 -0.949 . . . . 0.0 112.927 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.733 HG11 HD22 ' B' ' 23' ' ' LEU . 61.3 t -137.11 122.6 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 177.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.524 HG11 ' CZ ' ' B' ' 12' ' ' ARG . 97.5 t -106.77 129.52 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.139 -0.976 . . . . 0.0 111.649 -178.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.679 ' CG ' HD13 ' B' ' 32' ' ' ILE . 77.1 m-85 -109.21 110.62 21.88 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 39.7 t -94.77 127.2 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.925 -1.109 . . . . 0.0 108.439 178.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.6 m -86.14 174.71 8.96 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.768 0.794 . . . . 0.0 112.493 -177.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.422 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.65 -46.77 89.04 Favored 'General case' 0 N--CA 1.503 2.19 0 CA-C-O 121.193 0.521 . . . . 0.0 110.448 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -65.92 -11.22 45.61 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.544 -0.723 . . . . 0.0 111.425 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.97 15.46 28.48 Favored Glycine 0 N--CA 1.492 2.385 0 O-C-N 121.147 -0.971 . . . . 0.0 111.256 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.4 m -82.07 147.37 29.15 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 118.773 1.287 . . . . 0.0 109.903 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' ARG . . . . . 0.524 ' CZ ' HG11 ' B' ' 4' ' ' VAL . 50.8 ttt85 -118.49 128.77 54.91 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.529 -0.732 . . . . 0.0 111.829 -178.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 13' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' B' ' 13' ' ' ARG . 0.0 OUTLIER -126.01 127.73 46.34 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.554 -0.716 . . . . 0.0 109.79 179.11 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.3 tt0 -111.35 130.66 55.61 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.29 -0.881 . . . . 0.0 111.591 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 85.0 mt -122.79 159.35 28.27 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.754 -0.591 . . . . 0.0 111.114 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -109.62 91.68 3.74 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.7 t -90.27 133.45 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-O 121.688 0.756 . . . . 0.0 112.248 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.08 170.67 16.12 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.706 -0.621 . . . . 0.0 110.262 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -68.46 151.81 46.29 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.532 -0.73 . . . . 0.0 110.967 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.41 -12.46 55.35 Favored Glycine 0 N--CA 1.495 2.629 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.067 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 59.1 t -89.99 133.33 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 120.69 -1.476 . . . . 0.0 110.936 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 21.7 p -80.29 151.94 29.28 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.568 -0.707 . . . . 0.0 109.145 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.733 HD22 HG11 ' B' ' 3' ' ' VAL . 18.5 mt -61.21 -24.63 66.48 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.297 -0.877 . . . . 0.0 110.605 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 24' ' ' MET . . . . . 0.453 ' CE ' ' S2 ' ' B' ' 201' ' ' FES . 7.6 tmm? -69.7 -49.28 54.92 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.235 -0.916 . . . . 0.0 109.5 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -59.81 -41.71 91.87 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.619 -0.675 . . . . 0.0 109.913 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.1 -40.87 95.19 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.631 -0.668 . . . . 0.0 110.121 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' ALA . . . . . 0.73 ' HA ' HD12 ' B' ' 32' ' ' ILE . . . -68.33 -49.77 58.02 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.262 -0.899 . . . . 0.0 111.055 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 51.0 t -65.45 -39.12 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.349 -0.844 . . . . 0.0 110.744 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 15.8 t -70.15 -14.01 62.45 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.41 -0.806 . . . . 0.0 111.503 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -118.14 23.78 11.39 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.024 -1.048 . . . . 0.0 110.664 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.72 38.23 58.67 Favored Glycine 0 N--CA 1.493 2.469 0 O-C-N 121.532 -0.73 . . . . 0.0 111.876 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.73 HD12 ' HA ' ' B' ' 27' ' ' ALA . 1.7 mt -72.49 147.11 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.882 -1.364 . . . . 0.0 108.887 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.66 142.44 58.08 Favored 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 117.214 2.302 . . . . 0.0 117.214 -174.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 62.29 -36.18 0.12 Allowed 'General case' 0 N--CA 1.516 2.831 0 N-CA-C 116.612 2.079 . . . . 0.0 116.612 175.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 84.2 mt -59.67 122.85 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.401 0 O-C-N 119.85 -1.781 . . . . 0.0 110.672 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.535 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 84.4 t -100.15 -51.39 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.595 -0.691 . . . . 0.0 111.237 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 37' ' ' GLY . . . . . 0.623 ' HA2' ' S2 ' ' B' ' 201' ' ' FES . . . 63.15 56.48 20.18 Favored Glycine 0 N--CA 1.499 2.866 0 N-CA-C 107.472 -2.251 . . . . 0.0 107.472 -178.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -71.32 -49.33 43.73 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.985 -0.715 . . . . 0.0 112.259 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' CYS . . . . . 0.583 ' O ' HD13 ' A' ' 356' ' ' LEU . 2.3 p -66.5 -10.49 45.2 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.201 -0.937 . . . . 0.0 112.351 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 40' ' ' GLY . . . . . 0.454 ' CA ' HD22 ' A' ' 356' ' ' LEU . . . 96.81 -5.45 64.01 Favored Glycine 0 N--CA 1.497 2.731 0 O-C-N 120.825 -1.172 . . . . 0.0 111.973 177.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.07 19.57 10.63 Favored Glycine 0 N--CA 1.495 2.584 0 O-C-N 120.77 -1.429 . . . . 0.0 110.985 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 87.1 p -99.02 19.23 15.51 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.054 -1.263 . . . . 0.0 111.141 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.94 40.85 30.41 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.383 -0.823 . . . . 0.0 111.918 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.0 11.14 14.2 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.31 -0.868 . . . . 0.0 109.562 178.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 45' ' ' CYS . . . . . 0.694 ' HG ' 'FE1 ' ' B' ' 201' ' ' FES . 15.1 p -149.48 -179.1 6.82 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.522 -0.736 . . . . 0.0 109.102 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.06 34.09 3.1 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.86 -1.15 . . . . 0.0 111.411 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 47' ' ' THR . . . . . 0.535 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 72.7 p -97.6 13.31 30.57 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.962 -1.086 . . . . 0.0 111.299 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 48' ' ' CYS . . . . . 0.441 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.3 p -120.58 31.74 6.31 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 23.9 t-160 -72.67 133.08 44.45 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.589 -178.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.2 m -146.29 160.06 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 51' ' ' TYR . . . . . 0.413 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.4 m-85 -105.39 102.7 12.16 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.265 -0.897 . . . . 0.0 108.721 178.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.7 t -61.84 135.08 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 121.321 -0.862 . . . . 0.0 109.354 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.61 131.77 51.23 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.983 0.897 . . . . 0.0 109.542 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.416 ' H ' ' CD ' ' B' ' 54' ' ' GLU . 11.0 mp0 -44.3 -31.06 0.92 Allowed 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -178.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.77 -6.92 54.23 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.017 -1.052 . . . . 0.0 112.75 -178.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -119.89 -6.71 10.04 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 120.488 -1.383 . . . . 0.0 111.884 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.5 p -55.38 -37.83 68.07 Favored 'General case' 0 N--CA 1.507 2.406 0 O-C-N 121.173 -0.955 . . . . 0.0 112.835 -178.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 -81.14 -6.66 59.08 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.728 -1.232 . . . . 0.0 111.426 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -89.9 -11.57 41.47 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.033 -1.042 . . . . 0.0 109.872 178.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -104.08 141.02 21.65 Favored Pre-proline 0 N--CA 1.488 1.462 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.79 118.84 5.61 Favored 'Trans proline' 0 N--CA 1.488 1.173 0 O-C-N 123.448 1.236 . . . . 0.0 109.026 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.87 160.61 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.77 0 N-CA-C 116.692 2.108 . . . . 0.0 116.692 -177.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.614 ' HB1' ' HB3' ' B' ' 67' ' ' GLU . . . -65.82 146.13 55.13 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.245 178.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -89.7 -170.78 2.94 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.589 -0.694 . . . . 0.0 110.428 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -59.56 -41.98 91.4 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.321 -0.862 . . . . 0.0 111.748 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.41 -41.57 84.69 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.186 -0.946 . . . . 0.0 112.043 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.623 ' HG3' HD12 ' B' ' 84' ' ' LEU . 45.4 tt0 -68.19 -44.03 76.79 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.98 -1.075 . . . . 0.0 110.317 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 68' ' ' ILE . . . . . 0.527 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.6 mm -55.56 -42.21 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.285 -0.884 . . . . 0.0 109.326 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.16 -47.88 80.71 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 12.5 mmt -66.22 -33.91 76.83 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.273 -1.133 . . . . 0.0 111.182 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 71' ' ' LEU . . . . . 0.432 ' HA ' HD23 ' B' ' 71' ' ' LEU . 27.9 mt -63.48 -23.33 67.35 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.214 -0.928 . . . . 0.0 110.616 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 72' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 49.9 mt-10 -70.44 -8.76 53.46 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.366 -0.834 . . . . 0.0 110.875 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 82.7 p -119.83 12.56 12.14 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.053 -1.029 . . . . 0.0 112.548 -178.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 22.3 m -60.76 140.35 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 120.739 -1.225 . . . . 0.0 109.668 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 13.9 m -74.53 -39.02 62.62 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.449 -0.782 . . . . 0.0 110.195 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.24 168.81 17.5 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.428 -0.795 . . . . 0.0 110.106 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.28 139.11 55.75 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.388 -0.82 . . . . 0.0 110.563 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.3 tp -90.93 116.14 28.51 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.494 -0.754 . . . . 0.0 109.935 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -102.99 168.35 8.93 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -76.64 0.01 10.01 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 O-C-N 123.219 1.115 . . . . 0.0 110.434 178.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -120.5 22.38 11.27 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.941 -1.099 . . . . 0.0 108.406 176.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 4.3 m -80.81 137.21 36.21 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.832 -0.542 . . . . 0.0 110.367 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.3 mmm-85 -149.78 146.42 27.16 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 120.059 -0.657 . . . . 0.0 111.448 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.623 HD12 ' HG3' ' B' ' 67' ' ' GLU . 95.9 mt -80.61 98.97 7.89 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 104.784 -2.302 . . . . 0.0 104.784 175.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 85' ' ' CYS . . . . . 0.41 ' HB2' ' HB2' ' B' ' 23' ' ' LEU . 10.6 p -48.36 -17.86 0.18 Allowed 'General case' 0 N--CA 1.508 2.443 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -175.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.8 p -70.33 -14.0 62.39 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.669 -1.269 . . . . 0.0 109.389 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 59.2 mm-40 -92.72 -12.23 31.92 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.512 -0.742 . . . . 0.0 110.534 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 61.7 mt -91.52 103.97 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.194 -0.941 . . . . 0.0 110.647 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 45.7 mm -85.03 131.75 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 13.6 tpt -74.82 137.76 42.11 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 122.101 0.953 . . . . 0.0 113.243 -177.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 43.6 p -138.16 166.61 24.62 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 176.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -74.98 1.78 7.35 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 122.663 0.823 . . . . 0.0 111.025 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -87.67 -22.81 24.45 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 176.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.3 mt -93.8 13.04 23.69 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.427 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.5 126.4 23.4 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.122 -0.986 . . . . 0.0 111.142 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.22 6.79 68.45 Favored Glycine 0 N--CA 1.492 2.416 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.725 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.61 142.75 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 CA-C-N 119.263 1.532 . . . . 0.0 110.789 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 98' ' ' VAL . . . . . 0.471 HG22 ' HB ' ' B' ' 4' ' ' VAL . 60.9 t -122.49 132.96 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.561 -0.712 . . . . 0.0 109.856 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 16.5 m -130.33 135.73 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.47 -0.769 . . . . 0.0 109.877 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 100' ' ' ASP . . . . . 0.413 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.38 134.14 35.22 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.6 t -103.33 127.31 29.96 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.535 -0.728 . . . . 0.0 110.377 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -80.9 131.0 7.79 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 O-C-N 124.079 1.568 . . . . 0.0 108.286 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 103' ' ' ASP . . . . . 0.422 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.4 p-10 -62.47 3.44 0.2 Allowed 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -178.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -125.28 114.64 19.2 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.288 -1.508 . . . . 0.0 110.088 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 105' ' ' GLN . . . . . 0.505 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 32.6 mm-40 -113.31 -49.35 2.91 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.455 -0.778 . . . . 0.0 110.007 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 106' ' ' TRP . . . . . 0.528 ' CG ' ' HB2' ' A' ' 113' ' ' ALA . 10.3 m0 . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.53 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 501' ' ' HEM . . . . . 0.949 ' O2D' ' O ' ' A' ' 100' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 502' ' ' CAM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 201' ' ' FES . . . . . 0.694 'FE1 ' ' HG ' ' B' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.514 HD12 ' HD2' ' A' ' 15' ' ' PRO . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 14' ' ' LEU . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.419 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HG2' HG12 ' A' ' 54' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.569 HG12 ' HG2' ' A' ' 51' ' ' PRO . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.609 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.609 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 64' ' ' ILE . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.435 ' HA ' HD23 ' A' ' 324' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.0 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.6 mtt180 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.5 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.552 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 25.8 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 84.1 mtt-85 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.8 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.64 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.1 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.556 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.717 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.717 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 1.068 HD11 ' CZ ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.949 ' O ' ' O2D' ' A' ' 501' ' ' HEM . 74.3 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.64 ' O ' ' HB3' ' A' ' 83' ' ' SER . 3.9 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 46.0 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.605 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.298 63.0 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.552 ' HD2' ' CD1' ' A' ' 78' ' ' TYR 0.367 53.3 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.605 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 33.9 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.452 ' H ' ' CD ' ' A' ' 106' ' ' PRO 0.413 34.1 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 15.6 tpt85 -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 5.5 ttt-85 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.478 ' HB2' ' CE3' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.766 HD11 ' HA3' ' A' ' 226' ' ' GLY . 4.2 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.546 ' O ' HG22 ' A' ' 119' ' ' VAL . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.539 ' HA ' ' CD2' ' A' ' 358' ' ' LEU . 23.3 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.603 ' HA ' HG21 ' A' ' 123' ' ' VAL . 35.0 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.595 HG13 HG23 ' A' ' 118' ' ' VAL . 30.6 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.493 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.698 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 12.4 mtm -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.698 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.1 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.603 HG21 ' HA ' ' A' ' 118' ' ' VAL . 72.7 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.2 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.455 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.63 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.412 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.595 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 151' ' ' THR . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.799 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.799 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.441 ' O ' ' HG2' ' A' ' 164' ' ' MET . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.578 ' C ' HD23 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.455 ' N ' HD23 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.425 ' N ' ' HD2' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' HIS . . . . . 0.405 ' O ' ' HG ' ' A' ' 180' ' ' LEU . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.574 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 176' ' ' HIS . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.561 ' HA ' ' HE3' ' A' ' 184' ' ' MET . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' MET . . . . . 0.561 ' HE3' ' HA ' ' A' ' 181' ' ' THR . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.421 HD22 ' HE1' ' A' ' 184' ' ' MET . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.453 ' HG3' ' HB1' ' A' ' 224' ' ' ALA . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 220' ' ' ILE . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 43.5 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 42.0 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.453 ' HB1' ' HG3' ' A' ' 212' ' ' ARG . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.766 ' HA3' HD11 ' A' ' 114' ' ' LEU . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 6.9 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 2.6 m120 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 17.1 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 1.068 ' CZ ' HD11 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 34.2 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.717 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.487 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' MET . . . . . 0.595 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 16.4 pm0 -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.437 ' N ' ' HD2' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 282' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' CYS . . . . . . . . . . . . . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 288' ' ' LEU . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.706 HD23 ' H ' ' A' ' 294' ' ' LEU . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.502 HG11 HMA3 ' A' ' 501' ' ' HEM . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 297' ' ' ASP . . . . . 0.513 ' OD2' ' O2A' ' A' ' 501' ' ' HEM . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 298' ' ' GLY . . . . . 0.419 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 299' ' ' ARG . . . . . 0.419 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.0 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.459 ' HA ' HD13 ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 314' ' ' LYS . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.6 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 308' ' ' HIS . . . . . 0.425 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 36.9 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 303' ' ' SER . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 318' ' ' ILE . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 319' ' ' LEU . . . . . 0.647 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 321' ' ' PRO . . . . . 0.68 ' HG2' HD22 ' A' ' 324' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.68 HD22 ' HG2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 14.7 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 327' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 327' ' ' LEU . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.522 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 335' ' ' PRO . . . . . 0.522 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 99.3 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 8.8 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 45.1 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 349' ' ' THR . . . . . . . . . . . . . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 353' ' ' GLY . . . . . 0.413 ' O ' HD12 ' A' ' 356' ' ' LEU . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 91.4 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 356' ' ' LEU . . . . . 0.57 HD13 ' O ' ' B' ' 39' ' ' CYS . 0.3 OUTLIER -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 358' ' ' LEU . . . . . 0.539 ' CD2' ' HA ' ' A' ' 116' ' ' ASN . 0.6 OUTLIER -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 44.1 mtt85 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 16.6 tpp85 -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.2 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 68.2 mm-40 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 412' ' ' LYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 N--CA 1.495 1.815 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.49 138.58 38.5 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.181 -0.949 . . . . 0.0 112.936 -178.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.744 HG11 HD22 ' B' ' 23' ' ' LEU . 61.3 t -137.12 122.59 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 177.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.526 HG11 ' CZ ' ' B' ' 12' ' ' ARG . 97.8 t -106.79 129.56 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.109 -0.994 . . . . 0.0 111.635 -178.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.504 ' CG ' HD13 ' B' ' 32' ' ' ILE . 77.1 m-85 -109.23 110.63 21.89 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 40.0 t -94.84 127.25 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.88 -1.138 . . . . 0.0 108.345 178.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.4 m -86.15 174.69 8.97 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.747 0.784 . . . . 0.0 112.499 -177.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.427 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.68 -46.8 88.99 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-O 121.129 0.49 . . . . 0.0 110.418 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -65.83 -11.29 45.24 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.56 -0.712 . . . . 0.0 111.405 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.94 15.47 28.53 Favored Glycine 0 N--CA 1.492 2.368 0 O-C-N 121.163 -0.961 . . . . 0.0 111.312 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.1 m -82.09 147.4 29.12 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 118.723 1.261 . . . . 0.0 109.875 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' ARG . . . . . 0.526 ' CZ ' HG11 ' B' ' 4' ' ' VAL . 50.8 ttt85 -118.46 128.82 54.97 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.476 -0.765 . . . . 0.0 111.803 -178.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' B' ' 13' ' ' ARG . 0.0 OUTLIER -126.08 127.73 46.27 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.608 -0.683 . . . . 0.0 109.8 179.084 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.3 tt0 -111.37 130.61 55.63 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.236 -0.915 . . . . 0.0 111.623 -178.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 84.5 mt -122.8 159.38 28.21 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.732 -0.605 . . . . 0.0 111.075 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -109.63 91.63 3.72 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.8 t -90.2 133.47 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-O 121.625 0.726 . . . . 0.0 112.233 -176.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.09 170.7 16.05 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.784 -0.572 . . . . 0.0 110.266 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -68.47 151.79 46.31 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.503 -0.748 . . . . 0.0 110.965 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.5 -12.52 55.53 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.021 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 91.4 t -89.97 133.36 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 120.696 -1.473 . . . . 0.0 110.933 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 88.5 p -80.25 151.86 29.38 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.523 -0.736 . . . . 0.0 109.129 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.744 HD22 HG11 ' B' ' 3' ' ' VAL . 18.4 mt -61.2 -24.68 66.5 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.29 -0.881 . . . . 0.0 110.549 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' MET . . . . . 0.406 ' SD ' ' S2 ' ' B' ' 201' ' ' FES . 2.1 ttp -69.7 -49.24 55.27 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.186 -0.946 . . . . 0.0 109.474 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.81 -41.7 91.82 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.622 -0.674 . . . . 0.0 109.926 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.13 -40.87 95.05 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.607 -0.683 . . . . 0.0 110.099 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' ALA . . . . . 0.583 ' HA ' HD12 ' B' ' 32' ' ' ILE . . . -68.33 -49.79 57.89 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.254 -0.903 . . . . 0.0 111.023 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 71.8 t -65.41 -39.19 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.266 -0.896 . . . . 0.0 110.737 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 15.5 t -70.06 -14.08 62.51 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.342 -0.849 . . . . 0.0 111.562 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -118.13 23.84 11.36 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.016 -1.052 . . . . 0.0 110.658 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.65 38.31 58.55 Favored Glycine 0 N--CA 1.492 2.418 0 O-C-N 121.539 -0.725 . . . . 0.0 111.85 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.583 HD12 ' HA ' ' B' ' 27' ' ' ALA . 0.4 OUTLIER -72.55 147.13 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.829 -1.395 . . . . 0.0 108.875 178.991 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -62.7 142.52 58.08 Favored 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 -174.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 62.19 -36.14 0.12 Allowed 'General case' 0 N--CA 1.515 2.785 0 N-CA-C 116.693 2.108 . . . . 0.0 116.693 175.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.524 HD12 ' CG2' ' B' ' 32' ' ' ILE . 12.1 mt -59.7 122.9 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 O-C-N 119.879 -1.763 . . . . 0.0 110.656 -178.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.663 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 58.0 t -100.14 -51.41 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.626 -0.671 . . . . 0.0 111.192 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 37' ' ' GLY . . . . . 0.623 ' HA2' ' S2 ' ' B' ' 201' ' ' FES . . . 63.17 56.42 20.52 Favored Glycine 0 N--CA 1.499 2.895 0 N-CA-C 107.478 -2.249 . . . . 0.0 107.478 -178.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -71.29 -49.28 44.51 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.983 -0.716 . . . . 0.0 112.279 -177.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 39' ' ' CYS . . . . . 0.57 ' O ' HD13 ' A' ' 356' ' ' LEU . 2.3 p -66.55 -10.48 45.57 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.209 -0.932 . . . . 0.0 112.351 -178.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.82 -5.59 64.08 Favored Glycine 0 N--CA 1.499 2.846 0 O-C-N 120.808 -1.183 . . . . 0.0 112.013 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.16 19.56 10.59 Favored Glycine 0 N--CA 1.495 2.628 0 O-C-N 120.856 -1.379 . . . . 0.0 110.98 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 9.4 t -98.98 19.14 15.63 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.072 -1.251 . . . . 0.0 111.147 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.98 40.84 30.34 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.45 -0.781 . . . . 0.0 111.935 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 44' ' ' SER . . . . . 0.429 ' OG ' ' HB2' ' B' ' 39' ' ' CYS . 2.1 p -117.04 11.23 14.19 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.301 -0.875 . . . . 0.0 109.547 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 45' ' ' CYS . . . . . 0.691 ' HG ' 'FE1 ' ' B' ' 201' ' ' FES . 15.0 p -149.55 -179.11 6.83 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.04 34.08 3.11 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.879 -1.138 . . . . 0.0 111.339 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 47' ' ' THR . . . . . 0.663 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 23.0 p -97.6 13.24 30.81 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.978 -1.076 . . . . 0.0 111.268 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 48' ' ' CYS . . . . . 0.444 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.1 p -120.55 31.74 6.31 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 177.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 23.9 t-160 -72.68 133.01 44.42 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.612 -178.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.4 m -146.24 160.14 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 51' ' ' TYR . . . . . 0.414 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.5 m-85 -105.46 102.76 12.21 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.262 -0.899 . . . . 0.0 108.699 178.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.2 t -61.92 135.13 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 121.296 -0.878 . . . . 0.0 109.34 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.64 131.7 51.03 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.945 0.878 . . . . 0.0 109.525 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.413 ' H ' ' CD ' ' B' ' 54' ' ' GLU . 11.1 mp0 -44.21 -31.12 0.9 Allowed 'General case' 0 N--CA 1.506 2.343 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -178.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.73 -6.93 54.23 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.019 -1.051 . . . . 0.0 112.796 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -119.92 -6.68 10.03 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 120.416 -1.427 . . . . 0.0 111.86 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.4 p -55.39 -37.85 68.12 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.132 -0.98 . . . . 0.0 112.846 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -81.1 -6.66 59.07 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.711 -1.243 . . . . 0.0 111.49 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -89.88 -11.61 41.4 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.986 -1.071 . . . . 0.0 109.848 178.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.8 t -104.08 141.01 21.63 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -73.77 118.84 5.61 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 O-C-N 123.496 1.261 . . . . 0.0 108.983 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.9 160.59 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.75 0 N-CA-C 116.656 2.095 . . . . 0.0 116.656 -177.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.615 ' HB1' ' HB3' ' B' ' 67' ' ' GLU . . . -65.73 146.14 55.14 Favored 'General case' 0 N--CA 1.503 2.178 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.266 178.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -89.78 -170.81 2.94 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.602 -0.686 . . . . 0.0 110.383 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -59.54 -42.02 91.39 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.329 -0.857 . . . . 0.0 111.708 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.45 -41.52 84.57 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.158 -0.964 . . . . 0.0 112.045 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.615 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 45.5 tt0 -68.21 -43.92 76.93 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.954 -1.091 . . . . 0.0 110.343 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 68' ' ' ILE . . . . . 0.529 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.6 mm -55.63 -42.08 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.278 -0.889 . . . . 0.0 109.379 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.24 -47.87 80.44 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 28.5 mmt -66.17 -33.97 76.98 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.275 -1.132 . . . . 0.0 111.226 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 71' ' ' LEU . . . . . 0.447 ' HA ' HD23 ' B' ' 71' ' ' LEU . 28.1 mt -63.47 -23.33 67.35 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.217 -0.927 . . . . 0.0 110.622 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 72' ' ' GLU . . . . . 0.529 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 66.4 mt-10 -70.41 -8.72 53.02 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.339 -0.851 . . . . 0.0 110.926 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 84.8 p -119.91 12.6 12.09 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.008 -1.057 . . . . 0.0 112.461 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 19.4 m -60.84 140.44 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 O-C-N 120.692 -1.255 . . . . 0.0 109.653 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 25.4 m -74.58 -39.09 62.45 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.387 -0.821 . . . . 0.0 110.153 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.18 168.83 17.4 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.464 -0.773 . . . . 0.0 110.073 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.28 139.16 55.67 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.395 -0.815 . . . . 0.0 110.587 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.4 tp -90.95 116.11 28.5 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.498 -0.751 . . . . 0.0 109.907 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -102.94 168.37 8.91 Favored Pre-proline 0 C--N 1.302 -1.5 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -76.71 0.04 9.99 Favored 'Trans proline' 0 C--N 1.314 -1.255 0 O-C-N 123.279 1.147 . . . . 0.0 110.371 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -120.5 22.3 11.3 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.969 -1.082 . . . . 0.0 108.411 176.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 4.3 m -80.77 137.25 36.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.845 -0.534 . . . . 0.0 110.35 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.5 mmm-85 -149.77 146.41 27.16 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.446 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.444 ' HB3' ' SG ' ' B' ' 48' ' ' CYS . 78.4 mt -80.55 99.0 7.86 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 175.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 85' ' ' CYS . . . . . 0.405 ' HB2' ' HB2' ' B' ' 23' ' ' LEU . 11.3 p -48.5 -17.82 0.19 Allowed 'General case' 0 N--CA 1.508 2.439 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -175.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.8 p -70.28 -13.99 62.4 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.714 -1.241 . . . . 0.0 109.459 178.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -92.73 -12.25 31.87 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.489 -0.757 . . . . 0.0 110.545 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 61.7 mt -91.47 104.02 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.195 -0.941 . . . . 0.0 110.625 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 39.2 mm -85.04 131.78 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 13.8 tpt -74.85 137.84 42.1 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 122.126 0.965 . . . . 0.0 113.229 -177.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 43.7 p -138.23 166.57 24.8 Favored Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 176.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -74.92 1.71 7.39 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 O-C-N 122.683 0.833 . . . . 0.0 111.042 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -87.64 -22.82 24.48 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 176.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.7 mt -93.75 12.96 23.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.982 -0.449 . . . . 0.0 110.422 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -54.48 126.36 23.21 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.111 -0.993 . . . . 0.0 111.164 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.21 6.89 68.34 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.669 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.68 142.79 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 CA-C-N 119.36 1.58 . . . . 0.0 110.715 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 98' ' ' VAL . . . . . 0.48 HG22 ' HB ' ' B' ' 4' ' ' VAL . 60.7 t -122.53 133.01 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.532 -0.73 . . . . 0.0 109.819 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 16.5 m -130.41 135.78 59.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.489 -0.757 . . . . 0.0 109.798 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 100' ' ' ASP . . . . . 0.414 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.44 134.17 35.2 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.7 t -103.39 127.27 30.01 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.5 -0.75 . . . . 0.0 110.368 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -80.77 130.92 7.89 Favored 'Trans proline' 0 C--N 1.316 -1.168 0 O-C-N 124.064 1.56 . . . . 0.0 108.268 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 103' ' ' ASP . . . . . 0.427 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.4 p-10 -62.42 3.42 0.19 Allowed 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -178.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 39.5 mtm180 -125.32 114.66 19.2 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.306 -1.496 . . . . 0.0 110.061 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 105' ' ' GLN . . . . . 0.502 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 62.7 mm-40 -113.3 -49.39 2.91 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.497 -0.752 . . . . 0.0 109.954 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 106' ' ' TRP . . . . . 0.522 ' HA ' ' CE3' ' B' ' 106' ' ' TRP . 4.9 m95 . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.522 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 501' ' ' HEM . . . . . 0.949 ' O2D' ' O ' ' A' ' 100' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 502' ' ' CAM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 201' ' ' FES . . . . . 0.691 'FE1 ' ' HG ' ' B' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.514 HD12 ' HD2' ' A' ' 15' ' ' PRO . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 14' ' ' LEU . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.419 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HG2' HG12 ' A' ' 54' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.569 HG12 ' HG2' ' A' ' 51' ' ' PRO . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.609 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.609 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 64' ' ' ILE . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.435 ' HA ' HD23 ' A' ' 324' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.0 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.9 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.5 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.484 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 24.3 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.5 mtm180 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.64 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.2 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.556 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.717 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.717 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 1.068 HD11 ' CZ ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.949 ' O ' ' O2D' ' A' ' 501' ' ' HEM . 74.3 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.64 ' O ' ' HB3' ' A' ' 83' ' ' SER . 3.9 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 46.0 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.647 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.296 50.1 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 104' ' ' ASP 0.366 52.6 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.647 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 35.0 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.452 ' H ' ' CG ' ' A' ' 106' ' ' PRO 0.413 34.1 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.772 ' NH1' ' CBD' ' A' ' 501' ' ' HEM . 6.7 mtp180 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.789 ' HB2' ' CD2' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.685 HD11 ' HA3' ' A' ' 226' ' ' GLY . 24.8 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.546 ' O ' HG22 ' A' ' 119' ' ' VAL . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.603 ' HA ' HG21 ' A' ' 123' ' ' VAL . 35.1 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.593 HG13 HG23 ' A' ' 118' ' ' VAL . 30.6 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.493 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.697 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 37.1 mtm -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.697 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.1 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.603 HG21 ' HA ' ' A' ' 118' ' ' VAL . 72.0 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.7 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.452 ' HD2' ' HA ' ' A' ' 123' ' ' VAL . 35.6 mttt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.455 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.63 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.412 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.595 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 151' ' ' THR . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.799 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.799 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.441 ' O ' ' HG2' ' A' ' 164' ' ' MET . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.578 ' C ' HD23 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.455 ' N ' HD23 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.425 ' N ' ' HD2' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' HIS . . . . . 0.405 ' O ' ' HG ' ' A' ' 180' ' ' LEU . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.574 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 176' ' ' HIS . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.561 ' HA ' ' HE3' ' A' ' 184' ' ' MET . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' MET . . . . . 0.561 ' HE3' ' HA ' ' A' ' 181' ' ' THR . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.421 HD22 ' HE1' ' A' ' 184' ' ' MET . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.453 ' HG3' ' HB1' ' A' ' 224' ' ' ALA . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 220' ' ' ILE . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 33.3 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 53.1 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.453 ' HB1' ' HG3' ' A' ' 212' ' ' ARG . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.685 ' HA3' HD11 ' A' ' 114' ' ' LEU . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 4.6 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 1.1 m120 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 18.1 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 1.068 ' CZ ' HD11 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 45.4 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.717 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.487 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' MET . . . . . 0.595 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.437 ' N ' ' HD2' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 282' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' CYS . . . . . . . . . . . . . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 288' ' ' LEU . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.706 HD23 ' H ' ' A' ' 294' ' ' LEU . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.502 HG11 HMA3 ' A' ' 501' ' ' HEM . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 297' ' ' ASP . . . . . 0.513 ' OD2' ' O2A' ' A' ' 501' ' ' HEM . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 298' ' ' GLY . . . . . 0.419 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 299' ' ' ARG . . . . . 0.419 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.0 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.459 ' HA ' HD13 ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 314' ' ' LYS . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 307' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.6 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 308' ' ' HIS . . . . . 0.425 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 36.9 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 303' ' ' SER . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 318' ' ' ILE . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 319' ' ' LEU . . . . . 0.647 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 321' ' ' PRO . . . . . 0.68 ' HG2' HD22 ' A' ' 324' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.68 HD22 ' HG2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 13.7 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 327' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 327' ' ' LEU . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.522 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 335' ' ' PRO . . . . . 0.522 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 343' ' ' GLN . . . . . 0.466 ' CB ' ' HD3' ' A' ' 344' ' ' LYS . 1.9 mp0 -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 344' ' ' LYS . . . . . 0.524 ' HB2' ' HE2' ' A' ' 344' ' ' LYS . 1.5 mppt? -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 60.6 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 28.9 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 14.2 p80 -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 39.6 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 349' ' ' THR . . . . . . . . . . . . . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 99.6 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 356' ' ' LEU . . . . . 0.681 HD12 ' O ' ' B' ' 39' ' ' CYS . 0.1 OUTLIER -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 358' ' ' LEU . . . . . 0.424 HD12 HBD2 ' A' ' 501' ' ' HEM . 2.9 mt -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 35.9 mtt85 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 68.2 mm-40 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 412' ' ' LYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 N--CA 1.496 1.853 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.49 138.62 38.53 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.226 -0.921 . . . . 0.0 112.939 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.738 HG11 HD22 ' B' ' 23' ' ' LEU . 61.3 t -137.13 122.59 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.528 HG11 ' CZ ' ' B' ' 12' ' ' ARG . 97.4 t -106.81 129.54 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.149 -0.969 . . . . 0.0 111.654 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.511 ' CG ' HD13 ' B' ' 32' ' ' ILE . 77.2 m-85 -109.19 110.53 21.77 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.78 127.25 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.922 -1.111 . . . . 0.0 108.421 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.9 m -86.19 174.64 8.98 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.782 0.801 . . . . 0.0 112.481 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.427 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.61 -46.73 89.17 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-O 121.145 0.497 . . . . 0.0 110.467 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -65.94 -11.29 46.33 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.552 -0.718 . . . . 0.0 111.416 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.02 15.5 28.25 Favored Glycine 0 N--CA 1.492 2.421 0 O-C-N 121.103 -0.998 . . . . 0.0 111.218 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.3 m -82.14 147.36 29.08 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 118.773 1.286 . . . . 0.0 109.874 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' ARG . . . . . 0.528 ' CZ ' HG11 ' B' ' 4' ' ' VAL . 50.9 ttt85 -118.46 128.75 54.9 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.434 -0.791 . . . . 0.0 111.832 -178.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' B' ' 13' ' ' ARG . 0.0 OUTLIER -126.04 127.68 46.24 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.575 -0.703 . . . . 0.0 109.792 179.11 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -111.29 130.62 55.61 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.282 -0.887 . . . . 0.0 111.64 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 84.5 mt -122.77 159.39 28.13 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.741 -0.6 . . . . 0.0 111.107 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -109.66 91.65 3.73 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 176.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.5 t -90.17 133.4 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 CA-C-O 121.605 0.717 . . . . 0.0 112.271 -176.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.13 170.67 16.11 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.812 -0.555 . . . . 0.0 110.257 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -68.36 151.78 46.38 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.491 -0.756 . . . . 0.0 111.01 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.46 -12.46 55.52 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.997 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 60.1 t -89.97 133.27 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 120.691 -1.476 . . . . 0.0 110.932 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 21.2 p -80.22 151.89 29.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.544 -0.723 . . . . 0.0 109.142 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.738 HD22 HG11 ' B' ' 3' ' ' VAL . 18.5 mt -61.15 -24.64 66.44 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.362 -0.836 . . . . 0.0 110.619 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' MET . . . . . 0.478 ' SD ' ' S2 ' ' B' ' 201' ' ' FES . 6.3 ttp -69.76 -49.24 54.9 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.212 -0.93 . . . . 0.0 109.463 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -59.85 -41.65 91.88 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.583 -0.698 . . . . 0.0 109.921 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.16 -40.85 94.9 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.606 -0.684 . . . . 0.0 110.082 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' ALA . . . . . 0.578 ' HA ' HD12 ' B' ' 32' ' ' ILE . . . -68.32 -49.73 58.31 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.207 -0.933 . . . . 0.0 111.079 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 81.7 t -65.5 -39.18 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.333 -0.854 . . . . 0.0 110.7 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 21.4 t -70.1 -14.04 62.48 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.386 -0.822 . . . . 0.0 111.564 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -118.12 23.82 11.37 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.027 -1.046 . . . . 0.0 110.653 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.66 38.22 58.4 Favored Glycine 0 N--CA 1.493 2.46 0 O-C-N 121.52 -0.737 . . . . 0.0 111.872 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.578 HD12 ' HA ' ' B' ' 27' ' ' ALA . 0.4 OUTLIER -72.52 147.18 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.859 -1.377 . . . . 0.0 108.869 179.01 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.67 142.51 58.05 Favored 'General case' 0 N--CA 1.503 2.217 0 N-CA-C 117.169 2.285 . . . . 0.0 117.169 -174.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 62.21 -36.14 0.12 Allowed 'General case' 0 N--CA 1.516 2.835 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 175.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 23.1 mt -59.69 122.87 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 O-C-N 119.928 -1.732 . . . . 0.0 110.665 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.61 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 52.5 t -100.07 -51.47 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.633 -0.667 . . . . 0.0 111.248 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 37' ' ' GLY . . . . . 0.629 ' HA2' ' S2 ' ' B' ' 201' ' ' FES . . . 63.1 56.51 20.14 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 107.459 -2.256 . . . . 0.0 107.459 -178.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -71.27 -49.33 44.16 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.958 -0.731 . . . . 0.0 112.296 -177.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 39' ' ' CYS . . . . . 0.681 ' O ' HD12 ' A' ' 356' ' ' LEU . 2.3 p -66.56 -10.42 45.12 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.249 -0.907 . . . . 0.0 112.359 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 40' ' ' GLY . . . . . 0.516 ' HA3' HD12 ' A' ' 356' ' ' LEU . . . 96.79 -5.53 64.11 Favored Glycine 0 N--CA 1.498 2.779 0 O-C-N 120.763 -1.211 . . . . 0.0 111.985 177.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.16 19.52 10.62 Favored Glycine 0 N--CA 1.495 2.608 0 O-C-N 120.883 -1.363 . . . . 0.0 110.965 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 1.3 t -98.95 19.11 15.64 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.032 -1.276 . . . . 0.0 111.142 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 56.0 40.84 30.32 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.358 -0.839 . . . . 0.0 111.934 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 57.8 m -117.0 11.17 14.21 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.318 -0.864 . . . . 0.0 109.533 178.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 45' ' ' CYS . . . . . 0.703 ' HG ' 'FE1 ' ' B' ' 201' ' ' FES . 15.1 p -149.56 -179.07 6.8 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.511 -0.743 . . . . 0.0 109.039 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.07 33.98 3.11 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.85 -1.156 . . . . 0.0 111.357 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' THR . . . . . 0.61 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 65.1 p -97.51 13.23 30.68 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.0 -1.063 . . . . 0.0 111.275 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 48' ' ' CYS . . . . . 0.444 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.1 p -120.57 31.78 6.29 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 177.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 23.9 t-160 -72.68 133.07 44.44 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.588 -178.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.3 m -146.29 160.06 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' TYR . . . . . 0.419 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.5 m-85 -105.45 102.73 12.19 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.239 -0.913 . . . . 0.0 108.74 178.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.1 t -61.9 135.17 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.269 -0.894 . . . . 0.0 109.348 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.67 131.75 51.2 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.961 0.886 . . . . 0.0 109.495 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.414 ' H ' ' CD ' ' B' ' 54' ' ' GLU . 11.0 mp0 -44.3 -30.99 0.9 Allowed 'General case' 0 N--CA 1.506 2.357 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -178.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.79 -6.92 54.29 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.013 -1.055 . . . . 0.0 112.726 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -119.95 -6.6 10.02 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 120.456 -1.402 . . . . 0.0 111.9 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.4 p -55.48 -37.73 68.2 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 121.155 -0.966 . . . . 0.0 112.892 -178.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -81.2 -6.59 59.03 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 120.743 -1.223 . . . . 0.0 111.44 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -89.89 -11.66 41.21 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.962 -1.087 . . . . 0.0 109.825 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 41.0 t -104.11 141.1 21.81 Favored Pre-proline 0 N--CA 1.488 1.458 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -73.82 118.87 5.61 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 O-C-N 123.485 1.255 . . . . 0.0 108.984 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.93 160.62 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.752 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 -177.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.616 ' HB1' ' HB3' ' B' ' 67' ' ' GLU . . . -65.78 146.2 55.06 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.222 178.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -89.76 -170.78 2.93 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.592 -0.693 . . . . 0.0 110.397 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -59.56 -41.99 91.39 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.377 -0.827 . . . . 0.0 111.739 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.47 -41.54 84.46 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.109 -0.994 . . . . 0.0 111.994 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.616 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 45.4 tt0 -68.23 -43.94 76.81 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.962 -1.086 . . . . 0.0 110.367 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 68' ' ' ILE . . . . . 0.527 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.7 mm -55.57 -42.18 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.292 -0.88 . . . . 0.0 109.37 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.17 -47.86 80.84 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 12.4 mmt -66.19 -33.98 77.0 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.256 -1.144 . . . . 0.0 111.162 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 71' ' ' LEU . . . . . 0.456 ' HA ' HD23 ' B' ' 71' ' ' LEU . 28.0 mt -63.45 -23.34 67.36 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.172 -0.955 . . . . 0.0 110.606 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 72' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 49.2 mt-10 -70.41 -8.75 53.24 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.345 -0.847 . . . . 0.0 110.938 179.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 56.3 p -119.85 12.57 12.13 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.003 -1.061 . . . . 0.0 112.517 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 16.4 m -60.81 140.43 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 120.661 -1.274 . . . . 0.0 109.618 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 41.1 m -74.57 -39.05 62.49 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.432 -0.792 . . . . 0.0 110.187 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.22 168.81 17.47 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.441 -0.787 . . . . 0.0 110.089 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.3 139.18 55.67 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.387 -0.821 . . . . 0.0 110.585 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.4 tp -91.02 116.19 28.6 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.497 -0.752 . . . . 0.0 109.879 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -102.99 168.37 8.9 Favored Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -76.64 -0.05 10.06 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 O-C-N 123.259 1.136 . . . . 0.0 110.404 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -120.5 22.39 11.27 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.001 -1.062 . . . . 0.0 108.375 176.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 4.3 m -80.84 137.2 36.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.833 -0.542 . . . . 0.0 110.359 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.4 mmm-85 -149.74 146.4 27.18 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 120.029 -0.669 . . . . 0.0 111.466 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.444 ' HB3' ' SG ' ' B' ' 48' ' ' CYS . 79.2 mt -80.49 98.97 7.8 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 175.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 85' ' ' CYS . . . . . 0.403 ' HB2' ' HB2' ' B' ' 23' ' ' LEU . 10.7 p -48.45 -17.9 0.19 Allowed 'General case' 0 N--CA 1.507 2.412 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -175.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.8 p -70.24 -13.99 62.42 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.65 -1.281 . . . . 0.0 109.472 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 48.6 mm-40 -92.75 -12.16 32.03 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.509 -0.744 . . . . 0.0 110.502 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 88' ' ' ILE . . . . . 0.404 HG21 HD13 ' B' ' 88' ' ' ILE . 61.8 mt -91.56 104.0 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.16 -0.962 . . . . 0.0 110.567 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 45.3 mm -85.01 131.78 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 13.6 tpt -74.83 137.81 42.11 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 122.166 0.984 . . . . 0.0 113.183 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 43.7 p -138.23 166.52 25.18 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 176.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -74.86 1.67 7.39 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 122.595 0.787 . . . . 0.0 111.026 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -87.65 -22.81 24.48 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 176.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.6 mt -93.78 12.97 23.85 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.408 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -54.52 126.39 23.44 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.175 -0.953 . . . . 0.0 111.161 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.22 6.86 68.36 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.64 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.64 142.75 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 CA-C-N 119.367 1.584 . . . . 0.0 110.714 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 98' ' ' VAL . . . . . 0.477 HG22 ' HB ' ' B' ' 4' ' ' VAL . 60.8 t -122.53 132.99 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.583 -0.698 . . . . 0.0 109.866 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 16.4 m -130.38 135.77 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.518 -0.739 . . . . 0.0 109.795 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 100' ' ' ASP . . . . . 0.419 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.43 134.15 35.22 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.8 t -103.39 127.26 30.02 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.517 -0.739 . . . . 0.0 110.377 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -80.84 130.97 7.84 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 O-C-N 124.118 1.588 . . . . 0.0 108.273 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 103' ' ' ASP . . . . . 0.427 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.3 p-10 -62.35 3.34 0.19 Allowed 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -178.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 39.5 mtm180 -125.29 114.66 19.22 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.237 -1.539 . . . . 0.0 110.09 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 105' ' ' GLN . . . . . 0.509 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 51.7 mm-40 -113.32 -49.38 2.91 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.436 -0.79 . . . . 0.0 109.979 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 106' ' ' TRP . . . . . 0.789 ' CD2' ' HB2' ' A' ' 113' ' ' ALA . 51.1 m95 . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.491 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 501' ' ' HEM . . . . . 0.949 ' O2D' ' O ' ' A' ' 100' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 502' ' ' CAM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 201' ' ' FES . . . . . 0.703 'FE1 ' ' HG ' ' B' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.514 HD12 ' HD2' ' A' ' 15' ' ' PRO . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 14' ' ' LEU . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.419 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HG2' HG12 ' A' ' 54' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.569 HG12 ' HG2' ' A' ' 51' ' ' PRO . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.609 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.609 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 64' ' ' ILE . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.435 ' HA ' HD23 ' A' ' 324' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.9 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 45.7 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.6 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.402 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 29.5 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.9 mtm180 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.64 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.2 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.556 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.717 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.717 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 1.068 HD11 ' CZ ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.949 ' O ' ' O2D' ' A' ' 501' ' ' HEM . 67.8 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.64 ' O ' ' HB3' ' A' ' 83' ' ' SER . 3.9 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 45.3 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.647 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.296 50.2 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 104' ' ' ASP 0.366 52.7 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.647 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 35.0 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.452 ' H ' ' CG ' ' A' ' 106' ' ' PRO 0.372 31.8 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.53 ' HG2' HD11 ' A' ' 358' ' ' LEU . 3.3 mtp180 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.568 ' HB2' ' CG ' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.744 HD11 ' HA3' ' A' ' 226' ' ' GLY . 6.8 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.546 ' O ' HG22 ' A' ' 119' ' ' VAL . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.603 ' HA ' HG21 ' A' ' 123' ' ' VAL . 35.1 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.593 HG13 HG23 ' A' ' 118' ' ' VAL . 30.6 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.493 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.698 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 26.7 mtm -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.698 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.1 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.603 HG21 ' HA ' ' A' ' 118' ' ' VAL . 69.2 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 54.1 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 29.8 mtmt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.455 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.63 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.412 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.595 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 151' ' ' THR . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.799 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.799 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.441 ' O ' ' HG2' ' A' ' 164' ' ' MET . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.578 ' C ' HD23 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.455 ' N ' HD23 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.425 ' N ' ' HD2' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' HIS . . . . . 0.405 ' O ' ' HG ' ' A' ' 180' ' ' LEU . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.574 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 176' ' ' HIS . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.561 ' HA ' ' HE3' ' A' ' 184' ' ' MET . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' MET . . . . . 0.561 ' HE3' ' HA ' ' A' ' 181' ' ' THR . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.421 HD22 ' HE1' ' A' ' 184' ' ' MET . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.453 ' HG3' ' HB1' ' A' ' 224' ' ' ALA . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 220' ' ' ILE . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' A' ' 222' ' ' ILE . 26.5 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 42.0 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.453 ' HB1' ' HG3' ' A' ' 212' ' ' ARG . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.744 ' HA3' HD11 ' A' ' 114' ' ' LEU . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 4.0 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 1.2 m120 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 17.1 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 1.068 ' CZ ' HD11 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 35.4 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.717 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.487 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' MET . . . . . 0.595 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 8.7 pm0 -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.437 ' N ' ' HD2' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 282' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' CYS . . . . . . . . . . . . . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 288' ' ' LEU . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.706 HD23 ' H ' ' A' ' 294' ' ' LEU . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.502 HG11 HMA3 ' A' ' 501' ' ' HEM . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 297' ' ' ASP . . . . . 0.513 ' OD2' ' O2A' ' A' ' 501' ' ' HEM . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 298' ' ' GLY . . . . . 0.419 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 299' ' ' ARG . . . . . 0.419 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.0 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.459 ' HA ' HD13 ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 314' ' ' LYS . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 307' ' ' PHE . . . . . 0.428 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.4 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 308' ' ' HIS . . . . . 0.428 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 41.4 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 303' ' ' SER . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 318' ' ' ILE . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 319' ' ' LEU . . . . . 0.647 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 321' ' ' PRO . . . . . 0.68 ' HG2' HD22 ' A' ' 324' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.68 HD22 ' HG2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 39.5 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 327' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 327' ' ' LEU . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.522 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 335' ' ' PRO . . . . . 0.522 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 92.5 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 1.3 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 47.2 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 349' ' ' THR . . . . . . . . . . . . . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 62.6 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 91.7 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 356' ' ' LEU . . . . . 0.544 HD13 ' O ' ' B' ' 39' ' ' CYS . 1.1 tp -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 358' ' ' LEU . . . . . 0.53 HD11 ' HG2' ' A' ' 112' ' ' ARG . 1.6 mt -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 9.6 mtm180 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 14.2 tpp85 -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 68.2 mm-40 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 412' ' ' LYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 40.1 m . . . . . 0 N--CA 1.496 1.832 0 N-CA-C 109.713 -0.476 . . . . 0.0 109.713 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.46 138.56 38.52 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.211 -0.931 . . . . 0.0 112.94 -178.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.735 HG11 HD22 ' B' ' 23' ' ' LEU . 61.0 t -137.1 122.5 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 177.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.521 HG11 ' CZ ' ' B' ' 12' ' ' ARG . 97.6 t -106.77 129.58 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.131 -0.981 . . . . 0.0 111.622 -178.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -109.22 110.62 21.87 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 39.7 t -94.85 127.22 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.886 -1.133 . . . . 0.0 108.382 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.5 m -86.17 174.67 8.97 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.752 0.786 . . . . 0.0 112.534 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.423 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.65 -46.77 89.05 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 121.136 0.493 . . . . 0.0 110.428 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -65.85 -11.32 45.67 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.556 -0.715 . . . . 0.0 111.463 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.0 15.49 28.32 Favored Glycine 0 N--CA 1.492 2.376 0 O-C-N 121.166 -0.959 . . . . 0.0 111.273 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.3 m -82.11 147.42 29.09 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.047 -1.267 . . . . 0.0 109.894 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' ARG . . . . . 0.521 ' CZ ' HG11 ' B' ' 4' ' ' VAL . 50.8 ttt85 -118.49 128.75 54.89 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.408 -0.807 . . . . 0.0 111.808 -178.052 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 13' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' B' ' 13' ' ' ARG . 0.0 OUTLIER -126.07 127.68 46.21 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.54 -0.725 . . . . 0.0 109.813 179.104 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -111.32 130.61 55.62 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.312 -0.867 . . . . 0.0 111.602 -178.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 84.5 mt -122.8 159.38 28.21 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.687 -0.633 . . . . 0.0 111.09 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -109.6 91.61 3.72 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 176.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.7 t -90.18 133.45 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-O 121.601 0.715 . . . . 0.0 112.252 -176.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.07 170.67 16.11 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.804 -0.56 . . . . 0.0 110.247 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -68.45 151.83 46.27 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.555 -0.716 . . . . 0.0 110.986 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.43 -12.49 55.32 Favored Glycine 0 N--CA 1.495 2.629 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.02 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 91.3 t -89.95 133.37 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 120.705 -1.468 . . . . 0.0 110.899 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 96.6 p -80.3 151.96 29.26 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.735 HD22 HG11 ' B' ' 3' ' ' VAL . 18.5 mt -61.24 -24.62 66.49 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.307 -0.871 . . . . 0.0 110.589 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 13.6 tmm? -69.76 -49.2 55.32 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.238 -0.914 . . . . 0.0 109.493 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -59.83 -41.69 91.88 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.605 -0.684 . . . . 0.0 109.945 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.12 -40.87 95.1 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.648 -0.658 . . . . 0.0 110.165 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.28 -49.79 58.11 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.281 -0.887 . . . . 0.0 111.068 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 55.2 t -65.45 -39.13 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.287 -0.883 . . . . 0.0 110.755 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 24.9 m -70.16 -14.02 62.45 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.386 -0.821 . . . . 0.0 111.502 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' ASN . . . . . 0.509 ' HB3' ' CD1' ' B' ' 32' ' ' ILE . 0.5 OUTLIER -118.17 23.83 11.35 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.021 -1.049 . . . . 0.0 110.652 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.68 38.24 58.54 Favored Glycine 0 N--CA 1.493 2.471 0 O-C-N 121.533 -0.729 . . . . 0.0 111.905 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.509 ' CD1' ' HB3' ' B' ' 30' ' ' ASN . 1.1 mp -72.53 147.22 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.867 -1.372 . . . . 0.0 108.815 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -62.78 142.5 58.15 Favored 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 117.182 2.289 . . . . 0.0 117.182 -174.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 62.24 -36.11 0.12 Allowed 'General case' 0 N--CA 1.515 2.806 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 175.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 57.8 mt -59.74 122.88 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 CA-C-N 121.067 1.758 . . . . 0.0 110.664 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.705 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 48.2 t -100.1 -51.43 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.674 -0.641 . . . . 0.0 111.22 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 37' ' ' GLY . . . . . 0.628 ' HA2' ' S2 ' ' B' ' 201' ' ' FES . . . 63.13 56.51 20.07 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 107.47 -2.252 . . . . 0.0 107.47 -178.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.35 -49.29 43.85 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.988 -0.713 . . . . 0.0 112.26 -177.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 39' ' ' CYS . . . . . 0.553 ' HB3' ' HB3' ' B' ' 45' ' ' CYS . 2.3 p -66.55 -10.45 45.31 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.229 -0.919 . . . . 0.0 112.372 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 40' ' ' GLY . . . . . 0.507 ' CA ' HD22 ' A' ' 356' ' ' LEU . . . 96.82 -5.52 64.04 Favored Glycine 0 N--CA 1.498 2.823 0 O-C-N 120.841 -1.162 . . . . 0.0 111.938 177.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.2 19.42 10.69 Favored Glycine 0 N--CA 1.494 2.557 0 O-C-N 120.794 -1.415 . . . . 0.0 111.031 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 87.7 p -98.86 19.04 15.66 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.055 -1.262 . . . . 0.0 111.158 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 56.01 40.85 30.28 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.401 -0.812 . . . . 0.0 111.926 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 17.3 m -116.99 11.12 14.21 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.401 -0.812 . . . . 0.0 109.522 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 45' ' ' CYS . . . . . 0.742 ' HG ' 'FE1 ' ' B' ' 201' ' ' FES . 15.1 p -149.52 -179.04 6.78 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.537 -0.727 . . . . 0.0 109.073 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.1 34.07 3.09 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.804 -1.185 . . . . 0.0 111.339 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 47' ' ' THR . . . . . 0.705 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 5.6 p -97.6 13.24 30.79 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.972 -1.08 . . . . 0.0 111.288 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 48' ' ' CYS . . . . . 0.444 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.1 p -120.56 31.72 6.32 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 177.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 49' ' ' HIS . . . . . 0.476 ' NE2' ' HB3' ' B' ' 82' ' ' SER . 6.4 t-160 -72.63 133.02 44.47 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.618 -178.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.3 m -146.27 160.05 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' TYR . . . . . 0.417 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.5 m-85 -105.39 102.71 12.17 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.285 -0.885 . . . . 0.0 108.708 178.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.4 t -61.86 135.09 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.316 -0.865 . . . . 0.0 109.387 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.62 131.82 51.36 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.945 0.879 . . . . 0.0 109.522 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' B' ' 54' ' ' GLU . 11.0 mp0 -44.33 -31.03 0.92 Allowed 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.8 -6.91 54.25 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.021 -1.05 . . . . 0.0 112.766 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -119.94 -6.65 10.02 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 120.527 -1.358 . . . . 0.0 111.922 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.5 p -55.41 -37.77 68.06 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.151 -0.968 . . . . 0.0 112.915 -178.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -81.18 -6.59 59.02 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.744 -1.222 . . . . 0.0 111.481 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -89.87 -11.65 41.29 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.97 -1.081 . . . . 0.0 109.854 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.8 t -104.07 141.04 21.7 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -73.74 118.87 5.63 Favored 'Trans proline' 0 N--CA 1.488 1.176 0 O-C-N 123.444 1.233 . . . . 0.0 109.008 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.95 160.61 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.79 0 N-CA-C 116.645 2.091 . . . . 0.0 116.645 -177.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.618 ' HB1' ' HB3' ' B' ' 67' ' ' GLU . . . -65.77 146.17 55.1 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.216 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -89.75 -170.79 2.94 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.594 -0.691 . . . . 0.0 110.398 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -59.53 -42.02 91.36 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.321 -0.862 . . . . 0.0 111.719 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -41.47 84.46 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.242 -0.911 . . . . 0.0 112.027 -178.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.668 ' HG3' HD12 ' B' ' 84' ' ' LEU . 45.3 tt0 -68.26 -43.98 76.63 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.941 -1.099 . . . . 0.0 110.335 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 68' ' ' ILE . . . . . 0.513 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.7 mm -55.53 -42.16 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.283 -0.885 . . . . 0.0 109.394 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.23 -47.86 80.64 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 24.8 mmt -66.18 -33.97 76.98 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.316 -1.108 . . . . 0.0 111.186 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 71' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' B' ' 71' ' ' LEU . 27.5 mt -63.51 -23.32 67.34 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.203 -0.936 . . . . 0.0 110.62 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 72' ' ' GLU . . . . . 0.513 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 44.2 mt-10 -70.44 -8.67 52.75 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.38 -0.825 . . . . 0.0 110.926 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 36.4 m -119.87 12.55 12.1 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.069 -1.02 . . . . 0.0 112.518 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 35.3 m -60.78 140.49 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 120.75 -1.219 . . . . 0.0 109.677 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 33.8 m -74.63 -39.08 62.34 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.372 -0.83 . . . . 0.0 110.136 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.22 168.82 17.46 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.451 -0.78 . . . . 0.0 110.087 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.26 139.12 55.68 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.422 -0.799 . . . . 0.0 110.613 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.5 tp -91.01 116.19 28.6 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.569 -0.707 . . . . 0.0 109.873 179.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -103.02 168.3 9.0 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -76.61 -0.0 10.0 Favored 'Trans proline' 0 C--N 1.315 -1.217 0 O-C-N 123.222 1.117 . . . . 0.0 110.398 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -120.48 22.36 11.29 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.918 -1.114 . . . . 0.0 108.42 176.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 82' ' ' SER . . . . . 0.476 ' HB3' ' NE2' ' B' ' 49' ' ' HIS . 4.3 m -80.81 137.23 36.21 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.91 -0.494 . . . . 0.0 110.383 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.4 mmm-85 -149.78 146.41 27.16 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.47 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.668 HD12 ' HG3' ' B' ' 67' ' ' GLU . 96.3 mt -80.59 98.97 7.88 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 175.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 85' ' ' CYS . . . . . 0.409 ' HB2' ' HB2' ' B' ' 23' ' ' LEU . 10.5 p -48.37 -17.88 0.18 Allowed 'General case' 0 N--CA 1.508 2.448 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -175.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.9 p -70.29 -14.0 62.41 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.686 -1.259 . . . . 0.0 109.474 178.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -92.68 -12.23 32.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.492 -0.755 . . . . 0.0 110.553 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 61.8 mt -91.48 103.95 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.179 -0.951 . . . . 0.0 110.648 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 27.6 mm -85.03 131.8 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 13.8 tpt -74.89 137.78 41.99 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 122.176 0.988 . . . . 0.0 113.221 -177.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 43.6 p -138.2 166.59 24.73 Favored Pre-proline 0 N--CA 1.49 1.546 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 176.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -74.97 1.75 7.37 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 122.678 0.83 . . . . 0.0 111.023 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -87.69 -22.77 24.45 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.4 mt -93.85 12.99 23.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 122.024 -0.423 . . . . 0.0 110.412 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -54.5 126.37 23.31 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.185 -0.947 . . . . 0.0 111.172 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.23 6.86 68.33 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.633 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.65 142.76 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 CA-C-N 119.374 1.587 . . . . 0.0 110.773 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 98' ' ' VAL . . . . . 0.478 HG22 ' HB ' ' B' ' 4' ' ' VAL . 60.8 t -122.5 133.01 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.494 -0.754 . . . . 0.0 109.858 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 16.4 m -130.39 135.76 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.439 -0.788 . . . . 0.0 109.793 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 100' ' ' ASP . . . . . 0.417 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.43 134.17 35.2 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.4 t -103.39 127.29 29.96 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.482 -0.761 . . . . 0.0 110.386 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -80.82 131.01 7.87 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 O-C-N 124.016 1.535 . . . . 0.0 108.306 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 103' ' ' ASP . . . . . 0.423 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.4 p-10 -62.44 3.4 0.2 Allowed 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -178.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 4.0 mtm105 -125.32 114.6 19.12 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.282 -1.511 . . . . 0.0 110.075 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 105' ' ' GLN . . . . . 0.501 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 70.6 mm-40 -113.25 -49.43 2.91 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.46 -0.775 . . . . 0.0 110.0 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 106' ' ' TRP . . . . . 0.568 ' CG ' ' HB2' ' A' ' 113' ' ' ALA . 10.9 m0 . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.5 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 501' ' ' HEM . . . . . 0.949 ' O2D' ' O ' ' A' ' 100' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 502' ' ' CAM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 201' ' ' FES . . . . . 0.742 'FE1 ' ' HG ' ' B' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.514 HD12 ' HD2' ' A' ' 15' ' ' PRO . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 14' ' ' LEU . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.419 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HG2' HG12 ' A' ' 54' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.569 HG12 ' HG2' ' A' ' 51' ' ' PRO . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.609 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.609 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 64' ' ' ILE . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.435 ' HA ' HD23 ' A' ' 324' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.9 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.2 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.5 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.475 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 26.4 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.1 mtm180 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.64 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.2 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.556 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.717 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.717 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 1.068 HD11 ' CZ ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.949 ' O ' ' O2D' ' A' ' 501' ' ' HEM . 67.8 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.64 ' O ' ' HB3' ' A' ' 83' ' ' SER . 3.9 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 45.3 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.647 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.296 50.2 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' ' 104' ' ' ASP 0.366 53.2 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.647 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 35.0 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.452 ' H ' ' CG ' ' A' ' 106' ' ' PRO 0.372 31.8 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.8 ttp85 -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 8.6 mtp180 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.493 ' HB2' ' CG ' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.744 HD11 ' HA3' ' A' ' 226' ' ' GLY . 6.8 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.546 ' O ' HG22 ' A' ' 119' ' ' VAL . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.603 ' HA ' HG21 ' A' ' 123' ' ' VAL . 35.1 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.594 HG13 HG23 ' A' ' 118' ' ' VAL . 30.6 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.493 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.698 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 28.8 mtm -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.698 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.1 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.603 HG21 ' HA ' ' A' ' 118' ' ' VAL . 69.2 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 54.1 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 29.8 mtmt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.455 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.63 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.412 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.595 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 151' ' ' THR . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.799 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.799 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.441 ' O ' ' HG2' ' A' ' 164' ' ' MET . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.578 ' C ' HD23 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.455 ' N ' HD23 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.425 ' N ' ' HD2' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' HIS . . . . . 0.405 ' O ' ' HG ' ' A' ' 180' ' ' LEU . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.574 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 176' ' ' HIS . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.561 ' HA ' ' HE3' ' A' ' 184' ' ' MET . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' MET . . . . . 0.561 ' HE3' ' HA ' ' A' ' 181' ' ' THR . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.421 HD22 ' HE1' ' A' ' 184' ' ' MET . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.453 ' HG3' ' HB1' ' A' ' 224' ' ' ALA . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 220' ' ' ILE . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' A' ' 222' ' ' ILE . 26.5 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 42.0 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.453 ' HB1' ' HG3' ' A' ' 212' ' ' ARG . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.744 ' HA3' HD11 ' A' ' 114' ' ' LEU . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 4.0 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 17.1 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 1.068 ' CZ ' HD11 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 35.4 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.717 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.487 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' MET . . . . . 0.595 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 8.7 pm0 -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.437 ' N ' ' HD2' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 282' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' CYS . . . . . . . . . . . . . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 288' ' ' LEU . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.706 HD23 ' H ' ' A' ' 294' ' ' LEU . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.502 HG11 HMA3 ' A' ' 501' ' ' HEM . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 297' ' ' ASP . . . . . 0.513 ' OD2' ' O2A' ' A' ' 501' ' ' HEM . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 298' ' ' GLY . . . . . 0.419 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 299' ' ' ARG . . . . . 0.419 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.0 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.459 ' HA ' HD13 ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 314' ' ' LYS . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 307' ' ' PHE . . . . . 0.428 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.4 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 308' ' ' HIS . . . . . 0.428 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 41.4 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 303' ' ' SER . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 318' ' ' ILE . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 319' ' ' LEU . . . . . 0.647 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 321' ' ' PRO . . . . . 0.68 ' HG2' HD22 ' A' ' 324' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.68 HD22 ' HG2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 39.5 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 327' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 327' ' ' LEU . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.522 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 335' ' ' PRO . . . . . 0.522 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 92.5 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 1.3 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 47.2 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 349' ' ' THR . . . . . . . . . . . . . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 66.3 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 93.8 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 356' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 1.2 tp -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 14.2 tpp85 -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 68.2 mm-40 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 412' ' ' LYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 39.6 m . . . . . 0 N--CA 1.496 1.837 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.54 138.62 38.49 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.218 -0.926 . . . . 0.0 112.934 -178.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.725 HG11 HD22 ' B' ' 23' ' ' LEU . 60.6 t -137.14 122.58 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.533 HG11 ' CZ ' ' B' ' 12' ' ' ARG . 98.1 t -106.82 129.54 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.126 -0.984 . . . . 0.0 111.58 -178.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -109.2 110.58 21.83 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 40.0 t -94.79 127.2 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.899 -1.125 . . . . 0.0 108.367 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.4 m -86.12 174.67 9.0 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.773 0.797 . . . . 0.0 112.527 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.421 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.66 -46.73 89.24 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 121.132 0.491 . . . . 0.0 110.463 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -65.92 -11.26 45.95 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.592 -0.692 . . . . 0.0 111.401 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.97 15.47 28.45 Favored Glycine 0 N--CA 1.492 2.368 0 O-C-N 121.202 -0.936 . . . . 0.0 111.258 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.4 m -82.11 147.35 29.12 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 118.754 1.277 . . . . 0.0 109.899 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' ARG . . . . . 0.533 ' CZ ' HG11 ' B' ' 4' ' ' VAL . 50.8 ttt85 -118.42 128.74 54.91 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.418 -0.801 . . . . 0.0 111.873 -178.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 13' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' B' ' 13' ' ' ARG . 0.0 OUTLIER -126.03 127.7 46.29 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.574 -0.703 . . . . 0.0 109.794 179.117 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -111.31 130.62 55.61 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.255 -0.903 . . . . 0.0 111.666 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 84.6 mt -122.81 159.39 28.21 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.3 0.571 . . . . 0.0 111.073 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -109.62 91.64 3.73 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 106.436 -1.691 . . . . 0.0 106.436 176.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 39.0 t -90.2 133.44 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.577 0.703 . . . . 0.0 112.254 -176.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.09 170.67 16.1 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.805 -0.559 . . . . 0.0 110.282 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -68.37 151.81 46.34 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.498 -0.751 . . . . 0.0 111.021 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.42 -12.48 55.29 Favored Glycine 0 N--CA 1.495 2.623 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.066 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 98.8 t -89.98 133.36 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.673 -1.487 . . . . 0.0 110.922 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 52.0 p -80.29 151.93 29.29 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.725 HD22 HG11 ' B' ' 3' ' ' VAL . 18.4 mt -61.21 -24.54 66.41 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.31 -0.868 . . . . 0.0 110.66 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 11.2 tmm? -69.77 -49.25 54.77 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.258 -0.901 . . . . 0.0 109.462 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -41.74 91.94 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.645 -0.659 . . . . 0.0 109.892 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.06 -40.9 95.39 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.593 -0.692 . . . . 0.0 110.179 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.28 -49.72 58.6 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.285 -0.884 . . . . 0.0 111.12 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 89.5 t -65.42 -39.24 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.266 -0.896 . . . . 0.0 110.737 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 25.0 m -70.03 -14.11 62.53 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.328 -0.857 . . . . 0.0 111.53 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 30' ' ' ASN . . . . . 0.536 ' HB3' ' CD1' ' B' ' 32' ' ' ILE . 0.5 OUTLIER -118.18 23.86 11.33 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.062 -1.024 . . . . 0.0 110.604 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.68 38.23 58.51 Favored Glycine 0 N--CA 1.493 2.463 0 O-C-N 121.557 -0.714 . . . . 0.0 111.873 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.579 ' CG2' HD12 ' B' ' 35' ' ' ILE . 1.0 OUTLIER -72.54 147.18 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.813 -1.404 . . . . 0.0 108.839 179.024 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -62.67 142.5 58.06 Favored 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 117.231 2.308 . . . . 0.0 117.231 -174.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 62.18 -36.09 0.12 Allowed 'General case' 0 N--CA 1.515 2.814 0 N-CA-C 116.657 2.095 . . . . 0.0 116.657 175.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.579 HD12 ' CG2' ' B' ' 32' ' ' ILE . 20.2 mt -59.77 122.92 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 O-C-N 119.821 -1.799 . . . . 0.0 110.635 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.66 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 93.2 t -100.16 -51.4 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.595 -0.691 . . . . 0.0 111.192 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 37' ' ' GLY . . . . . 0.619 ' HA2' ' S2 ' ' B' ' 201' ' ' FES . . . 63.16 56.45 20.34 Favored Glycine 0 N--CA 1.499 2.897 0 N-CA-C 107.467 -2.253 . . . . 0.0 107.467 -178.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -71.33 -49.29 44.05 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.993 -0.71 . . . . 0.0 112.281 -177.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 39' ' ' CYS . . . . . 0.557 ' HB3' ' HB3' ' B' ' 45' ' ' CYS . 2.3 p -66.53 -10.43 44.8 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.219 -0.925 . . . . 0.0 112.373 -178.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.79 -5.47 64.08 Favored Glycine 0 N--CA 1.497 2.767 0 O-C-N 120.745 -1.222 . . . . 0.0 112.0 177.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.08 19.51 10.68 Favored Glycine 0 N--CA 1.495 2.59 0 O-C-N 120.814 -1.403 . . . . 0.0 111.038 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 87.9 p -98.94 19.17 15.52 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.025 -1.279 . . . . 0.0 111.137 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.664 ' HB3' ' HD3' ' B' ' 66' ' ' ARG . . . 55.94 40.89 30.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.395 -0.816 . . . . 0.0 111.918 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 5.7 t -117.02 11.17 14.19 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.356 -0.84 . . . . 0.0 109.566 178.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 45' ' ' CYS . . . . . 0.744 ' HG ' 'FE1 ' ' B' ' 201' ' ' FES . 15.1 p -149.52 -179.1 6.83 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.09 34.06 3.1 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.828 -1.17 . . . . 0.0 111.346 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 47' ' ' THR . . . . . 0.66 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 25.2 p -97.52 13.22 30.7 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.995 -1.066 . . . . 0.0 111.295 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' CYS . . . . . 0.439 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.1 p -120.56 31.74 6.31 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 177.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 49' ' ' HIS . . . . . 0.469 ' NE2' ' HB3' ' B' ' 82' ' ' SER . 6.5 t-160 -72.69 133.05 44.43 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.628 -178.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.3 m -146.27 160.09 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 51' ' ' TYR . . . . . 0.417 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.5 m-85 -105.43 102.74 12.19 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.257 -0.902 . . . . 0.0 108.689 178.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.0 t -61.97 135.12 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.343 -0.848 . . . . 0.0 109.358 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.63 131.79 51.3 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.957 0.884 . . . . 0.0 109.522 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.416 ' H ' ' CD ' ' B' ' 54' ' ' GLU . 11.0 mp0 -44.4 -30.9 0.92 Allowed 'General case' 0 N--CA 1.506 2.336 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -178.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.83 -6.91 54.29 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.016 -1.052 . . . . 0.0 112.772 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -119.98 -6.6 10.01 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.465 -1.397 . . . . 0.0 111.898 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.4 p -55.4 -37.85 68.16 Favored 'General case' 0 N--CA 1.507 2.415 0 O-C-N 121.186 -0.946 . . . . 0.0 112.854 -178.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 47.9 p-10 -81.17 -6.59 59.01 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 120.775 -1.203 . . . . 0.0 111.452 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -89.91 -11.68 41.12 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.983 -1.073 . . . . 0.0 109.822 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -104.04 141.08 21.77 Favored Pre-proline 0 N--CA 1.488 1.475 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -73.78 118.84 5.61 Favored 'Trans proline' 0 N--CA 1.489 1.208 0 O-C-N 123.49 1.258 . . . . 0.0 109.009 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.83 160.62 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.799 0 N-CA-C 116.621 2.082 . . . . 0.0 116.621 -177.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.604 ' HB1' ' HB3' ' B' ' 67' ' ' GLU . . . -65.81 146.11 55.15 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.285 178.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -89.76 -170.76 2.93 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.61 -0.681 . . . . 0.0 110.393 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -59.58 -41.98 91.49 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.325 -0.859 . . . . 0.0 111.711 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 66' ' ' ARG . . . . . 0.664 ' HD3' ' HB3' ' B' ' 43' ' ' ALA . 11.0 ttt180 -67.44 -41.58 84.51 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.141 -0.974 . . . . 0.0 111.989 -178.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.676 ' HG3' HD12 ' B' ' 84' ' ' LEU . 45.4 tt0 -68.23 -43.92 76.88 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.985 -1.072 . . . . 0.0 110.354 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 68' ' ' ILE . . . . . 0.517 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.7 mm -55.57 -42.2 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.311 -0.868 . . . . 0.0 109.354 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.17 -47.88 80.61 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 8.4 mmt -66.12 -33.97 76.99 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.234 -1.157 . . . . 0.0 111.241 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 27.5 mt -63.5 -23.34 67.36 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.213 -0.929 . . . . 0.0 110.636 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 72' ' ' GLU . . . . . 0.517 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 44.3 mt-10 -70.42 -8.72 53.04 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.314 -0.866 . . . . 0.0 110.897 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 1.4 t -119.84 12.56 12.13 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.001 -1.062 . . . . 0.0 112.523 -178.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 34.6 m -60.84 140.42 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 120.736 -1.227 . . . . 0.0 109.631 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.59 -39.03 62.46 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.393 -0.817 . . . . 0.0 110.152 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.22 168.84 17.42 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.486 -0.759 . . . . 0.0 110.086 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.33 139.15 55.78 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.397 -0.814 . . . . 0.0 110.602 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.3 tp -90.99 116.22 28.62 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.549 -0.719 . . . . 0.0 109.833 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -103.04 168.3 8.99 Favored Pre-proline 0 N--CA 1.489 1.5 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -76.62 -0.04 10.05 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 O-C-N 123.311 1.164 . . . . 0.0 110.382 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -120.46 22.37 11.29 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.931 -1.106 . . . . 0.0 108.397 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 82' ' ' SER . . . . . 0.469 ' HB3' ' NE2' ' B' ' 49' ' ' HIS . 4.3 m -80.8 137.23 36.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.879 -0.513 . . . . 0.0 110.32 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.4 mmm-85 -149.8 146.37 27.12 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.465 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.676 HD12 ' HG3' ' B' ' 67' ' ' GLU . 96.3 mt -80.51 98.96 7.81 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 175.081 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 85' ' ' CYS . . . . . 0.405 ' HB2' ' HB2' ' B' ' 23' ' ' LEU . 10.7 p -48.44 -17.86 0.19 Allowed 'General case' 0 N--CA 1.508 2.427 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -175.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.8 p -70.27 -14.0 62.41 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.669 -1.269 . . . . 0.0 109.435 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -92.7 -12.25 31.95 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.459 -0.776 . . . . 0.0 110.526 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 61.8 mt -91.51 103.96 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.198 -0.939 . . . . 0.0 110.664 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 26.5 mm -84.98 131.71 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 13.8 tpt -74.8 137.74 42.11 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 122.075 0.941 . . . . 0.0 113.25 -177.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 43.6 p -138.17 166.6 24.63 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -75.0 1.79 7.35 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 O-C-N 122.669 0.826 . . . . 0.0 111.001 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -87.67 -22.82 24.46 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 176.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.6 mt -93.79 13.02 23.72 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.418 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.53 126.4 23.47 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.146 -0.971 . . . . 0.0 111.148 -178.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.25 6.77 68.41 Favored Glycine 0 N--CA 1.494 2.523 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.662 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.61 142.69 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 CA-C-N 119.343 1.572 . . . . 0.0 110.755 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 98' ' ' VAL . . . . . 0.47 HG22 ' HB ' ' B' ' 4' ' ' VAL . 61.0 t -122.44 132.96 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.519 -0.738 . . . . 0.0 109.88 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 16.5 m -130.37 135.79 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.481 -0.762 . . . . 0.0 109.802 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 100' ' ' ASP . . . . . 0.417 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.44 134.11 35.26 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.9 t -103.34 127.33 29.9 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.493 -0.754 . . . . 0.0 110.391 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -80.89 130.92 7.75 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 O-C-N 124.084 1.571 . . . . 0.0 108.294 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 103' ' ' ASP . . . . . 0.421 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.3 p-10 -62.33 3.38 0.19 Allowed 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -178.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 3.8 mtm105 -125.32 114.68 19.22 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.288 -1.507 . . . . 0.0 110.069 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 105' ' ' GLN . . . . . 0.491 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 69.8 mm-40 -113.31 -49.37 2.91 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.476 -0.765 . . . . 0.0 110.0 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 106' ' ' TRP . . . . . 0.493 ' CG ' ' HB2' ' A' ' 113' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 118.392 -0.813 . . . . 0.0 110.504 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 501' ' ' HEM . . . . . 0.949 ' O2D' ' O ' ' A' ' 100' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 502' ' ' CAM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 201' ' ' FES . . . . . 0.744 'FE1 ' ' HG ' ' B' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.514 HD12 ' HD2' ' A' ' 15' ' ' PRO . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 14' ' ' LEU . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.419 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HG2' HG12 ' A' ' 54' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.569 HG12 ' HG2' ' A' ' 51' ' ' PRO . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.609 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.609 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 64' ' ' ILE . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.435 ' HA ' HD23 ' A' ' 324' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.0 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.6 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.5 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.427 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 30.0 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.6 mtm180 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.64 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.2 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.556 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.717 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.717 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 1.068 HD11 ' CZ ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.949 ' O ' ' O2D' ' A' ' 501' ' ' HEM . 68.2 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.64 ' O ' ' HB3' ' A' ' 83' ' ' SER . 3.8 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 46.0 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.647 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.296 50.2 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 104' ' ' ASP 0.366 52.9 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.647 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 35.0 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.452 ' H ' ' CG ' ' A' ' 106' ' ' PRO 0.413 34.1 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.642 ' CZ ' HD11 ' A' ' 358' ' ' LEU . 7.1 mtp180 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.723 ' HB2' ' CD2' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.685 HD11 ' HA3' ' A' ' 226' ' ' GLY . 24.8 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.546 ' O ' HG22 ' A' ' 119' ' ' VAL . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.603 ' HA ' HG21 ' A' ' 123' ' ' VAL . 35.1 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.593 HG13 HG23 ' A' ' 118' ' ' VAL . 30.6 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.493 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.697 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 31.7 mtm -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.697 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.1 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.603 HG21 ' HA ' ' A' ' 118' ' ' VAL . 72.0 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.7 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.452 ' HD2' ' HA ' ' A' ' 123' ' ' VAL . 35.6 mttt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.455 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.63 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.412 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.595 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 151' ' ' THR . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.799 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.799 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.441 ' O ' ' HG2' ' A' ' 164' ' ' MET . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.578 ' C ' HD23 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.455 ' N ' HD23 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.425 ' N ' ' HD2' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' HIS . . . . . 0.405 ' O ' ' HG ' ' A' ' 180' ' ' LEU . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.574 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 176' ' ' HIS . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.561 ' HA ' ' HE3' ' A' ' 184' ' ' MET . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' MET . . . . . 0.561 ' HE3' ' HA ' ' A' ' 181' ' ' THR . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.421 HD22 ' HE1' ' A' ' 184' ' ' MET . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.453 ' HG3' ' HB1' ' A' ' 224' ' ' ALA . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 220' ' ' ILE . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 33.3 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 53.1 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.453 ' HB1' ' HG3' ' A' ' 212' ' ' ARG . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.685 ' HA3' HD11 ' A' ' 114' ' ' LEU . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 4.6 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 1.1 m120 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 18.1 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 1.068 ' CZ ' HD11 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 45.4 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.717 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.487 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' MET . . . . . 0.595 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.437 ' N ' ' HD2' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 282' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' CYS . . . . . . . . . . . . . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 288' ' ' LEU . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.706 HD23 ' H ' ' A' ' 294' ' ' LEU . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.502 HG11 HMA3 ' A' ' 501' ' ' HEM . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 297' ' ' ASP . . . . . 0.513 ' OD2' ' O2A' ' A' ' 501' ' ' HEM . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 298' ' ' GLY . . . . . 0.419 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 299' ' ' ARG . . . . . 0.419 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.1 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.459 ' HA ' HD13 ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 314' ' ' LYS . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 307' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.6 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 308' ' ' HIS . . . . . 0.425 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 36.9 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 303' ' ' SER . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 318' ' ' ILE . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 319' ' ' LEU . . . . . 0.647 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 321' ' ' PRO . . . . . 0.68 ' HG2' HD22 ' A' ' 324' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.68 HD22 ' HG2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 13.7 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 327' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 327' ' ' LEU . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.522 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 335' ' ' PRO . . . . . 0.522 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 343' ' ' GLN . . . . . 0.41 ' CB ' ' HD3' ' A' ' 344' ' ' LYS . 1.9 mp0 -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 344' ' ' LYS . . . . . 0.511 ' HD3' ' N ' ' A' ' 344' ' ' LYS . 0.9 OUTLIER -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 60.7 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 10.6 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 39.9 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 349' ' ' THR . . . . . . . . . . . . . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 60.2 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 96.4 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 356' ' ' LEU . . . . . 0.509 HD22 ' CA ' ' B' ' 40' ' ' GLY . 1.5 tp -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 358' ' ' LEU . . . . . 1.314 ' CD1' HBD2 ' A' ' 501' ' ' HEM . 1.4 mp -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 43.4 mtt85 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 68.2 mm-40 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 412' ' ' LYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 N--CA 1.496 1.83 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.52 138.58 38.48 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.224 -0.922 . . . . 0.0 112.963 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.743 HG11 HD22 ' B' ' 23' ' ' LEU . 61.2 t -137.11 122.56 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.526 HG11 ' CZ ' ' B' ' 12' ' ' ARG . 97.0 t -106.76 129.54 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.115 -0.991 . . . . 0.0 111.628 -178.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.509 ' CG ' HD13 ' B' ' 32' ' ' ILE . 76.9 m-85 -109.2 110.6 21.85 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.82 127.26 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.927 -1.108 . . . . 0.0 108.34 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.4 m -86.2 174.64 8.97 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.753 0.787 . . . . 0.0 112.502 -177.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.427 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.6 -46.79 88.94 Favored 'General case' 0 N--CA 1.502 2.155 0 CA-C-O 121.138 0.494 . . . . 0.0 110.458 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -65.85 -11.31 45.58 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.57 -0.706 . . . . 0.0 111.433 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.99 15.43 28.49 Favored Glycine 0 N--CA 1.492 2.406 0 O-C-N 121.155 -0.965 . . . . 0.0 111.259 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.5 m -82.05 147.38 29.17 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 118.73 1.265 . . . . 0.0 109.88 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' ARG . . . . . 0.526 ' CZ ' HG11 ' B' ' 4' ' ' VAL . 50.8 ttt85 -118.43 128.74 54.9 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.487 -0.758 . . . . 0.0 111.859 -178.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' B' ' 13' ' ' ARG . 0.0 OUTLIER -126.07 127.71 46.24 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.598 -0.689 . . . . 0.0 109.804 179.08 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -111.3 130.63 55.61 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.282 -0.886 . . . . 0.0 111.647 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 84.8 mt -122.8 159.34 28.29 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.734 -0.604 . . . . 0.0 111.129 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -109.61 91.66 3.74 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 176.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.6 t -90.16 133.41 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-O 121.626 0.727 . . . . 0.0 112.253 -176.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.08 170.71 16.04 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.7 -0.625 . . . . 0.0 110.273 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -68.5 151.82 46.25 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.532 -0.73 . . . . 0.0 111.027 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.46 -12.49 55.43 Favored Glycine 0 N--CA 1.496 2.638 0 O-C-N 121.494 -0.754 . . . . 0.0 112.052 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 61.5 t -89.98 133.29 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.706 -1.467 . . . . 0.0 110.963 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 21.3 p -80.21 151.88 29.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.572 -0.705 . . . . 0.0 109.184 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.743 HD22 HG11 ' B' ' 3' ' ' VAL . 18.5 mt -61.18 -24.59 66.43 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.349 -0.844 . . . . 0.0 110.595 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 1.9 ttp -69.83 -49.2 54.9 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.236 -0.915 . . . . 0.0 109.473 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -59.79 -41.72 91.81 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.567 -0.708 . . . . 0.0 109.926 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.09 -40.86 95.2 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.59 -0.694 . . . . 0.0 110.152 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' ALA . . . . . 0.582 ' HA ' HD12 ' B' ' 32' ' ' ILE . . . -68.34 -49.74 58.19 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.275 -0.891 . . . . 0.0 111.045 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 78.2 t -65.47 -39.18 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.301 -0.875 . . . . 0.0 110.706 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 23.2 t -70.14 -13.96 62.43 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.359 -0.838 . . . . 0.0 111.553 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -118.21 23.88 11.32 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.057 -1.027 . . . . 0.0 110.665 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.7 38.24 58.63 Favored Glycine 0 N--CA 1.493 2.448 0 O-C-N 121.541 -0.724 . . . . 0.0 111.857 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.582 HD12 ' HA ' ' B' ' 27' ' ' ALA . 0.4 OUTLIER -72.57 147.19 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.866 -1.373 . . . . 0.0 108.864 179.043 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -62.72 142.53 58.09 Favored 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 117.175 2.287 . . . . 0.0 117.175 -174.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 62.22 -36.12 0.12 Allowed 'General case' 0 N--CA 1.515 2.791 0 N-CA-C 116.643 2.09 . . . . 0.0 116.643 175.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 77.6 mt -59.77 122.9 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.426 0 O-C-N 119.907 -1.746 . . . . 0.0 110.617 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.919 HG11 ' CZ2' ' B' ' 106' ' ' TRP . 97.4 t -100.15 -51.34 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.697 -0.627 . . . . 0.0 111.229 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 37' ' ' GLY . . . . . 0.623 ' HA2' ' S2 ' ' B' ' 201' ' ' FES . . . 63.14 56.47 20.26 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 107.466 -2.253 . . . . 0.0 107.466 -178.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 38' ' ' ASP . . . . . 0.403 ' HB2' ' CH2' ' B' ' 106' ' ' TRP . 12.6 t70 -71.34 -49.27 44.16 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.994 -0.709 . . . . 0.0 112.274 -177.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 39' ' ' CYS . . . . . 0.558 ' HB3' ' HB3' ' B' ' 45' ' ' CYS . 2.3 p -66.59 -10.4 45.19 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.213 -0.929 . . . . 0.0 112.385 -178.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 40' ' ' GLY . . . . . 0.509 ' CA ' HD22 ' A' ' 356' ' ' LEU . . . 96.77 -5.47 64.13 Favored Glycine 0 N--CA 1.498 2.782 0 O-C-N 120.819 -1.176 . . . . 0.0 112.007 177.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.1 19.52 10.66 Favored Glycine 0 N--CA 1.494 2.535 0 O-C-N 120.826 -1.397 . . . . 0.0 111.047 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 8.2 t -98.95 19.11 15.64 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.978 -1.307 . . . . 0.0 111.16 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.97 40.87 30.36 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.407 -0.808 . . . . 0.0 111.906 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.04 11.2 14.18 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.343 -0.848 . . . . 0.0 109.467 178.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 45' ' ' CYS . . . . . 0.69 ' HG ' 'FE1 ' ' B' ' 201' ' ' FES . 15.1 p -149.53 -179.08 6.81 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.549 -0.72 . . . . 0.0 109.082 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.08 34.08 3.1 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.83 -1.169 . . . . 0.0 111.403 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 47' ' ' THR . . . . . 0.648 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 37.8 p -97.63 13.26 30.76 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.925 -1.109 . . . . 0.0 111.25 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 48' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.1 p -120.54 31.73 6.32 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 177.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 23.9 t-160 -72.65 133.03 44.46 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-N 115.784 -0.643 . . . . 0.0 112.628 -178.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.3 m -146.3 160.11 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' TYR . . . . . 0.413 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.4 m-85 -105.44 102.68 12.13 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.294 -0.879 . . . . 0.0 108.684 178.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.2 t -61.86 135.11 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.317 -0.864 . . . . 0.0 109.35 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.68 131.81 51.38 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.94 0.876 . . . . 0.0 109.53 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.412 ' CD ' ' H ' ' B' ' 54' ' ' GLU . 11.0 mp0 -44.27 -31.08 0.91 Allowed 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -178.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.78 -6.93 54.3 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.969 -1.082 . . . . 0.0 112.749 -178.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -119.89 -6.72 10.04 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 120.449 -1.407 . . . . 0.0 111.908 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.4 p -55.37 -37.84 68.04 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.112 -0.993 . . . . 0.0 112.86 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 -81.18 -6.63 59.06 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.753 -1.217 . . . . 0.0 111.477 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -89.88 -11.62 41.35 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.991 -1.068 . . . . 0.0 109.855 178.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -104.07 141.05 21.72 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -73.76 118.89 5.63 Favored 'Trans proline' 0 N--CA 1.488 1.15 0 O-C-N 123.453 1.238 . . . . 0.0 109.016 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.89 160.65 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.764 0 N-CA-C 116.657 2.095 . . . . 0.0 116.657 -177.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.616 ' HB1' ' HB3' ' B' ' 67' ' ' GLU . . . -65.87 146.14 55.1 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-N 114.606 -1.179 . . . . 0.0 111.266 178.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -89.74 -170.79 2.94 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.569 -0.707 . . . . 0.0 110.362 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -59.53 -42.0 91.28 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.35 -0.844 . . . . 0.0 111.754 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -41.48 84.45 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.203 -0.935 . . . . 0.0 112.018 -178.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.616 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 45.3 tt0 -68.21 -43.98 76.81 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.031 -1.043 . . . . 0.0 110.318 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 68' ' ' ILE . . . . . 0.533 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.6 mm -55.6 -42.18 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.28 -0.888 . . . . 0.0 109.368 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.19 -47.83 81.04 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 11.2 mmt -66.23 -33.92 76.84 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.275 -1.133 . . . . 0.0 111.191 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 71' ' ' LEU . . . . . 0.45 ' HA ' HD23 ' B' ' 71' ' ' LEU . 27.9 mt -63.47 -23.4 67.38 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.236 -0.915 . . . . 0.0 110.588 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 72' ' ' GLU . . . . . 0.533 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 49.2 mt-10 -70.38 -8.71 52.78 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.358 -0.839 . . . . 0.0 110.919 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 82.8 p -119.87 12.54 12.1 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.067 -1.02 . . . . 0.0 112.509 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 16.2 m -60.76 140.38 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 120.643 -1.286 . . . . 0.0 109.681 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 52.0 m -74.53 -39.06 62.58 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.466 -0.771 . . . . 0.0 110.19 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.26 168.82 17.51 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.456 -0.777 . . . . 0.0 110.1 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -58.22 139.16 55.53 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.365 -0.834 . . . . 0.0 110.613 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.3 tp -90.99 116.15 28.55 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.506 -0.746 . . . . 0.0 109.864 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -103.04 168.3 8.99 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -76.61 -0.02 10.02 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 O-C-N 123.304 1.16 . . . . 0.0 110.372 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -120.46 22.41 11.28 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.01 -1.056 . . . . 0.0 108.45 176.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 4.3 m -80.88 137.27 36.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.908 -0.495 . . . . 0.0 110.32 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.4 mmm-85 -149.77 146.4 27.16 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 120.029 -0.668 . . . . 0.0 111.472 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.445 ' HB3' ' SG ' ' B' ' 48' ' ' CYS . 77.9 mt -80.59 98.94 7.86 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 104.789 -2.3 . . . . 0.0 104.789 175.104 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 85' ' ' CYS . . . . . 0.404 ' HB2' ' HB2' ' B' ' 23' ' ' LEU . 10.5 p -48.38 -17.88 0.18 Allowed 'General case' 0 N--CA 1.508 2.444 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -175.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.8 p -70.27 -13.99 62.4 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.628 -1.295 . . . . 0.0 109.429 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -92.65 -12.3 31.91 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.486 -0.759 . . . . 0.0 110.523 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 61.9 mt -91.44 103.89 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.121 -0.987 . . . . 0.0 110.678 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 45.6 mm -85.01 131.8 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 13.6 tpt -74.88 137.76 41.98 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 122.165 0.983 . . . . 0.0 113.201 -177.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 43.6 p -138.14 166.62 24.53 Favored Pre-proline 0 N--CA 1.491 1.578 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 176.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -74.93 1.67 7.43 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 122.628 0.804 . . . . 0.0 111.028 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -87.61 -22.86 24.5 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 176.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.6 mt -93.76 13.0 23.71 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.392 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -54.5 126.39 23.38 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.138 -0.976 . . . . 0.0 111.188 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.27 6.82 68.3 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 120.581 -0.818 . . . . 0.0 111.637 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.7 tt -62.63 142.81 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 CA-C-N 119.391 1.595 . . . . 0.0 110.747 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 98' ' ' VAL . . . . . 0.481 HG22 ' HB ' ' B' ' 4' ' ' VAL . 60.9 t -122.53 132.92 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.554 -0.716 . . . . 0.0 109.876 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 16.5 m -130.32 135.76 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.451 -0.78 . . . . 0.0 109.842 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 100' ' ' ASP . . . . . 0.413 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.35 134.13 35.21 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.9 t -103.4 127.31 29.92 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.558 -0.714 . . . . 0.0 110.364 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -80.82 130.96 7.84 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 124.115 1.587 . . . . 0.0 108.287 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 103' ' ' ASP . . . . . 0.427 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.4 p-10 -62.34 3.37 0.19 Allowed 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -178.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -125.29 114.71 19.29 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.305 -1.497 . . . . 0.0 110.011 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 105' ' ' GLN . . . . . 0.511 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 51.4 mm-40 -113.35 -49.4 2.91 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.505 -0.747 . . . . 0.0 109.958 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 106' ' ' TRP . . . . . 0.919 ' CZ2' HG11 ' B' ' 36' ' ' VAL . 82.7 m95 . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.512 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 501' ' ' HEM . . . . . 1.314 HBD2 ' CD1' ' A' ' 358' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 502' ' ' CAM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 201' ' ' FES . . . . . 0.69 'FE1 ' ' HG ' ' B' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.514 HD12 ' HD2' ' A' ' 15' ' ' PRO . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 14' ' ' LEU . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.419 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HG2' HG12 ' A' ' 54' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.569 HG12 ' HG2' ' A' ' 51' ' ' PRO . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.609 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.609 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 64' ' ' ILE . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.435 ' HA ' HD23 ' A' ' 324' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.0 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.415 ' CZ ' HG23 ' A' ' 348' ' ' THR . 5.6 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.6 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.474 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 27.1 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.7 mmt-85 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.64 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.2 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.556 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.717 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.717 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 1.068 HD11 ' CZ ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.949 ' O ' ' O2D' ' A' ' 501' ' ' HEM . 74.3 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.64 ' O ' ' HB3' ' A' ' 83' ' ' SER . 3.9 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 46.0 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.646 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.296 50.1 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' ' 104' ' ' ASP 0.366 52.7 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.646 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 34.8 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.451 ' H ' ' CG ' ' A' ' 106' ' ' PRO 0.342 30.7 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.406 ' O ' HD11 ' A' ' 358' ' ' LEU . 2.9 mtt-85 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.688 ' HB1' ' CD1' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.735 HD11 ' HA3' ' A' ' 226' ' ' GLY . 7.4 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.546 ' O ' HG22 ' A' ' 119' ' ' VAL . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.442 ' HA ' HD22 ' A' ' 358' ' ' LEU . 25.4 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.417 ' HB2' ' O ' ' A' ' 114' ' ' LEU . 27.6 mt-30 -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.597 ' HA ' HG21 ' A' ' 123' ' ' VAL . 35.0 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.595 HG13 HG23 ' A' ' 118' ' ' VAL . 30.6 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.493 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.698 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 0.0 OUTLIER -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.698 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.0 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.597 HG21 ' HA ' ' A' ' 118' ' ' VAL . 78.3 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.2 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 28.3 mtmt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.455 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.63 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.412 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.595 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 151' ' ' THR . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.799 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.799 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.441 ' O ' ' HG2' ' A' ' 164' ' ' MET . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.578 ' C ' HD23 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.455 ' N ' HD23 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.425 ' N ' ' HD2' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' HIS . . . . . 0.405 ' O ' ' HG ' ' A' ' 180' ' ' LEU . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.574 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 176' ' ' HIS . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.561 ' HA ' ' HE3' ' A' ' 184' ' ' MET . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' MET . . . . . 0.561 ' HE3' ' HA ' ' A' ' 181' ' ' THR . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.421 HD22 ' HE1' ' A' ' 184' ' ' MET . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.453 ' HG3' ' HB1' ' A' ' 224' ' ' ALA . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 220' ' ' ILE . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 44.9 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 42.0 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.453 ' HB1' ' HG3' ' A' ' 212' ' ' ARG . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.735 ' HA3' HD11 ' A' ' 114' ' ' LEU . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 4.3 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 13.5 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 1.068 ' CZ ' HD11 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 40.7 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.717 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.487 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' MET . . . . . 0.595 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 16.4 pm0 -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.437 ' N ' ' HD2' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 282' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' CYS . . . . . . . . . . . . . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 288' ' ' LEU . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.706 HD23 ' H ' ' A' ' 294' ' ' LEU . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.502 HG11 HMA3 ' A' ' 501' ' ' HEM . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 297' ' ' ASP . . . . . 0.513 ' OD2' ' O2A' ' A' ' 501' ' ' HEM . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 298' ' ' GLY . . . . . 0.419 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 299' ' ' ARG . . . . . 0.419 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.0 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.459 ' HA ' HD13 ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 314' ' ' LYS . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 307' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.6 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 308' ' ' HIS . . . . . 0.425 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 36.9 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 303' ' ' SER . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 318' ' ' ILE . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 319' ' ' LEU . . . . . 0.647 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 321' ' ' PRO . . . . . 0.68 ' HG2' HD22 ' A' ' 324' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.68 HD22 ' HG2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 13.7 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 327' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 327' ' ' LEU . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.522 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 335' ' ' PRO . . . . . 0.522 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 343' ' ' GLN . . . . . 0.46 ' CB ' ' HD3' ' A' ' 344' ' ' LYS . 1.9 mp0 -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 344' ' ' LYS . . . . . 0.504 ' HB2' ' HE2' ' A' ' 344' ' ' LYS . 1.7 mppt? -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 57.8 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 22.1 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 348' ' ' THR . . . . . 0.415 HG23 ' CZ ' ' A' ' 72' ' ' ARG . 16.5 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 349' ' ' THR . . . . . . . . . . . . . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 73.7 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 354' ' ' SER . . . . . 0.429 ' HA ' ' CB ' ' B' ' 44' ' ' SER . 97.1 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 356' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 358' ' ' LEU . . . . . 0.442 HD22 ' HA ' ' A' ' 116' ' ' ASN . 0.5 OUTLIER -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 40.9 mtt85 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 17.2 tpp85 -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 68.2 mm-40 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 412' ' ' LYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 N--CA 1.495 1.809 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.52 138.58 38.48 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.177 -0.952 . . . . 0.0 113.004 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.738 HG11 HD22 ' B' ' 23' ' ' LEU . 61.2 t -137.11 122.6 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.526 HG11 ' CZ ' ' B' ' 12' ' ' ARG . 97.5 t -106.78 129.58 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.15 -0.969 . . . . 0.0 111.635 -178.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.682 ' CG ' HD13 ' B' ' 32' ' ' ILE . 77.2 m-85 -109.28 110.6 21.83 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.82 127.23 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.935 -1.103 . . . . 0.0 108.363 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.6 m -86.2 174.69 8.94 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.737 0.779 . . . . 0.0 112.509 -177.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.422 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.66 -46.73 89.22 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 121.19 0.519 . . . . 0.0 110.457 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -65.93 -11.29 46.16 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.52 -0.737 . . . . 0.0 111.381 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.01 15.4 28.55 Favored Glycine 0 N--CA 1.492 2.388 0 O-C-N 121.177 -0.952 . . . . 0.0 111.287 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 89.8 m -82.05 147.35 29.18 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 118.733 1.266 . . . . 0.0 109.929 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' ARG . . . . . 0.526 ' CZ ' HG11 ' B' ' 4' ' ' VAL . 50.8 ttt85 -118.46 128.74 54.89 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.528 -0.732 . . . . 0.0 111.864 -178.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 13' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' B' ' 13' ' ' ARG . 0.0 OUTLIER -126.06 127.67 46.2 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.571 -0.705 . . . . 0.0 109.81 179.146 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -111.34 130.63 55.62 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.275 -0.891 . . . . 0.0 111.612 -178.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 84.7 mt -122.78 159.35 28.24 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.736 -0.602 . . . . 0.0 111.117 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -109.64 91.62 3.72 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 176.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.6 t -90.21 133.49 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-O 121.604 0.716 . . . . 0.0 112.288 -176.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.11 170.71 16.05 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.779 -0.576 . . . . 0.0 110.27 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -68.47 151.82 46.27 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.479 -0.763 . . . . 0.0 110.958 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.45 -12.51 55.34 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.048 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 59.4 t -90.03 133.32 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.704 -1.468 . . . . 0.0 110.896 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 22.3 p -80.23 151.96 29.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.583 -0.698 . . . . 0.0 109.173 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.738 HD22 HG11 ' B' ' 3' ' ' VAL . 18.4 mt -61.22 -24.63 66.48 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.299 -0.876 . . . . 0.0 110.578 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 8.5 tmm? -69.78 -49.19 55.31 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.234 -0.916 . . . . 0.0 109.521 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -59.81 -41.7 91.86 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.594 -0.691 . . . . 0.0 109.953 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.04 -40.91 95.47 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.616 -0.678 . . . . 0.0 110.135 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' ALA . . . . . 0.73 ' HA ' HD12 ' B' ' 32' ' ' ILE . . . -68.3 -49.78 58.12 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.266 -0.896 . . . . 0.0 111.046 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 69.3 t -65.42 -39.19 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.36 -0.837 . . . . 0.0 110.734 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 28.2 m -70.16 -13.97 62.43 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.372 -0.83 . . . . 0.0 111.526 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -118.2 23.8 11.37 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.04 -1.038 . . . . 0.0 110.663 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.72 38.27 58.81 Favored Glycine 0 N--CA 1.492 2.424 0 O-C-N 121.556 -0.715 . . . . 0.0 111.828 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.73 HD12 ' HA ' ' B' ' 27' ' ' ALA . 1.7 mt -72.55 147.17 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.836 -1.391 . . . . 0.0 108.853 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.68 142.48 58.08 Favored 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 117.215 2.302 . . . . 0.0 117.215 -174.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 62.18 -36.09 0.12 Allowed 'General case' 0 N--CA 1.516 2.855 0 N-CA-C 116.655 2.094 . . . . 0.0 116.655 175.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 84.4 mt -59.78 122.91 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.373 0 O-C-N 119.843 -1.785 . . . . 0.0 110.673 -178.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.591 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 18.9 t -100.12 -51.46 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.63 -0.669 . . . . 0.0 111.193 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 37' ' ' GLY . . . . . 0.633 ' HA2' ' S2 ' ' B' ' 201' ' ' FES . . . 63.16 56.5 20.08 Favored Glycine 0 N--CA 1.5 2.906 0 N-CA-C 107.447 -2.261 . . . . 0.0 107.447 -178.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.3 -49.31 44.11 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.974 -0.721 . . . . 0.0 112.269 -177.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 39' ' ' CYS . . . . . 0.555 ' HB3' ' HB3' ' B' ' 45' ' ' CYS . 2.3 p -66.59 -10.44 45.51 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.206 -0.934 . . . . 0.0 112.384 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.82 -5.51 64.02 Favored Glycine 0 N--CA 1.499 2.854 0 O-C-N 120.824 -1.172 . . . . 0.0 111.968 177.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.06 19.58 10.63 Favored Glycine 0 N--CA 1.495 2.589 0 O-C-N 120.815 -1.403 . . . . 0.0 111.071 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 90.1 p -99.01 19.15 15.63 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.062 -1.258 . . . . 0.0 111.119 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.99 40.82 30.33 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.42 -0.8 . . . . 0.0 111.941 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 44' ' ' SER . . . . . 0.429 ' CB ' ' HA ' ' A' ' 354' ' ' SER . 70.7 m -117.02 11.19 14.2 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.368 -0.832 . . . . 0.0 109.494 178.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 45' ' ' CYS . . . . . 0.697 ' HG ' 'FE1 ' ' B' ' 201' ' ' FES . 15.1 p -149.51 -179.09 6.82 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.54 -0.725 . . . . 0.0 109.049 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.07 34.09 3.1 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.849 -1.157 . . . . 0.0 111.362 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 47' ' ' THR . . . . . 0.591 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 81.9 p -97.61 13.27 30.73 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.0 -1.063 . . . . 0.0 111.277 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 29.1 p -120.54 31.74 6.31 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 23.9 t-160 -72.74 133.05 44.38 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.574 -178.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.3 m -146.26 160.07 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 51' ' ' TYR . . . . . 0.422 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.5 m-85 -105.41 102.7 12.16 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.26 -0.9 . . . . 0.0 108.709 178.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.3 t -61.87 135.15 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.319 -0.863 . . . . 0.0 109.362 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.7 131.79 51.34 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.981 0.896 . . . . 0.0 109.505 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' B' ' 54' ' ' GLU . 11.1 mp0 -44.28 -31.05 0.91 Allowed 'General case' 0 N--CA 1.505 2.314 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -178.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.76 -6.96 54.38 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.982 -1.074 . . . . 0.0 112.742 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -119.91 -6.61 10.04 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.492 -1.38 . . . . 0.0 111.892 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.3 p -55.49 -37.77 68.27 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.167 -0.958 . . . . 0.0 112.84 -178.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -81.14 -6.71 59.14 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.773 -1.204 . . . . 0.0 111.447 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -89.83 -11.66 41.37 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.017 -1.052 . . . . 0.0 109.841 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.7 t -104.05 141.02 21.65 Favored Pre-proline 0 N--CA 1.489 1.521 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -73.81 118.85 5.61 Favored 'Trans proline' 0 N--CA 1.488 1.172 0 O-C-N 123.487 1.256 . . . . 0.0 109.001 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.9 160.6 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.761 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 -177.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.616 ' HB1' ' HB3' ' B' ' 67' ' ' GLU . . . -65.71 146.16 55.13 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.239 178.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -89.84 -170.73 2.91 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.59 -0.694 . . . . 0.0 110.388 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.56 -42.0 91.42 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.287 -0.883 . . . . 0.0 111.75 -178.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 8.7 ttt180 -67.45 -41.55 84.53 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.173 -0.954 . . . . 0.0 112.014 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.616 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 45.5 tt0 -68.2 -43.97 76.88 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.938 -1.101 . . . . 0.0 110.329 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 68' ' ' ILE . . . . . 0.533 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.7 mm -55.55 -42.21 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.243 -0.911 . . . . 0.0 109.367 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.15 -47.88 80.75 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 70' ' ' MET . . . . . 0.415 ' HB3' HD11 ' B' ' 84' ' ' LEU . 5.3 mmt -66.17 -34.01 77.07 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.264 -1.139 . . . . 0.0 111.172 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 71' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' B' ' 71' ' ' LEU . 28.0 mt -63.48 -23.29 67.33 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.294 -0.879 . . . . 0.0 110.634 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 72' ' ' GLU . . . . . 0.533 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 49.8 mt-10 -70.45 -8.69 52.94 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.265 -0.897 . . . . 0.0 110.883 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 83.4 p -119.9 12.6 12.1 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.002 -1.061 . . . . 0.0 112.519 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 30.5 m -60.83 140.42 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 120.714 -1.241 . . . . 0.0 109.634 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 81.9 m -74.53 -39.11 62.56 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.419 -0.8 . . . . 0.0 110.15 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.2 168.81 17.46 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.454 -0.779 . . . . 0.0 110.121 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.32 139.15 55.74 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.44 -0.788 . . . . 0.0 110.566 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.4 tp -90.95 116.15 28.53 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.517 -0.739 . . . . 0.0 109.918 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -103.05 168.31 8.97 Favored Pre-proline 0 N--CA 1.489 1.515 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -76.58 -0.06 10.05 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 O-C-N 123.239 1.126 . . . . 0.0 110.404 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -120.46 22.36 11.3 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.002 -1.061 . . . . 0.0 108.385 176.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 4.3 m -80.78 137.22 36.23 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.853 -0.53 . . . . 0.0 110.407 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.5 mmm-85 -149.75 146.38 27.17 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.455 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.555 HD12 ' HG3' ' B' ' 67' ' ' GLU . 92.1 mt -80.6 98.92 7.86 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 175.091 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 85' ' ' CYS . . . . . 0.409 ' HB2' ' HB2' ' B' ' 23' ' ' LEU . 10.6 p -48.36 -17.89 0.18 Allowed 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -175.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.8 p -70.29 -14.01 62.41 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.662 -1.273 . . . . 0.0 109.464 178.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 80.5 mm-40 -92.66 -12.2 32.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.511 -0.743 . . . . 0.0 110.589 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 61.9 mt -91.49 103.96 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.188 -0.945 . . . . 0.0 110.624 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 46.0 mm -84.94 131.77 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 13.6 tpt -74.88 137.81 42.02 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 122.123 0.963 . . . . 0.0 113.236 -177.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 43.7 p -138.24 166.54 25.06 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 176.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -74.9 1.7 7.38 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 122.632 0.807 . . . . 0.0 111.05 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -87.58 -22.89 24.52 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 176.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.2 mt -93.8 13.02 23.75 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.394 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.47 126.39 23.32 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.203 -0.936 . . . . 0.0 111.162 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.27 6.77 68.36 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.666 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.57 142.75 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 CA-C-N 119.328 1.564 . . . . 0.0 110.779 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 98' ' ' VAL . . . . . 0.469 HG22 ' HB ' ' B' ' 4' ' ' VAL . 60.6 t -122.54 132.95 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.546 -0.722 . . . . 0.0 109.854 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 16.4 m -130.36 135.75 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.535 -0.728 . . . . 0.0 109.814 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 100' ' ' ASP . . . . . 0.422 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.39 134.15 35.2 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.2 t -103.43 127.35 29.82 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.52 -0.737 . . . . 0.0 110.351 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -80.81 130.95 7.86 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 O-C-N 124.129 1.594 . . . . 0.0 108.283 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 103' ' ' ASP . . . . . 0.422 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.4 p-10 -62.41 3.43 0.19 Allowed 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -125.33 114.63 19.15 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.257 -1.527 . . . . 0.0 110.054 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 105' ' ' GLN . . . . . 0.501 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 52.4 mm-40 -113.32 -49.34 2.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.438 -0.789 . . . . 0.0 110.016 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 106' ' ' TRP . . . . . 0.688 ' CD1' ' HB1' ' A' ' 113' ' ' ALA . 23.1 m0 . . . . . 0 N--CA 1.495 1.793 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.531 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 501' ' ' HEM . . . . . 0.949 ' O2D' ' O ' ' A' ' 100' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 502' ' ' CAM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 201' ' ' FES . . . . . 0.697 'FE1 ' ' HG ' ' B' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.514 HD12 ' HD2' ' A' ' 15' ' ' PRO . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 14' ' ' LEU . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.419 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HG2' HG12 ' A' ' 54' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.569 HG12 ' HG2' ' A' ' 51' ' ' PRO . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.609 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.609 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 64' ' ' ILE . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.435 ' HA ' HD23 ' A' ' 324' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.0 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.414 ' CZ ' HG23 ' A' ' 348' ' ' THR . 5.6 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.6 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.478 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 27.1 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.7 mmt-85 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.64 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.2 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.556 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.717 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.717 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 1.068 HD11 ' CZ ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.949 ' O ' ' O2D' ' A' ' 501' ' ' HEM . 74.3 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.64 ' O ' ' HB3' ' A' ' 83' ' ' SER . 3.9 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 46.0 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.646 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.296 50.1 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 104' ' ' ASP 0.366 52.9 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.646 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 34.8 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.451 ' H ' ' CG ' ' A' ' 106' ' ' PRO 0.342 30.7 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.478 ' HB1' ' HB3' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.739 HD11 ' HA3' ' A' ' 226' ' ' GLY . 7.0 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.566 ' O ' HG22 ' A' ' 119' ' ' VAL . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.417 ' HB2' ' O ' ' A' ' 114' ' ' LEU . 24.3 mt-30 -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.597 ' HA ' HG21 ' A' ' 123' ' ' VAL . 34.9 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.566 HG22 ' O ' ' A' ' 115' ' ' ALA . 27.5 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.493 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.698 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 0.0 OUTLIER -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.698 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.0 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.597 HG21 ' HA ' ' A' ' 118' ' ' VAL . 78.3 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 28.0 mtmt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.455 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.63 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.412 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.595 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 151' ' ' THR . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.799 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.799 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.441 ' O ' ' HG2' ' A' ' 164' ' ' MET . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.578 ' C ' HD23 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.455 ' N ' HD23 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.425 ' N ' ' HD2' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' HIS . . . . . 0.405 ' O ' ' HG ' ' A' ' 180' ' ' LEU . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.574 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 176' ' ' HIS . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.561 ' HA ' ' HE3' ' A' ' 184' ' ' MET . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' MET . . . . . 0.561 ' HE3' ' HA ' ' A' ' 181' ' ' THR . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.421 HD22 ' HE1' ' A' ' 184' ' ' MET . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.453 ' HG3' ' HB1' ' A' ' 224' ' ' ALA . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 220' ' ' ILE . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 44.9 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 42.0 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.453 ' HB1' ' HG3' ' A' ' 212' ' ' ARG . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.739 ' HA3' HD11 ' A' ' 114' ' ' LEU . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 4.3 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 13.5 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 1.068 ' CZ ' HD11 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 41.0 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.717 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.487 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' MET . . . . . 0.595 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 13.2 pm0 -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.437 ' N ' ' HD2' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 282' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' CYS . . . . . . . . . . . . . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 288' ' ' LEU . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.706 HD23 ' H ' ' A' ' 294' ' ' LEU . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.502 HG11 HMA3 ' A' ' 501' ' ' HEM . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 297' ' ' ASP . . . . . 0.513 ' OD2' ' O2A' ' A' ' 501' ' ' HEM . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 298' ' ' GLY . . . . . 0.419 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 299' ' ' ARG . . . . . 0.419 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.0 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.459 ' HA ' HD13 ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 314' ' ' LYS . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 307' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.6 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 308' ' ' HIS . . . . . 0.425 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 36.9 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 303' ' ' SER . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 318' ' ' ILE . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 319' ' ' LEU . . . . . 0.647 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 321' ' ' PRO . . . . . 0.68 ' HG2' HD22 ' A' ' 324' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.68 HD22 ' HG2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 13.7 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 327' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 327' ' ' LEU . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.522 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 335' ' ' PRO . . . . . 0.522 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 68.2 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 342' ' ' ARG . . . . . 0.4 ' HB3' HG22 ' A' ' 345' ' ' VAL . 43.4 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 343' ' ' GLN . . . . . 0.482 ' CB ' ' HD3' ' A' ' 344' ' ' LYS . 0.1 OUTLIER -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 344' ' ' LYS . . . . . 0.503 ' HB2' ' HE2' ' A' ' 344' ' ' LYS . 1.7 mppt? -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.4 HG22 ' HB3' ' A' ' 342' ' ' ARG . 60.0 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 13.2 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 348' ' ' THR . . . . . 0.414 HG23 ' CZ ' ' A' ' 72' ' ' ARG . 16.5 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 349' ' ' THR . . . . . . . . . . . . . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 354' ' ' SER . . . . . 0.592 ' HA ' ' HB3' ' B' ' 44' ' ' SER . 95.3 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 356' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 358' ' ' LEU . . . . . 1.114 ' CD1' HBD2 ' A' ' 501' ' ' HEM . 4.9 mp -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 38.2 mtt85 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 14.3 tpp85 -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 68.2 mm-40 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 412' ' ' LYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 40.3 m . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 121.079 0.466 . . . . 0.0 109.757 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.51 138.61 38.51 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.169 -0.957 . . . . 0.0 112.928 -178.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.727 HG11 HD22 ' B' ' 23' ' ' LEU . 61.2 t -137.17 122.57 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 177.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.53 HG11 ' CZ ' ' B' ' 12' ' ' ARG . 98.4 t -106.81 129.61 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.159 -0.963 . . . . 0.0 111.62 -178.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.683 ' CG ' HD13 ' B' ' 32' ' ' ILE . 77.3 m-85 -109.22 110.6 21.84 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.83 127.22 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 120.96 -1.087 . . . . 0.0 108.353 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.4 m -86.17 174.67 8.97 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.772 0.796 . . . . 0.0 112.503 -177.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.419 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.6 t-80 -60.7 -46.7 89.38 Favored 'General case' 0 N--CA 1.503 2.179 0 CA-C-O 121.142 0.496 . . . . 0.0 110.436 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -65.92 -11.28 46.08 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.575 -0.703 . . . . 0.0 111.387 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.96 15.48 28.45 Favored Glycine 0 N--CA 1.491 2.335 0 O-C-N 121.074 -1.016 . . . . 0.0 111.269 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.0 m -82.07 147.4 29.13 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 118.713 1.257 . . . . 0.0 109.926 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' ARG . . . . . 0.53 ' CZ ' HG11 ' B' ' 4' ' ' VAL . 50.9 ttt85 -118.49 128.8 54.93 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.428 -0.795 . . . . 0.0 111.83 -178.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.05 127.67 46.2 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.596 -0.69 . . . . 0.0 109.803 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -111.37 130.64 55.62 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.287 -0.883 . . . . 0.0 111.589 -178.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 84.6 mt -122.79 159.36 28.24 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.753 -0.592 . . . . 0.0 111.118 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -109.61 91.62 3.72 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 176.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.5 t -90.15 133.4 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-O 121.575 0.702 . . . . 0.0 112.303 -176.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.08 170.66 16.12 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.768 -0.582 . . . . 0.0 110.295 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -68.44 151.82 46.29 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.477 -0.764 . . . . 0.0 111.005 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.47 -12.53 55.39 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.03 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 61.1 t -89.99 133.34 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.655 -1.497 . . . . 0.0 110.928 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 97.7 p -80.29 151.88 29.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.513 -0.742 . . . . 0.0 109.127 178.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.727 HD22 HG11 ' B' ' 3' ' ' VAL . 18.5 mt -61.16 -24.63 66.43 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.312 -0.868 . . . . 0.0 110.631 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 24' ' ' MET . . . . . 0.459 ' SD ' ' S2 ' ' B' ' 201' ' ' FES . 2.7 ttp -69.75 -49.2 55.41 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.217 -0.927 . . . . 0.0 109.514 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.79 -41.75 91.86 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.591 -0.693 . . . . 0.0 109.941 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.06 -40.89 95.37 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.574 -0.704 . . . . 0.0 110.137 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' ALA . . . . . 0.718 ' HA ' HD12 ' B' ' 32' ' ' ILE . . . -68.3 -49.77 58.2 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.203 -0.935 . . . . 0.0 111.071 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 77.4 t -65.48 -39.15 84.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.305 -0.872 . . . . 0.0 110.723 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 26.0 m -70.14 -14.0 62.45 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.394 -0.816 . . . . 0.0 111.547 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -118.17 23.78 11.39 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.033 -1.042 . . . . 0.0 110.623 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.74 38.27 58.86 Favored Glycine 0 N--CA 1.493 2.459 0 O-C-N 121.566 -0.709 . . . . 0.0 111.81 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.718 HD12 ' HA ' ' B' ' 27' ' ' ALA . 1.7 mt -72.53 147.12 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.914 -1.345 . . . . 0.0 108.878 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.67 142.51 58.05 Favored 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 117.203 2.297 . . . . 0.0 117.203 -174.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 34' ' ' ASP . . . . . 0.458 ' O ' ' HG3' ' B' ' 105' ' ' GLN . 65.3 m-20 62.19 -36.14 0.12 Allowed 'General case' 0 N--CA 1.515 2.81 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 175.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 84.4 mt -59.69 122.85 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 O-C-N 119.864 -1.772 . . . . 0.0 110.701 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.634 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 2.4 t -100.09 -51.35 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.577 -0.702 . . . . 0.0 111.241 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 37' ' ' GLY . . . . . 0.629 ' HA2' ' S2 ' ' B' ' 201' ' ' FES . . . 63.1 56.49 20.24 Favored Glycine 0 N--CA 1.5 2.908 0 N-CA-C 107.447 -2.261 . . . . 0.0 107.447 -178.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' ASP . . . . . 0.419 ' N ' HG12 ' B' ' 36' ' ' VAL . 29.7 t0 -71.34 -49.24 44.44 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.991 -0.711 . . . . 0.0 112.262 -177.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 39' ' ' CYS . . . . . 0.555 ' HB3' ' HB3' ' B' ' 45' ' ' CYS . 2.3 p -66.55 -10.46 45.37 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.22 -0.925 . . . . 0.0 112.394 -178.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.77 -5.48 64.13 Favored Glycine 0 N--CA 1.499 2.836 0 O-C-N 120.806 -1.184 . . . . 0.0 111.981 177.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.14 19.51 10.64 Favored Glycine 0 N--CA 1.494 2.558 0 O-C-N 120.842 -1.387 . . . . 0.0 110.978 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 30.7 p -98.99 19.16 15.61 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.037 -1.273 . . . . 0.0 111.115 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 56.04 40.83 30.24 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.391 -0.818 . . . . 0.0 111.93 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 44' ' ' SER . . . . . 0.592 ' HB3' ' HA ' ' A' ' 354' ' ' SER . 5.7 m -117.05 11.21 14.18 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.318 -0.864 . . . . 0.0 109.557 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' CYS . . . . . 0.7 ' HG ' 'FE1 ' ' B' ' 201' ' ' FES . 15.1 p -149.56 -179.1 6.83 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.04 34.07 3.11 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.884 -1.135 . . . . 0.0 111.356 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' THR . . . . . 0.634 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 37.2 p -97.52 13.2 30.79 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.964 -1.085 . . . . 0.0 111.314 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 48' ' ' CYS . . . . . 0.415 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.1 p -120.57 31.77 6.3 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 23.8 t-160 -72.7 133.03 44.41 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.609 -178.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.3 m -146.29 160.07 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 51' ' ' TYR . . . . . 0.417 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.5 m-85 -105.42 102.76 12.21 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.3 -0.875 . . . . 0.0 108.681 178.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.2 t -61.98 135.12 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 121.315 -0.865 . . . . 0.0 109.349 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.65 131.81 51.36 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.944 0.878 . . . . 0.0 109.559 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.408 ' H ' ' CD ' ' B' ' 54' ' ' GLU . 11.0 mp0 -44.34 -30.98 0.91 Allowed 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.84 -6.9 54.25 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.984 -1.073 . . . . 0.0 112.712 -178.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -119.95 -6.67 10.02 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 120.503 -1.373 . . . . 0.0 111.871 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.5 p -55.37 -37.85 68.06 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.154 -0.967 . . . . 0.0 112.892 -178.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -81.1 -6.65 59.06 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.787 -1.196 . . . . 0.0 111.46 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -89.93 -11.6 41.28 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.078 -1.014 . . . . 0.0 109.831 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.8 t -104.07 141.05 21.71 Favored Pre-proline 0 N--CA 1.488 1.467 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -73.8 118.92 5.64 Favored 'Trans proline' 0 N--CA 1.489 1.209 0 O-C-N 123.514 1.271 . . . . 0.0 108.986 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.99 160.66 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.761 0 N-CA-C 116.647 2.092 . . . . 0.0 116.647 -177.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.612 ' HB1' ' HB3' ' B' ' 67' ' ' GLU . . . -65.77 146.15 55.12 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 114.572 -1.194 . . . . 0.0 111.247 178.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -89.78 -170.79 2.94 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.565 -0.709 . . . . 0.0 110.392 178.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -59.53 -42.05 91.38 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.343 -0.848 . . . . 0.0 111.686 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 5.0 ttt180 -67.39 -41.57 84.76 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.175 -0.953 . . . . 0.0 112.028 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.612 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 45.4 tt0 -68.23 -43.91 76.88 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.01 -1.056 . . . . 0.0 110.349 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 68' ' ' ILE . . . . . 0.526 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.6 mm -55.56 -42.18 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 O-C-N 121.287 -0.883 . . . . 0.0 109.372 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.22 -47.84 80.83 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 9.5 mmt -66.18 -33.99 77.01 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.27 -1.135 . . . . 0.0 111.207 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 71' ' ' LEU . . . . . 0.441 ' HA ' HD23 ' B' ' 71' ' ' LEU . 28.1 mt -63.45 -23.35 67.36 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.214 -0.929 . . . . 0.0 110.608 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 72' ' ' GLU . . . . . 0.526 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 49.9 mt-10 -70.41 -8.79 53.54 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.344 -0.848 . . . . 0.0 110.889 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 82.8 p -119.78 12.54 12.18 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.001 -1.062 . . . . 0.0 112.543 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 28.8 m -60.8 140.46 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 O-C-N 120.761 -1.212 . . . . 0.0 109.627 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 44.8 m -74.58 -39.07 62.45 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.406 -0.809 . . . . 0.0 110.174 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.2 168.82 17.43 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.476 -0.765 . . . . 0.0 110.076 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.27 139.15 55.64 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.451 -0.781 . . . . 0.0 110.615 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.4 tp -91.0 116.19 28.6 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.551 -0.718 . . . . 0.0 109.836 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -103.02 168.33 8.95 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -76.62 -0.03 10.04 Favored 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 123.27 1.142 . . . . 0.0 110.43 178.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -120.43 22.35 11.32 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.963 -1.086 . . . . 0.0 108.419 176.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 4.3 m -80.77 137.17 36.24 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.833 -0.542 . . . . 0.0 110.385 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.5 mmm-85 -149.75 146.39 27.17 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.443 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.592 HD12 ' HG3' ' B' ' 67' ' ' GLU . 95.0 mt -80.57 98.99 7.87 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 175.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 85' ' ' CYS . . . . . 0.402 ' HB2' ' HB2' ' B' ' 23' ' ' LEU . 10.6 p -48.43 -17.91 0.19 Allowed 'General case' 0 N--CA 1.508 2.439 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -175.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.8 p -70.3 -13.92 62.37 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.646 -1.284 . . . . 0.0 109.453 178.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -92.72 -12.3 31.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.465 -0.772 . . . . 0.0 110.533 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 88' ' ' ILE . . . . . 0.402 HG21 HD13 ' B' ' 88' ' ' ILE . 61.8 mt -91.46 103.96 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.117 -0.99 . . . . 0.0 110.671 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 47.3 mm -84.99 131.8 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 13.6 tpt -74.85 137.77 42.05 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 122.143 0.973 . . . . 0.0 113.244 -177.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 43.8 p -138.2 166.59 24.73 Favored Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 176.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -74.94 1.65 7.46 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 122.689 0.836 . . . . 0.0 110.996 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -87.58 -22.84 24.55 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 176.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.6 mt -93.77 12.95 23.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 122.035 -0.416 . . . . 0.0 110.389 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.45 126.38 23.24 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.128 -0.983 . . . . 0.0 111.177 -178.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.19 6.83 68.48 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.68 179.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.62 142.75 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-N 119.334 1.567 . . . . 0.0 110.81 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 98' ' ' VAL . . . . . 0.461 HG22 ' HB ' ' B' ' 4' ' ' VAL . 60.6 t -122.47 133.02 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.559 -0.713 . . . . 0.0 109.829 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 16.4 m -130.41 135.74 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.456 -0.778 . . . . 0.0 109.788 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 100' ' ' ASP . . . . . 0.417 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.38 134.16 35.19 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.2 t -103.4 127.31 29.91 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.505 -0.747 . . . . 0.0 110.359 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -80.87 130.96 7.79 Favored 'Trans proline' 0 C--N 1.316 -1.163 0 O-C-N 124.101 1.579 . . . . 0.0 108.277 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 103' ' ' ASP . . . . . 0.419 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.3 p-10 -62.37 3.41 0.19 Allowed 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -178.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -125.29 114.58 19.12 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.277 -1.514 . . . . 0.0 110.089 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 105' ' ' GLN . . . . . 0.513 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 23.9 mm-40 -113.25 -49.41 2.91 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.455 -0.778 . . . . 0.0 110.029 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 106' ' ' TRP . . . . . 0.478 ' HB3' ' HB1' ' A' ' 113' ' ' ALA . 17.0 m0 . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 118.249 -0.882 . . . . 0.0 110.547 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 501' ' ' HEM . . . . . 1.114 HBD2 ' CD1' ' A' ' 358' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 502' ' ' CAM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 201' ' ' FES . . . . . 0.7 'FE1 ' ' HG ' ' B' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.514 HD12 ' HD2' ' A' ' 15' ' ' PRO . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 14' ' ' LEU . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.419 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HG2' HG12 ' A' ' 54' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.569 HG12 ' HG2' ' A' ' 51' ' ' PRO . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.609 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.8 m120 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.609 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 64' ' ' ILE . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.435 ' HA ' HD23 ' A' ' 324' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.0 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.4 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.6 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.511 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 26.6 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.4 mtt-85 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.8 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.64 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.1 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.556 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.717 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.717 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 1.068 HD11 ' CZ ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.622 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 67.8 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.64 ' O ' ' HB3' ' A' ' 83' ' ' SER . 3.9 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 45.3 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.605 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.298 63.0 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.511 ' HD2' ' CD1' ' A' ' 78' ' ' TYR 0.367 53.3 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.605 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 33.9 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.452 ' H ' ' CD ' ' A' ' 106' ' ' PRO 0.409 34.0 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 12.9 mtp180 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.425 ' HB2' ' CE3' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.538 HD11 ' HA3' ' A' ' 226' ' ' GLY . 38.0 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.503 ' O ' HG22 ' A' ' 119' ' ' VAL . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.66 HG23 HG13 ' A' ' 119' ' ' VAL . 25.2 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.66 HG13 HG23 ' A' ' 118' ' ' VAL . 27.3 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.493 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.698 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 17.7 mtm -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.698 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.1 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.606 HG21 ' HA ' ' A' ' 118' ' ' VAL . 72.7 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 45.4 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.455 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.63 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.412 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.595 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 151' ' ' THR . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.799 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.799 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.441 ' O ' ' HG2' ' A' ' 164' ' ' MET . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.578 ' C ' HD23 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.455 ' N ' HD23 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.425 ' N ' ' HD2' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' HIS . . . . . 0.405 ' O ' ' HG ' ' A' ' 180' ' ' LEU . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.574 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 176' ' ' HIS . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.561 ' HA ' ' HE3' ' A' ' 184' ' ' MET . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . 0.561 ' HE3' ' HA ' ' A' ' 181' ' ' THR . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.421 HD22 ' HE1' ' A' ' 184' ' ' MET . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . 0.453 ' HG3' ' HB1' ' A' ' 224' ' ' ALA . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 220' ' ' ILE . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 42.7 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 42.0 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.453 ' HB1' ' HG3' ' A' ' 212' ' ' ARG . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.538 ' HA3' HD11 ' A' ' 114' ' ' LEU . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 6.2 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 1.3 m120 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 17.1 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . 1.068 ' CZ ' HD11 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 34.2 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.717 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.487 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' MET . . . . . 0.595 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 16.4 pm0 -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.439 ' N ' ' HD2' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 281' ' ' ILE . 45.4 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' CYS . . . . . . . . . . . . . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 288' ' ' LEU . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.706 HD23 ' H ' ' A' ' 294' ' ' LEU . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . 0.419 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . 0.419 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.7 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.459 ' HA ' HD13 ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 314' ' ' LYS . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.6 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' HIS . . . . . 0.425 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 36.9 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 303' ' ' SER . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 318' ' ' ILE . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' LEU . . . . . 0.647 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' PRO . . . . . 0.68 ' HG2' HD22 ' A' ' 324' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.68 HD22 ' HG2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 13.7 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 327' ' ' LEU . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.522 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' PRO . . . . . 0.522 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' GLN . . . . . 0.413 ' CB ' ' HD3' ' A' ' 344' ' ' LYS . 1.9 mp0 -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' LYS . . . . . 0.519 ' HD3' ' N ' ' A' ' 344' ' ' LYS . 1.8 mppt? -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 61.0 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 1.1 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 15.8 p80 -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 17.1 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' THR . . . . . . . . . . . . . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 90.8 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' LEU . . . . . 0.58 HD13 ' O ' ' B' ' 39' ' ' CYS . 0.6 OUTLIER -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 7.7 mtm180 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 17.2 tpp85 -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.1 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 412' ' ' LYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 39.6 m . . . . . 0 N--CA 1.496 1.832 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.51 138.6 38.5 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.234 -0.916 . . . . 0.0 112.92 -178.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . 0.736 HG11 HD22 ' B' ' 23' ' ' LEU . 61.4 t -137.15 122.57 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.53 HG11 ' CZ ' ' B' ' 12' ' ' ARG . 98.5 t -106.82 129.59 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.124 -0.985 . . . . 0.0 111.625 -178.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -109.18 110.6 21.87 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.82 127.19 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.93 -1.107 . . . . 0.0 108.343 178.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.2 m -86.15 174.68 8.98 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.789 0.804 . . . . 0.0 112.472 -177.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' HIS . . . . . 0.418 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.68 -46.69 89.39 Favored 'General case' 0 N--CA 1.503 2.18 0 CA-C-O 121.141 0.496 . . . . 0.0 110.453 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -65.94 -11.29 46.41 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.596 -0.69 . . . . 0.0 111.393 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.99 15.49 28.34 Favored Glycine 0 N--CA 1.493 2.441 0 O-C-N 121.174 -0.954 . . . . 0.0 111.238 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.6 m -82.12 147.37 29.1 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 118.789 1.295 . . . . 0.0 109.903 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . 0.53 ' CZ ' HG11 ' B' ' 4' ' ' VAL . 50.8 ttt85 -118.42 128.72 54.89 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.454 -0.779 . . . . 0.0 111.883 -178.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.99 127.64 46.22 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.595 -0.69 . . . . 0.0 109.843 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -111.28 130.6 55.61 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.281 -0.887 . . . . 0.0 111.632 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.62 HD11 HD11 ' B' ' 32' ' ' ILE . 84.6 mt -122.72 159.4 28.05 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.752 -0.592 . . . . 0.0 111.082 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -109.64 91.64 3.73 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 176.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.6 t -90.17 133.39 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.571 0.7 . . . . 0.0 112.314 -176.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.07 170.67 16.11 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.788 -0.57 . . . . 0.0 110.251 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -68.45 151.8 46.31 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.535 -0.728 . . . . 0.0 111.0 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.48 -12.52 55.44 Favored Glycine 0 N--CA 1.495 2.602 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.065 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 59.3 t -89.93 133.34 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 120.699 -1.471 . . . . 0.0 110.951 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 22.1 p -80.26 151.97 29.31 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.736 HD22 HG11 ' B' ' 3' ' ' VAL . 18.4 mt -61.24 -24.59 66.47 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.316 -0.865 . . . . 0.0 110.618 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 8.8 tmm? -69.76 -49.23 55.0 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.2 -0.938 . . . . 0.0 109.497 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -59.91 -41.62 92.12 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.56 -0.713 . . . . 0.0 109.895 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.07 -40.89 95.33 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.655 -0.653 . . . . 0.0 110.169 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . 0.697 ' HA ' HD13 ' B' ' 32' ' ' ILE . . . -68.35 -49.71 58.39 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.219 -0.926 . . . . 0.0 111.058 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 53.8 t -65.42 -39.25 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.298 -0.876 . . . . 0.0 110.711 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 24.0 m -70.01 -14.12 62.55 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.325 -0.859 . . . . 0.0 111.557 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -118.15 23.78 11.39 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.036 -1.04 . . . . 0.0 110.691 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.81 38.21 59.1 Favored Glycine 0 N--CA 1.493 2.454 0 O-C-N 121.527 -0.733 . . . . 0.0 111.83 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.697 HD13 ' HA ' ' B' ' 27' ' ' ALA . 1.0 OUTLIER -72.53 147.11 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.847 -1.384 . . . . 0.0 108.874 179.055 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -62.63 142.43 58.05 Favored 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 117.201 2.297 . . . . 0.0 117.201 -174.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . 0.447 ' O ' ' HG3' ' B' ' 105' ' ' GLN . 65.2 m-20 62.25 -36.14 0.12 Allowed 'General case' 0 N--CA 1.516 2.833 0 N-CA-C 116.66 2.096 . . . . 0.0 116.66 175.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 54.3 mt -59.76 122.89 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.419 0 O-C-N 119.89 -1.756 . . . . 0.0 110.62 -178.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.68 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 96.5 t -100.13 -51.36 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.695 -0.628 . . . . 0.0 111.183 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.13 56.4 20.67 Favored Glycine 0 N--CA 1.499 2.873 0 N-CA-C 107.491 -2.244 . . . . 0.0 107.491 -178.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -71.27 -49.23 45.17 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.994 -0.709 . . . . 0.0 112.34 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' CYS . . . . . 0.58 ' O ' HD13 ' A' ' 356' ' ' LEU . 2.3 p -66.6 -10.48 46.15 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.215 -0.928 . . . . 0.0 112.332 -178.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.87 -5.57 63.92 Favored Glycine 0 N--CA 1.498 2.804 0 O-C-N 120.787 -1.195 . . . . 0.0 111.968 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.17 19.5 10.63 Favored Glycine 0 N--CA 1.495 2.605 0 O-C-N 120.803 -1.41 . . . . 0.0 111.002 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 80.6 p -98.97 19.21 15.49 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.028 -1.278 . . . . 0.0 111.132 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.92 40.89 30.46 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.4 -0.812 . . . . 0.0 111.941 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 3.6 t -117.02 11.14 14.18 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.376 -0.828 . . . . 0.0 109.518 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' CYS . . . . . 0.549 ' HB3' ' HB3' ' B' ' 39' ' ' CYS . 15.1 p -149.53 -179.11 6.84 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.05 34.04 3.11 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.803 -1.186 . . . . 0.0 111.367 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' THR . . . . . 0.68 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 23.4 p -97.59 13.24 30.78 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.933 -1.105 . . . . 0.0 111.276 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' CYS . . . . . 0.442 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.1 p -120.58 31.77 6.3 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 177.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . 0.468 ' NE2' ' HB3' ' B' ' 82' ' ' SER . 6.5 t-160 -72.65 132.99 44.43 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.642 -178.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.2 m -146.21 160.1 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . 0.413 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.3 m-85 -105.43 102.71 12.17 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.238 -0.914 . . . . 0.0 108.706 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.4 t -61.87 135.13 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.282 -0.886 . . . . 0.0 109.369 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.67 131.74 51.16 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.954 0.883 . . . . 0.0 109.518 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' B' ' 54' ' ' GLU . 11.0 mp0 -44.26 -31.08 0.91 Allowed 'General case' 0 N--CA 1.507 2.384 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -178.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.78 -6.88 54.07 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 120.963 -1.086 . . . . 0.0 112.752 -178.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -119.9 -6.73 10.04 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.46 -1.4 . . . . 0.0 111.886 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.4 p -55.45 -37.75 68.13 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.174 -0.954 . . . . 0.0 112.863 -178.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -81.2 -6.62 59.06 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.741 -1.225 . . . . 0.0 111.453 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -89.84 -11.67 41.31 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.045 -1.034 . . . . 0.0 109.859 178.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -104.07 141.04 21.7 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -73.74 118.88 5.63 Favored 'Trans proline' 0 N--CA 1.488 1.18 0 O-C-N 123.509 1.268 . . . . 0.0 109.029 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.94 160.59 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.762 0 N-CA-C 116.65 2.092 . . . . 0.0 116.65 -177.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . 0.615 ' HB1' ' HB3' ' B' ' 67' ' ' GLU . . . -65.76 146.18 55.09 Favored 'General case' 0 N--CA 1.503 2.182 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.258 178.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -89.81 -170.76 2.92 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.606 -0.684 . . . . 0.0 110.383 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -59.59 -41.96 91.46 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.337 -0.852 . . . . 0.0 111.705 -178.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.46 -41.6 84.4 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.186 -0.946 . . . . 0.0 111.969 -178.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . 0.615 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 45.6 tt0 -68.22 -43.96 76.82 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.005 -1.059 . . . . 0.0 110.298 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' ILE . . . . . 0.516 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.6 mm -55.52 -42.22 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.311 -0.868 . . . . 0.0 109.359 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.25 -47.78 81.3 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 26.9 mmt -66.26 -33.91 76.8 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.268 -1.137 . . . . 0.0 111.17 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' LEU . . . . . 0.422 ' HA ' HD23 ' B' ' 71' ' ' LEU . 27.5 mt -63.49 -23.35 67.36 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.207 -0.933 . . . . 0.0 110.623 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 41.1 mt-10 -70.41 -8.74 53.13 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.354 -0.842 . . . . 0.0 110.911 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 73.5 p -119.82 12.53 12.14 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.009 -1.057 . . . . 0.0 112.504 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 34.9 m -60.78 140.45 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 120.745 -1.222 . . . . 0.0 109.622 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 36.6 m -74.58 -39.06 62.47 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.393 -0.817 . . . . 0.0 110.181 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.2 168.82 17.43 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.47 -0.769 . . . . 0.0 110.094 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.27 139.14 55.67 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.392 -0.818 . . . . 0.0 110.609 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.2 tp -91.02 116.13 28.55 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.489 -0.757 . . . . 0.0 109.869 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -102.97 168.29 9.02 Favored Pre-proline 0 C--N 1.301 -1.518 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -76.62 -0.01 10.02 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 123.243 1.128 . . . . 0.0 110.401 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -120.46 22.36 11.3 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.898 -1.126 . . . . 0.0 108.399 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' SER . . . . . 0.468 ' HB3' ' NE2' ' B' ' 49' ' ' HIS . 4.3 m -80.81 137.19 36.21 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.861 -0.524 . . . . 0.0 110.362 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.4 mmm-85 -149.75 146.38 27.16 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.487 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.593 HD12 ' HG3' ' B' ' 67' ' ' GLU . 97.5 mt -80.54 98.95 7.82 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 175.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 10.6 p -48.41 -17.86 0.18 Allowed 'General case' 0 N--CA 1.508 2.455 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -175.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.8 p -70.27 -14.01 62.42 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.616 -1.302 . . . . 0.0 109.464 178.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -92.7 -12.21 32.04 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.453 -0.779 . . . . 0.0 110.53 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' ILE . . . . . 0.4 HG21 HD13 ' B' ' 88' ' ' ILE . 61.8 mt -91.51 103.96 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.133 -0.979 . . . . 0.0 110.609 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 47.6 mm -84.96 131.79 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 13.6 tpt -74.84 137.8 42.08 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 122.164 0.983 . . . . 0.0 113.189 -177.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 43.7 p -138.25 166.59 24.63 Favored Pre-proline 0 N--CA 1.49 1.548 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 176.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -74.88 1.66 7.42 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 122.638 0.809 . . . . 0.0 111.035 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -87.65 -22.83 24.47 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.5 mt -93.72 12.96 23.75 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.465 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.52 126.44 23.6 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.184 -0.948 . . . . 0.0 111.15 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.21 6.81 68.46 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.66 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.58 142.74 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 CA-C-N 119.325 1.563 . . . . 0.0 110.768 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 98' ' ' VAL . . . . . 0.463 HG22 ' HB ' ' B' ' 4' ' ' VAL . 60.7 t -122.5 132.98 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.501 -0.749 . . . . 0.0 109.831 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 16.3 m -130.35 135.71 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.479 -0.763 . . . . 0.0 109.882 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 100' ' ' ASP . . . . . 0.413 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.34 134.16 35.18 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.1 t -103.46 127.32 29.85 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.545 -0.722 . . . . 0.0 110.32 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -80.85 130.93 7.81 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 O-C-N 124.114 1.586 . . . . 0.0 108.267 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' ASP . . . . . 0.418 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.4 p-10 -62.33 3.33 0.19 Allowed 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -178.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 4.0 mtm105 -125.29 114.71 19.29 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.306 -1.496 . . . . 0.0 110.064 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 105' ' ' GLN . . . . . 0.512 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 23.2 mm-40 -113.39 -49.36 2.9 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.486 -0.759 . . . . 0.0 109.969 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' TRP . . . . . 0.425 ' CE3' ' HB2' ' A' ' 113' ' ' ALA . 27.3 m95 . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.521 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.514 HD12 ' HD2' ' A' ' 15' ' ' PRO . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 14' ' ' LEU . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.419 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HG2' HG12 ' A' ' 54' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.569 HG12 ' HG2' ' A' ' 51' ' ' PRO . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.609 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.8 m120 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.609 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 64' ' ' ILE . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.435 ' HA ' HD23 ' A' ' 324' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.0 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.4 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.5 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.427 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 27.0 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.64 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.2 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.556 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.717 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.717 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 1.068 HD11 ' CZ ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.63 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 67.6 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.64 ' O ' ' HB3' ' A' ' 83' ' ' SER . 3.8 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 46.0 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.647 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.296 50.2 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 104' ' ' ASP 0.366 52.9 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.647 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 35.0 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.452 ' H ' ' CG ' ' A' ' 106' ' ' PRO 0.413 34.1 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 8.6 mtp180 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.552 ' HB2' ' CE3' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.687 HD11 ' HA3' ' A' ' 226' ' ' GLY . 24.5 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.546 ' O ' HG22 ' A' ' 119' ' ' VAL . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.603 ' HA ' HG21 ' A' ' 123' ' ' VAL . 35.1 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.593 HG13 HG23 ' A' ' 118' ' ' VAL . 30.6 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.493 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.698 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 21.5 mtm -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.698 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.1 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.603 HG21 ' HA ' ' A' ' 118' ' ' VAL . 72.0 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.7 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.452 ' HD2' ' HA ' ' A' ' 123' ' ' VAL . 35.6 mttt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.455 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.63 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.412 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.595 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 151' ' ' THR . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.799 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.799 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.441 ' O ' ' HG2' ' A' ' 164' ' ' MET . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.578 ' C ' HD23 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.455 ' N ' HD23 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.425 ' N ' ' HD2' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' HIS . . . . . 0.405 ' O ' ' HG ' ' A' ' 180' ' ' LEU . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.574 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 176' ' ' HIS . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.561 ' HA ' ' HE3' ' A' ' 184' ' ' MET . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . 0.561 ' HE3' ' HA ' ' A' ' 181' ' ' THR . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.421 HD22 ' HE1' ' A' ' 184' ' ' MET . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . 0.453 ' HG3' ' HB1' ' A' ' 224' ' ' ALA . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 220' ' ' ILE . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 33.3 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 53.1 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.453 ' HB1' ' HG3' ' A' ' 212' ' ' ARG . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.687 ' HA3' HD11 ' A' ' 114' ' ' LEU . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 4.6 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 1.3 m120 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 18.1 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . 1.068 ' CZ ' HD11 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 45.3 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.717 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.487 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' MET . . . . . 0.595 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.437 ' N ' ' HD2' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' CYS . . . . . . . . . . . . . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 288' ' ' LEU . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.706 HD23 ' H ' ' A' ' 294' ' ' LEU . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . 0.419 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . 0.419 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.1 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.459 ' HA ' HD13 ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 314' ' ' LYS . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.6 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' HIS . . . . . 0.425 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 36.9 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 303' ' ' SER . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 318' ' ' ILE . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' LEU . . . . . 0.647 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' PRO . . . . . 0.68 ' HG2' HD22 ' A' ' 324' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.68 HD22 ' HG2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 13.7 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 327' ' ' LEU . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.522 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' PRO . . . . . 0.522 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' GLN . . . . . 0.41 ' CB ' ' HD3' ' A' ' 344' ' ' LYS . 1.9 mp0 -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' LYS . . . . . 0.511 ' HD3' ' N ' ' A' ' 344' ' ' LYS . 0.9 OUTLIER -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 60.7 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 10.6 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 39.9 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' THR . . . . . . . . . . . . . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . 0.669 ' O ' HD12 ' A' ' 356' ' ' LEU . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' SER . . . . . 0.408 ' HA ' ' HB3' ' B' ' 44' ' ' SER . 97.5 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' LEU . . . . . 0.669 HD12 ' O ' ' A' ' 353' ' ' GLY . 0.2 OUTLIER -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 44.0 mtt85 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 412' ' ' LYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 39.7 m . . . . . 0 N--CA 1.495 1.805 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.49 138.61 38.52 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.246 -0.909 . . . . 0.0 112.958 -178.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . 0.744 HG11 HD22 ' B' ' 23' ' ' LEU . 61.0 t -137.16 122.52 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 177.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.528 HG11 ' CZ ' ' B' ' 12' ' ' ARG . 97.9 t -106.74 129.56 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.093 -1.004 . . . . 0.0 111.636 -178.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.513 ' CG ' HD13 ' B' ' 32' ' ' ILE . 77.2 m-85 -109.23 110.58 21.83 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.8 127.27 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 120.93 -1.106 . . . . 0.0 108.377 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.7 m -86.21 174.64 8.97 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.766 0.793 . . . . 0.0 112.498 -177.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' HIS . . . . . 0.432 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.6 -46.75 89.09 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.186 0.517 . . . . 0.0 110.472 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.2 p-10 -65.92 -11.28 46.04 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.583 -0.698 . . . . 0.0 111.419 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.98 15.51 28.3 Favored Glycine 0 N--CA 1.493 2.459 0 O-C-N 121.195 -0.941 . . . . 0.0 111.256 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.6 m -82.1 147.41 29.1 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 118.721 1.26 . . . . 0.0 109.884 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . 0.528 ' CZ ' HG11 ' B' ' 4' ' ' VAL . 50.8 ttt85 -118.52 128.78 54.91 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.508 -0.745 . . . . 0.0 111.816 -178.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' B' ' 13' ' ' ARG . 0.0 OUTLIER -126.07 127.72 46.27 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.623 -0.673 . . . . 0.0 109.79 179.109 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -111.26 130.62 55.6 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.284 -0.885 . . . . 0.0 111.617 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 84.4 mt -122.83 159.37 28.28 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.357 0.598 . . . . 0.0 111.08 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -109.64 91.67 3.74 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.7 t -90.22 133.49 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-O 121.654 0.74 . . . . 0.0 112.258 -176.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.13 170.67 16.12 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.766 -0.584 . . . . 0.0 110.242 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -68.45 151.83 46.27 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.5 -0.75 . . . . 0.0 110.954 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.42 -12.45 55.43 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.046 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.462 HG13 ' NE2' ' B' ' 25' ' ' GLN . 61.8 t -89.99 133.35 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 120.654 -1.498 . . . . 0.0 110.904 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 21.6 p -80.28 151.92 29.3 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.593 -0.692 . . . . 0.0 109.143 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.744 HD22 HG11 ' B' ' 3' ' ' VAL . 18.4 mt -61.19 -24.64 66.47 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.29 -0.881 . . . . 0.0 110.618 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 7.7 ttp -69.71 -49.26 55.05 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.263 -0.898 . . . . 0.0 109.489 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . 0.462 ' NE2' HG13 ' B' ' 21' ' ' VAL . 0.1 OUTLIER -59.82 -41.67 91.8 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.562 -0.711 . . . . 0.0 109.937 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.11 -40.89 95.17 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.552 -0.718 . . . . 0.0 110.114 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . 0.589 ' HA ' HD12 ' B' ' 32' ' ' ILE . . . -68.31 -49.76 58.18 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.2 -0.937 . . . . 0.0 111.066 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 76.8 t -65.42 -39.17 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.317 -0.864 . . . . 0.0 110.755 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 20.5 t -70.09 -14.06 62.49 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.383 -0.823 . . . . 0.0 111.529 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -118.18 23.85 11.34 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.065 -1.022 . . . . 0.0 110.661 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.7 38.24 58.59 Favored Glycine 0 N--CA 1.493 2.481 0 O-C-N 121.55 -0.719 . . . . 0.0 111.871 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.589 HD12 ' HA ' ' B' ' 27' ' ' ALA . 0.4 OUTLIER -72.54 147.21 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.792 -1.416 . . . . 0.0 108.892 179.002 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -62.72 142.48 58.11 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 117.202 2.297 . . . . 0.0 117.202 -174.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 62.29 -36.21 0.12 Allowed 'General case' 0 N--CA 1.515 2.787 0 N-CA-C 116.59 2.07 . . . . 0.0 116.59 175.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.8 mt -59.67 122.85 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.395 0 O-C-N 119.828 -1.795 . . . . 0.0 110.718 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.688 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 90.7 t -100.12 -51.4 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.616 -0.678 . . . . 0.0 111.196 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.16 56.41 20.55 Favored Glycine 0 N--CA 1.499 2.873 0 N-CA-C 107.482 -2.247 . . . . 0.0 107.482 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -71.22 -49.33 44.56 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.942 -0.74 . . . . 0.0 112.325 -177.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' CYS . . . . . 0.635 ' O ' HD13 ' A' ' 356' ' ' LEU . 2.3 p -66.55 -10.46 45.39 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.244 -0.91 . . . . 0.0 112.389 -178.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.82 -5.47 64.01 Favored Glycine 0 N--CA 1.499 2.846 0 O-C-N 120.842 -1.161 . . . . 0.0 111.959 177.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.14 19.52 10.63 Favored Glycine 0 N--CA 1.495 2.569 0 O-C-N 120.845 -1.385 . . . . 0.0 110.974 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 14.0 m -98.95 19.12 15.62 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.033 -1.275 . . . . 0.0 111.148 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.97 40.89 30.35 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.418 -0.801 . . . . 0.0 111.892 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . 0.408 ' HB3' ' HA ' ' A' ' 354' ' ' SER . 37.4 m -117.05 11.22 14.17 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.345 -0.847 . . . . 0.0 109.523 178.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' CYS . . . . . 0.55 ' HB3' ' HB3' ' B' ' 39' ' ' CYS . 15.1 p -149.54 -179.05 6.78 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.09 34.11 3.09 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.85 -1.156 . . . . 0.0 111.345 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' THR . . . . . 0.688 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 16.9 p -97.63 13.23 30.88 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.947 -1.096 . . . . 0.0 111.243 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.1 p -120.57 31.75 6.31 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -72.67 133.07 44.45 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.63 -178.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.3 m -146.33 160.11 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . 0.419 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.6 m-85 -105.43 102.75 12.2 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.244 -0.91 . . . . 0.0 108.674 178.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.2 t -61.93 135.17 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.226 -0.921 . . . . 0.0 109.351 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.69 131.76 51.24 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.975 0.893 . . . . 0.0 109.539 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.407 ' CD ' ' H ' ' B' ' 54' ' ' GLU . 11.0 mp0 -44.33 -30.98 0.91 Allowed 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -178.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.78 -6.97 54.47 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.982 -1.074 . . . . 0.0 112.75 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -119.87 -6.71 10.06 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.492 -1.38 . . . . 0.0 111.887 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.4 p -55.39 -37.83 68.08 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 121.136 -0.978 . . . . 0.0 112.815 -178.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -81.13 -6.69 59.12 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 120.724 -1.235 . . . . 0.0 111.484 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -89.78 -11.67 41.47 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.974 -1.078 . . . . 0.0 109.878 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -104.08 141.07 21.75 Favored Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -73.8 118.87 5.62 Favored 'Trans proline' 0 N--CA 1.488 1.192 0 O-C-N 123.543 1.286 . . . . 0.0 109.016 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.91 160.64 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.759 0 N-CA-C 116.62 2.081 . . . . 0.0 116.62 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . 0.611 ' HB1' ' HB3' ' B' ' 67' ' ' GLU . . . -65.82 146.19 55.06 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.253 178.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -89.79 -170.78 2.93 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.628 -0.67 . . . . 0.0 110.4 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -59.47 -42.07 91.18 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.31 -0.868 . . . . 0.0 111.716 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -41.47 84.5 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.171 -0.955 . . . . 0.0 112.016 -178.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . 0.709 ' HG3' HD12 ' B' ' 84' ' ' LEU . 45.5 tt0 -68.25 -43.96 76.71 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.97 -1.081 . . . . 0.0 110.335 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' ILE . . . . . 0.525 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.6 mm -55.58 -42.17 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 121.259 -0.901 . . . . 0.0 109.36 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.17 -47.91 80.35 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 13.7 mmt -66.16 -33.97 76.98 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.252 -1.146 . . . . 0.0 111.159 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' B' ' 71' ' ' LEU . 27.8 mt -63.53 -23.31 67.34 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.231 -0.918 . . . . 0.0 110.568 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 49.2 mt-10 -70.46 -8.67 52.85 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.352 -0.842 . . . . 0.0 110.919 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 86.4 p -119.83 12.48 12.12 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.035 -1.04 . . . . 0.0 112.528 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 34.9 m -60.68 140.39 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 O-C-N 120.701 -1.249 . . . . 0.0 109.647 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 24.5 m -74.58 -39.01 62.5 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.446 -0.784 . . . . 0.0 110.192 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.28 168.82 17.53 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.464 -0.773 . . . . 0.0 110.063 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -58.19 139.11 55.56 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.403 -0.811 . . . . 0.0 110.634 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.4 tp -90.97 116.14 28.54 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.535 -0.728 . . . . 0.0 109.89 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -103.03 168.34 8.94 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -76.65 -0.06 10.08 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 O-C-N 123.258 1.136 . . . . 0.0 110.388 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -120.4 22.36 11.32 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.992 -1.067 . . . . 0.0 108.395 176.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 4.3 m -80.83 137.23 36.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.898 -0.501 . . . . 0.0 110.382 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.5 mmm-85 -149.75 146.39 27.17 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 120.06 -0.656 . . . . 0.0 111.458 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.709 HD12 ' HG3' ' B' ' 67' ' ' GLU . 95.2 mt -80.58 98.92 7.84 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 175.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 10.5 p -48.33 -17.88 0.18 Allowed 'General case' 0 N--CA 1.508 2.43 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -175.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.9 p -70.32 -13.98 62.39 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.747 -1.221 . . . . 0.0 109.387 178.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -92.69 -12.25 31.97 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.508 -0.745 . . . . 0.0 110.501 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 61.9 mt -91.49 103.9 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.163 -0.961 . . . . 0.0 110.629 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 45.6 mm -84.94 131.78 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 13.6 tpt -74.83 137.74 42.07 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 122.111 0.957 . . . . 0.0 113.266 -177.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 43.7 p -138.17 166.63 24.45 Favored Pre-proline 0 N--CA 1.49 1.558 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 176.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -74.99 1.72 7.42 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 122.643 0.812 . . . . 0.0 110.968 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -87.62 -22.87 24.48 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 176.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.6 mt -93.74 12.95 23.84 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.437 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.44 126.38 23.22 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.201 -0.937 . . . . 0.0 111.148 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.15 6.92 68.45 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.575 -0.822 . . . . 0.0 111.682 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.65 142.74 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-N 119.319 1.559 . . . . 0.0 110.727 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 98' ' ' VAL . . . . . 0.481 HG22 ' HB ' ' B' ' 4' ' ' VAL . 60.7 t -122.52 133.01 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.513 -0.742 . . . . 0.0 109.843 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 16.5 m -130.41 135.74 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.403 -0.811 . . . . 0.0 109.78 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 100' ' ' ASP . . . . . 0.419 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.35 134.18 35.16 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.9 t -103.39 127.31 29.92 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.525 -0.734 . . . . 0.0 110.353 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -80.85 130.92 7.8 Favored 'Trans proline' 0 C--N 1.316 -1.172 0 O-C-N 124.139 1.6 . . . . 0.0 108.319 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' ASP . . . . . 0.432 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.3 p-10 -62.38 3.46 0.19 Allowed 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -178.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -125.32 114.59 19.11 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.256 -1.528 . . . . 0.0 110.067 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 105' ' ' GLN . . . . . 0.5 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 69.4 mm-40 -113.29 -49.35 2.91 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.497 -0.752 . . . . 0.0 109.987 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' TRP . . . . . 0.552 ' CE3' ' HB2' ' A' ' 113' ' ' ALA . 8.0 m95 . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.495 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.514 HD12 ' HD2' ' A' ' 15' ' ' PRO . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 14' ' ' LEU . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.419 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HG2' HG12 ' A' ' 54' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.569 HG12 ' HG2' ' A' ' 51' ' ' PRO . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.609 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.8 m120 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.609 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 64' ' ' ILE . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.435 ' HA ' HD23 ' A' ' 324' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.0 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.415 ' CZ ' HG23 ' A' ' 348' ' ' THR . 5.6 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.6 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.458 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 27.4 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.2 mmt-85 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.64 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.2 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.556 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.717 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.717 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 1.068 HD11 ' CZ ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.621 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 74.3 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.64 ' O ' ' HB3' ' A' ' 83' ' ' SER . 3.9 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 46.0 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.646 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.294 50.3 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 104' ' ' ASP 0.366 52.9 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.646 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 34.8 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.451 ' H ' ' CG ' ' A' ' 106' ' ' PRO 0.342 30.7 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.581 ' CG ' HD11 ' A' ' 358' ' ' LEU . 3.0 ttp180 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.528 ' HB2' ' CG ' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.752 HD11 ' HA3' ' A' ' 226' ' ' GLY . 6.7 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.546 ' O ' HG22 ' A' ' 119' ' ' VAL . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.603 ' HA ' HG21 ' A' ' 123' ' ' VAL . 35.0 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.594 HG13 HG23 ' A' ' 118' ' ' VAL . 30.6 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.493 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.698 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 7.0 mtm -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.698 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.1 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.603 HG21 ' HA ' ' A' ' 118' ' ' VAL . 72.7 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 46.0 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.455 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.63 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.412 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.595 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 151' ' ' THR . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.799 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.799 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.441 ' O ' ' HG2' ' A' ' 164' ' ' MET . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.578 ' C ' HD23 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.455 ' N ' HD23 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.425 ' N ' ' HD2' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' HIS . . . . . 0.405 ' O ' ' HG ' ' A' ' 180' ' ' LEU . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.574 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 176' ' ' HIS . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.561 ' HA ' ' HE3' ' A' ' 184' ' ' MET . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . 0.561 ' HE3' ' HA ' ' A' ' 181' ' ' THR . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.421 HD22 ' HE1' ' A' ' 184' ' ' MET . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . 0.453 ' HG3' ' HB1' ' A' ' 224' ' ' ALA . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 220' ' ' ILE . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 42.5 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 42.0 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.453 ' HB1' ' HG3' ' A' ' 212' ' ' ARG . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.752 ' HA3' HD11 ' A' ' 114' ' ' LEU . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 4.3 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 13.5 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . 1.068 ' CZ ' HD11 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 41.0 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.717 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.487 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' MET . . . . . 0.595 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 16.4 pm0 -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.437 ' N ' ' HD2' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' CYS . . . . . . . . . . . . . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 288' ' ' LEU . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.706 HD23 ' H ' ' A' ' 294' ' ' LEU . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . 0.419 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . 0.419 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.0 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.459 ' HA ' HD13 ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 314' ' ' LYS . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.6 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' HIS . . . . . 0.425 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 36.9 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 303' ' ' SER . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 318' ' ' ILE . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' LEU . . . . . 0.647 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' PRO . . . . . 0.68 ' HG2' HD22 ' A' ' 324' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.68 HD22 ' HG2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 13.7 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 327' ' ' LEU . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.522 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' PRO . . . . . 0.522 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' GLN . . . . . 0.46 ' CB ' ' HD3' ' A' ' 344' ' ' LYS . 1.9 mp0 -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' LYS . . . . . 0.504 ' HB2' ' HE2' ' A' ' 344' ' ' LYS . 1.7 mppt? -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 57.8 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 22.1 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' THR . . . . . 0.415 HG23 ' CZ ' ' A' ' 72' ' ' ARG . 16.5 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' THR . . . . . . . . . . . . . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 92.6 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' LEU . . . . . 0.583 HD13 ' O ' ' B' ' 39' ' ' CYS . 1.0 OUTLIER -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . 0.581 HD11 ' CG ' ' A' ' 112' ' ' ARG . 0.4 OUTLIER -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 39.3 mtt85 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 17.2 tpp85 -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 412' ' ' LYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 39.6 m . . . . . 0 N--CA 1.495 1.807 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.53 138.58 38.47 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.181 -0.949 . . . . 0.0 112.927 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . 0.733 HG11 HD22 ' B' ' 23' ' ' LEU . 61.3 t -137.11 122.6 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 177.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.524 HG11 ' CZ ' ' B' ' 12' ' ' ARG . 97.5 t -106.77 129.52 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.139 -0.976 . . . . 0.0 111.649 -178.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.679 ' CG ' HD13 ' B' ' 32' ' ' ILE . 77.1 m-85 -109.21 110.62 21.88 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 39.7 t -94.77 127.2 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.925 -1.109 . . . . 0.0 108.439 178.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.6 m -86.14 174.71 8.96 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.768 0.794 . . . . 0.0 112.493 -177.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' HIS . . . . . 0.422 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.65 -46.77 89.04 Favored 'General case' 0 N--CA 1.503 2.19 0 CA-C-O 121.193 0.521 . . . . 0.0 110.448 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -65.92 -11.22 45.61 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.544 -0.723 . . . . 0.0 111.425 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.97 15.46 28.48 Favored Glycine 0 N--CA 1.492 2.385 0 O-C-N 121.147 -0.971 . . . . 0.0 111.256 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.4 m -82.07 147.37 29.15 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 118.773 1.287 . . . . 0.0 109.903 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . 0.524 ' CZ ' HG11 ' B' ' 4' ' ' VAL . 50.8 ttt85 -118.49 128.77 54.91 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.529 -0.732 . . . . 0.0 111.829 -178.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' B' ' 13' ' ' ARG . 0.0 OUTLIER -126.01 127.73 46.34 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.554 -0.716 . . . . 0.0 109.79 179.11 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.3 tt0 -111.35 130.66 55.61 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.29 -0.881 . . . . 0.0 111.591 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 85.0 mt -122.79 159.35 28.27 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.754 -0.591 . . . . 0.0 111.114 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -109.62 91.68 3.74 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.7 t -90.27 133.45 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-O 121.688 0.756 . . . . 0.0 112.248 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.08 170.67 16.12 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.706 -0.621 . . . . 0.0 110.262 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -68.46 151.81 46.29 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.532 -0.73 . . . . 0.0 110.967 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.41 -12.46 55.35 Favored Glycine 0 N--CA 1.495 2.629 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.067 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 59.1 t -89.99 133.33 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 120.69 -1.476 . . . . 0.0 110.936 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 21.7 p -80.29 151.94 29.28 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.568 -0.707 . . . . 0.0 109.145 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.733 HD22 HG11 ' B' ' 3' ' ' VAL . 18.5 mt -61.21 -24.63 66.48 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.297 -0.877 . . . . 0.0 110.605 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 7.6 tmm? -69.7 -49.28 54.92 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.235 -0.916 . . . . 0.0 109.5 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -59.81 -41.71 91.87 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.619 -0.675 . . . . 0.0 109.913 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.1 -40.87 95.19 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.631 -0.668 . . . . 0.0 110.121 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . 0.73 ' HA ' HD12 ' B' ' 32' ' ' ILE . . . -68.33 -49.77 58.02 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.262 -0.899 . . . . 0.0 111.055 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 51.0 t -65.45 -39.12 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.349 -0.844 . . . . 0.0 110.744 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 15.8 t -70.15 -14.01 62.45 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.41 -0.806 . . . . 0.0 111.503 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -118.14 23.78 11.39 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.024 -1.048 . . . . 0.0 110.664 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.72 38.23 58.67 Favored Glycine 0 N--CA 1.493 2.469 0 O-C-N 121.532 -0.73 . . . . 0.0 111.876 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.73 HD12 ' HA ' ' B' ' 27' ' ' ALA . 1.7 mt -72.49 147.11 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.882 -1.364 . . . . 0.0 108.887 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.66 142.44 58.08 Favored 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 117.214 2.302 . . . . 0.0 117.214 -174.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 62.29 -36.18 0.12 Allowed 'General case' 0 N--CA 1.516 2.831 0 N-CA-C 116.612 2.079 . . . . 0.0 116.612 175.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 84.2 mt -59.67 122.85 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.401 0 O-C-N 119.85 -1.781 . . . . 0.0 110.672 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.535 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 84.4 t -100.15 -51.39 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.595 -0.691 . . . . 0.0 111.237 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.15 56.48 20.18 Favored Glycine 0 N--CA 1.499 2.866 0 N-CA-C 107.472 -2.251 . . . . 0.0 107.472 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -71.32 -49.33 43.73 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.985 -0.715 . . . . 0.0 112.259 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' CYS . . . . . 0.583 ' O ' HD13 ' A' ' 356' ' ' LEU . 2.3 p -66.5 -10.49 45.2 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.201 -0.937 . . . . 0.0 112.351 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . 0.454 ' CA ' HD22 ' A' ' 356' ' ' LEU . . . 96.81 -5.45 64.01 Favored Glycine 0 N--CA 1.497 2.731 0 O-C-N 120.825 -1.172 . . . . 0.0 111.973 177.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.07 19.57 10.63 Favored Glycine 0 N--CA 1.495 2.584 0 O-C-N 120.77 -1.429 . . . . 0.0 110.985 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 87.1 p -99.02 19.23 15.51 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.054 -1.263 . . . . 0.0 111.141 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.94 40.85 30.41 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.383 -0.823 . . . . 0.0 111.918 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.0 11.14 14.2 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.31 -0.868 . . . . 0.0 109.562 178.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' CYS . . . . . 0.552 ' HB3' ' HB3' ' B' ' 39' ' ' CYS . 15.1 p -149.48 -179.1 6.82 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.522 -0.736 . . . . 0.0 109.102 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.06 34.09 3.1 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.86 -1.15 . . . . 0.0 111.411 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' THR . . . . . 0.535 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 72.7 p -97.6 13.31 30.57 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.962 -1.086 . . . . 0.0 111.299 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' CYS . . . . . 0.441 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.3 p -120.58 31.74 6.31 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 23.9 t-160 -72.67 133.08 44.45 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.589 -178.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.2 m -146.29 160.06 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . 0.413 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.4 m-85 -105.39 102.7 12.16 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.265 -0.897 . . . . 0.0 108.721 178.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.7 t -61.84 135.08 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 121.321 -0.862 . . . . 0.0 109.354 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.61 131.77 51.23 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.983 0.897 . . . . 0.0 109.542 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.416 ' H ' ' CD ' ' B' ' 54' ' ' GLU . 11.0 mp0 -44.3 -31.06 0.92 Allowed 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -178.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.77 -6.92 54.23 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.017 -1.052 . . . . 0.0 112.75 -178.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -119.89 -6.71 10.04 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 120.488 -1.383 . . . . 0.0 111.884 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.5 p -55.38 -37.83 68.07 Favored 'General case' 0 N--CA 1.507 2.406 0 O-C-N 121.173 -0.955 . . . . 0.0 112.835 -178.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 -81.14 -6.66 59.08 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.728 -1.232 . . . . 0.0 111.426 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -89.9 -11.57 41.47 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.033 -1.042 . . . . 0.0 109.872 178.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -104.08 141.02 21.65 Favored Pre-proline 0 N--CA 1.488 1.462 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.79 118.84 5.61 Favored 'Trans proline' 0 N--CA 1.488 1.173 0 O-C-N 123.448 1.236 . . . . 0.0 109.026 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.87 160.61 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.77 0 N-CA-C 116.692 2.108 . . . . 0.0 116.692 -177.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . 0.614 ' HB1' ' HB3' ' B' ' 67' ' ' GLU . . . -65.82 146.13 55.13 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.245 178.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -89.7 -170.78 2.94 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.589 -0.694 . . . . 0.0 110.428 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -59.56 -41.98 91.4 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.321 -0.862 . . . . 0.0 111.748 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.41 -41.57 84.69 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.186 -0.946 . . . . 0.0 112.043 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . 0.623 ' HG3' HD12 ' B' ' 84' ' ' LEU . 45.4 tt0 -68.19 -44.03 76.79 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.98 -1.075 . . . . 0.0 110.317 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' ILE . . . . . 0.527 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.6 mm -55.56 -42.21 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.285 -0.884 . . . . 0.0 109.326 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.16 -47.88 80.71 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 12.5 mmt -66.22 -33.91 76.83 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.273 -1.133 . . . . 0.0 111.182 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' LEU . . . . . 0.432 ' HA ' HD23 ' B' ' 71' ' ' LEU . 27.9 mt -63.48 -23.33 67.35 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.214 -0.928 . . . . 0.0 110.616 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 49.9 mt-10 -70.44 -8.76 53.46 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.366 -0.834 . . . . 0.0 110.875 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 82.7 p -119.83 12.56 12.14 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.053 -1.029 . . . . 0.0 112.548 -178.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 22.3 m -60.76 140.35 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 120.739 -1.225 . . . . 0.0 109.668 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 13.9 m -74.53 -39.02 62.62 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.449 -0.782 . . . . 0.0 110.195 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.24 168.81 17.5 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.428 -0.795 . . . . 0.0 110.106 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.28 139.11 55.75 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.388 -0.82 . . . . 0.0 110.563 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.3 tp -90.93 116.14 28.51 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.494 -0.754 . . . . 0.0 109.935 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -102.99 168.35 8.93 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -76.64 0.01 10.01 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 O-C-N 123.219 1.115 . . . . 0.0 110.434 178.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -120.5 22.38 11.27 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.941 -1.099 . . . . 0.0 108.406 176.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 4.3 m -80.81 137.21 36.21 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.832 -0.542 . . . . 0.0 110.367 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.3 mmm-85 -149.78 146.42 27.16 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 120.059 -0.657 . . . . 0.0 111.448 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.623 HD12 ' HG3' ' B' ' 67' ' ' GLU . 95.9 mt -80.61 98.97 7.89 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 104.784 -2.302 . . . . 0.0 104.784 175.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' CYS . . . . . 0.41 ' HB2' ' HB2' ' B' ' 23' ' ' LEU . 10.6 p -48.36 -17.86 0.18 Allowed 'General case' 0 N--CA 1.508 2.443 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -175.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.8 p -70.33 -14.0 62.39 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.669 -1.269 . . . . 0.0 109.389 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 59.2 mm-40 -92.72 -12.23 31.92 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.512 -0.742 . . . . 0.0 110.534 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 61.7 mt -91.52 103.97 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.194 -0.941 . . . . 0.0 110.647 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 45.7 mm -85.03 131.75 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 13.6 tpt -74.82 137.76 42.11 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 122.101 0.953 . . . . 0.0 113.243 -177.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 43.6 p -138.16 166.61 24.62 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 176.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -74.98 1.78 7.35 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 122.663 0.823 . . . . 0.0 111.025 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -87.67 -22.81 24.45 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 176.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.3 mt -93.8 13.04 23.69 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.427 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.5 126.4 23.4 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.122 -0.986 . . . . 0.0 111.142 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.22 6.79 68.45 Favored Glycine 0 N--CA 1.492 2.416 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.725 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.61 142.75 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 CA-C-N 119.263 1.532 . . . . 0.0 110.789 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 98' ' ' VAL . . . . . 0.471 HG22 ' HB ' ' B' ' 4' ' ' VAL . 60.9 t -122.49 132.96 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.561 -0.712 . . . . 0.0 109.856 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 16.5 m -130.33 135.73 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.47 -0.769 . . . . 0.0 109.877 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 100' ' ' ASP . . . . . 0.413 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.38 134.14 35.22 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.6 t -103.33 127.31 29.96 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.535 -0.728 . . . . 0.0 110.377 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -80.9 131.0 7.79 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 O-C-N 124.079 1.568 . . . . 0.0 108.286 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 103' ' ' ASP . . . . . 0.422 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.4 p-10 -62.47 3.44 0.2 Allowed 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -178.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -125.28 114.64 19.2 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.288 -1.508 . . . . 0.0 110.088 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 105' ' ' GLN . . . . . 0.505 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 32.6 mm-40 -113.31 -49.35 2.91 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.455 -0.778 . . . . 0.0 110.007 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 106' ' ' TRP . . . . . 0.528 ' CG ' ' HB2' ' A' ' 113' ' ' ALA . 10.3 m0 . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.53 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.514 HD12 ' HD2' ' A' ' 15' ' ' PRO . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 14' ' ' LEU . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.419 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HG2' HG12 ' A' ' 54' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.569 HG12 ' HG2' ' A' ' 51' ' ' PRO . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.609 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.8 m120 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.609 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 64' ' ' ILE . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.435 ' HA ' HD23 ' A' ' 324' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.0 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.6 mtt180 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.5 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.552 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 25.8 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 84.1 mtt-85 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.8 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.64 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.1 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.556 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.717 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.717 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 1.068 HD11 ' CZ ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.621 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 74.3 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.64 ' O ' ' HB3' ' A' ' 83' ' ' SER . 3.9 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 46.0 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.605 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.298 63.0 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.552 ' HD2' ' CD1' ' A' ' 78' ' ' TYR 0.367 53.3 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.605 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 33.9 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.452 ' H ' ' CD ' ' A' ' 106' ' ' PRO 0.413 34.1 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 15.6 tpt85 -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 5.5 ttt-85 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.478 ' HB2' ' CE3' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.766 HD11 ' HA3' ' A' ' 226' ' ' GLY . 4.2 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.546 ' O ' HG22 ' A' ' 119' ' ' VAL . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.539 ' HA ' ' CD2' ' A' ' 358' ' ' LEU . 23.3 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.603 ' HA ' HG21 ' A' ' 123' ' ' VAL . 35.0 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.595 HG13 HG23 ' A' ' 118' ' ' VAL . 30.6 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.493 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.698 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 12.4 mtm -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.698 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.1 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.603 HG21 ' HA ' ' A' ' 118' ' ' VAL . 72.7 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.2 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.455 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.63 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.412 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.595 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 151' ' ' THR . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.799 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.799 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.441 ' O ' ' HG2' ' A' ' 164' ' ' MET . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.578 ' C ' HD23 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.455 ' N ' HD23 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.425 ' N ' ' HD2' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' HIS . . . . . 0.405 ' O ' ' HG ' ' A' ' 180' ' ' LEU . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.574 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 176' ' ' HIS . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.561 ' HA ' ' HE3' ' A' ' 184' ' ' MET . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . 0.561 ' HE3' ' HA ' ' A' ' 181' ' ' THR . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.421 HD22 ' HE1' ' A' ' 184' ' ' MET . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . 0.453 ' HG3' ' HB1' ' A' ' 224' ' ' ALA . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 220' ' ' ILE . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 43.5 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 42.0 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.453 ' HB1' ' HG3' ' A' ' 212' ' ' ARG . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.766 ' HA3' HD11 ' A' ' 114' ' ' LEU . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 6.9 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 2.6 m120 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 17.1 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . 1.068 ' CZ ' HD11 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 34.2 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.717 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.487 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' MET . . . . . 0.595 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 16.4 pm0 -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.437 ' N ' ' HD2' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' CYS . . . . . . . . . . . . . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 288' ' ' LEU . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.706 HD23 ' H ' ' A' ' 294' ' ' LEU . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . 0.419 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . 0.419 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.0 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.459 ' HA ' HD13 ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 314' ' ' LYS . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.6 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' HIS . . . . . 0.425 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 36.9 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 303' ' ' SER . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 318' ' ' ILE . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' LEU . . . . . 0.647 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' PRO . . . . . 0.68 ' HG2' HD22 ' A' ' 324' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.68 HD22 ' HG2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 14.7 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 327' ' ' LEU . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.522 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' PRO . . . . . 0.522 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 99.3 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 8.8 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 45.1 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' THR . . . . . . . . . . . . . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . 0.413 ' O ' HD12 ' A' ' 356' ' ' LEU . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 91.4 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' LEU . . . . . 0.57 HD13 ' O ' ' B' ' 39' ' ' CYS . 0.3 OUTLIER -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . 0.539 ' CD2' ' HA ' ' A' ' 116' ' ' ASN . 0.6 OUTLIER -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 44.1 mtt85 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 16.6 tpp85 -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.2 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 412' ' ' LYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 N--CA 1.495 1.815 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.49 138.58 38.5 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.181 -0.949 . . . . 0.0 112.936 -178.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . 0.744 HG11 HD22 ' B' ' 23' ' ' LEU . 61.3 t -137.12 122.59 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 177.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.526 HG11 ' CZ ' ' B' ' 12' ' ' ARG . 97.8 t -106.79 129.56 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.109 -0.994 . . . . 0.0 111.635 -178.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.504 ' CG ' HD13 ' B' ' 32' ' ' ILE . 77.1 m-85 -109.23 110.63 21.89 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 40.0 t -94.84 127.25 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.88 -1.138 . . . . 0.0 108.345 178.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.4 m -86.15 174.69 8.97 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.747 0.784 . . . . 0.0 112.499 -177.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' HIS . . . . . 0.427 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.68 -46.8 88.99 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-O 121.129 0.49 . . . . 0.0 110.418 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -65.83 -11.29 45.24 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.56 -0.712 . . . . 0.0 111.405 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.94 15.47 28.53 Favored Glycine 0 N--CA 1.492 2.368 0 O-C-N 121.163 -0.961 . . . . 0.0 111.312 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.1 m -82.09 147.4 29.12 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 118.723 1.261 . . . . 0.0 109.875 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . 0.526 ' CZ ' HG11 ' B' ' 4' ' ' VAL . 50.8 ttt85 -118.46 128.82 54.97 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.476 -0.765 . . . . 0.0 111.803 -178.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' B' ' 13' ' ' ARG . 0.0 OUTLIER -126.08 127.73 46.27 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.608 -0.683 . . . . 0.0 109.8 179.084 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.3 tt0 -111.37 130.61 55.63 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.236 -0.915 . . . . 0.0 111.623 -178.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 84.5 mt -122.8 159.38 28.21 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.732 -0.605 . . . . 0.0 111.075 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -109.63 91.63 3.72 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.8 t -90.2 133.47 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-O 121.625 0.726 . . . . 0.0 112.233 -176.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.09 170.7 16.05 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.784 -0.572 . . . . 0.0 110.266 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -68.47 151.79 46.31 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.503 -0.748 . . . . 0.0 110.965 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.5 -12.52 55.53 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.021 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 91.4 t -89.97 133.36 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 120.696 -1.473 . . . . 0.0 110.933 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 88.5 p -80.25 151.86 29.38 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.523 -0.736 . . . . 0.0 109.129 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.744 HD22 HG11 ' B' ' 3' ' ' VAL . 18.4 mt -61.2 -24.68 66.5 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.29 -0.881 . . . . 0.0 110.549 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 2.1 ttp -69.7 -49.24 55.27 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.186 -0.946 . . . . 0.0 109.474 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.81 -41.7 91.82 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.622 -0.674 . . . . 0.0 109.926 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.13 -40.87 95.05 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.607 -0.683 . . . . 0.0 110.099 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . 0.583 ' HA ' HD12 ' B' ' 32' ' ' ILE . . . -68.33 -49.79 57.89 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.254 -0.903 . . . . 0.0 111.023 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 71.8 t -65.41 -39.19 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.266 -0.896 . . . . 0.0 110.737 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 15.5 t -70.06 -14.08 62.51 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.342 -0.849 . . . . 0.0 111.562 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -118.13 23.84 11.36 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.016 -1.052 . . . . 0.0 110.658 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.65 38.31 58.55 Favored Glycine 0 N--CA 1.492 2.418 0 O-C-N 121.539 -0.725 . . . . 0.0 111.85 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.583 HD12 ' HA ' ' B' ' 27' ' ' ALA . 0.4 OUTLIER -72.55 147.13 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.829 -1.395 . . . . 0.0 108.875 178.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -62.7 142.52 58.08 Favored 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 -174.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 62.19 -36.14 0.12 Allowed 'General case' 0 N--CA 1.515 2.785 0 N-CA-C 116.693 2.108 . . . . 0.0 116.693 175.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.524 HD12 ' CG2' ' B' ' 32' ' ' ILE . 12.1 mt -59.7 122.9 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 O-C-N 119.879 -1.763 . . . . 0.0 110.656 -178.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.663 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 58.0 t -100.14 -51.41 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.626 -0.671 . . . . 0.0 111.192 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.17 56.42 20.52 Favored Glycine 0 N--CA 1.499 2.895 0 N-CA-C 107.478 -2.249 . . . . 0.0 107.478 -178.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -71.29 -49.28 44.51 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.983 -0.716 . . . . 0.0 112.279 -177.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' CYS . . . . . 0.57 ' O ' HD13 ' A' ' 356' ' ' LEU . 2.3 p -66.55 -10.48 45.57 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.209 -0.932 . . . . 0.0 112.351 -178.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.82 -5.59 64.08 Favored Glycine 0 N--CA 1.499 2.846 0 O-C-N 120.808 -1.183 . . . . 0.0 112.013 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.16 19.56 10.59 Favored Glycine 0 N--CA 1.495 2.628 0 O-C-N 120.856 -1.379 . . . . 0.0 110.98 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 9.4 t -98.98 19.14 15.63 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.072 -1.251 . . . . 0.0 111.147 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.98 40.84 30.34 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.45 -0.781 . . . . 0.0 111.935 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . 0.429 ' OG ' ' HB2' ' B' ' 39' ' ' CYS . 2.1 p -117.04 11.23 14.19 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.301 -0.875 . . . . 0.0 109.547 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' CYS . . . . . 0.56 ' HB3' ' HB3' ' B' ' 39' ' ' CYS . 15.0 p -149.55 -179.11 6.83 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.04 34.08 3.11 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.879 -1.138 . . . . 0.0 111.339 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' THR . . . . . 0.663 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 23.0 p -97.6 13.24 30.81 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.978 -1.076 . . . . 0.0 111.268 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' CYS . . . . . 0.444 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.1 p -120.55 31.74 6.31 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 177.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 23.9 t-160 -72.68 133.01 44.42 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.612 -178.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.4 m -146.24 160.14 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . 0.414 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.5 m-85 -105.46 102.76 12.21 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.262 -0.899 . . . . 0.0 108.699 178.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.2 t -61.92 135.13 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 121.296 -0.878 . . . . 0.0 109.34 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.64 131.7 51.03 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.945 0.878 . . . . 0.0 109.525 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.413 ' H ' ' CD ' ' B' ' 54' ' ' GLU . 11.1 mp0 -44.21 -31.12 0.9 Allowed 'General case' 0 N--CA 1.506 2.343 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -178.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.73 -6.93 54.23 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.019 -1.051 . . . . 0.0 112.796 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -119.92 -6.68 10.03 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 120.416 -1.427 . . . . 0.0 111.86 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.4 p -55.39 -37.85 68.12 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.132 -0.98 . . . . 0.0 112.846 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -81.1 -6.66 59.07 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.711 -1.243 . . . . 0.0 111.49 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -89.88 -11.61 41.4 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.986 -1.071 . . . . 0.0 109.848 178.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.8 t -104.08 141.01 21.63 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -73.77 118.84 5.61 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 O-C-N 123.496 1.261 . . . . 0.0 108.983 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.9 160.59 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.75 0 N-CA-C 116.656 2.095 . . . . 0.0 116.656 -177.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . 0.615 ' HB1' ' HB3' ' B' ' 67' ' ' GLU . . . -65.73 146.14 55.14 Favored 'General case' 0 N--CA 1.503 2.178 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.266 178.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -89.78 -170.81 2.94 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.602 -0.686 . . . . 0.0 110.383 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -59.54 -42.02 91.39 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.329 -0.857 . . . . 0.0 111.708 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.45 -41.52 84.57 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.158 -0.964 . . . . 0.0 112.045 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . 0.615 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 45.5 tt0 -68.21 -43.92 76.93 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.954 -1.091 . . . . 0.0 110.343 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' ILE . . . . . 0.529 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.6 mm -55.63 -42.08 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.278 -0.889 . . . . 0.0 109.379 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.24 -47.87 80.44 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 28.5 mmt -66.17 -33.97 76.98 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.275 -1.132 . . . . 0.0 111.226 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' LEU . . . . . 0.447 ' HA ' HD23 ' B' ' 71' ' ' LEU . 28.1 mt -63.47 -23.33 67.35 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.217 -0.927 . . . . 0.0 110.622 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . 0.529 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 66.4 mt-10 -70.41 -8.72 53.02 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.339 -0.851 . . . . 0.0 110.926 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 84.8 p -119.91 12.6 12.09 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.008 -1.057 . . . . 0.0 112.461 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 19.4 m -60.84 140.44 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 O-C-N 120.692 -1.255 . . . . 0.0 109.653 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 25.4 m -74.58 -39.09 62.45 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.387 -0.821 . . . . 0.0 110.153 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.18 168.83 17.4 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.464 -0.773 . . . . 0.0 110.073 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.28 139.16 55.67 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.395 -0.815 . . . . 0.0 110.587 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.4 tp -90.95 116.11 28.5 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.498 -0.751 . . . . 0.0 109.907 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -102.94 168.37 8.91 Favored Pre-proline 0 C--N 1.302 -1.5 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -76.71 0.04 9.99 Favored 'Trans proline' 0 C--N 1.314 -1.255 0 O-C-N 123.279 1.147 . . . . 0.0 110.371 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -120.5 22.3 11.3 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.969 -1.082 . . . . 0.0 108.411 176.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 4.3 m -80.77 137.25 36.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.845 -0.534 . . . . 0.0 110.35 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.5 mmm-85 -149.77 146.41 27.16 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.446 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.444 ' HB3' ' SG ' ' B' ' 48' ' ' CYS . 78.4 mt -80.55 99.0 7.86 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 175.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' CYS . . . . . 0.405 ' HB2' ' HB2' ' B' ' 23' ' ' LEU . 11.3 p -48.5 -17.82 0.19 Allowed 'General case' 0 N--CA 1.508 2.439 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -175.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.8 p -70.28 -13.99 62.4 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.714 -1.241 . . . . 0.0 109.459 178.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -92.73 -12.25 31.87 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.489 -0.757 . . . . 0.0 110.545 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 61.7 mt -91.47 104.02 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.195 -0.941 . . . . 0.0 110.625 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 39.2 mm -85.04 131.78 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 13.8 tpt -74.85 137.84 42.1 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 122.126 0.965 . . . . 0.0 113.229 -177.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 43.7 p -138.23 166.57 24.8 Favored Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 176.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -74.92 1.71 7.39 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 O-C-N 122.683 0.833 . . . . 0.0 111.042 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -87.64 -22.82 24.48 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 176.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.7 mt -93.75 12.96 23.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.982 -0.449 . . . . 0.0 110.422 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -54.48 126.36 23.21 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.111 -0.993 . . . . 0.0 111.164 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.21 6.89 68.34 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.669 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.68 142.79 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 CA-C-N 119.36 1.58 . . . . 0.0 110.715 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 98' ' ' VAL . . . . . 0.48 HG22 ' HB ' ' B' ' 4' ' ' VAL . 60.7 t -122.53 133.01 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.532 -0.73 . . . . 0.0 109.819 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 16.5 m -130.41 135.78 59.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.489 -0.757 . . . . 0.0 109.798 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 100' ' ' ASP . . . . . 0.414 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.44 134.17 35.2 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.7 t -103.39 127.27 30.01 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.5 -0.75 . . . . 0.0 110.368 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -80.77 130.92 7.89 Favored 'Trans proline' 0 C--N 1.316 -1.168 0 O-C-N 124.064 1.56 . . . . 0.0 108.268 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 103' ' ' ASP . . . . . 0.427 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.4 p-10 -62.42 3.42 0.19 Allowed 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -178.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 39.5 mtm180 -125.32 114.66 19.2 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.306 -1.496 . . . . 0.0 110.061 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 105' ' ' GLN . . . . . 0.502 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 62.7 mm-40 -113.3 -49.39 2.91 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.497 -0.752 . . . . 0.0 109.954 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 106' ' ' TRP . . . . . 0.522 ' HA ' ' CE3' ' B' ' 106' ' ' TRP . 4.9 m95 . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.522 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.514 HD12 ' HD2' ' A' ' 15' ' ' PRO . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 14' ' ' LEU . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.419 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HG2' HG12 ' A' ' 54' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.569 HG12 ' HG2' ' A' ' 51' ' ' PRO . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.609 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.8 m120 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.609 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 64' ' ' ILE . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.435 ' HA ' HD23 ' A' ' 324' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.0 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.9 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.5 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.484 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 24.3 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.5 mtm180 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.64 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.2 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.556 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.717 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.717 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 1.068 HD11 ' CZ ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.621 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 74.3 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.64 ' O ' ' HB3' ' A' ' 83' ' ' SER . 3.9 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 46.0 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.647 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.296 50.1 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 104' ' ' ASP 0.366 52.6 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.647 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 35.0 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.452 ' H ' ' CG ' ' A' ' 106' ' ' PRO 0.413 34.1 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.789 ' HB2' ' CD2' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.685 HD11 ' HA3' ' A' ' 226' ' ' GLY . 24.8 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.546 ' O ' HG22 ' A' ' 119' ' ' VAL . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.603 ' HA ' HG21 ' A' ' 123' ' ' VAL . 35.1 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.593 HG13 HG23 ' A' ' 118' ' ' VAL . 30.6 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.493 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.697 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 37.1 mtm -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.697 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.1 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.603 HG21 ' HA ' ' A' ' 118' ' ' VAL . 72.0 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.7 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.452 ' HD2' ' HA ' ' A' ' 123' ' ' VAL . 35.6 mttt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.455 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.63 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.412 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.595 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 151' ' ' THR . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.799 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.799 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.441 ' O ' ' HG2' ' A' ' 164' ' ' MET . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.578 ' C ' HD23 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.455 ' N ' HD23 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.425 ' N ' ' HD2' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' HIS . . . . . 0.405 ' O ' ' HG ' ' A' ' 180' ' ' LEU . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.574 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 176' ' ' HIS . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.561 ' HA ' ' HE3' ' A' ' 184' ' ' MET . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . 0.561 ' HE3' ' HA ' ' A' ' 181' ' ' THR . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.421 HD22 ' HE1' ' A' ' 184' ' ' MET . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . 0.453 ' HG3' ' HB1' ' A' ' 224' ' ' ALA . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 220' ' ' ILE . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 33.3 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 53.1 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.453 ' HB1' ' HG3' ' A' ' 212' ' ' ARG . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.685 ' HA3' HD11 ' A' ' 114' ' ' LEU . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 4.6 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 1.1 m120 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 18.1 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . 1.068 ' CZ ' HD11 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 45.4 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.717 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.487 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' MET . . . . . 0.595 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.437 ' N ' ' HD2' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' CYS . . . . . . . . . . . . . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 288' ' ' LEU . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.706 HD23 ' H ' ' A' ' 294' ' ' LEU . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . 0.419 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . 0.419 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.0 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.459 ' HA ' HD13 ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 314' ' ' LYS . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.6 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' HIS . . . . . 0.425 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 36.9 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 303' ' ' SER . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 318' ' ' ILE . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' LEU . . . . . 0.647 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' PRO . . . . . 0.68 ' HG2' HD22 ' A' ' 324' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.68 HD22 ' HG2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 13.7 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 327' ' ' LEU . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.522 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' PRO . . . . . 0.522 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' GLN . . . . . 0.466 ' CB ' ' HD3' ' A' ' 344' ' ' LYS . 1.9 mp0 -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' LYS . . . . . 0.524 ' HB2' ' HE2' ' A' ' 344' ' ' LYS . 1.5 mppt? -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 60.6 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 28.9 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 14.2 p80 -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 39.6 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' THR . . . . . . . . . . . . . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 99.6 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' LEU . . . . . 0.681 HD12 ' O ' ' B' ' 39' ' ' CYS . 0.1 OUTLIER -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 2.9 mt -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 35.9 mtt85 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 412' ' ' LYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 N--CA 1.496 1.853 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.49 138.62 38.53 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.226 -0.921 . . . . 0.0 112.939 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . 0.738 HG11 HD22 ' B' ' 23' ' ' LEU . 61.3 t -137.13 122.59 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.528 HG11 ' CZ ' ' B' ' 12' ' ' ARG . 97.4 t -106.81 129.54 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.149 -0.969 . . . . 0.0 111.654 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.511 ' CG ' HD13 ' B' ' 32' ' ' ILE . 77.2 m-85 -109.19 110.53 21.77 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.78 127.25 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.922 -1.111 . . . . 0.0 108.421 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.9 m -86.19 174.64 8.98 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.782 0.801 . . . . 0.0 112.481 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' HIS . . . . . 0.427 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.61 -46.73 89.17 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-O 121.145 0.497 . . . . 0.0 110.467 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -65.94 -11.29 46.33 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.552 -0.718 . . . . 0.0 111.416 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.02 15.5 28.25 Favored Glycine 0 N--CA 1.492 2.421 0 O-C-N 121.103 -0.998 . . . . 0.0 111.218 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.3 m -82.14 147.36 29.08 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 118.773 1.286 . . . . 0.0 109.874 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . 0.528 ' CZ ' HG11 ' B' ' 4' ' ' VAL . 50.9 ttt85 -118.46 128.75 54.9 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.434 -0.791 . . . . 0.0 111.832 -178.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' B' ' 13' ' ' ARG . 0.0 OUTLIER -126.04 127.68 46.24 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.575 -0.703 . . . . 0.0 109.792 179.11 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -111.29 130.62 55.61 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.282 -0.887 . . . . 0.0 111.64 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 84.5 mt -122.77 159.39 28.13 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.741 -0.6 . . . . 0.0 111.107 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -109.66 91.65 3.73 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 176.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.5 t -90.17 133.4 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 CA-C-O 121.605 0.717 . . . . 0.0 112.271 -176.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.13 170.67 16.11 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.812 -0.555 . . . . 0.0 110.257 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -68.36 151.78 46.38 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.491 -0.756 . . . . 0.0 111.01 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.46 -12.46 55.52 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.997 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 60.1 t -89.97 133.27 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 120.691 -1.476 . . . . 0.0 110.932 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 21.2 p -80.22 151.89 29.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.544 -0.723 . . . . 0.0 109.142 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.738 HD22 HG11 ' B' ' 3' ' ' VAL . 18.5 mt -61.15 -24.64 66.44 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.362 -0.836 . . . . 0.0 110.619 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 6.3 ttp -69.76 -49.24 54.9 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.212 -0.93 . . . . 0.0 109.463 178.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -59.85 -41.65 91.88 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.583 -0.698 . . . . 0.0 109.921 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.16 -40.85 94.9 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.606 -0.684 . . . . 0.0 110.082 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . 0.578 ' HA ' HD12 ' B' ' 32' ' ' ILE . . . -68.32 -49.73 58.31 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.207 -0.933 . . . . 0.0 111.079 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 81.7 t -65.5 -39.18 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.333 -0.854 . . . . 0.0 110.7 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 21.4 t -70.1 -14.04 62.48 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.386 -0.822 . . . . 0.0 111.564 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -118.12 23.82 11.37 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.027 -1.046 . . . . 0.0 110.653 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.66 38.22 58.4 Favored Glycine 0 N--CA 1.493 2.46 0 O-C-N 121.52 -0.737 . . . . 0.0 111.872 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.578 HD12 ' HA ' ' B' ' 27' ' ' ALA . 0.4 OUTLIER -72.52 147.18 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.859 -1.377 . . . . 0.0 108.869 179.01 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.67 142.51 58.05 Favored 'General case' 0 N--CA 1.503 2.217 0 N-CA-C 117.169 2.285 . . . . 0.0 117.169 -174.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 62.21 -36.14 0.12 Allowed 'General case' 0 N--CA 1.516 2.835 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 175.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 23.1 mt -59.69 122.87 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 O-C-N 119.928 -1.732 . . . . 0.0 110.665 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.61 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 52.5 t -100.07 -51.47 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.633 -0.667 . . . . 0.0 111.248 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.1 56.51 20.14 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 107.459 -2.256 . . . . 0.0 107.459 -178.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -71.27 -49.33 44.16 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.958 -0.731 . . . . 0.0 112.296 -177.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' CYS . . . . . 0.681 ' O ' HD12 ' A' ' 356' ' ' LEU . 2.3 p -66.56 -10.42 45.12 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.249 -0.907 . . . . 0.0 112.359 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . 0.516 ' HA3' HD12 ' A' ' 356' ' ' LEU . . . 96.79 -5.53 64.11 Favored Glycine 0 N--CA 1.498 2.779 0 O-C-N 120.763 -1.211 . . . . 0.0 111.985 177.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.16 19.52 10.62 Favored Glycine 0 N--CA 1.495 2.608 0 O-C-N 120.883 -1.363 . . . . 0.0 110.965 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 1.3 t -98.95 19.11 15.64 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.032 -1.276 . . . . 0.0 111.142 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 56.0 40.84 30.32 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.358 -0.839 . . . . 0.0 111.934 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 57.8 m -117.0 11.17 14.21 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.318 -0.864 . . . . 0.0 109.533 178.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' CYS . . . . . 0.551 ' HB3' ' HB3' ' B' ' 39' ' ' CYS . 15.1 p -149.56 -179.07 6.8 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.511 -0.743 . . . . 0.0 109.039 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.07 33.98 3.11 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.85 -1.156 . . . . 0.0 111.357 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' THR . . . . . 0.61 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 65.1 p -97.51 13.23 30.68 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.0 -1.063 . . . . 0.0 111.275 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' CYS . . . . . 0.444 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.1 p -120.57 31.78 6.29 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 177.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 23.9 t-160 -72.68 133.07 44.44 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.588 -178.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.3 m -146.29 160.06 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . 0.419 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.5 m-85 -105.45 102.73 12.19 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.239 -0.913 . . . . 0.0 108.74 178.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.1 t -61.9 135.17 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.269 -0.894 . . . . 0.0 109.348 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.67 131.75 51.2 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.961 0.886 . . . . 0.0 109.495 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.414 ' H ' ' CD ' ' B' ' 54' ' ' GLU . 11.0 mp0 -44.3 -30.99 0.9 Allowed 'General case' 0 N--CA 1.506 2.357 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -178.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.79 -6.92 54.29 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.013 -1.055 . . . . 0.0 112.726 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -119.95 -6.6 10.02 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 120.456 -1.402 . . . . 0.0 111.9 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.4 p -55.48 -37.73 68.2 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 121.155 -0.966 . . . . 0.0 112.892 -178.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -81.2 -6.59 59.03 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 120.743 -1.223 . . . . 0.0 111.44 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -89.89 -11.66 41.21 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.962 -1.087 . . . . 0.0 109.825 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 41.0 t -104.11 141.1 21.81 Favored Pre-proline 0 N--CA 1.488 1.458 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -73.82 118.87 5.61 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 O-C-N 123.485 1.255 . . . . 0.0 108.984 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.93 160.62 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.752 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 -177.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . 0.616 ' HB1' ' HB3' ' B' ' 67' ' ' GLU . . . -65.78 146.2 55.06 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.222 178.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -89.76 -170.78 2.93 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.592 -0.693 . . . . 0.0 110.397 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -59.56 -41.99 91.39 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.377 -0.827 . . . . 0.0 111.739 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.47 -41.54 84.46 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.109 -0.994 . . . . 0.0 111.994 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . 0.616 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 45.4 tt0 -68.23 -43.94 76.81 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.962 -1.086 . . . . 0.0 110.367 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' ILE . . . . . 0.527 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.7 mm -55.57 -42.18 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.292 -0.88 . . . . 0.0 109.37 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.17 -47.86 80.84 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 12.4 mmt -66.19 -33.98 77.0 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.256 -1.144 . . . . 0.0 111.162 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' LEU . . . . . 0.456 ' HA ' HD23 ' B' ' 71' ' ' LEU . 28.0 mt -63.45 -23.34 67.36 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.172 -0.955 . . . . 0.0 110.606 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 49.2 mt-10 -70.41 -8.75 53.24 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.345 -0.847 . . . . 0.0 110.938 179.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 56.3 p -119.85 12.57 12.13 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.003 -1.061 . . . . 0.0 112.517 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 16.4 m -60.81 140.43 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 120.661 -1.274 . . . . 0.0 109.618 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 41.1 m -74.57 -39.05 62.49 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.432 -0.792 . . . . 0.0 110.187 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.22 168.81 17.47 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.441 -0.787 . . . . 0.0 110.089 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.3 139.18 55.67 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.387 -0.821 . . . . 0.0 110.585 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.4 tp -91.02 116.19 28.6 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.497 -0.752 . . . . 0.0 109.879 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -102.99 168.37 8.9 Favored Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -76.64 -0.05 10.06 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 O-C-N 123.259 1.136 . . . . 0.0 110.404 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -120.5 22.39 11.27 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.001 -1.062 . . . . 0.0 108.375 176.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 4.3 m -80.84 137.2 36.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.833 -0.542 . . . . 0.0 110.359 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.4 mmm-85 -149.74 146.4 27.18 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 120.029 -0.669 . . . . 0.0 111.466 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.444 ' HB3' ' SG ' ' B' ' 48' ' ' CYS . 79.2 mt -80.49 98.97 7.8 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 175.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' CYS . . . . . 0.403 ' HB2' ' HB2' ' B' ' 23' ' ' LEU . 10.7 p -48.45 -17.9 0.19 Allowed 'General case' 0 N--CA 1.507 2.412 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -175.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.8 p -70.24 -13.99 62.42 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.65 -1.281 . . . . 0.0 109.472 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 48.6 mm-40 -92.75 -12.16 32.03 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.509 -0.744 . . . . 0.0 110.502 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' ILE . . . . . 0.404 HG21 HD13 ' B' ' 88' ' ' ILE . 61.8 mt -91.56 104.0 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.16 -0.962 . . . . 0.0 110.567 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 45.3 mm -85.01 131.78 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 13.6 tpt -74.83 137.81 42.11 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 122.166 0.984 . . . . 0.0 113.183 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 43.7 p -138.23 166.52 25.18 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 176.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -74.86 1.67 7.39 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 122.595 0.787 . . . . 0.0 111.026 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -87.65 -22.81 24.48 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 176.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.6 mt -93.78 12.97 23.85 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.408 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -54.52 126.39 23.44 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.175 -0.953 . . . . 0.0 111.161 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.22 6.86 68.36 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.64 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.64 142.75 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 CA-C-N 119.367 1.584 . . . . 0.0 110.714 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 98' ' ' VAL . . . . . 0.477 HG22 ' HB ' ' B' ' 4' ' ' VAL . 60.8 t -122.53 132.99 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.583 -0.698 . . . . 0.0 109.866 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 16.4 m -130.38 135.77 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.518 -0.739 . . . . 0.0 109.795 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 100' ' ' ASP . . . . . 0.419 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.43 134.15 35.22 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.8 t -103.39 127.26 30.02 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.517 -0.739 . . . . 0.0 110.377 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -80.84 130.97 7.84 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 O-C-N 124.118 1.588 . . . . 0.0 108.273 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 103' ' ' ASP . . . . . 0.427 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.3 p-10 -62.35 3.34 0.19 Allowed 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -178.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 39.5 mtm180 -125.29 114.66 19.22 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.237 -1.539 . . . . 0.0 110.09 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 105' ' ' GLN . . . . . 0.509 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 51.7 mm-40 -113.32 -49.38 2.91 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.436 -0.79 . . . . 0.0 109.979 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 106' ' ' TRP . . . . . 0.789 ' CD2' ' HB2' ' A' ' 113' ' ' ALA . 51.1 m95 . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.491 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.514 HD12 ' HD2' ' A' ' 15' ' ' PRO . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 14' ' ' LEU . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.419 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HG2' HG12 ' A' ' 54' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.569 HG12 ' HG2' ' A' ' 51' ' ' PRO . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.609 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.8 m120 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.609 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 64' ' ' ILE . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.435 ' HA ' HD23 ' A' ' 324' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.9 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 45.7 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.6 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.402 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 29.5 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.9 mtm180 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.64 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.2 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.556 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.717 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.717 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 1.068 HD11 ' CZ ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.622 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 67.8 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.64 ' O ' ' HB3' ' A' ' 83' ' ' SER . 3.9 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 45.3 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.647 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.296 50.2 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 104' ' ' ASP 0.366 52.7 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.647 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 35.0 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.452 ' H ' ' CG ' ' A' ' 106' ' ' PRO 0.372 31.8 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.53 ' HG2' HD11 ' A' ' 358' ' ' LEU . 3.3 mtp180 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.568 ' HB2' ' CG ' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.744 HD11 ' HA3' ' A' ' 226' ' ' GLY . 6.8 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.546 ' O ' HG22 ' A' ' 119' ' ' VAL . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.603 ' HA ' HG21 ' A' ' 123' ' ' VAL . 35.1 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.593 HG13 HG23 ' A' ' 118' ' ' VAL . 30.6 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.493 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.698 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 26.7 mtm -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.698 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.1 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.603 HG21 ' HA ' ' A' ' 118' ' ' VAL . 69.2 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 54.1 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 29.8 mtmt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.455 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.63 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.412 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.595 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 151' ' ' THR . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.799 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.799 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.441 ' O ' ' HG2' ' A' ' 164' ' ' MET . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.578 ' C ' HD23 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.455 ' N ' HD23 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.425 ' N ' ' HD2' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' HIS . . . . . 0.405 ' O ' ' HG ' ' A' ' 180' ' ' LEU . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.574 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 176' ' ' HIS . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.561 ' HA ' ' HE3' ' A' ' 184' ' ' MET . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . 0.561 ' HE3' ' HA ' ' A' ' 181' ' ' THR . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.421 HD22 ' HE1' ' A' ' 184' ' ' MET . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . 0.453 ' HG3' ' HB1' ' A' ' 224' ' ' ALA . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 220' ' ' ILE . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' A' ' 222' ' ' ILE . 26.5 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 42.0 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.453 ' HB1' ' HG3' ' A' ' 212' ' ' ARG . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.744 ' HA3' HD11 ' A' ' 114' ' ' LEU . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 4.0 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 1.2 m120 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 17.1 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . 1.068 ' CZ ' HD11 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 35.4 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.717 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.487 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' MET . . . . . 0.595 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 8.7 pm0 -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.437 ' N ' ' HD2' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' CYS . . . . . . . . . . . . . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 288' ' ' LEU . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.706 HD23 ' H ' ' A' ' 294' ' ' LEU . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . 0.419 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . 0.419 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.0 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.459 ' HA ' HD13 ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 314' ' ' LYS . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' PHE . . . . . 0.428 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.4 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' HIS . . . . . 0.428 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 41.4 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 303' ' ' SER . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 318' ' ' ILE . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' LEU . . . . . 0.647 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' PRO . . . . . 0.68 ' HG2' HD22 ' A' ' 324' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.68 HD22 ' HG2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 39.5 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 327' ' ' LEU . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.522 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' PRO . . . . . 0.522 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 92.5 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 1.3 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 47.2 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 349' ' ' THR . . . . . . . . . . . . . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 62.6 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 91.7 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 356' ' ' LEU . . . . . 0.544 HD13 ' O ' ' B' ' 39' ' ' CYS . 1.1 tp -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . 0.53 HD11 ' HG2' ' A' ' 112' ' ' ARG . 1.6 mt -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 9.6 mtm180 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 14.2 tpp85 -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 412' ' ' LYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 40.1 m . . . . . 0 N--CA 1.496 1.832 0 N-CA-C 109.713 -0.476 . . . . 0.0 109.713 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.46 138.56 38.52 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.211 -0.931 . . . . 0.0 112.94 -178.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . 0.735 HG11 HD22 ' B' ' 23' ' ' LEU . 61.0 t -137.1 122.5 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 177.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.521 HG11 ' CZ ' ' B' ' 12' ' ' ARG . 97.6 t -106.77 129.58 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.131 -0.981 . . . . 0.0 111.622 -178.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -109.22 110.62 21.87 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 39.7 t -94.85 127.22 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.886 -1.133 . . . . 0.0 108.382 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.5 m -86.17 174.67 8.97 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.752 0.786 . . . . 0.0 112.534 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' HIS . . . . . 0.423 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.65 -46.77 89.05 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 121.136 0.493 . . . . 0.0 110.428 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -65.85 -11.32 45.67 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.556 -0.715 . . . . 0.0 111.463 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.0 15.49 28.32 Favored Glycine 0 N--CA 1.492 2.376 0 O-C-N 121.166 -0.959 . . . . 0.0 111.273 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.3 m -82.11 147.42 29.09 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.047 -1.267 . . . . 0.0 109.894 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . 0.521 ' CZ ' HG11 ' B' ' 4' ' ' VAL . 50.8 ttt85 -118.49 128.75 54.89 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.408 -0.807 . . . . 0.0 111.808 -178.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' B' ' 13' ' ' ARG . 0.0 OUTLIER -126.07 127.68 46.21 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.54 -0.725 . . . . 0.0 109.813 179.104 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -111.32 130.61 55.62 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.312 -0.867 . . . . 0.0 111.602 -178.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 84.5 mt -122.8 159.38 28.21 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.687 -0.633 . . . . 0.0 111.09 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -109.6 91.61 3.72 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 176.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.7 t -90.18 133.45 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-O 121.601 0.715 . . . . 0.0 112.252 -176.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.07 170.67 16.11 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.804 -0.56 . . . . 0.0 110.247 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -68.45 151.83 46.27 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.555 -0.716 . . . . 0.0 110.986 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.43 -12.49 55.32 Favored Glycine 0 N--CA 1.495 2.629 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.02 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 91.3 t -89.95 133.37 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 120.705 -1.468 . . . . 0.0 110.899 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 96.6 p -80.3 151.96 29.26 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.735 HD22 HG11 ' B' ' 3' ' ' VAL . 18.5 mt -61.24 -24.62 66.49 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.307 -0.871 . . . . 0.0 110.589 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 13.6 tmm? -69.76 -49.2 55.32 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.238 -0.914 . . . . 0.0 109.493 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -59.83 -41.69 91.88 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.605 -0.684 . . . . 0.0 109.945 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.12 -40.87 95.1 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.648 -0.658 . . . . 0.0 110.165 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.28 -49.79 58.11 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.281 -0.887 . . . . 0.0 111.068 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 55.2 t -65.45 -39.13 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.287 -0.883 . . . . 0.0 110.755 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 24.9 m -70.16 -14.02 62.45 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.386 -0.821 . . . . 0.0 111.502 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' ASN . . . . . 0.509 ' HB3' ' CD1' ' B' ' 32' ' ' ILE . 0.5 OUTLIER -118.17 23.83 11.35 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.021 -1.049 . . . . 0.0 110.652 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.68 38.24 58.54 Favored Glycine 0 N--CA 1.493 2.471 0 O-C-N 121.533 -0.729 . . . . 0.0 111.905 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.509 ' CD1' ' HB3' ' B' ' 30' ' ' ASN . 1.1 mp -72.53 147.22 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.867 -1.372 . . . . 0.0 108.815 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -62.78 142.5 58.15 Favored 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 117.182 2.289 . . . . 0.0 117.182 -174.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 62.24 -36.11 0.12 Allowed 'General case' 0 N--CA 1.515 2.806 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 175.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 57.8 mt -59.74 122.88 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 CA-C-N 121.067 1.758 . . . . 0.0 110.664 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.705 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 48.2 t -100.1 -51.43 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.674 -0.641 . . . . 0.0 111.22 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.13 56.51 20.07 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 107.47 -2.252 . . . . 0.0 107.47 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.35 -49.29 43.85 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.988 -0.713 . . . . 0.0 112.26 -177.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' CYS . . . . . 0.553 ' HB3' ' HB3' ' B' ' 45' ' ' CYS . 2.3 p -66.55 -10.45 45.31 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.229 -0.919 . . . . 0.0 112.372 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . 0.507 ' CA ' HD22 ' A' ' 356' ' ' LEU . . . 96.82 -5.52 64.04 Favored Glycine 0 N--CA 1.498 2.823 0 O-C-N 120.841 -1.162 . . . . 0.0 111.938 177.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.2 19.42 10.69 Favored Glycine 0 N--CA 1.494 2.557 0 O-C-N 120.794 -1.415 . . . . 0.0 111.031 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 87.7 p -98.86 19.04 15.66 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.055 -1.262 . . . . 0.0 111.158 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 56.01 40.85 30.28 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.401 -0.812 . . . . 0.0 111.926 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 17.3 m -116.99 11.12 14.21 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.401 -0.812 . . . . 0.0 109.522 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' CYS . . . . . 0.553 ' HB3' ' HB3' ' B' ' 39' ' ' CYS . 15.1 p -149.52 -179.04 6.78 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.537 -0.727 . . . . 0.0 109.073 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.1 34.07 3.09 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.804 -1.185 . . . . 0.0 111.339 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' THR . . . . . 0.705 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 5.6 p -97.6 13.24 30.79 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.972 -1.08 . . . . 0.0 111.288 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' CYS . . . . . 0.444 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.1 p -120.56 31.72 6.32 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 177.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . 0.476 ' NE2' ' HB3' ' B' ' 82' ' ' SER . 6.4 t-160 -72.63 133.02 44.47 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.618 -178.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.3 m -146.27 160.05 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . 0.417 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.5 m-85 -105.39 102.71 12.17 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.285 -0.885 . . . . 0.0 108.708 178.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.4 t -61.86 135.09 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.316 -0.865 . . . . 0.0 109.387 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.62 131.82 51.36 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.945 0.879 . . . . 0.0 109.522 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' B' ' 54' ' ' GLU . 11.0 mp0 -44.33 -31.03 0.92 Allowed 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.8 -6.91 54.25 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.021 -1.05 . . . . 0.0 112.766 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -119.94 -6.65 10.02 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 120.527 -1.358 . . . . 0.0 111.922 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.5 p -55.41 -37.77 68.06 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.151 -0.968 . . . . 0.0 112.915 -178.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -81.18 -6.59 59.02 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.744 -1.222 . . . . 0.0 111.481 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -89.87 -11.65 41.29 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.97 -1.081 . . . . 0.0 109.854 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.8 t -104.07 141.04 21.7 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -73.74 118.87 5.63 Favored 'Trans proline' 0 N--CA 1.488 1.176 0 O-C-N 123.444 1.233 . . . . 0.0 109.008 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.95 160.61 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.79 0 N-CA-C 116.645 2.091 . . . . 0.0 116.645 -177.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . 0.618 ' HB1' ' HB3' ' B' ' 67' ' ' GLU . . . -65.77 146.17 55.1 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.216 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -89.75 -170.79 2.94 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.594 -0.691 . . . . 0.0 110.398 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -59.53 -42.02 91.36 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.321 -0.862 . . . . 0.0 111.719 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -41.47 84.46 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.242 -0.911 . . . . 0.0 112.027 -178.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . 0.668 ' HG3' HD12 ' B' ' 84' ' ' LEU . 45.3 tt0 -68.26 -43.98 76.63 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.941 -1.099 . . . . 0.0 110.335 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' ILE . . . . . 0.513 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.7 mm -55.53 -42.16 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.283 -0.885 . . . . 0.0 109.394 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.23 -47.86 80.64 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 24.8 mmt -66.18 -33.97 76.98 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.316 -1.108 . . . . 0.0 111.186 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' B' ' 71' ' ' LEU . 27.5 mt -63.51 -23.32 67.34 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.203 -0.936 . . . . 0.0 110.62 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . 0.513 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 44.2 mt-10 -70.44 -8.67 52.75 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.38 -0.825 . . . . 0.0 110.926 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 36.4 m -119.87 12.55 12.1 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.069 -1.02 . . . . 0.0 112.518 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 35.3 m -60.78 140.49 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 120.75 -1.219 . . . . 0.0 109.677 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 33.8 m -74.63 -39.08 62.34 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.372 -0.83 . . . . 0.0 110.136 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.22 168.82 17.46 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.451 -0.78 . . . . 0.0 110.087 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.26 139.12 55.68 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.422 -0.799 . . . . 0.0 110.613 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.5 tp -91.01 116.19 28.6 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.569 -0.707 . . . . 0.0 109.873 179.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -103.02 168.3 9.0 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -76.61 -0.0 10.0 Favored 'Trans proline' 0 C--N 1.315 -1.217 0 O-C-N 123.222 1.117 . . . . 0.0 110.398 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -120.48 22.36 11.29 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.918 -1.114 . . . . 0.0 108.42 176.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' SER . . . . . 0.476 ' HB3' ' NE2' ' B' ' 49' ' ' HIS . 4.3 m -80.81 137.23 36.21 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.91 -0.494 . . . . 0.0 110.383 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.4 mmm-85 -149.78 146.41 27.16 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.47 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.668 HD12 ' HG3' ' B' ' 67' ' ' GLU . 96.3 mt -80.59 98.97 7.88 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 175.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' CYS . . . . . 0.409 ' HB2' ' HB2' ' B' ' 23' ' ' LEU . 10.5 p -48.37 -17.88 0.18 Allowed 'General case' 0 N--CA 1.508 2.448 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -175.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.9 p -70.29 -14.0 62.41 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.686 -1.259 . . . . 0.0 109.474 178.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -92.68 -12.23 32.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.492 -0.755 . . . . 0.0 110.553 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 61.8 mt -91.48 103.95 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.179 -0.951 . . . . 0.0 110.648 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 27.6 mm -85.03 131.8 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 13.8 tpt -74.89 137.78 41.99 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 122.176 0.988 . . . . 0.0 113.221 -177.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 43.6 p -138.2 166.59 24.73 Favored Pre-proline 0 N--CA 1.49 1.546 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 176.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -74.97 1.75 7.37 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 122.678 0.83 . . . . 0.0 111.023 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -87.69 -22.77 24.45 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.4 mt -93.85 12.99 23.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 122.024 -0.423 . . . . 0.0 110.412 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -54.5 126.37 23.31 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.185 -0.947 . . . . 0.0 111.172 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.23 6.86 68.33 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.633 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.65 142.76 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 CA-C-N 119.374 1.587 . . . . 0.0 110.773 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 98' ' ' VAL . . . . . 0.478 HG22 ' HB ' ' B' ' 4' ' ' VAL . 60.8 t -122.5 133.01 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.494 -0.754 . . . . 0.0 109.858 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 16.4 m -130.39 135.76 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.439 -0.788 . . . . 0.0 109.793 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 100' ' ' ASP . . . . . 0.417 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.43 134.17 35.2 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.4 t -103.39 127.29 29.96 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.482 -0.761 . . . . 0.0 110.386 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -80.82 131.01 7.87 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 O-C-N 124.016 1.535 . . . . 0.0 108.306 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 103' ' ' ASP . . . . . 0.423 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.4 p-10 -62.44 3.4 0.2 Allowed 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -178.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 4.0 mtm105 -125.32 114.6 19.12 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.282 -1.511 . . . . 0.0 110.075 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 105' ' ' GLN . . . . . 0.501 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 70.6 mm-40 -113.25 -49.43 2.91 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.46 -0.775 . . . . 0.0 110.0 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 106' ' ' TRP . . . . . 0.568 ' CG ' ' HB2' ' A' ' 113' ' ' ALA . 10.9 m0 . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.5 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.514 HD12 ' HD2' ' A' ' 15' ' ' PRO . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 14' ' ' LEU . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.419 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HG2' HG12 ' A' ' 54' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.569 HG12 ' HG2' ' A' ' 51' ' ' PRO . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.609 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.8 m120 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.609 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 64' ' ' ILE . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.435 ' HA ' HD23 ' A' ' 324' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.9 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.2 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.5 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.475 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 26.4 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.1 mtm180 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.64 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.2 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.556 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.717 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.717 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 1.068 HD11 ' CZ ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.622 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 67.8 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.64 ' O ' ' HB3' ' A' ' 83' ' ' SER . 3.9 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 45.3 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.647 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.296 50.2 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' ' 104' ' ' ASP 0.366 53.2 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.647 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 35.0 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.452 ' H ' ' CG ' ' A' ' 106' ' ' PRO 0.372 31.8 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.8 ttp85 -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 8.6 mtp180 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.493 ' HB2' ' CG ' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.744 HD11 ' HA3' ' A' ' 226' ' ' GLY . 6.8 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.546 ' O ' HG22 ' A' ' 119' ' ' VAL . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.603 ' HA ' HG21 ' A' ' 123' ' ' VAL . 35.1 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.594 HG13 HG23 ' A' ' 118' ' ' VAL . 30.6 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.493 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.698 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 28.8 mtm -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.698 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.1 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.603 HG21 ' HA ' ' A' ' 118' ' ' VAL . 69.2 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 54.1 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 29.8 mtmt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.455 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.63 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.412 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.595 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 151' ' ' THR . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.799 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.799 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.441 ' O ' ' HG2' ' A' ' 164' ' ' MET . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.578 ' C ' HD23 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.455 ' N ' HD23 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.425 ' N ' ' HD2' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' HIS . . . . . 0.405 ' O ' ' HG ' ' A' ' 180' ' ' LEU . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.574 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 176' ' ' HIS . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.561 ' HA ' ' HE3' ' A' ' 184' ' ' MET . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . 0.561 ' HE3' ' HA ' ' A' ' 181' ' ' THR . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.421 HD22 ' HE1' ' A' ' 184' ' ' MET . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . 0.453 ' HG3' ' HB1' ' A' ' 224' ' ' ALA . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 220' ' ' ILE . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' A' ' 222' ' ' ILE . 26.5 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 42.0 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.453 ' HB1' ' HG3' ' A' ' 212' ' ' ARG . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.744 ' HA3' HD11 ' A' ' 114' ' ' LEU . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 4.0 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 17.1 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . 1.068 ' CZ ' HD11 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 35.4 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.717 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.487 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' MET . . . . . 0.595 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 8.7 pm0 -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.437 ' N ' ' HD2' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' CYS . . . . . . . . . . . . . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 288' ' ' LEU . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.706 HD23 ' H ' ' A' ' 294' ' ' LEU . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . 0.419 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . 0.419 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.0 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.459 ' HA ' HD13 ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 314' ' ' LYS . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' PHE . . . . . 0.428 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.4 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' HIS . . . . . 0.428 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 41.4 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 303' ' ' SER . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 318' ' ' ILE . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' LEU . . . . . 0.647 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' PRO . . . . . 0.68 ' HG2' HD22 ' A' ' 324' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.68 HD22 ' HG2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 39.5 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 327' ' ' LEU . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.522 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' PRO . . . . . 0.522 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 92.5 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 1.3 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 47.2 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 349' ' ' THR . . . . . . . . . . . . . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 66.3 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 93.8 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 356' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 1.2 tp -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 14.2 tpp85 -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 412' ' ' LYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 39.6 m . . . . . 0 N--CA 1.496 1.837 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.54 138.62 38.49 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.218 -0.926 . . . . 0.0 112.934 -178.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . 0.725 HG11 HD22 ' B' ' 23' ' ' LEU . 60.6 t -137.14 122.58 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.533 HG11 ' CZ ' ' B' ' 12' ' ' ARG . 98.1 t -106.82 129.54 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.126 -0.984 . . . . 0.0 111.58 -178.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -109.2 110.58 21.83 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 40.0 t -94.79 127.2 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.899 -1.125 . . . . 0.0 108.367 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.4 m -86.12 174.67 9.0 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.773 0.797 . . . . 0.0 112.527 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' HIS . . . . . 0.421 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.66 -46.73 89.24 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 121.132 0.491 . . . . 0.0 110.463 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -65.92 -11.26 45.95 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.592 -0.692 . . . . 0.0 111.401 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.97 15.47 28.45 Favored Glycine 0 N--CA 1.492 2.368 0 O-C-N 121.202 -0.936 . . . . 0.0 111.258 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.4 m -82.11 147.35 29.12 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 118.754 1.277 . . . . 0.0 109.899 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . 0.533 ' CZ ' HG11 ' B' ' 4' ' ' VAL . 50.8 ttt85 -118.42 128.74 54.91 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.418 -0.801 . . . . 0.0 111.873 -178.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' B' ' 13' ' ' ARG . 0.0 OUTLIER -126.03 127.7 46.29 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.574 -0.703 . . . . 0.0 109.794 179.117 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -111.31 130.62 55.61 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.255 -0.903 . . . . 0.0 111.666 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 84.6 mt -122.81 159.39 28.21 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.3 0.571 . . . . 0.0 111.073 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -109.62 91.64 3.73 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 106.436 -1.691 . . . . 0.0 106.436 176.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 39.0 t -90.2 133.44 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.577 0.703 . . . . 0.0 112.254 -176.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.09 170.67 16.1 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.805 -0.559 . . . . 0.0 110.282 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -68.37 151.81 46.34 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.498 -0.751 . . . . 0.0 111.021 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.42 -12.48 55.29 Favored Glycine 0 N--CA 1.495 2.623 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.066 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 98.8 t -89.98 133.36 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.673 -1.487 . . . . 0.0 110.922 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 52.0 p -80.29 151.93 29.29 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.725 HD22 HG11 ' B' ' 3' ' ' VAL . 18.4 mt -61.21 -24.54 66.41 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.31 -0.868 . . . . 0.0 110.66 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 11.2 tmm? -69.77 -49.25 54.77 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.258 -0.901 . . . . 0.0 109.462 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.81 -41.74 91.94 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.645 -0.659 . . . . 0.0 109.892 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.06 -40.9 95.39 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.593 -0.692 . . . . 0.0 110.179 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.28 -49.72 58.6 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.285 -0.884 . . . . 0.0 111.12 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 89.5 t -65.42 -39.24 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.266 -0.896 . . . . 0.0 110.737 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 25.0 m -70.03 -14.11 62.53 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.328 -0.857 . . . . 0.0 111.53 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' ASN . . . . . 0.536 ' HB3' ' CD1' ' B' ' 32' ' ' ILE . 0.5 OUTLIER -118.18 23.86 11.33 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.062 -1.024 . . . . 0.0 110.604 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.68 38.23 58.51 Favored Glycine 0 N--CA 1.493 2.463 0 O-C-N 121.557 -0.714 . . . . 0.0 111.873 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.579 ' CG2' HD12 ' B' ' 35' ' ' ILE . 1.0 OUTLIER -72.54 147.18 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.813 -1.404 . . . . 0.0 108.839 179.024 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -62.67 142.5 58.06 Favored 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 117.231 2.308 . . . . 0.0 117.231 -174.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 62.18 -36.09 0.12 Allowed 'General case' 0 N--CA 1.515 2.814 0 N-CA-C 116.657 2.095 . . . . 0.0 116.657 175.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.579 HD12 ' CG2' ' B' ' 32' ' ' ILE . 20.2 mt -59.77 122.92 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 O-C-N 119.821 -1.799 . . . . 0.0 110.635 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.66 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 93.2 t -100.16 -51.4 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.595 -0.691 . . . . 0.0 111.192 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.16 56.45 20.34 Favored Glycine 0 N--CA 1.499 2.897 0 N-CA-C 107.467 -2.253 . . . . 0.0 107.467 -178.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -71.33 -49.29 44.05 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.993 -0.71 . . . . 0.0 112.281 -177.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' CYS . . . . . 0.557 ' HB3' ' HB3' ' B' ' 45' ' ' CYS . 2.3 p -66.53 -10.43 44.8 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.219 -0.925 . . . . 0.0 112.373 -178.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.79 -5.47 64.08 Favored Glycine 0 N--CA 1.497 2.767 0 O-C-N 120.745 -1.222 . . . . 0.0 112.0 177.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.08 19.51 10.68 Favored Glycine 0 N--CA 1.495 2.59 0 O-C-N 120.814 -1.403 . . . . 0.0 111.038 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 87.9 p -98.94 19.17 15.52 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.025 -1.279 . . . . 0.0 111.137 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.664 ' HB3' ' HD3' ' B' ' 66' ' ' ARG . . . 55.94 40.89 30.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.395 -0.816 . . . . 0.0 111.918 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 5.7 t -117.02 11.17 14.19 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.356 -0.84 . . . . 0.0 109.566 178.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' CYS . . . . . 0.557 ' HB3' ' HB3' ' B' ' 39' ' ' CYS . 15.1 p -149.52 -179.1 6.83 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.09 34.06 3.1 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.828 -1.17 . . . . 0.0 111.346 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' THR . . . . . 0.66 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 25.2 p -97.52 13.22 30.7 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.995 -1.066 . . . . 0.0 111.295 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' CYS . . . . . 0.439 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.1 p -120.56 31.74 6.31 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 177.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . 0.469 ' NE2' ' HB3' ' B' ' 82' ' ' SER . 6.5 t-160 -72.69 133.05 44.43 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.628 -178.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.3 m -146.27 160.09 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . 0.417 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.5 m-85 -105.43 102.74 12.19 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.257 -0.902 . . . . 0.0 108.689 178.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.0 t -61.97 135.12 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.343 -0.848 . . . . 0.0 109.358 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.63 131.79 51.3 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.957 0.884 . . . . 0.0 109.522 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.416 ' H ' ' CD ' ' B' ' 54' ' ' GLU . 11.0 mp0 -44.4 -30.9 0.92 Allowed 'General case' 0 N--CA 1.506 2.336 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -178.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.83 -6.91 54.29 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.016 -1.052 . . . . 0.0 112.772 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -119.98 -6.6 10.01 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.465 -1.397 . . . . 0.0 111.898 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.4 p -55.4 -37.85 68.16 Favored 'General case' 0 N--CA 1.507 2.415 0 O-C-N 121.186 -0.946 . . . . 0.0 112.854 -178.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 47.9 p-10 -81.17 -6.59 59.01 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 120.775 -1.203 . . . . 0.0 111.452 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -89.91 -11.68 41.12 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.983 -1.073 . . . . 0.0 109.822 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -104.04 141.08 21.77 Favored Pre-proline 0 N--CA 1.488 1.475 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -73.78 118.84 5.61 Favored 'Trans proline' 0 N--CA 1.489 1.208 0 O-C-N 123.49 1.258 . . . . 0.0 109.009 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.83 160.62 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.799 0 N-CA-C 116.621 2.082 . . . . 0.0 116.621 -177.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . 0.604 ' HB1' ' HB3' ' B' ' 67' ' ' GLU . . . -65.81 146.11 55.15 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.285 178.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -89.76 -170.76 2.93 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.61 -0.681 . . . . 0.0 110.393 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -59.58 -41.98 91.49 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.325 -0.859 . . . . 0.0 111.711 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' ARG . . . . . 0.664 ' HD3' ' HB3' ' B' ' 43' ' ' ALA . 11.0 ttt180 -67.44 -41.58 84.51 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.141 -0.974 . . . . 0.0 111.989 -178.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . 0.676 ' HG3' HD12 ' B' ' 84' ' ' LEU . 45.4 tt0 -68.23 -43.92 76.88 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.985 -1.072 . . . . 0.0 110.354 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' ILE . . . . . 0.517 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.7 mm -55.57 -42.2 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.311 -0.868 . . . . 0.0 109.354 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.17 -47.88 80.61 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 8.4 mmt -66.12 -33.97 76.99 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.234 -1.157 . . . . 0.0 111.241 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 27.5 mt -63.5 -23.34 67.36 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.213 -0.929 . . . . 0.0 110.636 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . 0.517 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 44.3 mt-10 -70.42 -8.72 53.04 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.314 -0.866 . . . . 0.0 110.897 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 1.4 t -119.84 12.56 12.13 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.001 -1.062 . . . . 0.0 112.523 -178.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 34.6 m -60.84 140.42 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 120.736 -1.227 . . . . 0.0 109.631 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.59 -39.03 62.46 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.393 -0.817 . . . . 0.0 110.152 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.22 168.84 17.42 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.486 -0.759 . . . . 0.0 110.086 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.33 139.15 55.78 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.397 -0.814 . . . . 0.0 110.602 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.3 tp -90.99 116.22 28.62 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.549 -0.719 . . . . 0.0 109.833 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -103.04 168.3 8.99 Favored Pre-proline 0 N--CA 1.489 1.5 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -76.62 -0.04 10.05 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 O-C-N 123.311 1.164 . . . . 0.0 110.382 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -120.46 22.37 11.29 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.931 -1.106 . . . . 0.0 108.397 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' SER . . . . . 0.469 ' HB3' ' NE2' ' B' ' 49' ' ' HIS . 4.3 m -80.8 137.23 36.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.879 -0.513 . . . . 0.0 110.32 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.4 mmm-85 -149.8 146.37 27.12 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.465 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.676 HD12 ' HG3' ' B' ' 67' ' ' GLU . 96.3 mt -80.51 98.96 7.81 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 175.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' CYS . . . . . 0.405 ' HB2' ' HB2' ' B' ' 23' ' ' LEU . 10.7 p -48.44 -17.86 0.19 Allowed 'General case' 0 N--CA 1.508 2.427 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -175.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.8 p -70.27 -14.0 62.41 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.669 -1.269 . . . . 0.0 109.435 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -92.7 -12.25 31.95 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.459 -0.776 . . . . 0.0 110.526 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 61.8 mt -91.51 103.96 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.198 -0.939 . . . . 0.0 110.664 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 26.5 mm -84.98 131.71 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 13.8 tpt -74.8 137.74 42.11 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 122.075 0.941 . . . . 0.0 113.25 -177.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 43.6 p -138.17 166.6 24.63 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -75.0 1.79 7.35 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 O-C-N 122.669 0.826 . . . . 0.0 111.001 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -87.67 -22.82 24.46 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 176.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.6 mt -93.79 13.02 23.72 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.418 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.53 126.4 23.47 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.146 -0.971 . . . . 0.0 111.148 -178.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.25 6.77 68.41 Favored Glycine 0 N--CA 1.494 2.523 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.662 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.61 142.69 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 CA-C-N 119.343 1.572 . . . . 0.0 110.755 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 98' ' ' VAL . . . . . 0.47 HG22 ' HB ' ' B' ' 4' ' ' VAL . 61.0 t -122.44 132.96 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.519 -0.738 . . . . 0.0 109.88 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 16.5 m -130.37 135.79 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.481 -0.762 . . . . 0.0 109.802 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 100' ' ' ASP . . . . . 0.417 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.44 134.11 35.26 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.9 t -103.34 127.33 29.9 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.493 -0.754 . . . . 0.0 110.391 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -80.89 130.92 7.75 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 O-C-N 124.084 1.571 . . . . 0.0 108.294 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 103' ' ' ASP . . . . . 0.421 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.3 p-10 -62.33 3.38 0.19 Allowed 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -178.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 3.8 mtm105 -125.32 114.68 19.22 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.288 -1.507 . . . . 0.0 110.069 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 105' ' ' GLN . . . . . 0.491 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 69.8 mm-40 -113.31 -49.37 2.91 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.476 -0.765 . . . . 0.0 110.0 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 106' ' ' TRP . . . . . 0.493 ' CG ' ' HB2' ' A' ' 113' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 118.392 -0.813 . . . . 0.0 110.504 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.514 HD12 ' HD2' ' A' ' 15' ' ' PRO . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 14' ' ' LEU . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.419 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HG2' HG12 ' A' ' 54' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.569 HG12 ' HG2' ' A' ' 51' ' ' PRO . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.609 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.8 m120 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.609 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 64' ' ' ILE . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.435 ' HA ' HD23 ' A' ' 324' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.0 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.6 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.5 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.427 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 30.0 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.6 mtm180 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.64 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.2 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.556 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.717 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.717 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 1.068 HD11 ' CZ ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.63 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 68.2 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.64 ' O ' ' HB3' ' A' ' 83' ' ' SER . 3.8 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 46.0 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.647 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.296 50.2 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 104' ' ' ASP 0.366 52.9 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.647 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 35.0 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.452 ' H ' ' CG ' ' A' ' 106' ' ' PRO 0.413 34.1 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.642 ' CZ ' HD11 ' A' ' 358' ' ' LEU . 7.1 mtp180 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.723 ' HB2' ' CD2' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.685 HD11 ' HA3' ' A' ' 226' ' ' GLY . 24.8 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.546 ' O ' HG22 ' A' ' 119' ' ' VAL . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.603 ' HA ' HG21 ' A' ' 123' ' ' VAL . 35.1 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.593 HG13 HG23 ' A' ' 118' ' ' VAL . 30.6 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.493 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.697 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 31.7 mtm -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.697 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.1 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.603 HG21 ' HA ' ' A' ' 118' ' ' VAL . 72.0 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.7 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.452 ' HD2' ' HA ' ' A' ' 123' ' ' VAL . 35.6 mttt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.455 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.63 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.412 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.595 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 151' ' ' THR . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.799 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.799 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.441 ' O ' ' HG2' ' A' ' 164' ' ' MET . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.578 ' C ' HD23 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.455 ' N ' HD23 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.425 ' N ' ' HD2' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' HIS . . . . . 0.405 ' O ' ' HG ' ' A' ' 180' ' ' LEU . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.574 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 176' ' ' HIS . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.561 ' HA ' ' HE3' ' A' ' 184' ' ' MET . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . 0.561 ' HE3' ' HA ' ' A' ' 181' ' ' THR . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.421 HD22 ' HE1' ' A' ' 184' ' ' MET . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . 0.453 ' HG3' ' HB1' ' A' ' 224' ' ' ALA . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 220' ' ' ILE . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 33.3 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 53.1 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.453 ' HB1' ' HG3' ' A' ' 212' ' ' ARG . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.685 ' HA3' HD11 ' A' ' 114' ' ' LEU . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 4.6 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 1.1 m120 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 18.1 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . 1.068 ' CZ ' HD11 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 45.4 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.717 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.487 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' MET . . . . . 0.595 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.437 ' N ' ' HD2' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' CYS . . . . . . . . . . . . . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 288' ' ' LEU . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.706 HD23 ' H ' ' A' ' 294' ' ' LEU . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . 0.419 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . 0.419 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.1 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.459 ' HA ' HD13 ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 314' ' ' LYS . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.6 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' HIS . . . . . 0.425 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 36.9 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 303' ' ' SER . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 318' ' ' ILE . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' LEU . . . . . 0.647 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' PRO . . . . . 0.68 ' HG2' HD22 ' A' ' 324' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.68 HD22 ' HG2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 13.7 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 327' ' ' LEU . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.522 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' PRO . . . . . 0.522 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' GLN . . . . . 0.41 ' CB ' ' HD3' ' A' ' 344' ' ' LYS . 1.9 mp0 -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' LYS . . . . . 0.511 ' HD3' ' N ' ' A' ' 344' ' ' LYS . 0.9 OUTLIER -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 60.7 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 10.6 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 39.9 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 349' ' ' THR . . . . . . . . . . . . . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 60.2 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 96.4 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 356' ' ' LEU . . . . . 0.509 HD22 ' CA ' ' B' ' 40' ' ' GLY . 1.5 tp -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . 0.642 HD11 ' CZ ' ' A' ' 112' ' ' ARG . 1.4 mp -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 43.4 mtt85 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 412' ' ' LYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 N--CA 1.496 1.83 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.52 138.58 38.48 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.224 -0.922 . . . . 0.0 112.963 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . 0.743 HG11 HD22 ' B' ' 23' ' ' LEU . 61.2 t -137.11 122.56 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.526 HG11 ' CZ ' ' B' ' 12' ' ' ARG . 97.0 t -106.76 129.54 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.115 -0.991 . . . . 0.0 111.628 -178.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.509 ' CG ' HD13 ' B' ' 32' ' ' ILE . 76.9 m-85 -109.2 110.6 21.85 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.82 127.26 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.927 -1.108 . . . . 0.0 108.34 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.4 m -86.2 174.64 8.97 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.753 0.787 . . . . 0.0 112.502 -177.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' HIS . . . . . 0.427 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.6 -46.79 88.94 Favored 'General case' 0 N--CA 1.502 2.155 0 CA-C-O 121.138 0.494 . . . . 0.0 110.458 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -65.85 -11.31 45.58 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.57 -0.706 . . . . 0.0 111.433 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.99 15.43 28.49 Favored Glycine 0 N--CA 1.492 2.406 0 O-C-N 121.155 -0.965 . . . . 0.0 111.259 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.5 m -82.05 147.38 29.17 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 118.73 1.265 . . . . 0.0 109.88 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . 0.526 ' CZ ' HG11 ' B' ' 4' ' ' VAL . 50.8 ttt85 -118.43 128.74 54.9 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.487 -0.758 . . . . 0.0 111.859 -178.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' B' ' 13' ' ' ARG . 0.0 OUTLIER -126.07 127.71 46.24 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.598 -0.689 . . . . 0.0 109.804 179.08 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -111.3 130.63 55.61 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.282 -0.886 . . . . 0.0 111.647 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 84.8 mt -122.8 159.34 28.29 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.734 -0.604 . . . . 0.0 111.129 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -109.61 91.66 3.74 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 176.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.6 t -90.16 133.41 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-O 121.626 0.727 . . . . 0.0 112.253 -176.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.08 170.71 16.04 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.7 -0.625 . . . . 0.0 110.273 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -68.5 151.82 46.25 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.532 -0.73 . . . . 0.0 111.027 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.46 -12.49 55.43 Favored Glycine 0 N--CA 1.496 2.638 0 O-C-N 121.494 -0.754 . . . . 0.0 112.052 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 61.5 t -89.98 133.29 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.706 -1.467 . . . . 0.0 110.963 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 21.3 p -80.21 151.88 29.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.572 -0.705 . . . . 0.0 109.184 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.743 HD22 HG11 ' B' ' 3' ' ' VAL . 18.5 mt -61.18 -24.59 66.43 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.349 -0.844 . . . . 0.0 110.595 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 1.9 ttp -69.83 -49.2 54.9 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.236 -0.915 . . . . 0.0 109.473 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -59.79 -41.72 91.81 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.567 -0.708 . . . . 0.0 109.926 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.09 -40.86 95.2 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.59 -0.694 . . . . 0.0 110.152 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . 0.582 ' HA ' HD12 ' B' ' 32' ' ' ILE . . . -68.34 -49.74 58.19 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.275 -0.891 . . . . 0.0 111.045 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 78.2 t -65.47 -39.18 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.301 -0.875 . . . . 0.0 110.706 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 23.2 t -70.14 -13.96 62.43 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.359 -0.838 . . . . 0.0 111.553 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -118.21 23.88 11.32 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.057 -1.027 . . . . 0.0 110.665 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.7 38.24 58.63 Favored Glycine 0 N--CA 1.493 2.448 0 O-C-N 121.541 -0.724 . . . . 0.0 111.857 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.582 HD12 ' HA ' ' B' ' 27' ' ' ALA . 0.4 OUTLIER -72.57 147.19 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.866 -1.373 . . . . 0.0 108.864 179.043 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -62.72 142.53 58.09 Favored 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 117.175 2.287 . . . . 0.0 117.175 -174.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 62.22 -36.12 0.12 Allowed 'General case' 0 N--CA 1.515 2.791 0 N-CA-C 116.643 2.09 . . . . 0.0 116.643 175.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 77.6 mt -59.77 122.9 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.426 0 O-C-N 119.907 -1.746 . . . . 0.0 110.617 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.919 HG11 ' CZ2' ' B' ' 106' ' ' TRP . 97.4 t -100.15 -51.34 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.697 -0.627 . . . . 0.0 111.229 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.14 56.47 20.26 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 107.466 -2.253 . . . . 0.0 107.466 -178.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . 0.403 ' HB2' ' CH2' ' B' ' 106' ' ' TRP . 12.6 t70 -71.34 -49.27 44.16 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.994 -0.709 . . . . 0.0 112.274 -177.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' CYS . . . . . 0.558 ' HB3' ' HB3' ' B' ' 45' ' ' CYS . 2.3 p -66.59 -10.4 45.19 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.213 -0.929 . . . . 0.0 112.385 -178.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . 0.509 ' CA ' HD22 ' A' ' 356' ' ' LEU . . . 96.77 -5.47 64.13 Favored Glycine 0 N--CA 1.498 2.782 0 O-C-N 120.819 -1.176 . . . . 0.0 112.007 177.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.1 19.52 10.66 Favored Glycine 0 N--CA 1.494 2.535 0 O-C-N 120.826 -1.397 . . . . 0.0 111.047 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 8.2 t -98.95 19.11 15.64 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.978 -1.307 . . . . 0.0 111.16 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.97 40.87 30.36 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.407 -0.808 . . . . 0.0 111.906 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.04 11.2 14.18 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.343 -0.848 . . . . 0.0 109.467 178.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' CYS . . . . . 0.558 ' HB3' ' HB3' ' B' ' 39' ' ' CYS . 15.1 p -149.53 -179.08 6.81 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.549 -0.72 . . . . 0.0 109.082 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.08 34.08 3.1 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.83 -1.169 . . . . 0.0 111.403 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' THR . . . . . 0.648 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 37.8 p -97.63 13.26 30.76 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.925 -1.109 . . . . 0.0 111.25 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.1 p -120.54 31.73 6.32 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 177.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 23.9 t-160 -72.65 133.03 44.46 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-N 115.784 -0.643 . . . . 0.0 112.628 -178.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.3 m -146.3 160.11 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . 0.413 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.4 m-85 -105.44 102.68 12.13 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.294 -0.879 . . . . 0.0 108.684 178.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.2 t -61.86 135.11 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.317 -0.864 . . . . 0.0 109.35 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.68 131.81 51.38 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.94 0.876 . . . . 0.0 109.53 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.412 ' CD ' ' H ' ' B' ' 54' ' ' GLU . 11.0 mp0 -44.27 -31.08 0.91 Allowed 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -178.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.78 -6.93 54.3 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.969 -1.082 . . . . 0.0 112.749 -178.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -119.89 -6.72 10.04 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 120.449 -1.407 . . . . 0.0 111.908 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.4 p -55.37 -37.84 68.04 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.112 -0.993 . . . . 0.0 112.86 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 -81.18 -6.63 59.06 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.753 -1.217 . . . . 0.0 111.477 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -89.88 -11.62 41.35 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.991 -1.068 . . . . 0.0 109.855 178.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -104.07 141.05 21.72 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -73.76 118.89 5.63 Favored 'Trans proline' 0 N--CA 1.488 1.15 0 O-C-N 123.453 1.238 . . . . 0.0 109.016 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.89 160.65 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.764 0 N-CA-C 116.657 2.095 . . . . 0.0 116.657 -177.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . 0.616 ' HB1' ' HB3' ' B' ' 67' ' ' GLU . . . -65.87 146.14 55.1 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-N 114.606 -1.179 . . . . 0.0 111.266 178.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -89.74 -170.79 2.94 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.569 -0.707 . . . . 0.0 110.362 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -59.53 -42.0 91.28 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.35 -0.844 . . . . 0.0 111.754 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -41.48 84.45 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.203 -0.935 . . . . 0.0 112.018 -178.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . 0.616 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 45.3 tt0 -68.21 -43.98 76.81 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.031 -1.043 . . . . 0.0 110.318 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' ILE . . . . . 0.533 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.6 mm -55.6 -42.18 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.28 -0.888 . . . . 0.0 109.368 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.19 -47.83 81.04 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 11.2 mmt -66.23 -33.92 76.84 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.275 -1.133 . . . . 0.0 111.191 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' LEU . . . . . 0.45 ' HA ' HD23 ' B' ' 71' ' ' LEU . 27.9 mt -63.47 -23.4 67.38 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.236 -0.915 . . . . 0.0 110.588 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . 0.533 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 49.2 mt-10 -70.38 -8.71 52.78 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.358 -0.839 . . . . 0.0 110.919 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 82.8 p -119.87 12.54 12.1 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.067 -1.02 . . . . 0.0 112.509 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 16.2 m -60.76 140.38 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 120.643 -1.286 . . . . 0.0 109.681 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 52.0 m -74.53 -39.06 62.58 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.466 -0.771 . . . . 0.0 110.19 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.26 168.82 17.51 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.456 -0.777 . . . . 0.0 110.1 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -58.22 139.16 55.53 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.365 -0.834 . . . . 0.0 110.613 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.3 tp -90.99 116.15 28.55 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.506 -0.746 . . . . 0.0 109.864 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -103.04 168.3 8.99 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -76.61 -0.02 10.02 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 O-C-N 123.304 1.16 . . . . 0.0 110.372 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -120.46 22.41 11.28 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.01 -1.056 . . . . 0.0 108.45 176.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 4.3 m -80.88 137.27 36.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.908 -0.495 . . . . 0.0 110.32 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.4 mmm-85 -149.77 146.4 27.16 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 120.029 -0.668 . . . . 0.0 111.472 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.445 ' HB3' ' SG ' ' B' ' 48' ' ' CYS . 77.9 mt -80.59 98.94 7.86 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 104.789 -2.3 . . . . 0.0 104.789 175.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' CYS . . . . . 0.404 ' HB2' ' HB2' ' B' ' 23' ' ' LEU . 10.5 p -48.38 -17.88 0.18 Allowed 'General case' 0 N--CA 1.508 2.444 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -175.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.8 p -70.27 -13.99 62.4 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.628 -1.295 . . . . 0.0 109.429 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -92.65 -12.3 31.91 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.486 -0.759 . . . . 0.0 110.523 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 61.9 mt -91.44 103.89 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.121 -0.987 . . . . 0.0 110.678 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 45.6 mm -85.01 131.8 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 13.6 tpt -74.88 137.76 41.98 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 122.165 0.983 . . . . 0.0 113.201 -177.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 43.6 p -138.14 166.62 24.53 Favored Pre-proline 0 N--CA 1.491 1.578 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 176.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -74.93 1.67 7.43 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 122.628 0.804 . . . . 0.0 111.028 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -87.61 -22.86 24.5 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 176.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.6 mt -93.76 13.0 23.71 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.392 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -54.5 126.39 23.38 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.138 -0.976 . . . . 0.0 111.188 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.27 6.82 68.3 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 120.581 -0.818 . . . . 0.0 111.637 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.7 tt -62.63 142.81 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 CA-C-N 119.391 1.595 . . . . 0.0 110.747 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 98' ' ' VAL . . . . . 0.481 HG22 ' HB ' ' B' ' 4' ' ' VAL . 60.9 t -122.53 132.92 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.554 -0.716 . . . . 0.0 109.876 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 16.5 m -130.32 135.76 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.451 -0.78 . . . . 0.0 109.842 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 100' ' ' ASP . . . . . 0.413 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.35 134.13 35.21 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.9 t -103.4 127.31 29.92 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.558 -0.714 . . . . 0.0 110.364 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -80.82 130.96 7.84 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 124.115 1.587 . . . . 0.0 108.287 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 103' ' ' ASP . . . . . 0.427 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.4 p-10 -62.34 3.37 0.19 Allowed 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -178.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -125.29 114.71 19.29 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.305 -1.497 . . . . 0.0 110.011 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 105' ' ' GLN . . . . . 0.511 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 51.4 mm-40 -113.35 -49.4 2.91 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.505 -0.747 . . . . 0.0 109.958 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 106' ' ' TRP . . . . . 0.919 ' CZ2' HG11 ' B' ' 36' ' ' VAL . 82.7 m95 . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.512 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.514 HD12 ' HD2' ' A' ' 15' ' ' PRO . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 14' ' ' LEU . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.419 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HG2' HG12 ' A' ' 54' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.569 HG12 ' HG2' ' A' ' 51' ' ' PRO . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.609 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.8 m120 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.609 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 64' ' ' ILE . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.435 ' HA ' HD23 ' A' ' 324' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.0 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.415 ' CZ ' HG23 ' A' ' 348' ' ' THR . 5.6 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.6 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.474 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 27.1 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.7 mmt-85 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.64 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.2 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.556 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.717 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.717 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 1.068 HD11 ' CZ ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.621 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 74.3 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.64 ' O ' ' HB3' ' A' ' 83' ' ' SER . 3.9 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 46.0 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.646 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.296 50.1 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' ' 104' ' ' ASP 0.366 52.7 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.646 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 34.8 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.451 ' H ' ' CG ' ' A' ' 106' ' ' PRO 0.342 30.7 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.406 ' O ' HD11 ' A' ' 358' ' ' LEU . 2.9 mtt-85 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.688 ' HB1' ' CD1' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.735 HD11 ' HA3' ' A' ' 226' ' ' GLY . 7.4 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.546 ' O ' HG22 ' A' ' 119' ' ' VAL . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.442 ' HA ' HD22 ' A' ' 358' ' ' LEU . 25.4 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.417 ' HB2' ' O ' ' A' ' 114' ' ' LEU . 27.6 mt-30 -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.597 ' HA ' HG21 ' A' ' 123' ' ' VAL . 35.0 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.595 HG13 HG23 ' A' ' 118' ' ' VAL . 30.6 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.493 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.698 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 0.0 OUTLIER -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.698 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.0 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.597 HG21 ' HA ' ' A' ' 118' ' ' VAL . 78.3 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.2 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 28.3 mtmt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.455 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.63 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.412 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.595 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 151' ' ' THR . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.799 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.799 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.441 ' O ' ' HG2' ' A' ' 164' ' ' MET . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.578 ' C ' HD23 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.455 ' N ' HD23 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.425 ' N ' ' HD2' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' HIS . . . . . 0.405 ' O ' ' HG ' ' A' ' 180' ' ' LEU . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.574 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 176' ' ' HIS . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.561 ' HA ' ' HE3' ' A' ' 184' ' ' MET . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . 0.561 ' HE3' ' HA ' ' A' ' 181' ' ' THR . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.421 HD22 ' HE1' ' A' ' 184' ' ' MET . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . 0.453 ' HG3' ' HB1' ' A' ' 224' ' ' ALA . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 220' ' ' ILE . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 44.9 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 42.0 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.453 ' HB1' ' HG3' ' A' ' 212' ' ' ARG . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.735 ' HA3' HD11 ' A' ' 114' ' ' LEU . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 4.3 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 13.5 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . 1.068 ' CZ ' HD11 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 40.7 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.717 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.487 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' MET . . . . . 0.595 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 16.4 pm0 -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.437 ' N ' ' HD2' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' CYS . . . . . . . . . . . . . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 288' ' ' LEU . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.706 HD23 ' H ' ' A' ' 294' ' ' LEU . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . 0.419 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . 0.419 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.0 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.459 ' HA ' HD13 ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 314' ' ' LYS . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.6 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' HIS . . . . . 0.425 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 36.9 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 303' ' ' SER . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 318' ' ' ILE . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' LEU . . . . . 0.647 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' PRO . . . . . 0.68 ' HG2' HD22 ' A' ' 324' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.68 HD22 ' HG2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 13.7 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 327' ' ' LEU . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.522 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' PRO . . . . . 0.522 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' GLN . . . . . 0.46 ' CB ' ' HD3' ' A' ' 344' ' ' LYS . 1.9 mp0 -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' LYS . . . . . 0.504 ' HB2' ' HE2' ' A' ' 344' ' ' LYS . 1.7 mppt? -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 57.8 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 22.1 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 348' ' ' THR . . . . . 0.415 HG23 ' CZ ' ' A' ' 72' ' ' ARG . 16.5 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 349' ' ' THR . . . . . . . . . . . . . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 73.7 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 354' ' ' SER . . . . . 0.429 ' HA ' ' CB ' ' B' ' 44' ' ' SER . 97.1 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 356' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . 0.442 HD22 ' HA ' ' A' ' 116' ' ' ASN . 0.5 OUTLIER -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 40.9 mtt85 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 17.2 tpp85 -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 412' ' ' LYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 N--CA 1.495 1.809 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.52 138.58 38.48 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.177 -0.952 . . . . 0.0 113.004 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . 0.738 HG11 HD22 ' B' ' 23' ' ' LEU . 61.2 t -137.11 122.6 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.526 HG11 ' CZ ' ' B' ' 12' ' ' ARG . 97.5 t -106.78 129.58 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.15 -0.969 . . . . 0.0 111.635 -178.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.682 ' CG ' HD13 ' B' ' 32' ' ' ILE . 77.2 m-85 -109.28 110.6 21.83 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.82 127.23 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.935 -1.103 . . . . 0.0 108.363 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.6 m -86.2 174.69 8.94 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.737 0.779 . . . . 0.0 112.509 -177.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' HIS . . . . . 0.422 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.66 -46.73 89.22 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 121.19 0.519 . . . . 0.0 110.457 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -65.93 -11.29 46.16 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.52 -0.737 . . . . 0.0 111.381 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.01 15.4 28.55 Favored Glycine 0 N--CA 1.492 2.388 0 O-C-N 121.177 -0.952 . . . . 0.0 111.287 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 89.8 m -82.05 147.35 29.18 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 118.733 1.266 . . . . 0.0 109.929 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . 0.526 ' CZ ' HG11 ' B' ' 4' ' ' VAL . 50.8 ttt85 -118.46 128.74 54.89 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.528 -0.732 . . . . 0.0 111.864 -178.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' B' ' 13' ' ' ARG . 0.0 OUTLIER -126.06 127.67 46.2 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.571 -0.705 . . . . 0.0 109.81 179.146 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -111.34 130.63 55.62 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.275 -0.891 . . . . 0.0 111.612 -178.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 84.7 mt -122.78 159.35 28.24 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.736 -0.602 . . . . 0.0 111.117 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -109.64 91.62 3.72 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 176.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.6 t -90.21 133.49 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-O 121.604 0.716 . . . . 0.0 112.288 -176.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.11 170.71 16.05 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.779 -0.576 . . . . 0.0 110.27 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -68.47 151.82 46.27 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.479 -0.763 . . . . 0.0 110.958 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.45 -12.51 55.34 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.048 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 59.4 t -90.03 133.32 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.704 -1.468 . . . . 0.0 110.896 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 22.3 p -80.23 151.96 29.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.583 -0.698 . . . . 0.0 109.173 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.738 HD22 HG11 ' B' ' 3' ' ' VAL . 18.4 mt -61.22 -24.63 66.48 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.299 -0.876 . . . . 0.0 110.578 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 8.5 tmm? -69.78 -49.19 55.31 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.234 -0.916 . . . . 0.0 109.521 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -59.81 -41.7 91.86 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.594 -0.691 . . . . 0.0 109.953 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.04 -40.91 95.47 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.616 -0.678 . . . . 0.0 110.135 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . 0.73 ' HA ' HD12 ' B' ' 32' ' ' ILE . . . -68.3 -49.78 58.12 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.266 -0.896 . . . . 0.0 111.046 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 69.3 t -65.42 -39.19 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.36 -0.837 . . . . 0.0 110.734 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 28.2 m -70.16 -13.97 62.43 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.372 -0.83 . . . . 0.0 111.526 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -118.2 23.8 11.37 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.04 -1.038 . . . . 0.0 110.663 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.72 38.27 58.81 Favored Glycine 0 N--CA 1.492 2.424 0 O-C-N 121.556 -0.715 . . . . 0.0 111.828 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.73 HD12 ' HA ' ' B' ' 27' ' ' ALA . 1.7 mt -72.55 147.17 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.836 -1.391 . . . . 0.0 108.853 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.68 142.48 58.08 Favored 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 117.215 2.302 . . . . 0.0 117.215 -174.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 62.18 -36.09 0.12 Allowed 'General case' 0 N--CA 1.516 2.855 0 N-CA-C 116.655 2.094 . . . . 0.0 116.655 175.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 84.4 mt -59.78 122.91 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.373 0 O-C-N 119.843 -1.785 . . . . 0.0 110.673 -178.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.591 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 18.9 t -100.12 -51.46 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.63 -0.669 . . . . 0.0 111.193 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.16 56.5 20.08 Favored Glycine 0 N--CA 1.5 2.906 0 N-CA-C 107.447 -2.261 . . . . 0.0 107.447 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.3 -49.31 44.11 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.974 -0.721 . . . . 0.0 112.269 -177.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' CYS . . . . . 0.555 ' HB3' ' HB3' ' B' ' 45' ' ' CYS . 2.3 p -66.59 -10.44 45.51 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.206 -0.934 . . . . 0.0 112.384 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.82 -5.51 64.02 Favored Glycine 0 N--CA 1.499 2.854 0 O-C-N 120.824 -1.172 . . . . 0.0 111.968 177.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.06 19.58 10.63 Favored Glycine 0 N--CA 1.495 2.589 0 O-C-N 120.815 -1.403 . . . . 0.0 111.071 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 90.1 p -99.01 19.15 15.63 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.062 -1.258 . . . . 0.0 111.119 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.99 40.82 30.33 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.42 -0.8 . . . . 0.0 111.941 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . 0.429 ' CB ' ' HA ' ' A' ' 354' ' ' SER . 70.7 m -117.02 11.19 14.2 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.368 -0.832 . . . . 0.0 109.494 178.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' CYS . . . . . 0.555 ' HB3' ' HB3' ' B' ' 39' ' ' CYS . 15.1 p -149.51 -179.09 6.82 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.54 -0.725 . . . . 0.0 109.049 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.07 34.09 3.1 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.849 -1.157 . . . . 0.0 111.362 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' THR . . . . . 0.591 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 81.9 p -97.61 13.27 30.73 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.0 -1.063 . . . . 0.0 111.277 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 29.1 p -120.54 31.74 6.31 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 23.9 t-160 -72.74 133.05 44.38 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.574 -178.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.3 m -146.26 160.07 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . 0.422 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.5 m-85 -105.41 102.7 12.16 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.26 -0.9 . . . . 0.0 108.709 178.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.3 t -61.87 135.15 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.319 -0.863 . . . . 0.0 109.362 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.7 131.79 51.34 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.981 0.896 . . . . 0.0 109.505 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' B' ' 54' ' ' GLU . 11.1 mp0 -44.28 -31.05 0.91 Allowed 'General case' 0 N--CA 1.505 2.314 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -178.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.76 -6.96 54.38 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.982 -1.074 . . . . 0.0 112.742 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -119.91 -6.61 10.04 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.492 -1.38 . . . . 0.0 111.892 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.3 p -55.49 -37.77 68.27 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.167 -0.958 . . . . 0.0 112.84 -178.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -81.14 -6.71 59.14 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.773 -1.204 . . . . 0.0 111.447 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -89.83 -11.66 41.37 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.017 -1.052 . . . . 0.0 109.841 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.7 t -104.05 141.02 21.65 Favored Pre-proline 0 N--CA 1.489 1.521 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -73.81 118.85 5.61 Favored 'Trans proline' 0 N--CA 1.488 1.172 0 O-C-N 123.487 1.256 . . . . 0.0 109.001 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.9 160.6 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.761 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 -177.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . 0.616 ' HB1' ' HB3' ' B' ' 67' ' ' GLU . . . -65.71 146.16 55.13 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.239 178.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -89.84 -170.73 2.91 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.59 -0.694 . . . . 0.0 110.388 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.56 -42.0 91.42 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.287 -0.883 . . . . 0.0 111.75 -178.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 8.7 ttt180 -67.45 -41.55 84.53 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.173 -0.954 . . . . 0.0 112.014 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . 0.616 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 45.5 tt0 -68.2 -43.97 76.88 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.938 -1.101 . . . . 0.0 110.329 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' ILE . . . . . 0.533 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.7 mm -55.55 -42.21 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.243 -0.911 . . . . 0.0 109.367 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.15 -47.88 80.75 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' MET . . . . . 0.415 ' HB3' HD11 ' B' ' 84' ' ' LEU . 5.3 mmt -66.17 -34.01 77.07 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.264 -1.139 . . . . 0.0 111.172 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' B' ' 71' ' ' LEU . 28.0 mt -63.48 -23.29 67.33 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.294 -0.879 . . . . 0.0 110.634 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . 0.533 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 49.8 mt-10 -70.45 -8.69 52.94 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.265 -0.897 . . . . 0.0 110.883 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 83.4 p -119.9 12.6 12.1 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.002 -1.061 . . . . 0.0 112.519 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 30.5 m -60.83 140.42 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 120.714 -1.241 . . . . 0.0 109.634 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 81.9 m -74.53 -39.11 62.56 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.419 -0.8 . . . . 0.0 110.15 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.2 168.81 17.46 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.454 -0.779 . . . . 0.0 110.121 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.32 139.15 55.74 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.44 -0.788 . . . . 0.0 110.566 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.4 tp -90.95 116.15 28.53 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.517 -0.739 . . . . 0.0 109.918 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -103.05 168.31 8.97 Favored Pre-proline 0 N--CA 1.489 1.515 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -76.58 -0.06 10.05 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 O-C-N 123.239 1.126 . . . . 0.0 110.404 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -120.46 22.36 11.3 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.002 -1.061 . . . . 0.0 108.385 176.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 4.3 m -80.78 137.22 36.23 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.853 -0.53 . . . . 0.0 110.407 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.5 mmm-85 -149.75 146.38 27.17 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.455 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.555 HD12 ' HG3' ' B' ' 67' ' ' GLU . 92.1 mt -80.6 98.92 7.86 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 175.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' CYS . . . . . 0.409 ' HB2' ' HB2' ' B' ' 23' ' ' LEU . 10.6 p -48.36 -17.89 0.18 Allowed 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -175.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.8 p -70.29 -14.01 62.41 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.662 -1.273 . . . . 0.0 109.464 178.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 80.5 mm-40 -92.66 -12.2 32.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.511 -0.743 . . . . 0.0 110.589 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 61.9 mt -91.49 103.96 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.188 -0.945 . . . . 0.0 110.624 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 46.0 mm -84.94 131.77 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 13.6 tpt -74.88 137.81 42.02 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 122.123 0.963 . . . . 0.0 113.236 -177.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 43.7 p -138.24 166.54 25.06 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 176.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -74.9 1.7 7.38 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 122.632 0.807 . . . . 0.0 111.05 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -87.58 -22.89 24.52 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 176.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.2 mt -93.8 13.02 23.75 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.394 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.47 126.39 23.32 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.203 -0.936 . . . . 0.0 111.162 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.27 6.77 68.36 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.666 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.57 142.75 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 CA-C-N 119.328 1.564 . . . . 0.0 110.779 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 98' ' ' VAL . . . . . 0.469 HG22 ' HB ' ' B' ' 4' ' ' VAL . 60.6 t -122.54 132.95 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.546 -0.722 . . . . 0.0 109.854 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 16.4 m -130.36 135.75 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.535 -0.728 . . . . 0.0 109.814 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 100' ' ' ASP . . . . . 0.422 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.39 134.15 35.2 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.2 t -103.43 127.35 29.82 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.52 -0.737 . . . . 0.0 110.351 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -80.81 130.95 7.86 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 O-C-N 124.129 1.594 . . . . 0.0 108.283 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 103' ' ' ASP . . . . . 0.422 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.4 p-10 -62.41 3.43 0.19 Allowed 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -125.33 114.63 19.15 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.257 -1.527 . . . . 0.0 110.054 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 105' ' ' GLN . . . . . 0.501 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 52.4 mm-40 -113.32 -49.34 2.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.438 -0.789 . . . . 0.0 110.016 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 106' ' ' TRP . . . . . 0.688 ' CD1' ' HB1' ' A' ' 113' ' ' ALA . 23.1 m0 . . . . . 0 N--CA 1.495 1.793 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.531 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.514 HD12 ' HD2' ' A' ' 15' ' ' PRO . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 14' ' ' LEU . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.419 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HG2' HG12 ' A' ' 54' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.569 HG12 ' HG2' ' A' ' 51' ' ' PRO . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.609 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.8 m120 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.609 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 64' ' ' ILE . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.435 ' HA ' HD23 ' A' ' 324' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.0 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.414 ' CZ ' HG23 ' A' ' 348' ' ' THR . 5.6 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.6 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.478 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 27.1 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.7 mmt-85 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.64 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.2 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.556 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.717 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.717 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 1.068 HD11 ' CZ ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.621 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 74.3 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.64 ' O ' ' HB3' ' A' ' 83' ' ' SER . 3.9 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 46.0 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.646 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.296 50.1 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 104' ' ' ASP 0.366 52.9 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.646 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 34.8 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.451 ' H ' ' CG ' ' A' ' 106' ' ' PRO 0.342 30.7 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.478 ' HB1' ' HB3' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.739 HD11 ' HA3' ' A' ' 226' ' ' GLY . 7.0 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.566 ' O ' HG22 ' A' ' 119' ' ' VAL . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.417 ' HB2' ' O ' ' A' ' 114' ' ' LEU . 24.3 mt-30 -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.597 ' HA ' HG21 ' A' ' 123' ' ' VAL . 34.9 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.566 HG22 ' O ' ' A' ' 115' ' ' ALA . 27.5 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.493 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.698 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 0.0 OUTLIER -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.698 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.0 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.597 HG21 ' HA ' ' A' ' 118' ' ' VAL . 78.3 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 28.0 mtmt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.455 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.63 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.412 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.595 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 151' ' ' THR . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.799 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.799 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.441 ' O ' ' HG2' ' A' ' 164' ' ' MET . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.578 ' C ' HD23 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.455 ' N ' HD23 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.425 ' N ' ' HD2' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' HIS . . . . . 0.405 ' O ' ' HG ' ' A' ' 180' ' ' LEU . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.574 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 176' ' ' HIS . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.561 ' HA ' ' HE3' ' A' ' 184' ' ' MET . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . 0.561 ' HE3' ' HA ' ' A' ' 181' ' ' THR . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.421 HD22 ' HE1' ' A' ' 184' ' ' MET . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . 0.453 ' HG3' ' HB1' ' A' ' 224' ' ' ALA . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 220' ' ' ILE . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 44.9 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 42.0 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.453 ' HB1' ' HG3' ' A' ' 212' ' ' ARG . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.739 ' HA3' HD11 ' A' ' 114' ' ' LEU . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 4.3 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 13.5 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . 1.068 ' CZ ' HD11 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 41.0 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.717 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.487 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' MET . . . . . 0.595 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 13.2 pm0 -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.437 ' N ' ' HD2' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' CYS . . . . . . . . . . . . . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 288' ' ' LEU . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.706 HD23 ' H ' ' A' ' 294' ' ' LEU . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . 0.419 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . 0.419 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.0 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.459 ' HA ' HD13 ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 314' ' ' LYS . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.6 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' HIS . . . . . 0.425 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 36.9 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 303' ' ' SER . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 318' ' ' ILE . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' LEU . . . . . 0.647 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' PRO . . . . . 0.68 ' HG2' HD22 ' A' ' 324' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.68 HD22 ' HG2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 13.7 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 327' ' ' LEU . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.522 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' PRO . . . . . 0.522 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 68.2 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' ARG . . . . . 0.4 ' HB3' HG22 ' A' ' 345' ' ' VAL . 43.4 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' GLN . . . . . 0.482 ' CB ' ' HD3' ' A' ' 344' ' ' LYS . 0.1 OUTLIER -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' LYS . . . . . 0.503 ' HB2' ' HE2' ' A' ' 344' ' ' LYS . 1.7 mppt? -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.4 HG22 ' HB3' ' A' ' 342' ' ' ARG . 60.0 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 13.2 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 348' ' ' THR . . . . . 0.414 HG23 ' CZ ' ' A' ' 72' ' ' ARG . 16.5 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 349' ' ' THR . . . . . . . . . . . . . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 354' ' ' SER . . . . . 0.592 ' HA ' ' HB3' ' B' ' 44' ' ' SER . 95.3 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 356' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 4.9 mp -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 38.2 mtt85 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 14.3 tpp85 -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 412' ' ' LYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 40.3 m . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 121.079 0.466 . . . . 0.0 109.757 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.51 138.61 38.51 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.169 -0.957 . . . . 0.0 112.928 -178.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . 0.727 HG11 HD22 ' B' ' 23' ' ' LEU . 61.2 t -137.17 122.57 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 177.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.53 HG11 ' CZ ' ' B' ' 12' ' ' ARG . 98.4 t -106.81 129.61 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.159 -0.963 . . . . 0.0 111.62 -178.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.683 ' CG ' HD13 ' B' ' 32' ' ' ILE . 77.3 m-85 -109.22 110.6 21.84 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.83 127.22 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 120.96 -1.087 . . . . 0.0 108.353 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.4 m -86.17 174.67 8.97 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.772 0.796 . . . . 0.0 112.503 -177.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' HIS . . . . . 0.419 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.6 t-80 -60.7 -46.7 89.38 Favored 'General case' 0 N--CA 1.503 2.179 0 CA-C-O 121.142 0.496 . . . . 0.0 110.436 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -65.92 -11.28 46.08 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.575 -0.703 . . . . 0.0 111.387 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.96 15.48 28.45 Favored Glycine 0 N--CA 1.491 2.335 0 O-C-N 121.074 -1.016 . . . . 0.0 111.269 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.0 m -82.07 147.4 29.13 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 118.713 1.257 . . . . 0.0 109.926 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . 0.53 ' CZ ' HG11 ' B' ' 4' ' ' VAL . 50.9 ttt85 -118.49 128.8 54.93 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.428 -0.795 . . . . 0.0 111.83 -178.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.05 127.67 46.2 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.596 -0.69 . . . . 0.0 109.803 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -111.37 130.64 55.62 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.287 -0.883 . . . . 0.0 111.589 -178.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 84.6 mt -122.79 159.36 28.24 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.753 -0.592 . . . . 0.0 111.118 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -109.61 91.62 3.72 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 176.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.5 t -90.15 133.4 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-O 121.575 0.702 . . . . 0.0 112.303 -176.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.08 170.66 16.12 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.768 -0.582 . . . . 0.0 110.295 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -68.44 151.82 46.29 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.477 -0.764 . . . . 0.0 111.005 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.47 -12.53 55.39 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.03 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 61.1 t -89.99 133.34 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.655 -1.497 . . . . 0.0 110.928 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 97.7 p -80.29 151.88 29.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.513 -0.742 . . . . 0.0 109.127 178.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.727 HD22 HG11 ' B' ' 3' ' ' VAL . 18.5 mt -61.16 -24.63 66.43 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.312 -0.868 . . . . 0.0 110.631 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 2.7 ttp -69.75 -49.2 55.41 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.217 -0.927 . . . . 0.0 109.514 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.79 -41.75 91.86 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.591 -0.693 . . . . 0.0 109.941 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.06 -40.89 95.37 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.574 -0.704 . . . . 0.0 110.137 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . 0.718 ' HA ' HD12 ' B' ' 32' ' ' ILE . . . -68.3 -49.77 58.2 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.203 -0.935 . . . . 0.0 111.071 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 77.4 t -65.48 -39.15 84.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.305 -0.872 . . . . 0.0 110.723 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 26.0 m -70.14 -14.0 62.45 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.394 -0.816 . . . . 0.0 111.547 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -118.17 23.78 11.39 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.033 -1.042 . . . . 0.0 110.623 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.74 38.27 58.86 Favored Glycine 0 N--CA 1.493 2.459 0 O-C-N 121.566 -0.709 . . . . 0.0 111.81 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.718 HD12 ' HA ' ' B' ' 27' ' ' ALA . 1.7 mt -72.53 147.12 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.914 -1.345 . . . . 0.0 108.878 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.67 142.51 58.05 Favored 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 117.203 2.297 . . . . 0.0 117.203 -174.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . 0.458 ' O ' ' HG3' ' B' ' 105' ' ' GLN . 65.3 m-20 62.19 -36.14 0.12 Allowed 'General case' 0 N--CA 1.515 2.81 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 175.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 84.4 mt -59.69 122.85 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 O-C-N 119.864 -1.772 . . . . 0.0 110.701 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.634 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 2.4 t -100.09 -51.35 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.577 -0.702 . . . . 0.0 111.241 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.1 56.49 20.24 Favored Glycine 0 N--CA 1.5 2.908 0 N-CA-C 107.447 -2.261 . . . . 0.0 107.447 -178.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . 0.419 ' N ' HG12 ' B' ' 36' ' ' VAL . 29.7 t0 -71.34 -49.24 44.44 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.991 -0.711 . . . . 0.0 112.262 -177.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' CYS . . . . . 0.555 ' HB3' ' HB3' ' B' ' 45' ' ' CYS . 2.3 p -66.55 -10.46 45.37 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.22 -0.925 . . . . 0.0 112.394 -178.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.77 -5.48 64.13 Favored Glycine 0 N--CA 1.499 2.836 0 O-C-N 120.806 -1.184 . . . . 0.0 111.981 177.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.14 19.51 10.64 Favored Glycine 0 N--CA 1.494 2.558 0 O-C-N 120.842 -1.387 . . . . 0.0 110.978 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 30.7 p -98.99 19.16 15.61 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.037 -1.273 . . . . 0.0 111.115 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 56.04 40.83 30.24 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.391 -0.818 . . . . 0.0 111.93 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . 0.592 ' HB3' ' HA ' ' A' ' 354' ' ' SER . 5.7 m -117.05 11.21 14.18 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.318 -0.864 . . . . 0.0 109.557 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' CYS . . . . . 0.555 ' HB3' ' HB3' ' B' ' 39' ' ' CYS . 15.1 p -149.56 -179.1 6.83 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.04 34.07 3.11 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.884 -1.135 . . . . 0.0 111.356 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' THR . . . . . 0.634 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 37.2 p -97.52 13.2 30.79 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.964 -1.085 . . . . 0.0 111.314 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' CYS . . . . . 0.415 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.1 p -120.57 31.77 6.3 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 23.8 t-160 -72.7 133.03 44.41 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.609 -178.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.3 m -146.29 160.07 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . 0.417 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.5 m-85 -105.42 102.76 12.21 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.3 -0.875 . . . . 0.0 108.681 178.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.2 t -61.98 135.12 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 121.315 -0.865 . . . . 0.0 109.349 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.65 131.81 51.36 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.944 0.878 . . . . 0.0 109.559 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.408 ' H ' ' CD ' ' B' ' 54' ' ' GLU . 11.0 mp0 -44.34 -30.98 0.91 Allowed 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.84 -6.9 54.25 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.984 -1.073 . . . . 0.0 112.712 -178.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -119.95 -6.67 10.02 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 120.503 -1.373 . . . . 0.0 111.871 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.5 p -55.37 -37.85 68.06 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.154 -0.967 . . . . 0.0 112.892 -178.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -81.1 -6.65 59.06 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.787 -1.196 . . . . 0.0 111.46 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -89.93 -11.6 41.28 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.078 -1.014 . . . . 0.0 109.831 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.8 t -104.07 141.05 21.71 Favored Pre-proline 0 N--CA 1.488 1.467 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -73.8 118.92 5.64 Favored 'Trans proline' 0 N--CA 1.489 1.209 0 O-C-N 123.514 1.271 . . . . 0.0 108.986 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.99 160.66 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.761 0 N-CA-C 116.647 2.092 . . . . 0.0 116.647 -177.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . 0.612 ' HB1' ' HB3' ' B' ' 67' ' ' GLU . . . -65.77 146.15 55.12 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 114.572 -1.194 . . . . 0.0 111.247 178.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -89.78 -170.79 2.94 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.565 -0.709 . . . . 0.0 110.392 178.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -59.53 -42.05 91.38 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.343 -0.848 . . . . 0.0 111.686 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 5.0 ttt180 -67.39 -41.57 84.76 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.175 -0.953 . . . . 0.0 112.028 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . 0.612 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 45.4 tt0 -68.23 -43.91 76.88 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.01 -1.056 . . . . 0.0 110.349 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' ILE . . . . . 0.526 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.6 mm -55.56 -42.18 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 O-C-N 121.287 -0.883 . . . . 0.0 109.372 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.22 -47.84 80.83 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 9.5 mmt -66.18 -33.99 77.01 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.27 -1.135 . . . . 0.0 111.207 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' LEU . . . . . 0.441 ' HA ' HD23 ' B' ' 71' ' ' LEU . 28.1 mt -63.45 -23.35 67.36 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.214 -0.929 . . . . 0.0 110.608 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . 0.526 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 49.9 mt-10 -70.41 -8.79 53.54 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.344 -0.848 . . . . 0.0 110.889 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 82.8 p -119.78 12.54 12.18 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.001 -1.062 . . . . 0.0 112.543 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 28.8 m -60.8 140.46 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 O-C-N 120.761 -1.212 . . . . 0.0 109.627 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 44.8 m -74.58 -39.07 62.45 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.406 -0.809 . . . . 0.0 110.174 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.2 168.82 17.43 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.476 -0.765 . . . . 0.0 110.076 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.27 139.15 55.64 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.451 -0.781 . . . . 0.0 110.615 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.4 tp -91.0 116.19 28.6 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.551 -0.718 . . . . 0.0 109.836 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -103.02 168.33 8.95 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -76.62 -0.03 10.04 Favored 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 123.27 1.142 . . . . 0.0 110.43 178.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -120.43 22.35 11.32 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.963 -1.086 . . . . 0.0 108.419 176.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 4.3 m -80.77 137.17 36.24 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.833 -0.542 . . . . 0.0 110.385 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.5 mmm-85 -149.75 146.39 27.17 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.443 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.592 HD12 ' HG3' ' B' ' 67' ' ' GLU . 95.0 mt -80.57 98.99 7.87 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 175.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' CYS . . . . . 0.402 ' HB2' ' HB2' ' B' ' 23' ' ' LEU . 10.6 p -48.43 -17.91 0.19 Allowed 'General case' 0 N--CA 1.508 2.439 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -175.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.8 p -70.3 -13.92 62.37 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.646 -1.284 . . . . 0.0 109.453 178.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -92.72 -12.3 31.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.465 -0.772 . . . . 0.0 110.533 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' ILE . . . . . 0.402 HG21 HD13 ' B' ' 88' ' ' ILE . 61.8 mt -91.46 103.96 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.117 -0.99 . . . . 0.0 110.671 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 47.3 mm -84.99 131.8 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 13.6 tpt -74.85 137.77 42.05 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 122.143 0.973 . . . . 0.0 113.244 -177.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 43.8 p -138.2 166.59 24.73 Favored Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 176.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -74.94 1.65 7.46 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 122.689 0.836 . . . . 0.0 110.996 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -87.58 -22.84 24.55 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 176.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.6 mt -93.77 12.95 23.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 122.035 -0.416 . . . . 0.0 110.389 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.45 126.38 23.24 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.128 -0.983 . . . . 0.0 111.177 -178.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.19 6.83 68.48 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.68 179.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.62 142.75 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-N 119.334 1.567 . . . . 0.0 110.81 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 98' ' ' VAL . . . . . 0.461 HG22 ' HB ' ' B' ' 4' ' ' VAL . 60.6 t -122.47 133.02 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.559 -0.713 . . . . 0.0 109.829 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 16.4 m -130.41 135.74 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.456 -0.778 . . . . 0.0 109.788 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 100' ' ' ASP . . . . . 0.417 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.38 134.16 35.19 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.2 t -103.4 127.31 29.91 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.505 -0.747 . . . . 0.0 110.359 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -80.87 130.96 7.79 Favored 'Trans proline' 0 C--N 1.316 -1.163 0 O-C-N 124.101 1.579 . . . . 0.0 108.277 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 103' ' ' ASP . . . . . 0.419 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.3 p-10 -62.37 3.41 0.19 Allowed 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -178.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -125.29 114.58 19.12 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.277 -1.514 . . . . 0.0 110.089 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 105' ' ' GLN . . . . . 0.513 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 23.9 mm-40 -113.25 -49.41 2.91 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.455 -0.778 . . . . 0.0 110.029 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 106' ' ' TRP . . . . . 0.478 ' HB3' ' HB1' ' A' ' 113' ' ' ALA . 17.0 m0 . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 118.249 -0.882 . . . . 0.0 110.547 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.514 HD12 ' HD2' ' A' ' 15' ' ' PRO . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 14' ' ' LEU . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.419 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HG2' HG12 ' A' ' 54' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.569 HG12 ' HG2' ' A' ' 51' ' ' PRO . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.609 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.8 m120 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.609 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 64' ' ' ILE . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.435 ' HA ' HD23 ' A' ' 324' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.0 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.4 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.6 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.511 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 26.6 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.4 mtt-85 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.8 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.64 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.1 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.556 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.717 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.717 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 1.068 HD11 ' CZ ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.949 ' O ' ' O2D' ' A' ' 501' ' ' HEM . 67.8 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.64 ' O ' ' HB3' ' A' ' 83' ' ' SER . 3.9 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 45.3 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.605 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.298 63.0 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.511 ' HD2' ' CD1' ' A' ' 78' ' ' TYR 0.367 53.3 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.605 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 33.9 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.452 ' H ' ' CD ' ' A' ' 106' ' ' PRO 0.409 34.0 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.499 ' NH1' ' O1D' ' A' ' 501' ' ' HEM . 12.9 mtp180 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.425 ' HB2' ' CE3' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.538 HD11 ' HA3' ' A' ' 226' ' ' GLY . 38.0 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.503 ' O ' HG22 ' A' ' 119' ' ' VAL . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.66 HG23 HG13 ' A' ' 119' ' ' VAL . 25.2 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.66 HG13 HG23 ' A' ' 118' ' ' VAL . 27.3 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.493 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.698 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 17.7 mtm -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.698 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.1 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.606 HG21 ' HA ' ' A' ' 118' ' ' VAL . 72.7 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 45.4 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.455 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.63 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.412 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.595 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 151' ' ' THR . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.799 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.799 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.441 ' O ' ' HG2' ' A' ' 164' ' ' MET . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.578 ' C ' HD23 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.455 ' N ' HD23 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.425 ' N ' ' HD2' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' HIS . . . . . 0.405 ' O ' ' HG ' ' A' ' 180' ' ' LEU . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.574 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 176' ' ' HIS . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.561 ' HA ' ' HE3' ' A' ' 184' ' ' MET . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . 0.561 ' HE3' ' HA ' ' A' ' 181' ' ' THR . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.421 HD22 ' HE1' ' A' ' 184' ' ' MET . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.453 ' HG3' ' HB1' ' A' ' 224' ' ' ALA . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 220' ' ' ILE . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 42.7 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 42.0 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.453 ' HB1' ' HG3' ' A' ' 212' ' ' ARG . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.538 ' HA3' HD11 ' A' ' 114' ' ' LEU . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 6.2 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 1.3 m120 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 17.1 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 1.068 ' CZ ' HD11 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 34.2 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.717 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.487 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' MET . . . . . 0.595 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 16.4 pm0 -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.439 ' N ' ' HD2' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 281' ' ' ILE . 45.4 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' CYS . . . . . . . . . . . . . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 288' ' ' LEU . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.706 HD23 ' H ' ' A' ' 294' ' ' LEU . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.502 HG11 HMA3 ' A' ' 501' ' ' HEM . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . 0.513 ' OD2' ' O2A' ' A' ' 501' ' ' HEM . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . 0.419 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . 0.419 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.7 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.459 ' HA ' HD13 ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 314' ' ' LYS . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.6 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' HIS . . . . . 0.425 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 36.9 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 303' ' ' SER . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 318' ' ' ILE . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . 0.647 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . 0.68 ' HG2' HD22 ' A' ' 324' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.68 HD22 ' HG2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 13.7 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 327' ' ' LEU . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.522 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' PRO . . . . . 0.522 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . 0.413 ' CB ' ' HD3' ' A' ' 344' ' ' LYS . 1.9 mp0 -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' LYS . . . . . 0.519 ' HD3' ' N ' ' A' ' 344' ' ' LYS . 1.8 mppt? -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 61.0 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 1.1 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 15.8 p80 -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 17.1 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' THR . . . . . . . . . . . . . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 90.8 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' LEU . . . . . 0.58 HD13 ' O ' ' B' ' 39' ' ' CYS . 0.6 OUTLIER -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 7.7 mtm180 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 17.2 tpp85 -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.1 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 39.6 m . . . . . 0 N--CA 1.496 1.832 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.51 138.6 38.5 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.234 -0.916 . . . . 0.0 112.92 -178.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.736 HG11 HD22 ' B' ' 23' ' ' LEU . 61.4 t -137.15 122.57 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.53 HG11 ' CZ ' ' B' ' 12' ' ' ARG . 98.5 t -106.82 129.59 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.124 -0.985 . . . . 0.0 111.625 -178.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -109.18 110.6 21.87 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.82 127.19 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.93 -1.107 . . . . 0.0 108.343 178.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.2 m -86.15 174.68 8.98 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.789 0.804 . . . . 0.0 112.472 -177.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.418 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.68 -46.69 89.39 Favored 'General case' 0 N--CA 1.503 2.18 0 CA-C-O 121.141 0.496 . . . . 0.0 110.453 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -65.94 -11.29 46.41 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.596 -0.69 . . . . 0.0 111.393 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.99 15.49 28.34 Favored Glycine 0 N--CA 1.493 2.441 0 O-C-N 121.174 -0.954 . . . . 0.0 111.238 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.6 m -82.12 147.37 29.1 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 118.789 1.295 . . . . 0.0 109.903 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . 0.53 ' CZ ' HG11 ' B' ' 4' ' ' VAL . 50.8 ttt85 -118.42 128.72 54.89 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.454 -0.779 . . . . 0.0 111.883 -178.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.99 127.64 46.22 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.595 -0.69 . . . . 0.0 109.843 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -111.28 130.6 55.61 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.281 -0.887 . . . . 0.0 111.632 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.62 HD11 HD11 ' B' ' 32' ' ' ILE . 84.6 mt -122.72 159.4 28.05 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.752 -0.592 . . . . 0.0 111.082 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -109.64 91.64 3.73 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 176.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.6 t -90.17 133.39 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.571 0.7 . . . . 0.0 112.314 -176.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.07 170.67 16.11 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.788 -0.57 . . . . 0.0 110.251 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -68.45 151.8 46.31 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.535 -0.728 . . . . 0.0 111.0 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.48 -12.52 55.44 Favored Glycine 0 N--CA 1.495 2.602 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.065 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 59.3 t -89.93 133.34 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 120.699 -1.471 . . . . 0.0 110.951 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 22.1 p -80.26 151.97 29.31 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.736 HD22 HG11 ' B' ' 3' ' ' VAL . 18.4 mt -61.24 -24.59 66.47 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.316 -0.865 . . . . 0.0 110.618 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 8.8 tmm? -69.76 -49.23 55.0 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.2 -0.938 . . . . 0.0 109.497 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -59.91 -41.62 92.12 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.56 -0.713 . . . . 0.0 109.895 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.07 -40.89 95.33 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.655 -0.653 . . . . 0.0 110.169 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . 0.697 ' HA ' HD13 ' B' ' 32' ' ' ILE . . . -68.35 -49.71 58.39 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.219 -0.926 . . . . 0.0 111.058 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 53.8 t -65.42 -39.25 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.298 -0.876 . . . . 0.0 110.711 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 24.0 m -70.01 -14.12 62.55 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.325 -0.859 . . . . 0.0 111.557 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -118.15 23.78 11.39 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.036 -1.04 . . . . 0.0 110.691 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.81 38.21 59.1 Favored Glycine 0 N--CA 1.493 2.454 0 O-C-N 121.527 -0.733 . . . . 0.0 111.83 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.697 HD13 ' HA ' ' B' ' 27' ' ' ALA . 1.0 OUTLIER -72.53 147.11 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.847 -1.384 . . . . 0.0 108.874 179.055 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -62.63 142.43 58.05 Favored 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 117.201 2.297 . . . . 0.0 117.201 -174.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . 0.447 ' O ' ' HG3' ' B' ' 105' ' ' GLN . 65.2 m-20 62.25 -36.14 0.12 Allowed 'General case' 0 N--CA 1.516 2.833 0 N-CA-C 116.66 2.096 . . . . 0.0 116.66 175.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 54.3 mt -59.76 122.89 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.419 0 O-C-N 119.89 -1.756 . . . . 0.0 110.62 -178.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.68 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 96.5 t -100.13 -51.36 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.695 -0.628 . . . . 0.0 111.183 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . 0.625 ' HA2' ' S2 ' ' B' ' 201' ' ' FES . . . 63.13 56.4 20.67 Favored Glycine 0 N--CA 1.499 2.873 0 N-CA-C 107.491 -2.244 . . . . 0.0 107.491 -178.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -71.27 -49.23 45.17 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.994 -0.709 . . . . 0.0 112.34 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' CYS . . . . . 0.58 ' O ' HD13 ' A' ' 356' ' ' LEU . 2.3 p -66.6 -10.48 46.15 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.215 -0.928 . . . . 0.0 112.332 -178.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.87 -5.57 63.92 Favored Glycine 0 N--CA 1.498 2.804 0 O-C-N 120.787 -1.195 . . . . 0.0 111.968 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.17 19.5 10.63 Favored Glycine 0 N--CA 1.495 2.605 0 O-C-N 120.803 -1.41 . . . . 0.0 111.002 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 80.6 p -98.97 19.21 15.49 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.028 -1.278 . . . . 0.0 111.132 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.401 ' HA ' ' S1 ' ' B' ' 201' ' ' FES . . . 55.92 40.89 30.46 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.4 -0.812 . . . . 0.0 111.941 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 3.6 t -117.02 11.14 14.18 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.376 -0.828 . . . . 0.0 109.518 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' CYS . . . . . 0.723 ' HG ' 'FE1 ' ' B' ' 201' ' ' FES . 15.1 p -149.53 -179.11 6.84 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.05 34.04 3.11 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.803 -1.186 . . . . 0.0 111.367 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' THR . . . . . 0.68 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 23.4 p -97.59 13.24 30.78 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.933 -1.105 . . . . 0.0 111.276 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' CYS . . . . . 0.442 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.1 p -120.58 31.77 6.3 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 177.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . 0.468 ' NE2' ' HB3' ' B' ' 82' ' ' SER . 6.5 t-160 -72.65 132.99 44.43 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.642 -178.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.2 m -146.21 160.1 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . 0.413 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.3 m-85 -105.43 102.71 12.17 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.238 -0.914 . . . . 0.0 108.706 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.4 t -61.87 135.13 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.282 -0.886 . . . . 0.0 109.369 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.67 131.74 51.16 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.954 0.883 . . . . 0.0 109.518 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' B' ' 54' ' ' GLU . 11.0 mp0 -44.26 -31.08 0.91 Allowed 'General case' 0 N--CA 1.507 2.384 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -178.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.78 -6.88 54.07 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 120.963 -1.086 . . . . 0.0 112.752 -178.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -119.9 -6.73 10.04 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.46 -1.4 . . . . 0.0 111.886 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.4 p -55.45 -37.75 68.13 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.174 -0.954 . . . . 0.0 112.863 -178.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -81.2 -6.62 59.06 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.741 -1.225 . . . . 0.0 111.453 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -89.84 -11.67 41.31 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.045 -1.034 . . . . 0.0 109.859 178.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -104.07 141.04 21.7 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -73.74 118.88 5.63 Favored 'Trans proline' 0 N--CA 1.488 1.18 0 O-C-N 123.509 1.268 . . . . 0.0 109.029 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.94 160.59 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.762 0 N-CA-C 116.65 2.092 . . . . 0.0 116.65 -177.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.615 ' HB1' ' HB3' ' B' ' 67' ' ' GLU . . . -65.76 146.18 55.09 Favored 'General case' 0 N--CA 1.503 2.182 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.258 178.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -89.81 -170.76 2.92 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.606 -0.684 . . . . 0.0 110.383 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -59.59 -41.96 91.46 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.337 -0.852 . . . . 0.0 111.705 -178.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.46 -41.6 84.4 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.186 -0.946 . . . . 0.0 111.969 -178.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.615 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 45.6 tt0 -68.22 -43.96 76.82 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.005 -1.059 . . . . 0.0 110.298 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . 0.516 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.6 mm -55.52 -42.22 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.311 -0.868 . . . . 0.0 109.359 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.25 -47.78 81.3 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 26.9 mmt -66.26 -33.91 76.8 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.268 -1.137 . . . . 0.0 111.17 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . 0.422 ' HA ' HD23 ' B' ' 71' ' ' LEU . 27.5 mt -63.49 -23.35 67.36 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.207 -0.933 . . . . 0.0 110.623 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 41.1 mt-10 -70.41 -8.74 53.13 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.354 -0.842 . . . . 0.0 110.911 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 73.5 p -119.82 12.53 12.14 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.009 -1.057 . . . . 0.0 112.504 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 34.9 m -60.78 140.45 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 120.745 -1.222 . . . . 0.0 109.622 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 36.6 m -74.58 -39.06 62.47 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.393 -0.817 . . . . 0.0 110.181 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.2 168.82 17.43 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.47 -0.769 . . . . 0.0 110.094 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.27 139.14 55.67 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.392 -0.818 . . . . 0.0 110.609 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.2 tp -91.02 116.13 28.55 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.489 -0.757 . . . . 0.0 109.869 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -102.97 168.29 9.02 Favored Pre-proline 0 C--N 1.301 -1.518 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -76.62 -0.01 10.02 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 123.243 1.128 . . . . 0.0 110.401 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -120.46 22.36 11.3 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.898 -1.126 . . . . 0.0 108.399 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . 0.468 ' HB3' ' NE2' ' B' ' 49' ' ' HIS . 4.3 m -80.81 137.19 36.21 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.861 -0.524 . . . . 0.0 110.362 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.4 mmm-85 -149.75 146.38 27.16 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.487 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.593 HD12 ' HG3' ' B' ' 67' ' ' GLU . 97.5 mt -80.54 98.95 7.82 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 175.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 10.6 p -48.41 -17.86 0.18 Allowed 'General case' 0 N--CA 1.508 2.455 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -175.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.8 p -70.27 -14.01 62.42 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.616 -1.302 . . . . 0.0 109.464 178.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -92.7 -12.21 32.04 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.453 -0.779 . . . . 0.0 110.53 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . 0.4 HG21 HD13 ' B' ' 88' ' ' ILE . 61.8 mt -91.51 103.96 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.133 -0.979 . . . . 0.0 110.609 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 47.6 mm -84.96 131.79 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 13.6 tpt -74.84 137.8 42.08 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 122.164 0.983 . . . . 0.0 113.189 -177.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 43.7 p -138.25 166.59 24.63 Favored Pre-proline 0 N--CA 1.49 1.548 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 176.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -74.88 1.66 7.42 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 122.638 0.809 . . . . 0.0 111.035 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -87.65 -22.83 24.47 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.5 mt -93.72 12.96 23.75 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.465 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.52 126.44 23.6 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.184 -0.948 . . . . 0.0 111.15 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.21 6.81 68.46 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.66 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.58 142.74 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 CA-C-N 119.325 1.563 . . . . 0.0 110.768 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' VAL . . . . . 0.463 HG22 ' HB ' ' B' ' 4' ' ' VAL . 60.7 t -122.5 132.98 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.501 -0.749 . . . . 0.0 109.831 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 16.3 m -130.35 135.71 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.479 -0.763 . . . . 0.0 109.882 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' ASP . . . . . 0.413 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.34 134.16 35.18 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.1 t -103.46 127.32 29.85 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.545 -0.722 . . . . 0.0 110.32 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -80.85 130.93 7.81 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 O-C-N 124.114 1.586 . . . . 0.0 108.267 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' ASP . . . . . 0.418 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.4 p-10 -62.33 3.33 0.19 Allowed 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -178.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 4.0 mtm105 -125.29 114.71 19.29 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.306 -1.496 . . . . 0.0 110.064 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . 0.512 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 23.2 mm-40 -113.39 -49.36 2.9 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.486 -0.759 . . . . 0.0 109.969 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' TRP . . . . . 0.425 ' CE3' ' HB2' ' A' ' 113' ' ' ALA . 27.3 m95 . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.521 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 501' ' ' HEM . . . . . 0.949 ' O2D' ' O ' ' A' ' 100' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 502' ' ' CAM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 201' ' ' FES . . . . . 0.723 'FE1 ' ' HG ' ' B' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.514 HD12 ' HD2' ' A' ' 15' ' ' PRO . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 14' ' ' LEU . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.419 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HG2' HG12 ' A' ' 54' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.569 HG12 ' HG2' ' A' ' 51' ' ' PRO . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.609 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.8 m120 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.609 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 64' ' ' ILE . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.435 ' HA ' HD23 ' A' ' 324' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.0 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.4 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.5 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.427 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 27.0 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.64 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.2 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.556 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.717 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.717 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 1.068 HD11 ' CZ ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.949 ' O ' ' O2D' ' A' ' 501' ' ' HEM . 67.6 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.64 ' O ' ' HB3' ' A' ' 83' ' ' SER . 3.8 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 46.0 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.647 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.296 50.2 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 104' ' ' ASP 0.366 52.9 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.647 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 35.0 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.452 ' H ' ' CG ' ' A' ' 106' ' ' PRO 0.413 34.1 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 8.6 mtp180 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.552 ' HB2' ' CE3' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.687 HD11 ' HA3' ' A' ' 226' ' ' GLY . 24.5 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.546 ' O ' HG22 ' A' ' 119' ' ' VAL . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.603 ' HA ' HG21 ' A' ' 123' ' ' VAL . 35.1 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.593 HG13 HG23 ' A' ' 118' ' ' VAL . 30.6 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.493 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.698 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 21.5 mtm -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.698 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.1 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.603 HG21 ' HA ' ' A' ' 118' ' ' VAL . 72.0 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.7 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.452 ' HD2' ' HA ' ' A' ' 123' ' ' VAL . 35.6 mttt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.455 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.63 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.412 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.595 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 151' ' ' THR . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.799 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.799 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.441 ' O ' ' HG2' ' A' ' 164' ' ' MET . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.578 ' C ' HD23 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.455 ' N ' HD23 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.425 ' N ' ' HD2' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' HIS . . . . . 0.405 ' O ' ' HG ' ' A' ' 180' ' ' LEU . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.574 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 176' ' ' HIS . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.561 ' HA ' ' HE3' ' A' ' 184' ' ' MET . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . 0.561 ' HE3' ' HA ' ' A' ' 181' ' ' THR . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.421 HD22 ' HE1' ' A' ' 184' ' ' MET . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.453 ' HG3' ' HB1' ' A' ' 224' ' ' ALA . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 220' ' ' ILE . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 33.3 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 53.1 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.453 ' HB1' ' HG3' ' A' ' 212' ' ' ARG . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.687 ' HA3' HD11 ' A' ' 114' ' ' LEU . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 4.6 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 1.3 m120 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 18.1 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 1.068 ' CZ ' HD11 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 45.3 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.717 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.487 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' MET . . . . . 0.595 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.437 ' N ' ' HD2' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' CYS . . . . . . . . . . . . . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 288' ' ' LEU . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.706 HD23 ' H ' ' A' ' 294' ' ' LEU . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.502 HG11 HMA3 ' A' ' 501' ' ' HEM . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . 0.513 ' OD2' ' O2A' ' A' ' 501' ' ' HEM . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . 0.419 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . 0.419 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.1 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.459 ' HA ' HD13 ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 314' ' ' LYS . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.6 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' HIS . . . . . 0.425 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 36.9 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 303' ' ' SER . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 318' ' ' ILE . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . 0.647 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . 0.68 ' HG2' HD22 ' A' ' 324' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.68 HD22 ' HG2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 13.7 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 327' ' ' LEU . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.522 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' PRO . . . . . 0.522 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . 0.41 ' CB ' ' HD3' ' A' ' 344' ' ' LYS . 1.9 mp0 -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' LYS . . . . . 0.511 ' HD3' ' N ' ' A' ' 344' ' ' LYS . 0.9 OUTLIER -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 60.7 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 10.6 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 39.9 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' THR . . . . . . . . . . . . . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . 0.669 ' O ' HD12 ' A' ' 356' ' ' LEU . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' SER . . . . . 0.408 ' HA ' ' HB3' ' B' ' 44' ' ' SER . 97.5 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' LEU . . . . . 0.669 HD12 ' O ' ' A' ' 353' ' ' GLY . 0.2 OUTLIER -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 44.0 mtt85 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 39.7 m . . . . . 0 N--CA 1.495 1.805 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.49 138.61 38.52 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.246 -0.909 . . . . 0.0 112.958 -178.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.744 HG11 HD22 ' B' ' 23' ' ' LEU . 61.0 t -137.16 122.52 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 177.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.528 HG11 ' CZ ' ' B' ' 12' ' ' ARG . 97.9 t -106.74 129.56 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.093 -1.004 . . . . 0.0 111.636 -178.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.513 ' CG ' HD13 ' B' ' 32' ' ' ILE . 77.2 m-85 -109.23 110.58 21.83 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.8 127.27 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 120.93 -1.106 . . . . 0.0 108.377 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.7 m -86.21 174.64 8.97 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.766 0.793 . . . . 0.0 112.498 -177.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.432 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.6 -46.75 89.09 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.186 0.517 . . . . 0.0 110.472 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.2 p-10 -65.92 -11.28 46.04 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.583 -0.698 . . . . 0.0 111.419 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.98 15.51 28.3 Favored Glycine 0 N--CA 1.493 2.459 0 O-C-N 121.195 -0.941 . . . . 0.0 111.256 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.6 m -82.1 147.41 29.1 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 118.721 1.26 . . . . 0.0 109.884 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . 0.528 ' CZ ' HG11 ' B' ' 4' ' ' VAL . 50.8 ttt85 -118.52 128.78 54.91 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.508 -0.745 . . . . 0.0 111.816 -178.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' B' ' 13' ' ' ARG . 0.0 OUTLIER -126.07 127.72 46.27 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.623 -0.673 . . . . 0.0 109.79 179.109 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -111.26 130.62 55.6 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.284 -0.885 . . . . 0.0 111.617 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 84.4 mt -122.83 159.37 28.28 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.357 0.598 . . . . 0.0 111.08 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -109.64 91.67 3.74 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.7 t -90.22 133.49 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-O 121.654 0.74 . . . . 0.0 112.258 -176.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.13 170.67 16.12 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.766 -0.584 . . . . 0.0 110.242 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -68.45 151.83 46.27 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.5 -0.75 . . . . 0.0 110.954 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.42 -12.45 55.43 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.046 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.462 HG13 ' NE2' ' B' ' 25' ' ' GLN . 61.8 t -89.99 133.35 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 120.654 -1.498 . . . . 0.0 110.904 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 21.6 p -80.28 151.92 29.3 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.593 -0.692 . . . . 0.0 109.143 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.744 HD22 HG11 ' B' ' 3' ' ' VAL . 18.4 mt -61.19 -24.64 66.47 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.29 -0.881 . . . . 0.0 110.618 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . 0.425 ' SD ' ' S2 ' ' B' ' 201' ' ' FES . 7.7 ttp -69.71 -49.26 55.05 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.263 -0.898 . . . . 0.0 109.489 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . 0.462 ' NE2' HG13 ' B' ' 21' ' ' VAL . 0.1 OUTLIER -59.82 -41.67 91.8 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.562 -0.711 . . . . 0.0 109.937 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.11 -40.89 95.17 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.552 -0.718 . . . . 0.0 110.114 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . 0.589 ' HA ' HD12 ' B' ' 32' ' ' ILE . . . -68.31 -49.76 58.18 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.2 -0.937 . . . . 0.0 111.066 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 76.8 t -65.42 -39.17 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.317 -0.864 . . . . 0.0 110.755 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 20.5 t -70.09 -14.06 62.49 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.383 -0.823 . . . . 0.0 111.529 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -118.18 23.85 11.34 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.065 -1.022 . . . . 0.0 110.661 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.7 38.24 58.59 Favored Glycine 0 N--CA 1.493 2.481 0 O-C-N 121.55 -0.719 . . . . 0.0 111.871 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.589 HD12 ' HA ' ' B' ' 27' ' ' ALA . 0.4 OUTLIER -72.54 147.21 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.792 -1.416 . . . . 0.0 108.892 179.002 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -62.72 142.48 58.11 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 117.202 2.297 . . . . 0.0 117.202 -174.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 62.29 -36.21 0.12 Allowed 'General case' 0 N--CA 1.515 2.787 0 N-CA-C 116.59 2.07 . . . . 0.0 116.59 175.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.8 mt -59.67 122.85 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.395 0 O-C-N 119.828 -1.795 . . . . 0.0 110.718 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.688 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 90.7 t -100.12 -51.4 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.616 -0.678 . . . . 0.0 111.196 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . 0.628 ' HA2' ' S2 ' ' B' ' 201' ' ' FES . . . 63.16 56.41 20.55 Favored Glycine 0 N--CA 1.499 2.873 0 N-CA-C 107.482 -2.247 . . . . 0.0 107.482 -178.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -71.22 -49.33 44.56 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.942 -0.74 . . . . 0.0 112.325 -177.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' CYS . . . . . 0.635 ' O ' HD13 ' A' ' 356' ' ' LEU . 2.3 p -66.55 -10.46 45.39 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.244 -0.91 . . . . 0.0 112.389 -178.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.82 -5.47 64.01 Favored Glycine 0 N--CA 1.499 2.846 0 O-C-N 120.842 -1.161 . . . . 0.0 111.959 177.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.14 19.52 10.63 Favored Glycine 0 N--CA 1.495 2.569 0 O-C-N 120.845 -1.385 . . . . 0.0 110.974 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 14.0 m -98.95 19.12 15.62 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.033 -1.275 . . . . 0.0 111.148 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.97 40.89 30.35 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.418 -0.801 . . . . 0.0 111.892 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . 0.408 ' HB3' ' HA ' ' A' ' 354' ' ' SER . 37.4 m -117.05 11.22 14.17 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.345 -0.847 . . . . 0.0 109.523 178.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' CYS . . . . . 0.712 ' HG ' 'FE1 ' ' B' ' 201' ' ' FES . 15.1 p -149.54 -179.05 6.78 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.09 34.11 3.09 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.85 -1.156 . . . . 0.0 111.345 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' THR . . . . . 0.688 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 16.9 p -97.63 13.23 30.88 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.947 -1.096 . . . . 0.0 111.243 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.1 p -120.57 31.75 6.31 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -72.67 133.07 44.45 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.63 -178.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.3 m -146.33 160.11 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . 0.419 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.6 m-85 -105.43 102.75 12.2 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.244 -0.91 . . . . 0.0 108.674 178.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.2 t -61.93 135.17 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.226 -0.921 . . . . 0.0 109.351 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.69 131.76 51.24 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.975 0.893 . . . . 0.0 109.539 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.407 ' CD ' ' H ' ' B' ' 54' ' ' GLU . 11.0 mp0 -44.33 -30.98 0.91 Allowed 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -178.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.78 -6.97 54.47 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.982 -1.074 . . . . 0.0 112.75 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -119.87 -6.71 10.06 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.492 -1.38 . . . . 0.0 111.887 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.4 p -55.39 -37.83 68.08 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 121.136 -0.978 . . . . 0.0 112.815 -178.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -81.13 -6.69 59.12 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 120.724 -1.235 . . . . 0.0 111.484 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -89.78 -11.67 41.47 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.974 -1.078 . . . . 0.0 109.878 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -104.08 141.07 21.75 Favored Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -73.8 118.87 5.62 Favored 'Trans proline' 0 N--CA 1.488 1.192 0 O-C-N 123.543 1.286 . . . . 0.0 109.016 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.91 160.64 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.759 0 N-CA-C 116.62 2.081 . . . . 0.0 116.62 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.611 ' HB1' ' HB3' ' B' ' 67' ' ' GLU . . . -65.82 146.19 55.06 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.253 178.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -89.79 -170.78 2.93 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.628 -0.67 . . . . 0.0 110.4 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -59.47 -42.07 91.18 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.31 -0.868 . . . . 0.0 111.716 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -41.47 84.5 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.171 -0.955 . . . . 0.0 112.016 -178.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.709 ' HG3' HD12 ' B' ' 84' ' ' LEU . 45.5 tt0 -68.25 -43.96 76.71 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.97 -1.081 . . . . 0.0 110.335 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . 0.525 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.6 mm -55.58 -42.17 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 121.259 -0.901 . . . . 0.0 109.36 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.17 -47.91 80.35 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 13.7 mmt -66.16 -33.97 76.98 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.252 -1.146 . . . . 0.0 111.159 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' B' ' 71' ' ' LEU . 27.8 mt -63.53 -23.31 67.34 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.231 -0.918 . . . . 0.0 110.568 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 49.2 mt-10 -70.46 -8.67 52.85 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.352 -0.842 . . . . 0.0 110.919 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 86.4 p -119.83 12.48 12.12 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.035 -1.04 . . . . 0.0 112.528 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 34.9 m -60.68 140.39 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 O-C-N 120.701 -1.249 . . . . 0.0 109.647 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 24.5 m -74.58 -39.01 62.5 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.446 -0.784 . . . . 0.0 110.192 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.28 168.82 17.53 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.464 -0.773 . . . . 0.0 110.063 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -58.19 139.11 55.56 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.403 -0.811 . . . . 0.0 110.634 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.4 tp -90.97 116.14 28.54 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.535 -0.728 . . . . 0.0 109.89 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -103.03 168.34 8.94 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -76.65 -0.06 10.08 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 O-C-N 123.258 1.136 . . . . 0.0 110.388 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -120.4 22.36 11.32 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.992 -1.067 . . . . 0.0 108.395 176.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 4.3 m -80.83 137.23 36.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.898 -0.501 . . . . 0.0 110.382 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.5 mmm-85 -149.75 146.39 27.17 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 120.06 -0.656 . . . . 0.0 111.458 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.709 HD12 ' HG3' ' B' ' 67' ' ' GLU . 95.2 mt -80.58 98.92 7.84 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 175.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 10.5 p -48.33 -17.88 0.18 Allowed 'General case' 0 N--CA 1.508 2.43 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -175.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.9 p -70.32 -13.98 62.39 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.747 -1.221 . . . . 0.0 109.387 178.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -92.69 -12.25 31.97 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.508 -0.745 . . . . 0.0 110.501 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 61.9 mt -91.49 103.9 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.163 -0.961 . . . . 0.0 110.629 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 45.6 mm -84.94 131.78 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 13.6 tpt -74.83 137.74 42.07 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 122.111 0.957 . . . . 0.0 113.266 -177.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 43.7 p -138.17 166.63 24.45 Favored Pre-proline 0 N--CA 1.49 1.558 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 176.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -74.99 1.72 7.42 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 122.643 0.812 . . . . 0.0 110.968 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -87.62 -22.87 24.48 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 176.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.6 mt -93.74 12.95 23.84 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.437 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.44 126.38 23.22 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.201 -0.937 . . . . 0.0 111.148 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.15 6.92 68.45 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.575 -0.822 . . . . 0.0 111.682 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.65 142.74 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-N 119.319 1.559 . . . . 0.0 110.727 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' VAL . . . . . 0.481 HG22 ' HB ' ' B' ' 4' ' ' VAL . 60.7 t -122.52 133.01 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.513 -0.742 . . . . 0.0 109.843 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 16.5 m -130.41 135.74 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.403 -0.811 . . . . 0.0 109.78 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' ASP . . . . . 0.419 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.35 134.18 35.16 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.9 t -103.39 127.31 29.92 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.525 -0.734 . . . . 0.0 110.353 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -80.85 130.92 7.8 Favored 'Trans proline' 0 C--N 1.316 -1.172 0 O-C-N 124.139 1.6 . . . . 0.0 108.319 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' ASP . . . . . 0.432 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.3 p-10 -62.38 3.46 0.19 Allowed 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -178.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -125.32 114.59 19.11 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.256 -1.528 . . . . 0.0 110.067 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . 0.5 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 69.4 mm-40 -113.29 -49.35 2.91 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.497 -0.752 . . . . 0.0 109.987 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' TRP . . . . . 0.552 ' CE3' ' HB2' ' A' ' 113' ' ' ALA . 8.0 m95 . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.495 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 501' ' ' HEM . . . . . 0.949 ' O2D' ' O ' ' A' ' 100' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 502' ' ' CAM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 201' ' ' FES . . . . . 0.712 'FE1 ' ' HG ' ' B' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.514 HD12 ' HD2' ' A' ' 15' ' ' PRO . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 14' ' ' LEU . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.419 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HG2' HG12 ' A' ' 54' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.569 HG12 ' HG2' ' A' ' 51' ' ' PRO . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.609 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.8 m120 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.609 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 64' ' ' ILE . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.435 ' HA ' HD23 ' A' ' 324' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.0 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.415 ' CZ ' HG23 ' A' ' 348' ' ' THR . 5.6 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.6 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.458 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 27.4 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.2 mmt-85 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.64 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.2 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.556 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.717 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.717 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 1.068 HD11 ' CZ ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.949 ' O ' ' O2D' ' A' ' 501' ' ' HEM . 74.3 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.64 ' O ' ' HB3' ' A' ' 83' ' ' SER . 3.9 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 46.0 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.646 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.294 50.3 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 104' ' ' ASP 0.366 52.9 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.646 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 34.8 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.451 ' H ' ' CG ' ' A' ' 106' ' ' PRO 0.342 30.7 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.581 ' CG ' HD11 ' A' ' 358' ' ' LEU . 3.0 ttp180 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.528 ' HB2' ' CG ' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.752 HD11 ' HA3' ' A' ' 226' ' ' GLY . 6.7 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.546 ' O ' HG22 ' A' ' 119' ' ' VAL . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.603 ' HA ' HG21 ' A' ' 123' ' ' VAL . 35.0 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.594 HG13 HG23 ' A' ' 118' ' ' VAL . 30.6 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.493 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.698 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 7.0 mtm -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.698 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.1 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.603 HG21 ' HA ' ' A' ' 118' ' ' VAL . 72.7 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 46.0 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.455 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.63 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.412 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.595 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 151' ' ' THR . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.799 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.799 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.441 ' O ' ' HG2' ' A' ' 164' ' ' MET . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.578 ' C ' HD23 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.455 ' N ' HD23 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.425 ' N ' ' HD2' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' HIS . . . . . 0.405 ' O ' ' HG ' ' A' ' 180' ' ' LEU . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.574 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 176' ' ' HIS . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.561 ' HA ' ' HE3' ' A' ' 184' ' ' MET . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . 0.561 ' HE3' ' HA ' ' A' ' 181' ' ' THR . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.421 HD22 ' HE1' ' A' ' 184' ' ' MET . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.453 ' HG3' ' HB1' ' A' ' 224' ' ' ALA . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 220' ' ' ILE . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 42.5 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 42.0 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.453 ' HB1' ' HG3' ' A' ' 212' ' ' ARG . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.752 ' HA3' HD11 ' A' ' 114' ' ' LEU . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 4.3 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 13.5 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 1.068 ' CZ ' HD11 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 41.0 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.717 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.487 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' MET . . . . . 0.595 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 16.4 pm0 -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.437 ' N ' ' HD2' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' CYS . . . . . . . . . . . . . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 288' ' ' LEU . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.706 HD23 ' H ' ' A' ' 294' ' ' LEU . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.502 HG11 HMA3 ' A' ' 501' ' ' HEM . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . 0.513 ' OD2' ' O2A' ' A' ' 501' ' ' HEM . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . 0.419 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . 0.419 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.0 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.459 ' HA ' HD13 ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 314' ' ' LYS . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.6 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' HIS . . . . . 0.425 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 36.9 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 303' ' ' SER . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 318' ' ' ILE . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . 0.647 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . 0.68 ' HG2' HD22 ' A' ' 324' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.68 HD22 ' HG2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 13.7 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 327' ' ' LEU . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.522 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' PRO . . . . . 0.522 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . 0.46 ' CB ' ' HD3' ' A' ' 344' ' ' LYS . 1.9 mp0 -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' LYS . . . . . 0.504 ' HB2' ' HE2' ' A' ' 344' ' ' LYS . 1.7 mppt? -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 57.8 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 22.1 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' THR . . . . . 0.415 HG23 ' CZ ' ' A' ' 72' ' ' ARG . 16.5 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' THR . . . . . . . . . . . . . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 92.6 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' LEU . . . . . 0.583 HD13 ' O ' ' B' ' 39' ' ' CYS . 1.0 OUTLIER -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . 0.772 ' CD1' HBD2 ' A' ' 501' ' ' HEM . 0.4 OUTLIER -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 39.3 mtt85 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 17.2 tpp85 -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 39.6 m . . . . . 0 N--CA 1.495 1.807 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.53 138.58 38.47 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.181 -0.949 . . . . 0.0 112.927 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.733 HG11 HD22 ' B' ' 23' ' ' LEU . 61.3 t -137.11 122.6 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 177.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.524 HG11 ' CZ ' ' B' ' 12' ' ' ARG . 97.5 t -106.77 129.52 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.139 -0.976 . . . . 0.0 111.649 -178.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.679 ' CG ' HD13 ' B' ' 32' ' ' ILE . 77.1 m-85 -109.21 110.62 21.88 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 39.7 t -94.77 127.2 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.925 -1.109 . . . . 0.0 108.439 178.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.6 m -86.14 174.71 8.96 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.768 0.794 . . . . 0.0 112.493 -177.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.422 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.65 -46.77 89.04 Favored 'General case' 0 N--CA 1.503 2.19 0 CA-C-O 121.193 0.521 . . . . 0.0 110.448 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -65.92 -11.22 45.61 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.544 -0.723 . . . . 0.0 111.425 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.97 15.46 28.48 Favored Glycine 0 N--CA 1.492 2.385 0 O-C-N 121.147 -0.971 . . . . 0.0 111.256 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.4 m -82.07 147.37 29.15 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 118.773 1.287 . . . . 0.0 109.903 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . 0.524 ' CZ ' HG11 ' B' ' 4' ' ' VAL . 50.8 ttt85 -118.49 128.77 54.91 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.529 -0.732 . . . . 0.0 111.829 -178.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' B' ' 13' ' ' ARG . 0.0 OUTLIER -126.01 127.73 46.34 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.554 -0.716 . . . . 0.0 109.79 179.11 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.3 tt0 -111.35 130.66 55.61 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.29 -0.881 . . . . 0.0 111.591 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 85.0 mt -122.79 159.35 28.27 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.754 -0.591 . . . . 0.0 111.114 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -109.62 91.68 3.74 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.7 t -90.27 133.45 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-O 121.688 0.756 . . . . 0.0 112.248 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.08 170.67 16.12 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.706 -0.621 . . . . 0.0 110.262 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -68.46 151.81 46.29 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.532 -0.73 . . . . 0.0 110.967 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.41 -12.46 55.35 Favored Glycine 0 N--CA 1.495 2.629 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.067 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 59.1 t -89.99 133.33 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 120.69 -1.476 . . . . 0.0 110.936 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 21.7 p -80.29 151.94 29.28 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.568 -0.707 . . . . 0.0 109.145 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.733 HD22 HG11 ' B' ' 3' ' ' VAL . 18.5 mt -61.21 -24.63 66.48 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.297 -0.877 . . . . 0.0 110.605 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . 0.453 ' CE ' ' S2 ' ' B' ' 201' ' ' FES . 7.6 tmm? -69.7 -49.28 54.92 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.235 -0.916 . . . . 0.0 109.5 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -59.81 -41.71 91.87 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.619 -0.675 . . . . 0.0 109.913 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.1 -40.87 95.19 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.631 -0.668 . . . . 0.0 110.121 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . 0.73 ' HA ' HD12 ' B' ' 32' ' ' ILE . . . -68.33 -49.77 58.02 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.262 -0.899 . . . . 0.0 111.055 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 51.0 t -65.45 -39.12 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.349 -0.844 . . . . 0.0 110.744 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 15.8 t -70.15 -14.01 62.45 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.41 -0.806 . . . . 0.0 111.503 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -118.14 23.78 11.39 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.024 -1.048 . . . . 0.0 110.664 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.72 38.23 58.67 Favored Glycine 0 N--CA 1.493 2.469 0 O-C-N 121.532 -0.73 . . . . 0.0 111.876 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.73 HD12 ' HA ' ' B' ' 27' ' ' ALA . 1.7 mt -72.49 147.11 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.882 -1.364 . . . . 0.0 108.887 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.66 142.44 58.08 Favored 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 117.214 2.302 . . . . 0.0 117.214 -174.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 62.29 -36.18 0.12 Allowed 'General case' 0 N--CA 1.516 2.831 0 N-CA-C 116.612 2.079 . . . . 0.0 116.612 175.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 84.2 mt -59.67 122.85 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.401 0 O-C-N 119.85 -1.781 . . . . 0.0 110.672 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.535 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 84.4 t -100.15 -51.39 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.595 -0.691 . . . . 0.0 111.237 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . 0.623 ' HA2' ' S2 ' ' B' ' 201' ' ' FES . . . 63.15 56.48 20.18 Favored Glycine 0 N--CA 1.499 2.866 0 N-CA-C 107.472 -2.251 . . . . 0.0 107.472 -178.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -71.32 -49.33 43.73 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.985 -0.715 . . . . 0.0 112.259 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' CYS . . . . . 0.583 ' O ' HD13 ' A' ' 356' ' ' LEU . 2.3 p -66.5 -10.49 45.2 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.201 -0.937 . . . . 0.0 112.351 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . 0.454 ' CA ' HD22 ' A' ' 356' ' ' LEU . . . 96.81 -5.45 64.01 Favored Glycine 0 N--CA 1.497 2.731 0 O-C-N 120.825 -1.172 . . . . 0.0 111.973 177.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.07 19.57 10.63 Favored Glycine 0 N--CA 1.495 2.584 0 O-C-N 120.77 -1.429 . . . . 0.0 110.985 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 87.1 p -99.02 19.23 15.51 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.054 -1.263 . . . . 0.0 111.141 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.94 40.85 30.41 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.383 -0.823 . . . . 0.0 111.918 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.0 11.14 14.2 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.31 -0.868 . . . . 0.0 109.562 178.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' CYS . . . . . 0.694 ' HG ' 'FE1 ' ' B' ' 201' ' ' FES . 15.1 p -149.48 -179.1 6.82 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.522 -0.736 . . . . 0.0 109.102 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.06 34.09 3.1 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.86 -1.15 . . . . 0.0 111.411 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' THR . . . . . 0.535 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 72.7 p -97.6 13.31 30.57 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.962 -1.086 . . . . 0.0 111.299 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' CYS . . . . . 0.441 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.3 p -120.58 31.74 6.31 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 23.9 t-160 -72.67 133.08 44.45 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.589 -178.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.2 m -146.29 160.06 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . 0.413 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.4 m-85 -105.39 102.7 12.16 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.265 -0.897 . . . . 0.0 108.721 178.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.7 t -61.84 135.08 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 121.321 -0.862 . . . . 0.0 109.354 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.61 131.77 51.23 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.983 0.897 . . . . 0.0 109.542 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.416 ' H ' ' CD ' ' B' ' 54' ' ' GLU . 11.0 mp0 -44.3 -31.06 0.92 Allowed 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -178.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.77 -6.92 54.23 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.017 -1.052 . . . . 0.0 112.75 -178.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -119.89 -6.71 10.04 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 120.488 -1.383 . . . . 0.0 111.884 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.5 p -55.38 -37.83 68.07 Favored 'General case' 0 N--CA 1.507 2.406 0 O-C-N 121.173 -0.955 . . . . 0.0 112.835 -178.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 -81.14 -6.66 59.08 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.728 -1.232 . . . . 0.0 111.426 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -89.9 -11.57 41.47 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.033 -1.042 . . . . 0.0 109.872 178.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -104.08 141.02 21.65 Favored Pre-proline 0 N--CA 1.488 1.462 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.79 118.84 5.61 Favored 'Trans proline' 0 N--CA 1.488 1.173 0 O-C-N 123.448 1.236 . . . . 0.0 109.026 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.87 160.61 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.77 0 N-CA-C 116.692 2.108 . . . . 0.0 116.692 -177.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.614 ' HB1' ' HB3' ' B' ' 67' ' ' GLU . . . -65.82 146.13 55.13 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.245 178.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -89.7 -170.78 2.94 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.589 -0.694 . . . . 0.0 110.428 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -59.56 -41.98 91.4 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.321 -0.862 . . . . 0.0 111.748 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.41 -41.57 84.69 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.186 -0.946 . . . . 0.0 112.043 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.623 ' HG3' HD12 ' B' ' 84' ' ' LEU . 45.4 tt0 -68.19 -44.03 76.79 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.98 -1.075 . . . . 0.0 110.317 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . 0.527 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.6 mm -55.56 -42.21 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.285 -0.884 . . . . 0.0 109.326 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.16 -47.88 80.71 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 12.5 mmt -66.22 -33.91 76.83 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.273 -1.133 . . . . 0.0 111.182 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . 0.432 ' HA ' HD23 ' B' ' 71' ' ' LEU . 27.9 mt -63.48 -23.33 67.35 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.214 -0.928 . . . . 0.0 110.616 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 49.9 mt-10 -70.44 -8.76 53.46 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.366 -0.834 . . . . 0.0 110.875 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 82.7 p -119.83 12.56 12.14 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.053 -1.029 . . . . 0.0 112.548 -178.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 22.3 m -60.76 140.35 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 120.739 -1.225 . . . . 0.0 109.668 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 13.9 m -74.53 -39.02 62.62 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.449 -0.782 . . . . 0.0 110.195 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.24 168.81 17.5 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.428 -0.795 . . . . 0.0 110.106 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.28 139.11 55.75 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.388 -0.82 . . . . 0.0 110.563 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.3 tp -90.93 116.14 28.51 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.494 -0.754 . . . . 0.0 109.935 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -102.99 168.35 8.93 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -76.64 0.01 10.01 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 O-C-N 123.219 1.115 . . . . 0.0 110.434 178.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -120.5 22.38 11.27 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.941 -1.099 . . . . 0.0 108.406 176.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 4.3 m -80.81 137.21 36.21 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.832 -0.542 . . . . 0.0 110.367 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.3 mmm-85 -149.78 146.42 27.16 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 120.059 -0.657 . . . . 0.0 111.448 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.623 HD12 ' HG3' ' B' ' 67' ' ' GLU . 95.9 mt -80.61 98.97 7.89 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 104.784 -2.302 . . . . 0.0 104.784 175.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' CYS . . . . . 0.41 ' HB2' ' HB2' ' B' ' 23' ' ' LEU . 10.6 p -48.36 -17.86 0.18 Allowed 'General case' 0 N--CA 1.508 2.443 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -175.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.8 p -70.33 -14.0 62.39 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.669 -1.269 . . . . 0.0 109.389 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 59.2 mm-40 -92.72 -12.23 31.92 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.512 -0.742 . . . . 0.0 110.534 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 61.7 mt -91.52 103.97 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.194 -0.941 . . . . 0.0 110.647 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 45.7 mm -85.03 131.75 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 13.6 tpt -74.82 137.76 42.11 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 122.101 0.953 . . . . 0.0 113.243 -177.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 43.6 p -138.16 166.61 24.62 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 176.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -74.98 1.78 7.35 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 122.663 0.823 . . . . 0.0 111.025 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -87.67 -22.81 24.45 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 176.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.3 mt -93.8 13.04 23.69 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.427 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.5 126.4 23.4 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.122 -0.986 . . . . 0.0 111.142 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.22 6.79 68.45 Favored Glycine 0 N--CA 1.492 2.416 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.725 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.61 142.75 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 CA-C-N 119.263 1.532 . . . . 0.0 110.789 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' VAL . . . . . 0.471 HG22 ' HB ' ' B' ' 4' ' ' VAL . 60.9 t -122.49 132.96 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.561 -0.712 . . . . 0.0 109.856 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 16.5 m -130.33 135.73 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.47 -0.769 . . . . 0.0 109.877 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' ASP . . . . . 0.413 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.38 134.14 35.22 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.6 t -103.33 127.31 29.96 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.535 -0.728 . . . . 0.0 110.377 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -80.9 131.0 7.79 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 O-C-N 124.079 1.568 . . . . 0.0 108.286 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' ASP . . . . . 0.422 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.4 p-10 -62.47 3.44 0.2 Allowed 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -178.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -125.28 114.64 19.2 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.288 -1.508 . . . . 0.0 110.088 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . 0.505 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 32.6 mm-40 -113.31 -49.35 2.91 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.455 -0.778 . . . . 0.0 110.007 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' TRP . . . . . 0.528 ' CG ' ' HB2' ' A' ' 113' ' ' ALA . 10.3 m0 . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.53 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 501' ' ' HEM . . . . . 0.949 ' O2D' ' O ' ' A' ' 100' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 502' ' ' CAM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 201' ' ' FES . . . . . 0.694 'FE1 ' ' HG ' ' B' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.514 HD12 ' HD2' ' A' ' 15' ' ' PRO . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 14' ' ' LEU . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.419 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HG2' HG12 ' A' ' 54' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.569 HG12 ' HG2' ' A' ' 51' ' ' PRO . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.609 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.8 m120 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.609 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 64' ' ' ILE . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.435 ' HA ' HD23 ' A' ' 324' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.0 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.6 mtt180 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.5 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.552 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 25.8 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 84.1 mtt-85 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.8 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.64 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.1 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.556 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.717 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.717 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 1.068 HD11 ' CZ ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.949 ' O ' ' O2D' ' A' ' 501' ' ' HEM . 74.3 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.64 ' O ' ' HB3' ' A' ' 83' ' ' SER . 3.9 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 46.0 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.605 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.298 63.0 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.552 ' HD2' ' CD1' ' A' ' 78' ' ' TYR 0.367 53.3 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.605 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 33.9 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.452 ' H ' ' CD ' ' A' ' 106' ' ' PRO 0.413 34.1 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 15.6 tpt85 -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 5.5 ttt-85 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.478 ' HB2' ' CE3' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.766 HD11 ' HA3' ' A' ' 226' ' ' GLY . 4.2 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.546 ' O ' HG22 ' A' ' 119' ' ' VAL . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.539 ' HA ' ' CD2' ' A' ' 358' ' ' LEU . 23.3 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.603 ' HA ' HG21 ' A' ' 123' ' ' VAL . 35.0 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.595 HG13 HG23 ' A' ' 118' ' ' VAL . 30.6 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.493 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.698 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 12.4 mtm -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.698 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.1 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.603 HG21 ' HA ' ' A' ' 118' ' ' VAL . 72.7 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.2 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.455 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.63 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.412 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.595 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 151' ' ' THR . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.799 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.799 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.441 ' O ' ' HG2' ' A' ' 164' ' ' MET . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.578 ' C ' HD23 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.455 ' N ' HD23 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.425 ' N ' ' HD2' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' HIS . . . . . 0.405 ' O ' ' HG ' ' A' ' 180' ' ' LEU . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.574 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 176' ' ' HIS . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.561 ' HA ' ' HE3' ' A' ' 184' ' ' MET . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . 0.561 ' HE3' ' HA ' ' A' ' 181' ' ' THR . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.421 HD22 ' HE1' ' A' ' 184' ' ' MET . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.453 ' HG3' ' HB1' ' A' ' 224' ' ' ALA . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 220' ' ' ILE . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 43.5 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 42.0 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.453 ' HB1' ' HG3' ' A' ' 212' ' ' ARG . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.766 ' HA3' HD11 ' A' ' 114' ' ' LEU . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 6.9 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 2.6 m120 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 17.1 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 1.068 ' CZ ' HD11 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 34.2 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.717 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.487 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' MET . . . . . 0.595 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 16.4 pm0 -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.437 ' N ' ' HD2' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' CYS . . . . . . . . . . . . . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 288' ' ' LEU . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.706 HD23 ' H ' ' A' ' 294' ' ' LEU . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.502 HG11 HMA3 ' A' ' 501' ' ' HEM . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . 0.513 ' OD2' ' O2A' ' A' ' 501' ' ' HEM . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . 0.419 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . 0.419 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.0 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.459 ' HA ' HD13 ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 314' ' ' LYS . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.6 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' HIS . . . . . 0.425 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 36.9 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 303' ' ' SER . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 318' ' ' ILE . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . 0.647 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . 0.68 ' HG2' HD22 ' A' ' 324' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.68 HD22 ' HG2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 14.7 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 327' ' ' LEU . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.522 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' PRO . . . . . 0.522 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 99.3 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 8.8 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 45.1 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' THR . . . . . . . . . . . . . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . 0.413 ' O ' HD12 ' A' ' 356' ' ' LEU . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 91.4 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' LEU . . . . . 0.57 HD13 ' O ' ' B' ' 39' ' ' CYS . 0.3 OUTLIER -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . 0.539 ' CD2' ' HA ' ' A' ' 116' ' ' ASN . 0.6 OUTLIER -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 44.1 mtt85 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 16.6 tpp85 -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.2 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 N--CA 1.495 1.815 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.49 138.58 38.5 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.181 -0.949 . . . . 0.0 112.936 -178.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.744 HG11 HD22 ' B' ' 23' ' ' LEU . 61.3 t -137.12 122.59 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 177.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.526 HG11 ' CZ ' ' B' ' 12' ' ' ARG . 97.8 t -106.79 129.56 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.109 -0.994 . . . . 0.0 111.635 -178.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.504 ' CG ' HD13 ' B' ' 32' ' ' ILE . 77.1 m-85 -109.23 110.63 21.89 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 40.0 t -94.84 127.25 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.88 -1.138 . . . . 0.0 108.345 178.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.4 m -86.15 174.69 8.97 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.747 0.784 . . . . 0.0 112.499 -177.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.427 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.68 -46.8 88.99 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-O 121.129 0.49 . . . . 0.0 110.418 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -65.83 -11.29 45.24 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.56 -0.712 . . . . 0.0 111.405 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.94 15.47 28.53 Favored Glycine 0 N--CA 1.492 2.368 0 O-C-N 121.163 -0.961 . . . . 0.0 111.312 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.1 m -82.09 147.4 29.12 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 118.723 1.261 . . . . 0.0 109.875 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . 0.526 ' CZ ' HG11 ' B' ' 4' ' ' VAL . 50.8 ttt85 -118.46 128.82 54.97 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.476 -0.765 . . . . 0.0 111.803 -178.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' B' ' 13' ' ' ARG . 0.0 OUTLIER -126.08 127.73 46.27 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.608 -0.683 . . . . 0.0 109.8 179.084 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.3 tt0 -111.37 130.61 55.63 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.236 -0.915 . . . . 0.0 111.623 -178.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 84.5 mt -122.8 159.38 28.21 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.732 -0.605 . . . . 0.0 111.075 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -109.63 91.63 3.72 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.8 t -90.2 133.47 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-O 121.625 0.726 . . . . 0.0 112.233 -176.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.09 170.7 16.05 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.784 -0.572 . . . . 0.0 110.266 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -68.47 151.79 46.31 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.503 -0.748 . . . . 0.0 110.965 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.5 -12.52 55.53 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.021 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 91.4 t -89.97 133.36 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 120.696 -1.473 . . . . 0.0 110.933 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 88.5 p -80.25 151.86 29.38 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.523 -0.736 . . . . 0.0 109.129 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.744 HD22 HG11 ' B' ' 3' ' ' VAL . 18.4 mt -61.2 -24.68 66.5 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.29 -0.881 . . . . 0.0 110.549 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . 0.406 ' SD ' ' S2 ' ' B' ' 201' ' ' FES . 2.1 ttp -69.7 -49.24 55.27 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.186 -0.946 . . . . 0.0 109.474 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.81 -41.7 91.82 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.622 -0.674 . . . . 0.0 109.926 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.13 -40.87 95.05 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.607 -0.683 . . . . 0.0 110.099 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . 0.583 ' HA ' HD12 ' B' ' 32' ' ' ILE . . . -68.33 -49.79 57.89 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.254 -0.903 . . . . 0.0 111.023 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 71.8 t -65.41 -39.19 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.266 -0.896 . . . . 0.0 110.737 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 15.5 t -70.06 -14.08 62.51 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.342 -0.849 . . . . 0.0 111.562 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -118.13 23.84 11.36 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.016 -1.052 . . . . 0.0 110.658 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.65 38.31 58.55 Favored Glycine 0 N--CA 1.492 2.418 0 O-C-N 121.539 -0.725 . . . . 0.0 111.85 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.583 HD12 ' HA ' ' B' ' 27' ' ' ALA . 0.4 OUTLIER -72.55 147.13 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.829 -1.395 . . . . 0.0 108.875 178.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -62.7 142.52 58.08 Favored 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 -174.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 62.19 -36.14 0.12 Allowed 'General case' 0 N--CA 1.515 2.785 0 N-CA-C 116.693 2.108 . . . . 0.0 116.693 175.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.524 HD12 ' CG2' ' B' ' 32' ' ' ILE . 12.1 mt -59.7 122.9 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 O-C-N 119.879 -1.763 . . . . 0.0 110.656 -178.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.663 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 58.0 t -100.14 -51.41 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.626 -0.671 . . . . 0.0 111.192 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . 0.623 ' HA2' ' S2 ' ' B' ' 201' ' ' FES . . . 63.17 56.42 20.52 Favored Glycine 0 N--CA 1.499 2.895 0 N-CA-C 107.478 -2.249 . . . . 0.0 107.478 -178.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -71.29 -49.28 44.51 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.983 -0.716 . . . . 0.0 112.279 -177.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' CYS . . . . . 0.57 ' O ' HD13 ' A' ' 356' ' ' LEU . 2.3 p -66.55 -10.48 45.57 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.209 -0.932 . . . . 0.0 112.351 -178.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.82 -5.59 64.08 Favored Glycine 0 N--CA 1.499 2.846 0 O-C-N 120.808 -1.183 . . . . 0.0 112.013 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.16 19.56 10.59 Favored Glycine 0 N--CA 1.495 2.628 0 O-C-N 120.856 -1.379 . . . . 0.0 110.98 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 9.4 t -98.98 19.14 15.63 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.072 -1.251 . . . . 0.0 111.147 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.98 40.84 30.34 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.45 -0.781 . . . . 0.0 111.935 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . 0.429 ' OG ' ' HB2' ' B' ' 39' ' ' CYS . 2.1 p -117.04 11.23 14.19 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.301 -0.875 . . . . 0.0 109.547 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' CYS . . . . . 0.691 ' HG ' 'FE1 ' ' B' ' 201' ' ' FES . 15.0 p -149.55 -179.11 6.83 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.04 34.08 3.11 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.879 -1.138 . . . . 0.0 111.339 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' THR . . . . . 0.663 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 23.0 p -97.6 13.24 30.81 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.978 -1.076 . . . . 0.0 111.268 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' CYS . . . . . 0.444 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.1 p -120.55 31.74 6.31 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 177.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 23.9 t-160 -72.68 133.01 44.42 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.612 -178.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.4 m -146.24 160.14 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . 0.414 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.5 m-85 -105.46 102.76 12.21 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.262 -0.899 . . . . 0.0 108.699 178.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.2 t -61.92 135.13 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 121.296 -0.878 . . . . 0.0 109.34 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.64 131.7 51.03 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.945 0.878 . . . . 0.0 109.525 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.413 ' H ' ' CD ' ' B' ' 54' ' ' GLU . 11.1 mp0 -44.21 -31.12 0.9 Allowed 'General case' 0 N--CA 1.506 2.343 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -178.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.73 -6.93 54.23 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.019 -1.051 . . . . 0.0 112.796 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -119.92 -6.68 10.03 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 120.416 -1.427 . . . . 0.0 111.86 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.4 p -55.39 -37.85 68.12 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.132 -0.98 . . . . 0.0 112.846 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -81.1 -6.66 59.07 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.711 -1.243 . . . . 0.0 111.49 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -89.88 -11.61 41.4 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.986 -1.071 . . . . 0.0 109.848 178.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.8 t -104.08 141.01 21.63 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -73.77 118.84 5.61 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 O-C-N 123.496 1.261 . . . . 0.0 108.983 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.9 160.59 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.75 0 N-CA-C 116.656 2.095 . . . . 0.0 116.656 -177.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.615 ' HB1' ' HB3' ' B' ' 67' ' ' GLU . . . -65.73 146.14 55.14 Favored 'General case' 0 N--CA 1.503 2.178 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.266 178.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -89.78 -170.81 2.94 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.602 -0.686 . . . . 0.0 110.383 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -59.54 -42.02 91.39 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.329 -0.857 . . . . 0.0 111.708 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.45 -41.52 84.57 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.158 -0.964 . . . . 0.0 112.045 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.615 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 45.5 tt0 -68.21 -43.92 76.93 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.954 -1.091 . . . . 0.0 110.343 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . 0.529 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.6 mm -55.63 -42.08 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.278 -0.889 . . . . 0.0 109.379 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.24 -47.87 80.44 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 28.5 mmt -66.17 -33.97 76.98 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.275 -1.132 . . . . 0.0 111.226 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . 0.447 ' HA ' HD23 ' B' ' 71' ' ' LEU . 28.1 mt -63.47 -23.33 67.35 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.217 -0.927 . . . . 0.0 110.622 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . 0.529 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 66.4 mt-10 -70.41 -8.72 53.02 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.339 -0.851 . . . . 0.0 110.926 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 84.8 p -119.91 12.6 12.09 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.008 -1.057 . . . . 0.0 112.461 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 19.4 m -60.84 140.44 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 O-C-N 120.692 -1.255 . . . . 0.0 109.653 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 25.4 m -74.58 -39.09 62.45 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.387 -0.821 . . . . 0.0 110.153 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.18 168.83 17.4 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.464 -0.773 . . . . 0.0 110.073 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.28 139.16 55.67 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.395 -0.815 . . . . 0.0 110.587 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.4 tp -90.95 116.11 28.5 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.498 -0.751 . . . . 0.0 109.907 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -102.94 168.37 8.91 Favored Pre-proline 0 C--N 1.302 -1.5 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -76.71 0.04 9.99 Favored 'Trans proline' 0 C--N 1.314 -1.255 0 O-C-N 123.279 1.147 . . . . 0.0 110.371 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -120.5 22.3 11.3 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.969 -1.082 . . . . 0.0 108.411 176.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 4.3 m -80.77 137.25 36.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.845 -0.534 . . . . 0.0 110.35 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.5 mmm-85 -149.77 146.41 27.16 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.446 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.444 ' HB3' ' SG ' ' B' ' 48' ' ' CYS . 78.4 mt -80.55 99.0 7.86 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 175.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' CYS . . . . . 0.405 ' HB2' ' HB2' ' B' ' 23' ' ' LEU . 11.3 p -48.5 -17.82 0.19 Allowed 'General case' 0 N--CA 1.508 2.439 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -175.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.8 p -70.28 -13.99 62.4 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.714 -1.241 . . . . 0.0 109.459 178.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -92.73 -12.25 31.87 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.489 -0.757 . . . . 0.0 110.545 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 61.7 mt -91.47 104.02 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.195 -0.941 . . . . 0.0 110.625 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 39.2 mm -85.04 131.78 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 13.8 tpt -74.85 137.84 42.1 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 122.126 0.965 . . . . 0.0 113.229 -177.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 43.7 p -138.23 166.57 24.8 Favored Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 176.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -74.92 1.71 7.39 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 O-C-N 122.683 0.833 . . . . 0.0 111.042 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -87.64 -22.82 24.48 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 176.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.7 mt -93.75 12.96 23.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.982 -0.449 . . . . 0.0 110.422 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -54.48 126.36 23.21 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.111 -0.993 . . . . 0.0 111.164 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.21 6.89 68.34 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.669 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.68 142.79 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 CA-C-N 119.36 1.58 . . . . 0.0 110.715 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' VAL . . . . . 0.48 HG22 ' HB ' ' B' ' 4' ' ' VAL . 60.7 t -122.53 133.01 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.532 -0.73 . . . . 0.0 109.819 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 16.5 m -130.41 135.78 59.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.489 -0.757 . . . . 0.0 109.798 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' ASP . . . . . 0.414 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.44 134.17 35.2 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.7 t -103.39 127.27 30.01 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.5 -0.75 . . . . 0.0 110.368 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -80.77 130.92 7.89 Favored 'Trans proline' 0 C--N 1.316 -1.168 0 O-C-N 124.064 1.56 . . . . 0.0 108.268 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' ASP . . . . . 0.427 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.4 p-10 -62.42 3.42 0.19 Allowed 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -178.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 39.5 mtm180 -125.32 114.66 19.2 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.306 -1.496 . . . . 0.0 110.061 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . 0.502 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 62.7 mm-40 -113.3 -49.39 2.91 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.497 -0.752 . . . . 0.0 109.954 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' TRP . . . . . 0.522 ' HA ' ' CE3' ' B' ' 106' ' ' TRP . 4.9 m95 . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.522 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 501' ' ' HEM . . . . . 0.949 ' O2D' ' O ' ' A' ' 100' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 502' ' ' CAM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 201' ' ' FES . . . . . 0.691 'FE1 ' ' HG ' ' B' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.514 HD12 ' HD2' ' A' ' 15' ' ' PRO . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 14' ' ' LEU . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.419 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HG2' HG12 ' A' ' 54' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.569 HG12 ' HG2' ' A' ' 51' ' ' PRO . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.609 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.8 m120 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.609 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 64' ' ' ILE . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.435 ' HA ' HD23 ' A' ' 324' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.0 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.9 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.5 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.484 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 24.3 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.5 mtm180 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.64 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.2 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.556 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.717 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.717 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 1.068 HD11 ' CZ ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.949 ' O ' ' O2D' ' A' ' 501' ' ' HEM . 74.3 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.64 ' O ' ' HB3' ' A' ' 83' ' ' SER . 3.9 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 46.0 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.647 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.296 50.1 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 104' ' ' ASP 0.366 52.6 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.647 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 35.0 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.452 ' H ' ' CG ' ' A' ' 106' ' ' PRO 0.413 34.1 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.772 ' NH1' ' CBD' ' A' ' 501' ' ' HEM . 6.7 mtp180 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.789 ' HB2' ' CD2' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.685 HD11 ' HA3' ' A' ' 226' ' ' GLY . 24.8 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.546 ' O ' HG22 ' A' ' 119' ' ' VAL . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.603 ' HA ' HG21 ' A' ' 123' ' ' VAL . 35.1 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.593 HG13 HG23 ' A' ' 118' ' ' VAL . 30.6 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.493 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.697 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 37.1 mtm -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.697 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.1 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.603 HG21 ' HA ' ' A' ' 118' ' ' VAL . 72.0 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.7 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.452 ' HD2' ' HA ' ' A' ' 123' ' ' VAL . 35.6 mttt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.455 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.63 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.412 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.595 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 151' ' ' THR . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.799 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.799 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.441 ' O ' ' HG2' ' A' ' 164' ' ' MET . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.578 ' C ' HD23 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.455 ' N ' HD23 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.425 ' N ' ' HD2' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' HIS . . . . . 0.405 ' O ' ' HG ' ' A' ' 180' ' ' LEU . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.574 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 176' ' ' HIS . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.561 ' HA ' ' HE3' ' A' ' 184' ' ' MET . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . 0.561 ' HE3' ' HA ' ' A' ' 181' ' ' THR . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.421 HD22 ' HE1' ' A' ' 184' ' ' MET . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.453 ' HG3' ' HB1' ' A' ' 224' ' ' ALA . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 220' ' ' ILE . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 33.3 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 53.1 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.453 ' HB1' ' HG3' ' A' ' 212' ' ' ARG . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.685 ' HA3' HD11 ' A' ' 114' ' ' LEU . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 4.6 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 1.1 m120 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 18.1 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 1.068 ' CZ ' HD11 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 45.4 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.717 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.487 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' MET . . . . . 0.595 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.437 ' N ' ' HD2' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' CYS . . . . . . . . . . . . . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 288' ' ' LEU . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.706 HD23 ' H ' ' A' ' 294' ' ' LEU . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.502 HG11 HMA3 ' A' ' 501' ' ' HEM . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . 0.513 ' OD2' ' O2A' ' A' ' 501' ' ' HEM . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . 0.419 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . 0.419 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.0 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.459 ' HA ' HD13 ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 314' ' ' LYS . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.6 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' HIS . . . . . 0.425 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 36.9 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 303' ' ' SER . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 318' ' ' ILE . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . 0.647 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . 0.68 ' HG2' HD22 ' A' ' 324' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.68 HD22 ' HG2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 13.7 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 327' ' ' LEU . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.522 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' PRO . . . . . 0.522 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . 0.466 ' CB ' ' HD3' ' A' ' 344' ' ' LYS . 1.9 mp0 -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' LYS . . . . . 0.524 ' HB2' ' HE2' ' A' ' 344' ' ' LYS . 1.5 mppt? -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 60.6 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 28.9 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 14.2 p80 -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 39.6 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' THR . . . . . . . . . . . . . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 99.6 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' LEU . . . . . 0.681 HD12 ' O ' ' B' ' 39' ' ' CYS . 0.1 OUTLIER -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . 0.424 HD12 HBD2 ' A' ' 501' ' ' HEM . 2.9 mt -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 35.9 mtt85 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 N--CA 1.496 1.853 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.49 138.62 38.53 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.226 -0.921 . . . . 0.0 112.939 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.738 HG11 HD22 ' B' ' 23' ' ' LEU . 61.3 t -137.13 122.59 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.528 HG11 ' CZ ' ' B' ' 12' ' ' ARG . 97.4 t -106.81 129.54 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.149 -0.969 . . . . 0.0 111.654 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.511 ' CG ' HD13 ' B' ' 32' ' ' ILE . 77.2 m-85 -109.19 110.53 21.77 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.78 127.25 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.922 -1.111 . . . . 0.0 108.421 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.9 m -86.19 174.64 8.98 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.782 0.801 . . . . 0.0 112.481 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.427 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.61 -46.73 89.17 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-O 121.145 0.497 . . . . 0.0 110.467 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -65.94 -11.29 46.33 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.552 -0.718 . . . . 0.0 111.416 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.02 15.5 28.25 Favored Glycine 0 N--CA 1.492 2.421 0 O-C-N 121.103 -0.998 . . . . 0.0 111.218 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.3 m -82.14 147.36 29.08 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 118.773 1.286 . . . . 0.0 109.874 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . 0.528 ' CZ ' HG11 ' B' ' 4' ' ' VAL . 50.9 ttt85 -118.46 128.75 54.9 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.434 -0.791 . . . . 0.0 111.832 -178.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' B' ' 13' ' ' ARG . 0.0 OUTLIER -126.04 127.68 46.24 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.575 -0.703 . . . . 0.0 109.792 179.11 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -111.29 130.62 55.61 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.282 -0.887 . . . . 0.0 111.64 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 84.5 mt -122.77 159.39 28.13 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.741 -0.6 . . . . 0.0 111.107 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -109.66 91.65 3.73 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 176.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.5 t -90.17 133.4 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 CA-C-O 121.605 0.717 . . . . 0.0 112.271 -176.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.13 170.67 16.11 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.812 -0.555 . . . . 0.0 110.257 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -68.36 151.78 46.38 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.491 -0.756 . . . . 0.0 111.01 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.46 -12.46 55.52 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.997 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 60.1 t -89.97 133.27 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 120.691 -1.476 . . . . 0.0 110.932 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 21.2 p -80.22 151.89 29.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.544 -0.723 . . . . 0.0 109.142 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.738 HD22 HG11 ' B' ' 3' ' ' VAL . 18.5 mt -61.15 -24.64 66.44 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.362 -0.836 . . . . 0.0 110.619 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . 0.478 ' SD ' ' S2 ' ' B' ' 201' ' ' FES . 6.3 ttp -69.76 -49.24 54.9 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.212 -0.93 . . . . 0.0 109.463 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -59.85 -41.65 91.88 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.583 -0.698 . . . . 0.0 109.921 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.16 -40.85 94.9 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.606 -0.684 . . . . 0.0 110.082 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . 0.578 ' HA ' HD12 ' B' ' 32' ' ' ILE . . . -68.32 -49.73 58.31 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.207 -0.933 . . . . 0.0 111.079 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 81.7 t -65.5 -39.18 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.333 -0.854 . . . . 0.0 110.7 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 21.4 t -70.1 -14.04 62.48 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.386 -0.822 . . . . 0.0 111.564 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -118.12 23.82 11.37 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.027 -1.046 . . . . 0.0 110.653 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.66 38.22 58.4 Favored Glycine 0 N--CA 1.493 2.46 0 O-C-N 121.52 -0.737 . . . . 0.0 111.872 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.578 HD12 ' HA ' ' B' ' 27' ' ' ALA . 0.4 OUTLIER -72.52 147.18 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.859 -1.377 . . . . 0.0 108.869 179.01 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.67 142.51 58.05 Favored 'General case' 0 N--CA 1.503 2.217 0 N-CA-C 117.169 2.285 . . . . 0.0 117.169 -174.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 62.21 -36.14 0.12 Allowed 'General case' 0 N--CA 1.516 2.835 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 175.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 23.1 mt -59.69 122.87 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 O-C-N 119.928 -1.732 . . . . 0.0 110.665 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.61 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 52.5 t -100.07 -51.47 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.633 -0.667 . . . . 0.0 111.248 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . 0.629 ' HA2' ' S2 ' ' B' ' 201' ' ' FES . . . 63.1 56.51 20.14 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 107.459 -2.256 . . . . 0.0 107.459 -178.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -71.27 -49.33 44.16 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.958 -0.731 . . . . 0.0 112.296 -177.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' CYS . . . . . 0.681 ' O ' HD12 ' A' ' 356' ' ' LEU . 2.3 p -66.56 -10.42 45.12 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.249 -0.907 . . . . 0.0 112.359 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . 0.516 ' HA3' HD12 ' A' ' 356' ' ' LEU . . . 96.79 -5.53 64.11 Favored Glycine 0 N--CA 1.498 2.779 0 O-C-N 120.763 -1.211 . . . . 0.0 111.985 177.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.16 19.52 10.62 Favored Glycine 0 N--CA 1.495 2.608 0 O-C-N 120.883 -1.363 . . . . 0.0 110.965 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 1.3 t -98.95 19.11 15.64 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.032 -1.276 . . . . 0.0 111.142 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 56.0 40.84 30.32 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.358 -0.839 . . . . 0.0 111.934 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 57.8 m -117.0 11.17 14.21 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.318 -0.864 . . . . 0.0 109.533 178.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' CYS . . . . . 0.703 ' HG ' 'FE1 ' ' B' ' 201' ' ' FES . 15.1 p -149.56 -179.07 6.8 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.511 -0.743 . . . . 0.0 109.039 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.07 33.98 3.11 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.85 -1.156 . . . . 0.0 111.357 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' THR . . . . . 0.61 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 65.1 p -97.51 13.23 30.68 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.0 -1.063 . . . . 0.0 111.275 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' CYS . . . . . 0.444 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.1 p -120.57 31.78 6.29 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 177.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 23.9 t-160 -72.68 133.07 44.44 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.588 -178.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.3 m -146.29 160.06 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . 0.419 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.5 m-85 -105.45 102.73 12.19 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.239 -0.913 . . . . 0.0 108.74 178.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.1 t -61.9 135.17 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.269 -0.894 . . . . 0.0 109.348 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.67 131.75 51.2 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.961 0.886 . . . . 0.0 109.495 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.414 ' H ' ' CD ' ' B' ' 54' ' ' GLU . 11.0 mp0 -44.3 -30.99 0.9 Allowed 'General case' 0 N--CA 1.506 2.357 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -178.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.79 -6.92 54.29 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.013 -1.055 . . . . 0.0 112.726 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -119.95 -6.6 10.02 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 120.456 -1.402 . . . . 0.0 111.9 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.4 p -55.48 -37.73 68.2 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 121.155 -0.966 . . . . 0.0 112.892 -178.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -81.2 -6.59 59.03 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 120.743 -1.223 . . . . 0.0 111.44 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -89.89 -11.66 41.21 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.962 -1.087 . . . . 0.0 109.825 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 41.0 t -104.11 141.1 21.81 Favored Pre-proline 0 N--CA 1.488 1.458 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -73.82 118.87 5.61 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 O-C-N 123.485 1.255 . . . . 0.0 108.984 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.93 160.62 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.752 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 -177.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.616 ' HB1' ' HB3' ' B' ' 67' ' ' GLU . . . -65.78 146.2 55.06 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.222 178.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -89.76 -170.78 2.93 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.592 -0.693 . . . . 0.0 110.397 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -59.56 -41.99 91.39 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.377 -0.827 . . . . 0.0 111.739 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.47 -41.54 84.46 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.109 -0.994 . . . . 0.0 111.994 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.616 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 45.4 tt0 -68.23 -43.94 76.81 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.962 -1.086 . . . . 0.0 110.367 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . 0.527 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.7 mm -55.57 -42.18 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.292 -0.88 . . . . 0.0 109.37 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.17 -47.86 80.84 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 12.4 mmt -66.19 -33.98 77.0 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.256 -1.144 . . . . 0.0 111.162 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . 0.456 ' HA ' HD23 ' B' ' 71' ' ' LEU . 28.0 mt -63.45 -23.34 67.36 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.172 -0.955 . . . . 0.0 110.606 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 49.2 mt-10 -70.41 -8.75 53.24 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.345 -0.847 . . . . 0.0 110.938 179.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 56.3 p -119.85 12.57 12.13 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.003 -1.061 . . . . 0.0 112.517 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 16.4 m -60.81 140.43 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 120.661 -1.274 . . . . 0.0 109.618 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 41.1 m -74.57 -39.05 62.49 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.432 -0.792 . . . . 0.0 110.187 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.22 168.81 17.47 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.441 -0.787 . . . . 0.0 110.089 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.3 139.18 55.67 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.387 -0.821 . . . . 0.0 110.585 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.4 tp -91.02 116.19 28.6 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.497 -0.752 . . . . 0.0 109.879 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -102.99 168.37 8.9 Favored Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -76.64 -0.05 10.06 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 O-C-N 123.259 1.136 . . . . 0.0 110.404 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -120.5 22.39 11.27 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.001 -1.062 . . . . 0.0 108.375 176.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 4.3 m -80.84 137.2 36.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.833 -0.542 . . . . 0.0 110.359 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.4 mmm-85 -149.74 146.4 27.18 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 120.029 -0.669 . . . . 0.0 111.466 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.444 ' HB3' ' SG ' ' B' ' 48' ' ' CYS . 79.2 mt -80.49 98.97 7.8 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 175.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' CYS . . . . . 0.403 ' HB2' ' HB2' ' B' ' 23' ' ' LEU . 10.7 p -48.45 -17.9 0.19 Allowed 'General case' 0 N--CA 1.507 2.412 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -175.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.8 p -70.24 -13.99 62.42 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.65 -1.281 . . . . 0.0 109.472 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 48.6 mm-40 -92.75 -12.16 32.03 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.509 -0.744 . . . . 0.0 110.502 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . 0.404 HG21 HD13 ' B' ' 88' ' ' ILE . 61.8 mt -91.56 104.0 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.16 -0.962 . . . . 0.0 110.567 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 45.3 mm -85.01 131.78 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 13.6 tpt -74.83 137.81 42.11 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 122.166 0.984 . . . . 0.0 113.183 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 43.7 p -138.23 166.52 25.18 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 176.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -74.86 1.67 7.39 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 122.595 0.787 . . . . 0.0 111.026 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -87.65 -22.81 24.48 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 176.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.6 mt -93.78 12.97 23.85 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.408 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -54.52 126.39 23.44 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.175 -0.953 . . . . 0.0 111.161 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.22 6.86 68.36 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.64 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.64 142.75 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 CA-C-N 119.367 1.584 . . . . 0.0 110.714 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' VAL . . . . . 0.477 HG22 ' HB ' ' B' ' 4' ' ' VAL . 60.8 t -122.53 132.99 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.583 -0.698 . . . . 0.0 109.866 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 16.4 m -130.38 135.77 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.518 -0.739 . . . . 0.0 109.795 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' ASP . . . . . 0.419 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.43 134.15 35.22 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.8 t -103.39 127.26 30.02 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.517 -0.739 . . . . 0.0 110.377 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -80.84 130.97 7.84 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 O-C-N 124.118 1.588 . . . . 0.0 108.273 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' ASP . . . . . 0.427 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.3 p-10 -62.35 3.34 0.19 Allowed 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -178.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 39.5 mtm180 -125.29 114.66 19.22 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.237 -1.539 . . . . 0.0 110.09 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . 0.509 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 51.7 mm-40 -113.32 -49.38 2.91 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.436 -0.79 . . . . 0.0 109.979 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' TRP . . . . . 0.789 ' CD2' ' HB2' ' A' ' 113' ' ' ALA . 51.1 m95 . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.491 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 501' ' ' HEM . . . . . 0.949 ' O2D' ' O ' ' A' ' 100' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 502' ' ' CAM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 201' ' ' FES . . . . . 0.703 'FE1 ' ' HG ' ' B' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.514 HD12 ' HD2' ' A' ' 15' ' ' PRO . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 14' ' ' LEU . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.419 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HG2' HG12 ' A' ' 54' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.569 HG12 ' HG2' ' A' ' 51' ' ' PRO . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.609 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.8 m120 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.609 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 64' ' ' ILE . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.435 ' HA ' HD23 ' A' ' 324' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.9 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 45.7 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.6 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.402 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 29.5 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.9 mtm180 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.64 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.2 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.556 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.717 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.717 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 1.068 HD11 ' CZ ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.949 ' O ' ' O2D' ' A' ' 501' ' ' HEM . 67.8 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.64 ' O ' ' HB3' ' A' ' 83' ' ' SER . 3.9 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 45.3 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.647 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.296 50.2 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 104' ' ' ASP 0.366 52.7 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.647 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 35.0 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.452 ' H ' ' CG ' ' A' ' 106' ' ' PRO 0.372 31.8 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.53 ' HG2' HD11 ' A' ' 358' ' ' LEU . 3.3 mtp180 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.568 ' HB2' ' CG ' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.744 HD11 ' HA3' ' A' ' 226' ' ' GLY . 6.8 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.546 ' O ' HG22 ' A' ' 119' ' ' VAL . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.603 ' HA ' HG21 ' A' ' 123' ' ' VAL . 35.1 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.593 HG13 HG23 ' A' ' 118' ' ' VAL . 30.6 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.493 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.698 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 26.7 mtm -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.698 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.1 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.603 HG21 ' HA ' ' A' ' 118' ' ' VAL . 69.2 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 54.1 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 29.8 mtmt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.455 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.63 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.412 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.595 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 151' ' ' THR . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.799 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.799 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.441 ' O ' ' HG2' ' A' ' 164' ' ' MET . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.578 ' C ' HD23 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.455 ' N ' HD23 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.425 ' N ' ' HD2' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' HIS . . . . . 0.405 ' O ' ' HG ' ' A' ' 180' ' ' LEU . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.574 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 176' ' ' HIS . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.561 ' HA ' ' HE3' ' A' ' 184' ' ' MET . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . 0.561 ' HE3' ' HA ' ' A' ' 181' ' ' THR . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.421 HD22 ' HE1' ' A' ' 184' ' ' MET . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.453 ' HG3' ' HB1' ' A' ' 224' ' ' ALA . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 220' ' ' ILE . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' A' ' 222' ' ' ILE . 26.5 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 42.0 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.453 ' HB1' ' HG3' ' A' ' 212' ' ' ARG . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.744 ' HA3' HD11 ' A' ' 114' ' ' LEU . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 4.0 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 1.2 m120 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 17.1 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 1.068 ' CZ ' HD11 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 35.4 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.717 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.487 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' MET . . . . . 0.595 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 8.7 pm0 -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.437 ' N ' ' HD2' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' CYS . . . . . . . . . . . . . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 288' ' ' LEU . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.706 HD23 ' H ' ' A' ' 294' ' ' LEU . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.502 HG11 HMA3 ' A' ' 501' ' ' HEM . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . 0.513 ' OD2' ' O2A' ' A' ' 501' ' ' HEM . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . 0.419 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . 0.419 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.0 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.459 ' HA ' HD13 ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 314' ' ' LYS . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' PHE . . . . . 0.428 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.4 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' HIS . . . . . 0.428 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 41.4 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 303' ' ' SER . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 318' ' ' ILE . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . 0.647 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . 0.68 ' HG2' HD22 ' A' ' 324' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.68 HD22 ' HG2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 39.5 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 327' ' ' LEU . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.522 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' PRO . . . . . 0.522 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 92.5 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 1.3 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 47.2 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' THR . . . . . . . . . . . . . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 62.6 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 91.7 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' LEU . . . . . 0.544 HD13 ' O ' ' B' ' 39' ' ' CYS . 1.1 tp -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . 0.53 HD11 ' HG2' ' A' ' 112' ' ' ARG . 1.6 mt -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 9.6 mtm180 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 14.2 tpp85 -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 40.1 m . . . . . 0 N--CA 1.496 1.832 0 N-CA-C 109.713 -0.476 . . . . 0.0 109.713 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.46 138.56 38.52 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.211 -0.931 . . . . 0.0 112.94 -178.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.735 HG11 HD22 ' B' ' 23' ' ' LEU . 61.0 t -137.1 122.5 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 177.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.521 HG11 ' CZ ' ' B' ' 12' ' ' ARG . 97.6 t -106.77 129.58 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.131 -0.981 . . . . 0.0 111.622 -178.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -109.22 110.62 21.87 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 39.7 t -94.85 127.22 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.886 -1.133 . . . . 0.0 108.382 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.5 m -86.17 174.67 8.97 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.752 0.786 . . . . 0.0 112.534 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.423 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.65 -46.77 89.05 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 121.136 0.493 . . . . 0.0 110.428 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -65.85 -11.32 45.67 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.556 -0.715 . . . . 0.0 111.463 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.0 15.49 28.32 Favored Glycine 0 N--CA 1.492 2.376 0 O-C-N 121.166 -0.959 . . . . 0.0 111.273 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.3 m -82.11 147.42 29.09 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.047 -1.267 . . . . 0.0 109.894 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . 0.521 ' CZ ' HG11 ' B' ' 4' ' ' VAL . 50.8 ttt85 -118.49 128.75 54.89 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.408 -0.807 . . . . 0.0 111.808 -178.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' B' ' 13' ' ' ARG . 0.0 OUTLIER -126.07 127.68 46.21 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.54 -0.725 . . . . 0.0 109.813 179.104 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -111.32 130.61 55.62 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.312 -0.867 . . . . 0.0 111.602 -178.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 84.5 mt -122.8 159.38 28.21 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.687 -0.633 . . . . 0.0 111.09 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -109.6 91.61 3.72 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 176.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.7 t -90.18 133.45 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-O 121.601 0.715 . . . . 0.0 112.252 -176.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.07 170.67 16.11 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.804 -0.56 . . . . 0.0 110.247 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -68.45 151.83 46.27 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.555 -0.716 . . . . 0.0 110.986 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.43 -12.49 55.32 Favored Glycine 0 N--CA 1.495 2.629 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.02 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 91.3 t -89.95 133.37 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 120.705 -1.468 . . . . 0.0 110.899 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 96.6 p -80.3 151.96 29.26 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.735 HD22 HG11 ' B' ' 3' ' ' VAL . 18.5 mt -61.24 -24.62 66.49 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.307 -0.871 . . . . 0.0 110.589 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 13.6 tmm? -69.76 -49.2 55.32 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.238 -0.914 . . . . 0.0 109.493 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -59.83 -41.69 91.88 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.605 -0.684 . . . . 0.0 109.945 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.12 -40.87 95.1 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.648 -0.658 . . . . 0.0 110.165 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.28 -49.79 58.11 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.281 -0.887 . . . . 0.0 111.068 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 55.2 t -65.45 -39.13 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.287 -0.883 . . . . 0.0 110.755 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 24.9 m -70.16 -14.02 62.45 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.386 -0.821 . . . . 0.0 111.502 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' ASN . . . . . 0.509 ' HB3' ' CD1' ' B' ' 32' ' ' ILE . 0.5 OUTLIER -118.17 23.83 11.35 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.021 -1.049 . . . . 0.0 110.652 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.68 38.24 58.54 Favored Glycine 0 N--CA 1.493 2.471 0 O-C-N 121.533 -0.729 . . . . 0.0 111.905 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.509 ' CD1' ' HB3' ' B' ' 30' ' ' ASN . 1.1 mp -72.53 147.22 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.867 -1.372 . . . . 0.0 108.815 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -62.78 142.5 58.15 Favored 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 117.182 2.289 . . . . 0.0 117.182 -174.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 62.24 -36.11 0.12 Allowed 'General case' 0 N--CA 1.515 2.806 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 175.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 57.8 mt -59.74 122.88 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 CA-C-N 121.067 1.758 . . . . 0.0 110.664 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.705 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 48.2 t -100.1 -51.43 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.674 -0.641 . . . . 0.0 111.22 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . 0.628 ' HA2' ' S2 ' ' B' ' 201' ' ' FES . . . 63.13 56.51 20.07 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 107.47 -2.252 . . . . 0.0 107.47 -178.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.35 -49.29 43.85 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.988 -0.713 . . . . 0.0 112.26 -177.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' CYS . . . . . 0.553 ' HB3' ' HB3' ' B' ' 45' ' ' CYS . 2.3 p -66.55 -10.45 45.31 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.229 -0.919 . . . . 0.0 112.372 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . 0.507 ' CA ' HD22 ' A' ' 356' ' ' LEU . . . 96.82 -5.52 64.04 Favored Glycine 0 N--CA 1.498 2.823 0 O-C-N 120.841 -1.162 . . . . 0.0 111.938 177.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.2 19.42 10.69 Favored Glycine 0 N--CA 1.494 2.557 0 O-C-N 120.794 -1.415 . . . . 0.0 111.031 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 87.7 p -98.86 19.04 15.66 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.055 -1.262 . . . . 0.0 111.158 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 56.01 40.85 30.28 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.401 -0.812 . . . . 0.0 111.926 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 17.3 m -116.99 11.12 14.21 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.401 -0.812 . . . . 0.0 109.522 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' CYS . . . . . 0.742 ' HG ' 'FE1 ' ' B' ' 201' ' ' FES . 15.1 p -149.52 -179.04 6.78 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.537 -0.727 . . . . 0.0 109.073 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.1 34.07 3.09 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.804 -1.185 . . . . 0.0 111.339 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' THR . . . . . 0.705 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 5.6 p -97.6 13.24 30.79 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.972 -1.08 . . . . 0.0 111.288 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' CYS . . . . . 0.444 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.1 p -120.56 31.72 6.32 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 177.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . 0.476 ' NE2' ' HB3' ' B' ' 82' ' ' SER . 6.4 t-160 -72.63 133.02 44.47 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.618 -178.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.3 m -146.27 160.05 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . 0.417 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.5 m-85 -105.39 102.71 12.17 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.285 -0.885 . . . . 0.0 108.708 178.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.4 t -61.86 135.09 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.316 -0.865 . . . . 0.0 109.387 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.62 131.82 51.36 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.945 0.879 . . . . 0.0 109.522 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' B' ' 54' ' ' GLU . 11.0 mp0 -44.33 -31.03 0.92 Allowed 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.8 -6.91 54.25 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.021 -1.05 . . . . 0.0 112.766 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -119.94 -6.65 10.02 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 120.527 -1.358 . . . . 0.0 111.922 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.5 p -55.41 -37.77 68.06 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.151 -0.968 . . . . 0.0 112.915 -178.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -81.18 -6.59 59.02 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.744 -1.222 . . . . 0.0 111.481 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -89.87 -11.65 41.29 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.97 -1.081 . . . . 0.0 109.854 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.8 t -104.07 141.04 21.7 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -73.74 118.87 5.63 Favored 'Trans proline' 0 N--CA 1.488 1.176 0 O-C-N 123.444 1.233 . . . . 0.0 109.008 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.95 160.61 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.79 0 N-CA-C 116.645 2.091 . . . . 0.0 116.645 -177.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.618 ' HB1' ' HB3' ' B' ' 67' ' ' GLU . . . -65.77 146.17 55.1 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.216 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -89.75 -170.79 2.94 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.594 -0.691 . . . . 0.0 110.398 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -59.53 -42.02 91.36 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.321 -0.862 . . . . 0.0 111.719 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -41.47 84.46 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.242 -0.911 . . . . 0.0 112.027 -178.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.668 ' HG3' HD12 ' B' ' 84' ' ' LEU . 45.3 tt0 -68.26 -43.98 76.63 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.941 -1.099 . . . . 0.0 110.335 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . 0.513 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.7 mm -55.53 -42.16 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.283 -0.885 . . . . 0.0 109.394 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.23 -47.86 80.64 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 24.8 mmt -66.18 -33.97 76.98 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.316 -1.108 . . . . 0.0 111.186 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' B' ' 71' ' ' LEU . 27.5 mt -63.51 -23.32 67.34 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.203 -0.936 . . . . 0.0 110.62 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . 0.513 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 44.2 mt-10 -70.44 -8.67 52.75 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.38 -0.825 . . . . 0.0 110.926 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 36.4 m -119.87 12.55 12.1 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.069 -1.02 . . . . 0.0 112.518 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 35.3 m -60.78 140.49 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 120.75 -1.219 . . . . 0.0 109.677 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 33.8 m -74.63 -39.08 62.34 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.372 -0.83 . . . . 0.0 110.136 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.22 168.82 17.46 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.451 -0.78 . . . . 0.0 110.087 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.26 139.12 55.68 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.422 -0.799 . . . . 0.0 110.613 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.5 tp -91.01 116.19 28.6 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.569 -0.707 . . . . 0.0 109.873 179.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -103.02 168.3 9.0 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -76.61 -0.0 10.0 Favored 'Trans proline' 0 C--N 1.315 -1.217 0 O-C-N 123.222 1.117 . . . . 0.0 110.398 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -120.48 22.36 11.29 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.918 -1.114 . . . . 0.0 108.42 176.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . 0.476 ' HB3' ' NE2' ' B' ' 49' ' ' HIS . 4.3 m -80.81 137.23 36.21 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.91 -0.494 . . . . 0.0 110.383 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.4 mmm-85 -149.78 146.41 27.16 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.47 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.668 HD12 ' HG3' ' B' ' 67' ' ' GLU . 96.3 mt -80.59 98.97 7.88 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 175.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' CYS . . . . . 0.409 ' HB2' ' HB2' ' B' ' 23' ' ' LEU . 10.5 p -48.37 -17.88 0.18 Allowed 'General case' 0 N--CA 1.508 2.448 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -175.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.9 p -70.29 -14.0 62.41 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.686 -1.259 . . . . 0.0 109.474 178.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -92.68 -12.23 32.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.492 -0.755 . . . . 0.0 110.553 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 61.8 mt -91.48 103.95 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.179 -0.951 . . . . 0.0 110.648 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 27.6 mm -85.03 131.8 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 13.8 tpt -74.89 137.78 41.99 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 122.176 0.988 . . . . 0.0 113.221 -177.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 43.6 p -138.2 166.59 24.73 Favored Pre-proline 0 N--CA 1.49 1.546 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 176.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -74.97 1.75 7.37 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 122.678 0.83 . . . . 0.0 111.023 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -87.69 -22.77 24.45 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.4 mt -93.85 12.99 23.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 122.024 -0.423 . . . . 0.0 110.412 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -54.5 126.37 23.31 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.185 -0.947 . . . . 0.0 111.172 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.23 6.86 68.33 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.633 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.65 142.76 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 CA-C-N 119.374 1.587 . . . . 0.0 110.773 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' VAL . . . . . 0.478 HG22 ' HB ' ' B' ' 4' ' ' VAL . 60.8 t -122.5 133.01 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.494 -0.754 . . . . 0.0 109.858 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 16.4 m -130.39 135.76 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.439 -0.788 . . . . 0.0 109.793 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' ASP . . . . . 0.417 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.43 134.17 35.2 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.4 t -103.39 127.29 29.96 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.482 -0.761 . . . . 0.0 110.386 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -80.82 131.01 7.87 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 O-C-N 124.016 1.535 . . . . 0.0 108.306 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' ASP . . . . . 0.423 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.4 p-10 -62.44 3.4 0.2 Allowed 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -178.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 4.0 mtm105 -125.32 114.6 19.12 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.282 -1.511 . . . . 0.0 110.075 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . 0.501 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 70.6 mm-40 -113.25 -49.43 2.91 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.46 -0.775 . . . . 0.0 110.0 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' TRP . . . . . 0.568 ' CG ' ' HB2' ' A' ' 113' ' ' ALA . 10.9 m0 . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.5 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 501' ' ' HEM . . . . . 0.949 ' O2D' ' O ' ' A' ' 100' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 502' ' ' CAM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 201' ' ' FES . . . . . 0.742 'FE1 ' ' HG ' ' B' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.514 HD12 ' HD2' ' A' ' 15' ' ' PRO . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 14' ' ' LEU . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.419 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HG2' HG12 ' A' ' 54' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.569 HG12 ' HG2' ' A' ' 51' ' ' PRO . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.609 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.8 m120 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.609 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 64' ' ' ILE . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.435 ' HA ' HD23 ' A' ' 324' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.9 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.2 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.5 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.475 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 26.4 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.1 mtm180 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.64 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.2 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.556 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.717 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.717 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 1.068 HD11 ' CZ ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.949 ' O ' ' O2D' ' A' ' 501' ' ' HEM . 67.8 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.64 ' O ' ' HB3' ' A' ' 83' ' ' SER . 3.9 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 45.3 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.647 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.296 50.2 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' ' 104' ' ' ASP 0.366 53.2 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.647 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 35.0 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.452 ' H ' ' CG ' ' A' ' 106' ' ' PRO 0.372 31.8 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.8 ttp85 -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 8.6 mtp180 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.493 ' HB2' ' CG ' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.744 HD11 ' HA3' ' A' ' 226' ' ' GLY . 6.8 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.546 ' O ' HG22 ' A' ' 119' ' ' VAL . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.603 ' HA ' HG21 ' A' ' 123' ' ' VAL . 35.1 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.594 HG13 HG23 ' A' ' 118' ' ' VAL . 30.6 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.493 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.698 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 28.8 mtm -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.698 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.1 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.603 HG21 ' HA ' ' A' ' 118' ' ' VAL . 69.2 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 54.1 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 29.8 mtmt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.455 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.63 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.412 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.595 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 151' ' ' THR . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.799 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.799 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.441 ' O ' ' HG2' ' A' ' 164' ' ' MET . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.578 ' C ' HD23 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.455 ' N ' HD23 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.425 ' N ' ' HD2' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' HIS . . . . . 0.405 ' O ' ' HG ' ' A' ' 180' ' ' LEU . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.574 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 176' ' ' HIS . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.561 ' HA ' ' HE3' ' A' ' 184' ' ' MET . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . 0.561 ' HE3' ' HA ' ' A' ' 181' ' ' THR . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.421 HD22 ' HE1' ' A' ' 184' ' ' MET . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.453 ' HG3' ' HB1' ' A' ' 224' ' ' ALA . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 220' ' ' ILE . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' A' ' 222' ' ' ILE . 26.5 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 42.0 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.453 ' HB1' ' HG3' ' A' ' 212' ' ' ARG . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.744 ' HA3' HD11 ' A' ' 114' ' ' LEU . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 4.0 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 17.1 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 1.068 ' CZ ' HD11 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 35.4 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.717 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.487 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' MET . . . . . 0.595 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 8.7 pm0 -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.437 ' N ' ' HD2' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' CYS . . . . . . . . . . . . . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 288' ' ' LEU . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.706 HD23 ' H ' ' A' ' 294' ' ' LEU . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.502 HG11 HMA3 ' A' ' 501' ' ' HEM . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . 0.513 ' OD2' ' O2A' ' A' ' 501' ' ' HEM . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . 0.419 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . 0.419 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.0 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.459 ' HA ' HD13 ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 314' ' ' LYS . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' PHE . . . . . 0.428 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.4 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' HIS . . . . . 0.428 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 41.4 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 303' ' ' SER . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 318' ' ' ILE . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . 0.647 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . 0.68 ' HG2' HD22 ' A' ' 324' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.68 HD22 ' HG2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 39.5 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 327' ' ' LEU . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.522 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' PRO . . . . . 0.522 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 92.5 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 1.3 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 47.2 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' THR . . . . . . . . . . . . . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 66.3 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 93.8 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 1.2 tp -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 14.2 tpp85 -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 39.6 m . . . . . 0 N--CA 1.496 1.837 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.54 138.62 38.49 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.218 -0.926 . . . . 0.0 112.934 -178.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.725 HG11 HD22 ' B' ' 23' ' ' LEU . 60.6 t -137.14 122.58 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.533 HG11 ' CZ ' ' B' ' 12' ' ' ARG . 98.1 t -106.82 129.54 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.126 -0.984 . . . . 0.0 111.58 -178.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -109.2 110.58 21.83 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 40.0 t -94.79 127.2 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.899 -1.125 . . . . 0.0 108.367 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.4 m -86.12 174.67 9.0 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.773 0.797 . . . . 0.0 112.527 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.421 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.66 -46.73 89.24 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 121.132 0.491 . . . . 0.0 110.463 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -65.92 -11.26 45.95 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.592 -0.692 . . . . 0.0 111.401 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.97 15.47 28.45 Favored Glycine 0 N--CA 1.492 2.368 0 O-C-N 121.202 -0.936 . . . . 0.0 111.258 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.4 m -82.11 147.35 29.12 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 118.754 1.277 . . . . 0.0 109.899 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . 0.533 ' CZ ' HG11 ' B' ' 4' ' ' VAL . 50.8 ttt85 -118.42 128.74 54.91 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.418 -0.801 . . . . 0.0 111.873 -178.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' B' ' 13' ' ' ARG . 0.0 OUTLIER -126.03 127.7 46.29 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.574 -0.703 . . . . 0.0 109.794 179.117 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -111.31 130.62 55.61 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.255 -0.903 . . . . 0.0 111.666 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 84.6 mt -122.81 159.39 28.21 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.3 0.571 . . . . 0.0 111.073 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -109.62 91.64 3.73 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 106.436 -1.691 . . . . 0.0 106.436 176.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 39.0 t -90.2 133.44 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.577 0.703 . . . . 0.0 112.254 -176.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.09 170.67 16.1 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.805 -0.559 . . . . 0.0 110.282 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -68.37 151.81 46.34 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.498 -0.751 . . . . 0.0 111.021 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.42 -12.48 55.29 Favored Glycine 0 N--CA 1.495 2.623 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.066 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 98.8 t -89.98 133.36 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.673 -1.487 . . . . 0.0 110.922 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 52.0 p -80.29 151.93 29.29 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.725 HD22 HG11 ' B' ' 3' ' ' VAL . 18.4 mt -61.21 -24.54 66.41 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.31 -0.868 . . . . 0.0 110.66 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 11.2 tmm? -69.77 -49.25 54.77 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.258 -0.901 . . . . 0.0 109.462 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.81 -41.74 91.94 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.645 -0.659 . . . . 0.0 109.892 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.06 -40.9 95.39 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.593 -0.692 . . . . 0.0 110.179 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.28 -49.72 58.6 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.285 -0.884 . . . . 0.0 111.12 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 89.5 t -65.42 -39.24 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.266 -0.896 . . . . 0.0 110.737 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 25.0 m -70.03 -14.11 62.53 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.328 -0.857 . . . . 0.0 111.53 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' ASN . . . . . 0.536 ' HB3' ' CD1' ' B' ' 32' ' ' ILE . 0.5 OUTLIER -118.18 23.86 11.33 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.062 -1.024 . . . . 0.0 110.604 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.68 38.23 58.51 Favored Glycine 0 N--CA 1.493 2.463 0 O-C-N 121.557 -0.714 . . . . 0.0 111.873 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.579 ' CG2' HD12 ' B' ' 35' ' ' ILE . 1.0 OUTLIER -72.54 147.18 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.813 -1.404 . . . . 0.0 108.839 179.024 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -62.67 142.5 58.06 Favored 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 117.231 2.308 . . . . 0.0 117.231 -174.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 62.18 -36.09 0.12 Allowed 'General case' 0 N--CA 1.515 2.814 0 N-CA-C 116.657 2.095 . . . . 0.0 116.657 175.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.579 HD12 ' CG2' ' B' ' 32' ' ' ILE . 20.2 mt -59.77 122.92 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 O-C-N 119.821 -1.799 . . . . 0.0 110.635 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.66 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 93.2 t -100.16 -51.4 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.595 -0.691 . . . . 0.0 111.192 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . 0.619 ' HA2' ' S2 ' ' B' ' 201' ' ' FES . . . 63.16 56.45 20.34 Favored Glycine 0 N--CA 1.499 2.897 0 N-CA-C 107.467 -2.253 . . . . 0.0 107.467 -178.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -71.33 -49.29 44.05 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.993 -0.71 . . . . 0.0 112.281 -177.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' CYS . . . . . 0.557 ' HB3' ' HB3' ' B' ' 45' ' ' CYS . 2.3 p -66.53 -10.43 44.8 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.219 -0.925 . . . . 0.0 112.373 -178.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.79 -5.47 64.08 Favored Glycine 0 N--CA 1.497 2.767 0 O-C-N 120.745 -1.222 . . . . 0.0 112.0 177.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.08 19.51 10.68 Favored Glycine 0 N--CA 1.495 2.59 0 O-C-N 120.814 -1.403 . . . . 0.0 111.038 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 87.9 p -98.94 19.17 15.52 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.025 -1.279 . . . . 0.0 111.137 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.664 ' HB3' ' HD3' ' B' ' 66' ' ' ARG . . . 55.94 40.89 30.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.395 -0.816 . . . . 0.0 111.918 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 5.7 t -117.02 11.17 14.19 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.356 -0.84 . . . . 0.0 109.566 178.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' CYS . . . . . 0.744 ' HG ' 'FE1 ' ' B' ' 201' ' ' FES . 15.1 p -149.52 -179.1 6.83 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.09 34.06 3.1 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.828 -1.17 . . . . 0.0 111.346 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' THR . . . . . 0.66 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 25.2 p -97.52 13.22 30.7 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.995 -1.066 . . . . 0.0 111.295 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' CYS . . . . . 0.439 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.1 p -120.56 31.74 6.31 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 177.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . 0.469 ' NE2' ' HB3' ' B' ' 82' ' ' SER . 6.5 t-160 -72.69 133.05 44.43 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.628 -178.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.3 m -146.27 160.09 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . 0.417 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.5 m-85 -105.43 102.74 12.19 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.257 -0.902 . . . . 0.0 108.689 178.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.0 t -61.97 135.12 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.343 -0.848 . . . . 0.0 109.358 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.63 131.79 51.3 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.957 0.884 . . . . 0.0 109.522 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.416 ' H ' ' CD ' ' B' ' 54' ' ' GLU . 11.0 mp0 -44.4 -30.9 0.92 Allowed 'General case' 0 N--CA 1.506 2.336 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -178.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.83 -6.91 54.29 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.016 -1.052 . . . . 0.0 112.772 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -119.98 -6.6 10.01 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.465 -1.397 . . . . 0.0 111.898 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.4 p -55.4 -37.85 68.16 Favored 'General case' 0 N--CA 1.507 2.415 0 O-C-N 121.186 -0.946 . . . . 0.0 112.854 -178.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 47.9 p-10 -81.17 -6.59 59.01 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 120.775 -1.203 . . . . 0.0 111.452 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -89.91 -11.68 41.12 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.983 -1.073 . . . . 0.0 109.822 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -104.04 141.08 21.77 Favored Pre-proline 0 N--CA 1.488 1.475 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -73.78 118.84 5.61 Favored 'Trans proline' 0 N--CA 1.489 1.208 0 O-C-N 123.49 1.258 . . . . 0.0 109.009 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.83 160.62 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.799 0 N-CA-C 116.621 2.082 . . . . 0.0 116.621 -177.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.604 ' HB1' ' HB3' ' B' ' 67' ' ' GLU . . . -65.81 146.11 55.15 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.285 178.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -89.76 -170.76 2.93 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.61 -0.681 . . . . 0.0 110.393 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -59.58 -41.98 91.49 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.325 -0.859 . . . . 0.0 111.711 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' ARG . . . . . 0.664 ' HD3' ' HB3' ' B' ' 43' ' ' ALA . 11.0 ttt180 -67.44 -41.58 84.51 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.141 -0.974 . . . . 0.0 111.989 -178.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.676 ' HG3' HD12 ' B' ' 84' ' ' LEU . 45.4 tt0 -68.23 -43.92 76.88 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.985 -1.072 . . . . 0.0 110.354 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . 0.517 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.7 mm -55.57 -42.2 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.311 -0.868 . . . . 0.0 109.354 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.17 -47.88 80.61 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 8.4 mmt -66.12 -33.97 76.99 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.234 -1.157 . . . . 0.0 111.241 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 27.5 mt -63.5 -23.34 67.36 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.213 -0.929 . . . . 0.0 110.636 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . 0.517 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 44.3 mt-10 -70.42 -8.72 53.04 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.314 -0.866 . . . . 0.0 110.897 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 1.4 t -119.84 12.56 12.13 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.001 -1.062 . . . . 0.0 112.523 -178.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 34.6 m -60.84 140.42 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 120.736 -1.227 . . . . 0.0 109.631 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.59 -39.03 62.46 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.393 -0.817 . . . . 0.0 110.152 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.22 168.84 17.42 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.486 -0.759 . . . . 0.0 110.086 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.33 139.15 55.78 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.397 -0.814 . . . . 0.0 110.602 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.3 tp -90.99 116.22 28.62 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.549 -0.719 . . . . 0.0 109.833 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -103.04 168.3 8.99 Favored Pre-proline 0 N--CA 1.489 1.5 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -76.62 -0.04 10.05 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 O-C-N 123.311 1.164 . . . . 0.0 110.382 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -120.46 22.37 11.29 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.931 -1.106 . . . . 0.0 108.397 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . 0.469 ' HB3' ' NE2' ' B' ' 49' ' ' HIS . 4.3 m -80.8 137.23 36.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.879 -0.513 . . . . 0.0 110.32 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.4 mmm-85 -149.8 146.37 27.12 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.465 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.676 HD12 ' HG3' ' B' ' 67' ' ' GLU . 96.3 mt -80.51 98.96 7.81 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 175.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' CYS . . . . . 0.405 ' HB2' ' HB2' ' B' ' 23' ' ' LEU . 10.7 p -48.44 -17.86 0.19 Allowed 'General case' 0 N--CA 1.508 2.427 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -175.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.8 p -70.27 -14.0 62.41 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.669 -1.269 . . . . 0.0 109.435 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -92.7 -12.25 31.95 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.459 -0.776 . . . . 0.0 110.526 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 61.8 mt -91.51 103.96 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.198 -0.939 . . . . 0.0 110.664 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 26.5 mm -84.98 131.71 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 13.8 tpt -74.8 137.74 42.11 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 122.075 0.941 . . . . 0.0 113.25 -177.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 43.6 p -138.17 166.6 24.63 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -75.0 1.79 7.35 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 O-C-N 122.669 0.826 . . . . 0.0 111.001 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -87.67 -22.82 24.46 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 176.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.6 mt -93.79 13.02 23.72 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.418 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.53 126.4 23.47 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.146 -0.971 . . . . 0.0 111.148 -178.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.25 6.77 68.41 Favored Glycine 0 N--CA 1.494 2.523 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.662 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.61 142.69 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 CA-C-N 119.343 1.572 . . . . 0.0 110.755 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' VAL . . . . . 0.47 HG22 ' HB ' ' B' ' 4' ' ' VAL . 61.0 t -122.44 132.96 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.519 -0.738 . . . . 0.0 109.88 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 16.5 m -130.37 135.79 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.481 -0.762 . . . . 0.0 109.802 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' ASP . . . . . 0.417 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.44 134.11 35.26 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.9 t -103.34 127.33 29.9 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.493 -0.754 . . . . 0.0 110.391 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -80.89 130.92 7.75 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 O-C-N 124.084 1.571 . . . . 0.0 108.294 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' ASP . . . . . 0.421 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.3 p-10 -62.33 3.38 0.19 Allowed 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -178.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 3.8 mtm105 -125.32 114.68 19.22 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.288 -1.507 . . . . 0.0 110.069 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . 0.491 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 69.8 mm-40 -113.31 -49.37 2.91 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.476 -0.765 . . . . 0.0 110.0 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' TRP . . . . . 0.493 ' CG ' ' HB2' ' A' ' 113' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 118.392 -0.813 . . . . 0.0 110.504 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 501' ' ' HEM . . . . . 0.949 ' O2D' ' O ' ' A' ' 100' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 502' ' ' CAM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 201' ' ' FES . . . . . 0.744 'FE1 ' ' HG ' ' B' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.514 HD12 ' HD2' ' A' ' 15' ' ' PRO . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 14' ' ' LEU . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.419 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HG2' HG12 ' A' ' 54' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.569 HG12 ' HG2' ' A' ' 51' ' ' PRO . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.609 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.8 m120 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.609 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 64' ' ' ILE . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.435 ' HA ' HD23 ' A' ' 324' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.0 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.6 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.5 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.427 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 30.0 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.6 mtm180 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.64 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.2 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.556 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.717 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.717 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 1.068 HD11 ' CZ ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.949 ' O ' ' O2D' ' A' ' 501' ' ' HEM . 68.2 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.64 ' O ' ' HB3' ' A' ' 83' ' ' SER . 3.8 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 46.0 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.647 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.296 50.2 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 104' ' ' ASP 0.366 52.9 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.647 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 35.0 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.452 ' H ' ' CG ' ' A' ' 106' ' ' PRO 0.413 34.1 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.642 ' CZ ' HD11 ' A' ' 358' ' ' LEU . 7.1 mtp180 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.723 ' HB2' ' CD2' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.685 HD11 ' HA3' ' A' ' 226' ' ' GLY . 24.8 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.546 ' O ' HG22 ' A' ' 119' ' ' VAL . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.603 ' HA ' HG21 ' A' ' 123' ' ' VAL . 35.1 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.593 HG13 HG23 ' A' ' 118' ' ' VAL . 30.6 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.493 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.697 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 31.7 mtm -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.697 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.1 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.603 HG21 ' HA ' ' A' ' 118' ' ' VAL . 72.0 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.7 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.452 ' HD2' ' HA ' ' A' ' 123' ' ' VAL . 35.6 mttt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.455 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.63 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.412 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.595 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 151' ' ' THR . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.799 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.799 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.441 ' O ' ' HG2' ' A' ' 164' ' ' MET . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.578 ' C ' HD23 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.455 ' N ' HD23 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.425 ' N ' ' HD2' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' HIS . . . . . 0.405 ' O ' ' HG ' ' A' ' 180' ' ' LEU . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.574 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 176' ' ' HIS . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.561 ' HA ' ' HE3' ' A' ' 184' ' ' MET . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . 0.561 ' HE3' ' HA ' ' A' ' 181' ' ' THR . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.421 HD22 ' HE1' ' A' ' 184' ' ' MET . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.453 ' HG3' ' HB1' ' A' ' 224' ' ' ALA . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 220' ' ' ILE . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 33.3 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 53.1 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.453 ' HB1' ' HG3' ' A' ' 212' ' ' ARG . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.685 ' HA3' HD11 ' A' ' 114' ' ' LEU . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 4.6 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 1.1 m120 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 18.1 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 1.068 ' CZ ' HD11 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 45.4 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.717 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.487 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' MET . . . . . 0.595 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.437 ' N ' ' HD2' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' CYS . . . . . . . . . . . . . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 288' ' ' LEU . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.706 HD23 ' H ' ' A' ' 294' ' ' LEU . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.502 HG11 HMA3 ' A' ' 501' ' ' HEM . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . 0.513 ' OD2' ' O2A' ' A' ' 501' ' ' HEM . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . 0.419 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . 0.419 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.1 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.459 ' HA ' HD13 ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 314' ' ' LYS . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.6 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' HIS . . . . . 0.425 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 36.9 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 303' ' ' SER . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 318' ' ' ILE . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . 0.647 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . 0.68 ' HG2' HD22 ' A' ' 324' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.68 HD22 ' HG2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 13.7 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 327' ' ' LEU . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.522 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' PRO . . . . . 0.522 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . 0.41 ' CB ' ' HD3' ' A' ' 344' ' ' LYS . 1.9 mp0 -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' LYS . . . . . 0.511 ' HD3' ' N ' ' A' ' 344' ' ' LYS . 0.9 OUTLIER -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 60.7 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 10.6 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 39.9 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' THR . . . . . . . . . . . . . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 60.2 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 96.4 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' LEU . . . . . 0.509 HD22 ' CA ' ' B' ' 40' ' ' GLY . 1.5 tp -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . 1.314 ' CD1' HBD2 ' A' ' 501' ' ' HEM . 1.4 mp -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 43.4 mtt85 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 N--CA 1.496 1.83 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.52 138.58 38.48 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.224 -0.922 . . . . 0.0 112.963 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.743 HG11 HD22 ' B' ' 23' ' ' LEU . 61.2 t -137.11 122.56 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.526 HG11 ' CZ ' ' B' ' 12' ' ' ARG . 97.0 t -106.76 129.54 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.115 -0.991 . . . . 0.0 111.628 -178.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.509 ' CG ' HD13 ' B' ' 32' ' ' ILE . 76.9 m-85 -109.2 110.6 21.85 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.82 127.26 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.927 -1.108 . . . . 0.0 108.34 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.4 m -86.2 174.64 8.97 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.753 0.787 . . . . 0.0 112.502 -177.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.427 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.6 -46.79 88.94 Favored 'General case' 0 N--CA 1.502 2.155 0 CA-C-O 121.138 0.494 . . . . 0.0 110.458 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -65.85 -11.31 45.58 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.57 -0.706 . . . . 0.0 111.433 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.99 15.43 28.49 Favored Glycine 0 N--CA 1.492 2.406 0 O-C-N 121.155 -0.965 . . . . 0.0 111.259 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.5 m -82.05 147.38 29.17 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 118.73 1.265 . . . . 0.0 109.88 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . 0.526 ' CZ ' HG11 ' B' ' 4' ' ' VAL . 50.8 ttt85 -118.43 128.74 54.9 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.487 -0.758 . . . . 0.0 111.859 -178.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' B' ' 13' ' ' ARG . 0.0 OUTLIER -126.07 127.71 46.24 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.598 -0.689 . . . . 0.0 109.804 179.08 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -111.3 130.63 55.61 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.282 -0.886 . . . . 0.0 111.647 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 84.8 mt -122.8 159.34 28.29 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.734 -0.604 . . . . 0.0 111.129 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -109.61 91.66 3.74 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 176.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.6 t -90.16 133.41 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-O 121.626 0.727 . . . . 0.0 112.253 -176.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.08 170.71 16.04 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.7 -0.625 . . . . 0.0 110.273 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -68.5 151.82 46.25 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.532 -0.73 . . . . 0.0 111.027 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.46 -12.49 55.43 Favored Glycine 0 N--CA 1.496 2.638 0 O-C-N 121.494 -0.754 . . . . 0.0 112.052 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 61.5 t -89.98 133.29 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.706 -1.467 . . . . 0.0 110.963 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 21.3 p -80.21 151.88 29.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.572 -0.705 . . . . 0.0 109.184 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.743 HD22 HG11 ' B' ' 3' ' ' VAL . 18.5 mt -61.18 -24.59 66.43 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.349 -0.844 . . . . 0.0 110.595 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 1.9 ttp -69.83 -49.2 54.9 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.236 -0.915 . . . . 0.0 109.473 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -59.79 -41.72 91.81 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.567 -0.708 . . . . 0.0 109.926 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.09 -40.86 95.2 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.59 -0.694 . . . . 0.0 110.152 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . 0.582 ' HA ' HD12 ' B' ' 32' ' ' ILE . . . -68.34 -49.74 58.19 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.275 -0.891 . . . . 0.0 111.045 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 78.2 t -65.47 -39.18 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.301 -0.875 . . . . 0.0 110.706 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 23.2 t -70.14 -13.96 62.43 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.359 -0.838 . . . . 0.0 111.553 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -118.21 23.88 11.32 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.057 -1.027 . . . . 0.0 110.665 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.7 38.24 58.63 Favored Glycine 0 N--CA 1.493 2.448 0 O-C-N 121.541 -0.724 . . . . 0.0 111.857 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.582 HD12 ' HA ' ' B' ' 27' ' ' ALA . 0.4 OUTLIER -72.57 147.19 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.866 -1.373 . . . . 0.0 108.864 179.043 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -62.72 142.53 58.09 Favored 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 117.175 2.287 . . . . 0.0 117.175 -174.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 62.22 -36.12 0.12 Allowed 'General case' 0 N--CA 1.515 2.791 0 N-CA-C 116.643 2.09 . . . . 0.0 116.643 175.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 77.6 mt -59.77 122.9 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.426 0 O-C-N 119.907 -1.746 . . . . 0.0 110.617 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.919 HG11 ' CZ2' ' B' ' 106' ' ' TRP . 97.4 t -100.15 -51.34 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.697 -0.627 . . . . 0.0 111.229 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . 0.623 ' HA2' ' S2 ' ' B' ' 201' ' ' FES . . . 63.14 56.47 20.26 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 107.466 -2.253 . . . . 0.0 107.466 -178.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . 0.403 ' HB2' ' CH2' ' B' ' 106' ' ' TRP . 12.6 t70 -71.34 -49.27 44.16 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.994 -0.709 . . . . 0.0 112.274 -177.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' CYS . . . . . 0.558 ' HB3' ' HB3' ' B' ' 45' ' ' CYS . 2.3 p -66.59 -10.4 45.19 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.213 -0.929 . . . . 0.0 112.385 -178.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . 0.509 ' CA ' HD22 ' A' ' 356' ' ' LEU . . . 96.77 -5.47 64.13 Favored Glycine 0 N--CA 1.498 2.782 0 O-C-N 120.819 -1.176 . . . . 0.0 112.007 177.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.1 19.52 10.66 Favored Glycine 0 N--CA 1.494 2.535 0 O-C-N 120.826 -1.397 . . . . 0.0 111.047 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 8.2 t -98.95 19.11 15.64 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.978 -1.307 . . . . 0.0 111.16 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.97 40.87 30.36 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.407 -0.808 . . . . 0.0 111.906 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.04 11.2 14.18 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.343 -0.848 . . . . 0.0 109.467 178.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' CYS . . . . . 0.69 ' HG ' 'FE1 ' ' B' ' 201' ' ' FES . 15.1 p -149.53 -179.08 6.81 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.549 -0.72 . . . . 0.0 109.082 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.08 34.08 3.1 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.83 -1.169 . . . . 0.0 111.403 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' THR . . . . . 0.648 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 37.8 p -97.63 13.26 30.76 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.925 -1.109 . . . . 0.0 111.25 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.1 p -120.54 31.73 6.32 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 177.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 23.9 t-160 -72.65 133.03 44.46 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-N 115.784 -0.643 . . . . 0.0 112.628 -178.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.3 m -146.3 160.11 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . 0.413 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.4 m-85 -105.44 102.68 12.13 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.294 -0.879 . . . . 0.0 108.684 178.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.2 t -61.86 135.11 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.317 -0.864 . . . . 0.0 109.35 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.68 131.81 51.38 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.94 0.876 . . . . 0.0 109.53 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.412 ' CD ' ' H ' ' B' ' 54' ' ' GLU . 11.0 mp0 -44.27 -31.08 0.91 Allowed 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -178.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.78 -6.93 54.3 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.969 -1.082 . . . . 0.0 112.749 -178.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -119.89 -6.72 10.04 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 120.449 -1.407 . . . . 0.0 111.908 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.4 p -55.37 -37.84 68.04 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.112 -0.993 . . . . 0.0 112.86 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 -81.18 -6.63 59.06 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.753 -1.217 . . . . 0.0 111.477 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -89.88 -11.62 41.35 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.991 -1.068 . . . . 0.0 109.855 178.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -104.07 141.05 21.72 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -73.76 118.89 5.63 Favored 'Trans proline' 0 N--CA 1.488 1.15 0 O-C-N 123.453 1.238 . . . . 0.0 109.016 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.89 160.65 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.764 0 N-CA-C 116.657 2.095 . . . . 0.0 116.657 -177.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.616 ' HB1' ' HB3' ' B' ' 67' ' ' GLU . . . -65.87 146.14 55.1 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-N 114.606 -1.179 . . . . 0.0 111.266 178.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -89.74 -170.79 2.94 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.569 -0.707 . . . . 0.0 110.362 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -59.53 -42.0 91.28 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.35 -0.844 . . . . 0.0 111.754 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -41.48 84.45 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.203 -0.935 . . . . 0.0 112.018 -178.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.616 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 45.3 tt0 -68.21 -43.98 76.81 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.031 -1.043 . . . . 0.0 110.318 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . 0.533 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.6 mm -55.6 -42.18 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.28 -0.888 . . . . 0.0 109.368 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.19 -47.83 81.04 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 11.2 mmt -66.23 -33.92 76.84 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.275 -1.133 . . . . 0.0 111.191 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . 0.45 ' HA ' HD23 ' B' ' 71' ' ' LEU . 27.9 mt -63.47 -23.4 67.38 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.236 -0.915 . . . . 0.0 110.588 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . 0.533 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 49.2 mt-10 -70.38 -8.71 52.78 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.358 -0.839 . . . . 0.0 110.919 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 82.8 p -119.87 12.54 12.1 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.067 -1.02 . . . . 0.0 112.509 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 16.2 m -60.76 140.38 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 120.643 -1.286 . . . . 0.0 109.681 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 52.0 m -74.53 -39.06 62.58 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.466 -0.771 . . . . 0.0 110.19 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.26 168.82 17.51 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.456 -0.777 . . . . 0.0 110.1 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -58.22 139.16 55.53 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.365 -0.834 . . . . 0.0 110.613 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.3 tp -90.99 116.15 28.55 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.506 -0.746 . . . . 0.0 109.864 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -103.04 168.3 8.99 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -76.61 -0.02 10.02 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 O-C-N 123.304 1.16 . . . . 0.0 110.372 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -120.46 22.41 11.28 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.01 -1.056 . . . . 0.0 108.45 176.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 4.3 m -80.88 137.27 36.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.908 -0.495 . . . . 0.0 110.32 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.4 mmm-85 -149.77 146.4 27.16 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 120.029 -0.668 . . . . 0.0 111.472 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.445 ' HB3' ' SG ' ' B' ' 48' ' ' CYS . 77.9 mt -80.59 98.94 7.86 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 104.789 -2.3 . . . . 0.0 104.789 175.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' CYS . . . . . 0.404 ' HB2' ' HB2' ' B' ' 23' ' ' LEU . 10.5 p -48.38 -17.88 0.18 Allowed 'General case' 0 N--CA 1.508 2.444 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -175.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.8 p -70.27 -13.99 62.4 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.628 -1.295 . . . . 0.0 109.429 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -92.65 -12.3 31.91 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.486 -0.759 . . . . 0.0 110.523 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 61.9 mt -91.44 103.89 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.121 -0.987 . . . . 0.0 110.678 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 45.6 mm -85.01 131.8 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 13.6 tpt -74.88 137.76 41.98 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 122.165 0.983 . . . . 0.0 113.201 -177.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 43.6 p -138.14 166.62 24.53 Favored Pre-proline 0 N--CA 1.491 1.578 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 176.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -74.93 1.67 7.43 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 122.628 0.804 . . . . 0.0 111.028 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -87.61 -22.86 24.5 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 176.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.6 mt -93.76 13.0 23.71 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.392 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -54.5 126.39 23.38 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.138 -0.976 . . . . 0.0 111.188 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.27 6.82 68.3 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 120.581 -0.818 . . . . 0.0 111.637 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.7 tt -62.63 142.81 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 CA-C-N 119.391 1.595 . . . . 0.0 110.747 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' VAL . . . . . 0.481 HG22 ' HB ' ' B' ' 4' ' ' VAL . 60.9 t -122.53 132.92 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.554 -0.716 . . . . 0.0 109.876 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 16.5 m -130.32 135.76 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.451 -0.78 . . . . 0.0 109.842 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' ASP . . . . . 0.413 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.35 134.13 35.21 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.9 t -103.4 127.31 29.92 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.558 -0.714 . . . . 0.0 110.364 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -80.82 130.96 7.84 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 124.115 1.587 . . . . 0.0 108.287 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' ASP . . . . . 0.427 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.4 p-10 -62.34 3.37 0.19 Allowed 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -178.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -125.29 114.71 19.29 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.305 -1.497 . . . . 0.0 110.011 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . 0.511 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 51.4 mm-40 -113.35 -49.4 2.91 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.505 -0.747 . . . . 0.0 109.958 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' TRP . . . . . 0.919 ' CZ2' HG11 ' B' ' 36' ' ' VAL . 82.7 m95 . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.512 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 501' ' ' HEM . . . . . 1.314 HBD2 ' CD1' ' A' ' 358' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 502' ' ' CAM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 201' ' ' FES . . . . . 0.69 'FE1 ' ' HG ' ' B' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.514 HD12 ' HD2' ' A' ' 15' ' ' PRO . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 14' ' ' LEU . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.419 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HG2' HG12 ' A' ' 54' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.569 HG12 ' HG2' ' A' ' 51' ' ' PRO . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.609 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.8 m120 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.609 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 64' ' ' ILE . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.435 ' HA ' HD23 ' A' ' 324' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.0 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.415 ' CZ ' HG23 ' A' ' 348' ' ' THR . 5.6 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.6 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.474 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 27.1 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.7 mmt-85 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.64 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.2 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.556 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.717 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.717 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 1.068 HD11 ' CZ ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.949 ' O ' ' O2D' ' A' ' 501' ' ' HEM . 74.3 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.64 ' O ' ' HB3' ' A' ' 83' ' ' SER . 3.9 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 46.0 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.646 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.296 50.1 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' ' 104' ' ' ASP 0.366 52.7 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.646 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 34.8 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.451 ' H ' ' CG ' ' A' ' 106' ' ' PRO 0.342 30.7 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.406 ' O ' HD11 ' A' ' 358' ' ' LEU . 2.9 mtt-85 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.688 ' HB1' ' CD1' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.735 HD11 ' HA3' ' A' ' 226' ' ' GLY . 7.4 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.546 ' O ' HG22 ' A' ' 119' ' ' VAL . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.442 ' HA ' HD22 ' A' ' 358' ' ' LEU . 25.4 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.417 ' HB2' ' O ' ' A' ' 114' ' ' LEU . 27.6 mt-30 -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.597 ' HA ' HG21 ' A' ' 123' ' ' VAL . 35.0 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.595 HG13 HG23 ' A' ' 118' ' ' VAL . 30.6 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.493 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.698 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 0.0 OUTLIER -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.698 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.0 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.597 HG21 ' HA ' ' A' ' 118' ' ' VAL . 78.3 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.2 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 28.3 mtmt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.455 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.63 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.412 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.595 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 151' ' ' THR . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.799 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.799 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.441 ' O ' ' HG2' ' A' ' 164' ' ' MET . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.578 ' C ' HD23 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.455 ' N ' HD23 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.425 ' N ' ' HD2' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' HIS . . . . . 0.405 ' O ' ' HG ' ' A' ' 180' ' ' LEU . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.574 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 176' ' ' HIS . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.561 ' HA ' ' HE3' ' A' ' 184' ' ' MET . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . 0.561 ' HE3' ' HA ' ' A' ' 181' ' ' THR . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.421 HD22 ' HE1' ' A' ' 184' ' ' MET . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.453 ' HG3' ' HB1' ' A' ' 224' ' ' ALA . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 220' ' ' ILE . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 44.9 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 42.0 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.453 ' HB1' ' HG3' ' A' ' 212' ' ' ARG . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.735 ' HA3' HD11 ' A' ' 114' ' ' LEU . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 4.3 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 13.5 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 1.068 ' CZ ' HD11 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 40.7 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.717 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.487 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' MET . . . . . 0.595 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 16.4 pm0 -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.437 ' N ' ' HD2' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' CYS . . . . . . . . . . . . . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 288' ' ' LEU . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.706 HD23 ' H ' ' A' ' 294' ' ' LEU . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.502 HG11 HMA3 ' A' ' 501' ' ' HEM . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . 0.513 ' OD2' ' O2A' ' A' ' 501' ' ' HEM . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . 0.419 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . 0.419 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.0 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.459 ' HA ' HD13 ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 314' ' ' LYS . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.6 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' HIS . . . . . 0.425 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 36.9 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 303' ' ' SER . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 318' ' ' ILE . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . 0.647 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . 0.68 ' HG2' HD22 ' A' ' 324' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.68 HD22 ' HG2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 13.7 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 327' ' ' LEU . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.522 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' PRO . . . . . 0.522 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.8 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . 0.46 ' CB ' ' HD3' ' A' ' 344' ' ' LYS . 1.9 mp0 -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' LYS . . . . . 0.504 ' HB2' ' HE2' ' A' ' 344' ' ' LYS . 1.7 mppt? -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 57.8 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 22.1 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' THR . . . . . 0.415 HG23 ' CZ ' ' A' ' 72' ' ' ARG . 16.5 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' THR . . . . . . . . . . . . . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 73.7 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' SER . . . . . 0.429 ' HA ' ' CB ' ' B' ' 44' ' ' SER . 97.1 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . 0.442 HD22 ' HA ' ' A' ' 116' ' ' ASN . 0.5 OUTLIER -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 40.9 mtt85 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 17.2 tpp85 -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 N--CA 1.495 1.809 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.52 138.58 38.48 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.177 -0.952 . . . . 0.0 113.004 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.738 HG11 HD22 ' B' ' 23' ' ' LEU . 61.2 t -137.11 122.6 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.526 HG11 ' CZ ' ' B' ' 12' ' ' ARG . 97.5 t -106.78 129.58 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.15 -0.969 . . . . 0.0 111.635 -178.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.682 ' CG ' HD13 ' B' ' 32' ' ' ILE . 77.2 m-85 -109.28 110.6 21.83 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.82 127.23 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.935 -1.103 . . . . 0.0 108.363 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.6 m -86.2 174.69 8.94 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.737 0.779 . . . . 0.0 112.509 -177.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.422 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.7 t-80 -60.66 -46.73 89.22 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 121.19 0.519 . . . . 0.0 110.457 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -65.93 -11.29 46.16 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.52 -0.737 . . . . 0.0 111.381 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.01 15.4 28.55 Favored Glycine 0 N--CA 1.492 2.388 0 O-C-N 121.177 -0.952 . . . . 0.0 111.287 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 89.8 m -82.05 147.35 29.18 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 118.733 1.266 . . . . 0.0 109.929 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . 0.526 ' CZ ' HG11 ' B' ' 4' ' ' VAL . 50.8 ttt85 -118.46 128.74 54.89 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.528 -0.732 . . . . 0.0 111.864 -178.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' B' ' 13' ' ' ARG . 0.0 OUTLIER -126.06 127.67 46.2 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.571 -0.705 . . . . 0.0 109.81 179.146 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -111.34 130.63 55.62 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.275 -0.891 . . . . 0.0 111.612 -178.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 84.7 mt -122.78 159.35 28.24 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.736 -0.602 . . . . 0.0 111.117 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -109.64 91.62 3.72 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 176.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.6 t -90.21 133.49 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-O 121.604 0.716 . . . . 0.0 112.288 -176.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.11 170.71 16.05 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.779 -0.576 . . . . 0.0 110.27 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -68.47 151.82 46.27 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.479 -0.763 . . . . 0.0 110.958 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.45 -12.51 55.34 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.048 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 59.4 t -90.03 133.32 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.704 -1.468 . . . . 0.0 110.896 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 22.3 p -80.23 151.96 29.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.583 -0.698 . . . . 0.0 109.173 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.738 HD22 HG11 ' B' ' 3' ' ' VAL . 18.4 mt -61.22 -24.63 66.48 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.299 -0.876 . . . . 0.0 110.578 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 8.5 tmm? -69.78 -49.19 55.31 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.234 -0.916 . . . . 0.0 109.521 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -59.81 -41.7 91.86 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.594 -0.691 . . . . 0.0 109.953 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.04 -40.91 95.47 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.616 -0.678 . . . . 0.0 110.135 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . 0.73 ' HA ' HD12 ' B' ' 32' ' ' ILE . . . -68.3 -49.78 58.12 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.266 -0.896 . . . . 0.0 111.046 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 69.3 t -65.42 -39.19 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.36 -0.837 . . . . 0.0 110.734 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 28.2 m -70.16 -13.97 62.43 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.372 -0.83 . . . . 0.0 111.526 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -118.2 23.8 11.37 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.04 -1.038 . . . . 0.0 110.663 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.72 38.27 58.81 Favored Glycine 0 N--CA 1.492 2.424 0 O-C-N 121.556 -0.715 . . . . 0.0 111.828 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.73 HD12 ' HA ' ' B' ' 27' ' ' ALA . 1.7 mt -72.55 147.17 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.836 -1.391 . . . . 0.0 108.853 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.68 142.48 58.08 Favored 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 117.215 2.302 . . . . 0.0 117.215 -174.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 62.18 -36.09 0.12 Allowed 'General case' 0 N--CA 1.516 2.855 0 N-CA-C 116.655 2.094 . . . . 0.0 116.655 175.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 84.4 mt -59.78 122.91 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.373 0 O-C-N 119.843 -1.785 . . . . 0.0 110.673 -178.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.591 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 18.9 t -100.12 -51.46 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.63 -0.669 . . . . 0.0 111.193 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . 0.633 ' HA2' ' S2 ' ' B' ' 201' ' ' FES . . . 63.16 56.5 20.08 Favored Glycine 0 N--CA 1.5 2.906 0 N-CA-C 107.447 -2.261 . . . . 0.0 107.447 -178.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.3 -49.31 44.11 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.974 -0.721 . . . . 0.0 112.269 -177.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' CYS . . . . . 0.555 ' HB3' ' HB3' ' B' ' 45' ' ' CYS . 2.3 p -66.59 -10.44 45.51 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.206 -0.934 . . . . 0.0 112.384 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.82 -5.51 64.02 Favored Glycine 0 N--CA 1.499 2.854 0 O-C-N 120.824 -1.172 . . . . 0.0 111.968 177.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.06 19.58 10.63 Favored Glycine 0 N--CA 1.495 2.589 0 O-C-N 120.815 -1.403 . . . . 0.0 111.071 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 90.1 p -99.01 19.15 15.63 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.062 -1.258 . . . . 0.0 111.119 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.99 40.82 30.33 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.42 -0.8 . . . . 0.0 111.941 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . 0.429 ' CB ' ' HA ' ' A' ' 354' ' ' SER . 70.7 m -117.02 11.19 14.2 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.368 -0.832 . . . . 0.0 109.494 178.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' CYS . . . . . 0.697 ' HG ' 'FE1 ' ' B' ' 201' ' ' FES . 15.1 p -149.51 -179.09 6.82 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.54 -0.725 . . . . 0.0 109.049 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.07 34.09 3.1 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.849 -1.157 . . . . 0.0 111.362 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' THR . . . . . 0.591 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 81.9 p -97.61 13.27 30.73 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.0 -1.063 . . . . 0.0 111.277 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 29.1 p -120.54 31.74 6.31 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 23.9 t-160 -72.74 133.05 44.38 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.574 -178.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.3 m -146.26 160.07 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . 0.422 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.5 m-85 -105.41 102.7 12.16 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.26 -0.9 . . . . 0.0 108.709 178.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.3 t -61.87 135.15 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.319 -0.863 . . . . 0.0 109.362 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.7 131.79 51.34 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.981 0.896 . . . . 0.0 109.505 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' B' ' 54' ' ' GLU . 11.1 mp0 -44.28 -31.05 0.91 Allowed 'General case' 0 N--CA 1.505 2.314 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -178.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.76 -6.96 54.38 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.982 -1.074 . . . . 0.0 112.742 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -119.91 -6.61 10.04 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.492 -1.38 . . . . 0.0 111.892 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.3 p -55.49 -37.77 68.27 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.167 -0.958 . . . . 0.0 112.84 -178.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -81.14 -6.71 59.14 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.773 -1.204 . . . . 0.0 111.447 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -89.83 -11.66 41.37 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.017 -1.052 . . . . 0.0 109.841 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.7 t -104.05 141.02 21.65 Favored Pre-proline 0 N--CA 1.489 1.521 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -73.81 118.85 5.61 Favored 'Trans proline' 0 N--CA 1.488 1.172 0 O-C-N 123.487 1.256 . . . . 0.0 109.001 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.9 160.6 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.761 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 -177.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.616 ' HB1' ' HB3' ' B' ' 67' ' ' GLU . . . -65.71 146.16 55.13 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.239 178.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -89.84 -170.73 2.91 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.59 -0.694 . . . . 0.0 110.388 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.56 -42.0 91.42 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.287 -0.883 . . . . 0.0 111.75 -178.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 8.7 ttt180 -67.45 -41.55 84.53 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.173 -0.954 . . . . 0.0 112.014 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.616 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 45.5 tt0 -68.2 -43.97 76.88 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.938 -1.101 . . . . 0.0 110.329 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . 0.533 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.7 mm -55.55 -42.21 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.243 -0.911 . . . . 0.0 109.367 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.15 -47.88 80.75 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' MET . . . . . 0.415 ' HB3' HD11 ' B' ' 84' ' ' LEU . 5.3 mmt -66.17 -34.01 77.07 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.264 -1.139 . . . . 0.0 111.172 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' B' ' 71' ' ' LEU . 28.0 mt -63.48 -23.29 67.33 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.294 -0.879 . . . . 0.0 110.634 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . 0.533 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 49.8 mt-10 -70.45 -8.69 52.94 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.265 -0.897 . . . . 0.0 110.883 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 83.4 p -119.9 12.6 12.1 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.002 -1.061 . . . . 0.0 112.519 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 30.5 m -60.83 140.42 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 120.714 -1.241 . . . . 0.0 109.634 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 81.9 m -74.53 -39.11 62.56 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.419 -0.8 . . . . 0.0 110.15 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.2 168.81 17.46 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.454 -0.779 . . . . 0.0 110.121 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.32 139.15 55.74 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.44 -0.788 . . . . 0.0 110.566 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.4 tp -90.95 116.15 28.53 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.517 -0.739 . . . . 0.0 109.918 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -103.05 168.31 8.97 Favored Pre-proline 0 N--CA 1.489 1.515 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -76.58 -0.06 10.05 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 O-C-N 123.239 1.126 . . . . 0.0 110.404 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -120.46 22.36 11.3 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.002 -1.061 . . . . 0.0 108.385 176.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 4.3 m -80.78 137.22 36.23 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.853 -0.53 . . . . 0.0 110.407 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.5 mmm-85 -149.75 146.38 27.17 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.455 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.555 HD12 ' HG3' ' B' ' 67' ' ' GLU . 92.1 mt -80.6 98.92 7.86 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 175.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' CYS . . . . . 0.409 ' HB2' ' HB2' ' B' ' 23' ' ' LEU . 10.6 p -48.36 -17.89 0.18 Allowed 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -175.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.8 p -70.29 -14.01 62.41 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.662 -1.273 . . . . 0.0 109.464 178.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 80.5 mm-40 -92.66 -12.2 32.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.511 -0.743 . . . . 0.0 110.589 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 61.9 mt -91.49 103.96 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.188 -0.945 . . . . 0.0 110.624 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 46.0 mm -84.94 131.77 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 13.6 tpt -74.88 137.81 42.02 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 122.123 0.963 . . . . 0.0 113.236 -177.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 43.7 p -138.24 166.54 25.06 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 176.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -74.9 1.7 7.38 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 122.632 0.807 . . . . 0.0 111.05 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -87.58 -22.89 24.52 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 176.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.2 mt -93.8 13.02 23.75 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.394 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.47 126.39 23.32 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.203 -0.936 . . . . 0.0 111.162 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.27 6.77 68.36 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.666 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.57 142.75 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 CA-C-N 119.328 1.564 . . . . 0.0 110.779 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' VAL . . . . . 0.469 HG22 ' HB ' ' B' ' 4' ' ' VAL . 60.6 t -122.54 132.95 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.546 -0.722 . . . . 0.0 109.854 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 16.4 m -130.36 135.75 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.535 -0.728 . . . . 0.0 109.814 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' ASP . . . . . 0.422 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.39 134.15 35.2 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.2 t -103.43 127.35 29.82 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.52 -0.737 . . . . 0.0 110.351 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -80.81 130.95 7.86 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 O-C-N 124.129 1.594 . . . . 0.0 108.283 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' ASP . . . . . 0.422 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.4 p-10 -62.41 3.43 0.19 Allowed 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -125.33 114.63 19.15 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.257 -1.527 . . . . 0.0 110.054 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . 0.501 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 52.4 mm-40 -113.32 -49.34 2.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.438 -0.789 . . . . 0.0 110.016 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' TRP . . . . . 0.688 ' CD1' ' HB1' ' A' ' 113' ' ' ALA . 23.1 m0 . . . . . 0 N--CA 1.495 1.793 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.531 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 501' ' ' HEM . . . . . 0.949 ' O2D' ' O ' ' A' ' 100' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 502' ' ' CAM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 201' ' ' FES . . . . . 0.697 'FE1 ' ' HG ' ' B' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 11' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.331 0.586 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.44 153.47 58.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.24 123.64 11.14 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.379 1.199 . . . . 0.0 111.905 -176.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.514 HD12 ' HD2' ' A' ' 15' ' ' PRO . 28.3 tp -49.14 126.76 15.15 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.59 -0.694 . . . . 0.0 111.074 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 14' ' ' LEU . 37.0 Cg_endo -76.11 146.62 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 N-CA-C 107.837 -1.64 . . . . 0.0 107.837 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.55 -14.25 41.37 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.358 2.038 . . . . 0.0 116.626 -173.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -91.91 -6.58 51.15 Favored 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 121.307 1.867 . . . . 0.0 108.816 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.419 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 41.2 t -95.55 119.68 64.82 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.74 145.57 51.84 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.027 1.54 . . . . 0.0 110.977 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -30.75 68.8 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -73.49 -6.17 44.71 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.928 -1.108 . . . . 0.0 113.426 -177.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -102.32 8.98 40.19 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.604 -1.31 . . . . 0.0 110.663 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.33 129.27 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 122.567 1.175 . . . . 0.0 113.396 -178.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -145.31 100.23 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 176.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -70.82 74.32 0.6 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -93.23 127.68 38.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -100.22 114.04 27.17 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.9 ptm -71.67 -16.32 62.25 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.638 -0.664 . . . . 0.0 112.726 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -95.36 -12.71 25.59 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.819 -1.176 . . . . 0.0 110.583 179.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -162.5 73.5 2.17 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.745 . . . . 0.0 109.117 178.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.93 149.76 89.05 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.835 1.439 . . . . 0.0 111.415 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -62.44 -34.86 77.62 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -102.11 36.66 2.05 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.74 -1.225 . . . . 0.0 111.459 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.37 -27.7 69.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.365 -0.834 . . . . 0.0 111.834 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.0 p -67.83 -23.44 65.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.77 . . . . 0.0 111.383 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.06 0.27 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.89 -1.131 . . . . 0.0 110.551 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.23 135.74 5.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.78 -36.28 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.23 -1.159 . . . . 0.0 111.62 -178.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -66.77 -35.23 79.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.725 -1.234 . . . . 0.0 108.311 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -70.53 -36.2 73.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -63.82 -46.18 86.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 122.015 -0.428 . . . . 0.0 110.05 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -71.66 -28.51 63.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.41 -0.806 . . . . 0.0 110.631 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.41 -13.4 61.99 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.715 -0.615 . . . . 0.0 112.461 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 41' ' ' ALA . 17.3 m -64.65 -20.45 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 120.714 -1.242 . . . . 0.0 108.862 178.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.1 mt -69.56 -15.08 63.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.748 -0.595 . . . . 0.0 109.557 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -104.52 13.07 32.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 112.179 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -70.63 163.81 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.6 -1.313 . . . . 0.0 109.028 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -50.66 -43.22 57.2 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -75.92 -4.8 42.98 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -176.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.6 t -100.08 133.22 21.71 Favored Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 120.014 -1.678 . . . . 0.0 111.897 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HG2' HG12 ' A' ' 54' ' ' VAL . 44.2 Cg_endo -70.67 160.37 49.65 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 124.021 1.537 . . . . 0.0 111.336 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -59.0 -29.76 67.47 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.7 tp -134.86 110.16 8.98 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.97 -1.081 . . . . 0.0 109.881 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.569 HG12 ' HG2' ' A' ' 51' ' ' PRO . 18.9 m -113.28 167.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.04 0.924 . . . . 0.0 112.619 -178.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -119.97 122.67 41.7 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.609 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 10.0 t -104.12 136.45 43.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.576 -0.702 . . . . 0.0 109.845 178.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -84.87 1.46 46.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.58 -0.7 . . . . 0.0 110.36 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.9 m -78.88 155.81 28.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.619 -0.675 . . . . 0.0 110.527 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.8 m120 52.13 41.16 29.89 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.13 39.29 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.092 -1.005 . . . . 0.0 112.159 177.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.609 ' HA2' ' O ' ' A' ' 56' ' ' THR . . . 98.72 125.15 5.27 Favored Glycine 0 N--CA 1.495 2.597 0 CA-C-N 118.794 1.297 . . . . 0.0 110.612 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -168.97 160.48 10.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.778 -0.837 . . . . 0.0 110.839 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -79.39 159.27 27.16 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.642 -0.662 . . . . 0.0 111.682 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 64' ' ' ILE . 33.1 mt -139.83 110.6 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.558 -0.714 . . . . 0.0 110.269 176.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 118.75 19.94 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.435 ' HA ' HD23 ' A' ' 324' ' ' LEU . 70.8 p -94.87 -9.29 34.74 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -115.65 153.39 31.39 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.662 -1.274 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.74 96.08 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -56.04 -45.99 79.02 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.008 -1.289 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.0 mp -70.38 -41.46 73.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 111.116 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 69.3 mt -64.45 -43.5 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.72 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.414 ' CZ ' HG23 ' A' ' 348' ' ' THR . 5.6 mtt-85 -66.04 -46.49 77.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.536 -0.727 . . . . 0.0 109.787 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -60.1 -41.55 92.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.832 -0.542 . . . . 0.0 111.472 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.6 80.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.459 -0.775 . . . . 0.0 111.381 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 320' ' ' LEU . 3.6 m-85 -73.26 -22.81 60.31 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.356 -0.84 . . . . 0.0 110.738 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -78.53 -38.44 40.58 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.524 0.678 . . . . 0.0 109.965 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -89.97 87.67 7.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.142 0.496 . . . . 0.0 110.526 -178.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.478 ' CD1' ' HD2' ' A' ' 105' ' ' PRO . 27.1 p90 -82.14 -8.06 59.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.673 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.7 mmt-85 -72.01 -31.02 65.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.853 -1.154 . . . . 0.0 109.869 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -99.32 -43.99 6.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -101.41 106.37 17.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -94.0 151.38 19.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.665 0.745 . . . . 0.0 112.959 -176.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.64 ' HB3' ' O ' ' A' ' 101' ' ' THR . 8.2 m -91.99 1.21 57.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.861 -0.524 . . . . 0.0 110.918 178.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -54.29 -39.38 66.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.922 . . . . 0.0 110.08 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.4 t -128.25 82.7 68.0 Favored Pre-proline 0 N--CA 1.525 3.303 0 O-C-N 121.329 -0.857 . . . . 0.0 111.394 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -94.59 -5.01 2.33 Favored 'Trans proline' 0 N--CA 1.536 3.975 0 N-CA-C 122.037 3.822 . . . . 0.0 122.037 -174.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.556 ' O ' HG13 ' A' ' 88' ' ' ILE 0.288 2.6 m-85 -101.78 178.09 4.72 Favored 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 121.188 1.813 . . . . 0.0 106.358 178.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 87' ' ' PHE 0.579 1.3 mt -120.81 13.79 0.07 OUTLIER Pre-proline 1 N--CA 1.552 4.661 1 N-CA-C 124.395 4.961 . . . . 0.0 124.395 -174.456 . . . . . . . . 5 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' A' ' 92' ' ' ALA . 50.0 Cg_endo -92.5 108.92 0.23 Allowed 'Trans proline' 0 N--CA 1.501 1.952 1 N-CA-C 95.984 -6.198 . . . . 0.0 95.984 165.347 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.55 ' C ' ' O ' ' A' ' 89' ' ' PRO . 59.0 ttm-85 -37.49 -27.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 122.773 2.533 . . . . 0.0 113.196 -167.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 89' ' ' PRO . 14.0 pm0 -72.51 -26.39 61.75 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 177.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.717 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . . . -77.38 -34.22 55.01 Favored 'General case' 0 N--CA 1.52 3.053 0 O-C-N 119.361 -2.087 . . . . 0.0 109.725 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.22 -36.58 90.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -72.3 -34.81 68.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.501 -0.999 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.56 -21.02 45.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.392 -0.817 . . . . 0.0 111.136 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.68 123.36 18.65 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.61 39.39 0.64 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.717 ' HB3' ' HB2' ' A' ' 244' ' ' LEU 0.29 6.5 m-30 -62.1 -176.56 0.1 Allowed 'General case' 0 CA--C 1.595 2.679 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 1.068 HD11 ' CZ ' ' A' ' 240' ' ' ARG 0.562 3.4 mt -123.19 10.38 0.06 OUTLIER Pre-proline 1 N--CA 1.575 5.797 3 N-CA-C 125.215 5.265 . . . . 0.0 125.215 -175.434 . . . . . . . . 5 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.949 ' O ' ' O2D' ' A' ' 501' ' ' HEM . 74.3 Cg_endo -119.13 19.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 123.029 2.118 . . . . 0.0 107.286 165.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.64 ' O ' ' HB3' ' A' ' 83' ' ' SER . 3.9 m -135.06 -43.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -173.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.6 p -78.28 13.47 1.5 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 119.517 -1.99 . . . . 0.0 109.438 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 46.0 mtt -116.71 145.67 43.3 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.646 ' O ' ' HD2' ' A' ' 106' ' ' PRO 0.296 50.1 m-20 -93.97 143.63 26.78 Favored Pre-proline 0 N--CA 1.514 2.745 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 104' ' ' ASP 0.366 52.9 Cg_endo -67.88 23.23 0.12 Allowed 'Trans proline' 0 N--CA 1.515 2.789 1 N-CA-C 130.85 7.212 . . . . 0.0 130.85 -160.559 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.646 ' HD2' ' O ' ' A' ' 104' ' ' ASP . 34.8 Cg_endo -78.44 -55.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.328 1 N-CA-C 99.115 -4.994 . . . . 0.0 99.115 168.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.451 ' H ' ' CG ' ' A' ' 106' ' ' PRO 0.342 30.7 tt0 -65.44 -51.45 60.1 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 111.634 -2.53 . . . . 0.0 116.779 173.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -51.7 -38.11 53.72 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.07 -45.22 42.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -178.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -61.39 -23.2 65.63 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.41 -1.431 . . . . 0.0 113.479 -177.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -85.65 -19.18 31.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.615 -1.303 . . . . 0.0 112.286 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -68.42 -32.78 73.05 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.177 -0.952 . . . . 0.0 111.806 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.478 ' HB1' ' HB3' ' B' ' 106' ' ' TRP . . . -66.6 -39.36 88.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.835 . . . . 0.0 110.755 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.739 HD11 ' HA3' ' A' ' 226' ' ' GLY . 7.0 tp -68.53 -39.12 81.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.913 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.566 ' O ' HG22 ' A' ' 119' ' ' VAL . . . -68.88 -31.91 71.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.684 -0.635 . . . . 0.0 109.632 178.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -64.63 -31.9 73.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.712 -0.618 . . . . 0.0 109.75 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.417 ' HB2' ' O ' ' A' ' 114' ' ' LEU . 24.3 mt-30 -62.71 -31.17 72.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.673 -0.642 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.597 ' HA ' HG21 ' A' ' 123' ' ' VAL . 34.9 m -104.23 -18.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.566 HG22 ' O ' ' A' ' 115' ' ' ALA . 27.5 m -132.73 4.94 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 119.963 -1.71 . . . . 0.0 111.523 177.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.493 ' C ' ' HD2' ' A' ' 122' ' ' PRO . . . -82.3 -163.72 33.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.267 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.698 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 0.0 OUTLIER -60.86 -37.11 41.41 Favored Pre-proline 0 N--CA 1.503 2.191 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.676 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.698 ' HD2' ' N ' ' A' ' 121' ' ' MET . 37.0 Cg_endo -61.39 -26.86 81.96 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 122.924 0.96 . . . . 0.0 111.153 -178.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.597 HG21 ' HA ' ' A' ' 118' ' ' VAL . 78.3 t -89.35 -26.26 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.132 177.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.39 -34.12 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -72.75 -35.63 67.52 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 28.0 mtmt -67.71 -35.3 78.54 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.613 177.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.63 2.87 54.33 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -49.63 -50.89 41.27 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.831 -1.168 . . . . 0.0 112.153 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -63.12 -49.7 73.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.167 -0.958 . . . . 0.0 112.361 -178.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.455 ' HA ' ' HD2' ' A' ' 130' ' ' ARG . 45.9 mmm-85 -64.34 -34.59 78.49 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.15 -0.969 . . . . 0.0 111.834 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.04 -42.72 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 0.0 109.262 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.0 -42.05 76.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.982 -0.449 . . . . 0.0 110.195 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.78 -45.05 87.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.759 -0.588 . . . . 0.0 111.544 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 134' ' ' LEU . 39.7 tp -66.92 -39.43 87.37 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.168 -0.957 . . . . 0.0 111.164 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.03 95.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.4 -40.65 81.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.786 -0.571 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -66.04 -47.25 75.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.498 -0.751 . . . . 0.0 111.02 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.12 -42.79 99.58 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.4 -0.813 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.31 -39.34 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.498 -0.751 . . . . 0.0 111.726 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.84 -33.93 77.16 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.986 -1.071 . . . . 0.0 109.824 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -69.44 -31.24 69.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.512 -0.742 . . . . 0.0 110.158 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.41 -29.71 24.17 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.639 -0.663 . . . . 0.0 111.571 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.63 ' HB3' ' HD3' ' A' ' 144' ' ' PRO . 59.2 ttp85 -43.22 -53.38 11.07 Favored Pre-proline 0 N--CA 1.508 2.445 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -175.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 143' ' ' ARG . 43.6 Cg_endo -73.51 -7.13 19.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 122.868 0.931 . . . . 0.0 113.3 -176.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -77.09 -34.81 56.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.088 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.39 7.96 86.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.412 ' O ' ' HB3' ' A' ' 148' ' ' CYS . 5.7 pt20 -171.51 162.6 6.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 147' ' ' GLN . 20.8 p -177.37 151.84 0.8 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.343 -0.848 . . . . 0.0 111.955 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -91.17 85.75 5.98 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.595 ' CZ ' ' HG3' ' A' ' 261' ' ' MET . 41.8 t80 -42.64 -40.78 2.86 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 46.7 p -64.81 -37.68 88.44 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.52 -1.363 . . . . 0.0 111.955 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -95.29 -27.31 15.55 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.388 -0.82 . . . . 0.0 111.603 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.97 -20.42 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.167 -0.958 . . . . 0.0 113.394 -177.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -144.34 -52.13 0.31 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.736 -1.227 . . . . 0.0 112.761 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 151' ' ' THR . . . -51.55 -35.2 39.89 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.339 -0.851 . . . . 0.0 112.855 -177.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 157' ' ' PRO . 61.6 mt-10 -89.56 -54.63 0.31 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.0 112.5 -178.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 156' ' ' GLU . 39.7 Cg_endo -64.33 -36.81 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.155 1.082 . . . . 0.0 114.794 -177.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.799 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 24.5 t80 -61.96 -60.16 11.05 Favored Pre-proline 0 N--CA 1.509 2.502 0 O-C-N 120.409 -1.432 . . . . 0.0 112.594 -177.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.799 ' HD3' ' HB3' ' A' ' 158' ' ' PHE . 45.4 Cg_endo -78.9 -20.62 10.18 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.203 1.107 . . . . 0.0 112.953 -178.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.441 ' O ' ' HG2' ' A' ' 164' ' ' MET . 53.8 mt -83.14 -38.27 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 O-C-N 120.692 -1.255 . . . . 0.0 108.785 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 157' ' ' PRO . 56.6 mtt180 -66.89 -35.98 81.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 162' ' ' ILE . 23.0 mm -67.36 -37.45 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.267 178.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -69.77 -43.46 72.15 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.022 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 160' ' ' ILE . 54.1 mmm -60.56 -33.08 72.17 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 26.8 tp -70.66 -42.58 70.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.578 ' C ' HD23 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -67.3 -30.05 69.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 179.183 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.455 ' N ' HD23 ' A' ' 166' ' ' LEU . . . -96.35 -3.73 43.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.191 -0.943 . . . . 0.0 111.563 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.36 35.35 82.04 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.177 -0.952 . . . . 0.0 110.725 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 89.3 mt -110.12 145.84 32.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.186 -1.185 . . . . 0.0 109.1 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.13 137.1 25.71 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.672 1.354 . . . . 0.0 110.914 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.88 -20.07 55.09 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.35 -13.31 60.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.99 3.34 55.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.834 . . . . 0.0 111.628 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.425 ' N ' ' HD2' ' A' ' 175' ' ' PRO . 33.3 mt -64.89 -44.2 71.31 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.11 -0.994 . . . . 0.0 113.508 -177.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 174' ' ' ILE . 45.1 Cg_endo -72.01 -14.12 29.09 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.828 0.909 . . . . 0.0 111.413 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' HIS . . . . . 0.405 ' O ' ' HG ' ' A' ' 180' ' ' LEU . 60.3 t60 -87.13 -44.68 11.33 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.37 -49.96 50.59 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.652 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -54.14 -30.6 49.61 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.536 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.574 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 85.7 t80 -72.37 -47.56 48.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 176' ' ' HIS . 42.4 mt -59.16 -50.42 74.12 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.45 -0.782 . . . . 0.0 110.485 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.561 ' HA ' ' HE3' ' A' ' 184' ' ' MET . 60.4 p -57.8 -39.31 77.25 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.606 -0.684 . . . . 0.0 111.561 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.59 -27.24 65.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.503 -0.748 . . . . 0.0 111.105 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 40.6 mm-40 -72.86 -19.4 61.3 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.994 -1.066 . . . . 0.0 110.036 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . 0.561 ' HE3' ' HA ' ' A' ' 181' ' ' THR . 63.2 mtm -86.52 -19.67 29.15 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.315 -0.866 . . . . 0.0 110.979 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 55.5 p -111.03 -47.3 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.513 -0.742 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -129.08 75.09 80.71 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.18 131.96 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 O-C-N 123.747 1.393 . . . . 0.0 112.183 -178.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -88.68 -6.06 57.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.726 -0.609 . . . . 0.0 110.511 178.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 113.66 -18.36 19.96 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.88 -1.137 . . . . 0.0 112.578 178.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.2 p -76.98 -25.12 52.39 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.471 1.635 . . . . 0.0 112.496 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 9.0 mtt -135.04 142.04 46.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.866 -1.146 . . . . 0.0 111.642 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.4 p -80.39 171.58 14.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -64.59 -39.3 93.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.645 -1.284 . . . . 0.0 109.469 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.1 97.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.912 -0.493 . . . . 0.0 111.449 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -65.74 -40.63 92.32 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.43 -0.794 . . . . 0.0 110.235 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.21 76.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.681 -0.637 . . . . 0.0 109.927 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -67.37 -41.95 84.21 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.412 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -68.5 -34.22 75.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.421 -0.8 . . . . 0.0 109.924 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.67 79.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 108.974 178.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.421 HD22 ' HE1' ' A' ' 184' ' ' MET . 11.2 tp -69.19 -37.52 78.17 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.56 -40.06 84.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.08 -35.12 70.94 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -74.54 -35.22 63.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.895 -0.503 . . . . 0.0 110.666 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 67.8 mt -84.14 -30.09 26.18 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.7 mt -50.78 -56.12 21.78 Favored Pre-proline 0 N--CA 1.51 2.531 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -175.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 -25.27 33.99 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.53 0.753 . . . . 0.0 111.854 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.79 -33.19 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.138 -0.976 . . . . 0.0 109.712 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 13.6 mt -72.23 -36.77 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -70.15 -38.31 75.45 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -65.71 -42.13 91.48 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.49 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -76.53 -13.39 60.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.863 -0.523 . . . . 0.0 111.348 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.453 ' HG3' ' HB1' ' A' ' 224' ' ' ALA . 5.8 mtp85 -84.69 -26.38 27.77 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -82.23 -47.49 12.38 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -118.9 87.97 34.81 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -75.32 128.08 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.042 1.022 . . . . 0.0 111.67 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.08 -138.38 7.67 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 119.761 -1.209 . . . . 0.0 112.681 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 47.3 p -110.65 -9.96 14.51 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.579 -0.953 . . . . 0.0 112.939 -177.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -70.47 167.02 19.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 112.29 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.95 88.54 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 220' ' ' ILE . 62.2 mt -67.34 -33.21 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.927 -1.108 . . . . 0.0 109.977 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.5 m -68.11 -43.95 77.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 108.88 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 44.9 mm -64.75 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.869 -0.519 . . . . 0.0 111.135 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 42.0 t -71.81 -45.67 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.922 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.453 ' HB1' ' HG3' ' A' ' 212' ' ' ARG . . . -63.34 -30.6 71.71 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.6 . . . . 0.0 111.415 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -106.77 11.4 30.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.349 -0.844 . . . . 0.0 110.779 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.739 ' HA3' HD11 ' A' ' 114' ' ' LEU . . . -80.13 170.53 53.79 Favored Glycine 0 N--CA 1.499 2.839 0 CA-C-O 122.238 0.91 . . . . 0.0 112.606 -177.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -122.77 146.22 47.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.834 -0.803 . . . . 0.0 109.208 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 4.3 m -118.47 106.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.021 0.915 . . . . 0.0 109.422 178.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.9 42.41 10.33 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.68 70.77 Favored Glycine 0 N--CA 1.503 3.128 0 O-C-N 121.366 -0.834 . . . . 0.0 114.777 175.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -121.7 155.33 60.09 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-N 120.569 2.184 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -77.7 131.27 11.2 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.82 1.431 . . . . 0.0 113.577 -176.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 13.5 tt -63.92 149.33 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.676 0.751 . . . . 0.0 112.182 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 32.9 p -86.61 161.26 18.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.861 -0.524 . . . . 0.0 109.992 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.4 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.0 110.018 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.94 -45.61 81.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.797 -0.564 . . . . 0.0 110.317 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.3 -41.31 96.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.596 -0.69 . . . . 0.0 109.962 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.14 97.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 109.924 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -64.86 -42.77 94.6 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.122 0.487 . . . . 0.0 110.185 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 1.068 ' CZ ' HD11 ' A' ' 99' ' ' ILE . 69.1 mtp180 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.76 -0.587 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 41.0 ttm -82.3 -43.07 17.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 23.5 m -61.46 -36.81 81.47 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.654 -0.654 . . . . 0.0 110.03 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.76 -42.72 99.55 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 178.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.717 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . 45.9 tp -66.16 -39.46 89.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.704 -0.88 . . . . 0.0 110.511 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.55 -38.37 90.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 246' ' ' LEU . 6.1 mt -63.29 -44.3 95.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.82 -42.8 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.89 -34.1 87.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -82.65 -22.07 58.82 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 121.202 -1.176 . . . . 0.0 111.464 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.4 mp -107.03 -10.75 15.83 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.873 1.337 . . . . 0.0 113.756 -177.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -141.72 40.09 1.69 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 119.992 -1.693 . . . . 0.0 114.716 -177.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 41.5 p -129.01 -71.77 0.62 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.663 -1.273 . . . . 0.0 109.193 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.28 -33.53 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.487 HG22 ' HG2' ' A' ' 159' ' ' PRO . 51.1 t -52.63 -44.17 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.808 -0.557 . . . . 0.0 110.073 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.36 -42.74 29.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.584 -0.698 . . . . 0.0 111.535 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.37 -38.39 86.84 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.193 -0.942 . . . . 0.0 111.843 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 257' ' ' LEU . 29.8 mt -57.29 -37.89 73.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.307 -0.871 . . . . 0.0 110.406 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.3 m -70.12 -40.78 74.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.684 -0.635 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -61.63 -41.71 97.88 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.029 -1.044 . . . . 0.0 109.037 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 45.8 m -68.11 -47.99 66.67 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.361 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' MET . . . . . 0.595 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 78.4 mmm -67.64 -32.1 72.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -64.57 -39.8 94.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.324 -0.86 . . . . 0.0 108.747 177.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -67.57 -48.81 65.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.79 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 264' ' ' LEU . 28.2 mt -59.32 -39.43 83.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.412 -0.805 . . . . 0.0 110.058 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -64.06 -30.44 71.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.632 -0.667 . . . . 0.0 110.483 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -94.27 0.65 55.77 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.749 -0.594 . . . . 0.0 111.9 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.3 t -139.42 95.06 9.25 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 0.0 109.759 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.12 -11.94 23.34 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.936 1.493 . . . . 0.0 112.031 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -78.33 -34.56 48.46 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -73.11 -34.67 66.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -63.54 -41.84 98.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.6 -40.71 96.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.072 -0.392 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.13 -39.98 84.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.72 -30.3 36.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.998 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.1 -39.62 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.359 -0.838 . . . . 0.0 109.202 178.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -71.4 -38.61 71.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.839 -0.538 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -133.29 83.71 49.47 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.703 -0.623 . . . . 0.0 110.118 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.92 -21.43 72.28 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.803 1.669 . . . . 0.0 112.784 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 13.2 pm0 -73.7 -1.21 18.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.803 -1.186 . . . . 0.0 110.898 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -94.93 -3.05 49.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.321 -0.862 . . . . 0.0 109.962 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.437 ' N ' ' HD2' ' A' ' 282' ' ' PRO . 19.1 mt -60.78 -40.56 76.06 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 281' ' ' ILE . 45.2 Cg_endo -73.99 -17.35 22.37 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 122.73 0.858 . . . . 0.0 110.211 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.59 -35.28 22.85 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.09 -36.91 80.56 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.658 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' CYS . . . . . . . . . . . . . 6.1 t -60.54 -39.91 89.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.879 -0.513 . . . . 0.0 109.941 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -68.14 -41.13 82.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.788 -0.57 . . . . 0.0 109.919 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -67.09 -33.93 76.55 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.678 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 288' ' ' LEU . 73.2 mt -72.0 -35.34 69.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 17.8 mt -63.15 -29.34 70.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -79.82 -53.42 6.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.544 -0.723 . . . . 0.0 110.604 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 47.8 tpt85 -65.34 -41.29 94.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.664 . . . . 0.0 111.342 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -105.34 37.08 2.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 111.955 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 8.7 t -56.01 155.17 6.62 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.706 HD23 ' H ' ' A' ' 294' ' ' LEU . 2.7 pt? -149.24 21.05 0.96 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.206 -1.397 . . . . 0.0 114.282 -176.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.502 HG11 HMA3 ' A' ' 501' ' ' HEM . 98.8 t -115.87 147.12 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.056 -1.652 . . . . 0.0 110.088 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 321' ' ' PRO . . . -158.39 85.35 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 112.287 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . 0.513 ' OD2' ' O2A' ' A' ' 501' ' ' HEM . 14.3 p-10 -113.4 -156.42 0.59 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . 0.419 ' C ' ' HG2' ' A' ' 299' ' ' ARG . . . -170.87 -152.5 8.22 Favored Glycine 0 N--CA 1.499 2.87 0 C-N-CA 117.628 -2.225 . . . . 0.0 113.372 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . 0.419 ' HG2' ' C ' ' A' ' 298' ' ' GLY . 67.0 mmt-85 -141.54 177.05 8.4 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.441 0.638 . . . . 0.0 110.737 -178.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.3 140.48 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.459 ' HA ' HD13 ' A' ' 301' ' ' LEU . 4.1 mm? -66.06 129.9 41.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 64.0 p -82.58 -16.54 48.1 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.555 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 314' ' ' LYS . 31.1 p -166.08 168.33 15.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.18 140.74 52.39 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -163.33 128.92 3.13 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.03 -1.044 . . . . 0.0 111.838 -176.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.38 120.1 25.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 44.6 t80 -124.66 108.48 12.07 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.174 0.511 . . . . 0.0 109.828 -178.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' HIS . . . . . 0.425 ' HB2' ' O ' ' A' ' 307' ' ' PHE . 36.9 m-70 61.89 42.29 10.52 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.071 0.463 . . . . 0.0 111.914 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.14 87.77 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.529 -0.732 . . . . 0.0 112.675 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.02 136.28 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 119.781 1.791 . . . . 0.0 110.736 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.58 115.45 23.28 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.321 0.581 . . . . 0.0 111.15 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 43.9 mt -97.7 149.0 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -111.87 143.71 42.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.631 -0.668 . . . . 0.0 110.751 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 303' ' ' SER . 78.2 tttt -51.53 126.33 17.09 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.258 0.552 . . . . 0.0 110.492 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 102.45 -15.91 55.59 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.91 139.29 58.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -1.036 . . . . 0.0 111.158 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -97.12 133.75 41.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 318' ' ' ILE . 13.7 tt -125.65 119.19 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 122.073 0.94 . . . . 0.0 110.085 178.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . 0.647 ' O ' ' HD3' ' A' ' 321' ' ' PRO . 31.6 tp -79.47 112.56 16.84 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 20.5 mt -104.58 90.94 3.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . 0.68 ' HG2' HD22 ' A' ' 324' ' ' LEU . 43.5 Cg_endo -78.05 110.74 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.417 1.219 . . . . 0.0 112.447 -175.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -54.25 -26.76 30.68 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.603 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.8 ttm -70.33 -22.75 62.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 0.0 112.219 -178.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.68 HD22 ' HG2' ' A' ' 321' ' ' PRO . 7.0 mp -80.02 -30.98 39.63 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 13.7 m -59.3 -48.49 81.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.922 -1.111 . . . . 0.0 111.677 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -69.09 -29.23 72.32 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.113 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 327' ' ' LEU . 35.9 mt -82.02 -7.7 59.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.236 . . . . 0.0 111.473 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.03 126.71 30.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.301 -0.875 . . . . 0.0 110.549 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.522 ' HG3' ' HD3' ' A' ' 335' ' ' PRO . 5.6 tt0 -64.94 -28.15 69.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.51 -18.24 64.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.307 -0.871 . . . . 0.0 109.763 178.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -100.14 -35.04 9.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.709 -0.619 . . . . 0.0 110.404 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -141.54 124.32 16.07 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.05 55.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.118 -0.989 . . . . 0.0 109.084 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 85.4 m 47.45 59.57 16.36 Favored Pre-proline 0 N--CA 1.507 2.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' PRO . . . . . 0.522 ' HD3' ' HG3' ' A' ' 329' ' ' GLU . 40.1 Cg_endo -62.83 -32.05 77.71 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.213 1.942 . . . . 0.0 114.2 -176.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 58.9 mmm -79.45 -10.96 59.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.722 -1.236 . . . . 0.0 111.572 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -88.28 135.05 33.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.933 -1.104 . . . . 0.0 109.847 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.23 116.32 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.206 -0.934 . . . . 0.0 110.541 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -124.85 104.67 8.74 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -60.51 -21.11 62.09 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.449 -0.782 . . . . 0.0 110.852 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 68.2 m -95.95 9.19 41.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' ARG . . . . . 0.4 ' HB3' HG22 ' A' ' 345' ' ' VAL . 43.4 ttm-85 -49.62 119.2 3.26 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . 0.482 ' CB ' ' HD3' ' A' ' 344' ' ' LYS . 0.1 OUTLIER -58.91 -53.54 57.26 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.513 -0.742 . . . . 0.0 112.119 -178.236 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' LYS . . . . . 0.503 ' HB2' ' HE2' ' A' ' 344' ' ' LYS . 1.7 mppt? -111.88 93.71 4.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.688 -1.258 . . . . 0.0 110.948 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.4 HG22 ' HB3' ' A' ' 342' ' ' ARG . 60.0 t -86.44 92.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 13.2 t -95.81 133.46 39.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.868 -0.52 . . . . 0.0 110.928 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -168.01 163.95 13.65 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.868 0.842 . . . . 0.0 111.271 178.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' THR . . . . . 0.414 HG23 ' CZ ' ' A' ' 72' ' ' ARG . 16.5 p -122.17 26.25 8.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' THR . . . . . . . . . . . . . 52.2 m -47.44 -43.36 23.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 111.758 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -87.76 14.79 7.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.948 . . . . 0.0 111.572 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 100.03 -173.09 25.14 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -161.77 144.11 11.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.896 -0.767 . . . . 0.0 109.0 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.3 -146.03 18.01 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' SER . . . . . 0.592 ' HA ' ' HB3' ' B' ' 44' ' ' SER . 95.3 p -83.06 -10.89 58.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.539 -0.977 . . . . 0.0 112.181 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -98.52 26.16 5.77 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.843 -1.161 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.01 139.14 23.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.0 110.122 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 43.1 t -50.44 127.02 16.57 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.484 0.659 . . . . 0.0 112.332 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . 1.114 ' CD1' HBD2 ' A' ' 501' ' ' HEM . 4.9 mp -85.33 -18.84 32.62 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -103.34 23.06 34.29 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 120.267 -0.968 . . . . 0.0 110.816 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -72.14 -23.2 61.26 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.787 -1.419 . . . . 0.0 110.71 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -74.95 -39.67 61.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.05 -1.031 . . . . 0.0 108.853 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 54.0 tp -69.15 -33.55 73.59 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.56 -49.49 53.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 122.033 -0.417 . . . . 0.0 110.1 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 38.2 mtt85 -58.85 -40.86 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.464 -0.772 . . . . 0.0 110.487 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 14.3 tpp85 -64.13 -44.05 93.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.913 -0.492 . . . . 0.0 110.186 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -66.92 -35.4 79.9 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.417 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 86.8 mt -71.16 -50.0 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 109.957 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.68 -40.9 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 110.898 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 31.2 t -66.61 -35.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.987 -1.07 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.2 m -68.37 -47.73 66.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.47 -0.769 . . . . 0.0 109.979 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.1 -44.09 96.66 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.462 -0.774 . . . . 0.0 111.278 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -68.04 -48.14 66.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 111.598 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -73.75 -26.53 60.71 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.131 -0.981 . . . . 0.0 112.304 -178.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -76.2 -46.51 28.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.717 -1.239 . . . . 0.0 109.467 179.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.27 -24.46 65.79 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.1 m -72.56 -36.64 68.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.323 -0.861 . . . . 0.0 109.855 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -95.19 -44.26 7.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.82 80.23 32.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.962 -0.461 . . . . 0.0 109.8 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.94 -30.9 32.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.883 1.465 . . . . 0.0 112.634 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -120.66 123.43 42.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.024 -1.048 . . . . 0.0 111.523 -178.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -154.39 155.61 35.34 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 39.8 m -140.73 170.96 14.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.623 -0.673 . . . . 0.0 111.215 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.59 139.47 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -51.71 139.91 29.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.249 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.15 124.99 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.615 1.324 . . . . 0.0 112.968 -177.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 93.7 -11.22 71.56 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.461 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -81.09 134.29 35.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.101 -1.234 . . . . 0.0 113.233 -177.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -111.2 107.23 16.49 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.84 131.04 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 121.858 0.837 . . . . 0.0 112.05 -177.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.606 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -106.05 168.86 8.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.816 -0.553 . . . . 0.0 110.691 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -132.77 146.11 51.57 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.9 t -112.73 162.97 15.13 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.816 0.817 . . . . 0.0 112.494 -177.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.85 -158.92 30.89 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 39.3 mm -55.74 -40.03 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.018 -1.284 . . . . 0.0 107.844 178.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.3 t -126.29 121.58 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.7 m -79.61 164.46 23.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.109 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -159.98 -173.82 28.97 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.165 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.8 t -116.35 129.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.917 -0.755 . . . . 0.0 109.42 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.67 -43.36 93.81 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.035 -1.04 . . . . 0.0 111.452 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -159.52 148.55 18.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.307 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 52.6 tp -140.96 82.67 14.85 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.353 -0.842 . . . . 0.0 111.012 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -74.59 119.9 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.769 1.405 . . . . 0.0 110.932 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 71.6 mt -114.12 153.95 28.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.679 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.32 149.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.481 0.658 . . . . 0.0 109.704 177.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.73 156.08 24.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.524 -0.735 . . . . 0.0 109.347 178.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -82.94 121.57 77.49 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.91 3.71 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.43 1.226 . . . . 0.0 110.753 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -87.69 -18.21 30.04 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 46.2 p -95.63 -1.3 50.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.078 -0.389 . . . . 0.0 110.711 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 28.7 p -94.09 172.23 8.35 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.974 -1.079 . . . . 0.0 110.09 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 412' ' ' LYS . 3.6 pttm -150.54 130.95 13.76 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.222 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -79.4 136.09 36.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.712 . . . . 0.0 109.638 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 179.99 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 40.3 m . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 121.079 0.466 . . . . 0.0 109.757 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.51 138.61 38.51 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.169 -0.957 . . . . 0.0 112.928 -178.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.727 HG11 HD22 ' B' ' 23' ' ' LEU . 61.2 t -137.17 122.57 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 177.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.53 HG11 ' CZ ' ' B' ' 12' ' ' ARG . 98.4 t -106.81 129.61 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.159 -0.963 . . . . 0.0 111.62 -178.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.683 ' CG ' HD13 ' B' ' 32' ' ' ILE . 77.3 m-85 -109.22 110.6 21.84 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.83 127.22 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 120.96 -1.087 . . . . 0.0 108.353 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.4 m -86.17 174.67 8.97 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.772 0.796 . . . . 0.0 112.503 -177.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.419 ' CB ' ' HB3' ' B' ' 103' ' ' ASP . 61.6 t-80 -60.7 -46.7 89.38 Favored 'General case' 0 N--CA 1.503 2.179 0 CA-C-O 121.142 0.496 . . . . 0.0 110.436 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -65.92 -11.28 46.08 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.575 -0.703 . . . . 0.0 111.387 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.96 15.48 28.45 Favored Glycine 0 N--CA 1.491 2.335 0 O-C-N 121.074 -1.016 . . . . 0.0 111.269 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.0 m -82.07 147.4 29.13 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 118.713 1.257 . . . . 0.0 109.926 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . 0.53 ' CZ ' HG11 ' B' ' 4' ' ' VAL . 50.9 ttt85 -118.49 128.8 54.93 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.428 -0.795 . . . . 0.0 111.83 -178.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.05 127.67 46.2 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.596 -0.69 . . . . 0.0 109.803 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -111.37 130.64 55.62 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.287 -0.883 . . . . 0.0 111.589 -178.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 84.6 mt -122.79 159.36 28.24 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.753 -0.592 . . . . 0.0 111.118 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -109.61 91.62 3.72 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 176.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 38.5 t -90.15 133.4 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-O 121.575 0.702 . . . . 0.0 112.303 -176.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.08 170.66 16.12 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.768 -0.582 . . . . 0.0 110.295 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -68.44 151.82 46.29 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.477 -0.764 . . . . 0.0 111.005 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.47 -12.53 55.39 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.03 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 61.1 t -89.99 133.34 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.655 -1.497 . . . . 0.0 110.928 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 97.7 p -80.29 151.88 29.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.513 -0.742 . . . . 0.0 109.127 178.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.727 HD22 HG11 ' B' ' 3' ' ' VAL . 18.5 mt -61.16 -24.63 66.43 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.312 -0.868 . . . . 0.0 110.631 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . 0.459 ' SD ' ' S2 ' ' B' ' 201' ' ' FES . 2.7 ttp -69.75 -49.2 55.41 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.217 -0.927 . . . . 0.0 109.514 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.79 -41.75 91.86 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.591 -0.693 . . . . 0.0 109.941 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.06 -40.89 95.37 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.574 -0.704 . . . . 0.0 110.137 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . 0.718 ' HA ' HD12 ' B' ' 32' ' ' ILE . . . -68.3 -49.77 58.2 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.203 -0.935 . . . . 0.0 111.071 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 77.4 t -65.48 -39.15 84.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.305 -0.872 . . . . 0.0 110.723 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 26.0 m -70.14 -14.0 62.45 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.394 -0.816 . . . . 0.0 111.547 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -118.17 23.78 11.39 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.033 -1.042 . . . . 0.0 110.623 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.74 38.27 58.86 Favored Glycine 0 N--CA 1.493 2.459 0 O-C-N 121.566 -0.709 . . . . 0.0 111.81 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.718 HD12 ' HA ' ' B' ' 27' ' ' ALA . 1.7 mt -72.53 147.12 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.914 -1.345 . . . . 0.0 108.878 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.67 142.51 58.05 Favored 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 117.203 2.297 . . . . 0.0 117.203 -174.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . 0.458 ' O ' ' HG3' ' B' ' 105' ' ' GLN . 65.3 m-20 62.19 -36.14 0.12 Allowed 'General case' 0 N--CA 1.515 2.81 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 175.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 84.4 mt -59.69 122.85 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 O-C-N 119.864 -1.772 . . . . 0.0 110.701 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.634 ' HB ' ' HB ' ' B' ' 47' ' ' THR . 2.4 t -100.09 -51.35 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.577 -0.702 . . . . 0.0 111.241 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . 0.629 ' HA2' ' S2 ' ' B' ' 201' ' ' FES . . . 63.1 56.49 20.24 Favored Glycine 0 N--CA 1.5 2.908 0 N-CA-C 107.447 -2.261 . . . . 0.0 107.447 -178.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . 0.419 ' N ' HG12 ' B' ' 36' ' ' VAL . 29.7 t0 -71.34 -49.24 44.44 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.991 -0.711 . . . . 0.0 112.262 -177.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' CYS . . . . . 0.555 ' HB3' ' HB3' ' B' ' 45' ' ' CYS . 2.3 p -66.55 -10.46 45.37 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.22 -0.925 . . . . 0.0 112.394 -178.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.77 -5.48 64.13 Favored Glycine 0 N--CA 1.499 2.836 0 O-C-N 120.806 -1.184 . . . . 0.0 111.981 177.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.14 19.51 10.64 Favored Glycine 0 N--CA 1.494 2.558 0 O-C-N 120.842 -1.387 . . . . 0.0 110.978 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 30.7 p -98.99 19.16 15.61 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.037 -1.273 . . . . 0.0 111.115 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . 56.04 40.83 30.24 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.391 -0.818 . . . . 0.0 111.93 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . 0.592 ' HB3' ' HA ' ' A' ' 354' ' ' SER . 5.7 m -117.05 11.21 14.18 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.318 -0.864 . . . . 0.0 109.557 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' CYS . . . . . 0.7 ' HG ' 'FE1 ' ' B' ' 201' ' ' FES . 15.1 p -149.56 -179.1 6.83 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.04 34.07 3.11 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.884 -1.135 . . . . 0.0 111.356 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' THR . . . . . 0.634 ' HB ' ' HB ' ' B' ' 36' ' ' VAL . 37.2 p -97.52 13.2 30.79 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.964 -1.085 . . . . 0.0 111.314 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' CYS . . . . . 0.415 ' SG ' ' HB3' ' B' ' 84' ' ' LEU . 29.1 p -120.57 31.77 6.3 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 23.8 t-160 -72.7 133.03 44.41 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.609 -178.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.3 m -146.29 160.07 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . 0.417 ' HB2' ' HB2' ' B' ' 100' ' ' ASP . 48.5 m-85 -105.42 102.76 12.21 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.3 -0.875 . . . . 0.0 108.681 178.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 93.2 t -61.98 135.12 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 121.315 -0.865 . . . . 0.0 109.349 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.65 131.81 51.36 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.944 0.878 . . . . 0.0 109.559 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.408 ' H ' ' CD ' ' B' ' 54' ' ' GLU . 11.0 mp0 -44.34 -30.98 0.91 Allowed 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.84 -6.9 54.25 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.984 -1.073 . . . . 0.0 112.712 -178.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -119.95 -6.67 10.02 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 120.503 -1.373 . . . . 0.0 111.871 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 40.5 p -55.37 -37.85 68.06 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.154 -0.967 . . . . 0.0 112.892 -178.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -81.1 -6.65 59.06 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.787 -1.196 . . . . 0.0 111.46 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -89.93 -11.6 41.28 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.078 -1.014 . . . . 0.0 109.831 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.8 t -104.07 141.05 21.71 Favored Pre-proline 0 N--CA 1.488 1.467 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -73.8 118.92 5.64 Favored 'Trans proline' 0 N--CA 1.489 1.209 0 O-C-N 123.514 1.271 . . . . 0.0 108.986 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -36.99 160.66 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.761 0 N-CA-C 116.647 2.092 . . . . 0.0 116.647 -177.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.612 ' HB1' ' HB3' ' B' ' 67' ' ' GLU . . . -65.77 146.15 55.12 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 114.572 -1.194 . . . . 0.0 111.247 178.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -89.78 -170.79 2.94 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.565 -0.709 . . . . 0.0 110.392 178.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -59.53 -42.05 91.38 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.343 -0.848 . . . . 0.0 111.686 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 5.0 ttt180 -67.39 -41.57 84.76 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.175 -0.953 . . . . 0.0 112.028 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.612 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 45.4 tt0 -68.23 -43.91 76.88 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.01 -1.056 . . . . 0.0 110.349 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . 0.526 ' O ' ' HG3' ' B' ' 72' ' ' GLU . 20.6 mm -55.56 -42.18 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 O-C-N 121.287 -0.883 . . . . 0.0 109.372 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.22 -47.84 80.83 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 9.5 mmt -66.18 -33.99 77.01 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.27 -1.135 . . . . 0.0 111.207 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . 0.441 ' HA ' HD23 ' B' ' 71' ' ' LEU . 28.1 mt -63.45 -23.35 67.36 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.214 -0.929 . . . . 0.0 110.608 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . 0.526 ' HG3' ' O ' ' B' ' 68' ' ' ILE . 49.9 mt-10 -70.41 -8.79 53.54 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.344 -0.848 . . . . 0.0 110.889 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 82.8 p -119.78 12.54 12.18 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.001 -1.062 . . . . 0.0 112.543 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 28.8 m -60.8 140.46 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 O-C-N 120.761 -1.212 . . . . 0.0 109.627 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 44.8 m -74.58 -39.07 62.45 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.406 -0.809 . . . . 0.0 110.174 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.2 168.82 17.43 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.476 -0.765 . . . . 0.0 110.076 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.27 139.15 55.64 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.451 -0.781 . . . . 0.0 110.615 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 24.4 tp -91.0 116.19 28.6 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.551 -0.718 . . . . 0.0 109.836 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -103.02 168.33 8.95 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -76.62 -0.03 10.04 Favored 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 123.27 1.142 . . . . 0.0 110.43 178.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -120.43 22.35 11.32 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.963 -1.086 . . . . 0.0 108.419 176.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 4.3 m -80.77 137.17 36.24 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.833 -0.542 . . . . 0.0 110.385 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 26.5 mmm-85 -149.75 146.39 27.17 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.443 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.592 HD12 ' HG3' ' B' ' 67' ' ' GLU . 95.0 mt -80.57 98.99 7.87 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 175.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' CYS . . . . . 0.402 ' HB2' ' HB2' ' B' ' 23' ' ' LEU . 10.6 p -48.43 -17.91 0.19 Allowed 'General case' 0 N--CA 1.508 2.439 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -175.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' CYS . . . . . . . . . . . . . 16.8 p -70.3 -13.92 62.37 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.646 -1.284 . . . . 0.0 109.453 178.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -92.72 -12.3 31.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.465 -0.772 . . . . 0.0 110.533 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . 0.402 HG21 HD13 ' B' ' 88' ' ' ILE . 61.8 mt -91.46 103.96 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.117 -0.99 . . . . 0.0 110.671 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 47.3 mm -84.99 131.8 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 13.6 tpt -74.85 137.77 42.05 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 122.143 0.973 . . . . 0.0 113.244 -177.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 43.8 p -138.2 166.59 24.73 Favored Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 176.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -74.94 1.65 7.46 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 122.689 0.836 . . . . 0.0 110.996 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -87.58 -22.84 24.55 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 176.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 44.6 mt -93.77 12.95 23.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 122.035 -0.416 . . . . 0.0 110.389 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.45 126.38 23.24 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.128 -0.983 . . . . 0.0 111.177 -178.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.19 6.83 68.48 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.68 179.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.62 142.75 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-N 119.334 1.567 . . . . 0.0 110.81 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' VAL . . . . . 0.461 HG22 ' HB ' ' B' ' 4' ' ' VAL . 60.6 t -122.47 133.02 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.559 -0.713 . . . . 0.0 109.829 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 16.4 m -130.41 135.74 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.456 -0.778 . . . . 0.0 109.788 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' ASP . . . . . 0.417 ' HB2' ' HB2' ' B' ' 51' ' ' TYR . 6.3 m-20 -92.38 134.16 35.19 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 94.2 t -103.4 127.31 29.91 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.505 -0.747 . . . . 0.0 110.359 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -80.87 130.96 7.79 Favored 'Trans proline' 0 C--N 1.316 -1.163 0 O-C-N 124.101 1.579 . . . . 0.0 108.277 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' ASP . . . . . 0.419 ' HB3' ' CB ' ' B' ' 8' ' ' HIS . 5.3 p-10 -62.37 3.41 0.19 Allowed 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -178.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -125.29 114.58 19.12 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.277 -1.514 . . . . 0.0 110.089 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . 0.513 ' HB3' ' HA ' ' B' ' 47' ' ' THR . 23.9 mm-40 -113.25 -49.41 2.91 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.455 -0.778 . . . . 0.0 110.029 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' TRP . . . . . 0.478 ' HB3' ' HB1' ' A' ' 113' ' ' ALA . 17.0 m0 . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 118.249 -0.882 . . . . 0.0 110.547 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 501' ' ' HEM . . . . . 1.114 HBD2 ' CD1' ' A' ' 358' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 502' ' ' CAM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 201' ' ' FES . . . . . 0.7 'FE1 ' ' HG ' ' B' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_